1	Articles	NNPS	O	Articles	_	0	SENT_1	[p1l101t138r251b174],

1	1	CD	NUMBER	1	_	0	SENT_2	[p1l256t328r314b408],
2	"	``	O	"	punct	8	SENT_2	[p1l256t328r314b408],
3	Effect	NN	O	effect	dep	8	SENT_2	[p1l358t328r527b383],
4	of	IN	O	of	_	0	SENT_2	[p1l543t328r607b383],
5	[	CD	NUMBER	[	prep_of	3	SENT_2	[p1l624t328r1023b400],
6	32-adrenergic	JJ	O	32-adrenergic	amod	8	SENT_2	[p1l624t328r1023b400],
7	receptor	NN	O	receptor	nn	8	SENT_2	[p1l1043t338r1292b399],
8	polymorphism	NN	O	polymorphism	dep	1	SENT_2	[p1l1308t328r1749b399],
9	on	IN	O	on	dep	1	SENT_2	[p1l1768t346r1842b383],
10	response	NN	O	response	pobj	9	SENT_2	[p1l358t437r621b490],
11	to	TO	O	to	_	0	SENT_2	[p1l635t429r700b474],
12	longacting	VBG	O	longact	prepc_to	10	SENT_2	[p1l720t420r1040b491],
13	[	CD	NUMBER	[	number	14	SENT_2	[p1l1062t419r1115b490],
14	3	CD	NUMBER	3	dobj	12	SENT_2	[p1l1062t419r1115b490],
15	,	,	O	,	_	0	SENT_2	[p1l1062t419r1115b490],
16	agonist	NN	O	agonist	appos	14	SENT_2	[p1l1133t422r1359b491],
17	in	IN	O	in	_	0	SENT_2	[p1l1379t422r1430b473],
18	asthma	NN	O	asthma	nn	21	SENT_2	[p1l1449t420r1674b474],
19	(	CD	NUMBER	(	num	21	SENT_2	[p1l1693t422r1912b488],
20	LARGE	NN	O	large	nn	21	SENT_2	[p1l1693t422r1912b488],
21	trial	NN	O	trial	prep_in	16	SENT_2	[p1l1926t420r2089b488],
22	)	CD	NUMBER	)	dep	12	SENT_2	[p1l1926t420r2089b488],
23	:	:	O	:	_	0	SENT_2	[p1l1926t420r2089b488],
24	a	DT	O	a	det	32	SENT_2	[p1l355t528r387b565],
25	genotype-stratiﬁed	JJ	O	genotype-stratiﬁed	amod	32	SENT_2	[p1l404t510r1013b582],
26	,	,	O	,	_	0	SENT_2	[p1l404t510r1013b582],
27	randomised	JJ	O	randomised	amod	32	SENT_2	[p1l1035t510r1407b574],
28	,	,	O	,	_	0	SENT_2	[p1l1035t510r1407b574],
29	placebo-controlled	JJ	O	placebo-controlled	amod	32	SENT_2	[p1l1426t510r2010b581],
30	,	,	O	,	_	0	SENT_2	[p1l1426t510r2010b581],
31	crossover	JJ	O	crossover	amod	32	SENT_2	[p1l356t619r639b655],
32	trial	NN	O	trial	dep	22	SENT_2	[p1l651t601r771b655],

1	Michael	NNP	PERSON	Michael	dep	114	SENT_3	[p1l328t720r427b746],
2	E	NNP	PERSON	E	dep	114	SENT_3	[p1l435t723r449b746],
3	Wechsler	NNP	PERSON	Wechsler	dep	114	SENT_3	[p1l455t720r571b750],
4	,	,	O	,	_	0	SENT_3	[p1l455t720r571b750],
5	Susan	NNP	PERSON	Susan	dep	114	SENT_3	[p1l579t722r655b746],
6	J	NNP	PERSON	J	dep	114	SENT_3	[p1l659t722r670b752],
7	Kunselman	NNP	PERSON	Kunselman	dep	114	SENT_3	[p1l678t720r825b750],
8	,	,	O	,	_	0	SENT_3	[p1l678t720r825b750],
9	Vernon	NNP	PERSON	Vernon	dep	114	SENT_3	[p1l833t722r921b746],
10	M	NNP	PERSON	M	dep	114	SENT_3	[p1l929t722r953b746],
11	Chinchilli	NNP	PERSON	Chinchilli	dep	114	SENT_3	[p1l962t720r1083b750],
12	,	,	O	,	_	0	SENT_3	[p1l962t720r1083b750],
13	Eugene	NNP	PERSON	Eugene	dep	114	SENT_3	[p1l1093t723r1183b754],
14	Bleecker	NNP	PERSON	Bleecker	dep	114	SENT_3	[p1l1191t720r1297b750],
15	,	,	O	,	_	0	SENT_3	[p1l1191t720r1297b750],
16	HomerA	NNP	PERSON	HomerA	dep	114	SENT_3	[p1l1306t722r1415b746],
17	Boushey	NNP	PERSON	Boushey	dep	114	SENT_3	[p1l1423t720r1535b754],
18	,	,	O	,	_	0	SENT_3	[p1l1423t720r1535b754],
19	William	NNP	PERSON	William	dep	114	SENT_3	[p1l1543t720r1638b746],
20	}	NNP	PERSON	}	dep	114	SENT_3	[p1l1643t722r1653b752],
21	Calhoun	NNP	PERSON	Calhoun	dep	114	SENT_3	[p1l1661t720r1772b750],
22	,	,	O	,	_	0	SENT_3	[p1l1661t720r1772b750],
23	Bill	NNP	PERSON	Bill	dep	114	SENT_3	[p1l1782t720r1819b746],
24	TAmeredes	NNPS	PERSON	TAmeredes	dep	114	SENT_3	[p1l1826t720r1977b750],
25	,	,	O	,	_	0	SENT_3	[p1l1826t720r1977b750],
26	Mario	NNP	PERSON	Mario	dep	114	SENT_3	[p1l1986t722r2060b746],
27	Castro	NNP	PERSON	Castro	dep	114	SENT_3	[p1l2068t722r2154b750],
28	,	,	O	,	_	0	SENT_3	[p1l2068t722r2154b750],
29	Timothy	NNP	PERSON	Timothy	dep	114	SENT_3	[p1l328t765r449b799],
30	}	NNP	PERSON	}	dep	114	SENT_3	[p1l328t765r449b799],
31	Craig	NNP	PERSON	Craig	dep	114	SENT_3	[p1l457t767r527b799],
32	,	,	O	,	_	0	SENT_3	[p1l457t767r527b799],
33	Loren	NNP	PERSON	Loren	dep	114	SENT_3	[p1l537t767r604b791],
34	Denlinger	NNP	PERSON	Denlinger	dep	114	SENT_3	[p1l613t765r737b799],
35	,	,	O	,	_	0	SENT_3	[p1l613t765r737b799],
36	john	NN	PERSON	john	dep	114	SENT_3	[p1l742t765r802b797],
37	V	NN	PERSON	v	dep	114	SENT_3	[p1l810t767r827b791],
38	Fahy	NNP	PERSON	Fahy	dep	114	SENT_3	[p1l834t765r899b799],
39	,	,	O	,	_	0	SENT_3	[p1l834t765r899b799],
40	Nizarjarjour	NNP	O	Nizarjarjour	dep	114	SENT_3	[p1l908t767r1070b799],
41	,	,	O	,	_	0	SENT_3	[p1l908t767r1070b799],
42	Shamsah	NNP	PERSON	Shamsah	dep	114	SENT_3	[p1l1078t765r1196b791],
43	Kazani	NNP	PERSON	Kazani	dep	114	SENT_3	[p1l1205t767r1294b795],
44	,	,	O	,	_	0	SENT_3	[p1l1205t767r1294b795],
45	Sophia	NNP	PERSON	Sophia	dep	114	SENT_3	[p1l1302t765r1388b799],
46	Kim	NNP	PERSON	Kim	dep	114	SENT_3	[p1l1397t767r1450b795],
47	,	,	O	,	_	0	SENT_3	[p1l1397t767r1450b795],
48	Monica	NNP	PERSON	Monica	dep	114	SENT_3	[p1l1459t767r1552b791],
49	Kraft	NNP	PERSON	Kraft	dep	114	SENT_3	[p1l1561t765r1628b799],
50	,	,	O	,	_	0	SENT_3	[p1l1561t765r1628b799],
51	Stephen	NNP	PERSON	Stephen	dep	114	SENT_3	[p1l1637t765r1739b799],
52	C	NNP	PERSON	C	dep	114	SENT_3	[p1l1748t767r1764b791],
53	Lazarus	NNP	PERSON	Lazarus	dep	114	SENT_3	[p1l1771t767r1873b795],
54	,	,	O	,	_	0	SENT_3	[p1l1771t767r1873b795],
55	Robert	NNP	PERSON	Robert	dep	114	SENT_3	[p1l1883t765r1965b791],
56	F	NN	PERSON	f	dep	114	SENT_3	[p1l1972t767r1986b790],
57	Lemanskejr	NN	PERSON	lemanskejr	dep	114	SENT_3	[p1l1993t765r2148b797],
58	,	,	O	,	_	0	SENT_3	[p1l1993t765r2148b797],
59	Amy	NNP	PERSON	Amy	dep	114	SENT_3	[p1l327t813r387b844],
60	Markezich	NNP	PERSON	Markezich	dep	114	SENT_3	[p1l394t810r530b841],
61	,	,	O	,	_	0	SENT_3	[p1l394t810r530b841],
62	Richard	NNP	PERSON	Richard	dep	114	SENT_3	[p1l539t810r633b836],
63	j	NNP	PERSON	j	dep	114	SENT_3	[p1l636t813r647b842],
64	Martin	NNP	PERSON	Martin	dep	114	SENT_3	[p1l654t812r747b841],
65	,	,	O	,	_	0	SENT_3	[p1l654t812r747b841],
66	Perdita	NNP	PERSON	Perdita	dep	114	SENT_3	[p1l757t810r844b836],
67	Permaul	NNP	PERSON	Permaul	dep	114	SENT_3	[p1l853t810r963b841],
68	,	,	O	,	_	0	SENT_3	[p1l853t810r963b841],
69	Stephen	NNP	PERSON	Stephen	dep	114	SENT_3	[p1l971t810r1073b844],
70	P	NN	PERSON	p	dep	114	SENT_3	[p1l1082t813r1098b836],
71	Peters	NNP	PERSON	Peters	dep	114	SENT_3	[p1l1105t813r1186b841],
72	,	,	O	,	_	0	SENT_3	[p1l1105t813r1186b841],
73	Joe	NNP	PERSON	Joe	dep	114	SENT_3	[p1l1191t813r1232b842],
74	Ramsdell	NNP	PERSON	Ramsdell	dep	114	SENT_3	[p1l1239t810r1358b841],
75	,	,	O	,	_	0	SENT_3	[p1l1239t810r1358b841],
76	Christine	NNP	PERSON	Christine	dep	114	SENT_3	[p1l1368t810r1479b836],
77	A	NNP	PERSON	A	dep	114	SENT_3	[p1l1485t813r1503b836],
78	Sorkness	NNP	PERSON	Sorkness	dep	114	SENT_3	[p1l1511t810r1627b841],
79	,	,	O	,	_	0	SENT_3	[p1l1511t810r1627b841],
80	E	NNP	O	E	dep	114	SENT_3	[p1l1637t813r1651b836],
81	Rand	NNP	O	Rand	dep	114	SENT_3	[p1l1658t810r1722b836],
82	Sutherland	NNP	O	Sutherland	dep	114	SENT_3	[p1l1728t810r1874b841],
83	,	,	O	,	_	0	SENT_3	[p1l1728t810r1874b841],
84	Stanley	NNP	PERSON	Stanley	dep	114	SENT_3	[p1l1882t810r1976b844],
85	j	NN	O	j	dep	114	SENT_3	[p1l1979t813r1990b842],
86	Szeﬂer	NNP	O	Szeﬂer	dep	114	SENT_3	[p1l1997t810r2084b844],
87	,	,	O	,	_	0	SENT_3	[p1l1997t810r2084b844],
88	Michael	NNP	PERSON	Michael	dep	114	SENT_3	[p1l328t855r427b881],
89	J	NNP	PERSON	J	dep	114	SENT_3	[p1l430t857r440b887],
90	Walter	NNP	PERSON	Walter	dep	114	SENT_3	[p1l448t855r536b885],
91	,	,	O	,	_	0	SENT_3	[p1l448t855r536b885],
92	Stephen	NNP	PERSON	Stephen	dep	114	SENT_3	[p1l544t855r646b889],
93	lWasserman	NNP	PERSON	lWasserman	dep	114	SENT_3	[p1l656t857r822b885],
94	,	,	O	,	_	0	SENT_3	[p1l656t857r822b885],
95	Elliot	NNP	LOCATION	Elliot	dep	114	SENT_3	[p1l831t855r895b881],
96	Israel	NNP	LOCATION	Israel	dep	114	SENT_3	[p1l902t855r972b885],
97	,	,	O	,	_	0	SENT_3	[p1l902t855r972b885],
98	for	IN	O	for	dep	114	SENT_3	[p1l981t855r1017b889],
99	the	DT	O	the	dep	114	SENT_3	[p1l1023t855r1064b881],
100	National	NNP	ORGANIZATION	National	dep	114	SENT_3	[p1l1072t855r1182b881],
101	Heart	NNP	ORGANIZATION	Heart	dep	114	SENT_3	[p1l1190t857r1265b885],
102	,	,	O	,	_	0	SENT_3	[p1l1190t857r1265b885],
103	Lung	NN	O	lung	dep	114	SENT_3	[p1l1274t857r1342b889],
104	,	,	O	,	_	0	SENT_3	[p1l1274t857r1342b889],
105	and	CC	O	and	dep	114	SENT_3	[p1l1352t855r1399b881],
106	Blood	NN	O	blood	dep	114	SENT_3	[p1l1407t855r1477b881],
107	lnstitute	NN	O	lnstitute	dep	114	SENT_3	[p1l1485t857r1612b881],
108	’s	POS	O	’s	dep	114	SENT_3	[p1l1485t857r1612b881],
109	Asthma	NNP	O	Asthma	dep	114	SENT_3	[p1l1619t855r1721b881],
110	Clinical	JJ	O	clinical	dep	114	SENT_3	[p1l1729t855r1819b881],
111	Research	NN	O	research	dep	114	SENT_3	[p1l1827t855r1936b881],
112	Networl	NN	O	networl	dep	114	SENT_3	[p1l1945t855r2067b881],
113	<	JJR	O	<	dep	114	SENT_3	[p1l1945t855r2067b881],
114	*	CD	NUMBER	*	_	0	SENT_3	[p1l1945t855r2067b881],

1	Summar	NNP	O	Summar	_	0	SENT_4	[p1l6t942r162b973],

1	Lancet	NNP	O	Lancet	_	0	SENT_5	[p1l64t998r131b1017],
2	2039	CD	DATE	2039	num	1	SENT_5	[p1l137t951r198b1020],
3	;	:	O	;	_	0	SENT_5	[p1l137t951r198b1020],
4	374	CD	NUMBER	374	num	6	SENT_5	[p1l204t999r249b1020],
5	:	:	O	:	_	0	SENT_5	[p1l204t999r249b1020],
6	1754-64	CD	NUMBER	1754-64	dep	1	SENT_5	[p1l262t997r354b1020],
7	Background	NN	O	background	nsubj	10	SENT_5	[p1l399t990r578b1027],
8	Some	DT	O	some	det	9	SENT_5	[p1l598t991r684b1018],
9	studies	NNS	O	study	dep	7	SENT_5	[p1l702t989r812b1018],
10	suggest	VBP	O	suggest	rcmod	6	SENT_5	[p1l830t995r948b1027],
11	that	IN	O	that	complm	12	SENT_5	[p1l965t989r1026b1018],
12	patients	NNS	O	patient	dep	10	SENT_5	[p1l1042t990r1166b1027],
13	with	IN	O	with	_	0	SENT_5	[p1l1183t989r1252b1018],
14	asthma	NN	O	asthma	prep_with	12	SENT_5	[p1l1269t989r1384b1018],
15	who	WP	O	who	nsubj	17	SENT_5	[p1l1401t989r1467b1018],
16	are	VBP	O	be	cop	17	SENT_5	[p1l1484t999r1532b1018],
17	homozygous	JJ	O	homozygous	rcmod	12	SENT_5	[p1l1549t989r1749b1027],
18	for	IN	O	for	_	0	SENT_5	[p1l1767t989r1812b1018],
19	arginine	NN	O	arginine	prep_for	17	SENT_5	[p1l1828t990r1960b1027],
20	at	IN	O	at	_	0	SENT_5	[p1l1977t995r2004b1018],
21	the	DT	O	the	det	23	SENT_5	[p1l2021t989r2070b1018],
22	16th	JJ	ORDINAL	16th	amod	23	SENT_5	[p1l2089t989r2154b1018],
23	aminoacid	JJ	O	aminoacid	prep_at	17	SENT_5	[p1l6t1035r171b1064],

1	See	VB	O	see	ccomp	28	SENT_6	[p1l84t1093r119b1111],
2	Comment	NN	O	comment	nn	3	SENT_6	[p1l126t1093r234b1111],
3	page	NN	O	page	dobj	1	SENT_6	[p1l241t1098r290b1117],
4	1726	CD	DATE	1726	num	5	SENT_6	[p1l297t1091r348b1114],
5	position	NN	O	position	dep	3	SENT_6	[p1l386t1082r513b1119],
6	of	IN	O	of	_	0	SENT_6	[p1l529t1081r565b1110],
7	the	DT	O	the	det	13	SENT_6	[p1l575t1081r624b1110],
8	[	CD	NUMBER	[	num	13	SENT_6	[p1l642t1081r848b1119],
9	3,-adrenergic	JJ	O	3,-adrenergic	amod	13	SENT_6	[p1l642t1081r848b1119],
10	receptor	NN	O	receptor	nn	13	SENT_6	[p1l864t1087r993b1118],
11	(	NN	O	(	nn	13	SENT_6	[p1l1011t1083r1078b1119],
12	B16	NN	O	b16	nn	13	SENT_6	[p1l1011t1083r1078b1119],
13	Arg/Arg	NN	O	arg/arg	prep_of	5	SENT_6	[p1l1093t1083r1234b1119],
14	)	CD	NUMBER	)	num	15	SENT_6	[p1l1093t1083r1234b1119],
15	beneﬁt	NN	O	beneﬁt	npadvmod	16	SENT_6	[p1l1252t1081r1361b1110],
16	less	RBR	O	less	advmod	1	SENT_6	[p1l1377t1081r1434b1110],
17	from	IN	O	from	_	0	SENT_6	[p1l1451t1081r1528b1110],
18	treatment	NN	O	treatment	prep_from	1	SENT_6	[p1l1544t1087r1698b1110],
19	with	IN	O	with	_	0	SENT_6	[p1l1713t1081r1782b1110],
20	longacting	VBG	O	longact	prepc_with	18	SENT_6	[p1l1798t1081r1964b1119],
21	[	NN	O	[	dobj	20	SENT_6	[p1l1981t1081r2010b1118],
22	3	CD	NUMBER	3	num	21	SENT_6	[p1l1981t1081r2010b1118],
23	,	,	O	,	_	0	SENT_6	[p1l1981t1081r2010b1118],
24	agonists	NNS	O	agonist	nsubj	28	SENT_6	[p1l2026t1082r2154b1119],
25	and	CC	O	and	_	0	SENT_6	[p1l6t1127r64b1155],
26	*	NN	O	*	nn	27	SENT_6	[p1l81t1140r410b1165],
27	Forothergtudycontributorgsee	NN	O	forothergtudycontributorgsee	nsubj	28	SENT_6	[p1l81t1140r410b1165],
28	inhaled	VBD	O	inhale	_	0	SENT_6	[p1l451t1127r568b1156],
29	corticosteroids	NNS	O	corticosteroid	dobj	28	SENT_6	[p1l587t1127r815b1156],
30	than	IN	O	than	mark	31	SENT_6	[p1l834t1127r905b1156],
31	do	VBP	O	do	advcl	28	SENT_6	[p1l925t1127r962b1156],
32	those	DT	O	those	det	39	SENT_6	[p1l981t1127r1065b1156],
33	homozygous	JJ	O	homozygous	amod	39	SENT_6	[p1l1084t1127r1284b1165],
34	for	IN	O	for	_	0	SENT_6	[p1l1304t1127r1349b1156],
35	glycine	NN	O	glycine	nn	38	SENT_6	[p1l1368t1127r1478b1165],
36	(	CD	NUMBER	(	num	38	SENT_6	[p1l1500t1130r1566b1165],
37	B16	NN	O	b16	nn	38	SENT_6	[p1l1500t1130r1566b1165],
38	Gly/Gly	NN	O	gly/gly	prep_for	33	SENT_6	[p1l1587t1127r1729b1165],
39	)	NN	O	)	dobj	31	SENT_6	[p1l1587t1127r1729b1165],
40	.	.	O	.	_	0	SENT_6	[p1l1587t1127r1729b1165],

1	We	PRP	O	we	nsubj	2	SENT_7	[p1l1749t1130r1799b1156],
2	investigated	VBD	O	investigate	_	0	SENT_7	[p1l1819t1127r2006b1165],
3	whether	IN	O	whether	complm	5	SENT_7	[p1l2024t1127r2154b1156],
4	there	EX	O	there	expl	5	SENT_7	[p1l6t1172r87b1200],
5	is	VBZ	O	be	ccomp	2	SENT_7	[p1l103t1173r127b1200],
6	a	DT	O	a	det	10	SENT_7	[p1l144t1182r160b1200],
7	end	NN	O	end	nn	10	SENT_7	[p1l222t1220r260b1240],
8	ofpaper	NN	O	ofpaper	nn	10	SENT_7	[p1l265t1220r348b1246],
9	genotype-speciﬁc	NN	O	genotype-speciﬁc	nn	10	SENT_7	[p1l384t1217r653b1255],
10	response	NN	O	response	nsubj	5	SENT_7	[p1l663t1227r804b1255],
11	to	TO	O	to	_	0	SENT_7	[p1l814t1223r843b1246],
12	treatment	NN	O	treatment	prep_to	5	SENT_7	[p1l853t1223r1007b1246],
13	with	IN	O	with	_	0	SENT_7	[p1l1017t1217r1086b1246],
14	a	DT	O	a	det	16	SENT_7	[p1l1096t1227r1112b1246],
15	longacting	NN	O	longacting	nn	16	SENT_7	[p1l1122t1217r1288b1255],
16	B	NN	O	b	prep_with	12	SENT_7	[p1l1299t1217r1328b1254],
17	,	,	O	,	_	0	SENT_7	[p1l1299t1217r1328b1254],
18	agonist	NN	O	agonist	appos	16	SENT_7	[p1l1338t1218r1452b1255],
19	in	IN	O	in	_	0	SENT_7	[p1l1462t1218r1493b1246],
20	combination	NN	O	combination	prep_in	18	SENT_7	[p1l1504t1217r1703b1246],
21	with	IN	O	with	_	0	SENT_7	[p1l1712t1217r1782b1246],
22	inhaled	VBN	O	inhale	prepc_with	5	SENT_7	[p1l1792t1217r1909b1246],
23	corticosteroid	NN	O	corticosteroid	dobj	22	SENT_7	[p1l1919t1217r2140b1246],
24	.	.	O	.	_	0	SENT_7	[p1l1919t1217r2140b1246],

1	Brigham	NNP	LOCATION	Brigham	poss	5	SENT_8	[p1l6t1268r95b1294],
2	and	CC	O	and	_	0	SENT_8	[p1l101t1268r141b1288],
3	Women	NNP	O	Women	poss	5	SENT_8	[p1l145t1269r244b1288],
4	's	POS	O	's	_	0	SENT_8	[p1l145t1269r244b1288],
5	Hospital	NNP	O	Hospital	_	0	SENT_8	[p1l251t1268r344b1294],
6	,	,	O	,	_	0	SENT_8	[p1l251t1268r344b1294],
7	H	NNP	O	H	appos	5	SENT_8	[p1l6t1304r336b1363],
8	‘	CD	NUMBER	‘	num	7	SENT_8	[p1l6t1304r336b1363],
9	"	``	O	"	punct	7	SENT_8	[p1l6t1304r336b1363],
10	an	DT	O	a	det	13	SENT_8	[p1l6t1304r336b1363],
11	"	``	O	"	punct	13	SENT_8	[p1l6t1304r336b1363],
12	‘	NN	O	‘	nn	13	SENT_8	[p1l6t1304r336b1363],
13	llAMlj	NN	O	llamlj	dep	7	SENT_8	[p1l6t1304r336b1363],
14	;	:	O	;	_	0	SENT_8	[p1l6t1304r336b1363],
15	l	NN	O	l	dep	5	SENT_8	[p1l6t1304r336b1363],
16	‘	CD	NUMBER	‘	dep	15	SENT_8	[p1l6t1304r336b1363],
17	:	:	O	:	_	0	SENT_8	[p1l6t1304r336b1363],
18	\	CD	NUMBER	\	number	19	SENT_8	[p1l6t1304r336b1363],
19	°	CD	NUMBER	°	dep	15	SENT_8	[p1l6t1304r336b1363],
20	‘	NN	O	‘	dep	19	SENT_8	[p1l6t1304r336b1363],
21	;	:	O	;	_	0	SENT_8	[p1l6t1304r336b1363],
22	"	``	O	"	punct	24	SENT_8	[p1l6t1304r336b1363],
23	'	''	O	'	_	0	SENT_8	[p1l6t1304r336b1363],
24	Vﬁl	NNP	O	Vﬁl	dep	15	SENT_8	[p1l6t1304r336b1363],
25	\	CD	NUMBER	\	number	26	SENT_8	[p1l6t1304r336b1363],
26	‘	CD	NUMBER	‘	num	28	SENT_8	[p1l6t1304r336b1363],
27	A	DT	O	a	det	28	SENT_8	[p1l6t1304r336b1363],
28	‘	NN	O	‘	dep	24	SENT_8	[p1l6t1304r336b1363],
29	:	:	O	:	_	0	SENT_8	[p1l6t1304r336b1363],
30	°	NN	O	°	dep	15	SENT_8	[p1l6t1304r336b1363],
31	'	''	O	'	_	0	SENT_8	[p1l6t1304r336b1363],
32	;	:	O	;	_	0	SENT_8	[p1l6t1304r336b1363],
33	1B	NN	O	1b	nn	34	SENT_8	[p1l6t1304r336b1363],
34	|	NNS	O	|	dep	30	SENT_8	[p1l6t1304r336b1363],
35	"	``	O	"	punct	34	SENT_8	[p1l6t1304r336b1363],
36	‘	CD	NUMBER	‘	dep	34	SENT_8	[p1l6t1304r336b1363],
37	:	:	O	:	_	0	SENT_8	[p1l6t1304r336b1363],
38	\	CD	NUMBER	\	number	39	SENT_8	[p1l6t1304r336b1363],
39	‘	CD	NUMBER	‘	dep	15	SENT_8	[p1l6t1304r336b1363],
40	/	:	O	/	punct	42	SENT_8	[p1l6t1304r336b1363],
41	1	CD	NUMBER	1	number	42	SENT_8	[p1l6t1304r336b1363],
42	’	CD	NUMBER	’	dep	39	SENT_8	[p1l6t1304r336b1363],
43	:	:	O	:	_	0	SENT_8	[p1l6t1304r336b1363],
44	Methods	NNS	O	method	dep	39	SENT_8	[p1l374t1309r503b1335],
45	In	IN	O	in	dep	5	SENT_8	[p1l513t1310r546b1335],
46	this	DT	O	this	det	47	SENT_8	[p1l555t1308r611b1335],
47	multicentre	NN	O	multicentre	pobj	45	SENT_8	[p1l621t1308r807b1340],
48	,	,	O	,	_	0	SENT_8	[p1l621t1308r807b1340],
49	randomised	VBN	O	randomise	partmod	47	SENT_8	[p1l817t1308r1008b1340],
50	,	,	O	,	_	0	SENT_8	[p1l817t1308r1008b1340],
51	double-blind	JJ	O	double-blind	amod	54	SENT_8	[p1l1018t1308r1219b1340],
52	,	,	O	,	_	0	SENT_8	[p1l1018t1308r1219b1340],
53	placebo-controlled	JJ	O	placebo-controlled	amod	54	SENT_8	[p1l1230t1308r1509b1344],
54	trial	NN	O	trial	appos	47	SENT_8	[p1l1518t1308r1586b1340],
55	,	,	O	,	_	0	SENT_8	[p1l1518t1308r1586b1340],
56	adult	JJ	O	adult	amod	57	SENT_8	[p1l1597t1308r1674b1335],
57	patients	NNS	O	patient	appos	47	SENT_8	[p1l1682t1309r1803b1344],
58	with	IN	O	with	_	0	SENT_8	[p1l1812t1308r1879b1335],
59	moderate	JJ	O	moderate	amod	60	SENT_8	[p1l1888t1308r2033b1335],
60	asthma	NN	O	asthma	prep_with	57	SENT_8	[p1l2042t1308r2153b1335],

1	,	,	O	,	_	0	SENT_9	[p1l98t1355r102b1362],
2	EC	NNP	ORGANIZATION	EC	nn	4	SENT_9	[p1l226t1346r246b1358],
3	5	CD	NUMBER	5	num	4	SENT_9	[p1l259t1346r268b1358],
4	er	NN	O	er	nsubjpass	14	SENT_9	[p1l274t1346r292b1358],
5	,	,	O	,	_	0	SENT_9	[p1l332t1355r336b1362],
6	S	NN	O	s	nn	7	SENT_9	[p1l108t1376r118b1394],
7	Kazan	NNP	PERSON	Kazan	appos	4	SENT_9	[p1l125t1376r186b1394],
8	,	,	O	,	_	0	SENT_9	[p1l125t1376r186b1394],
9	MD	NNP	O	MD	nn	12	SENT_9	[p1l193t1376r226b1393],
10	5	CD	NUMBER	5	num	12	SENT_9	[p1l238t1376r248b1394],
11	Kim	NNP	PERSON	Kim	nn	12	SENT_9	[p1l255t1376r291b1394],
12	MD	NNP	O	MD	appos	7	SENT_9	[p1l298t1376r331b1393],
13	were	VBD	O	be	auxpass	14	SENT_9	[p1l372t1362r445b1380],
14	enrolled	VBN	O	enrol	_	0	SENT_9	[p1l456t1352r581b1380],
15	in	IN	O	in	_	0	SENT_9	[p1l592t1353r622b1379],
16	pairs	NNS	O	pair	prep_in	14	SENT_9	[p1l634t1353r707b1388],
17	matched	VBN	O	match	partmod	16	SENT_9	[p1l720t1352r851b1380],
18	for	IN	O	for	_	0	SENT_9	[p1l862t1352r906b1380],
19	forced	JJ	O	forced	amod	21	SENT_9	[p1l916t1352r1012b1380],
20	expiratory	JJ	O	expiratory	amod	21	SENT_9	[p1l1023t1353r1175b1388],
21	volume	NN	O	volume	prep_for	17	SENT_9	[p1l1184t1352r1298b1380],
22	in	IN	O	in	_	0	SENT_9	[p1l1310t1353r1340b1379],
23	1	CD	NUMBER	1	num	24	SENT_9	[p1l1352t1355r1366b1379],
24	s	NNS	O	s	prep_in	17	SENT_9	[p1l1378t1362r1391b1380],
25	and	CC	O	and	_	0	SENT_9	[p1l1402t1352r1459b1380],
26	ethnic	JJ	O	ethnic	amod	27	SENT_9	[p1l1470t1352r1565b1380],
27	origin	NN	O	origin	prep_in	17	SENT_9	[p1l1576t1353r1675b1389],
28	,	,	O	,	_	0	SENT_9	[p1l1576t1353r1675b1389],
29	according	VBG	O	accord	_	0	SENT_9	[p1l1688t1352r1837b1389],
30	to	TO	O	to	prepc_according_to	17	SENT_9	[p1l1847t1358r1876b1380],
31	whether	IN	O	whether	complm	33	SENT_9	[p1l1886t1352r2012b1380],
32	they	PRP	O	they	nsubj	33	SENT_9	[p1l2022t1352r2087b1388],
33	had	VBD	O	have	pcomp	17	SENT_9	[p1l2097t1352r2154b1380],
34	AMa	NNP	O	AMa	dobj	33	SENT_9	[p1l25t1410r188b1432],
35	,	,	O	,	_	0	SENT_9	[p1l25t1410r188b1432],
36	»	CD	NUMBER	»	num	37	SENT_9	[p1l25t1410r188b1432],
37	keZjC	NN	O	kezjc	appos	34	SENT_9	[p1l25t1410r188b1432],
38	|	CD	NUMBER	|	num	39	SENT_9	[p1l25t1410r188b1432],
39	1MD	NN	O	1md	dep	37	SENT_9	[p1l25t1410r188b1432],
40	’	CD	NUMBER	’	num	41	SENT_9	[p1l25t1410r188b1432],
41	PPerm3	NN	O	pperm3	dep	37	SENT_9	[p1l196t1410r336b1432],
42	.	.	O	.	_	0	SENT_9	[p1l196t1410r336b1432],

1	_	NN	O	_	_	0	SENT_10	[p1l196t1410r336b1432],
2	.	.	O	.	_	0	SENT_10	[p1l196t1410r336b1432],

1	|	NN	O	|	nn	2	SENT_11	[p1l196t1410r336b1432],
2	MD	NN	O	md	nsubj	3	SENT_11	[p1l196t1410r336b1432],
3	’	VBP	O	’	_	0	SENT_11	[p1l196t1410r336b1432],
4	the	DT	O	the	det	6	SENT_11	[p1l372t1396r420b1424],
5	B16	NN	O	b16	nn	6	SENT_11	[p1l433t1399r487b1424],
6	Arg/Arg	NN	O	arg/arg	dobj	3	SENT_11	[p1l499t1398r628b1433],
7	(	CD	NUMBER	(	num	8	SENT_11	[p1l641t1399r737b1433],
8	n	NN	O	n	dep	6	SENT_11	[p1l641t1399r737b1433],
9	=	JJ	O	=	dep	3	SENT_11	[p1l641t1399r737b1433],
10	42	CD	NUMBER	42	number	11	SENT_11	[p1l641t1399r737b1433],
11	)	CD	NUMBER	)	dep	9	SENT_11	[p1l641t1399r737b1433],
12	or	CC	O	or	_	0	SENT_11	[p1l750t1406r782b1424],
13	B16	CD	NUMBER	b16	num	16	SENT_11	[p1l795t1399r849b1424],
14	Gly/Gly	JJ	O	gly/gly	amod	16	SENT_11	[p1l862t1396r982b1433],
15	(	NN	O	(	nn	16	SENT_11	[p1l995t1398r1091b1433],
16	n	NN	O	n	dep	3	SENT_11	[p1l995t1398r1091b1433],
17	=	JJ	O	=	advmod	16	SENT_11	[p1l995t1398r1091b1433],
18	45	CD	NUMBER	45	number	19	SENT_11	[p1l995t1398r1091b1433],
19	)	CD	NUMBER	)	num	20	SENT_11	[p1l995t1398r1091b1433],
20	genotype	NN	O	genotype	dep	9	SENT_11	[p1l1105t1402r1250b1433],
21	.	.	O	.	_	0	SENT_11	[p1l1105t1402r1250b1433],

1	Individuals	NNS	O	individual	nsubjpass	8	SENT_12	[p1l1264t1396r1434b1424],
2	in	IN	O	in	_	0	SENT_12	[p1l1447t1398r1478b1424],
3	a	DT	O	a	det	5	SENT_12	[p1l1489t1406r1505b1424],
4	matched	VBN	O	match	amod	5	SENT_12	[p1l1517t1396r1649b1424],
5	pair	NN	O	pair	prep_in	1	SENT_12	[p1l1660t1398r1720b1433],
6	were	VBD	O	be	auxpass	8	SENT_12	[p1l1731t1406r1804b1424],
7	randomly	RB	O	randomly	advmod	8	SENT_12	[p1l1816t1396r1963b1433],
8	assigned	VBN	O	assign	_	0	SENT_12	[p1l1974t1396r2107b1433],
9	by	IN	O	by	_	0	SENT_12	[p1l2118t1396r2154b1433],
10	E	NN	O	e	nn	12	SENT_12	[p1l6t1447r16b1465],
11	Israel	NNP	LOCATION	Israel	nn	12	SENT_12	[p1l25t1446r74b1465],
12	MD	NNP	LOCATION	MD	agent	8	SENT_12	[p1l83t1447r132b1470],
13	)	NN	O	)	dep	12	SENT_12	[p1l83t1447r132b1470],
14	;	:	O	;	_	0	SENT_12	[p1l83t1447r132b1470],
15	Penn	NNP	ORGANIZATION	Penn	nn	19	SENT_12	[p1l141t1447r192b1465],
16	Statecollege	NNP	ORGANIZATION	Statecollege	nn	19	SENT_12	[p1l198t1446r335b1472],
17	computer-generated	JJ	O	computer-generated	amod	19	SENT_12	[p1l374t1441r689b1479],
18	randomisation	NN	O	randomisation	nn	19	SENT_12	[p1l702t1441r932b1470],
19	sequence	NN	O	sequence	dep	12	SENT_12	[p1l947t1451r1091b1478],
20	to	TO	O	to	aux	21	SENT_12	[p1l1105t1447r1134b1470],
21	receive	VB	O	receive	xcomp	8	SENT_12	[p1l1148t1442r1256b1470],
22	inhaled	VBN	O	inhale	dep	21	SENT_12	[p1l1271t1441r1388b1470],
23	longacting	VBG	O	longact	dep	22	SENT_12	[p1l1401t1441r1567b1479],
24	[	CD	NUMBER	[	number	25	SENT_12	[p1l1581t1441r1610b1478],
25	3	CD	NUMBER	3	dobj	23	SENT_12	[p1l1581t1441r1610b1478],
26	,	,	O	,	_	0	SENT_12	[p1l1581t1441r1610b1478],
27	agonist	NN	O	agonist	nn	29	SENT_12	[p1l1623t1443r1737b1479],
28	(	NN	O	(	nn	29	SENT_12	[p1l1752t1441r1926b1479],
29	salmeterol	NN	O	salmeterol	appos	25	SENT_12	[p1l1752t1441r1926b1479],
30	50	CD	NUMBER	50	num	31	SENT_12	[p1l1941t1443r1976b1470],
31	pg	NN	O	pg	npadvmod	32	SENT_12	[p1l1990t1452r2030b1479],
32	twice	RB	O	twice	advmod	34	SENT_12	[p1l2043t1442r2124b1470],
33	a	DT	DURATION	a	det	34	SENT_12	[p1l2138t1451r2154b1470],
34	day	NN	DURATION	day	tmod	29	SENT_12	[p1l6t1486r68b1524],
35	)	CD	NUMBER	)	number	36	SENT_12	[p1l6t1486r68b1524],
36	°	CD	NUMBER	°	num	37	SENT_12	[p1l32t1526r161b1549],
37	fM	NN	O	fm	dep	29	SENT_12	[p1l32t1526r161b1549],
38	°	CD	NUMBER	°	number	39	SENT_12	[p1l32t1526r161b1549],
39	‘“	CD	NUMBER	‘“	num	43	SENT_12	[p1l32t1526r161b1549],
40	°	NN	O	°	nn	43	SENT_12	[p1l32t1526r161b1549],
41	l	NN	O	l	nn	43	SENT_12	[p1l32t1526r161b1549],
42	"	''	O	"	punct	43	SENT_12	[p1l32t1526r161b1549],
43	°	NN	O	°	dep	37	SENT_12	[p1l32t1526r161b1549],
44	'	''	O	'	_	0	SENT_12	[p1l32t1526r161b1549],
45	”	CD	NUMBER	”	num	46	SENT_12	[p1l179t1526r358b1552],
46	°	CD	NUMBER	°	dobj	23	SENT_12	[p1l179t1526r358b1552],
47	"	``	O	"	punct	48	SENT_12	[p1l179t1526r358b1552],
48	l	NN	O	l	dobj	8	SENT_12	[p1l179t1526r358b1552],
49	‘	CD	NUMBER	‘	number	50	SENT_12	[p1l179t1526r358b1552],
50	°	CD	NUMBER	°	dep	48	SENT_12	[p1l179t1526r358b1552],
51	Y	NN	O	y	dep	50	SENT_12	[p1l179t1526r358b1552],
52	"	''	O	"	punct	51	SENT_12	[p1l179t1526r358b1552],
53	’	NN	O	’	dep	50	SENT_12	[p1l179t1526r358b1552],
54	A	DT	O	a	dep	53	SENT_12	[p1l179t1526r358b1552],
55	'	''	O	'	_	0	SENT_12	[p1l179t1526r358b1552],
56	”	CD	NUMBER	”	num	57	SENT_12	[p1l179t1526r358b1552],
57	5A	NN	O	5a	nsubj	60	SENT_12	[p1l179t1526r358b1552],
58	or	CC	O	or	_	0	SENT_12	[p1l406t1541r439b1560],
59	placebo	NN	O	placebo	conj_or	57	SENT_12	[p1l467t1531r585b1563],
60	given	VBN	O	give	rcmod	48	SENT_12	[p1l614t1532r698b1563],
61	in	IN	O	in	_	0	SENT_12	[p1l726t1532r758b1559],
62	a	DT	O	a	det	66	SENT_12	[p1l786t1541r802b1560],
63	double-blind	JJ	O	double-blind	amod	66	SENT_12	[p1l831t1531r1037b1563],
64	,	,	O	,	_	0	SENT_12	[p1l831t1531r1037b1563],
65	crossover	JJ	O	crossover	amod	66	SENT_12	[p1l1067t1541r1214b1560],
66	design	NN	O	design	prep_in	60	SENT_12	[p1l1243t1531r1346b1563],
67	for	IN	O	for	_	0	SENT_12	[p1l1374t1531r1419b1560],
68	two	CD	NUMBER	two	num	70	SENT_12	[p1l1446t1537r1502b1560],
69	18-week	JJ	DURATION	18-week	amod	70	SENT_12	[p1l1532t1531r1656b1560],
70	periods	NNS	O	period	prep_for	66	SENT_12	[p1l1683t1531r1807b1563],
71	.	.	O	.	_	0	SENT_12	[p1l1683t1531r1807b1563],

1	Open-label	JJ	O	open-label	_	0	SENT_13	[p1l1838t1531r2008b1563],
2	inhaled	VBN	O	inhale	dep	1	SENT_13	[p1l2037t1531r2154b1560],
3	corticosteroid	NN	O	corticosteroid	dobj	2	SENT_13	[p1l6t1577r219b1606],

1	(	NN	O	(	nn	2	SENT_14	[p1l154t1607r182b1630],
2	SJ	NN	O	sj	_	0	SENT_14	[p1l154t1607r182b1630],
3	Kunselman	NNP	O	Kunselman	nn	4	SENT_14	[p1l190t1606r299b1625],
4	MA	NNP	O	MA	dep	2	SENT_14	[p1l307t1607r346b1629],
5	,	,	O	,	_	0	SENT_14	[p1l307t1607r346b1629],
6	ProfVMChinchil	NNP	O	ProfVMChinchil	nn	9	SENT_14	[p1l115t1642r294b1662],
7	|	NNP	O	|	nn	9	SENT_14	[p1l115t1642r294b1662],
8	i	FW	O	i	nn	9	SENT_14	[p1l115t1642r294b1662],
9	PhD	NNP	O	PhD	appos	4	SENT_14	[p1l302t1642r346b1665],
10	,	,	O	,	_	0	SENT_14	[p1l302t1642r346b1665],
11	V	NNP	O	V	nn	12	SENT_14	[p1l825t1665r842b1671],
12	L	NNP	O	L	appos	4	SENT_14	[p1l1157t1665r1167b1670],
13	_	IN	O	_	amod	12	SENT_14	[p1l1328t1665r1337b1670],

1	(	NN	O	(	nn	3	SENT_15	[p1l6t1679r303b1717],
2	hydroﬂuoroalkane	NN	O	hydroﬂuoroalkane	nn	3	SENT_15	[p1l6t1679r303b1717],
3	beclometasone	NN	O	beclometasone	nsubjpass	11	SENT_15	[p1l312t1679r547b1708],
4	240	CD	NUMBER	240	num	5	SENT_15	[p1l557t1682r611b1708],
5	pg	NN	O	pg	npadvmod	6	SENT_15	[p1l621t1689r661b1717],
6	twice	RB	O	twice	advmod	8	SENT_15	[p1l670t1680r751b1708],
7	a	DT	DURATION	a	det	8	SENT_15	[p1l761t1689r777b1708],
8	day	NN	DURATION	day	tmod	3	SENT_15	[p1l787t1679r849b1717],
9	)	CD	NUMBER	)	dep	3	SENT_15	[p1l787t1679r849b1717],
10	was	VBD	O	be	auxpass	11	SENT_15	[p1l860t1689r918b1708],
11	given	VBN	O	give	_	0	SENT_15	[p1l929t1680r1013b1717],
12	to	TO	O	to	_	0	SENT_15	[p1l1022t1685r1052b1708],
13	all	DT	O	all	det	14	SENT_15	[p1l1061t1679r1098b1708],
14	participants	NNS	O	participant	prep_to	11	SENT_15	[p1l1107t1680r1292b1717],
15	during	IN	O	during	_	0	SENT_15	[p1l1302t1679r1408b1717],
16	the	DT	O	the	det	18	SENT_15	[p1l1417t1679r1466b1708],
17	treatment	NN	O	treatment	nn	18	SENT_15	[p1l1476t1685r1630b1708],
18	periods	NNS	O	period	prep_during	11	SENT_15	[p1l1639t1679r1763b1717],
19	.	.	O	.	_	0	SENT_15	[p1l1639t1679r1763b1717],

1	The	DT	O	the	det	6	SENT_16	[p1l1774t1679r1834b1708],
2	ProfT	NNP	O	ProfT	nn	6	SENT_16	[p1l39t1730r96b1751],
3	J	NNP	O	J	nn	6	SENT_16	[p1l99t1732r105b1755],
4	Craig	NNP	PERSON	Craig	nn	6	SENT_16	[p1l117t1732r166b1757],
5	DO	NNP	O	DO	nn	6	SENT_16	[p1l179t1731r287b1756],
6	)	NN	O	)	_	0	SENT_16	[p1l179t1731r287b1756],
7	;	:	O	;	_	0	SENT_16	[p1l179t1731r287b1756],
8	Wake	NNP	O	Wake	nn	9	SENT_16	[p1l179t1731r287b1756],
9	Forest	NNP	O	Forest	dep	6	SENT_16	[p1l299t1732r363b1751],
10	primary	JJ	O	primary	amod	11	SENT_16	[p1l405t1719r531b1756],
11	endpoint	NN	O	endpoint	nsubj	12	SENT_16	[p1l546t1718r687b1755],
12	was	VBD	O	be	rcmod	9	SENT_16	[p1l702t1728r760b1747],
13	morning	NN	TIME	morning	nn	14	SENT_16	[p1l778t1719r917b1756],
14	peak	NN	O	peak	nsubj	19	SENT_16	[p1l932t1718r1006b1755],
15	expiratory	JJ	O	expiratory	amod	19	SENT_16	[p1l1022t1719r1178b1756],
16	ﬂow	NN	O	ﬂow	nn	19	SENT_16	[p1l1193t1718r1260b1747],
17	(	CD	NUMBER	(	num	19	SENT_16	[p1l1277t1719r1371b1756],
18	PEF	NN	O	pef	nn	19	SENT_16	[p1l1277t1719r1371b1756],
19	)	NN	O	)	xcomp	12	SENT_16	[p1l1277t1719r1371b1756],
20	.	.	O	.	_	0	SENT_16	[p1l1277t1719r1371b1756],

1	Analysis	NN	O	analysis	nsubj	2	SENT_17	[p1l1388t1718r1520b1756],
2	was	VBD	O	be	_	0	SENT_17	[p1l1537t1728r1595b1747],
3	by	IN	O	by	_	0	SENT_17	[p1l1612t1718r1648b1755],
4	intention	NN	O	intention	prep_by	2	SENT_17	[p1l1664t1719r1808b1747],
5	to	TO	O	to	aux	6	SENT_17	[p1l1824t1723r1853b1746],
6	treat	VB	O	treat	xcomp	2	SENT_17	[p1l1869t1723r1947b1747],
7	.	.	O	.	_	0	SENT_17	[p1l1869t1723r1947b1747],

1	This	DT	O	this	det	2	SENT_18	[p1l1965t1718r2034b1747],
2	trial	NN	O	trial	nsubjpass	4	SENT_18	[p1l2050t1718r2113b1747],
3	is	VBZ	O	be	auxpass	4	SENT_18	[p1l2129t1719r2154b1747],
4	registered	VBN	O	register	_	0	SENT_18	[p1l6t1763r162b1800],

1	University	NNP	ORGANIZATION	University	nn	3	SENT_19	[p1l80t1812r189b1837],
2	Health	NNP	ORGANIZATION	Health	nn	3	SENT_19	[p1l195t1811r264b1831],
3	Science	NNP	ORGANIZATION	Science	_	0	SENT_19	[p1l270t1812r347b1831],
4	with	IN	O	with	_	0	SENT_19	[p1l383t1808r452b1837],
5	ClinicalTrials	NNPS	O	ClinicalTrials	prep_with	3	SENT_19	[p1l464t1808r738b1846],
6	.	.	O	.	_	0	SENT_19	[p1l464t1808r738b1846],

1	gov	NN	O	gov	_	0	SENT_20	[p1l464t1808r738b1846],
2	,	,	O	,	_	0	SENT_20	[p1l464t1808r738b1846],
3	number	NN	O	number	nn	4	SENT_20	[p1l750t1808r877b1837],
4	NCT00200967	NN	O	nct00200967	appos	1	SENT_20	[p1l887t1810r1119b1837],
5	.	.	O	.	_	0	SENT_20	[p1l887t1810r1119b1837],

1	Center	NNP	O	Center	_	0	SENT_21	[p1l6t1849r80b1871],
2	,	,	O	,	_	0	SENT_21	[p1l6t1849r80b1871],
3	Winston	NNP	PERSON	Winston	appos	1	SENT_21	[p1l84t1848r254b1871],
4	.	.	O	.	_	0	SENT_21	[p1l84t1848r254b1871],

1	—	NN	O	—	_	0	SENT_22	[p1l84t1848r254b1871],
2	.	.	O	.	_	0	SENT_22	[p1l84t1848r254b1871],

1	Sa	NNP	O	Sa	_	0	SENT_23	[p1l84t1848r254b1871],
2	|	CD	NUMBER	|	num	3	SENT_23	[p1l84t1848r254b1871],
3	em	NN	O	em	dep	18	SENT_23	[p1l84t1848r254b1871],
4	,	,	O	,	_	0	SENT_23	[p1l84t1848r254b1871],
5	NC	NN	O	nc	appos	3	SENT_23	[p1l261t1849r297b1871],
6	,	,	O	,	_	0	SENT_23	[p1l261t1849r297b1871],
7	USA	NNP	LOCATION	USA	appos	3	SENT_23	[p1l303t1849r347b1868],
8	(	CD	NUMBER	(	num	7	SENT_23	[p1l148t1884r198b1909],
9	Prof	NNP	O	Prof	nn	12	SENT_23	[p1l148t1884r198b1909],
10	E	NNP	O	E	nn	12	SENT_23	[p1l203t1886r213b1904],
11	Bleecker	NNP	O	Bleecker	nn	12	SENT_23	[p1l220t1884r302b1904],
12	MD	NNP	O	MD	dep	7	SENT_23	[p1l308t1886r347b1908],
13	,	,	O	,	_	0	SENT_23	[p1l308t1886r347b1908],
14	Prof	NNP	PERSON	Prof	nn	15	SENT_23	[p1l9t1921r51b1941],
15	S	NNP	PERSON	S	appos	3	SENT_23	[p1l55t1922r66b1941],
16	P	NN	PERSON	p	dep	18	SENT_23	[p1l73t1923r84b1941],
17	Peters	NNP	PERSON	Peters	nn	18	SENT_23	[p1l91t1923r150b1941],
18	MD	NNP	O	MD	dep	1	SENT_23	[p1l157t1922r206b1946],
19	)	NN	O	)	dep	18	SENT_23	[p1l157t1922r206b1946],
20	;	:	O	;	_	0	SENT_23	[p1l157t1922r206b1946],
21	University	NNP	ORGANIZATION	University	dep	1	SENT_23	[p1l212t1922r321b1947],
22	of	IN	ORGANIZATION	of	_	0	SENT_23	[p1l326t1921r349b1941],
23	California	NNP	ORGANIZATION	California	nn	27	SENT_23	[p1l6t1957r113b1981],
24	,	,	O	,	_	0	SENT_23	[p1l6t1957r113b1981],
25	San	NNP	ORGANIZATION	San	appos	27	SENT_23	[p1l119t1959r156b1977],
26	Francisco	NNP	ORGANIZATION	Francisco	nn	27	SENT_23	[p1l164t1958r260b1977],
27	Medical	NNP	ORGANIZATION	Medical	prep_of	21	SENT_23	[p1l266t1957r347b1977],

1	Findings	NNS	O	finding	npadvmod	16	SENT_24	[p1l8t2037r137b2073],
2	After	IN	O	after	_	0	SENT_24	[p1l144t2036r225b2064],
3	18	CD	DURATION	18	num	4	SENT_24	[p1l233t2038r265b2064],
4	weeks	NNS	NUMBER	week	prep_after	16	SENT_24	[p1l274t2036r369b2064],
5	of	IN	O	of	_	0	SENT_24	[p1l378t2036r414b2064],
6	treatment	NN	O	treatment	prep_of	4	SENT_24	[p1l416t2041r579b2069],
7	,	,	O	,	_	0	SENT_24	[p1l416t2041r579b2069],
8	mean	VB	O	mean	csubj	16	SENT_24	[p1l589t2046r677b2064],
9	morning	NN	TIME	morning	nn	10	SENT_24	[p1l686t2037r825b2073],
10	PEF	NN	O	pef	tmod	8	SENT_24	[p1l834t2038r896b2064],
11	in	IN	O	in	_	0	SENT_24	[p1l906t2037r937b2064],
12	Arg/Arg	NN	O	arg/arg	nn	13	SENT_24	[p1l945t2038r1078b2073],
13	participants	NNS	O	participant	prep_in	8	SENT_24	[p1l1086t2037r1271b2073],
14	was	VBD	O	be	cop	16	SENT_24	[p1l1280t2046r1338b2064],
15	21-4	CD	NUMBER	21-4	num	16	SENT_24	[p1l1348t2038r1418b2064],
16	L/min	NN	O	l/min	_	0	SENT_24	[p1l1427t2037r1526b2073],
17	(	CD	PERCENT	(	number	18	SENT_24	[p1l1536t2037r1613b2073],
18	95	CD	PERCENT	95	num	19	SENT_24	[p1l1536t2037r1613b2073],
19	%	NN	PERCENT	%	dep	16	SENT_24	[p1l1536t2037r1613b2073],
20	CI	NN	O	ci	dep	16	SENT_24	[p1l1623t2038r1659b2064],
21	11	CD	NUMBER	11	num	20	SENT_24	[p1l1669t2038r1712b2064],
22	-	:	O	-	_	0	SENT_24	[p1l1669t2038r1712b2064],
23	8-31	CD	NUMBER	8-31	dep	16	SENT_24	[p1l1720t2038r1790b2064],
24	-	:	O	-	_	0	SENT_24	[p1l1797t2052r1803b2057],
25	1	CD	DATE	1	number	26	SENT_24	[p1l1810t2038r1834b2073],
26	)	CD	NUMBER	)	npadvmod	27	SENT_24	[p1l1810t2038r1834b2073],
27	higher	JJR	O	higher	amod	23	SENT_24	[p1l6t2082r111b2119],
28	when	WRB	O	when	advmod	31	SENT_24	[p1l120t2082r207b2110],
29	participants	NNS	O	participant	nsubjpass	31	SENT_24	[p1l219t2083r404b2119],
30	were	VBD	O	be	auxpass	31	SENT_24	[p1l416t2092r491b2110],
31	assigned	VBN	O	assign	ccomp	27	SENT_24	[p1l502t2082r640b2119],
32	to	TO	O	to	aux	33	SENT_24	[p1l651t2087r680b2110],
33	receive	VB	O	receive	xcomp	31	SENT_24	[p1l691t2083r800b2110],
34	salmeterol	NN	O	salmeterol	dobj	33	SENT_24	[p1l812t2082r977b2110],
35	than	IN	O	than	_	0	SENT_24	[p1l988t2082r1059b2110],
36	when	WRB	O	when	advmod	37	SENT_24	[p1l1069t2082r1156b2110],
37	assigned	VBN	O	assign	prepc_than	33	SENT_24	[p1l1168t2082r1305b2119],
38	to	TO	O	to	aux	39	SENT_24	[p1l1316t2087r1345b2110],
39	receive	VB	O	receive	xcomp	37	SENT_24	[p1l1357t2083r1466b2110],
40	placebo	NN	O	placebo	nn	42	SENT_24	[p1l1477t2082r1596b2119],
41	(	NN	O	(	nn	42	SENT_24	[p1l1609t2084r1677b2119],
42	p	NN	O	p	dobj	39	SENT_24	[p1l1609t2084r1677b2119],
43	<	JJR	O	<	amod	44	SENT_24	[p1l1609t2084r1677b2119],
44	o	NN	O	o	dep	42	SENT_24	[p1l1609t2084r1677b2119],
45	-	:	O	-	_	0	SENT_24	[p1l1685t2098r1690b2103],
46	0001	CD	DATE	0001	number	47	SENT_24	[p1l1698t2084r1789b2119],
47	)	CD	NUMBER	)	dep	44	SENT_24	[p1l1698t2084r1789b2119],
48	.	.	O	.	_	0	SENT_24	[p1l1698t2084r1789b2119],

1	In	IN	O	in	_	0	SENT_25	[p1l1802t2084r1836b2110],
2	Center	NNP	O	Center	prep_in	10	SENT_25	[p1l13t2128r86b2149],
3	,	,	O	,	_	0	SENT_25	[p1l13t2128r86b2149],
4	San	NNP	LOCATION	San	nn	9	SENT_25	[p1l93t2128r130b2146],
5	Francisco	NNP	LOCATION	Francisco	nn	9	SENT_25	[p1l137t2127r239b2149],
6	,	,	O	,	_	0	SENT_25	[p1l137t2127r239b2149],
7	CA	NNP	LOCATION	CA	appos	9	SENT_25	[p1l245t2128r279b2149],
8	,	,	O	,	_	0	SENT_25	[p1l245t2128r279b2149],
9	USA	NNP	LOCATION	USA	nsubj	10	SENT_25	[p1l286t2128r329b2146],
10	(	VBD	O	(	_	0	SENT_25	[p1l103t2162r153b2187],
11	Prof	NNP	O	Prof	nn	15	SENT_25	[p1l103t2162r153b2187],
12	H	NNP	O	H	nn	15	SENT_25	[p1l159t2164r171b2182],
13	A	NNP	O	A	nn	15	SENT_25	[p1l178t2164r192b2182],
14	Boushey	NNP	O	Boushey	nn	15	SENT_25	[p1l199t2163r284b2188],
15	MD	NNP	O	MD	dobj	10	SENT_25	[p1l290t2164r328b2186],
16	,	,	O	,	_	0	SENT_25	[p1l290t2164r328b2186],
17	Prof	NNP	O	Prof	nn	21	SENT_25	[p1l162t2199r212b2223],
18	]	CD	NUMBER	]	num	21	SENT_25	[p1l162t2199r212b2223],
19	V	NNP	O	V	nn	21	SENT_25	[p1l217t2201r232b2219],
20	Fahy	NNP	ORGANIZATION	Fahy	nn	21	SENT_25	[p1l238t2199r284b2225],
21	MD	NNP	ORGANIZATION	MD	appos	15	SENT_25	[p1l290t2201r329b2222],
22	,	,	O	,	_	0	SENT_25	[p1l290t2201r329b2222],
23	Prof	NNP	PERSON	Prof	nn	27	SENT_25	[p1l6t2235r48b2255],
24	S	NN	PERSON	s	nn	27	SENT_25	[p1l52t2237r62b2255],
25	C	NN	PERSON	c	nn	27	SENT_25	[p1l68t2237r80b2255],
26	Lazarus	NNP	PERSON	Lazarus	nn	27	SENT_25	[p1l87t2237r160b2255],
27	MD	NNP	O	MD	appos	15	SENT_25	[p1l166t2237r215b2260],
28	)	NN	O	)	dep	27	SENT_25	[p1l166t2237r215b2260],
29	;	:	O	;	_	0	SENT_25	[p1l166t2237r215b2260],
30	University	NNP	O	University	dep	15	SENT_25	[p1l221t2236r330b2261],

1	Gly/Gly	RB	O	gly/gly	advmod	2	SENT_26	[p1l7t2328r131b2365],
2	participants	NNS	O	participant	ccomp	8	SENT_26	[p1l142t2329r337b2365],
3	,	,	O	,	_	0	SENT_26	[p1l142t2329r337b2365],
4	moming	JJ	O	moming	amod	5	SENT_26	[p1l351t2329r490b2365],
5	PEF	NN	O	pef	nsubj	8	SENT_26	[p1l503t2330r565b2356],
6	was	VBD	O	be	cop	8	SENT_26	[p1l578t2338r636b2356],
7	21-5	CD	NUMBER	21-5	num	8	SENT_26	[p1l650t2329r718b2356],
8	L/min	NN	O	l/min	_	0	SENT_26	[p1l733t2329r831b2365],
9	(	CD	NUMBER	(	dep	8	SENT_26	[p1l845t2330r1024b2365],
10	11-0-32-1	CD	NUMBER	11-0-32-1	num	11	SENT_26	[p1l845t2330r1024b2365],
11	)	CD	NUMBER	)	npadvmod	12	SENT_26	[p1l845t2330r1024b2365],
12	higher	JJR	O	higher	advmod	8	SENT_26	[p1l1037t2328r1142b2365],
13	when	WRB	O	when	advmod	16	SENT_26	[p1l1152t2328r1239b2356],
14	participants	NNS	O	participant	nsubjpass	16	SENT_26	[p1l1251t2329r1437b2365],
15	were	VBD	O	be	auxpass	16	SENT_26	[p1l1449t2338r1525b2356],
16	assigned	VBN	O	assign	dep	12	SENT_26	[p1l1536t2328r1674b2365],
17	to	TO	O	to	aux	18	SENT_26	[p1l1685t2334r1715b2356],
18	receive	VB	O	receive	xcomp	16	SENT_26	[p1l1727t2329r1836b2356],
19	salmeterol	NN	O	salmeterol	dobj	18	SENT_26	[p1l7t2374r172b2402],
20	than	IN	O	than	_	0	SENT_26	[p1l187t2374r258b2402],
21	when	WRB	O	when	advmod	22	SENT_26	[p1l274t2374r361b2402],
22	assigned	VBN	O	assign	prepc_than	19	SENT_26	[p1l377t2374r515b2411],
23	to	TO	O	to	aux	24	SENT_26	[p1l530t2379r559b2402],
24	receive	VB	O	receive	xcomp	22	SENT_26	[p1l576t2375r685b2402],
25	placebo	NN	O	placebo	nn	27	SENT_26	[p1l701t2374r820b2411],
26	(	NN	O	(	nn	27	SENT_26	[p1l838t2376r1018b2411],
27	p	NN	O	p	nsubj	28	SENT_26	[p1l838t2376r1018b2411],
28	<	JJR	O	<	xcomp	24	SENT_26	[p1l838t2376r1018b2411],
29	0-0001	CD	NUMBER	0-0001	num	30	SENT_26	[p1l838t2376r1018b2411],
30	)	NN	O	)	dep	19	SENT_26	[p1l838t2376r1018b2411],
31	.	.	O	.	_	0	SENT_26	[p1l838t2376r1018b2411],

1	The	DT	O	the	det	2	SENT_27	[p1l1035t2374r1096b2402],
2	improvement	NN	O	improvement	nsubj	7	SENT_27	[p1l1112t2375r1327b2411],
3	in	IN	O	in	_	0	SENT_27	[p1l1343t2375r1374b2402],
4	PEF	NN	O	pef	prep_in	2	SENT_27	[p1l1391t2375r1454b2402],
5	did	VBD	O	do	aux	7	SENT_27	[p1l1471t2374r1521b2402],
6	not	RB	O	not	neg	7	SENT_27	[p1l1537t2379r1589b2402],
7	differ	VB	O	differ	_	0	SENT_27	[p1l1605t2374r1690b2402],
8	between	IN	O	between	_	0	SENT_27	[p1l1705t2374r1836b2402],
9	genotypes	NNS	O	genotype	prep_between	7	SENT_27	[p1l6t2425r164b2457],
10	(	CD	NUMBER	(	num	11	SENT_27	[p1l179t2420r347b2457],
11	difference	NN	O	difference	tmod	7	SENT_27	[p1l179t2420r347b2457],
12	[	CD	NUMBER	[	num	13	SENT_27	[p1l361t2420r654b2457],
13	Arg/Arg	NN	O	arg/arg	dep	11	SENT_27	[p1l361t2420r654b2457],
14	.	.	O	.	_	0	SENT_27	[p1l361t2420r654b2457],

1	—	NN	O	—	_	0	SENT_28	[p1l361t2420r654b2457],
2	.	.	O	.	_	0	SENT_28	[p1l361t2420r654b2457],

1	Gly/Gly	RB	O	gly/gly	advmod	3	SENT_29	[p1l361t2420r654b2457],
2	]	CD	NUMBER	]	number	3	SENT_29	[p1l361t2420r654b2457],
3	-0	CD	NUMBER	-0	_	0	SENT_29	[p1l667t2422r747b2453],
4	-1	CD	NUMBER	-1	dep	3	SENT_29	[p1l667t2422r747b2453],
5	,	,	O	,	_	0	SENT_29	[p1l667t2422r747b2453],
6	-14	CD	NUMBER	-14	num	7	SENT_29	[p1l760t2422r851b2448],
7	-4	CD	NUMBER	-4	appos	3	SENT_29	[p1l760t2422r851b2448],
8	to	TO	O	to	_	0	SENT_29	[p1l863t2425r892b2448],
9	14-2	CD	NUMBER	14-2	prep_to	7	SENT_29	[p1l906t2422r984b2453],
10	;	:	O	;	_	0	SENT_29	[p1l906t2422r984b2453],
11	p	NN	O	p	dep	3	SENT_29	[p1l998t2422r1133b2457],
12	=	JJ	O	=	amod	14	SENT_29	[p1l998t2422r1133b2457],
13	0-99	CD	NUMBER	0-99	tmod	12	SENT_29	[p1l998t2422r1133b2457],
14	)	NN	O	)	dep	11	SENT_29	[p1l998t2422r1133b2457],
15	.	.	O	.	_	0	SENT_29	[p1l998t2422r1133b2457],

1	In	IN	O	in	_	0	SENT_30	[p1l1148t2422r1182b2448],
2	Gly/Gly	JJ	O	gly/gly	amod	4	SENT_30	[p1l1196t2420r1320b2457],
3	partici	NNS	O	particus	nn	4	SENT_30	[p1l1332t2421r1432b2457],
4	ants	NNS	O	ant	prep_in	13	SENT_30	[p1l1453t2425r1527b2453],
5	,	,	O	,	_	0	SENT_30	[p1l1453t2425r1527b2453],
6	methacholine	JJ	O	methacholine	amod	7	SENT_30	[p1l1541t2420r1758b2448],
7	PC	NN	O	pc	appos	4	SENT_30	[p1l1772t2422r1836b2455],
8	,	,	O	,	_	0	SENT_30	[p1l1772t2422r1836b2455],
9	"	``	O	"	punct	12	SENT_30	[p1l1772t2422r1836b2455],
10	ofTexas	NNP	O	ofTexas	nn	12	SENT_30	[p1l50t2467r140b2491],
11	,	,	O	,	_	0	SENT_30	[p1l50t2467r140b2491],
12	Ga	NNP	O	Ga	nsubj	13	SENT_30	[p1l146t2468r297b2491],
13	|	VBD	O	|	_	0	SENT_30	[p1l146t2468r297b2491],
14	veston	NN	O	veston	nn	22	SENT_30	[p1l146t2468r297b2491],
15	,	,	O	,	_	0	SENT_30	[p1l146t2468r297b2491],
16	TX	NNP	LOCATION	TX	nn	18	SENT_30	[p1l146t2468r297b2491],
17	,	,	O	,	_	0	SENT_30	[p1l146t2468r297b2491],
18	USA	NNP	LOCATION	USA	appos	14	SENT_30	[p1l303t2469r347b2488],
19	(	CD	PERCENT	(	num	18	SENT_30	[p1l388t2459r465b2495],
20	20	CD	PERCENT	20	number	21	SENT_30	[p1l388t2459r465b2495],
21	%	NN	PERCENT	%	amod	22	SENT_30	[p1l388t2459r465b2495],
22	reduction	NN	O	reduction	dobj	13	SENT_30	[p1l481t2457r632b2486],
23	in	IN	O	in	_	0	SENT_30	[p1l647t2458r679b2485],
24	forced	JJ	O	forced	amod	26	SENT_30	[p1l694t2457r793b2486],
25	expiratory	JJ	O	expiratory	amod	26	SENT_30	[p1l807t2458r965b2495],
26	volume	NN	O	volume	prep_in	13	SENT_30	[p1l978t2457r1096b2486],
27	in	IN	O	in	_	0	SENT_30	[p1l1111t2458r1142b2485],
28	1	CD	NUMBER	1	num	29	SENT_30	[p1l1158t2460r1172b2485],
29	s	NNS	O	s	prep_in	13	SENT_30	[p1l1188t2467r1210b2490],
30	;	:	O	;	_	0	SENT_30	[p1l1188t2467r1210b2490],
31	a	DT	O	a	det	32	SENT_30	[p1l1227t2467r1243b2486],
32	prespeciﬁe	NN	O	prespeciﬁe	nsubj	38	SENT_30	[p1l1258t2457r1429b2495],
33	secondary	JJ	O	secondary	amod	35	SENT_30	[p1l1465t2457r1622b2495],
34	outcome	NN	O	outcome	nn	35	SENT_30	[p1l1637t2460r1783b2495],
35	)	NN	O	)	dep	32	SENT_30	[p1l1637t2460r1783b2495],
36	was	VBD	O	be	cop	38	SENT_30	[p1l1799t2467r1858b2486],
37	2	CD	NUMBER	2	num	38	SENT_30	[p1l1875t2460r1891b2485],
38	~	NN	O	~	parataxis	13	SENT_30	[p1l1900t2473r1906b2479],
39	4	CD	NUMBER	4	num	40	SENT_30	[p1l1915t2459r1932b2485],
40	times	NNS	O	time	npadvmod	41	SENT_30	[p1l1947t2458r2034b2486],
41	higher	JJR	O	higher	amod	38	SENT_30	[p1l2050t2457r2154b2495],
42	when	WRB	O	when	advmod	38	SENT_30	[p1l6t2503r93b2532],

1	(	NN	O	(	_	0	SENT_31	[p1l122t2540r206b2565],
2	ProfWJ	NNP	O	ProfWJ	nn	4	SENT_31	[p1l122t2540r206b2565],
3	Calhoun	NNP	PERSON	Calhoun	nn	4	SENT_31	[p1l212t2540r294b2560],
4	MD	NNP	O	MD	dep	1	SENT_31	[p1l302t2542r341b2563],
5	,	,	O	,	_	0	SENT_31	[p1l302t2542r341b2563],
6	B	NNP	O	B	nn	8	SENT_31	[p1l11t2578r22b2596],
7	T	NN	O	t	nn	8	SENT_31	[p1l26t2578r40b2596],
8	Ameredes	NNS	O	amerede	appos	4	SENT_31	[p1l44t2576r145b2596],
9	Ph	NN	O	ph	nn	11	SENT_31	[p1l152t2576r175b2596],
10	D	NN	O	d	nn	11	SENT_31	[p1l179t2577r206b2601],
11	)	NN	O	)	dep	8	SENT_31	[p1l179t2577r206b2601],
12	;	:	O	;	_	0	SENT_31	[p1l179t2577r206b2601],
13	Washington	NNP	ORGANIZATION	Washington	nn	15	SENT_31	[p1l211t2576r341b2602],
14	University	NNP	ORGANIZATION	University	nn	15	SENT_31	[p1l22t2614r131b2639],
15	School	NNP	ORGANIZATION	School	dep	8	SENT_31	[p1l136t2613r205b2633],
16	of	IN	ORGANIZATION	of	_	0	SENT_31	[p1l211t2613r234b2633],
17	Medicine	NNP	ORGANIZATION	Medicine	prep_of	15	SENT_31	[p1l239t2613r341b2636],
18	,	,	O	,	_	0	SENT_31	[p1l239t2613r341b2636],
19	St	NNP	LOCATION	St	nn	24	SENT_31	[p1l6t2651r27b2669],
20	Louis	NNP	LOCATION	Louis	nn	24	SENT_31	[p1l34t2650r93b2673],
21	,	,	O	,	_	0	SENT_31	[p1l34t2650r93b2673],
22	MO	NNP	DURATION	MO	appos	24	SENT_31	[p1l100t2651r143b2673],
23	,	,	O	,	_	0	SENT_31	[p1l100t2651r143b2673],
24	USA	NNP	LOCATION	USA	appos	17	SENT_31	[p1l149t2651r193b2669],
25	(	CD	NUMBER	(	num	24	SENT_31	[p1l199t2650r226b2674],
26	M	NN	O	m	nn	28	SENT_31	[p1l199t2650r226b2674],
27	Castro	NNP	PERSON	Castro	nn	28	SENT_31	[p1l232t2651r295b2669],
28	MD	NNP	O	MD	dep	24	SENT_31	[p1l302t2651r341b2673],
29	,	,	O	,	_	0	SENT_31	[p1l302t2651r341b2673],

1	participants	NNS	O	participant	nsubjpass	3	SENT_32	[p1l6t2745r192b2781],
2	were	VBD	O	be	auxpass	3	SENT_32	[p1l201t2754r276b2772],
3	assigned	VBN	O	assign	_	0	SENT_32	[p1l285t2744r423b2781],
4	to	TO	O	to	_	0	SENT_32	[p1l431t2749r461b2772],
5	salmeterol	NN	O	salmeterol	prep_to	3	SENT_32	[p1l470t2744r635b2772],
6	than	IN	O	than	_	0	SENT_32	[p1l643t2744r715b2772],
7	when	WRB	O	when	advmod	8	SENT_32	[p1l723t2744r810b2772],
8	assigned	VBN	O	assign	prepc_than	3	SENT_32	[p1l819t2744r956b2781],
9	to	TO	O	to	_	0	SENT_32	[p1l965t2750r994b2772],
10	placebo	NN	O	placebo	nn	12	SENT_32	[p1l1003t2744r1122b2781],
11	(	NN	O	(	nn	12	SENT_32	[p1l1133t2746r1201b2781],
12	p	NN	O	p	prep_to	8	SENT_32	[p1l1133t2746r1201b2781],
13	<	JJR	O	<	amod	14	SENT_32	[p1l1133t2746r1201b2781],
14	o	NN	O	o	dep	12	SENT_32	[p1l1133t2746r1201b2781],
15	-	:	O	-	_	0	SENT_32	[p1l1209t2760r1214b2765],
16	0001	CD	DATE	0001	number	17	SENT_32	[p1l1222t2746r1313b2781],
17	)	CD	NUMBER	)	dep	14	SENT_32	[p1l1222t2746r1313b2781],
18	.	.	O	.	_	0	SENT_32	[p1l1222t2746r1313b2781],

1	Responsiveness	NN	O	responsiveness	nsubj	6	SENT_33	[p1l1324t2745r1572b2781],
2	to	TO	O	to	_	0	SENT_33	[p1l1581t2749r1611b2772],
3	methacholine	NN	O	methacholine	prep_to	1	SENT_33	[p1l1620t2744r1836b2772],
4	did	VBD	O	do	aux	6	SENT_33	[p1l6t2790r56b2818],
5	not	RB	O	not	neg	6	SENT_33	[p1l70t2795r122b2818],
6	differ	VB	O	differ	dep	14	SENT_33	[p1l136t2790r221b2818],
7	between	IN	O	between	_	0	SENT_33	[p1l234t2790r366b2818],
8	salmeterol	NN	O	salmeterol	prep_between	6	SENT_33	[p1l381t2790r545b2818],
9	and	CC	O	and	_	0	SENT_33	[p1l559t2790r618b2818],
10	placebo	NN	O	placebo	prep_between	6	SENT_33	[p1l632t2790r751b2827],
11	in	IN	O	in	_	0	SENT_33	[p1l766t2791r797b2818],
12	Arg/Arg	NN	O	arg/arg	nn	13	SENT_33	[p1l810t2792r944b2827],
13	participants	NNS	O	participant	prep_in	6	SENT_33	[p1l958t2791r1143b2827],
14	(	VBP	O	(	_	0	SENT_33	[p1l1160t2791r1305b2827],
15	p	NN	O	p	nsubj	16	SENT_33	[p1l1160t2791r1305b2827],
16	=	JJ	O	=	xcomp	14	SENT_33	[p1l1160t2791r1305b2827],
17	0-87	CD	NUMBER	0-87	num	18	SENT_33	[p1l1160t2791r1305b2827],
18	)	NN	O	)	nsubj	14	SENT_33	[p1l1160t2791r1305b2827],
19	.	.	O	.	_	0	SENT_33	[p1l1160t2791r1305b2827],

1	The	DT	O	the	det	6	SENT_34	[p1l1320t2790r1381b2818],
2	2-5	CD	NUMBER	2-5	number	3	SENT_34	[p1l1396t2791r1448b2818],
3	times	NNS	O	time	dep	6	SENT_34	[p1l1463t2791r1551b2818],
4	higher	JJR	O	higher	dep	3	SENT_34	[p1l1565t2790r1670b2827],
5	genotypespeciﬁc	NN	O	genotypespeciﬁc	nn	6	SENT_34	[p1l1683t2795r1836b2827, p1l7t2836r124b2873],
6	difference	NN	O	difference	nsubj	13	SENT_34	[p1l143t2835r301b2864],
7	in	IN	O	in	_	0	SENT_34	[p1l320t2837r351b2863],
8	responsiveness	NN	O	responsiveness	prep_in	6	SENT_34	[p1l370t2837r609b2873],
9	to	TO	O	to	_	0	SENT_34	[p1l629t2841r658b2864],
10	methacholine	NN	O	methacholine	prep_to	8	SENT_34	[p1l678t2835r894b2864],
11	was	VBD	O	be	cop	13	SENT_34	[p1l912t2845r971b2864],
12	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_34	[p1l992t2836r1157b2873],
13	(	NN	O	(	_	0	SENT_34	[p1l1178t2838r1258b2873],
14	1-32	CD	NUMBER	1-32	num	13	SENT_34	[p1l1178t2838r1258b2873],
15	doubling	VBG	O	double	partmod	13	SENT_34	[p1l1278t2835r1419b2873],
16	dose	NN	O	dose	nn	17	SENT_34	[p1l1438t2835r1509b2864],
17	difference	NN	O	difference	nn	31	SENT_34	[p1l1528t2835r1686b2864],
18	between	IN	O	between	_	0	SENT_34	[p1l1704t2835r1836b2864],
19	MJWalter	NN	O	mjwalter	nn	21	SENT_34	[p1l51t2884r151b2909],
20	MD	NN	O	md	nn	21	SENT_34	[p1l161t2885r210b2909],
21	)	NN	O	)	prep_between	17	SENT_34	[p1l161t2885r210b2909],
22	;	:	O	;	_	0	SENT_34	[p1l161t2885r210b2909],
23	Universityof	JJ	O	universityof	amod	24	SENT_34	[p1l220t2884r356b2910],
24	genotypes	NNS	O	genotype	dep	17	SENT_34	[p1l396t2880r562b2912],
25	,	,	O	,	_	0	SENT_34	[p1l396t2880r562b2912],
26	0-43-2-21	NN	O	0-43-2-21	appos	24	SENT_34	[p1l587t2877r775b2908],
27	,	,	O	,	_	0	SENT_34	[p1l587t2877r775b2908],
28	p	NN	O	p	appos	24	SENT_34	[p1l799t2877r980b2912],
29	=	JJ	O	=	amod	31	SENT_34	[p1l799t2877r980b2912],
30	0-0038	CD	NUMBER	0-0038	tmod	29	SENT_34	[p1l799t2877r980b2912],
31	)	NN	O	)	dobj	15	SENT_34	[p1l799t2877r980b2912],
32	.	.	O	.	_	0	SENT_34	[p1l799t2877r980b2912],

1	Seven	CD	NUMBER	seven	num	3	SENT_35	[p1l1006t2877r1096b2903],
2	Arg/Arg	NN	O	arg/arg	nn	3	SENT_35	[p1l1118t2877r1251b2912],
3	participants	NNS	O	participant	nsubj	4	SENT_35	[p1l1274t2876r1459b2912],
4	(	VBP	O	(	_	0	SENT_35	[p1l1485t2875r1622b2912],
5	placebo	NN	O	placebo	dobj	4	SENT_35	[p1l1485t2875r1622b2912],
6	,	,	O	,	_	0	SENT_35	[p1l1485t2875r1622b2912],
7	n	NN	O	n	conj_and	5	SENT_35	[p1l1646t2876r1714b2908],
8	=	JJ	O	=	amod	7	SENT_35	[p1l1646t2876r1714b2908],
9	5	CD	NUMBER	5	tmod	8	SENT_35	[p1l1646t2876r1714b2908],
10	;	:	O	;	_	0	SENT_35	[p1l1646t2876r1714b2908],
11	salmeterol	NN	O	salmeterol	dep	7	SENT_35	[p1l1739t2875r1912b2908],
12	,	,	O	,	_	0	SENT_35	[p1l1739t2875r1912b2908],
13	n	NN	O	n	appos	11	SENT_35	[p1l1936t2877r2006b2912],
14	=	JJ	O	=	amod	16	SENT_35	[p1l1936t2877r2006b2912],
15	2	CD	NUMBER	2	tmod	14	SENT_35	[p1l1936t2877r2006b2912],
16	)	NN	O	)	dep	13	SENT_35	[p1l1936t2877r2006b2912],
17	and	CC	O	and	_	0	SENT_35	[p1l2030t2875r2089b2903],
18	six	CD	NUMBER	six	num	20	SENT_35	[p1l2112t2876r2154b2903],
19	Gly/Gly	NNP	O	Gly/Gly	nn	20	SENT_35	[p1l6t2920r130b2957],
20	Wisconsin	NNP	LOCATION	Wisconsin	dobj	4	SENT_35	[p1l6t2965r222b2989],
21	.	.	O	.	_	0	SENT_35	[p1l6t2965r222b2989],

1	—	NN	O	—	_	0	SENT_36	[p1l6t2965r222b2989],
2	.	.	O	.	_	0	SENT_36	[p1l6t2965r222b2989],

1	Madison	NNP	O	Madison	nn	7	SENT_37	[p1l6t2965r222b2989],
2	,	,	O	,	_	0	SENT_37	[p1l6t2965r222b2989],
3	Madison	NNP	PERSON	Madison	appos	7	SENT_37	[p1l229t2965r326b2989],
4	,	,	O	,	_	0	SENT_37	[p1l229t2965r326b2989],
5	WI	NNP	O	WI	appos	7	SENT_37	[p1l69t3004r103b3025],
6	,	,	O	,	_	0	SENT_37	[p1l69t3004r103b3025],
7	USA	NNP	LOCATION	USA	_	0	SENT_37	[p1l110t3003r154b3022],
8	(	CD	NUMBER	(	num	7	SENT_37	[p1l160t3003r178b3027],
9	L	NN	PERSON	l	nn	11	SENT_37	[p1l160t3003r178b3027],
10	Denlinger	NN	PERSON	denlinger	nn	11	SENT_37	[p1l184t3002r281b3028],
11	MD	NN	O	md	dep	7	SENT_37	[p1l287t3004r326b3025],
12	,	,	O	,	_	0	SENT_37	[p1l287t3004r326b3025],
13	Prof	NNP	O	Prof	nn	17	SENT_37	[p1l63t3038r105b3058],
14	C	NNP	O	C	nn	17	SENT_37	[p1l109t3040r121b3058],
15	A	NNP	O	A	nn	17	SENT_37	[p1l126t3040r140b3058],
16	Sorkness	NNP	O	Sorkness	nn	17	SENT_37	[p1l146t3038r234b3058],
17	PharmD	NNP	O	PharmD	appos	11	SENT_37	[p1l241t3038r326b3062],
18	,	,	O	,	_	0	SENT_37	[p1l241t3038r326b3062],
19	Prof	NNP	O	Prof	nn	21	SENT_37	[p1l148t3075r189b3095],
20	Njarjour	NNP	O	Njarjour	nn	21	SENT_37	[p1l195t3077r281b3101],
21	MD	NNP	O	MD	appos	17	SENT_37	[p1l287t3077r326b3098],
22	,	,	O	,	_	0	SENT_37	[p1l287t3077r326b3098],

1	participants	NNS	O	participant	_	0	SENT_38	[p1l6t3171r192b3207],
2	(	CD	NUMBER	(	num	3	SENT_38	[p1l206t3170r343b3208],
3	placebo	NN	O	placebo	dep	1	SENT_38	[p1l206t3170r343b3208],
4	,	,	O	,	_	0	SENT_38	[p1l206t3170r343b3208],
5	n	NN	O	n	appos	3	SENT_38	[p1l356t3173r424b3203],
6	=	JJ	O	=	amod	5	SENT_38	[p1l356t3173r424b3203],
7	3	CD	NUMBER	3	tmod	6	SENT_38	[p1l356t3173r424b3203],
8	;	:	O	;	_	0	SENT_38	[p1l356t3173r424b3203],
9	salmeterol	NN	O	salmeterol	dep	1	SENT_38	[p1l438t3170r610b3203],
10	,	,	O	,	_	0	SENT_38	[p1l438t3170r610b3203],
11	n	NN	O	n	appos	9	SENT_38	[p1l623t3173r693b3208],
12	=	JJ	O	=	amod	14	SENT_38	[p1l623t3173r693b3208],
13	3	CD	NUMBER	3	num	14	SENT_38	[p1l623t3173r693b3208],
14	)	NN	O	)	nsubj	15	SENT_38	[p1l623t3173r693b3208],
15	had	VBD	O	have	rcmod	11	SENT_38	[p1l705t3170r764b3199],
16	an	DT	O	a	det	18	SENT_38	[p1l774t3180r812b3199],
17	asthma	NN	O	asthma	nn	18	SENT_38	[p1l823t3170r939b3199],
18	exacerbation	NN	O	exacerbation	dobj	15	SENT_38	[p1l950t3170r1156b3199],
19	.	.	O	.	_	0	SENT_38	[p1l950t3170r1156b3199],

1	Five	CD	NUMBER	five	num	4	SENT_39	[p1l1170t3171r1233b3199],
2	serious	JJ	O	serious	amod	4	SENT_39	[p1l1245t3171r1357b3199],
3	adverse	JJ	O	adverse	amod	4	SENT_39	[p1l1369t3170r1487b3199],
4	events	NNS	O	event	nsubj	6	SENT_39	[p1l1498t3176r1597b3199],
5	were	VBD	O	be	aux	6	SENT_39	[p1l1608t3180r1683b3199],
6	reported	VBN	O	report	_	0	SENT_39	[p1l1694t3170r1835b3207],
7	,	,	O	,	_	0	SENT_39	[p1l1694t3170r1835b3207],
8	one	CD	NUMBER	one	dep	9	SENT_39	[p1l7t3226r64b3244],
9	each	DT	O	each	advmod	18	SENT_39	[p1l79t3216r150b3244],
10	during	IN	O	during	_	0	SENT_39	[p1l165t3216r273b3253],
11	the	DT	O	the	det	15	SENT_39	[p1l287t3216r336b3244],
12	pre-match	JJ	O	pre-match	amod	15	SENT_39	[p1l351t3216r512b3253],
13	and	CC	O	and	_	0	SENT_39	[p1l527t3216r586b3244],
14	run-in	JJ	O	run-in	amod	15	SENT_39	[p1l601t3217r700b3244],
15	phases	NNS	O	phase	prep_during	9	SENT_39	[p1l715t3216r822b3253],
16	on	IN	O	on	_	0	SENT_39	[p1l838t3226r878b3244],
17	open-label	JJ	O	open-label	prep_on	9	SENT_39	[p1l893t3216r1056b3253],
18	inhaled	VBN	O	inhale	dep	6	SENT_39	[p1l1071t3216r1189b3244],
19	corticosteroid	NN	O	corticosteroid	dobj	18	SENT_39	[p1l1204t3216r1427b3249],
20	,	,	O	,	_	0	SENT_39	[p1l1204t3216r1427b3249],
21	two	CD	NUMBER	two	dep	6	SENT_39	[p1l1443t3222r1499b3244],
22	during	IN	O	during	_	0	SENT_39	[p1l1515t3216r1622b3253],
23	double-blind	JJ	O	double-blind	amod	24	SENT_39	[p1l1637t3216r1837b3244],
24	treatment	NN	O	treatment	prep_during	21	SENT_39	[p1l6t3267r162b3290],
25	with	IN	O	with	dep	21	SENT_39	[p1l179t3262r248b3290],
26	salmeterol/inhaled	VBN	O	salmeterol/inhaled	pcomp	25	SENT_39	[p1l267t3262r567b3299],
27	corticosteroid	NN	O	corticosteroid	dobj	26	SENT_39	[p1l585t3262r808b3295],
28	,	,	O	,	_	0	SENT_39	[p1l585t3262r808b3295],
29	and	CC	O	and	_	0	SENT_39	[p1l827t3262r886b3290],
30	one	CD	NUMBER	one	dobj	26	SENT_39	[p1l904t3272r961b3290],
31	during	IN	O	during	_	0	SENT_39	[p1l979t3262r1086b3299],
32	double-blind	JJ	O	double-blind	amod	33	SENT_39	[p1l1104t3262r1305b3290],
33	treatment	NN	O	treatment	prep_during	30	SENT_39	[p1l1322t3267r1478b3290],
34	with	IN	O	with	_	0	SENT_39	[p1l1495t3262r1565b3290],
35	placebo/inhaled	VBN	O	placebo/inhaled	prepc_with	26	SENT_39	[p1l1583t3262r1837b3299],
36	ProfR	NN	O	profr	nn	41	SENT_39	[p1l32t3309r90b3330],
37	F	NN	O	f	nn	41	SENT_39	[p1l97t3311r107b3329],
38	Lemanske	NN	PERSON	lemanske	nn	41	SENT_39	[p1l114t3309r213b3330],
39	Jr	NNP	PERSON	Jr	nn	41	SENT_39	[p1l216t3311r232b3334],
40	MD	NNP	O	MD	nn	41	SENT_39	[p1l239t3311r287b3335],
41	)	NN	O	)	dobj	35	SENT_39	[p1l239t3311r287b3335],
42	;	:	O	;	_	0	SENT_39	[p1l239t3311r287b3335],
43	Duke	NNP	PERSON	Duke	nn	44	SENT_39	[p1l294t3309r347b3330],
44	corticosteroid	NN	O	corticosteroid	dep	41	SENT_39	[p1l384t3301r606b3330],
45	.	.	O	.	_	0	SENT_39	[p1l384t3301r606b3330],

1	None	NN	O	none	nsubj	9	SENT_40	[p1l619t3304r703b3330],
2	of	IN	O	of	_	0	SENT_40	[p1l714t3301r750b3330],
3	the	DT	O	the	det	5	SENT_40	[p1l754t3301r804b3330],
4	serious	JJ	O	serious	amod	5	SENT_40	[p1l815t3302r927b3330],
5	events	NNS	O	event	prep_of	1	SENT_40	[p1l939t3307r1038b3330],
6	was	VBD	O	be	cop	7	SENT_40	[p1l1049t3311r1107b3330],
7	asthma-related	JJ	O	asthma-related	_	0	SENT_40	[p1l1119t3301r1353b3330],
8	or	CC	O	or	_	0	SENT_40	[p1l1364t3311r1396b3330],
9	related	JJ	O	related	conj_or	7	SENT_40	[p1l1406t3301r1514b3330],
10	to	TO	O	to	aux	11	SENT_40	[p1l1524t3307r1553b3330],
11	study	VB	O	study	xcomp	7	SENT_40	[p1l1565t3301r1649b3339],
12	drugs	NNS	O	drug	dobj	11	SENT_40	[p1l1659t3301r1748b3339],
13	or	CC	O	or	_	0	SENT_40	[p1l1760t3311r1793b3330],
14	procedures	NNS	O	procedure	dobj	11	SENT_40	[p1l1803t3301r1986b3339],
15	.	.	O	.	_	0	SENT_40	[p1l1803t3301r1986b3339],

1	University	NNP	ORGANIZATION	University	nn	9	SENT_41	[p1l72t3347r181b3372],
2	Medical	NNP	ORGANIZATION	Medical	nn	9	SENT_41	[p1l187t3346r267b3366],
3	Center	NNP	ORGANIZATION	Center	nn	9	SENT_41	[p1l273t3348r347b3370],
4	,	,	O	,	_	0	SENT_41	[p1l273t3348r347b3370],
5	Durham	NNP	LOCATION	Durham	appos	9	SENT_41	[p1l146t3383r237b3406],
6	,	,	O	,	_	0	SENT_41	[p1l146t3383r237b3406],
7	NC	NNP	O	NC	appos	9	SENT_41	[p1l244t3384r279b3406],
8	,	,	O	,	_	0	SENT_41	[p1l244t3384r279b3406],
9	USA	NNP	LOCATION	USA	_	0	SENT_41	[p1l285t3384r329b3403],
10	(	CD	NUMBER	(	num	9	SENT_41	[p1l48t3419r121b3445],
11	ProfM	NNP	O	ProfM	nn	14	SENT_41	[p1l48t3419r121b3445],
12	Kraft	NNP	PERSON	Kraft	nn	14	SENT_41	[p1l129t3419r176b3439],
13	MD	NN	O	md	nn	14	SENT_41	[p1l183t3421r231b3445],
14	)	NN	O	)	dep	9	SENT_41	[p1l183t3421r231b3445],
15	;	:	O	;	_	0	SENT_41	[p1l183t3421r231b3445],
16	National	NNP	ORGANIZATION	National	nn	19	SENT_41	[p1l238t3419r328b3439],
17	Jewish	NNP	ORGANIZATION	Jewish	nn	19	SENT_41	[p1l6t3456r76b3481],
18	Medical	NNP	ORGANIZATION	Medical	nn	19	SENT_41	[p1l83t3456r163b3476],
19	Center	NNP	ORGANIZATION	Center	dep	14	SENT_41	[p1l169t3458r242b3480],
20	,	,	O	,	_	0	SENT_41	[p1l169t3458r242b3480],
21	Denver	NNP	LOCATION	Denver	appos	19	SENT_41	[p1l250t3458r328b3480],
22	,	,	O	,	_	0	SENT_41	[p1l250t3458r328b3480],

1	Interpretation	NN	O	interpretation	npadvmod	20	SENT_42	[p1l7t3529r220b3563],
2	In	IN	O	in	_	0	SENT_42	[p1l242t3530r276b3555],
3	asthma	NN	O	asthma	nn	4	SENT_42	[p1l296t3527r410b3555],
4	patients	NNS	O	patient	prep_in	20	SENT_42	[p1l430t3528r553b3564],
5	with	IN	O	with	_	0	SENT_42	[p1l573t3527r643b3555],
6	B16	NN	O	b16	nn	7	SENT_42	[p1l663t3529r720b3555],
7	Arg/Arg	NN	O	arg/arg	prep_with	4	SENT_42	[p1l739t3529r871b3564],
8	and	CC	O	and	_	0	SENT_42	[p1l890t3527r949b3555],
9	B16	NN	O	b16	nn	11	SENT_42	[p1l969t3529r1025b3555],
10	Gly/Gly	NN	O	gly/gly	nn	11	SENT_42	[p1l1046t3527r1170b3564],
11	genotypes	NNS	O	genotype	conj_and	7	SENT_42	[p1l1189t3532r1354b3564],
12	,	,	O	,	_	0	SENT_42	[p1l1189t3532r1354b3564],
13	combination	NN	O	combination	nn	14	SENT_42	[p1l1375t3527r1574b3555],
14	treatment	NN	O	treatment	nsubj	20	SENT_42	[p1l1593t3532r1747b3555],
15	with	IN	O	with	dep	14	SENT_42	[p1l1766t3527r1835b3555],
16	salmeterol	NN	O	salmeterol	pobj	15	SENT_42	[p1l6t3572r169b3601],
17	and	CC	O	and	_	0	SENT_42	[p1l180t3572r239b3601],
18	inhaled	VBN	O	inhale	dep	14	SENT_42	[p1l250t3572r367b3601],
19	corticosteroid	NN	O	corticosteroid	dobj	18	SENT_42	[p1l378t3572r592b3601],
20	improved	VBD	O	improve	_	0	SENT_42	[p1l603t3572r753b3610],
21	airway	NN	O	airway	nn	22	SENT_42	[p1l764t3574r866b3610],
22	function	NN	O	function	dobj	20	SENT_42	[p1l876t3572r1009b3601],
23	when	WRB	O	when	advmod	24	SENT_42	[p1l1020t3572r1107b3601],
24	compared	VBN	O	compare	advcl	20	SENT_42	[p1l1118t3572r1274b3610],
25	with	IN	O	with	_	0	SENT_42	[p1l1285t3572r1354b3601],
26	inhaled	VBN	O	inhale	prepc_with	24	SENT_42	[p1l1366t3572r1483b3601],
27	corticosteroid	NN	O	corticosteroid	nn	29	SENT_42	[p1l1494t3572r1707b3601],
28	therapy	NN	O	therapy	nn	29	SENT_42	[p1l1718t3572r1836b3610],
29	co	NN	O	co	nsubj	38	SENT_42	[p1l59t3623r93b3645],
30	,	,	O	,	_	0	SENT_42	[p1l59t3623r93b3645],
31	USA	NNP	LOCATION	USA	appos	29	SENT_42	[p1l100t3623r144b3641],
32	(	CD	NUMBER	(	num	31	SENT_42	[p1l150t3621r216b3647],
33	ProfR	NNP	O	ProfR	nn	36	SENT_42	[p1l150t3621r216b3647],
34	J	NNP	O	J	nn	36	SENT_42	[p1l220t3623r226b3646],
35	Martin	NNP	PERSON	Martin	nn	36	SENT_42	[p1l240t3623r306b3641],
36	MD	NNP	O	MD	dep	31	SENT_42	[p1l319t3623r358b3645],
37	,	,	O	,	_	0	SENT_42	[p1l319t3623r358b3645],
38	alone	RB	O	alone	xcomp	26	SENT_42	[p1l402t3614r494b3643],
39	.	.	O	.	_	0	SENT_42	[p1l402t3614r494b3643],

1	These	DT	O	these	det	2	SENT_43	[p1l512t3614r606b3643],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_43	[p1l623t3614r752b3652],
3	suggest	VBP	O	suggest	_	0	SENT_43	[p1l771t3620r889b3652],
4	that	IN	O	that	complm	7	SENT_43	[p1l905t3614r966b3643],
5	patients	NNS	O	patient	nsubj	7	SENT_43	[p1l982t3615r1106b3652],
6	should	MD	O	should	aux	7	SENT_43	[p1l1125t3614r1231b3643],
7	continue	VB	O	continue	ccomp	3	SENT_43	[p1l1248t3615r1386b3643],
8	to	TO	O	to	aux	10	SENT_43	[p1l1402t3620r1432b3643],
9	be	VB	O	be	auxpass	10	SENT_43	[p1l1449t3614r1485b3643],
10	treated	VBN	O	treat	xcomp	7	SENT_43	[p1l1502t3614r1610b3643],
11	with	IN	O	with	_	0	SENT_43	[p1l1626t3614r1695b3643],
12	longacting	VBG	O	longact	prepc_with	10	SENT_43	[p1l1713t3614r1878b3652],
13	[	NN	O	[	dobj	12	SENT_43	[p1l1896t3614r1925b3651],
14	5	CD	NUMBER	5	num	13	SENT_43	[p1l1896t3614r1925b3651],
15	,	,	O	,	_	0	SENT_43	[p1l1896t3614r1925b3651],
16	agonists	NNS	O	agonist	appos	13	SENT_43	[p1l1942t3615r2070b3652],
17	plus	CC	O	plus	prep	16	SENT_43	[p1l2088t3614r2154b3652],
18	moderateE	NN	O	moderatee	dep	17	SENT_43	[p1l6t3660r164b3689, p1l157t3697r167b3714],

1	R	NN	O	r	nn	3	SENT_44	[p1l174t3697r185b3715],
2	Sutherland	NNP	PERSON	Sutherland	nn	3	SENT_44	[p1l191t3695r300b3715],
3	MD	NNP	O	MD	_	0	SENT_44	[p1l307t3697r346b3718],
4	,	,	O	,	_	0	SENT_44	[p1l307t3697r346b3718],
5	ProfSJ	NNP	O	ProfSJ	nn	8	SENT_44	[p1l107t3731r174b3756],
6	Szeﬂer	NNP	O	Szeﬂer	nn	8	SENT_44	[p1l181t3731r247b3751],
7	MD	NN	O	md	nn	8	SENT_44	[p1l253t3732r301b3756],
8	)	NN	O	)	dep	3	SENT_44	[p1l253t3732r301b3756],
9	;	:	O	;	_	0	SENT_44	[p1l253t3732r301b3756],
10	and	CC	O	and	dep	8	SENT_44	[p1l307t3731r347b3751],
11	University	NNP	ORGANIZATION	University	dep	10	SENT_44	[p1l99t3769r208b3794],
12	of	IN	ORGANIZATION	of	_	0	SENT_44	[p1l213t3768r236b3788],
13	California	NNP	ORGANIZATION	California	prep_of	11	SENT_44	[p1l240t3768r346b3791],
14	,	,	O	,	_	0	SENT_44	[p1l240t3768r346b3791],

1	dose	NN	O	dose	nsubj	2	SENT_45	[p2l6t20r77b48],
2	inhaled	VBD	O	inhale	_	0	SENT_45	[p2l87t20r205b48],
3	corticosteroids	NNS	O	corticosteroid	dobj	2	SENT_45	[p2l214t20r442b48],
4	irrespective	RB	O	irrespective	_	0	SENT_45	[p2l453t21r633b57],
5	of	IN	O	of	_	0	SENT_45	[p2l644t20r679b48],
6	B16	NN	O	b16	nn	7	SENT_45	[p2l685t22r741b48],
7	genotype	NN	O	genotype	prep_irrespective_of	2	SENT_45	[p2l752t25r901b57],
8	.	.	O	.	_	0	SENT_45	[p2l752t25r901b57],

1	Further	JJ	O	further	amod	2	SENT_46	[p2l914t20r1031b48],
2	investigation	NN	O	investigation	nsubjpass	4	SENT_46	[p2l1041t21r1242b57],
3	is	VBZ	O	be	auxpass	4	SENT_46	[p2l1252t21r1277b48],
4	needed	VBN	O	need	_	0	SENT_46	[p2l1288t20r1401b48],
5	to	TO	O	to	aux	6	SENT_46	[p2l1410t25r1440b48],
6	establish	VB	O	establish	xcomp	4	SENT_46	[p2l1450t20r1588b48],
7	the	DT	O	the	det	8	SENT_46	[p2l1597t20r1647b48],
8	importance	NN	O	importance	dobj	6	SENT_46	[p2l1657t21r1836b57],
9	of	IN	O	of	_	0	SENT_46	[p2l6t66r42b94],
10	the	DT	O	the	det	12	SENT_46	[p2l46t66r95b94],
11	genotype-speciﬁc	NN	O	genotype-speciﬁc	nn	12	SENT_46	[p2l106t66r375b103],
12	difference	NN	O	difference	prep_of	8	SENT_46	[p2l386t66r542b94],
13	in	IN	O	in	_	0	SENT_46	[p2l553t67r584b94],
14	responsiveness	NN	O	responsiveness	prep_in	12	SENT_46	[p2l595t67r832b103],
15	to	TO	O	to	_	0	SENT_46	[p2l842t71r872b94],
16	methacholine	NN	O	methacholine	prep_to	6	SENT_46	[p2l883t66r1105b94],
17	.	.	O	.	_	0	SENT_46	[p2l883t66r1105b94],

1	San	NNP	ORGANIZATION	San	nn	2	SENT_47	[p2l75t115r112b133],
2	Diego	NNP	ORGANIZATION	Diego	_	0	SENT_47	[p2l120t114r180b139],
3	Medical	NNP	ORGANIZATION	Medical	nn	4	SENT_47	[p2l187t113r267b133],
4	Center	NNP	ORGANIZATION	Center	dep	2	SENT_47	[p2l273t115r347b136],
5	,	,	O	,	_	0	SENT_47	[p2l273t115r347b136],

1	San	NNP	LOCATION	San	nn	2	SENT_48	[p2l146t151r183b169],
2	Diego	NNP	LOCATION	Diego	_	0	SENT_48	[p2l191t150r257b176],
3	,	,	O	,	_	0	SENT_48	[p2l191t150r257b176],
4	CA	NNP	LOCATION	CA	appos	2	SENT_48	[p2l263t151r297b173],
5	,	,	O	,	_	0	SENT_48	[p2l263t151r297b173],
6	USA	NNP	ORGANIZATION	USA	nn	9	SENT_48	[p2l303t151r347b169],
7	Funding	NNP	ORGANIZATION	Funding	nn	9	SENT_48	[p2l385t144r507b180],
8	National	NNP	ORGANIZATION	National	nn	9	SENT_48	[p2l519t143r652b172],
9	Institutes	NNPS	ORGANIZATION	Institutes	appos	2	SENT_48	[p2l663t144r810b172],
10	of	IN	ORGANIZATION	of	_	0	SENT_48	[p2l822t143r857b172],
11	Health	NNP	ORGANIZATION	Health	prep_of	9	SENT_48	[p2l863t143r976b172],
12	.	.	O	.	_	0	SENT_48	[p2l863t143r976b172],

1	(	NN	O	(	nsubj	11	SENT_49	[p2l145t186r204b211],
2	Profj	NNP	PERSON	Profj	nn	4	SENT_49	[p2l145t186r204b211],
3	Ramsdell	NNP	PERSON	Ramsdell	nn	4	SENT_49	[p2l212t186r300b206],
4	MD	NNP	O	MD	dep	1	SENT_49	[p2l307t188r346b209],
5	,	,	O	,	_	0	SENT_49	[p2l307t188r346b209],
6	is	VBZ	O	be	cop	11	SENT_49	[p2l134t222r158b242],
7	Pro	FW	O	pro	nn	11	SENT_49	[p2l869t231r876b237, p2l101t224r133b242],
8	IW	FW	O	iw	nn	11	SENT_49	[p2l165t224r195b242],
9	ssssss	FW	O	ssssss	nn	11	SENT_49	[p2l195t229r264b242],
10	anMD	NN	O	anmd	nn	11	SENT_49	[p2l266t223r338b247],
11	)	NN	O	)	_	0	SENT_49	[p2l266t223r338b247],
12	lntroductlon	NN	O	lntroductlon	dep	11	SENT_49	[p2l693t230r924b263],
13	Correspondence	NN	O	correspondence	dobj	12	SENT_49	[p2l145t270r307b296],
14	to	TO	O	to	_	0	SENT_49	[p2l312t274r338b290],
15	:	:	O	:	_	0	SENT_49	[p2l312t274r338b290],
16	-	:	O	-	_	0	SENT_49	[p2l789t282r793b286],
17	-	:	O	-	_	0	SENT_49	[p2l850t282r854b286],
18	-	:	O	-	_	0	SENT_49	[p2l1083t282r1087b286],
19	-	:	O	-	_	0	SENT_49	[p2l1259t282r1263b286],
20	DrmhaelEwechslewrigham	NN	DATE	drmhaelewechslewrigham	prep_to	12	SENT_49	[p2l1454t282r1458b286, p2l28t307r338b333],

1	.	.	O	.	_	0	SENT_50	[p2l692t280r904b332],

1	COII1l	NN	O	coii1l	_	0	SENT_51	[p2l692t280r904b332],
2	)	CD	NUMBER	)	num	3	SENT_51	[p2l692t280r904b332],
3	1I1alI10I1	NN	O	1i1ali10i1	dep	1	SENT_51	[p2l692t280r904b332],
4	.	.	O	.	_	0	SENT_51	[p2l692t280r904b332],

1	therapy	NN	O	therapy	nsubj	10	SENT_52	[p2l917t280r1035b332],
2	with	IN	O	with	_	0	SENT_52	[p2l1053t280r1122b332],
3	longacting	VBG	O	longact	prepc_with	1	SENT_52	[p2l1141t280r1306b318],
4	B2	NN	O	b2	nn	6	SENT_52	[p2l1328t280r1355b317],
5	agonistsiand	NN	O	agonistsiand	nn	6	SENT_52	[p2l1375t280r1582b332],
6	andWomenr5Ho5pita	NN	O	andwomenr5ho5pita	dobj	3	SENT_52	[p2l6t343r339b369],
7	,	,	O	,	_	0	SENT_52	[p2l6t343r339b369],
8	’	CD	NUMBER	’	num	9	SENT_52	[p2l6t343r339b369],
9	75Hands	NNS	O	75hand	appos	6	SENT_52	[p2l6t343r339b369],
10	inhaled	VBD	O	inhale	_	0	SENT_52	[p2l691t326r808b355],
11	corticosteroids	NNS	O	corticosteroid	nsubj	13	SENT_52	[p2l838t326r1064b355],
12	is	VBZ	O	be	cop	13	SENT_52	[p2l1095t336r1119b355],
13	one	CD	NUMBER	one	ccomp	10	SENT_52	[p2l1150t336r1206b355],
14	of	IN	O	of	_	0	SENT_52	[p2l1237t326r1272b355],
15	the	DT	O	the	det	18	SENT_52	[p2l1295t326r1344b355],
16	most	RBS	O	most	advmod	17	SENT_52	[p2l1374t332r1452b355],
17	widely	RB	O	widely	advmod	18	SENT_52	[p2l1481t326r1582b363],
18	others	NNS	O	other	prep_of	13	SENT_52	[p2l7t444r103b472],
19	suggest	VBP	O	suggest	rcmod	18	SENT_52	[p2l127t450r244b481],
20	that	IN	O	that	complm	28	SENT_52	[p2l265t444r326b472],
21	a	DT	O	a	det	22	SENT_52	[p2l347t454r363b472],
22	subpopulation	NN	O	subpopulation	nsubj	28	SENT_52	[p2l385t444r610b481],
23	of	IN	O	of	_	0	SENT_52	[p2l632t444r667b472],
24	patients	NNS	O	patient	prep_of	22	SENT_52	[p2l683t446r806b481],
25	with	IN	O	with	_	0	SENT_52	[p2l828t444r897b472],
26	asthma	NN	O	asthma	prep_with	24	SENT_52	[p2l7t490r121b518],
27	could	MD	O	could	aux	28	SENT_52	[p2l132t490r218b518],
28	be	VB	O	be	ccomp	19	SENT_52	[p2l228t490r264b518],
29	at	IN	O	at	_	0	SENT_52	[p2l275t495r303b518],
30	risk	NN	O	risk	prep_at	28	SENT_52	[p2l313t490r372b518],
31	for	IN	O	for	_	0	SENT_52	[p2l382t490r427b518],
32	severe	JJ	O	severe	amod	33	SENT_52	[p2l438t500r534b518],
33	exacerbations	NNS	O	exacerbation	prep_for	30	SENT_52	[p2l546t490r757b518],
34	or	CC	O	or	_	0	SENT_52	[p2l769t500r801b518],
35	death	NN	O	death	conj_or	33	SENT_52	[p2l812t490r897b518],
36	with	IN	O	with	_	0	SENT_52	[p2l6t536r75b564],
37	use	NN	O	use	prep_with	28	SENT_52	[p2l85t546r138b564],
38	of	IN	O	of	_	0	SENT_52	[p2l150t536r185b564],
39	longacting	VBG	O	longact	amod	41	SENT_52	[p2l189t536r354b573],
40	B2	NN	O	b2	nn	41	SENT_52	[p2l367t535r393b572],
41	agonists	NNS	O	agonist	prep_of	37	SENT_52	[p2l405t537r566b573],
42	.	.	O	.	_	0	SENT_52	[p2l405t537r566b573],

1	“	NNP	O	“	nn	8	SENT_53	[p2l405t537r566b573],
2	Street	NNP	O	Street	nn	8	SENT_53	[p2l37t585r101b607],
3	,	,	O	,	_	0	SENT_53	[p2l37t585r101b607],
4	Boston	NNP	LOCATION	Boston	appos	8	SENT_53	[p2l113t585r188b607],
5	,	,	O	,	_	0	SENT_53	[p2l113t585r188b607],
6	MA02115	NNP	O	MA02115	appos	8	SENT_53	[p2l200t585r307b607],
7	,	,	O	,	_	0	SENT_53	[p2l200t585r307b607],
8	USA	NNP	LOCATION	USA	nsubj	20	SENT_53	[p2l318t585r360b604],
9	prescribed	VBD	O	prescribe	rcmod	8	SENT_53	[p2l401t576r566b614],
10	treatments	NNS	O	treatment	dobj	9	SENT_53	[p2l586t582r754b605],
11	for	IN	O	for	_	0	SENT_53	[p2l776t576r820b605],
12	the	DT	O	the	det	13	SENT_53	[p2l840t576r888b605],
13	control	NN	O	control	prep_for	9	SENT_53	[p2l910t576r1020b605],
14	of	IN	O	of	_	0	SENT_53	[p2l1041t576r1076b605],
15	asthma	NN	O	asthma	prep_of	13	SENT_53	[p2l1092t576r1206b605],
16	in	IN	O	in	_	0	SENT_53	[p2l1227t578r1258b604],
17	the	DT	O	the	det	19	SENT_53	[p2l1278t576r1327b605],
18	B2	NN	O	b2	nn	19	SENT_53	[p2l1411t576r1438b613],
19	agonists	NNS	O	agonist	prep_in	9	SENT_53	[p2l1456t578r1586b614],
20	act	VBP	O	act	_	0	SENT_53	[p2l1605t582r1649b605],
21	primarily	RB	O	primarily	advmod	20	SENT_53	[p2l1666t576r1815b614],
22	at	IN	O	at	_	0	SENT_53	[p2l1832t582r1860b605],
23	the	DT	O	the	det	25	SENT_53	[p2l1876t576r1926b605],
24	B2-adrenergic	JJ	O	b2-adrenergic	amod	25	SENT_53	[p2l1946t576r2154b614],
25	receptor	NN	O	receptor	prep_at	20	SENT_53	[p2l6t627r137b659],
26	"	''	O	"	punct	25	SENT_53	[p2l79t665r346b691],

1	‘	NN	O	‘	nsubj	6	SENT_54	[p2l79t665r346b691],
2	We	PRP	O	we	dep	1	SENT_54	[p2l79t665r346b691],
3	"	``	O	"	punct	4	SENT_54	[p2l79t665r346b691],
4	“	NN	O	“	dep	1	SENT_54	[p2l79t665r346b691],
5	'	''	O	'	_	0	SENT_54	[p2l79t665r346b691],
6	e'@P3	NN	O	e'@p3	_	0	SENT_54	[p2l79t665r346b691],
7	"	''	O	"	punct	6	SENT_54	[p2l79t665r346b691],
8	"	``	O	"	punct	6	SENT_54	[p2l79t665r346b691],
9	e	SYM	O	e	dep	10	SENT_54	[p2l79t665r346b691],
10	"	``	O	"	dep	6	SENT_54	[p2l79t665r346b691],
11	-	:	O	-	_	0	SENT_54	[p2l79t665r346b691],
12	°	NN	O	°	dep	6	SENT_54	[p2l79t665r346b691],
13	'	''	O	'	_	0	SENT_54	[p2l79t665r346b691],
14	9	CD	NUMBER	9	num	15	SENT_54	[p2l79t665r346b691],
15	world	NN	O	world	dep	12	SENT_54	[p2l397t667r494b696],
16	.	.	O	.	_	0	SENT_54	[p2l397t667r494b696],

1	Some	DT	O	some	det	2	SENT_55	[p2l539t669r624b696],
2	studies	NNS	O	study	nsubj	3	SENT_55	[p2l667t667r776b696],
3	suggest	VBP	O	suggest	_	0	SENT_55	[p2l818t672r936b705],
4	that	IN	O	that	advmod	3	SENT_55	[p2l976t667r1044b700],
5	,	,	O	,	_	0	SENT_55	[p2l976t667r1044b700],
6	on	IN	O	on	_	0	SENT_55	[p2l1087t677r1126b696],
7	average	NN	O	average	prep_on	3	SENT_55	[p2l1167t677r1292b705],
8	,	,	O	,	_	0	SENT_55	[p2l1167t677r1292b705],
9	this	DT	O	this	det	12	SENT_55	[p2l1334t667r1391b696],
10	(	NN	O	(	nn	12	SENT_55	[p2l1457t669r1607b705],
11	ADRB2	NN	O	adrb2	nn	12	SENT_55	[p2l1457t669r1607b705],
12	)	NN	O	)	appos	7	SENT_55	[p2l1457t669r1607b705],
13	.	.	O	.	_	0	SENT_55	[p2l1457t669r1607b705],

1	A	DT	O	a	det	6	SENT_56	[p2l1637t669r1662b695],
2	common	JJ	O	common	amod	6	SENT_56	[p2l1692t677r1834b696],
3	single	JJ	O	single	amod	6	SENT_56	[p2l1865t667r1958b705],
4	nucleotide	NN	O	nucleotide	nn	6	SENT_56	[p2l1989t667r2154b696],
5	polymorphism	NN	O	polymorphism	nn	6	SENT_56	[p2l6t712r241b749],
6	combination	NN	O	combination	nsubj	7	SENT_56	[p2l325t757r523b786],
7	improves	VBZ	O	improve	_	0	SENT_56	[p2l531t759r675b795],
8	lung	NN	O	lung	nn	10	SENT_56	[p2l683t757r754b795],
9	functionandasthma	NN	O	functionandasthma	nn	10	SENT_56	[p2l762t757r1081b786],
10	control	NN	O	control	dobj	7	SENT_56	[p2l1089t757r1216b790],
11	?	.	O	?	_	0	SENT_56	[p2l1089t757r1216b790],

1	in	IN	O	in	_	0	SENT_57	[p2l1264t759r1295b786],
2	the	DT	O	the	det	4	SENT_57	[p2l1318t757r1367b786],
3	coding	VBG	O	code	amod	4	SENT_57	[p2l1391t757r1498b795],
4	region	NN	O	region	pobj	1	SENT_57	[p2l1521t759r1623b795],
5	of	IN	O	of	_	0	SENT_57	[p2l1646t757r1681b786],
6	ADRB2	NN	O	adrb2	nn	7	SENT_57	[p2l1699t759r1821b786],
7	codes	NNS	O	code	prep_of	4	SENT_57	[p2l1843t757r1929b786],
8	for	IN	O	for	_	0	SENT_57	[p2l1954t757r1999b786],
9	arginine	NN	O	arginine	prep_for	7	SENT_57	[p2l2022t759r2154b795],

1	1754	CD	DATE	1754	_	0	SENT_58	[p2l6t873r63b894],
2	www	NN	O	www	dep	1	SENT_58	[p2l1621t870r1844b891],
3	.	.	O	.	_	0	SENT_58	[p2l1621t870r1844b891],

1	the	DT	O	the	det	4	SENT_59	[p2l1621t870r1844b891],
2	|	NN	O	|	nn	4	SENT_59	[p2l1621t870r1844b891],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_59	[p2l1621t870r1844b891],
4	Vol	NNP	O	Vol	_	0	SENT_59	[p2l1862t870r1898b891],
5	374	CD	NUMBER	374	num	6	SENT_59	[p2l1906t873r1949b894],
6	November21	NN	O	november21	dep	4	SENT_59	[p2l1969t870r2132b895],
7	,	,	O	,	_	0	SENT_59	[p2l1969t870r2132b895],
8	2009	CD	DATE	2009	appos	6	SENT_59	[p2l6t895r67b917],

1	Articles	NNPS	O	Articles	_	0	SENT_60	[p2l6t1124r156b1160],
2	I	PRP	O	I	dep	1	SENT_60	[p2l205t992r252b1160],

1	instead	RB	O	instead	advmod	2	SENT_61	[p2l9t1419r283b1487],
2	of	IN	O	of	advcl	18	SENT_61	[p2l314t1419r397b1487],
3	glycine	NN	O	glycine	pobj	2	SENT_61	[p2l417t1419r682b1509],
4	at	IN	O	at	_	0	SENT_61	[p2l715t1433r781b1487],
5	the	DT	O	the	det	13	SENT_61	[p2l810t1419r927b1487],
6	16th	JJ	ORDINAL	16th	amod	13	SENT_61	[p2l962t1419r1118b1487],
7	aminoacid	JJ	O	aminoacid	amod	13	SENT_61	[p2l1150t1419r1548b1487],
8	of	IN	O	of	_	0	SENT_61	[p2l1578t1419r1662b1487],
9	the	DT	O	the	det	12	SENT_61	[p2l1679t1419r1797b1487],
10	receptor	NN	O	receptor	nn	12	SENT_61	[p2l1829t1432r2141b1508],
11	(	NN	O	(	nn	12	SENT_61	[p2l14t1529r232b1619],
12	allele	NN	O	allele	prep_of	7	SENT_61	[p2l14t1529r232b1619],
13	frequency	NN	O	frequency	prep_at	3	SENT_61	[p2l266t1529r645b1618],
14	0-4	CD	NUMBER	0-4	nsubj	18	SENT_61	[p2l677t1535r806b1596],
15	in	IN	O	in	_	0	SENT_61	[p2l835t1533r910b1595],
16	white	JJ	O	white	amod	17	SENT_61	[p2l941t1529r1150b1596],
17	people	NNS	O	people	prep_in	14	SENT_61	[p2l1183t1529r1501b1619],
18	‘‘	VBP	O	‘‘	_	0	SENT_61	[p2l1183t1529r1501b1619],
19	)	NN	O	)	dobj	18	SENT_61	[p2l1183t1529r1501b1619],
20	.	.	O	.	_	0	SENT_61	[p2l1183t1529r1501b1619],

1	In	IN	O	in	_	0	SENT_62	[p2l1542t1536r1621b1595],
2	retrospective	JJ	O	retrospective	amod	5	SENT_62	[p2l1654t1533r2139b1618],
3	and	CC	O	and	_	0	SENT_62	[p2l10t1638r149b1707],
4	prospective	JJ	O	prospective	conj_and	2	SENT_62	[p2l197t1643r628b1727],
5	studies	NNS	O	study	nsubj	11	SENT_62	[p2l681t1638r945b1707],
6	in	IN	O	in	_	0	SENT_62	[p2l998t1643r1073b1706],
7	patients	NNS	O	patient	prep_in	5	SENT_62	[p2l1122t1643r1422b1727],
8	with	IN	O	with	_	0	SENT_62	[p2l1473t1638r1640b1707],
9	asthma	NN	O	asthma	prep_with	7	SENT_62	[p2l1691t1638r1968b1707],
10	not	RB	O	not	neg	11	SENT_62	[p2l2018t1652r2141b1707],
11	taking	VBG	O	take	prepc_in	30	SENT_62	[p2l8t1747r245b1837],
12	inhaled	VBN	O	inhale	dep	11	SENT_62	[p2l267t1747r552b1815],
13	corticosteroids	NNS	O	corticosteroid	dobj	12	SENT_62	[p2l574t1747r1149b1825],
14	,	,	O	,	_	0	SENT_62	[p2l574t1747r1149b1825],
15	regular	JJ	O	regular	amod	16	SENT_62	[p2l1175t1747r1447b1837],
16	use	NN	O	use	nsubjpass	30	SENT_62	[p2l1467t1771r1595b1815],
17	of	IN	O	of	_	0	SENT_62	[p2l1619t1747r1703b1815],
18	shortacting	VBG	O	shortact	amod	20	SENT_62	[p2l1715t1747r2140b1837],
19	B2	NN	O	b2	nn	20	SENT_62	[p2l14t1856r78b1944],
20	agonists	NNS	O	agonist	prep_of	16	SENT_62	[p2l123t1862r455b1946],
21	,	,	O	,	_	0	SENT_62	[p2l123t1862r455b1946],
22	such	JJ	O	such	_	0	SENT_62	[p2l505t1857r680b1924],
23	as	IN	O	as	_	0	SENT_62	[p2l725t1881r797b1924],
24	salbutamol	NN	O	salbutamol	nn	27	SENT_62	[p2l846t1857r1264b1924],
25	(	CD	NUMBER	(	num	27	SENT_62	[p2l1314t1857r1722b1947],
26	albuterol	NN	O	albuterol	nn	27	SENT_62	[p2l1314t1857r1722b1947],
27	)	NN	O	)	prep_such_as	16	SENT_62	[p2l1314t1857r1722b1947],
28	,	,	O	,	_	0	SENT_62	[p2l1314t1857r1722b1947],
29	was	VBD	O	be	auxpass	30	SENT_62	[p2l1767t1881r1907b1924],
30	associated	VBN	O	associate	_	0	SENT_62	[p2l1955t1881r2138b1924, p2l9t1965r231b2034],
31	with	IN	O	with	_	0	SENT_62	[p2l319t1965r487b2034],
32	lower	JJR	O	lower	amod	34	SENT_62	[p2l576t1965r786b2033],
33	lung	NN	O	lung	nn	34	SENT_62	[p2l875t1965r1048b2055],
34	function	NN	O	function	prep_with	30	SENT_62	[p2l1139t1965r1461b2034],
35	in	IN	O	in	_	0	SENT_62	[p2l1553t1970r1628b2032],
36	individuals	NNS	O	individual	prep_in	34	SENT_62	[p2l1719t1965r2137b2034],
37	homozygous	JJ	O	homozygous	amod	36	SENT_62	[p2l7t2074r492b2164],
38	for	IN	O	for	_	0	SENT_62	[p2l519t2074r627b2142],
39	arginine	NN	O	arginine	prep_for	37	SENT_62	[p2l652t2079r968b2164],
40	at	IN	O	at	_	0	SENT_62	[p2l995t2088r1060b2142],
41	the	DT	O	the	det	48	SENT_62	[p2l1083t2074r1200b2142],
42	16th	JJ	ORDINAL	16th	amod	48	SENT_62	[p2l1229t2074r1384b2142],
43	aminoacid	JJ	O	aminoacid	amod	48	SENT_62	[p2l1410t2074r1808b2142],
44	position	NN	O	position	nn	48	SENT_62	[p2l1832t2079r2140b2163],
45	(	CD	NUMBER	(	num	48	SENT_62	[p2l14t2190r172b2273],
46	B16	NN	O	b16	nn	48	SENT_62	[p2l14t2190r172b2273],
47	Arg/Arg	NN	O	arg/arg	nn	48	SENT_62	[p2l233t2189r573b2273],
48	)	NN	O	)	prep_at	30	SENT_62	[p2l233t2189r573b2273],
49	than	IN	O	than	mark	67	SENT_62	[p2l639t2184r810b2252],
50	in	IN	O	in	_	0	SENT_62	[p2l870t2188r946b2250],
51	individuals	NNS	O	individual	prep_in	67	SENT_62	[p2l1006t2184r1424b2252],
52	homozygous	JJ	O	homozygous	amod	51	SENT_62	[p2l1486t2184r1970b2273],
53	for	IN	O	for	_	0	SENT_62	[p2l2033t2183r2141b2252],
54	glycine	NN	O	glycine	prep_for	52	SENT_62	[p2l10t2292r275b2382],
55	at	IN	O	at	_	0	SENT_62	[p2l314t2306r380b2360],
56	that	DT	O	that	det	60	SENT_62	[p2l414t2292r561b2360],
57	position	NN	O	position	nn	60	SENT_62	[p2l597t2297r905b2381],
58	(	CD	NUMBER	(	num	60	SENT_62	[p2l948t2298r1105b2382],
59	B16	NN	O	b16	nn	60	SENT_62	[p2l948t2298r1105b2382],
60	Gly/Gly	NN	O	gly/gly	prep_at	54	SENT_62	[p2l1146t2292r1552b2382],
61	)	CD	NUMBER	)	num	62	SENT_62	[p2l1146t2292r1552b2382],
62	.5	NN	NUMBER	.5	dep	60	SENT_62	[p2l1146t2292r1552b2382],
63	'	''	O	'	_	0	SENT_62	[p2l1146t2292r1552b2382],
64	6	CD	NUMBER	6	tmod	52	SENT_62	[p2l1146t2292r1552b2382],
65	Another	DT	O	another	det	66	SENT_62	[p2l1587t2292r1902b2360],
66	study	NN	O	study	nsubj	67	SENT_62	[p2l1940t2292r2142b2382],
67	showed	VBD	O	show	dep	48	SENT_62	[p2l11t2401r297b2469],
68	increased	VBN	O	increase	amod	69	SENT_62	[p2l323t2401r685b2469],
69	risk	NN	O	risk	dobj	67	SENT_62	[p2l711t2401r854b2469],
70	of	IN	O	of	_	0	SENT_62	[p2l880t2401r963b2469],
71	exacerbations	NNS	O	exacerbation	prep_of	69	SENT_62	[p2l979t2401r1491b2469],
72	with	IN	O	with	_	0	SENT_62	[p2l1519t2401r1686b2469],
73	regular	JJ	O	regular	amod	74	SENT_62	[p2l1713t2401r1986b2491],
74	use	NN	O	use	prep_with	69	SENT_62	[p2l2010t2425r2139b2469],
75	of	IN	O	of	_	0	SENT_62	[p2l10t2512r93b2580],
76	salbutamol	NN	O	salbutamol	prep_of	69	SENT_62	[p2l125t2512r543b2580],
77	but	CC	O	but	_	0	SENT_62	[p2l584t2512r710b2580],
78	not	RB	O	not	_	0	SENT_62	[p2l750t2525r874b2580],
79	salmeterol	NN	O	salmeterol	conj_negcc	69	SENT_62	[p2l918t2512r1313b2580],
80	in	IN	O	in	_	0	SENT_62	[p2l1355t2517r1430b2578],
81	patients	NNS	O	patient	prep_in	79	SENT_62	[p2l1472t2516r1770b2601],
82	with	IN	O	with	_	0	SENT_62	[p2l1813t2512r1981b2580],
83	the	DT	O	the	det	86	SENT_62	[p2l2021t2512r2139b2580],
84	B16	NN	O	b16	nn	86	SENT_62	[p2l13t2627r144b2689],
85	Arg/Arg	NN	O	arg/arg	nn	86	SENT_62	[p2l171t2626r490b2710],
86	genotype	NN	O	genotype	prep_with	81	SENT_62	[p2l518t2625r904b2710],
87	?	.	O	?	_	0	SENT_62	[p2l518t2625r904b2710],

1	In	IN	O	in	_	0	SENT_63	[p2l83t2736r162b2796],
2	view	NN	O	view	prep_in	9	SENT_63	[p2l236t2734r407b2797],
3	of	IN	O	of	_	0	SENT_63	[p2l483t2729r566b2797],
4	these	DT	O	these	det	6	SENT_63	[p2l628t2729r825b2797],
5	genotype-speciﬁc	JJ	O	genotype-speciﬁc	amod	6	SENT_63	[p2l903t2729r1551b2819],
6	ﬁndings	NNS	O	ﬁndings	prep_of	2	SENT_63	[p2l1627t2729r1958b2819],
7	,	,	O	,	_	0	SENT_63	[p2l1627t2729r1958b2819],
8	we	PRP	O	we	nsubj	9	SENT_63	[p2l2036t2753r2139b2797],
9	undertook	VBD	O	undertake	_	0	SENT_63	[p2l7t2839r400b2906],
10	a	DT	O	a	det	13	SENT_63	[p2l429t2863r466b2906],
11	genotype-stratiﬁed	JJ	O	genotype-stratiﬁed	amod	13	SENT_63	[p2l498t2839r1199b2928],
12	retrospective	NN	O	retrospective	nn	13	SENT_63	[p2l1229t2843r1709b2928],
13	analysis	NN	O	analysis	dobj	9	SENT_63	[p2l1741t2839r2036b2928],
14	of	IN	O	of	_	0	SENT_63	[p2l2069t2839r2153b2906],
15	patients	NNS	O	patient	prep_of	13	SENT_63	[p2l8t2953r305b3037],
16	with	IN	O	with	_	0	SENT_63	[p2l324t2948r490b3017],
17	asthma	NN	O	asthma	prep_with	9	SENT_63	[p2l509t2948r784b3017],
18	who	WP	O	who	nsubj	20	SENT_63	[p2l800t2948r958b3017],
19	had	VBD	O	have	aux	20	SENT_63	[p2l976t2948r1115b3017],
20	participated	VBN	O	participate	rcmod	17	SENT_63	[p2l1132t2948r1579b3037],
21	in	IN	O	in	_	0	SENT_63	[p2l1595t2953r1670b3016],
22	randomised	JJ	O	randomised	amod	23	SENT_63	[p2l1688t2948r2141b3017],
23	trials	NNS	O	trial	prep_in	20	SENT_63	[p2l8t3057r194b3125],
24	of	IN	O	of	_	0	SENT_63	[p2l237t3057r320b3125],
25	the	DT	O	the	det	29	SENT_63	[p2l345t3057r462b3125],
26	longacting	VBG	O	longact	amod	29	SENT_63	[p2l501t3057r899b3147],
27	B2	NN	O	b2	nn	29	SENT_63	[p2l944t3057r1007b3144],
28	agonist	NN	O	agonist	nn	29	SENT_63	[p2l1047t3062r1320b3147],
29	salmeterol	NN	O	salmeterol	prep_of	23	SENT_63	[p2l1362t3057r1799b3125],
30	?	.	O	?	_	0	SENT_63	[p2l1362t3057r1799b3125],

1	Patients	NNS	O	patient	nsubj	7	SENT_64	[p2l1842t3062r2137b3125],
2	with	IN	O	with	_	0	SENT_64	[p2l7t3167r173b3234],
3	the	DT	O	the	det	6	SENT_64	[p2l219t3167r335b3234],
4	B16	NN	O	b16	nn	6	SENT_64	[p2l387t3173r517b3234],
5	Arg/Arg	NN	O	arg/arg	nn	6	SENT_64	[p2l565t3172r881b3257],
6	genotype	NN	O	genotype	prep_with	1	SENT_64	[p2l929t3180r1266b3256],
7	did	VBD	O	do	_	0	SENT_64	[p2l1315t3167r1434b3234],
8	not	RB	O	not	neg	9	SENT_64	[p2l1479t3180r1603b3234],
9	beneﬁt	NN	O	beneﬁt	dobj	7	SENT_64	[p2l1647t3167r1909b3234],
10	from	IN	O	from	_	0	SENT_64	[p2l1955t3167r2140b3234],
11	treatment	NN	O	treatment	prep_from	7	SENT_64	[p2l8t3289r379b3343],
12	with	IN	O	with	_	0	SENT_64	[p2l436t3275r603b3343],
13	salmeterol	NN	O	salmeterol	prep_with	7	SENT_64	[p2l666t3275r1077b3354],
14	,	,	O	,	_	0	SENT_64	[p2l666t3275r1077b3354],
15	even	RB	O	even	advmod	17	SENT_64	[p2l1143t3300r1314b3343],
16	when	WRB	O	when	advmod	17	SENT_64	[p2l1372t3275r1580b3343],
17	used	VBN	O	use	dep	7	SENT_64	[p2l1639t3275r1817b3343],
18	with	IN	O	with	_	0	SENT_64	[p2l1875t3275r2042b3343],
19	a	DT	O	a	det	20	SENT_64	[p2l2103t3300r2140b3343],
20	concomitant	JJ	O	concomitant	prep_with	17	SENT_64	[p2l9t3389r482b3451],
21	inhaled	VBN	O	inhale	partmod	20	SENT_64	[p2l523t3384r804b3451],
22	corticosteroid	NN	O	corticosteroid	dobj	21	SENT_64	[p2l847t3384r1378b3451],
23	.	.	O	.	_	0	SENT_64	[p2l847t3384r1378b3451],

1	We	PRP	O	we	nsubj	4	SENT_65	[p2l1423t3391r1540b3452],
2	have	VBP	O	have	aux	4	SENT_65	[p2l1582t3384r1753b3451],
3	therefore	RB	O	therefore	advmod	4	SENT_65	[p2l1795t3384r2139b3451],
4	examined	VBN	O	examine	_	0	SENT_65	[p2l10t3494r376b3562],
5	prospectively	RB	O	prospectively	advmod	8	SENT_65	[p2l427t3494r920b3583],
6	whether	IN	O	whether	dep	8	SENT_65	[p2l968t3494r1279b3562],
7	there	EX	O	there	expl	8	SENT_65	[p2l1328t3494r1521b3562],
8	is	VBZ	O	be	ccomp	4	SENT_65	[p2l1574t3498r1631b3562],
9	a	DT	O	a	det	11	SENT_65	[p2l1687t3518r1724b3562],
10	genotypespeciﬁc	NN	O	genotypespeciﬁc	nn	11	SENT_65	[p2l1776t3507r2138b3583, p2l11t3602r290b3691],
11	difference	NN	O	difference	nsubj	8	SENT_65	[p2l371t3602r747b3671],
12	in	IN	O	in	_	0	SENT_65	[p2l827t3607r901b3669],
13	the	DT	O	the	det	14	SENT_65	[p2l980t3602r1097b3670],
14	response	NN	O	response	prep_in	11	SENT_65	[p2l1177t3627r1514b3691],
15	to	TO	O	to	_	0	SENT_65	[p2l1594t3616r1662b3670],
16	longacting	VBG	O	longact	amod	18	SENT_65	[p2l1742t3602r2140b3692],
17	B2	NN	O	b2	nn	18	SENT_65	[p2l14t3711r77b3798],
18	agonists	NNS	O	agonist	prep_to	14	SENT_65	[p2l102t3716r431b3801],
19	,	,	O	,	_	0	SENT_65	[p2l102t3716r431b3801],
20	by	IN	O	by	_	0	SENT_65	[p2l457t3711r544b3800],
21	undertaking	VBG	O	undertake	prepc_by	4	SENT_65	[p2l565t3711r1028b3801],
22	a	DT	O	a	det	25	SENT_65	[p2l1053t3735r1090b3779],
23	randomised	JJ	O	randomised	amod	25	SENT_65	[p2l1113t3711r1566b3779],
24	controlled	JJ	O	controlled	amod	25	SENT_65	[p2l1589t3711r1968b3779],
25	trial	NN	O	trial	dobj	21	SENT_65	[p2l1989t3711r2140b3779],
26	that	IN	O	that	nsubj	27	SENT_65	[p3l8t17r153b85],
27	compared	VBN	O	compare	rcmod	25	SENT_65	[p3l203t17r578b106],
28	the	DT	O	the	det	29	SENT_65	[p3l626t17r742b85],
29	effects	NNS	O	effect	dobj	27	SENT_65	[p3l794t17r1032b85],
30	of	IN	O	of	_	0	SENT_65	[p3l1085t17r1168b85],
31	salmeterol	NN	O	salmeterol	prep_of	29	SENT_65	[p3l1207t17r1600b85],
32	plus	CC	O	plus	advmod	33	SENT_65	[p3l1649t17r1806b106],
33	inhaled	VBN	O	inhale	partmod	31	SENT_65	[p3l1858t17r2141b85],
34	corticosteroid	NN	O	corticosteroid	dobj	33	SENT_65	[p3l9t125r523b193],
35	with	IN	O	with	prep	34	SENT_65	[p3l597t125r763b193],
36	inhaled	VBN	O	inhale	dep	35	SENT_65	[p3l839t125r1122b193],
37	corticosteroid	NN	O	corticosteroid	dobj	36	SENT_65	[p3l1198t125r1712b193],
38	alone	RB	O	alone	advmod	36	SENT_65	[p3l1788t125r1988b193],
39	in	IN	O	in	prep	36	SENT_65	[p3l2065t130r2140b192],

1	B16	NN	O	b16	nn	3	SENT_66	[p3l13t240r142b302],
2	Arg/Arg	NN	O	arg/arg	nn	3	SENT_66	[p3l182t239r498b324],
3	patients	NNS	O	patient	_	0	SENT_66	[p3l536t239r832b323],
4	with	IN	O	with	_	0	SENT_66	[p3l871t234r1038b302],
5	asthma	NN	O	asthma	prep_with	3	SENT_66	[p3l1077t234r1352b302],
6	versus	CC	O	versus	prep	3	SENT_66	[p3l1388t258r1628b302],
7	B16	NN	O	b16	nn	9	SENT_66	[p3l1673t240r1803b302],
8	Gly/Gly	NN	O	gly/gly	nn	9	SENT_66	[p3l1845t234r2141b323],
9	patients	NNS	O	patient	dep	6	SENT_66	[p3l8t349r305b432],
10	with	IN	O	with	_	0	SENT_66	[p3l332t345r498b412],
11	asthma	NN	O	asthma	prep_with	3	SENT_66	[p3l526t345r819b412],
12	.	.	O	.	_	0	SENT_66	[p3l526t345r819b412],

1	Methods	NNS	O	method	_	0	SENT_67	[p3l13t551r401b630],

1	Participants	NNS	O	participant	nsubj	4	SENT_68	[p3l13t673r466b760],
2	Seven	CD	NUMBER	seven	num	3	SENT_68	[p3l14t786r229b849],
3	centres	NNS	O	centre	dep	1	SENT_68	[p3l256t794r522b849],
4	recruited	VBN	O	recruit	_	0	SENT_68	[p3l551t780r889b849],
5	participants	NNS	O	participant	dobj	4	SENT_68	[p3l915t785r1355b869],
6	for	IN	O	for	_	0	SENT_68	[p3l1385t780r1491b849],
7	the	DT	O	the	det	9	SENT_68	[p3l1516t780r1632b849],
8	LARGE	JJ	O	large	amod	9	SENT_68	[p3l1664t785r1939b849],
9	trial	NN	O	trial	prep_for	5	SENT_68	[p3l1969t780r2136b849],
10	.	.	O	.	_	0	SENT_68	[p3l1969t780r2136b849],

1	Patients	NNS	O	patient	nsubjpass	5	SENT_69	[p3l13t894r305b956],
2	with	IN	O	with	_	0	SENT_69	[p3l351t889r516b957],
3	asthma	NN	O	asthma	prep_with	1	SENT_69	[p3l562t889r835b956],
4	were	VBD	O	be	auxpass	5	SENT_69	[p3l878t913r1056b956],
5	recruited	VBN	O	recruit	conj_and	5	SENT_69	[p3l1102t889r1440b956],
6	from	IN	O	from	_	0	SENT_69	[p3l1484t889r1668b956],
7	the	DT	O	the	det	9	SENT_69	[p3l1712t889r1828b956],
8	clinical	JJ	O	clinical	amod	9	SENT_69	[p3l1875t889r2140b956],
9	practices	NNS	O	practice	prep_from	5	SENT_69	[p3l8t1003r335b1087],
10	of	IN	O	of	_	0	SENT_69	[p3l390t999r473b1066],
11	each	DT	O	each	det	13	SENT_69	[p3l512t999r680b1066],
12	study	NN	O	study	nn	13	SENT_69	[p3l734t999r934b1088],
13	site	NN	O	site	prep_of	9	SENT_69	[p3l986t1003r1111b1066],
14	and	CC	O	and	_	0	SENT_69	[p3l1164t999r1302b1066],
15	through	IN	O	through	_	0	SENT_69	[p3l1351t999r1654b1088],
16	community	NN	O	community	nn	17	SENT_69	[p3l1706t1003r2142b1088],
17	advertising	NN	O	advertising	prep_through	5	SENT_69	[p3l10t1107r422b1197],
18	by	IN	O	by	_	0	SENT_69	[p3l459t1107r546b1197],
19	use	NN	O	use	agent	5	SENT_69	[p3l581t1132r709b1175],
20	of	IN	O	of	_	0	SENT_69	[p3l749t1107r832b1175],
21	a	DT	O	a	det	22	SENT_69	[p3l859t1132r895b1175],
22	variety	NN	O	variety	prep_of	19	SENT_69	[p3l932t1112r1180b1197],
23	of	IN	O	of	_	0	SENT_69	[p3l1218t1107r1301b1175],
24	media	NNS	O	media	prep_of	22	SENT_69	[p3l1326t1107r1576b1175],
25	.	.	O	.	_	0	SENT_69	[p3l1326t1107r1576b1175],

1	After	IN	O	after	mark	4	SENT_70	[p3l1617t1107r1806b1175],
2	patients	NNS	O	patient	nsubj	4	SENT_70	[p3l1843t1112r2137b1196],
3	had	VBD	O	have	aux	4	SENT_70	[p3l7t1216r146b1284],
4	given	VBN	O	give	advcl	22	SENT_70	[p3l219t1221r418b1306],
5	written	VBN	O	write	dep	4	SENT_70	[p3l488t1221r756b1284],
6	informed	VBN	O	inform	amod	8	SENT_70	[p3l829t1216r1180b1284],
7	consent	NN	O	consent	nn	8	SENT_70	[p3l1252t1229r1544b1284],
8	(	NN	O	(	dobj	5	SENT_70	[p3l1620t1216r1985b1306],
9	approved	VBN	O	approve	partmod	8	SENT_70	[p3l1620t1216r1985b1306],
10	by	IN	O	by	_	0	SENT_70	[p3l2055t1216r2142b1305],
11	participating	VBG	O	participate	agent	9	SENT_70	[p3l8t1331r484b1416],
12	site	NN	O	site	dobj	11	SENT_70	[p3l557t1331r682b1395],
13	institutional	JJ	O	institutional	amod	15	SENT_70	[p3l754t1327r1210b1395],
14	review	NN	O	review	nn	15	SENT_70	[p3l1281t1331r1525b1395],
15	boards	NNS	O	board	nsubj	16	SENT_70	[p3l1593t1327r1890b1416],
16	)	VBP	O	)	rcmod	12	SENT_70	[p3l1593t1327r1890b1416],
17	,	,	O	,	_	0	SENT_70	[p3l1593t1327r1890b1416],
18	their	PRP$	O	they	poss	20	SENT_70	[p3l1964t1327r2141b1395],
19	medical	JJ	O	medical	amod	20	SENT_70	[p3l9t1435r303b1504],
20	history	NN	O	history	nsubjpass	22	SENT_70	[p3l343t1435r603b1525],
21	was	VBD	O	be	auxpass	22	SENT_70	[p3l641t1460r779b1504],
22	reviewed	VBN	O	review	_	0	SENT_70	[p3l824t1435r1156b1504],
23	(	RB	O	(	advmod	22	SENT_70	[p3l1202t1442r1326b1525],
24	eg	FW	O	eg	dobj	22	SENT_70	[p3l1202t1442r1326b1525],
25	,	,	O	,	_	0	SENT_70	[p3l1202t1442r1326b1525],
26	medication	NN	O	medication	nn	27	SENT_70	[p3l1372t1435r1792b1503],
27	use	NN	O	use	dep	33	SENT_70	[p3l1832t1460r1959b1503],
28	and	CC	O	and	_	0	SENT_70	[p3l2003t1435r2141b1503],
29	history	NN	O	history	dep	33	SENT_70	[p3l7t1544r267b1633],
30	of	IN	O	of	_	0	SENT_70	[p3l294t1544r377b1612],
31	asthma	NN	O	asthma	nn	32	SENT_70	[p3l392t1544r665b1612],
32	exacerbations	NNS	O	exacerbation	prep_of	27	SENT_70	[p3l694t1544r1222b1634],
33	)	CD	NUMBER	)	conj_and	22	SENT_70	[p3l694t1544r1222b1634],
34	and	CC	O	and	_	0	SENT_70	[p3l1257t1544r1394b1612],
35	they	PRP	O	they	nsubjpass	37	SENT_70	[p3l1420t1544r1579b1633],
36	were	VBD	O	be	auxpass	37	SENT_70	[p3l1602t1568r1781b1612],
37	screened	VBN	O	screen	conj_and	22	SENT_70	[p3l1812t1544r2141b1612],
38	for	IN	O	for	_	0	SENT_70	[p3l9t1653r115b1722],
39	eligibility	NN	O	eligibility	prep_for	37	SENT_70	[p3l143t1654r491b1743],
40	on	IN	O	on	_	0	SENT_70	[p3l519t1678r612b1722],
41	the	DT	O	the	det	42	SENT_70	[p3l640t1654r756b1722],
42	basis	NN	O	basis	prep_on	37	SENT_70	[p3l784t1654r968b1722],
43	of	IN	O	of	_	0	SENT_70	[p3l1001t1653r1084b1722],
44	the	DT	O	the	det	48	SENT_70	[p3l1099t1654r1215b1722],
45	inclusion	NN	O	inclusion	nn	48	SENT_70	[p3l1244t1654r1593b1722],
46	and	CC	O	and	_	0	SENT_70	[p3l1623t1654r1761b1722],
47	exclusion	NN	O	exclusion	nn	48	SENT_70	[p3l1789t1654r2140b1722],
48	criteria	NNS	O	criterion	prep_of	42	SENT_70	[p3l9t1768r272b1831],
49	shown	VBN	O	show	partmod	48	SENT_70	[p3l319t1763r564b1832],
50	in	IN	O	in	_	0	SENT_70	[p3l609t1768r683b1830],
51	the	DT	O	the	det	52	SENT_70	[p3l727t1763r844b1831],
52	panel	NN	O	panel	prep_in	49	SENT_70	[p3l890t1763r1112b1852],
53	.	.	O	.	_	0	SENT_70	[p3l890t1763r1112b1852],

1	Blood	NN	O	blood	nn	2	SENT_71	[p3l1165t1763r1376b1831],
2	samples	NNS	O	sample	nsubjpass	5	SENT_71	[p3l1424t1763r1725b1852],
3	were	VBD	O	be	auxpass	5	SENT_71	[p3l1771t1788r1949b1831],
4	also	RB	O	also	advmod	5	SENT_71	[p3l1996t1763r2139b1831],
5	taken	VBN	O	take	_	0	SENT_71	[p3l8t1872r231b1940],
6	.	.	O	.	_	0	SENT_71	[p3l8t1872r231b1940],

1	B16	NN	O	b16	nn	2	SENT_72	[p3l289t1878r418b1940],
2	genotyping	NN	O	genotyping	nsubjpass	9	SENT_72	[p3l471t1877r889b1962],
3	by	IN	O	by	_	0	SENT_72	[p3l937t1872r1024b1961],
4	restriction	NN	O	restriction	nn	7	SENT_72	[p3l1073t1877r1457b1940],
5	fragment	NN	O	fragment	nn	7	SENT_72	[p3l1507t1872r1854b1962],
6	length	NN	O	length	nn	7	SENT_72	[p3l1901t1872r2140b1962],
7	polymorphism	NN	O	polymorphism	prep_by	2	SENT_72	[p3l8t1982r563b2071],
8	was	VBD	O	be	auxpass	9	SENT_72	[p3l639t2006r778b2050],
9	conﬁrmed	VBN	O	conﬁrmed	dep	13	SENT_72	[p3l860t1981r1247b2050],
10	by	IN	O	by	_	0	SENT_72	[p3l1323t1982r1411b2071],
11	sequencing	NN	O	sequencing	agent	9	SENT_72	[p3l1490t1986r1916b2071],
12	(	CD	NUMBER	(	num	11	SENT_72	[p3l2001t1988r2139b2071],
13	see	VBP	O	see	_	0	SENT_72	[p3l2001t1988r2139b2071],
14	webappendix	JJ	O	webappendix	amod	15	SENT_72	[p3l7t2090r503b2179],
15	p	NN	O	p	dobj	13	SENT_72	[p3l542t2115r586b2179],
16	1	CD	NUMBER	1	nsubj	13	SENT_72	[p3l632t2096r662b2157],
17	for	IN	O	for	_	0	SENT_72	[p3l703t2090r810b2158],
18	details	NNS	O	detail	prep_for	16	SENT_72	[p3l851t2090r1088b2158],
19	of	IN	O	of	_	0	SENT_72	[p3l1133t2090r1216b2158],
20	genotyping	VBG	O	genotype	amod	21	SENT_72	[p3l1246t2095r1710b2180],
21	)	NN	O	)	prep_of	18	SENT_72	[p3l1246t2095r1710b2180],
22	.	.	O	.	_	0	SENT_72	[p3l1246t2095r1710b2180],

1	The	DT	O	the	det	3	SENT_73	[p3l1754t2090r1897b2158],
2	study	NN	O	study	nn	3	SENT_73	[p3l1942t2090r2142b2180],
3	protocol	NN	O	protocol	nsubjpass	5	SENT_73	[p3l8t2200r313b2289],
4	was	VBD	O	be	auxpass	5	SENT_73	[p3l344t2224r482b2268],
5	reviewed	VBN	O	review	_	0	SENT_73	[p3l518t2200r850b2268],
6	and	CC	O	and	_	0	SENT_73	[p3l883t2200r1020b2268],
7	approved	VBN	O	approve	conj_and	5	SENT_73	[p3l1053t2200r1396b2289],
8	by	IN	O	by	_	0	SENT_73	[p3l1426t2200r1513b2289],
9	an	DT	O	a	det	13	SENT_73	[p3l1545t2224r1634b2268],
10	independent	JJ	O	independent	amod	13	SENT_73	[p3l1667t2200r2141b2289],
11	protocol	NN	O	protocol	nn	13	SENT_73	[p3l8t2310r313b2398],
12	review	NN	O	review	nn	13	SENT_73	[p3l381t2314r625b2378],
13	committee	NN	O	committee	agent	5	SENT_73	[p3l693t2314r1092b2378],
14	appointed	VBN	O	appoint	partmod	13	SENT_73	[p3l1162t2310r1536b2398],
15	by	IN	O	by	_	0	SENT_73	[p3l1602t2310r1689b2399],
16	the	DT	O	the	det	18	SENT_73	[p3l1754t2310r1871b2378],
17	study	NN	O	study	nn	18	SENT_73	[p3l1942t2310r2142b2399],
18	sponsor	NN	O	sponsor	agent	14	SENT_73	[p3l11t2442r317b2507],
19	.	.	O	.	_	0	SENT_73	[p3l11t2442r317b2507],

1	A	DT	O	a	det	3	SENT_74	[p3l361t2423r420b2485],
2	separate	JJ	O	separate	amod	3	SENT_74	[p3l463t2432r768b2507],
3	data	NNS	O	datum	nsubj	15	SENT_74	[p3l811t2418r963b2486],
4	and	CC	O	and	_	0	SENT_74	[p3l1005t2418r1143b2486],
5	safety	NN	O	safety	nn	7	SENT_74	[p3l1186t2418r1398b2507],
6	monitoring	NN	O	monitoring	nn	7	SENT_74	[p3l1437t2423r1865b2508],
7	board	NN	O	board	conj_and	3	SENT_74	[p3l1904t2418r2136b2496],
8	,	,	O	,	_	0	SENT_74	[p3l1904t2418r2136b2496],
9	also	RB	O	also	advmod	10	SENT_74	[p3l10t2529r152b2597],
10	appointed	VBN	O	appoint	partmod	3	SENT_74	[p3l198t2529r571b2618],
11	by	IN	O	by	_	0	SENT_74	[p3l612t2529r699b2618],
12	the	DT	O	the	det	13	SENT_74	[p3l739t2529r856b2597],
13	sponsor	NN	O	sponsor	agent	10	SENT_74	[p3l903t2553r1209b2618],
14	,	,	O	,	_	0	SENT_74	[p3l903t2553r1209b2618],
15	oversaw	VB	O	oversee	_	0	SENT_74	[p3l1258t2553r1557b2597],
16	the	DT	O	the	det	17	SENT_74	[p3l1598t2529r1714b2597],
17	study	NN	O	study	dobj	15	SENT_74	[p3l1761t2529r1961b2618],
18	and	CC	O	and	_	0	SENT_74	[p3l2003t2529r2141b2597],
19	reviewed	VBN	O	review	conj_and	15	SENT_74	[p3l9t2638r341b2707],
20	adverse	JJ	O	adverse	amod	21	SENT_74	[p3l366t2638r644b2707],
21	events	NNS	O	event	dobj	19	SENT_74	[p3l671t2652r904b2707],
22	as	IN	O	as	mark	26	SENT_74	[p3l933t2663r1005b2707],
23	the	DT	O	the	det	24	SENT_74	[p3l1032t2638r1149b2707],
24	trial	NN	O	trial	nsubjpass	26	SENT_74	[p3l1174t2638r1323b2707],
25	was	VBD	O	be	auxpass	26	SENT_74	[p3l1346t2663r1484b2707],
26	implemented	VBN	O	implement	advcl	19	SENT_74	[p3l1513t2638r2035b2727],
27	.	.	O	.	_	0	SENT_74	[p3l1513t2638r2035b2727],

1	Figure	NNP	O	Figure	nsubj	3	SENT_75	[p3l83t2752r326b2837],
2	1	CD	NUMBER	1	num	1	SENT_75	[p3l353t2753r383b2814],
3	shows	VBZ	O	show	_	0	SENT_75	[p3l409t2747r640b2815],
4	the	DT	O	the	det	6	SENT_75	[p3l665t2747r784b2815],
5	study	NN	O	study	nn	6	SENT_75	[p3l810t2747r1014b2836],
6	design	NN	O	design	dobj	3	SENT_75	[p3l1036t2747r1306b2837],
7	.	.	O	.	_	0	SENT_75	[p3l1036t2747r1306b2837],

1	Arg/Arg	NN	O	arg/arg	nn	4	SENT_76	[p3l1332t2752r1653b2837],
2	and	CC	O	and	_	0	SENT_76	[p3l1677t2747r1817b2815],
3	Gly/Gly	JJ	O	gly/gly	conj_and	1	SENT_76	[p3l1842t2747r2142b2837],
4	individuals	NNS	O	individual	nsubj	36	SENT_76	[p3l9t2858r431b2926],
5	who	WP	O	who	nsubj	6	SENT_76	[p3l459t2858r618b2926],
6	met	VBD	O	meet	rcmod	4	SENT_76	[p3l647t2871r795b2926],
7	the	DT	O	the	det	9	SENT_76	[p3l820t2858r938b2926],
8	study	NN	O	study	nn	9	SENT_76	[p3l969t2858r1173b2947],
9	criteria	NNS	O	criterion	nsubj	10	SENT_76	[p3l1200t2862r1469b2926],
10	entered	VBD	O	enter	ccomp	6	SENT_76	[p3l1498t2858r1786b2926],
11	a	DT	O	a	det	12	SENT_76	[p3l1813t2882r1850b2926],
12	pool	NN	O	pool	dobj	10	SENT_76	[p3l1877t2858r2041b2947],
13	of	IN	O	of	_	0	SENT_76	[p3l2069t2858r2153b2926],
14	eligible	JJ	O	eligible	amod	15	SENT_76	[p3l10t2966r286b3056],
15	patients	NNS	O	patient	prep_of	12	SENT_76	[p3l307t2971r608b3055],
16	waiting	VBG	O	wait	partmod	15	SENT_76	[p3l629t2971r914b3056],
17	to	TO	O	to	aux	19	SENT_76	[p3l933t2980r1003b3034],
18	be	VB	O	be	auxpass	19	SENT_76	[p3l1023t2966r1110b3035],
19	matched	VBN	O	match	xcomp	16	SENT_76	[p3l1131t2966r1461b3035],
20	with	IN	O	with	_	0	SENT_76	[p3l1478t2966r1647b3034],
21	a	DT	O	a	det	22	SENT_76	[p3l1668t2991r1705b3034],
22	participant	NN	O	participant	prep_with	19	SENT_76	[p3l1724t2971r2141b3055],
23	with	IN	O	with	_	0	SENT_76	[p3l7t3075r175b3143],
24	the	DT	O	the	det	26	SENT_76	[p3l256t3075r375b3143],
25	opposite	JJ	O	opposite	amod	26	SENT_76	[p3l459t3080r780b3164],
26	genotype	NN	O	genotype	prep_with	19	SENT_76	[p3l865t3088r1228b3165],
27	,	,	O	,	_	0	SENT_76	[p3l865t3088r1228b3165],
28	stratiﬁed	VBN	O	stratiﬁed	partmod	26	SENT_76	[p3l1316t3075r1653b3143],
29	by	IN	O	by	_	0	SENT_76	[p3l1733t3075r1822b3164],
30	forced	JJ	O	forced	amod	32	SENT_76	[p3l1902t3075r2141b3143],
31	expiratory	JJ	O	expiratory	amod	32	SENT_76	[p3l10t3189r391b3274],
32	volume	NN	O	volume	agent	28	SENT_76	[p3l445t3185r729b3252],
33	in	IN	O	in	_	0	SENT_76	[p3l787t3189r862b3251],
34	1	CD	NUMBER	1	num	35	SENT_76	[p3l922t3191r953b3251],
35	s	NNS	O	s	prep_in	32	SENT_76	[p3l1012t3209r1041b3252],
36	(	VBP	O	(	_	0	SENT_76	[p3l1107t3189r1333b3275],
37	FEV1	NN	O	fev1	nn	38	SENT_76	[p3l1107t3189r1333b3275],
38	)	NN	O	)	dobj	36	SENT_76	[p3l1107t3189r1333b3275],
39	and	CC	O	and	_	0	SENT_76	[p3l1397t3185r1537b3253],
40	ethnic	JJ	O	ethnic	amod	41	SENT_76	[p3l1594t3185r1830b3253],
41	origin	NN	O	origin	dobj	36	SENT_76	[p3l1888t3190r2136b3275],
42	.	.	O	.	_	0	SENT_76	[p3l1888t3190r2136b3275],

1	Individuals	NNS	O	individual	nsubjpass	7	SENT_77	[p3l13t3294r439b3361],
2	with	IN	O	with	_	0	SENT_77	[p3l480t3294r649b3361],
3	the	DT	O	the	det	5	SENT_77	[p3l688t3294r806b3361],
4	Arg/Gly	NNP	O	Arg/Gly	nn	5	SENT_77	[p3l846t3294r1160b3383],
5	genotype	NN	O	genotype	prep_with	1	SENT_77	[p3l1200t3307r1543b3383],
6	were	VBD	O	be	auxpass	7	SENT_77	[p3l1582t3318r1763b3361],
7	excluded	VBN	O	exclude	ccomp	32	SENT_77	[p3l1806t3294r2141b3361],
8	because	IN	O	because	mark	15	SENT_77	[p3l7t3403r310b3472],
9	outcomes	NNS	O	outcome	nsubj	26	SENT_77	[p3l403t3417r769b3472],
10	for	IN	O	for	_	0	SENT_77	[p3l864t3403r972b3472],
11	such	JJ	O	such	amod	12	SENT_77	[p3l1065t3403r1241b3472],
12	patients	NNS	O	patient	prep_for	9	SENT_77	[p3l1332t3408r1634b3492],
13	had	VBD	O	have	aux	15	SENT_77	[p3l1727t3403r1867b3472],
14	been	VBN	O	be	cop	15	SENT_77	[p3l1956t3403r2140b3472],
15	inconsistent	JJ	O	inconsistent	advcl	7	SENT_77	[p4l9t22r480b85],
16	in	IN	O	in	_	0	SENT_77	[p4l519t22r594b84],
17	previous	JJ	O	previous	amod	18	SENT_77	[p4l634t22r958b106],
18	studies	NNS	O	study	prep_in	15	SENT_77	[p4l1004t17r1270b85],
19	and	CC	O	and	_	0	SENT_77	[p4l1313t17r1453b85],
20	preliminary	JJ	O	preliminary	amod	21	SENT_77	[p4l1491t17r1945b106],
21	data	NNS	O	datum	conj_and	18	SENT_77	[p4l1984t17r2140b85],
22	with	IN	O	with	_	0	SENT_77	[p4l7t127r175b194],
23	both	DT	O	both	det	24	SENT_77	[p4l210t127r382b194],
24	shortacting	NN	O	shortacting	prep_with	15	SENT_77	[p4l421t127r850b216],
25	and	CC	O	and	_	0	SENT_77	[p4l888t127r1028b194],
26	longacting	VBG	O	longact	conj_and	15	SENT_77	[p4l1061t127r1466b216],
27	[	CD	NUMBER	[	number	28	SENT_77	[p4l1508t126r1571b214],
28	3	CD	NUMBER	3	dobj	26	SENT_77	[p4l1508t126r1571b214],
29	,	,	O	,	_	0	SENT_77	[p4l1508t126r1571b214],
30	agonists	NNS	O	agonist	nsubjpass	32	SENT_77	[p4l1608t132r1921b216],
31	were	VBD	O	be	auxpass	32	SENT_77	[p4l1958t151r2139b194],
32	based	VBN	O	base	_	0	SENT_77	[p4l7t235r226b303],
33	on	IN	O	on	_	0	SENT_77	[p4l254t260r348b303],
34	differences	NNS	O	difference	prep_on	32	SENT_77	[p4l378t235r797b304],
35	between	IN	O	between	_	0	SENT_77	[p4l827t235r1144b303],
36	individuals	NNS	O	individual	prep_between	34	SENT_77	[p4l1173t235r1595b304],
37	with	IN	O	with	_	0	SENT_77	[p4l1624t235r1793b304],
38	Arg/Arg	NN	O	arg/arg	nn	39	SENT_77	[p4l1819t241r2140b325],
39	www	NN	O	www	prep_with	36	SENT_77	[p4l7t505r540b556],
40	.	.	O	.	_	0	SENT_77	[p4l7t505r540b556],

1	the	DT	O	the	det	2	SENT_78	[p4l7t505r540b556],
2	|	NN	O	|	_	0	SENT_78	[p4l7t505r540b556],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_78	[p4l7t505r540b556],
4	Vol	NNP	O	Vol	dep	2	SENT_78	[p4l583t505r670b556],
5	374	CD	NUMBER	374	num	4	SENT_78	[p4l690t512r791b564],
6	November	NNP	DATE	November	tmod	4	SENT_78	[p4l840t505r1132b556],
7	21	CD	DATE	21	num	6	SENT_78	[p4l1150t512r1230b565],
8	,	,	DATE	,	_	0	SENT_78	[p4l1150t512r1230b565],
9	2009	CD	DATE	2009	num	6	SENT_78	[p4l1250t512r1393b564],

1	and	CC	O	and	_	0	SENT_79	[p4l10t693r110b741],
2	Gly/Gly	JJ	O	gly/gly	amod	3	SENT_79	[p4l161t693r375b757],
3	genotypes	NNS	O	genotype	dep	1	SENT_79	[p4l425t703r712b757],
4	.	.	O	.	_	0	SENT_79	[p4l425t703r712b757],

1	Match-eligible	JJ	O	match-eligible	amod	2	SENT_80	[p4l767t693r1154b757],
2	participants	NNS	O	participant	nsubj	3	SENT_80	[p4l1205t696r1527b756],
3	began	VBD	O	begin	_	0	SENT_80	[p4l8t772r172b836],
4	treatment	NN	O	treatment	dobj	3	SENT_80	[p4l190t781r459b820],
5	with	IN	O	with	_	0	SENT_80	[p4l476t772r596b820],
6	open-label	JJ	O	open-label	prep_with	3	SENT_80	[p4l616t772r911b835],
7	,	,	O	,	_	0	SENT_80	[p4l616t772r911b835],
8	inhaled	VBN	O	inhale	partmod	6	SENT_80	[p4l933t772r1138b820],
9	corticosteroid	NN	O	corticosteroid	nn	13	SENT_80	[p4l1156t772r1529b820],
10	(	NN	O	(	nn	13	SENT_80	[p4l13t849r530b913],
11	hydroﬂuoroalkane	NN	O	hydroﬂuoroalkane	nn	13	SENT_80	[p4l13t849r530b913],
12	beclometasone	NN	O	beclometasone	nn	13	SENT_80	[p4l651t849r1058b898],
13	dipropionate	NN	O	dipropionate	dobj	8	SENT_80	[p4l1180t849r1528b912],
14	[	CD	NUMBER	[	num	15	SENT_80	[p4l12t930r213b990],
15	QVAR	NN	O	qvar	dep	13	SENT_80	[p4l12t930r213b990],
16	,	,	O	,	_	0	SENT_80	[p4l12t930r213b990],
17	Teva	NNP	ORGANIZATION	Teva	dep	13	SENT_80	[p4l240t930r374b983],
18	,	,	O	,	_	0	SENT_80	[p4l240t930r374b983],
19	Petach	NNP	ORGANIZATION	Petach	nn	20	SENT_80	[p4l405t927r582b975],
20	Tikva	NNP	ORGANIZATION	Tikva	dep	13	SENT_80	[p4l606t927r767b983],
21	,	,	O	,	_	0	SENT_80	[p4l606t927r767b983],
22	Israel	NNP	LOCATION	Israel	dep	13	SENT_80	[p4l797t927r960b990],
23	]	CD	NUMBER	]	number	24	SENT_80	[p4l797t927r960b990],
24	240	CD	NUMBER	240	num	25	SENT_80	[p4l991t931r1080b975],
25	ug	NN	O	ug	npadvmod	26	SENT_80	[p4l1105t944r1174b991],
26	twice	RB	O	twice	advmod	28	SENT_80	[p4l1198t930r1338b975],
27	a	DT	DURATION	a	det	28	SENT_80	[p4l1365t944r1392b975],
28	day	NN	DURATION	day	tmod	22	SENT_80	[p4l1418t927r1524b991],
29	)	CD	NUMBER	)	dep	22	SENT_80	[p4l1418t927r1524b991],
30	and	CC	O	and	_	0	SENT_80	[p4l10t1006r110b1054],
31	salbutamol	NN	O	salbutamol	dep	13	SENT_80	[p4l130t1006r431b1054],
32	(	RB	O	(	advmod	8	SENT_80	[p4l454t1010r524b1069],
33	as	IN	O	as	_	0	SENT_80	[p4l454t1010r524b1069],
34	needed	VBN	O	need	amod	35	SENT_80	[p4l545t1005r775b1069],
35	)	NN	O	)	prep_as	8	SENT_80	[p4l545t1005r775b1069],
36	,	,	O	,	_	0	SENT_80	[p4l545t1005r775b1069],
37	and	CC	O	and	_	0	SENT_80	[p4l798t1005r897b1054],
38	returned	VBD	O	return	conj_and	3	SENT_80	[p4l916t1005r1154b1054],
39	after	IN	O	after	_	0	SENT_80	[p4l1174t1005r1296b1054],
40	3	CD	DURATION	3	num	41	SENT_80	[p4l1318t1010r1342b1054],
41	weeks	NNS	NUMBER	week	prep_after	38	SENT_80	[p4l1363t1006r1527b1054],
42	of	IN	O	of	_	0	SENT_80	[p4l10t1083r70b1132],
43	treatment	NN	O	treatment	prep_of	41	SENT_80	[p4l86t1093r355b1132],
44	for	IN	O	for	_	0	SENT_80	[p4l380t1083r457b1132],
45	spirometry	NN	O	spirometry	prep_for	38	SENT_80	[p4l484t1086r782b1147],
46	to	TO	O	to	aux	47	SENT_80	[p4l805t1093r855b1132],
47	establish	VB	O	establish	xcomp	38	SENT_80	[p4l883t1083r1123b1132],
48	baseline	NN	O	baseline	nn	49	SENT_80	[p4l1148t1083r1373b1132],
49	FEV	NN	O	fev	dobj	47	SENT_80	[p4l1402t1086r1529b1144],
50	,	,	O	,	_	0	SENT_80	[p4l1402t1086r1529b1144],
51	for	IN	O	for	conj_and	3	SENT_80	[p4l9t1161r86b1209],
52	matching	VBG	O	match	pcomp	51	SENT_80	[p4l131t1161r404b1225],
53	.	.	O	.	_	0	SENT_80	[p4l131t1161r404b1225],

1	Participants	NNS	O	participant	nsubj	2	SENT_81	[p4l456t1164r776b1224],
2	returned	VBD	O	return	_	0	SENT_81	[p4l824t1161r1062b1209],
3	every	DT	SET	every	quantmod	4	SENT_81	[p4l1107t1178r1248b1224],
4	4	CD	SET	4	num	5	SENT_81	[p4l1291t1165r1321b1208],
5	weeks	NNS	NUMBER	week	npadvmod	6	SENT_81	[p4l1363t1161r1527b1209],
6	thereafter	RB	O	thereafter	advmod	2	SENT_81	[p4l8t1239r275b1287],
7	for	IN	O	for	_	0	SENT_81	[p4l321t1239r398b1287],
8	diary	NN	O	diary	nn	9	SENT_81	[p4l445t1239r581b1302],
9	review	NN	O	review	prep_for	2	SENT_81	[p4l626t1242r812b1294],
10	,	,	O	,	_	0	SENT_81	[p4l626t1242r812b1294],
11	medication	NN	O	medication	nn	13	SENT_81	[p4l861t1239r1168b1287],
12	compliance	NN	O	compliance	nn	13	SENT_81	[p4l1215t1239r1528b1302],
13	review	NN	O	review	prep_for	2	SENT_81	[p4l9t1319r194b1372],
14	,	,	O	,	_	0	SENT_81	[p4l9t1319r194b1372],
15	spirometry	NN	O	spirometry	prep_for	2	SENT_81	[p4l219t1319r524b1380],
16	,	,	O	,	_	0	SENT_81	[p4l219t1319r524b1380],
17	and	CC	O	and	_	0	SENT_81	[p4l547t1316r647b1365],
18	safety	NN	O	safety	nn	19	SENT_81	[p4l668t1316r823b1380],
19	checks	NNS	O	check	prep_for	2	SENT_81	[p4l842t1316r1021b1365],
20	until	IN	O	until	mark	24	SENT_81	[p4l1042t1316r1172b1365],
21	a	DT	O	a	det	22	SENT_81	[p4l1192t1334r1219b1365],
22	match	NN	O	match	nsubjpass	24	SENT_81	[p4l1238t1316r1408b1365],
23	was	VBD	O	be	auxpass	24	SENT_81	[p4l1426t1334r1527b1365],
24	identiﬁed	VBN	O	identiﬁed	advcl	2	SENT_81	[p4l9t1394r284b1442],
25	.	.	O	.	_	0	SENT_81	[p4l9t1394r284b1442],

1	Pairs	NNS	O	pair	nsubj	33	SENT_82	[p4l306t1397r437b1442],
2	of	IN	O	of	_	0	SENT_82	[p4l457t1394r517b1442],
3	matched	VBN	O	match	amod	4	SENT_82	[p4l525t1394r761b1442],
4	participants	NNS	O	participant	prep_of	1	SENT_82	[p4l777t1397r1099b1457],
5	(	CD	NUMBER	(	dep	4	SENT_82	[p4l1122t1397r1199b1458],
6	ie	FW	O	ie	dep	5	SENT_82	[p4l1122t1397r1199b1458],
7	,	,	O	,	_	0	SENT_82	[p4l1122t1397r1199b1458],
8	an	DT	O	a	det	9	SENT_82	[p4l1219t1411r1284b1442],
9	Arg/Arg	NN	O	arg/arg	dep	5	SENT_82	[p4l1300t1397r1528b1458],
10	and	CC	O	and	_	0	SENT_82	[p4l10t1473r110b1521],
11	a	DT	O	a	det	13	SENT_82	[p4l130t1490r156b1521],
12	Gly/Gly	JJ	O	gly/gly	amod	13	SENT_82	[p4l178t1472r392b1536],
13	participant	NN	O	participant	dep	5	SENT_82	[p4l410t1476r708b1535],
14	within	IN	O	within	dep	6	SENT_82	[p4l725t1473r902b1521],
15	10	CD	PERCENT	10	num	16	SENT_82	[p4l924t1475r1033b1523],
16	%	NN	PERCENT	%	pobj	14	SENT_82	[p4l924t1475r1033b1523],
17	of	IN	O	of	_	0	SENT_82	[p4l1054t1472r1114b1521],
18	predicted	VBN	O	predict	amod	19	SENT_82	[p4l1125t1472r1380b1535],
19	FEV	NN	O	fev	prep_of	16	SENT_82	[p4l1402t1475r1529b1533],
20	,	,	O	,	_	0	SENT_82	[p4l1402t1475r1529b1533],
21	and	CC	O	and	_	0	SENT_82	[p4l10t1550r110b1599],
22	of	IN	O	of	dep	4	SENT_82	[p4l144t1550r204b1599],
23	the	DT	O	the	det	27	SENT_82	[p4l228t1550r313b1599],
24	same	JJ	O	same	amod	27	SENT_82	[p4l349t1568r489b1599],
25	ethnic	JJ	O	ethnic	amod	27	SENT_82	[p4l525t1550r693b1599],
26	origin	NN	O	origin	nn	27	SENT_82	[p4l728t1553r891b1614],
27	[	NN	O	[	nn	32	SENT_82	[p4l928t1550r1091b1613],
28	white	JJ	O	white	amod	32	SENT_82	[p4l928t1550r1091b1613],
29	or	CC	O	or	_	0	SENT_82	[p4l1126t1568r1181b1599],
30	non-white	JJ	O	non-white	conj_or	28	SENT_82	[p4l1215t1550r1524b1614],
31	]	NN	O	]	nn	32	SENT_82	[p4l1215t1550r1524b1614],
32	)	NN	O	)	pobj	22	SENT_82	[p4l1215t1550r1524b1614],
33	returned	VBD	O	return	_	0	SENT_82	[p4l9t1627r247b1675],
34	to	TO	O	to	aux	35	SENT_82	[p4l265t1637r315b1675],
35	enter	VB	O	enter	xcomp	33	SENT_82	[p4l336t1637r477b1675],
36	the	DT	O	the	det	38	SENT_82	[p4l495t1627r579b1675],
37	main	JJ	O	main	amod	38	SENT_82	[p4l600t1630r741b1675],
38	study	NN	O	study	dobj	35	SENT_82	[p4l763t1627r915b1690],
39	.	.	O	.	_	0	SENT_82	[p4l763t1627r915b1690],

1	Matched	VBN	O	match	_	0	SENT_83	[p4l62t1705r293b1753],
2	participants	NNS	O	participant	dobj	1	SENT_83	[p4l311t1708r630b1767],
3	entered	VBD	O	enter	dep	1	SENT_83	[p4l653t1705r856b1753],
4	an	DT	O	a	det	7	SENT_83	[p4l876t1722r940b1753],
5	8-week	JJ	DURATION	8-week	amod	7	SENT_83	[p4l960t1705r1147b1753],
6	run-in	NN	O	run-in	nn	7	SENT_83	[p4l1165t1708r1336b1753],
7	period	NN	O	period	dobj	3	SENT_83	[p4l1355t1705r1529b1767],
8	to	TO	O	to	aux	9	SENT_83	[p4l8t1792r58b1831],
9	wash	VB	O	wash	xcomp	3	SENT_83	[p4l73t1782r211b1831],
10	out	RP	O	out	prt	9	SENT_83	[p4l228t1792r315b1831],
11	previous	JJ	O	previous	amod	12	SENT_83	[p4l329t1785r559b1845],
12	use	NN	O	use	dobj	9	SENT_83	[p4l576t1800r668b1831],
13	of	IN	O	of	_	0	SENT_83	[p4l685t1782r744b1831],
14	longacting	VBG	O	longact	amod	15	SENT_83	[p4l750t1782r1036b1846],
15	[	NN	O	[	prep_of	12	SENT_83	[p4l1056t1782r1101b1844],
16	3	CD	NUMBER	3	nsubj	1	SENT_83	[p4l1056t1782r1101b1844],
17	,	,	O	,	_	0	SENT_83	[p4l1056t1782r1101b1844],
18	agonist	NN	O	agonist	nn	19	SENT_83	[p4l1117t1785r1314b1846],
19	(	NN	O	(	appos	16	SENT_83	[p4l1333t1782r1526b1846],
20	which	WDT	O	which	nsubjpass	27	SENT_83	[p4l1333t1782r1526b1846],
21	,	,	O	,	_	0	SENT_83	[p4l1333t1782r1526b1846],
22	in	IN	O	in	_	0	SENT_83	[p4l9t1863r63b1908],
23	previous	JJ	O	previous	amod	24	SENT_83	[p4l80t1863r309b1923],
24	studies	NNS	O	study	prep_in	27	SENT_83	[p4l331t1860r535b1916],
25	,	,	O	,	_	0	SENT_83	[p4l331t1860r535b1916],
26	was	VBD	O	be	auxpass	27	SENT_83	[p4l553t1877r653b1908],
27	seen	VBN	O	see	rcmod	19	SENT_83	[p4l674t1877r794b1908],
28	to	TO	O	to	aux	29	SENT_83	[p4l811t1870r861b1908],
29	last	VB	O	last	xcomp	27	SENT_83	[p4l878t1860r971b1908],
30	as	RB	O	as	advmod	31	SENT_83	[p4l989t1877r1040b1908],
31	long	RB	O	long	advmod	29	SENT_83	[p4l1059t1860r1178b1924],
32	as	IN	O	as	_	0	SENT_83	[p4l1196t1877r1248b1908],
33	8	CD	NUMBER	8	num	34	SENT_83	[p4l1268t1864r1296b1908],
34	weel	NN	O	weel	npadvmod	35	SENT_83	[p4l1313t1860r1525b1924],
35	<	JJR	O	<	prep_as	31	SENT_83	[p4l1313t1860r1525b1924],
36	s7	CD	NUMBER	s7	num	37	SENT_83	[p4l1313t1860r1525b1924],
37	)	NN	O	)	dobj	29	SENT_83	[p4l1313t1860r1525b1924],
38	.	.	O	.	_	0	SENT_83	[p4l1313t1860r1525b1924],

1	During	IN	O	during	_	0	SENT_84	[p4l12t1942r205b2003],
2	this	DT	O	this	det	4	SENT_84	[p4l258t1939r357b1987],
3	run-in	JJ	O	run-in	amod	4	SENT_84	[p4l413t1942r583b1987],
4	period	NN	O	period	prep_during	7	SENT_84	[p4l637t1939r824b2002],
5	,	,	O	,	_	0	SENT_84	[p4l637t1939r824b2002],
6	participants	NNS	O	participant	nsubj	7	SENT_84	[p4l880t1942r1199b2002],
7	continued	VBD	O	continue	_	0	SENT_84	[p4l1256t1939r1529b1987],
8	treatment	NN	O	treatment	dobj	7	SENT_84	[p4l8t2026r275b2065],
9	with	IN	O	with	_	0	SENT_84	[p4l289t2016r408b2065],
10	open-label	JJ	O	open-label	amod	13	SENT_84	[p4l425t2016r704b2079],
11	hydroﬂuoroalkane	NN	O	hydroﬂuoroalkane	nn	13	SENT_84	[p4l719t2016r1217b2080],
12	beclometasone	NN	O	beclometasone	nn	13	SENT_84	[p4l1233t2016r1527b2065, p4l11t2111r134b2142],
13	(	NN	O	(	prep_with	8	SENT_84	[p4l159t2098r266b2158],
14	240	CD	NUMBER	240	num	15	SENT_84	[p4l159t2098r266b2158],
15	ug	NN	O	ug	npadvmod	16	SENT_84	[p4l287t2111r355b2158],
16	twice	RB	O	twice	advmod	8	SENT_84	[p4l375t2097r514b2142],
17	a	DT	DURATION	a	det	18	SENT_84	[p4l537t2111r563b2142],
18	day	NN	DURATION	day	pobj	16	SENT_84	[p4l584t2094r708b2158],
19	)	CD	NUMBER	)	dep	8	SENT_84	[p4l584t2094r708b2158],
20	.	.	O	.	_	0	SENT_84	[p4l584t2094r708b2158],

1	Inhaled	VBN	O	inhale	_	0	SENT_85	[p4l734t2094r940b2142],
2	salbutamol	NN	O	salbutamol	nsubjpass	4	SENT_85	[p4l962t2094r1260b2142],
3	was	VBD	O	be	auxpass	4	SENT_85	[p4l1280t2111r1379b2142],
4	used	VBN	O	use	ccomp	1	SENT_85	[p4l1401t2094r1529b2142],
5	See	VB	O	see	ccomp	4	SENT_85	[p4l1592t2109r1650b2140],
6	Onlineforwebappendix	NN	O	onlineforwebappendix	dobj	5	SENT_85	[p4l1662t2106r2088b2150],

1	Panel	NN	O	panel	_	0	SENT_86	[p4l63t2286r200b2330],
2	:	:	O	:	_	0	SENT_86	[p4l63t2286r200b2330],
3	Inclusion	NNP	O	Inclusion	dep	1	SENT_86	[p4l218t2286r431b2330],
4	and	CC	O	and	_	0	SENT_86	[p4l447t2286r537b2330],
5	exclusion	NN	O	exclusion	nn	6	SENT_86	[p4l551t2286r775b2330],
6	criteria	NNS	O	criterion	dep	1	SENT_86	[p4l791t2288r960b2330],

1	Screening	VBG	O	screen	_	0	SENT_87	[p4l63t2406r298b2462],
2	inclusion	NN	O	inclusion	nn	3	SENT_87	[p4l315t2404r529b2448],
3	criteria	NNS	O	criterion	dobj	1	SENT_87	[p4l545t2406r714b2448],
4	-	:	O	-	_	0	SENT_87	[p4l65t2500r78b2514],
5	Male	NN	O	male	nn	8	SENT_87	[p4l145t2480r253b2524],
6	and	CC	O	and	_	0	SENT_87	[p4l267t2480r352b2524],
7	female	JJ	O	female	nn	8	SENT_87	[p4l365t2479r521b2524],
8	patients	NNS	O	patient	dep	3	SENT_87	[p4l536t2483r734b2537],
9	,	,	O	,	_	0	SENT_87	[p4l536t2483r734b2537],
10	aged	VBN	O	age	dep	8	SENT_87	[p4l750t2480r860b2538],
11	18	CD	DURATION	18	num	12	SENT_87	[p4l875t2479r929b2524],
12	years	NNS	NUMBER	year	tmod	10	SENT_87	[p4l942t2495r1059b2537],
13	or	CC	O	or	_	0	SENT_87	[p4l1073t2495r1120b2524],
14	older	JJR	O	older	dep	8	SENT_87	[p4l1132t2480r1248b2524],
15	-	:	O	-	_	0	SENT_87	[p4l65t2576r78b2590],
16	Ability	NN	O	ability	dep	3	SENT_87	[p4l143t2557r293b2614],
17	to	TO	O	to	aux	18	SENT_87	[p4l303t2565r352b2600],
18	provide	VB	O	provide	infmod	16	SENT_87	[p4l367t2557r540b2614],
19	written	JJ	O	written	amod	21	SENT_87	[p4l552t2560r719b2600],
20	informed	JJ	O	informed	amod	21	SENT_87	[p4l738t2556r949b2600],
21	consent	NN	O	consent	dobj	18	SENT_87	[p4l964t2564r1145b2600],
22	-	:	O	-	_	0	SENT_87	[p4l65t2652r78b2666],
23	Clinical	JJ	O	clinical	amod	24	SENT_87	[p4l145t2632r302b2676],
24	history	NN	O	history	dep	3	SENT_87	[p4l322t2632r479b2690],
25	consistent	JJ	O	consistent	amod	24	SENT_87	[p4l492t2636r729b2676],
26	with	IN	O	with	_	0	SENT_87	[p4l741t2632r842b2676],
27	asthma	NN	O	asthma	prep_with	25	SENT_87	[p4l859t2632r1029b2676],
28	-	:	O	-	_	0	SENT_87	[p4l65t2728r78b2742],
29	FEV1	NN	O	fev1	dep	3	SENT_87	[p4l146t2712r242b2763],
30	40	CD	PERCENT	40	number	31	SENT_87	[p4l256t2714r357b2758],
31	%	NN	PERCENT	%	num	34	SENT_87	[p4l256t2714r357b2758],
32	or	CC	O	or	_	0	SENT_87	[p4l371t2723r418b2752],
33	more	JJR	O	more	conj_or	31	SENT_87	[p4l434t2723r552b2752],
34	ofpredicted	JJ	O	ofpredicted	dep	29	SENT_87	[p4l566t2707r841b2765],
35	or	CC	O	or	_	0	SENT_87	[p4l854t2723r901b2752],
36	50	CD	PERCENT	50	number	37	SENT_87	[p4l915t2714r1012b2758],
37	%	NN	PERCENT	%	dep	3	SENT_87	[p4l915t2714r1012b2758],
38	or	CC	O	or	_	0	SENT_87	[p4l1027t2723r1074b2752],
39	more	JJR	O	more	conj_or	37	SENT_87	[p4l1090t2723r1207b2752],
40	of	IN	O	of	_	0	SENT_87	[p4l1221t2707r1270b2752],
41	predicted	VBN	O	predict	prepc_of	37	SENT_87	[p4l1281t2708r1496b2765],
42	for	IN	O	for	_	0	SENT_87	[p4l1509t2707r1575b2752],
43	patients	NNS	O	patient	nsubj	45	SENT_87	[p4l1589t2711r1775b2765],
44	regularly	RB	O	regularly	advmod	45	SENT_87	[p4l1793t2708r1989b2766],
45	using	VBG	O	use	prepc_for	41	SENT_87	[p4l145t2788r265b2842],
46	inhaled	VBN	O	inhale	dep	45	SENT_87	[p4l283t2785r449b2829],
47	corticosteroids	NNS	O	corticosteroid	dobj	46	SENT_87	[p4l464t2785r803b2829],

1	-	:	O	-	_	0	SENT_88	[p4l65t2880r78b2894],
2	lfon	NN	O	lfon	nsubj	3	SENT_88	[p4l146t2860r242b2904],
3	inhaled	VBD	O	inhale	_	0	SENT_88	[p4l261t2860r427b2904],
4	steroids	NNS	O	steroid	dobj	3	SENT_88	[p4l441t2860r633b2912],
5	,	,	O	,	_	0	SENT_88	[p4l441t2860r633b2912],
6	patients	NNS	O	patient	nsubj	9	SENT_88	[p4l649t2864r835b2917],
7	must	MD	O	must	aux	9	SENT_88	[p4l853t2868r967b2904],
8	have	VB	O	have	aux	9	SENT_88	[p4l984t2860r1088b2904],
9	been	VBN	O	be	dep	4	SENT_88	[p4l1105t2860r1211b2904],
10	on	IN	O	on	_	0	SENT_88	[p4l1227t2875r1284b2904],
11	a	DT	O	a	det	13	SENT_88	[p4l1300t2875r1323b2904],
12	stable	JJ	O	stable	amod	13	SENT_88	[p4l1338t2860r1472b2904],
13	dose	NN	O	dose	prep_on	9	SENT_88	[p4l1486t2860r1591b2904],
14	for	IN	O	for	_	0	SENT_88	[p4l1604t2860r1671b2904],
15	at	IN	DURATION	at	quantmod	17	SENT_88	[p4l1684t2868r1728b2904],
16	least	JJS	DURATION	least	mwe	15	SENT_88	[p4l1745t2860r1847b2904],
17	2	CD	DURATION	2	num	18	SENT_88	[p4l1862t2866r1885b2904],
18	weeks	NNS	NUMBER	week	prep_for	13	SENT_88	[p4l1900t2860r2040b2904],
19	-	:	O	-	_	0	SENT_88	[p4l65t2956r78b2970],
20	Genotype	NN	O	genotype	nn	22	SENT_88	[p4l144t2939r366b2993],
21	B16	NN	O	b16	nn	22	SENT_88	[p4l383t2935r468b2980],
22	Arg/Arg	NN	O	arg/arg	dep	13	SENT_88	[p4l482t2937r663b2994],
23	or	CC	O	or	_	0	SENT_88	[p4l679t2951r726b2980],
24	B16	NN	O	b16	nn	25	SENT_88	[p4l742t2935r827b2980],
25	Gly/Gly	NN	O	gly/gly	conj_or	22	SENT_88	[p4l842t2936r1006b2993],
26	-	:	O	-	_	0	SENT_88	[p4l65t3032r78b3046],
27	Reversible	JJ	O	reversible	amod	29	SENT_88	[p4l146t3013r377b3056],
28	airway	NN	O	airway	nn	29	SENT_88	[p4l393t3016r546b3070],
29	obstruction	NN	O	obstruction	dep	13	SENT_88	[p4l559t3013r827b3056],
30	(	CD	PERCENT	(	num	32	SENT_88	[p4l847t3015r990b3068],
31	z12	CD	PERCENT	z12	num	32	SENT_88	[p4l847t3015r990b3068],
32	%	NN	PERCENT	%	dep	29	SENT_88	[p4l847t3015r990b3068],
33	and	CC	O	and	_	0	SENT_88	[p4l1006t3013r1092b3056],
34	200	CD	NUMBER	200	num	36	SENT_88	[p4l1108t3018r1196b3056],
35	mL	NN	O	ml	nn	36	SENT_88	[p4l1215t3017r1285b3056],
36	improvement	NN	O	improvement	conj_and	13	SENT_88	[p4l1301t3016r1620b3070],
37	in	IN	O	in	_	0	SENT_88	[p4l1637t3016r1675b3056],
38	FEV1	NN	O	fev1	prep_in	36	SENT_88	[p4l1695t3017r1793b3068],
39	after	IN	O	after	_	0	SENT_88	[p4l1807t3012r1917b3056],
40	two	CD	NUMBER	two	num	41	SENT_88	[p4l1928t3021r2019b3056],
41	puffs	NNS	O	puff	prep_after	9	SENT_88	[p4l143t3088r257b3145],
42	of	IN	O	of	prep	41	SENT_88	[p4l272t3088r322b3132],
43	inhaled	VBN	O	inhale	dep	42	SENT_88	[p4l336t3088r504b3132],
44	salbutamol	NN	O	salbutamol	nn	54	SENT_88	[p4l520t3088r797b3144],
45	)	CD	NUMBER	)	num	44	SENT_88	[p4l520t3088r797b3144],
46	or	CC	O	or	_	0	SENT_88	[p4l814t3103r861b3132],
47	bronchial	JJ	O	bronchial	amod	48	SENT_88	[p4l877t3088r1090b3132],
48	hyperresponsiveness	NN	O	hyperresponsiveness	conj_or	44	SENT_88	[p4l1110t3088r1593b3145],
49	with	IN	O	with	_	0	SENT_88	[p4l1606t3088r1709b3132],
50	methacholine	NN	O	methacholine	prep_with	48	SENT_88	[p4l1729t3088r2048b3132],
51	(	CD	PERCENT	(	num	50	SENT_88	[p4l145t3166r261b3219],
52	20	CD	PERCENT	20	number	53	SENT_88	[p4l145t3166r261b3219],
53	%	NN	PERCENT	%	amod	54	SENT_88	[p4l145t3166r261b3219],
54	reduction	NN	O	reduction	dobj	43	SENT_88	[p4l281t3164r500b3208],
55	in	IN	O	in	_	0	SENT_88	[p4l520t3168r558b3207],
56	FEV1	NN	O	fev1	nn	58	SENT_88	[p4l578t3166r815b3220],
57	[	CD	NUMBER	[	num	58	SENT_88	[p4l578t3166r815b3220],
58	PC	NN	O	pc	prep_in	43	SENT_88	[p4l578t3166r815b3220],
59	,	,	O	,	_	0	SENT_88	[p4l578t3166r815b3220],
60	,	,	O	,	_	0	SENT_88	[p4l578t3166r815b3220],
61	,	,	O	,	_	0	SENT_88	[p4l578t3166r815b3220],
62	]	NN	O	]	dobj	3	SENT_88	[p4l578t3166r815b3220],
63	in	IN	O	in	_	0	SENT_88	[p4l835t3167r873b3207],
64	response	NN	O	response	prep_in	62	SENT_88	[p4l893t3179r1097b3221],
65	to	TO	O	to	_	0	SENT_88	[p4l1109t3172r1158b3208],
66	a	DT	O	a	det	67	SENT_88	[p4l1174t3179r1198b3208],
67	concentration	NN	O	concentration	prep_to	64	SENT_88	[p4l1213t3167r1539b3208],
68	of	IN	O	of	_	0	SENT_88	[p4l1556t3163r1605b3208],
69	inhaled	VBN	O	inhale	prepc_of	67	SENT_88	[p4l1619t3164r1788b3208],
70	methacholine	NN	O	methacholine	nn	72	SENT_88	[p4l146t3240r465b3284],
71	s8	NN	O	s8	nn	72	SENT_88	[p4l482t3240r539b3284],
72	mg/mL	NN	O	mg/ml	dobj	69	SENT_88	[p4l559t3242r738b3298],
73	,	,	O	,	_	0	SENT_88	[p4l559t3242r738b3298],
74	or	CC	O	or	_	0	SENT_88	[p4l754t3255r802b3284],
75	PCZO	NN	O	pczo	nn	76	SENT_88	[p4l819t3244r905b3296],
76	s16	NN	O	s16	dobj	3	SENT_88	[p4l922t3240r1007b3284],
77	mg/mL	NN	O	mg/ml	nn	78	SENT_88	[p4l1026t3242r1194b3298],
78	ifon	NN	O	ifon	nsubj	79	SENT_88	[p4l1210t3240r1309b3284],
79	inhaled	VBD	O	inhale	rcmod	76	SENT_88	[p4l1328t3240r1497b3284],
80	corticosteroids	NNS	O	corticosteroid	dobj	79	SENT_88	[p4l1513t3241r1876b3296],
81	)	IN	O	)	prep	79	SENT_88	[p4l1513t3241r1876b3296],

1	-	:	O	-	_	0	SENT_89	[p4l65t3336r78b3350],
2	Non	NN	O	non	npadvmod	35	SENT_89	[p4l146t3316r433b3360],
3	—	CD	NUMBER	—	num	4	SENT_89	[p4l146t3316r433b3360],
4	smoker	NN	O	smoker	dep	10	SENT_89	[p4l146t3316r433b3360],
5	(	CD	NUMBER	(	num	7	SENT_89	[p4l449t3316r570b3372],
6	total	JJ	O	total	amod	7	SENT_89	[p4l449t3316r570b3372],
7	lifetime	NN	O	lifetime	dep	4	SENT_89	[p4l590t3316r763b3360],
8	smoking	NN	O	smoking	nn	9	SENT_89	[p4l778t3316r974b3374],
9	history	NN	O	history	dep	10	SENT_89	[p4l993t3316r1150b3374],
10	<	JJR	O	<	dep	2	SENT_89	[p4l1165t3322r1248b3360],
11	10	CD	NUMBER	10	num	12	SENT_89	[p4l1165t3322r1248b3360],
12	pack	NN	O	pack	dep	10	SENT_89	[p4l1263t3316r1513b3374],
13	—	CD	NUMBER	—	num	14	SENT_89	[p4l1263t3316r1513b3374],
14	years	NNS	NUMBER	year	dep	12	SENT_89	[p4l1263t3316r1513b3374],
15	;	:	O	;	_	0	SENT_89	[p4l1263t3316r1513b3374],
16	no	DT	O	no	det	20	SENT_89	[p4l1531t3331r1587b3360],
17	more	JJR	O	more	dep	19	SENT_89	[p4l1604t3331r1721b3360],
18	than	IN	O	than	dep	19	SENT_89	[p4l1733t3316r1838b3360],
19	ﬁve	JJ	O	ﬁve	amod	20	SENT_89	[p4l1853t3316r1935b3360],
20	occasions	NNS	O	occasion	dep	12	SENT_89	[p4l144t3395r362b3436],
21	of	IN	O	of	_	0	SENT_89	[p4l376t3391r425b3436],
22	smoking	NN	O	smoking	prep_of	20	SENT_89	[p4l436t3392r631b3450],
23	in	IN	O	in	_	0	SENT_89	[p4l650t3395r687b3435],
24	the	DT	DATE	the	det	26	SENT_89	[p4l701t3392r776b3436],
25	past	JJ	DATE	past	amod	26	SENT_89	[p4l791t3400r887b3449],
26	year	NN	DATE	year	prep_in	22	SENT_89	[p4l898t3407r1005b3449],
27	;	:	O	;	_	0	SENT_89	[p4l898t3407r1005b3449],
28	no	DT	O	no	det	29	SENT_89	[p4l1023t3407r1079b3436],
29	smoking	NN	O	smoking	dep	12	SENT_89	[p4l1094t3392r1289b3450],
30	or	CC	O	or	_	0	SENT_89	[p4l1305t3407r1352b3436],
31	use	NN	O	use	dep	12	SENT_89	[p4l1366t3407r1439b3436],
32	of	IN	O	of	_	0	SENT_89	[p4l1453t3391r1502b3436],
33	smokeless	JJ	O	smokeless	amod	34	SENT_89	[p4l1513t3392r1746b3436],
34	tobacco	NN	O	tobacco	prep_of	29	SENT_89	[p4l1757t3392r1939b3436],
35	in	IN	O	in	_	0	SENT_89	[p4l1956t3395r1993b3435],
36	the	DT	DURATION	the	det	39	SENT_89	[p4l2006t3392r2082b3436],
37	previous	JJ	DURATION	previous	amod	39	SENT_89	[p4l143t3472r338b3526],
38	30	CD	DURATION	30	num	39	SENT_89	[p4l352t3475r409b3519],
39	days	NNS	NUMBER	day	pobj	35	SENT_89	[p4l423t3469r541b3526],
40	)	IN	O	)	dep	35	SENT_89	[p4l423t3469r541b3526],

1	Exclusion	NN	O	exclusion	nn	2	SENT_90	[p4l65t3587r288b3631],
2	criteria	NNS	O	criterion	_	0	SENT_90	[p4l304t3588r474b3631],

1	-	:	O	-	_	0	SENT_91	[p5l65t42r78b56],
2	Use	NN	O	use	_	0	SENT_91	[p5l146t26r225b66],
3	of	IN	O	of	_	0	SENT_91	[p5l239t22r288b66],
4	greater	JJR	O	greater	prep_of	2	SENT_91	[p5l299t30r463b80],
5	than	IN	O	than	mark	11	SENT_91	[p5l473t22r577b66],
6	the	DT	O	the	det	7	SENT_91	[p5l591t22r666b66],
7	equivalent	NN	O	equivalent	nsubj	11	SENT_91	[p5l681t22r922b79],
8	of	IN	O	of	_	0	SENT_91	[p5l935t22r984b66],
9	1000	CD	DATE	1000	num	10	SENT_91	[p5l996t28r1112b66],
10	pg	NN	O	pg	prep_of	7	SENT_91	[p5l1130t37r1183b80],
11	inhaled	VBD	O	inhale	dep	4	SENT_91	[p5l1201t22r1367b66],
12	ﬂuticasone	NN	O	ﬂuticasone	dobj	11	SENT_91	[p5l1380t22r1632b66],
13	daily	JJ	SET	daily	amod	12	SENT_91	[p5l1646t22r1753b79],

1	Chronic	JJ	O	chronic	amod	4	SENT_92	[p5l145t99r320b143],
2	use	NN	O	use	nn	4	SENT_92	[p5l336t114r409b143],
3	ofany	NN	O	ofany	nn	4	SENT_92	[p5l424t98r566b156],
4	medication	NN	O	medication	_	0	SENT_92	[p5l583t99r840b143],
5	other	JJ	O	other	amod	4	SENT_92	[p5l856t99r981b143],
6	than	IN	O	than	_	0	SENT_92	[p5l992t99r1097b143],
7	[	CD	NUMBER	[	number	8	SENT_92	[p5l1117t98r1142b156],
8	3	CD	NUMBER	3	num	9	SENT_92	[p5l1117t98r1142b156],
9	agonists	NNS	O	agonist	prep_than	5	SENT_92	[p5l1158t102r1351b156],
10	or	CC	O	or	_	0	SENT_92	[p5l1366t113r1413b143],
11	inhaled	VBN	O	inhale	amod	4	SENT_92	[p5l1428t99r1596b143],
12	corticosteroids	NNS	O	corticosteroid	dobj	11	SENT_92	[p5l1611t99r1965b150],
13	,	,	O	,	_	0	SENT_92	[p5l1611t99r1965b150],
14	except	IN	O	except	_	0	SENT_92	[p5l144t183r294b232],
15	as	IN	O	as	mark	16	SENT_92	[p5l309t189r354b219],
16	designated	VBN	O	designate	prepc_except	11	SENT_92	[p5l368t175r623b232],
17	by	IN	O	by	_	0	SENT_92	[p5l639t175r691b232],
18	protocol	NN	O	protocol	prep_by	16	SENT_92	[p5l705t175r897b232],
19	-	:	O	-	_	0	SENT_92	[p5l65t270r78b284],
20	Lung	NN	O	lung	nn	21	SENT_92	[p5l146t254r255b308],
21	disease	NN	O	disease	dep	4	SENT_92	[p5l271t250r434b294],
22	other	JJ	O	other	dep	21	SENT_92	[p5l448t250r572b294],
23	than	IN	O	than	_	0	SENT_92	[p5l582t250r686b294],
24	asthma	NN	O	asthma	prep_than	21	SENT_92	[p5l703t250r873b294],

1	Established	VBN	O	establish	_	0	SENT_93	[p5l146t327r402b371],
2	or	CC	O	or	_	0	SENT_93	[p5l416t341r462b371],
3	suspected	VBN	O	suspect	conj_or	1	SENT_93	[p5l476t327r702b384],
4	diagnosis	NN	O	diagnosis	dobj	1	SENT_93	[p5l716t327r931b384],
5	of	IN	O	of	_	0	SENT_93	[p5l945t326r994b371],
6	vocal	JJ	O	vocal	amod	8	SENT_93	[p5l1004t327r1119b371],
7	cord	NN	O	cord	nn	8	SENT_93	[p5l1136t327r1235b371],
8	dysfunction	NN	O	dysfunction	prep_of	4	SENT_93	[p5l1248t326r1518b384],

1	-	:	O	-	_	0	SENT_94	[p5l65t422r78b436],
2	Signiﬁcant	NN	O	signiﬁcant	nn	4	SENT_94	[p5l144t402r388b460],
3	medical	JJ	O	medical	amod	4	SENT_94	[p5l405t402r577b446],
4	illness	NN	O	illness	_	0	SENT_94	[p5l596t403r731b446],
5	(	CD	NUMBER	(	npadvmod	6	SENT_94	[p5l747t403r889b458],
6	other	JJ	O	other	amod	4	SENT_94	[p5l747t403r889b458],
7	than	IN	O	than	_	0	SENT_94	[p5l899t403r1003b446],
8	asthma	NN	O	asthma	nn	9	SENT_94	[p5l1020t403r1207b458],
9	)	NN	O	)	prep_than	4	SENT_94	[p5l1020t403r1207b458],
10	that	WDT	O	that	nsubj	13	SENT_94	[p5l1220t403r1316b446],
11	is	VBZ	O	be	cop	13	SENT_94	[p5l1333t406r1363b446],
12	not	RB	O	not	neg	13	SENT_94	[p5l1380t411r1457b446],
13	stable	JJ	O	stable	rcmod	4	SENT_94	[p5l1471t403r1605b446],
14	-	:	O	-	_	0	SENT_94	[p5l65t498r78b512],
15	History	NN	O	history	dep	13	SENT_94	[p5l146t482r309b535],
16	of	IN	O	of	_	0	SENT_94	[p5l322t478r371b522],
17	respiratory	JJ	O	respiratory	amod	19	SENT_94	[p5l384t482r630b535],
18	tract	NN	O	tract	nn	19	SENT_94	[p5l640t486r747b522],
19	infection	NN	O	infection	prep_of	15	SENT_94	[p5l763t478r963b522],
20	within	IN	O	within	_	0	SENT_94	[p5l978t478r1124b522],
21	the	DT	DURATION	the	det	24	SENT_94	[p5l1138t478r1213b522],
22	previous	JJ	DURATION	previous	amod	24	SENT_94	[p5l1228t482r1422b535],
23	6	CD	DURATION	6	num	24	SENT_94	[p5l1439t478r1465b522],
24	weeks	NNS	NUMBER	week	prep_within	19	SENT_94	[p5l1479t478r1619b522],

1	History	NN	O	history	_	0	SENT_95	[p5l146t558r309b612],
2	of	IN	O	of	_	0	SENT_95	[p5l322t554r371b599],
3	a	DT	O	a	det	5	SENT_95	[p5l381t570r405b599],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_95	[p5l419t554r658b612],
5	exacerbation	NN	O	exacerbation	prep_of	1	SENT_95	[p5l672t555r965b599],
6	of	IN	O	of	_	0	SENT_95	[p5l981t554r1030b599],
7	asthma	NN	O	asthma	prep_of	5	SENT_95	[p5l1041t555r1211b599],
8	in	IN	O	in	_	0	SENT_95	[p5l1228t558r1265b598],
9	the	DT	DURATION	the	det	12	SENT_95	[p5l1279t555r1354b599],
10	previous	JJ	DURATION	previous	amod	12	SENT_95	[p5l1369t558r1563b612],
11	6	CD	DURATION	6	num	12	SENT_95	[p5l1580t554r1606b599],
12	weeks	NNS	NUMBER	week	prep_in	1	SENT_95	[p5l1620t555r1760b599],

1	-	:	O	-	_	0	SENT_96	[p5l65t650r78b664],
2	History	NN	O	history	_	0	SENT_96	[p5l146t634r309b688],
3	of	IN	O	of	_	0	SENT_96	[p5l322t630r371b674],
4	life	NN	O	life	npadvmod	6	SENT_96	[p5l384t630r741b688],
5	—	CD	NUMBER	—	num	4	SENT_96	[p5l384t630r741b688],
6	threatening	JJ	O	threatening	amod	7	SENT_96	[p5l384t630r741b688],
7	asthma	NN	O	asthma	prep_of	2	SENT_96	[p5l758t630r928b674],
8	requiring	VBG	O	require	partmod	7	SENT_96	[p5l945t634r1149b688],
9	treatment	NN	O	treatment	dobj	8	SENT_96	[p5l1162t638r1398b674],
10	with	IN	O	with	_	0	SENT_96	[p5l1410t630r1511b674],
11	intubation	NN	O	intubation	prep_with	8	SENT_96	[p5l1530t630r1770b674],
12	and	CC	O	and	_	0	SENT_96	[p5l1786t630r1871b674],
13	mechanical	JJ	O	mechanical	amod	14	SENT_96	[p5l146t706r399b750],
14	ventilation	NN	O	ventilation	conj_and	2	SENT_96	[p5l415t706r664b750],
15	within	IN	O	within	_	0	SENT_96	[p5l678t706r825b750],
16	the	DT	DURATION	the	det	19	SENT_96	[p5l838t706r913b750],
17	past	JJ	DATE	past	amod	19	SENT_96	[p5l928t714r1024b763],
18	10	CD	DATE	10	num	19	SENT_96	[p5l1038t712r1093b750],
19	years	NNS	DATE	year	prep_within	14	SENT_96	[p5l1104t721r1221b763],

1	-	:	O	-	_	0	SENT_97	[p5l65t803r78b817],
2	Hyposensitisation	NN	O	hyposensitisation	nn	3	SENT_97	[p5l146t786r554b840],
3	therapy	NN	O	therapy	_	0	SENT_97	[p5l567t783r745b840],
4	other	JJ	O	other	dep	3	SENT_97	[p5l757t783r881b827],
5	than	IN	O	than	_	0	SENT_97	[p5l891t783r996b827],
6	an	DT	O	a	det	9	SENT_97	[p5l1013t798r1065b827],
7	established	JJ	O	established	amod	9	SENT_97	[p5l1082t783r1338b827],
8	maintenance	NN	O	maintenance	nn	9	SENT_97	[p5l1356t786r1653b827],
9	regimen	NN	O	regimen	prep_than	3	SENT_97	[p5l1670t786r1856b840],
10	-	:	O	-	_	0	SENT_97	[p5l65t878r78b892],
11	Pregnancy	NN	O	pregnancy	dep	9	SENT_97	[p5l146t862r383b916],
12	or	CC	O	or	_	0	SENT_97	[p5l396t873r442b902],
13	lactation	NN	O	lactation	dep	9	SENT_97	[p5l458t858r668b902],
14	.	.	O	.	_	0	SENT_97	[p5l458t858r668b902],

1	If	IN	O	if	_	0	SENT_98	[p5l688t858r717b902],
2	potentially	RB	O	potentially	advmod	3	SENT_98	[p5l728t858r977b915],
3	able	JJ	O	able	amod	6	SENT_98	[p5l990t858r1082b902],
4	to	TO	O	to	aux	5	SENT_98	[p5l1094t866r1142b902],
5	bear	VB	O	bear	xcomp	3	SENT_98	[p5l1159t858r1256b902],
6	children	NNS	O	child	pobj	1	SENT_98	[p5l1270t858r1464b910],
7	,	,	O	,	_	0	SENT_98	[p5l1270t858r1464b910],
8	not	RB	O	not	neg	9	SENT_98	[p5l1483t866r1560b902],
9	using	VBG	O	use	dep	1	SENT_98	[p5l1574t862r1694b916],
10	an	DT	O	a	det	12	SENT_98	[p5l1711t873r1762b902],
11	acceptable	JJ	O	acceptable	amod	12	SENT_98	[p5l1779t858r2020b915],
12	form	NN	O	form	dobj	9	SENT_98	[p5l142t935r253b979],
13	of	IN	O	of	_	0	SENT_98	[p5l269t935r318b979],
14	birth	NN	O	birth	nn	16	SENT_98	[p5l330t935r436b979],
15	control	NN	O	control	nn	16	SENT_98	[p5l453t935r614b979],
16	Patients	NNS	O	patient	prep_of	12	SENT_98	[p5l146t1013r326b1054],
17	who	WP	O	who	nsubjpass	19	SENT_98	[p5l337t1010r436b1054],
18	were	VBD	O	be	auxpass	19	SENT_98	[p5l448t1024r557b1054],
19	randomised	VBN	O	randomise	rcmod	12	SENT_98	[p5l573t1010r839b1054],
20	in	IN	O	in	_	0	SENT_98	[p5l854t1013r892b1053],
21	the	DT	O	the	det	22	SENT_98	[p5l904t1010r979b1054],
22	BAGS	NNS	O	bag	prep_in	19	SENT_98	[p5l995t1013r1116b1054],
23	trial	NN	O	trial	nn	26	SENT_98	[p5l1128t1010r1244b1061],
24	,9	CD	NUMBER	,9	num	26	SENT_98	[p5l1128t1010r1244b1061],
25	BARGE	NN	O	barge	nn	26	SENT_98	[p5l1261t1013r1414b1054],
26	trial	NN	O	trial	dep	22	SENT_98	[p5l1425t1010r1540b1061],
27	,5	CD	NUMBER	,5	num	29	SENT_98	[p5l1425t1010r1540b1061],
28	SOCS	NN	MISC	soc	nn	29	SENT_98	[p5l1554t1013r1672b1054],
29	trial	NN	O	trial	dep	22	SENT_98	[p5l1683t1010r1813b1061],
30	,	,	O	,	_	0	SENT_98	[p5l1683t1010r1813b1061],
31	“	NN	O	“	nn	34	SENT_98	[p5l1683t1010r1813b1061],
32	or	CC	O	or	_	0	SENT_98	[p5l1825t1025r1872b1054],
33	SLIC	NN	ORGANIZATION	slic	nn	34	SENT_98	[p5l1885t1013r1977b1054],
34	trial	NN	O	trial	prep_in	19	SENT_98	[p5l1988t1010r2103b1054],
35	“	CD	NUMBER	“	num	36	SENT_98	[p5l1988t1010r2103b1054],
36	History	NN	O	history	dep	34	SENT_98	[p5l146t1089r309b1143],
37	of	IN	O	of	_	0	SENT_98	[p5l322t1085r371b1129],
38	hypersensitivity	NN	O	hypersensitivity	prep_of	36	SENT_98	[p5l384t1086r746b1143],
39	to	TO	O	to	_	0	SENT_98	[p5l756t1094r805b1129],
40	soya	NN	O	soya	nn	41	SENT_98	[p5l820t1100r921b1143],
41	lecithin	NN	O	lecithin	prep_to	38	SENT_98	[p5l938t1086r1102b1129],
42	or	CC	O	or	_	0	SENT_98	[p5l1118t1100r1164b1129],
43	related	JJ	O	related	amod	45	SENT_98	[p5l1181t1085r1336b1129],
44	food	NN	O	food	nn	45	SENT_98	[p5l1349t1085r1457b1129],
45	products	NNS	O	product	prep_in	19	SENT_98	[p5l1471t1086r1672b1143],
46	such	JJ	O	such	_	0	SENT_98	[p5l1686t1085r1786b1129],
47	as	IN	O	as	_	0	SENT_98	[p5l1803t1100r1848b1129],
48	soya	NN	O	soya	nn	49	SENT_98	[p5l1863t1100r1964b1143],
49	beans	NNS	O	bean	prep_such_as	45	SENT_98	[p5l1980t1086r2110b1129],
50	or	CC	O	or	_	0	SENT_98	[p5l144t1177r191b1206],
51	peanuts	NNS	O	peanut	prep_such_as	45	SENT_98	[p5l203t1170r386b1219],

1	FEV1	NN	O	fev1	_	0	SENT_99	[p5l64t1291r256b1331],
2	=	JJ	O	=	amod	5	SENT_99	[p5l64t1291r256b1331],
3	forced	JJ	O	forced	amod	5	SENT_99	[p5l64t1291r256b1331],
4	expiratory	JJ	O	expiratory	amod	5	SENT_99	[p5l266t1294r432b1332],
5	volume	NN	O	volume	dep	1	SENT_99	[p5l440t1291r562b1323],
6	in	IN	O	in	_	0	SENT_99	[p5l574t1294r601b1322],
7	1	CD	NUMBER	1	num	8	SENT_99	[p5l613t1296r629b1322],
8	s.	NN	O	s.	prep_in	5	SENT_99	[p5l640t1302r661b1323],

1	I	PRP	O	I	nsubj	2	SENT_100	[p5l6t1572r54b1740],
2	Articles	NNPS	O	Articles	_	0	SENT_100	[p5l101t1704r251b1740],
3	as	IN	O	as	_	0	SENT_100	[p5l9t2024r82b2068],
4	rescue	NN	O	rescue	nn	5	SENT_100	[p5l131t2024r376b2068],
5	therapy	NN	O	therapy	prep_as	2	SENT_100	[p5l422t2000r720b2089],
6	.	.	O	.	_	0	SENT_100	[p5l422t2000r720b2089],

1	Asthma	NN	O	asthma	nn	2	SENT_101	[p5l769t2000r1069b2068],
2	control	NN	O	control	nsubjpass	4	SENT_101	[p5l1116t2000r1384b2068],
3	was	VBD	O	be	auxpass	4	SENT_101	[p5l1428t2024r1568b2068],
4	monitored	VBN	O	monitor	_	0	SENT_101	[p5l1617t2000r2021b2068],
5	by	IN	O	by	_	0	SENT_101	[p5l2064t2000r2153b2089],
6	peak	NN	O	peak	nn	7	SENT_101	[p5l7t2110r186b2199],
7	expiratory	NN	O	expiratory	agent	4	SENT_101	[p5l224t2114r604b2199],
8	flow	NN	O	flow	nn	10	SENT_101	[p5l641t2110r803b2177],
9	(	CD	NUMBER	(	num	10	SENT_101	[p5l846t2114r1047b2200],
10	PEP	NN	O	pep	npadvmod	7	SENT_101	[p5l846t2114r1047b2200],
11	)	CD	NUMBER	)	num	10	SENT_101	[p5l846t2114r1047b2200],
12	via	IN	O	via	_	0	SENT_101	[p5l1090t2114r1197b2178],
13	an	DT	O	a	det	20	SENT_101	[p5l1236t2134r1326b2177],
14	electronic	JJ	O	electronic	amod	20	SENT_101	[p5l1366t2110r1738b2177],
15	peak	NN	O	peak	nn	20	SENT_101	[p5l1776t2110r1954b2199],
16	ﬂow	NN	O	ﬂow	nn	20	SENT_101	[p5l1991t2110r2153b2177],
17	meter	NN	O	meter	nn	20	SENT_101	[p5l7t2232r233b2286],
18	(	CD	NUMBER	(	num	20	SENT_101	[p5l273t2224r473b2308],
19	AM1	NN	O	am1	nn	20	SENT_101	[p5l273t2224r473b2308],
20	device	NN	O	device	prep_via	7	SENT_101	[p5l510t2218r764b2296],
21	,	,	O	,	_	0	SENT_101	[p5l510t2218r764b2296],
22	Cardinal	NNP	ORGANIZATION	Cardinal	nn	23	SENT_101	[p5l806t2218r1130b2286],
23	Health	NNP	ORGANIZATION	Health	appos	20	SENT_101	[p5l1170t2218r1444b2296],
24	,	,	O	,	_	0	SENT_101	[p5l1170t2218r1444b2296],
25	Yorba	NNP	PERSON	Yorba	nn	30	SENT_101	[p5l1483t2218r1699b2286],
26	Linda	NNP	PERSON	Linda	nn	30	SENT_101	[p5l1739t2218r1970b2297],
27	,	,	O	,	_	0	SENT_101	[p5l1739t2218r1970b2297],
28	CA	NNP	LOCATION	CA	appos	30	SENT_101	[p5l2012t2224r2147b2296],
29	,	,	O	,	_	0	SENT_101	[p5l2012t2224r2147b2296],
30	USA	NNP	LOCATION	USA	appos	20	SENT_101	[p5l12t2332r236b2417],
31	)	CD	NUMBER	)	num	30	SENT_101	[p5l12t2332r236b2417],
32	,	,	O	,	_	0	SENT_101	[p5l12t2332r236b2417],
33	and	CC	O	and	_	0	SENT_101	[p5l302t2327r442b2395],
34	by	IN	O	by	_	0	SENT_101	[p5l500t2327r589b2416],
35	spirometric	JJ	O	spirometric	amod	36	SENT_101	[p5l651t2332r1091b2416],
36	values	NNS	O	value	prep_by	49	SENT_101	[p5l1149t2327r1408b2405],
37	,	,	O	,	_	0	SENT_101	[p5l1149t2327r1408b2405],
38	morning/evening	VBG	O	morning/evening	partmod	49	SENT_101	[p5l1473t2332r2151b2417],
39	peak	JJ	O	peak	amod	42	SENT_101	[p5l7t2437r186b2525],
40	ﬂow	NN	O	ﬂow	nn	42	SENT_101	[p5l217t2436r379b2505],
41	variability	NN	O	variability	nn	42	SENT_101	[p5l408t2437r787b2526],
42	index	NN	O	index	dobj	38	SENT_101	[p5l819t2437r1045b2515],
43	,	,	O	,	_	0	SENT_101	[p5l819t2437r1045b2515],
44	asthma	NN	O	asthma	nn	45	SENT_101	[p5l1083t2437r1361b2505],
45	symptoms	NNS	O	symptom	dobj	38	SENT_101	[p5l1396t2450r1812b2526],
46	,	,	O	,	_	0	SENT_101	[p5l1396t2450r1812b2526],
47	and	CC	O	and	_	0	SENT_101	[p5l1850t2437r1989b2505],
48	use	NN	O	use	dobj	38	SENT_101	[p5l2020t2461r2150b2505],
49	of	IN	O	of	conj_and	20	SENT_101	[p5l9t2545r93b2613],
50	rescue	NN	O	rescue	nn	51	SENT_101	[p5l102t2570r348b2613],
51	therapy	NN	O	therapy	pobj	49	SENT_101	[p5l369t2545r668b2635],
52	.	.	O	.	_	0	SENT_101	[p5l369t2545r668b2635],

1	Baseline	NN	O	baseline	nn	2	SENT_102	[p5l698t2545r1017b2613],
2	data	NNS	O	datum	nsubjpass	4	SENT_102	[p5l1041t2545r1197b2613],
3	were	VBD	O	be	auxpass	4	SENT_102	[p5l1218t2570r1399b2613],
4	obtained	VBN	O	obtain	_	0	SENT_102	[p5l1423t2545r1754b2613],
5	for	IN	O	for	_	0	SENT_102	[p5l1775t2545r1884b2613],
6	airway	NN	O	airway	nn	7	SENT_102	[p5l1906t2550r2153b2635],
7	responsiveness	NN	O	responsiveness	prep_for	4	SENT_102	[p5l8t2659r586b2743],
8	(	CD	PERCENT	(	num	11	SENT_102	[p5l673t2658r859b2744],
9	20	CD	PERCENT	20	number	10	SENT_102	[p5l673t2658r859b2744],
10	%	NN	PERCENT	%	amod	11	SENT_102	[p5l673t2658r859b2744],
11	reduction	NN	O	reduction	dobj	4	SENT_102	[p5l938t2654r1305b2722],
12	in	IN	O	in	_	0	SENT_102	[p5l1383t2659r1458b2721],
13	F	NN	O	f	nn	14	SENT_102	[p5l1539t2658r1580b2721],
14	EV1	NN	O	ev1	prep_in	11	SENT_102	[p5l1592t2658r1717b2739],
15	[	CD	NUMBER	[	num	17	SENT_102	[p5l1798t2659r1993b2743],
16	PC20	NN	O	pc20	nn	17	SENT_102	[p5l1798t2659r1993b2743],
17	]	NN	O	]	nsubj	34	SENT_102	[p5l1798t2659r1993b2743],
18	in	IN	O	in	_	0	SENT_102	[p5l2076t2659r2151b2721],
19	response	NN	O	response	prep_in	17	SENT_102	[p5l8t2788r348b2853],
20	to	TO	O	to	_	0	SENT_102	[p5l384t2777r454b2831],
21	methacholine	NN	O	methacholine	nn	22	SENT_102	[p5l490t2764r1063b2854],
22	)	NN	O	)	prep_to	19	SENT_102	[p5l490t2764r1063b2854],
23	,	,	O	,	_	0	SENT_102	[p5l490t2764r1063b2854],
24	bronchodilator	NN	O	bronchodilator	nn	25	SENT_102	[p5l1101t2764r1670b2831],
25	response	NN	O	response	appos	17	SENT_102	[p5l1704t2788r2045b2853],
26	to	TO	O	to	_	0	SENT_102	[p5l2080t2777r2150b2831],
27	ipratropium	NN	O	ipratropium	prep_to	25	SENT_102	[p5l7t2878r492b2962],
28	,	,	O	,	_	0	SENT_102	[p5l7t2878r492b2962],
29	bronchodilator	NN	O	bronchodilator	nn	30	SENT_102	[p5l552t2873r1122b2942],
30	response	NN	O	response	appos	17	SENT_102	[p5l1178t2898r1519b2962],
31	to	TO	O	to	_	0	SENT_102	[p5l1576t2887r1646b2942],
32	salbutamol	NN	O	salbutamol	prep_to	30	SENT_102	[p5l1708t2873r2148b2952],
33	,	,	O	,	_	0	SENT_102	[p5l1708t2873r2148b2952],
34	exhaled	VBD	O	exhale	rcmod	14	SENT_102	[p5l8t2983r297b3051],
35	nitric	JJ	O	nitric	amod	37	SENT_102	[p5l336t2988r539b3051],
36	oxide	NN	O	oxide	nn	37	SENT_102	[p5l580t2983r777b3051],
37	concentration	NN	O	concentration	dobj	34	SENT_102	[p5l818t2988r1365b3061],
38	,	,	O	,	_	0	SENT_102	[p5l818t2988r1365b3061],
39	and	CC	O	and	_	0	SENT_102	[p5l1409t2983r1549b3051],
40	pH	NN	O	ph	conj_and	11	SENT_102	[p5l1587t2990r1704b3072],
41	in	IN	O	in	_	0	SENT_102	[p5l1748t2988r1824b3050],
42	exhaled	VBN	O	exhale	amod	44	SENT_102	[p5l1864t2983r2152b3051],
43	breath	NN	O	breath	nn	44	SENT_102	[p5l6t3093r251b3160],
44	condensate	NN	O	condensate	prep_in	40	SENT_102	[p5l279t3093r727b3160],
45	.	.	O	.	_	0	SENT_102	[p5l279t3093r727b3160],

1	Randomisation	NN	O	randomisation	nsubjpass	11	SENT_103	[p5l12t3311r592b3380],
2	and	CC	O	and	_	0	SENT_103	[p5l617t3311r759b3380],
3	masking	VBG	O	mask	amod	4	SENT_103	[p5l784t3311r1104b3402],
4	Individuals	NNS	O	individual	nsubjpass	11	SENT_103	[p5l12t3422r440b3490],
5	in	IN	O	in	_	0	SENT_103	[p5l475t3426r551b3488],
6	a	DT	O	a	det	8	SENT_103	[p5l585t3446r622b3489],
7	matched	VBN	O	match	amod	8	SENT_103	[p5l655t3422r987b3489],
8	pair	NN	O	pair	prep_in	1	SENT_103	[p5l1018t3426r1169b3511],
9	were	VBD	O	be	auxpass	11	SENT_103	[p5l1198t3446r1380b3490],
10	randomly	RB	O	randomly	advmod	11	SENT_103	[p5l1414t3422r1785b3511],
11	assigned	VBN	O	assign	_	0	SENT_103	[p5l1817t3422r2152b3512],
12	to	TO	O	to	_	0	SENT_103	[p5l6t3545r77b3600],
13	the	DT	O	the	det	17	SENT_103	[p5l106t3531r225b3600],
14	same	JJ	O	same	amod	17	SENT_103	[p5l258t3556r455b3600],
15	crossover	NN	O	crossover	nn	17	SENT_103	[p5l486t3556r847b3600],
16	treatment	NN	O	treatment	nn	17	SENT_103	[p5l874t3545r1254b3600],
17	sequence	NN	O	sequence	prep_to	11	SENT_103	[p5l1284t3556r1657b3620],
18	.	.	O	.	_	0	SENT_103	[p5l1284t3556r1657b3620],

1	Randomisation	NN	O	randomisation	nsubjpass	3	SENT_104	[p5l1695t3531r2149b3600, p5l6t3646r158b3709],
2	was	VBD	O	be	auxpass	3	SENT_104	[p5l218t3665r359b3709],
3	done	VBN	O	do	_	0	SENT_104	[p5l424t3641r609b3709],
4	by	IN	O	by	_	0	SENT_104	[p5l670t3641r758b3730],
5	a	DT	O	a	det	9	SENT_104	[p5l819t3665r856b3709],
6	password-protected	JJ	O	password-protected	amod	9	SENT_104	[p5l917t3641r1686b3730],
7	,	,	O	,	_	0	SENT_104	[p5l917t3641r1686b3730],
8	web-based	JJ	O	web-based	amod	9	SENT_104	[p5l1750t3641r2152b3709],
9	scheme	NN	O	scheme	agent	3	SENT_104	[p6l10t18r300b86],
10	administered	VBN	O	administer	partmod	9	SENT_104	[p6l333t18r845b86],
11	by	IN	O	by	_	0	SENT_104	[p6l874t18r963b107],
12	the	DT	O	the	det	22	SENT_104	[p6l992t18r1111b86],
13	Asthma	NNP	ORGANIZATION	Asthma	nn	22	SENT_104	[p6l1142t18r1443b86],
14	Clinical	JJ	ORGANIZATION	clinical	amod	22	SENT_104	[p6l1478t18r1771b86],
15	Research	NN	ORGANIZATION	research	nn	22	SENT_104	[p6l1807t18r2151b86],
16	Network	NNP	ORGANIZATION	Network	nn	22	SENT_104	[p6l10t126r335b194],
17	(	CD	NUMBER	(	num	22	SENT_104	[p6l438t132r731b216],
18	ACRN	NNP	O	ACRN	nn	22	SENT_104	[p6l438t132r731b216],
19	)	NNP	O	)	nn	22	SENT_104	[p6l438t132r731b216],
20	Data	NNP	O	Data	nn	22	SENT_104	[p6l840t133r1012b194],
21	Coordinating	NNP	O	Coordinating	nn	22	SENT_104	[p6l1114t126r1621b216],
22	Center	NNP	O	Center	agent	10	SENT_104	[p6l1723t132r1990b194],
23	.	.	O	.	_	0	SENT_104	[p6l1723t132r1990b194],

1	A	DT	O	a	det	2	SENT_105	[p6l2092t132r2152b193],
2	statistician	NN	O	statistician	nsubj	11	SENT_105	[p6l10t240r424b303],
3	(	CD	NUMBER	(	num	4	SENT_105	[p6l464t240r651b325],
4	SIK	NNP	O	SIK	dep	2	SENT_105	[p6l464t240r651b325],
5	)	CD	NUMBER	)	num	4	SENT_105	[p6l464t240r651b325],
6	at	IN	O	at	_	0	SENT_105	[p6l694t248r760b303],
7	the	DT	O	the	det	8	SENT_105	[p6l793t235r911b303],
8	data	NNS	O	datum	prep_at	4	SENT_105	[p6l948t235r1105b303],
9	coordinating	VBG	O	coordinate	partmod	2	SENT_105	[p6l1141t235r1631b325],
10	centre	NN	O	centre	dobj	9	SENT_105	[p6l1667t248r1902b303],
11	wrote	VBD	O	write	_	0	SENT_105	[p6l1936t248r2150b303],
12	the	DT	O	the	det	14	SENT_105	[p6l6t346r125b414],
13	randomisation	NN	O	randomisation	nn	14	SENT_105	[p6l171t346r738b414],
14	program	NN	O	program	dobj	11	SENT_105	[p6l782t370r1114b435],
15	in	IN	O	in	_	0	SENT_105	[p6l1159t350r1235b412],
16	SAS	NNP	ORGANIZATION	SAS	nn	17	SENT_105	[p6l1285t351r1436b414],
17	version	NN	O	version	prep_in	11	SENT_105	[p6l1484t350r1766b414],
18	9.1	CD	NUMBER	9.1	advmod	11	SENT_105	[p6l1812t352r1933b414],
19	.	.	O	.	_	0	SENT_105	[p6l1812t352r1933b414],

1	This	DT	O	this	det	2	SENT_106	[p6l1981t346r2148b414],
2	code	NN	O	code	nsubjpass	4	SENT_106	[p6l8t454r181b522],
3	was	VBD	O	be	auxpass	4	SENT_106	[p6l206t478r347b522],
4	passed	VBN	O	pass	_	0	SENT_106	[p6l376t454r635b543],
5	to	TO	O	to	_	0	SENT_106	[p6l659t468r729b522],
6	an	DT	O	a	prep_to	4	SENT_106	[p6l758t479r848b522],
7	unmasked	VBN	O	unmask	partmod	6	SENT_106	[p6l874t454r1278b522],
8	database	NN	O	database	nn	9	SENT_106	[p6l1304t454r1633b522],
9	programmer	NN	O	programmer	dobj	7	SENT_106	[p6l1660t479r2152b544],
10	who	WP	O	who	nsubj	11	SENT_106	[p6l6t563r166b631],
11	assigned	VBD	O	assign	rcmod	9	SENT_106	[p6l208t563r543b653],
12	a	DT	O	a	det	17	SENT_106	[p6l583t587r620b631],
13	new	JJ	O	new	amod	17	SENT_106	[p6l660t587r819b631],
14	random	JJ	O	random	amod	17	SENT_106	[p6l857t563r1160b631],
15	number	NN	O	number	nn	17	SENT_106	[p6l1200t563r1511b631],
16	generator	NN	O	generator	nn	17	SENT_106	[p6l1550t576r1919b653],
17	seed	NN	O	seed	nsubj	27	SENT_106	[p6l1960t563r2147b641],
18	,	,	O	,	_	0	SENT_106	[p6l1960t563r2147b641],
19	assigned	VBN	O	assign	partmod	17	SENT_106	[p6l9t673r343b762],
20	blinding	VBG	O	blind	xcomp	19	SENT_106	[p6l379t673r705b762],
21	codes	NNS	O	code	dobj	20	SENT_106	[p6l745t673r954b741],
22	to	TO	O	to	_	0	SENT_106	[p6l993t686r1063b741],
23	each	DT	O	each	prep_to	20	SENT_106	[p6l1103t673r1275b741],
24	of	IN	O	of	_	0	SENT_106	[p6l1314t672r1398b741],
25	the	DT	O	the	det	26	SENT_106	[p6l1422t673r1541b741],
26	treatments	NNS	O	treatment	prep_of	23	SENT_106	[p6l1578t686r1993b741],
27	(	VBP	O	(	ccomp	11	SENT_106	[p6l2039t677r2147b762],
28	ie	FW	O	ie	dobj	27	SENT_106	[p6l2039t677r2147b762],
29	,	,	O	,	_	0	SENT_106	[p6l2039t677r2147b762],
30	placebo	NN	O	placebo	conj_or	28	SENT_106	[p6l7t781r297b870],
31	or	CC	O	or	_	0	SENT_106	[p6l325t806r402b849],
32	salmeterol	NN	O	salmeterol	nn	33	SENT_106	[p6l428t781r879b871],
33	)	NN	O	)	conj_or	28	SENT_106	[p6l428t781r879b871],
34	,	,	O	,	_	0	SENT_106	[p6l428t781r879b871],
35	and	CC	O	and	_	0	SENT_106	[p6l908t781r1049b849],
36	ran	VBD	O	run	ccomp	11	SENT_106	[p6l1073t806r1200b849],
37	the	DT	O	the	det	38	SENT_106	[p6l1224t781r1342b849],
38	program	NN	O	program	dobj	36	SENT_106	[p6l1368t806r1701b871],
39	to	TO	O	to	aux	40	SENT_106	[p6l1724t795r1795b849],
40	generate	VB	O	generate	xcomp	36	SENT_106	[p6l1823t795r2150b871],
41	the	DT	O	the	det	43	SENT_106	[p6l6t891r125b958],
42	randomisation	NN	O	randomisation	nn	43	SENT_106	[p6l146t891r713b958],
43	codes	NNS	O	code	dobj	40	SENT_106	[p6l733t891r942b958],
44	used	VBN	O	use	partmod	43	SENT_106	[p6l964t891r1145b958],
45	in	IN	O	in	_	0	SENT_106	[p6l1164t895r1240b957],
46	the	DT	O	the	det	47	SENT_106	[p6l1259t891r1377b958],
47	study	NN	O	study	prep_in	44	SENT_106	[p6l1401t891r1616b980],
48	.	.	O	.	_	0	SENT_106	[p6l1401t891r1616b980],

1	The	DT	O	the	det	4	SENT_107	[p6l1639t891r1785b958],
2	resulting	VBG	O	result	amod	4	SENT_107	[p6l1805t891r2151b981],
3	randomisation	NN	O	randomisation	nn	4	SENT_107	[p6l7t1001r574b1069],
4	list	NN	O	list	nsubjpass	12	SENT_107	[p6l596t1001r713b1069],
5	was	VBD	O	be	auxpass	6	SENT_107	[p6l733t1025r874b1069],
6	imported	VBN	O	import	_	0	SENT_107	[p6l899t1001r1254b1089],
7	into	IN	O	into	_	0	SENT_107	[p6l1277t1005r1426b1069],
8	the	DT	O	the	det	10	SENT_107	[p6l1449t1001r1568b1069],
9	study	NN	O	study	nn	10	SENT_107	[p6l1595t1001r1799b1090],
10	database	NN	O	database	prep_into	6	SENT_107	[p6l1822t1001r2150b1069],
11	and	CC	O	and	_	0	SENT_107	[p6l9t1109r149b1177],
12	accessed	VBN	O	access	conj_and	6	SENT_107	[p6l179t1109r509b1177],
13	by	IN	O	by	_	0	SENT_107	[p6l535t1109r624b1199],
14	the	DT	O	the	det	16	SENT_107	[p6l650t1109r769b1177],
15	clinic	NN	O	clinic	nn	16	SENT_107	[p6l800t1109r1007b1177],
16	coordinators	NNS	O	coordinator	prep_by	12	SENT_107	[p6l1037t1109r1518b1177],
17	via	IN	O	via	_	0	SENT_107	[p6l1548t1114r1655b1177],
18	a	DT	O	a	det	20	SENT_107	[p6l1686t1134r1722b1177],
19	web-based	JJ	O	web-based	amod	20	SENT_107	[p6l1750t1109r2152b1177],
20	application	NN	O	application	prep_via	16	SENT_107	[p6l9t1219r453b1308],
21	.	.	O	.	_	0	SENT_107	[p6l9t1219r453b1308],

1	The	DT	O	the	det	2	SENT_108	[p6l501t1219r647b1286],
2	application	NN	O	application	nsubj	3	SENT_108	[p6l693t1219r1118b1308],
3	returned	VBD	O	return	_	0	SENT_108	[p6l1162t1219r1498b1286],
4	only	RB	O	only	advmod	3	SENT_108	[p6l1542t1219r1705b1308],
5	a	DT	O	a	det	8	SENT_108	[p6l1749t1243r1786b1286],
6	drug	NN	O	drug	nn	8	SENT_108	[p6l1831t1219r2009b1309],
7	kit	NN	O	kit	nn	8	SENT_108	[p6l2052t1219r2152b1286],
8	number	NN	O	number	dobj	3	SENT_108	[p6l7t1327r318b1395],
9	from	IN	O	from	_	0	SENT_108	[p6l345t1327r533b1395],
10	which	WDT	O	which	rel	15	SENT_108	[p6l559t1327r793b1396],
11	all	DT	O	all	det	13	SENT_108	[p6l823t1327r910b1395],
12	study	NN	O	study	nn	13	SENT_108	[p6l941t1327r1146b1417],
13	drugs	NNS	O	drug	nsubjpass	15	SENT_108	[p6l1173t1327r1388b1417],
14	were	VBD	O	be	auxpass	15	SENT_108	[p6l1416t1352r1598b1396],
15	dispensed	VBN	O	dispense	rcmod	8	SENT_108	[p6l1629t1327r2016b1416],
16	for	IN	O	for	_	0	SENT_108	[p6l2043t1327r2152b1395],
17	the	DT	O	the	det	18	SENT_108	[p6l6t1437r125b1505],
18	participant	NN	O	participant	prep_for	15	SENT_108	[p6l158t1442r577b1526],
19	who	WP	O	who	nsubjpass	22	SENT_108	[p6l605t1437r766b1506],
20	had	VBD	O	have	aux	22	SENT_108	[p6l798t1437r940b1505],
21	been	VBN	O	be	auxpass	22	SENT_108	[p6l969t1437r1153b1506],
22	randomised	VBN	O	randomise	rcmod	18	SENT_108	[p6l1185t1437r1665b1505],
23	.	.	O	.	_	0	SENT_108	[p6l1185t1437r1665b1505],

1	SIK	NNP	O	SIK	nsubj	4	SENT_109	[p6l1707t1442r1845b1525],
2	did	VBD	O	do	aux	4	SENT_109	[p6l1876t1437r1996b1505],
3	not	RB	O	not	neg	4	SENT_109	[p6l2027t1451r2152b1505],
4	have	VB	O	have	_	0	SENT_109	[p6l6t1547r181b1614],
5	access	NN	O	access	dobj	4	SENT_109	[p6l260t1571r495b1614],
6	to	TO	O	to	_	0	SENT_109	[p6l573t1560r643b1614],
7	the	DT	O	the	det	9	SENT_109	[p6l720t1547r839b1614],
8	blinding	JJ	O	blinding	amod	9	SENT_109	[p6l915t1547r1242b1637],
9	codes	NNS	O	code	prep_to	5	SENT_109	[p6l1320t1547r1530b1614],
10	during	IN	O	during	_	0	SENT_109	[p6l1610t1547r1869b1637],
11	study	NN	O	study	nn	12	SENT_109	[p6l1948t1547r2153b1636],
12	implementation	NN	O	implementation	prep_during	4	SENT_109	[p6l7t1655r631b1744],
13	or	CC	O	or	_	0	SENT_109	[p6l661t1680r739b1723],
14	analysis	NN	O	analysis	prep_during	4	SENT_109	[p6l768t1655r1091b1745],
15	.	.	O	.	_	0	SENT_109	[p6l768t1655r1091b1745],

1	The	DT	O	the	det	3	SENT_110	[p6l1124t1655r1270b1723],
2	database	NN	O	database	nn	3	SENT_110	[p6l1301t1655r1630b1723],
3	programmer	NN	O	programmer	nsubjpass	6	SENT_110	[p6l1659t1680r2152b1745],
4	was	VBD	O	be	auxpass	6	SENT_110	[p6l6t1788r147b1833],
5	not	RB	O	not	neg	6	SENT_110	[p6l189t1778r314b1833],
6	involved	VBN	O	involve	_	0	SENT_110	[p6l352t1764r675b1833],
7	in	IN	O	in	_	0	SENT_110	[p6l713t1769r789b1832],
8	the	DT	O	the	det	9	SENT_110	[p6l827t1764r946b1833],
9	rest	NN	O	rest	prep_in	6	SENT_110	[p6l987t1778r1129b1833],
10	of	IN	O	of	_	0	SENT_110	[p6l1167t1764r1252b1833],
11	the	DT	O	the	det	12	SENT_110	[p6l1277t1764r1396b1833],
12	trial	NN	O	trial	prep_of	9	SENT_110	[p6l1436t1764r1590b1833],
13	other	JJ	O	other	dep	12	SENT_110	[p6l1630t1764r1832b1833],
14	than	IN	O	than	_	0	SENT_110	[p6l1868t1764r2041b1832],
15	to	TO	O	to	aux	16	SENT_110	[p6l2079t1777r2150b1833],
16	provide	VB	O	provide	prep_than	12	SENT_110	[p6l7t1876r294b1965],
17	routine	JJ	O	routine	amod	18	SENT_110	[p6l322t1880r602b1944],
18	maintenance	NN	O	maintenance	dobj	16	SENT_110	[p6l631t1880r1131b1944],
19	of	IN	O	of	_	0	SENT_110	[p6l1161t1876r1246b1944],
20	the	DT	O	the	det	22	SENT_110	[p6l1260t1876r1379b1944],
21	LARGE	NN	O	large	nn	22	SENT_110	[p6l1412t1880r1692b1944],
22	database	NN	O	database	prep_of	18	SENT_110	[p6l1725t1876r2074b1944],
23	.	.	O	.	_	0	SENT_110	[p6l1725t1876r2074b1944],

1	Clinic	NNP	O	Clinic	nn	2	SENT_111	[p6l81t1985r306b2054],
2	personnel	NNS	O	personnel	nsubj	11	SENT_111	[p6l346t1985r747b2074],
3	,	,	O	,	_	0	SENT_111	[p6l346t1985r747b2074],
4	participants	NNS	O	participant	conj_and	2	SENT_111	[p6l791t1990r1263b2074],
5	,	,	O	,	_	0	SENT_111	[p6l791t1990r1263b2074],
6	and	CC	O	and	_	0	SENT_111	[p6l1308t1985r1448b2054],
7	most	JJS	O	most	amod	8	SENT_111	[p6l1488t1999r1679b2054],
8	data	NNS	O	datum	conj_and	2	SENT_111	[p6l1719t1985r1874b2054],
9	centre	NN	O	centre	nn	10	SENT_111	[p6l1916t1999r2150b2054],
10	personnel	NNS	O	personnel	dep	8	SENT_111	[p6l7t2094r389b2183],
11	(	VBP	O	(	_	0	SENT_111	[p6l441t2101r657b2184],
12	apart	RB	O	apart	_	0	SENT_111	[p6l441t2101r657b2184],
13	from	IN	O	from	_	0	SENT_111	[p6l703t2094r890b2162],
14	the	DT	O	the	det	16	SENT_111	[p6l936t2094r1054b2162],
15	database	NN	O	database	nn	16	SENT_111	[p6l1103t2094r1429b2162],
16	programmer	NN	O	programmer	prep_apart_from	11	SENT_111	[p6l1476t2118r1965b2184],
17	and	CC	O	and	_	0	SENT_111	[p6l2012t2094r2152b2162],
18	administrative	JJ	O	administrative	amod	20	SENT_111	[p6l9t2205r560b2273],
19	coordinator	NN	O	coordinator	nn	20	SENT_111	[p6l593t2205r1056b2294],
20	)	NN	O	)	nsubjpass	22	SENT_111	[p6l593t2205r1056b2294],
21	remained	VBD	O	remain	auxpass	22	SENT_111	[p6l1094t2205r1461b2273],
22	masked	VBN	O	mask	conj_and	11	SENT_111	[p6l1491t2205r1787b2273],
23	throughout	IN	O	throughout	_	0	SENT_111	[p6l1817t2205r2149b2294, p6l9t2327r131b2381],
24	study	NN	O	study	nn	25	SENT_111	[p6l185t2313r389b2403],
25	implementation	NN	O	implementation	prep_throughout	22	SENT_111	[p6l440t2313r1077b2402],
26	.	.	O	.	_	0	SENT_111	[p6l440t2313r1077b2402],

1	Investigators	NNS	O	investigator	nsubjpass	7	SENT_112	[p6l1138t2318r1626b2403],
2	undertaking	VBG	O	undertake	partmod	1	SENT_112	[p6l1680t2313r2151b2403],
3	the	DT	O	the	det	5	SENT_112	[p6l7t2424r126b2492],
4	data	NN	O	datum	nn	5	SENT_112	[p6l172t2424r327b2492],
5	analyses	NNS	O	analysis	dobj	2	SENT_112	[p6l372t2424r687b2513],
6	were	VBD	O	be	auxpass	7	SENT_112	[p6l731t2448r912b2492],
7	masked	VBN	O	mask	_	0	SENT_112	[p6l957t2424r1253b2492],
8	to	TO	O	to	_	0	SENT_112	[p6l1295t2437r1365b2492],
9	both	DT	O	both	preconj	13	SENT_112	[p6l1408t2424r1580b2492],
10	genotype	NN	O	genotype	nn	13	SENT_112	[p6l1625t2437r1967b2513],
11	and	CC	O	and	_	0	SENT_112	[p6l2013t2424r2153b2492],
12	treatment	NN	O	treatment	conj_and	10	SENT_112	[p6l7t2546r384b2600],
13	allocation	NN	O	allocation	prep_to	7	SENT_112	[p6l419t2532r806b2600],
14	.	.	O	.	_	0	SENT_112	[p6l419t2532r806b2600],

1	Success	NN	O	success	nsubjpass	5	SENT_113	[p6l851t2538r1139b2600],
2	of	IN	O	of	_	0	SENT_113	[p6l1178t2532r1262b2600],
3	masking	VBG	O	mask	prep_of	1	SENT_113	[p6l1284t2532r1614b2622],
4	was	VBD	O	be	auxpass	5	SENT_113	[p6l1647t2557r1787b2601],
5	assessed	VBN	O	assess	dep	17	SENT_113	[p6l1827t2532r2153b2600],
6	via	IN	O	via	_	0	SENT_113	[p6l7t2647r113b2710],
7	questionnaires	NNS	O	questionnaire	prep_via	5	SENT_113	[p6l193t2647r757b2731],
8	completed	VBN	O	complete	partmod	7	SENT_113	[p6l840t2642r1238b2731],
9	by	IN	O	by	_	0	SENT_113	[p6l1314t2642r1403b2731],
10	participants	NNS	O	participant	agent	8	SENT_113	[p6l1480t2647r1930b2731],
11	and	CC	O	and	_	0	SENT_113	[p6l2013t2642r2153b2710],
12	coordinators	NNS	O	coordinator	conj_and	10	SENT_113	[p6l9t2780r486b2848],
13	every	DT	O	every	det	14	SENT_113	[p6l558t2804r756b2869],
14	time	NN	O	time	tmod	8	SENT_113	[p6l820t2784r993b2848],
15	a	DT	O	a	det	16	SENT_113	[p6l1062t2804r1100b2847],
16	participant	NN	O	participant	nsubj	17	SENT_113	[p6l1167t2784r1583b2868],
17	completed	VBD	O	complete	_	0	SENT_113	[p6l1650t2780r2047b2868],
18	a	DT	O	a	det	20	SENT_113	[p6l2115t2804r2152b2848],
19	treatment	NN	O	treatment	nn	20	SENT_113	[p6l7t2902r384b2956],
20	period	NN	O	period	dobj	17	SENT_113	[p6l404t2888r667b2977],
21	.	.	O	.	_	0	SENT_113	[p6l404t2888r667b2977],

1	Participants	NNS	O	participant	nsubjpass	3	SENT_114	[p6l698t2893r1146b2977],
2	were	VBD	O	be	auxpass	3	SENT_114	[p6l1168t2913r1349b2956],
3	asked	VBN	O	ask	conj_and	3	SENT_114	[p6l1373t2888r1587b2956],
4	for	IN	O	for	_	0	SENT_114	[p6l1608t2888r1716b2956],
5	their	PRP$	O	they	poss	6	SENT_114	[p6l1735t2888r1917b2956],
6	guess	NN	O	guess	prep_for	3	SENT_114	[p6l1939t2912r2149b2978],
7	as	IN	O	as	amod	6	SENT_114	[p6l10t3022r83b3066],
8	to	TO	O	to	_	0	SENT_114	[p6l118t3011r188b3066],
9	which	WDT	O	which	det	10	SENT_114	[p6l221t2998r453b3066],
10	treatment	NN	O	treatment	dobj	14	SENT_114	[p6l486t3011r863b3066],
11	they	PRP	O	they	nsubj	14	SENT_114	[p6l894t2998r1056b3087],
12	had	VBD	O	have	aux	14	SENT_114	[p6l1086t2998r1228b3066],
13	just	RB	O	just	advmod	14	SENT_114	[p6l1260t3003r1402b3087],
14	completed	VBN	O	complete	prepc_to	3	SENT_114	[p6l1435t2998r1851b3087],
15	,	,	O	,	_	0	SENT_114	[p6l1435t2998r1851b3087],
16	as	RB	O	as	_	0	SENT_114	[p6l1890t3022r1963b3066],
17	well	RB	O	well	_	0	SENT_114	[p6l1998t2998r2152b3066],
18	as	IN	O	as	_	0	SENT_114	[p6l10t3132r83b3176],
19	for	IN	O	for	_	0	SENT_114	[p6l124t3107r232b3176],
20	any	DT	O	any	det	22	SENT_114	[p6l270t3132r402b3197],
21	speciﬁc	NN	O	speciﬁc	nn	22	SENT_114	[p6l441t3107r724b3196],
22	sensations	NNS	O	sensation	prep_for	3	SENT_114	[p6l764t3112r1162b3176],
23	they	PRP	O	they	nsubj	25	SENT_114	[p6l1202t3108r1364b3197],
24	had	VBD	O	have	aux	25	SENT_114	[p6l1399t3108r1540b3176],
25	noted	VBN	O	note	rcmod	22	SENT_114	[p6l1577t3108r1792b3176],
26	with	IN	O	with	_	0	SENT_114	[p6l1828t3108r1996b3176],
27	the	DT	O	the	det	31	SENT_114	[p6l2033t3108r2151b3176],
28	study	NN	O	study	nn	31	SENT_114	[p6l11t3216r214b3306],
29	drug	NN	O	drug	nn	31	SENT_114	[p6l250t3216r427b3306],
30	(	CD	NUMBER	(	num	31	SENT_114	[p6l469t3223r686b3306],
31	taste	NN	O	taste	prep_with	25	SENT_114	[p6l469t3223r686b3306],
32	,	,	O	,	_	0	SENT_114	[p6l469t3223r686b3306],
33	smell	NN	O	smell	appos	31	SENT_114	[p6l728t3216r952b3294],
34	,	,	O	,	_	0	SENT_114	[p6l728t3216r952b3294],
35	etc	FW	O	etc	nn	36	SENT_114	[p6l993t3223r1146b3306],
36	)	FW	O	)	appos	33	SENT_114	[p6l993t3223r1146b3306],
37	.	.	O	.	_	0	SENT_114	[p6l993t3223r1146b3306],

1	Coordinators	NNS	O	coordinator	nsubjpass	3	SENT_115	[p6l1189t3216r1683b3284],
2	were	VBD	O	be	auxpass	3	SENT_115	[p6l1720t3241r1900b3284],
3	asked	VBN	O	ask	_	0	SENT_115	[p6l1939t3216r2153b3284],
4	for	IN	O	for	_	0	SENT_115	[p6l8t3326r117b3393],
5	their	PRP$	O	they	poss	6	SENT_115	[p6l139t3326r320b3393],
6	guess	NN	O	guess	prep_for	3	SENT_115	[p6l345t3350r556b3416],
7	as	IN	O	as	_	0	SENT_115	[p6l584t3350r657b3393],
8	to	TO	O	to	prepc_as_to	3	SENT_115	[p6l683t3339r753b3393],
9	which	WDT	O	which	det	10	SENT_115	[p6l777t3326r1009b3393],
10	treatment	NN	O	treatment	dobj	15	SENT_115	[p6l1032t3339r1409b3393],
11	the	DT	O	the	det	12	SENT_115	[p6l1431t3326r1549b3393],
12	participant	NN	O	participant	nsubj	15	SENT_115	[p6l1574t3330r1990b3415],
13	had	VBD	O	have	aux	15	SENT_115	[p6l2012t3326r2153b3393],
14	just	RB	O	just	advmod	15	SENT_115	[p6l8t3440r150b3525],
15	completed	VBN	O	complete	pcomp	3	SENT_115	[p6l177t3436r592b3524],
16	.	.	O	.	_	0	SENT_115	[p6l177t3436r592b3524],

1	Procedures	NNS	O	procedure	_	0	SENT_116	[p6l13t3656r428b3725],

1	In	IN	O	in	_	0	SENT_117	[p7l13t35r92b95],
2	each	DT	O	each	det	4	SENT_117	[p7l153t28r323b96],
3	treatment	NN	O	treatment	nn	4	SENT_117	[p7l381t41r755b96],
4	sequence	NN	O	sequence	prep_in	7	SENT_117	[p7l816t52r1185b117],
5	,	,	O	,	_	0	SENT_117	[p7l816t52r1185b117],
6	there	EX	O	there	expl	7	SENT_117	[p7l1247t28r1442b96],
7	was	VBD	O	be	_	0	SENT_117	[p7l1500t52r1640b96],
8	an	DT	O	a	det	12	SENT_117	[p7l1704t52r1793b96],
9	18-week	JJ	DURATION	18-week	amod	12	SENT_117	[p7l1856t28r2153b96],
10	double-blind	JJ	O	double-blind	amod	12	SENT_117	[p7l9t139r491b207],
11	treatment	NN	O	treatment	nn	12	SENT_117	[p7l552t152r927b207],
12	phase	NN	O	phase	nsubj	7	SENT_117	[p7l989t139r1207b228],
13	in	IN	O	in	_	0	SENT_117	[p7l1272t143r1347b206],
14	which	WDT	O	which	rel	16	SENT_117	[p7l1409t139r1639b207],
15	participants	NNS	O	participant	nsubj	16	SENT_117	[p7l1703t143r2149b228],
16	received	VBD	O	receive	rcmod	12	SENT_117	[p7l8t247r320b316],
17	either	CC	O	either	dep	16	SENT_117	[p7l347t247r567b316],
18	inhaled	VBD	O	inhale	conj	16	SENT_117	[p7l593t247r877b316],
19	longacting	VBG	O	longact	ccomp	18	SENT_117	[p7l902t247r1302b337],
20	(	CD	NUMBER	(	number	21	SENT_117	[p7l1334t247r1398b335],
21	3	CD	NUMBER	3	dobj	19	SENT_117	[p7l1334t247r1398b335],
22	,	,	O	,	_	0	SENT_117	[p7l1334t247r1398b335],
23	agonist	NN	O	agonist	nn	25	SENT_117	[p7l1426t252r1701b337],
24	(	NN	O	(	nn	25	SENT_117	[p7l1733t247r2152b337],
25	salmeterol	NN	O	salmeterol	appos	21	SENT_117	[p7l1733t247r2152b337],
26	50	CD	NUMBER	50	num	27	SENT_117	[p7l13t360r95b424],
27	pg	NN	O	pg	npadvmod	28	SENT_117	[p7l131t380r227b446],
28	twice	RB	O	twice	advmod	30	SENT_117	[p7l262t361r457b424],
29	a	DT	DURATION	a	det	30	SENT_117	[p7l496t380r533b424],
30	day	NN	DURATION	day	tmod	25	SENT_117	[p7l571t356r715b445],
31	;	:	O	;	_	0	SENT_117	[p7l571t356r715b445],
32	Serevent	NNP	O	Serevent	nn	34	SENT_117	[p7l761t361r1082b424],
33	50	CD	NUMBER	50	num	34	SENT_117	[p7l1122t360r1205b424],
34	pg	NN	O	pg	dep	25	SENT_117	[p7l1241t380r1336b446],
35	Diskus	NNP	O	Diskus	nn	42	SENT_117	[p7l1377t356r1656b434],
36	,	,	O	,	_	0	SENT_117	[p7l1377t356r1656b434],
37	GSK	NNP	ORGANIZATION	GSK	appos	42	SENT_117	[p7l1699t361r1891b434],
38	,	,	O	,	_	0	SENT_117	[p7l1699t361r1891b434],
39	North	NNP	LOCATION	North	appos	42	SENT_117	[p7l1934t356r2151b424],
40	Carolina	NNP	LOCATION	Carolina	nn	42	SENT_117	[p7l11t466r349b544],
41	,	,	O	,	_	0	SENT_117	[p7l11t466r349b544],
42	USA	NNP	LOCATION	USA	dep	34	SENT_117	[p7l403t471r601b556],
43	)	CD	NUMBER	)	num	42	SENT_117	[p7l403t471r601b556],
44	or	CC	O	or	_	0	SENT_117	[p7l654t490r732b534],
45	matching	VBG	O	match	conj_or	19	SENT_117	[p7l777t466r1138b556],
46	placebo	NN	O	placebo	dobj	45	SENT_117	[p7l1184t466r1490b555],
47	.	.	O	.	_	0	SENT_117	[p7l1184t466r1490b555],

1	Additionally	RB	O	additionally	advmod	5	SENT_118	[p7l1539t466r2014b555],
2	,	,	O	,	_	0	SENT_118	[p7l1539t466r2014b555],
3	all	DT	O	all	det	4	SENT_118	[p7l2065t466r2151b533],
4	participants	NNS	O	participant	nsubj	5	SENT_118	[p7l8t579r455b663],
5	received	VBD	O	receive	_	0	SENT_118	[p7l568t574r880b643],
6	open-label	JJ	O	open-label	dobj	5	SENT_118	[p7l991t574r1401b663],
7	,	,	O	,	_	0	SENT_118	[p7l991t574r1401b663],
8	inhaled	VBN	O	inhale	partmod	6	SENT_118	[p7l1515t574r1800b643],
9	hydroﬂuoroalkane	NN	O	hydroﬂuoroalkane	nn	11	SENT_118	[p7l1908t574r2150b664, p7l8t683r484b751],
10	beclometasone	NN	O	beclometasone	nn	11	SENT_118	[p7l504t683r1071b751],
11	(	NN	O	(	dobj	8	SENT_118	[p7l1099t689r1248b773],
12	240	CD	NUMBER	240	num	13	SENT_118	[p7l1099t689r1248b773],
13	pg	NN	O	pg	npadvmod	14	SENT_118	[p7l1269t707r1365b773],
14	twice	RB	O	twice	advmod	11	SENT_118	[p7l1385t688r1580b751],
15	a	DT	DURATION	a	det	16	SENT_118	[p7l1603t707r1640b751],
16	day	NN	DURATION	day	pobj	14	SENT_118	[p7l1662t683r1835b773],
17	)	CD	NUMBER	)	tmod	11	SENT_118	[p7l1662t683r1835b773],
18	.	.	O	.	_	0	SENT_118	[p7l1662t683r1835b773],

1	Inhaled	VBN	O	inhale	_	0	SENT_119	[p7l1864t683r2153b751],
2	ipratropium	NN	O	ipratropium	nn	3	SENT_119	[p7l8t798r470b882],
3	bromide	NN	O	bromide	nsubj	6	SENT_119	[p7l502t794r823b862],
4	(	CD	NUMBER	(	number	5	SENT_119	[p7l864t800r1018b883],
5	two	CD	NUMBER	two	num	6	SENT_119	[p7l864t800r1018b883],
6	actuations	NNS	O	actuation	xcomp	1	SENT_119	[p7l1054t798r1439b862],
7	[	CD	NUMBER	[	num	8	SENT_119	[p7l1479t794r1709b882],
8	puffs	NNS	O	puff	dep	9	SENT_119	[p7l1479t794r1709b882],
9	]	RB	O	]	amod	6	SENT_119	[p7l1479t794r1709b882],
10	as	IN	O	as	_	0	SENT_119	[p7l1748t818r1821b862],
11	needed	VBN	O	need	prep_as	1	SENT_119	[p7l1857t794r2147b872],
12	;	:	O	;	_	0	SENT_119	[p7l1857t794r2147b872],
13	Atrovent	NNP	O	Atrovent	nsubjpass	25	SENT_119	[p7l7t907r350b981],
14	,	,	O	,	_	0	SENT_119	[p7l7t907r350b981],
15	Boehringer	NNP	PERSON	Boehringer	nn	22	SENT_119	[p7l400t902r827b992],
16	Ingelheim	NNP	PERSON	Ingelheim	nn	22	SENT_119	[p7l871t902r1282b992],
17	,	,	O	,	_	0	SENT_119	[p7l871t902r1282b992],
18	Ridgeﬁeld	NNP	PERSON	Ridgeﬁeld	appos	22	SENT_119	[p7l1331t902r1732b992],
19	,	,	O	,	_	0	SENT_119	[p7l1331t902r1732b992],
20	CT	NNP	O	CT	appos	22	SENT_119	[p7l1780t907r1899b981],
21	,	,	O	,	_	0	SENT_119	[p7l1780t907r1899b981],
22	USA	NNP	LOCATION	USA	appos	13	SENT_119	[p7l1948t908r2146b992],
23	)	CD	NUMBER	)	num	22	SENT_119	[p7l1948t908r2146b992],
24	was	VBD	O	be	auxpass	25	SENT_119	[p7l7t1035r147b1079],
25	used	VBN	O	use	parataxis	1	SENT_119	[p7l215t1011r394b1079],
26	as	IN	O	as	_	0	SENT_119	[p7l461t1035r533b1079],
27	primary	JJ	O	primary	amod	29	SENT_119	[p7l603t1016r907b1101],
28	rescue	NN	O	rescue	nn	29	SENT_119	[p7l972t1035r1215b1079],
29	therapy	NN	O	therapy	prep_as	25	SENT_119	[p7l1281t1011r1567b1100],
30	to	TO	O	to	aux	31	SENT_119	[p7l1631t1024r1701b1079],
31	avoid	VB	O	avoid	xcomp	25	SENT_119	[p7l1770t1011r1969b1079],
32	the	DT	O	the	det	34	SENT_119	[p7l2033t1011r2151b1079],
33	confounding	JJ	O	confounding	amod	34	SENT_119	[p7l9t1120r497b1210],
34	effects	NNS	O	effect	dobj	31	SENT_119	[p7l559t1121r798b1188],
35	of	IN	O	of	_	0	SENT_119	[p7l863t1120r947b1188],
36	B,-adrenergic	JJ	O	b,-adrenergic	amod	37	SENT_119	[p7l1001t1120r1496b1211],
37	stimulation	NN	O	stimulation	prep_of	34	SENT_119	[p7l1560t1121r1995b1189],
38	on	IN	O	on	_	0	SENT_119	[p7l2058t1145r2152b1189],
39	outcome	NN	O	outcome	nn	40	SENT_119	[p7l9t1244r336b1299],
40	variables	NNS	O	variable	prep_on	31	SENT_119	[p7l381t1230r734b1299],
41	.	.	O	.	_	0	SENT_119	[p7l381t1230r734b1299],

1	However	RB	O	however	advmod	17	SENT_120	[p7l788t1237r1135b1309],
2	,	,	O	,	_	0	SENT_120	[p7l788t1237r1135b1309],
3	if	IN	O	if	mark	10	SENT_120	[p7l1184t1230r1249b1298],
4	an	DT	O	a	det	5	SENT_120	[p7l1282t1255r1372b1299],
5	episode	NN	O	episode	nsubj	10	SENT_120	[p7l1419t1230r1704b1319],
6	of	IN	O	of	_	0	SENT_120	[p7l1751t1230r1835b1299],
7	adverse	JJ	O	adverse	amod	9	SENT_120	[p7l1869t1230r2150b1299],
8	asthma	NN	O	asthma	nn	9	SENT_120	[p7l9t1340r286b1408],
9	control	NN	O	control	prep_of	5	SENT_120	[p7l318t1340r584b1408],
10	responded	VBD	O	respond	advcl	17	SENT_120	[p7l615t1340r1014b1429],
11	incompletely	RB	O	incompletely	advmod	10	SENT_120	[p7l1044t1340r1536b1429],
12	to	TO	O	to	_	0	SENT_120	[p7l1564t1353r1634b1408],
13	ipratropium	NN	O	ipratropium	prep_to	10	SENT_120	[p7l1667t1345r2147b1429],
14	,	,	O	,	_	0	SENT_120	[p7l1667t1345r2147b1429],
15	salbutamol	NN	O	salbutamol	nsubjpass	17	SENT_120	[p7l11t1451r428b1519],
16	was	VBD	O	be	auxpass	17	SENT_120	[p7l467t1475r607b1519],
17	used	VBN	O	use	_	0	SENT_120	[p7l648t1451r828b1519],
18	as	IN	O	as	_	0	SENT_120	[p7l869t1475r941b1519],
19	a	DT	O	a	det	22	SENT_120	[p7l985t1475r1023b1519],
20	superseding	VBG	O	supersede	amod	22	SENT_120	[p7l1065t1451r1528b1540],
21	rescue	NN	O	rescue	nn	22	SENT_120	[p7l1568t1475r1811b1519],
22	therapy	NN	O	therapy	prep_as	17	SENT_120	[p7l1852t1451r2147b1540],
23	.	.	O	.	_	0	SENT_120	[p7l1852t1451r2147b1540],

1	Patients	NNS	O	patient	nsubj	2	SENT_121	[p7l13t1564r309b1628],
2	received	VBD	O	receive	_	0	SENT_121	[p7l345t1559r656b1628],
3	the	DT	O	the	det	6	SENT_121	[p7l686t1559r804b1628],
4	alternative	JJ	O	alternative	amod	6	SENT_121	[p7l838t1559r1232b1628],
5	double-blind	JJ	O	double-blind	amod	6	SENT_121	[p7l1267t1559r1748b1628],
6	treatment	NN	O	treatment	dobj	2	SENT_121	[p7l1779t1573r2153b1628],
7	for	IN	O	for	_	0	SENT_121	[p7l8t1670r117b1738],
8	the	DT	O	the	det	11	SENT_121	[p7l140t1670r258b1738],
9	second	JJ	ORDINAL	second	amod	11	SENT_121	[p7l288t1670r550b1738],
10	treatment	NN	O	treatment	nn	11	SENT_121	[p7l574t1683r947b1738],
11	period	NN	O	period	prep_for	2	SENT_121	[p7l972t1670r1234b1759],
12	.	.	O	.	_	0	SENT_121	[p7l972t1670r1234b1759],

1	At	IN	O	at	_	0	SENT_122	[p7l78t1786r161b1849],
2	the	DT	O	the	det	3	SENT_122	[p7l194t1781r312b1849],
3	end	NN	O	end	prep_at	12	SENT_122	[p7l350t1781r490b1849],
4	of	IN	O	of	_	0	SENT_122	[p7l525t1780r609b1849],
5	each	DT	O	each	det	8	SENT_122	[p7l633t1781r803b1849],
6	double-blind	JJ	O	double-blind	amod	8	SENT_122	[p7l840t1780r1322b1849],
7	treatment	NN	O	treatment	nn	8	SENT_122	[p7l1355t1794r1729b1849],
8	period	NN	O	period	prep_of	3	SENT_122	[p7l1763t1781r2025b1869],
9	,	,	O	,	_	0	SENT_122	[p7l1763t1781r2025b1869],
10	all	DT	O	all	det	11	SENT_122	[p7l2066t1781r2152b1849],
11	participants	NNS	O	participant	appos	8	SENT_122	[p7l8t1894r455b1978],
12	resumed	VBD	O	resume	_	0	SENT_122	[p7l496t1889r830b1957],
13	regular	JJ	O	regular	amod	14	SENT_122	[p7l867t1889r1141b1979],
14	use	NN	O	use	dobj	12	SENT_122	[p7l1177t1913r1306b1957],
15	of	IN	O	of	_	0	SENT_122	[p7l1345t1889r1430b1957],
16	hydroﬂuoroalkane	NN	O	hydroﬂuoroalkane	nn	17	SENT_122	[p7l1454t1889r2151b1979],
17	beclometasone	NN	O	beclometasone	prep_of	14	SENT_122	[p7l7t1998r594b2076],
18	,	,	O	,	_	0	SENT_122	[p7l7t1998r594b2076],
19	with	IN	O	with	_	0	SENT_122	[p7l629t1998r797b2066],
20	salbutamol	NN	O	salbutamol	prep_with	14	SENT_122	[p7l833t1998r1251b2066],
21	(	CD	NUMBER	(	num	20	SENT_122	[p7l1290t2005r1386b2088],
22	as	IN	O	as	_	0	SENT_122	[p7l1290t2005r1386b2088],
23	needed	VBN	O	need	amod	24	SENT_122	[p7l1422t1998r1742b2088],
24	)	NN	O	)	prep_as	20	SENT_122	[p7l1422t1998r1742b2088],
25	,	,	O	,	_	0	SENT_122	[p7l1422t1998r1742b2088],
26	for	IN	O	for	_	0	SENT_122	[p7l1780t1998r1887b2066],
27	a	DT	O	a	det	29	SENT_122	[p7l1921t2022r1958b2066],
28	runout	NN	O	runout	nn	29	SENT_122	[p7l1992t2022r2150b2066, p7l9t2121r131b2176],
29	period	NN	O	period	prep_for	12	SENT_122	[p7l163t2107r407b2196],
30	(	CD	NUMBER	(	num	33	SENT_122	[p7l444t2107r690b2197],
31	ﬁgure	NN	O	ﬁgure	nn	33	SENT_122	[p7l444t2107r690b2197],
32	1	CD	NUMBER	1	num	33	SENT_122	[p7l727t2114r804b2197],
33	)	NN	O	)	nsubj	12	SENT_122	[p7l727t2114r804b2197],
34	.	.	O	.	_	0	SENT_122	[p7l727t2114r804b2197],

1	During	IN	O	during	_	0	SENT_123	[p7l846t2112r1116b2197],
2	the	DT	O	the	det	5	SENT_123	[p7l1148t2107r1266b2176],
3	two	CD	NUMBER	two	num	5	SENT_123	[p7l1298t2121r1432b2176],
4	treatment	NN	O	treatment	nn	5	SENT_123	[p7l1466t2121r1840b2176],
5	periods	NNS	O	period	prep_during	14	SENT_123	[p7l1871t2107r2149b2196],
6	and	CC	O	and	_	0	SENT_123	[p7l9t2217r149b2286],
7	two	CD	NUMBER	two	num	9	SENT_123	[p7l175t2231r309b2286],
8	run-out	NN	O	run-out	nn	9	SENT_123	[p7l338t2231r626b2286],
9	periods	NNS	O	period	prep_during	14	SENT_123	[p7l652t2217r952b2306],
10	,	,	O	,	_	0	SENT_123	[p7l652t2217r952b2306],
11	asthma	NN	O	asthma	nn	12	SENT_123	[p7l984t2217r1261b2286],
12	control	NN	O	control	nsubjpass	14	SENT_123	[p7l1290t2217r1555b2286],
13	was	VBD	O	be	auxpass	14	SENT_123	[p7l1581t2241r1721b2286],
14	monitored	VBN	O	monitor	_	0	SENT_123	[p7l1752t2217r2153b2286],
15	by	IN	O	by	_	0	SENT_123	[p7l7t2327r95b2416],
16	the	DT	O	the	det	18	SENT_123	[p7l124t2327r242b2395],
17	same	JJ	O	same	amod	18	SENT_123	[p7l277t2351r472b2395],
18	indicators	NNS	O	indicator	agent	14	SENT_123	[p7l505t2327r878b2395],
19	as	IN	O	as	prep	14	SENT_123	[p7l914t2351r987b2394],
20	in	IN	O	in	pcomp	19	SENT_123	[p7l1021t2331r1096b2393],
21	the	DT	O	the	det	23	SENT_123	[p7l1127t2327r1245b2394],
22	run-in	JJ	O	run-in	amod	23	SENT_123	[p7l1278t2331r1517b2394],
23	stage	NN	O	stage	pobj	20	SENT_123	[p7l1551t2340r1759b2417],
24	.	.	O	.	_	0	SENT_123	[p7l1551t2340r1759b2417],

1	Although	IN	O	although	mark	6	SENT_124	[p7l1794t2327r2152b2417],
2	the	DT	O	the	det	5	SENT_124	[p7l7t2437r125b2505],
3	second	JJ	ORDINAL	second	amod	5	SENT_124	[p7l153t2437r414b2505],
4	run-out	NN	O	run-out	nn	5	SENT_124	[p7l438t2450r725b2505],
5	period	NN	O	period	nsubj	6	SENT_124	[p7l747t2437r991b2525],
6	lasted	VBD	O	last	advcl	39	SENT_124	[p7l1013t2437r1234b2505],
7	10	CD	DURATION	10	num	8	SENT_124	[p7l1260t2443r1335b2505],
8	weeks	NNS	NUMBER	week	tmod	6	SENT_124	[p7l1358t2437r1586b2505],
9	(	RB	O	(	advmod	6	SENT_124	[p7l1619t2443r1716b2526],
10	as	IN	O	as	_	0	SENT_124	[p7l1619t2443r1716b2526],
11	opposed	VBN	O	oppose	amod	19	SENT_124	[p7l1744t2437r2058b2525],
12	to	TO	O	to	_	0	SENT_124	[p7l2081t2450r2151b2505],
13	8	CD	DURATION	8	num	14	SENT_124	[p7l9t2551r49b2613],
14	weeks	NNS	NUMBER	week	prep_to	11	SENT_124	[p7l85t2545r314b2614],
15	for	IN	O	for	_	0	SENT_124	[p7l353t2545r461b2613],
16	the	DT	O	the	det	18	SENT_124	[p7l495t2545r613b2613],
17	first	JJ	ORDINAL	first	amod	18	SENT_124	[p7l650t2545r801b2613],
18	run-out	NN	O	run-out	prep_for	14	SENT_124	[p7l836t2559r1124b2613],
19	period	NN	O	period	prep_as	6	SENT_124	[p7l1159t2545r1423b2635],
20	)	CD	NUMBER	)	tmod	6	SENT_124	[p7l1159t2545r1423b2635],
21	to	TO	O	to	aux	22	SENT_124	[p7l1464t2559r1534b2613],
22	assess	VB	O	assess	xcomp	6	SENT_124	[p7l1573t2569r1803b2613],
23	whether	IN	O	whether	complm	30	SENT_124	[p7l1840t2545r2153b2613],
24	any	DT	O	any	det	27	SENT_124	[p7l9t2679r142b2744],
25	potential	JJ	O	potential	amod	27	SENT_124	[p7l167t2655r501b2744],
26	genotype-speciﬁc	JJ	O	genotype-speciﬁc	amod	27	SENT_124	[p7l530t2655r1183b2745],
27	effects	NNS	O	effect	nsubjpass	30	SENT_124	[p7l1212t2655r1450b2723],
28	would	MD	O	would	aux	30	SENT_124	[p7l1479t2655r1714b2723],
29	be	VB	O	be	auxpass	30	SENT_124	[p7l1739t2655r1826b2723],
30	seen	VBN	O	see	ccomp	22	SENT_124	[p7l1858t2679r2027b2723],
31	up	RP	DURATION	up	prt	30	SENT_124	[p7l2053t2679r2151b2744],
32	to	TO	DURATION	to	_	0	SENT_124	[p7l7t2777r77b2832],
33	10	CD	DURATION	10	num	34	SENT_124	[p7l121t2769r197b2832],
34	weeks	NNS	NUMBER	week	prep_to	30	SENT_124	[p7l236t2763r486b2841],
35	,	,	O	,	_	0	SENT_124	[p7l236t2763r486b2841],
36	run-out	NN	O	run-out	nn	37	SENT_124	[p7l530t2777r817b2832],
37	measurements	NNS	O	measurement	nsubjpass	39	SENT_124	[p7l855t2777r1420b2832],
38	were	VBD	O	be	auxpass	39	SENT_124	[p7l1461t2788r1641b2832],
39	taken	VBN	O	take	_	0	SENT_124	[p7l1681t2763r1888b2832],
40	at	IN	O	at	advmod	39	SENT_124	[p7l1929t2777r1995b2832],
41	the	DT	O	the	pobj	40	SENT_124	[p7l2032t2763r2151b2832],

1	Arg/Arg	NNP	O	Arg/Arg	nn	4	SENT_125	[p7l75t2961r162b2986],
2	Matched	NNP	O	Matched	nn	4	SENT_125	[p7l254t2960r350b2980],
3	Randomisation	NNP	O	Randomisation	nn	4	SENT_125	[p7l445t2960r612b2980],
4	Crossover	NNP	O	Crossover	_	0	SENT_125	[p7l1082t2961r1188b2980],
5	an	DT	O	a	det	9	SENT_125	[p7l75t2999r100b3013],
6	/	:	O	/	punct	7	SENT_125	[p7l157t2993r201b3019],
7	Gly	NN	O	gly	dep	8	SENT_125	[p7l157t2993r201b3019],
8	participants	NNS	O	participant	nn	9	SENT_125	[p7l253t2993r386b3019],
9	pa	NN	O	pa	dep	4	SENT_125	[p7l75t3032r101b3052],
10	i	FW	O	i	nn	12	SENT_125	[p7l122t3026r126b3045],
11	ipants	FW	O	ipants	nn	12	SENT_125	[p7l140t3026r207b3052],
12	entermain	NN	O	entermain	dep	9	SENT_125	[p7l253t3026r372b3046],

1	-	:	O	-	_	0	SENT_126	[p7l101t3298r103b3300],
2	‘	NN	O	‘	nn	3	SENT_126	[p7l114t3292r117b3305],
3	r	NN	O	r	dep	14	SENT_126	[p7l114t3292r117b3305],
4	i	FW	O	i	dep	3	SENT_126	[p7l128t3292r171b3309],
5	:	:	O	:	_	0	SENT_126	[p7l128t3292r171b3309],
6	-	:	O	-	_	0	SENT_126	[p7l128t3292r171b3309],
7	,	,	O	,	_	0	SENT_126	[p7l128t3292r171b3309],
8	=	JJ	O	=	amod	4	SENT_126	[p7l128t3292r171b3309],
9	:	:	O	:	_	0	SENT_126	[p7l128t3292r171b3309],
10	,1	CD	NUMBER	,1	dep	3	SENT_126	[p7l128t3292r171b3309],
11	i	FW	O	i	nn	13	SENT_126	[p7l128t3292r171b3309],
12	‘	FW	O	‘	nn	13	SENT_126	[p7l128t3292r171b3309],
13	r	NN	O	r	dep	10	SENT_126	[p7l128t3292r171b3309],
14	+	CC	O	+	_	0	SENT_126	[p7l287t3295r298b3307],

1	“	NN	O	“	_	0	SENT_127	[p7l154t3321r159b3332],
2	'	''	O	'	_	0	SENT_127	[p7l169t3324r177b3332],
3	‘	CD	NUMBER	‘	num	6	SENT_127	[p7l169t3324r177b3332],
4	CIT	NNP	O	CIT	nn	6	SENT_127	[p7l197t3321r216b3342],
5	salbutamolprn	NN	O	salbutamolprn	nn	6	SENT_127	[p7l253t3320r410b3347],
6	salbutamolprn	NN	O	salbutamolprn	dep	1	SENT_127	[p7l894t3320r1050b3347],
7	salbutamolprn	NN	O	salbutamolprn	dep	1	SENT_127	[p7l1537t3320r1693b3347],

1	|	NN	O	|	nn	2	SENT_128	[p7l229t3422r1763b3437],
2	IIl	NN	O	iil	dep	14	SENT_128	[p7l229t3422r1763b3437],
3	|	CD	NUMBER	|	num	5	SENT_128	[p7l229t3422r1763b3437],
4	Il	NN	O	il	nn	5	SENT_128	[p7l229t3422r1763b3437],
5	|	NN	O	|	dep	2	SENT_128	[p7l229t3422r1763b3437],
6	l	NN	O	l	dep	14	SENT_128	[p7l229t3422r1763b3437],
7	|	CD	NUMBER	|	num	6	SENT_128	[p7l229t3422r1763b3437],
8	lIl	NN	O	lil	nn	14	SENT_128	[p7l229t3422r1763b3437],
9	|	NN	O	|	nn	14	SENT_128	[p7l229t3422r1763b3437],
10	IllIIIllllllIlllllllIIIIIIIIIl	NN	O	illiiillllllillllllliiiiiiiiil	nn	14	SENT_128	[p7l229t3422r1763b3437],
11	|	CD	NUMBER	|	num	14	SENT_128	[p7l229t3422r1763b3437],
12	Il	NN	O	il	nn	14	SENT_128	[p7l229t3422r1763b3437],
13	|	NN	O	|	nn	14	SENT_128	[p7l229t3422r1763b3437],
14	l	NN	O	l	dep	25	SENT_128	[p7l229t3422r1763b3437],
15	|	CD	NUMBER	|	number	16	SENT_128	[p7l229t3422r1763b3437],
16	|	CD	NUMBER	|	dep	14	SENT_128	[p7l229t3422r1763b3437],
17	Il	NN	O	il	nn	20	SENT_128	[p7l229t3422r1763b3437],
18	|	CD	NUMBER	|	num	20	SENT_128	[p7l229t3422r1763b3437],
19	Il	NN	O	il	nn	20	SENT_128	[p7l229t3422r1763b3437],
20	|	NN	O	|	dep	16	SENT_128	[p7l229t3422r1763b3437],
21	l	NN	O	l	tmod	16	SENT_128	[p7l229t3422r1763b3437],
22	|	CD	NUMBER	|	num	25	SENT_128	[p7l229t3422r1763b3437],
23	|	NN	O	|	nn	25	SENT_128	[p7l229t3422r1763b3437],
24	IlI	NN	O	ili	nn	25	SENT_128	[p7l229t3422r1763b3437],
25	o	NN	O	o	dep	33	SENT_128	[p7l224t3448r236b3465],
26	8	CD	NUMBER	8	number	27	SENT_128	[p7l422t3445r434b3465],
27	16	CD	NUMBER	16	num	29	SENT_128	[p7l613t3445r638b3465],
28	24	CD	NUMBER	24	number	29	SENT_128	[p7l810t3448r837b3468],
29	32	CD	NUMBER	32	dep	25	SENT_128	[p7l1008t3448r1032b3468],
30	40	CD	NUMBER	40	number	31	SENT_128	[p7l1204t3448r1231b3468],
31	48	CD	NUMBER	48	amod	29	SENT_128	[p7l1401t3445r1429b3468],
32	56	CD	NUMBER	56	num	33	SENT_128	[p7l1601t3445r1627b3468],
33	62	CD	NUMBER	62	_	0	SENT_128	[p7l1750t3445r1775b3465],

1	Week	NN	DURATION	week	_	0	SENT_129	[p7l913t3485r969b3505],

1	Figure	NNP	O	Figure	_	0	SENT_130	[p7l7t3576r75b3603],
2	1	CD	NUMBER	1	num	1	SENT_130	[p7l81t3578r100b3596],
3	:	:	O	:	_	0	SENT_130	[p7l81t3578r100b3596],
4	Schematic	JJ	O	schematic	amod	5	SENT_130	[p7l108t3575r228b3596],
5	diagram	NN	O	diagram	dep	1	SENT_130	[p7l234t3575r331b3603],
6	of	IN	O	of	_	0	SENT_130	[p7l338t3575r363b3596],
7	the	DT	O	the	det	9	SENT_130	[p7l367t3575r406b3596],
8	trial	NN	O	trial	nn	9	SENT_130	[p7l411t3575r458b3596],
9	protocol	NN	O	protocol	prep_of	5	SENT_130	[p7l465t3575r563b3603],
10	After	IN	O	after	_	0	SENT_130	[p7l19t3611r75b3632],
11	screening	NN	O	screening	prep_after	15	SENT_130	[p7l81t3613r186b3639],
12	and	CC	O	and	_	0	SENT_130	[p7l194t3611r235b3632],
13	genotyping	NN	O	genotyping	conj_and	11	SENT_130	[p7l242t3613r375b3639],
14	,	,	O	,	_	0	SENT_130	[p7l242t3613r375b3639],
15	genotype	NN	O	genotype	dep	9	SENT_130	[p7l383t3611r577b3639],
16	—	NN	O	—	dep	15	SENT_130	[p7l383t3611r577b3639],
17	e	SYM	O	e	dep	15	SENT_130	[p7l383t3611r577b3639],
18	|	SYM	O	|	dep	5	SENT_130	[p7l383t3611r577b3639],
19	igib	FW	O	igib	nn	20	SENT_130	[p7l383t3611r577b3639],
20	|	FW	O	|	amod	5	SENT_130	[p7l383t3611r577b3639],
21	e	SYM	O	e	dep	48	SENT_130	[p7l383t3611r577b3639],
22	and	CC	O	and	cc	30	SENT_130	[p7l584t3611r625b3632],
23	matched	VBN	O	match	amod	24	SENT_130	[p7l633t3611r729b3632],
24	participants	NNS	O	participant	nsubj	30	SENT_130	[p7l736t3613r867b3639],
25	who	WP	O	who	nsubj	26	SENT_130	[p7l873t3611r922b3632],
26	received	VBD	O	receive	rcmod	24	SENT_130	[p7l930t3611r1020b3632],
27	8	CD	DURATION	8	num	28	SENT_130	[p7l1027t3611r1040b3632],
28	weeks	NNS	NUMBER	week	tmod	26	SENT_130	[p7l1047t3611r1114b3632],
29	of	IN	O	of	prep	26	SENT_130	[p7l1121t3611r1145b3632],
30	inhaled	VBN	O	inhale	csubjpass	48	SENT_130	[p7l1151t3611r1231b3632],
31	corticosteroid	NN	O	corticosteroid	dobj	30	SENT_130	[p7l1238t3611r1391b3632],
32	;	:	O	;	_	0	SENT_130	[p7l1442t3619r1446b3636],
33	hydroﬂuoroalkane	NN	O	hydroﬂuoroalkane	nn	35	SENT_130	[p7l1455t3611r1658b3639],
34	beclometasone	NN	O	beclometasone	nn	35	SENT_130	[p7l1665t3611r1834b3632],
35	dipropionate	NN	O	dipropionate	dep	31	SENT_130	[p7l1843t3611r1986b3639],
36	240	CD	NUMBER	240	num	37	SENT_130	[p7l1994t3614r2036b3635],
37	pg	NN	O	pg	npadvmod	38	SENT_130	[p7l2044t3618r2070b3639],
38	twice	RB	O	twice	advmod	40	SENT_130	[p7l2077t3613r2136b3632],
39	a	DT	DURATION	a	det	40	SENT_130	[p7l2143t3618r2154b3632],
40	day	NN	DURATION	day	tmod	35	SENT_130	[p7l693t3647r739b3675],
41	)	CD	NUMBER	)	tmod	30	SENT_130	[p7l693t3647r739b3675],
42	during	IN	O	during	_	0	SENT_130	[p7l746t3647r818b3675],
43	the	DT	O	the	det	45	SENT_130	[p7l824t3647r861b3668],
44	run-in	JJ	O	run-in	amod	45	SENT_130	[p7l869t3649r935b3668],
45	period	NN	O	period	prep_during	30	SENT_130	[p7l943t3647r1014b3675],
46	were	VBD	O	be	auxpass	48	SENT_130	[p7l1019t3654r1073b3668],
47	randomly	RB	O	randomly	advmod	48	SENT_130	[p7l1081t3647r1187b3675],
48	assigned	VBN	O	assign	dep	1	SENT_130	[p7l1193t3647r1288b3675],
49	to	TO	O	to	aux	50	SENT_130	[p7l1294t3651r1318b3668],
50	contin	VB	O	contin	xcomp	48	SENT_130	[p7l1325t3649r1394b3668],
51	S	NN	O	s	dobj	50	SENT_130	[p7l1451t3649r1463b3668],
52	with	IN	O	with	prep	50	SENT_130	[p7l1469t3647r1518b3668],
53	either	CC	O	either	dep	52	SENT_130	[p7l1526t3647r1591b3668],
54	salmeterol	NN	O	salmeterol	nn	55	SENT_130	[p7l1597t3647r1712b3668],
55	lacebo	NN	O	lacebo	conj	52	SENT_130	[p7l1765t3647r1834b3668],
56	for	IN	O	for	_	0	SENT_130	[p7l1840t3647r1872b3668],
57	18	CD	DURATION	18	num	58	SENT_130	[p7l1879t3647r1905b3668],
58	weeks	NNS	NUMBER	week	prep_for	52	SENT_130	[p7l1912t3647r1985b3672],
59	,	,	O	,	_	0	SENT_130	[p7l1912t3647r1985b3672],
60	followed	VBN	O	follow	_	0	SENT_130	[p7l1992t3647r2090b3668],
61	by	IN	O	by	prepc_followed_by	48	SENT_130	[p7l2097t3647r2122b3675],
62	an	DT	O	a	pobj	48	SENT_130	[p7l2129t3654r2154b3668],

1	8-week	JJ	DURATION	8-week	amod	3	SENT_131	[p7l409t3683r490b3705],
2	run-out	NN	O	run-out	nn	3	SENT_131	[p7l499t3687r583b3705],
3	period	NN	O	period	nsubj	8	SENT_131	[p7l590t3683r660b3711],
4	on	IN	O	on	_	0	SENT_131	[p7l667t3690r694b3705],
5	ICS	NN	O	ic	prep_on	8	SENT_131	[p7l703t3685r735b3705],
6	alone	RB	O	alone	advmod	8	SENT_131	[p7l743t3683r808b3708],
7	,	,	O	,	_	0	SENT_131	[p7l743t3683r808b3708],
8	followed	VBD	O	follow	_	0	SENT_131	[p7l815t3683r912b3705],
9	bythe	NN	O	bythe	nn	11	SENT_131	[p7l920t3683r987b3711],
10	alternative	JJ	O	alternative	amod	11	SENT_131	[p7l994t3683r1112b3705],
11	treatment	NN	O	treatment	dobj	8	SENT_131	[p7l1118t3687r1232b3705],
12	and	CC	O	and	_	0	SENT_131	[p7l1238t3683r1279b3705],
13	a	DT	O	a	det	16	SENT_131	[p7l1286t3690r1297b3705],
14	10-week	JJ	DURATION	10-week	amod	16	SENT_131	[p7l1305t3683r1399b3705],
15	run-out	NN	O	run-out	nn	16	SENT_131	[p7l1407t3687r1492b3705],
16	period	NN	O	period	conj_and	11	SENT_131	[p7l1498t3683r1575b3711],
17	.	.	O	.	_	0	SENT_131	[p7l1498t3683r1575b3711],

1	prn	NN	O	prn	nsubj	2	SENT_132	[p7l1582t3690r1657b3711],
2	=	JJ	O	=	_	0	SENT_132	[p7l1582t3690r1657b3711],
3	as	IN	O	as	_	0	SENT_132	[p7l1582t3690r1657b3711],
4	need	NN	O	need	prep_as	2	SENT_132	[p7l1665t3683r1718b3705],
5	.	.	O	.	_	0	SENT_132	[p7l1747t3701r1750b3705],

1	1756	CD	DATE	1756	num	3	SENT_133	[p7l6t3721r63b3746],
2	vvvvvv.thelancet.com	NNP	O	vvvvvv.thelancet.com	nn	3	SENT_133	[p7l1621t3721r1844b3742],
3	Vol	NNP	O	Vol	_	0	SENT_133	[p7l1862t3721r1898b3742],
4	374	CD	NUMBER	374	dep	3	SENT_133	[p7l1906t3724r1949b3746],
5	November	NNP	DATE	November	tmod	4	SENT_133	[p7l1969t3721r2092b3742],
6	21	CD	DATE	21	num	5	SENT_133	[p7l2098t3724r2132b3746],
7	,	,	DATE	,	_	0	SENT_133	[p7l2098t3724r2132b3746],
8	2009	CD	DATE	2009	num	5	SENT_133	[p7l6t3762r67b3784],

1	Articles	NNPS	O	Articles	_	0	SENT_134	[p8l6t189r156b225],
2	I	PRP	O	I	dep	1	SENT_134	[p8l204t57r252b225],

1	end	NN	DURATION	end	_	0	SENT_135	[p8l9t484r148b552],
2	of	IN	DURATION	of	prep	1	SENT_135	[p8l183t484r267b552],
3	8	CD	DURATION	8	num	4	SENT_135	[p8l289t490r329b552],
4	weeks	NNS	NUMBER	week	pobj	2	SENT_135	[p8l362t484r590b552],
5	and	CC	O	and	_	0	SENT_135	[p8l628t484r767b552],
6	compared	VBN	O	compare	prep	1	SENT_135	[p8l801t484r1176b573],
7	with	IN	O	with	pcomp	6	SENT_135	[p8l1208t484r1374b552],
8	the	DT	O	the	det	9	SENT_135	[p8l1407t484r1525b552],
9	end	NN	O	end	pobj	7	SENT_135	[p8l1561t484r1700b552],
10	of	IN	O	of	_	0	SENT_135	[p8l1735t484r1818b552],
11	the	DT	O	the	det	15	SENT_135	[p8l1839t484r1956b552],
12	ﬁrst	NN	O	ﬁrst	nn	15	SENT_135	[p8l1991t484r2141b552],
13	8-week	JJ	DURATION	8-week	amod	15	SENT_135	[p8l10t595r270b663],
14	run-out	NN	O	run-out	nn	15	SENT_135	[p8l295t608r580b663],
15	period	NN	O	period	prep_of	9	SENT_135	[p8l605t595r864b684],
16	.	.	O	.	_	0	SENT_135	[p8l605t595r864b684],

1	Participant	NN	O	participant	nn	2	SENT_136	[p8l83t708r488b792],
2	adherence	NN	O	adherence	nsubjpass	7	SENT_136	[p8l547t703r930b771],
3	with	IN	O	with	_	0	SENT_136	[p8l988t703r1154b772],
4	medication	NN	O	medication	nn	5	SENT_136	[p8l1212t703r1632b771],
5	dosing	NN	O	dosing	prep_with	2	SENT_136	[p8l1692t703r1942b793],
6	was	VBD	O	be	auxpass	7	SENT_136	[p8l1999t728r2137b772],
7	determined	VBN	O	determine	_	0	SENT_136	[p8l10t812r444b880],
8	by	IN	O	by	_	0	SENT_136	[p8l506t812r592b901],
9	use	NN	O	use	agent	7	SENT_136	[p8l654t836r782b880],
10	of	IN	O	of	_	0	SENT_136	[p8l848t812r931b880],
11	a	DT	O	a	det	13	SENT_136	[p8l984t836r1021b880],
12	DOSER	NN	O	doser	nn	13	SENT_136	[p8l1089t816r1378b880],
13	device	NN	O	device	prep_of	9	SENT_136	[p8l1442t812r1671b880],
14	(	CD	NUMBER	(	num	16	SENT_136	[p8l1742t812r2142b902],
15	Meditrack	NNP	O	Meditrack	nn	16	SENT_136	[p8l1742t812r2142b902],
16	Products	NNPS	O	Products	tmod	7	SENT_136	[p8l13t923r359b1001],
17	;	:	O	;	_	0	SENT_136	[p8l13t923r359b1001],
18	Hudson	NNP	LOCATION	Hudson	nn	22	SENT_136	[p8l457t923r775b1001],
19	,	,	O	,	_	0	SENT_136	[p8l457t923r775b1001],
20	MA	NNP	LOCATION	MA	appos	22	SENT_136	[p8l871t928r1025b1001],
21	,	,	O	,	_	0	SENT_136	[p8l871t928r1025b1001],
22	USA	NNP	LOCATION	USA	dep	16	SENT_136	[p8l1121t928r1317b1012],
23	)	CD	NUMBER	)	num	22	SENT_136	[p8l1121t928r1317b1012],
24	attached	VBN	O	attach	partmod	22	SENT_136	[p8l1413t923r1725b991],
25	to	TO	O	to	_	0	SENT_136	[p8l1812t936r1880b990],
26	each	DT	O	each	det	29	SENT_136	[p8l1972t923r2140b991],
27	beclometasone	NN	O	beclometasone	nn	29	SENT_136	[p8l7t1031r566b1099],
28	metered-dose	JJ	O	metered-dose	amod	29	SENT_136	[p8l597t1031r1102b1099],
29	inhaler	NN	O	inhaler	prep_to	24	SENT_136	[p8l1133t1031r1400b1099],
30	(	CD	NUMBER	(	num	31	SENT_136	[p8l1435t1038r1680b1121],
31	MDI	NNP	O	MDI	dep	16	SENT_136	[p8l1435t1038r1680b1121],
32	)	CD	NUMBER	)	num	31	SENT_136	[p8l1435t1038r1680b1121],
33	.	.	O	.	_	0	SENT_136	[p8l1435t1038r1680b1121],

1	This	DT	O	this	det	2	SENT_137	[p8l1713t1031r1876b1099],
2	device	NN	O	device	nsubj	3	SENT_137	[p8l1910t1031r2139b1099],
3	registers	VBZ	O	register	_	0	SENT_137	[p8l8t1145r327b1230],
4	each	DT	O	each	det	5	SENT_137	[p8l371t1140r539b1208],
5	actuation	NN	O	actuation	dobj	3	SENT_137	[p8l579t1145r924b1208],
6	of	IN	O	of	_	0	SENT_137	[p8l965t1140r1048b1208],
7	the	DT	O	the	det	8	SENT_137	[p8l1074t1140r1191b1208],
8	MDI	NNP	ORGANIZATION	MDI	prep_of	5	SENT_137	[p8l1235t1147r1405b1207],
9	and	CC	O	and	_	0	SENT_137	[p8l1450t1140r1588b1208],
10	stores	NNS	O	store	prep_of	5	SENT_137	[p8l1630t1153r1844b1208],
11	a	DT	O	a	det	13	SENT_137	[p8l1888t1164r1925b1208],
12	daily	JJ	SET	daily	amod	13	SENT_137	[p8l1966t1140r2142b1230],
13	history	NN	O	history	dep	10	SENT_137	[p8l7t1251r277b1340],
14	,	,	O	,	_	0	SENT_137	[p8l7t1251r277b1340],
15	which	WDT	O	which	nsubjpass	17	SENT_137	[p8l316t1251r543b1319],
16	was	VBD	O	be	auxpass	17	SENT_137	[p8l578t1275r717b1319],
17	reviewed	VBN	O	review	rcmod	5	SENT_137	[p8l756t1251r1088b1319],
18	at	IN	O	at	_	0	SENT_137	[p8l1125t1264r1190b1319],
19	each	DT	O	each	det	21	SENT_137	[p8l1226t1251r1394b1319],
20	clinic	NN	O	clinic	nn	21	SENT_137	[p8l1432t1251r1631b1319],
21	visit	NN	O	visit	prep_at	17	SENT_137	[p8l1666t1255r1838b1319],
22	.	.	O	.	_	0	SENT_137	[p8l1666t1255r1838b1319],

1	Diskus	NNP	O	Diskus	nn	3	SENT_138	[p8l1883t1251r2137b1319],
2	inhalation	NN	O	inhalation	nn	3	SENT_138	[p8l9t1359r390b1427],
3	counters	NNS	O	counter	nsubjpass	5	SENT_138	[p8l420t1373r740b1427],
4	were	VBD	O	be	auxpass	5	SENT_138	[p8l769t1384r947b1427],
5	used	VBN	O	use	_	0	SENT_138	[p8l975t1359r1153b1427],
6	to	TO	O	to	aux	7	SENT_138	[p8l1180t1373r1248b1427],
7	determine	VB	O	determine	xcomp	5	SENT_138	[p8l1279t1359r1664b1427],
8	the	DT	O	the	det	9	SENT_138	[p8l1692t1359r1808b1427],
9	number	NN	O	number	dobj	7	SENT_138	[p8l1838t1359r2141b1427],
10	of	IN	O	of	_	0	SENT_138	[p8l10t1469r92b1537],
11	inhalations	NNS	O	inhalation	prep_of	9	SENT_138	[p8l101t1469r518b1537],
12	of	IN	O	of	_	0	SENT_138	[p8l543t1469r626b1537],
13	salmeterol	NN	O	salmeterol	prep_of	11	SENT_138	[p8l638t1469r1027b1537],
14	or	CC	O	or	_	0	SENT_138	[p8l1049t1493r1126b1537],
15	placebo	NN	O	placebo	prep_of	11	SENT_138	[p8l1146t1469r1447b1558],
16	.	.	O	.	_	0	SENT_138	[p8l1146t1469r1447b1558],

1	These	DT	O	these	det	3	SENT_139	[p8l1472t1469r1695b1537],
2	two	CD	NUMBER	two	num	3	SENT_139	[p8l1716t1482r1848b1537],
3	devices	NNS	O	device	nsubj	4	SENT_139	[p8l1873t1469r2138b1537],
4	gave	VBD	O	give	_	0	SENT_139	[p8l10t1603r172b1668],
5	objective	JJ	O	objective	amod	6	SENT_139	[p8l206t1579r531b1668],
6	measurements	NNS	O	measurement	dobj	4	SENT_139	[p8l563t1592r1121b1647],
7	of	IN	O	of	_	0	SENT_139	[p8l1156t1578r1239b1647],
8	the	DT	O	the	det	9	SENT_139	[p8l1257t1579r1373b1647],
9	number	NN	O	number	prep_of	6	SENT_139	[p8l1405t1579r1709b1647],
10	of	IN	O	of	_	0	SENT_139	[p8l1740t1578r1823b1647],
11	puffs	NNS	O	puff	prep_of	9	SENT_139	[p8l1842t1579r2030b1667],
12	or	CC	O	or	_	0	SENT_139	[p8l2065t1603r2141b1647],
13	doses	NNS	O	dose	prep_of	9	SENT_139	[p8l9t1687r213b1755],
14	actuated	VBN	O	actuate	partmod	11	SENT_139	[p8l242t1687r571b1755],
15	.	.	O	.	_	0	SENT_139	[p8l242t1687r571b1755],

1	Diary	NN	O	diary	nn	2	SENT_140	[p8l83t1802r284b1887],
2	cards	NNS	O	card	nsubjpass	19	SENT_140	[p8l302t1798r516b1876],
3	,	,	O	,	_	0	SENT_140	[p8l302t1798r516b1876],
4	on	IN	O	on	_	0	SENT_140	[p8l539t1822r633b1866],
5	which	WDT	O	which	rel	7	SENT_140	[p8l650t1798r878b1866],
6	participants	NNS	O	participant	nsubj	7	SENT_140	[p8l896t1802r1336b1887],
7	recorded	VBD	O	record	rcmod	2	SENT_140	[p8l1358t1798r1685b1866],
8	the	DT	O	the	det	9	SENT_140	[p8l1702t1798r1818b1866],
9	number	NN	O	number	dobj	7	SENT_140	[p8l1838t1798r2141b1866],
10	of	IN	O	of	_	0	SENT_140	[p8l10t1906r92b1975],
11	puffs	NNS	O	puff	prep_of	9	SENT_140	[p8l112t1907r300b1995],
12	of	IN	O	of	_	0	SENT_140	[p8l336t1906r419b1975],
13	each	DT	O	each	det	14	SENT_140	[p8l439t1907r607b1975],
14	drug	NN	O	drug	prep_of	11	SENT_140	[p8l640t1907r814b1996],
15	per	IN	O	per	_	0	SENT_140	[p8l846t1931r968b1995],
16	day	NN	DURATION	day	prep_per	14	SENT_140	[p8l1000t1907r1136b1996],
17	,	,	O	,	_	0	SENT_140	[p8l1000t1907r1136b1996],
18	were	VBD	O	be	auxpass	19	SENT_140	[p8l1169t1931r1348b1975],
19	used	VBN	O	use	_	0	SENT_140	[p8l1379t1907r1557b1975],
20	as	IN	O	as	_	0	SENT_140	[p8l1589t1931r1661b1975],
21	a	DT	O	a	det	23	SENT_140	[p8l1697t1931r1733b1975],
22	secondary	JJ	O	secondary	amod	23	SENT_140	[p8l1768t1907r2142b1996],
23	source	NN	O	source	prep_as	19	SENT_140	[p8l11t2040r253b2085],
24	of	IN	O	of	_	0	SENT_140	[p8l314t2016r397b2084],
25	compliance	NN	O	compliance	nn	26	SENT_140	[p8l445t2016r874b2105],
26	information	NN	O	information	prep_of	23	SENT_140	[p8l934t2016r1405b2085],
27	.	.	O	.	_	0	SENT_140	[p8l934t2016r1405b2085],

1	These	DT	O	these	det	2	SENT_141	[p8l1467t2016r1690b2085],
2	data	NNS	O	datum	nsubjpass	4	SENT_141	[p8l1752t2016r1904b2084],
3	were	VBD	O	be	auxpass	4	SENT_141	[p8l1961t2041r2139b2085],
4	compared	VBN	O	compare	_	0	SENT_141	[p8l9t2127r382b2216],
5	with	IN	O	with	_	0	SENT_141	[p8l476t2127r642b2195],
6	PEF	NN	O	pef	nn	7	SENT_141	[p8l743t2131r889b2194],
7	measurements	NNS	O	measurement	prep_with	4	SENT_141	[p8l990t2140r1547b2195],
8	electronically	RB	O	electronically	advmod	9	SENT_141	[p8l1648t2127r2142b2216],
9	recorded	VBN	O	record	partmod	7	SENT_141	[p8l8t2236r336b2305],
10	and	CC	O	and	_	0	SENT_141	[p8l390t2236r528b2305],
11	date/time	JJ	O	date/time	prep_with	4	SENT_141	[p8l581t2236r942b2325],
12	stamped	VBN	O	stamp	partmod	11	SENT_141	[p8l999t2236r1317b2325],
13	from	IN	O	from	_	0	SENT_141	[p8l1369t2236r1553b2305],
14	the	DT	O	the	det	19	SENT_141	[p8l1605t2236r1721b2305],
15	electronic	JJ	O	electronic	amod	19	SENT_141	[p8l1777t2236r2140b2305],
16	peak	NN	O	peak	nn	19	SENT_141	[p8l8t2346r183b2435],
17	flow	NN	O	flow	nn	19	SENT_141	[p8l249t2346r409b2415],
18	meter	NN	O	meter	nn	19	SENT_141	[p8l474t2360r695b2414],
19	device	NN	O	device	prep_from	12	SENT_141	[p8l762t2346r1010b2415],
20	.	.	O	.	_	0	SENT_141	[p8l762t2346r1010b2415],

1	Because	IN	O	because	mark	4	SENT_142	[p8l1085t2353r1386b2415],
2	participants	NNS	O	participant	nsubjpass	4	SENT_142	[p8l1454t2351r1893b2435],
3	were	VBD	O	be	auxpass	4	SENT_142	[p8l1961t2371r2139b2415],
4	instructed	VBN	O	instruct	advcl	25	SENT_142	[p8l8t2456r388b2523],
5	to	TO	O	to	aux	6	SENT_142	[p8l449t2469r518b2523],
6	take	VB	O	take	xcomp	4	SENT_142	[p8l581t2456r733b2523],
7	their	PRP$	O	they	poss	8	SENT_142	[p8l795t2456r973b2523],
8	morning	NN	TIME	morning	dobj	6	SENT_142	[p8l1035t2460r1365b2546],
9	and	CC	O	and	_	0	SENT_142	[p8l1429t2456r1567b2523],
10	evening	NN	TIME	evening	nn	12	SENT_142	[p8l1630t2460r1923b2546],
11	PEF	NN	O	pef	nn	12	SENT_142	[p8l1990t2460r2136b2522],
12	measurements	NNS	O	measurement	dobj	6	SENT_142	[p8l8t2578r566b2632],
13	immediately	RB	O	immediately	advmod	6	SENT_142	[p8l621t2564r1090b2654],
14	before	IN	O	before	_	0	SENT_142	[p8l1139t2564r1375b2632],
15	taking	VBG	O	take	prepc_before	6	SENT_142	[p8l1426t2564r1661b2654],
16	their	PRP$	O	they	poss	18	SENT_142	[p8l1711t2564r1890b2632],
17	study	NN	O	study	nn	18	SENT_142	[p8l1942t2564r2142b2654],
18	drugs	NNS	O	drug	dobj	15	SENT_142	[p8l9t2673r240b2763],
19	,	,	O	,	_	0	SENT_142	[p8l9t2673r240b2763],
20	timing	NN	O	timing	nsubjpass	25	SENT_142	[p8l266t2678r518b2763],
21	of	IN	O	of	_	0	SENT_142	[p8l543t2673r626b2741],
22	PEP	NN	O	pep	nn	23	SENT_142	[p8l640t2677r787b2740],
23	monitoring	NN	O	monitoring	prep_of	20	SENT_142	[p8l814t2678r1242b2763],
24	was	VBD	O	be	auxpass	25	SENT_142	[p8l1264t2697r1402b2741],
25	used	VBN	O	use	_	0	SENT_142	[p8l1427t2673r1604b2741],
26	as	IN	O	as	_	0	SENT_142	[p8l1627t2697r1699b2741],
27	a	DT	O	a	det	28	SENT_142	[p8l1727t2697r1763b2741],
28	surrogate	NN	O	surrogate	prep_as	25	SENT_142	[p8l1789t2686r2139b2763],
29	for	IN	O	for	_	0	SENT_142	[p8l9t2783r115b2850],
30	timing	NN	O	timing	prep_for	28	SENT_142	[p8l138t2787r390b2873],
31	of	IN	O	of	_	0	SENT_142	[p8l417t2783r500b2850],
32	dosing	NN	O	dosing	prep_of	30	SENT_142	[p8l514t2783r764b2873],
33	with	IN	O	with	_	0	SENT_142	[p8l787t2783r953b2850],
34	study	NN	O	study	nn	35	SENT_142	[p8l981t2783r1180b2872],
35	drugs	NNS	O	drug	prep_with	25	SENT_142	[p8l1205t2783r1435b2873],
36	.	.	O	.	_	0	SENT_142	[p8l1205t2783r1435b2873],

1	The	DT	O	the	det	3	SENT_143	[p8l78t2891r223b2959],
2	primary	JJ	O	primary	amod	3	SENT_143	[p8l246t2896r551b2981],
3	endpoint	NN	O	endpoint	nsubj	17	SENT_143	[p8l573t2891r915b2980],
4	of	IN	O	of	_	0	SENT_143	[p8l938t2891r1021b2959],
5	the	DT	O	the	det	6	SENT_143	[p8l1030t2891r1148b2959],
6	study	NN	O	study	prep_of	3	SENT_143	[p8l1174t2891r1387b2981],
7	,	,	O	,	_	0	SENT_143	[p8l1174t2891r1387b2981],
8	assessed	VBN	O	assess	partmod	3	SENT_143	[p8l1415t2891r1739b2959],
9	separately	RB	O	separately	advmod	8	SENT_143	[p8l1764t2891r2142b2981],
10	within	IN	O	within	_	0	SENT_143	[p8l7t3000r253b3068],
11	and	CC	O	and	_	0	SENT_143	[p8l281t3000r420b3068],
12	between	IN	O	between	_	0	SENT_143	[p8l445t3000r761b3068],
13	genotypes	NNS	O	genotype	prep_within	8	SENT_143	[p8l789t3013r1188b3090],
14	,	,	O	,	_	0	SENT_143	[p8l789t3013r1188b3090],
15	was	VBD	O	be	cop	17	SENT_143	[p8l1217t3024r1357b3068],
16	morning	NN	TIME	morning	nn	17	SENT_143	[p8l1386t3005r1721b3090],
17	PEF	NN	O	pef	_	0	SENT_143	[p8l1752t3004r1900b3067],
18	at	IN	O	at	_	0	SENT_143	[p8l1931t3013r1997b3068],
19	the	DT	DURATION	the	det	20	SENT_143	[p8l2021t3000r2139b3068],
20	end	NN	DURATION	end	prep_at	17	SENT_143	[p8l9t3109r149b3178],
21	of	IN	DURATION	of	_	0	SENT_143	[p8l170t3109r254b3178],
22	18-week	JJ	DURATION	18-week	amod	23	SENT_143	[p8l264t3110r563b3178],
23	treatment	NN	O	treatment	prep_of	20	SENT_143	[p8l580t3123r973b3178],
24	.	.	O	.	_	0	SENT_143	[p8l580t3123r973b3178],

1	Secondary	JJ	O	secondary	amod	2	SENT_144	[p8l1004t3110r1391b3199],
2	endpoints	NNS	O	endpoint	nsubj	3	SENT_144	[p8l1411t3110r1787b3198],
3	included	VBD	O	include	_	0	SENT_144	[p8l1810t3110r2141b3178],
4	evening	NN	TIME	evening	nn	5	SENT_144	[p8l10t3223r308b3308],
5	PEF	NN	O	pef	dobj	3	SENT_144	[p8l377t3223r548b3296],
6	,	,	O	,	_	0	SENT_144	[p8l377t3223r548b3296],
7	peak	NN	O	peak	nn	9	SENT_144	[p8l617t3218r795b3307],
8	ﬂow	NN	O	ﬂow	nn	9	SENT_144	[p8l859t3218r1020b3286],
9	variability	NN	O	variability	appos	5	SENT_144	[p8l1082t3218r1459b3308],
10	(	CD	NUMBER	(	number	11	SENT_144	[p8l1528t3223r1873b3308],
11	[	CD	NUMBER	[	num	16	SENT_144	[p8l1528t3223r1873b3308],
12	evening	NN	TIME	evening	nn	16	SENT_144	[p8l1528t3223r1873b3308],
13	PEF	NN	O	pef	nn	16	SENT_144	[p8l1943t3223r2142b3285],
14	—	CD	NUMBER	—	num	16	SENT_144	[p8l1943t3223r2142b3285],
15	morning	NN	TIME	morning	nn	16	SENT_144	[p8l9t3332r343b3417],
16	PEF	NN	O	pef	dep	9	SENT_144	[p8l385t3332r900b3417],
17	]	CD	NUMBER	]	dobj	44	SENT_144	[p8l385t3332r900b3417],
18	/	:	O	/	punct	21	SENT_144	[p8l385t3332r900b3417],
19	evening	NN	TIME	evening	nn	21	SENT_144	[p8l385t3332r900b3417],
20	PEF	NN	O	pef	nn	21	SENT_144	[p8l943t3332r1142b3417],
21	)	NN	O	)	dep	17	SENT_144	[p8l943t3332r1142b3417],
22	,	,	O	,	_	0	SENT_144	[p8l943t3332r1142b3417],
23	FEV1	NN	O	fev1	appos	21	SENT_144	[p8l1188t3332r1383b3412],
24	,	,	O	,	_	0	SENT_144	[p8l1188t3332r1383b3412],
25	airway	NN	O	airway	nn	27	SENT_144	[p8l1426t3332r1672b3417],
26	responsiveness	NN	O	responsiveness	nn	27	SENT_144	[p8l1709t3332r2138b3416, p8l8t3460r174b3504],
27	(	NN	O	(	appos	21	SENT_144	[p8l231t3436r774b3526],
28	methacholine	NN	O	methacholine	nn	30	SENT_144	[p8l231t3436r774b3526],
29	PCZO	NN	O	pczo	nn	30	SENT_144	[p8l828t3441r1029b3526],
30	)	NN	O	)	nsubj	44	SENT_144	[p8l828t3441r1029b3526],
31	,	,	O	,	_	0	SENT_144	[p8l828t3441r1029b3526],
32	bronchodilator	NN	O	bronchodilator	nn	33	SENT_144	[p8l1079t3436r1646b3504],
33	reversibility	NN	O	reversibility	appos	30	SENT_144	[p8l1693t3436r2142b3526],
34	with	IN	O	with	_	0	SENT_144	[p8l7t3547r174b3615],
35	four	CD	NUMBER	four	num	36	SENT_144	[p8l222t3547r382b3615],
36	puﬁ	NN	O	puﬁ	prep_with	33	SENT_144	[p8l429t3547r620b3636],
37	's	POS	O	's	possessive	36	SENT_144	[p8l429t3547r620b3636],
38	of	IN	O	of	_	0	SENT_144	[p8l672t3547r755b3615],
39	either	CC	O	either	preconj	40	SENT_144	[p8l792t3547r1013b3615],
40	ipratropium	NN	O	ipratropium	prep_of	36	SENT_144	[p8l1060t3551r1522b3636],
41	or	CC	O	or	_	0	SENT_144	[p8l1572t3571r1649b3615],
42	salbutamol	NN	O	salbutamol	conj_or	40	SENT_144	[p8l1698t3547r2136b3625],
43	,	,	O	,	_	0	SENT_144	[p8l1698t3547r2136b3625],
44	exhaled	VBD	O	exhale	rcmod	5	SENT_144	[p8l9t3656r297b3725],
45	nitric	JJ	O	nitric	amod	47	SENT_144	[p8l335t3661r537b3725],
46	oxide	NN	O	oxide	nn	47	SENT_144	[p8l577t3656r773b3725],
47	concentration	NN	O	concentration	dobj	44	SENT_144	[p8l815t3661r1358b3735],
48	,	,	O	,	_	0	SENT_144	[p8l815t3661r1358b3735],
49	and	CC	O	and	_	0	SENT_144	[p8l1402t3656r1541b3725],
50	pH	NN	O	ph	conj_and	5	SENT_144	[p8l1578t3663r1696b3745],
51	in	IN	O	in	_	0	SENT_144	[p8l1739t3661r1814b3723],
52	exhaled	VBN	O	exhale	amod	54	SENT_144	[p8l1854t3656r2141b3725],
53	breath	NN	O	breath	nn	54	SENT_144	[p9l7t17r250b85],
54	condensate	NN	O	condensate	prep_in	50	SENT_144	[p9l285t17r731b95],
55	,	,	O	,	_	0	SENT_144	[p9l285t17r731b95],
56	as	IN	O	as	mark	57	SENT_144	[p9l770t41r843b85],
57	described	VBN	O	describe	dep	54	SENT_144	[p9l880t17r1244b85],
58	elsewhere	RB	O	elsewhere	advmod	57	SENT_144	[p9l1278t17r1719b85],
59	.	.	O	.	_	0	SENT_144	[p9l1278t17r1719b85],

1	”	NN	O	”	nn	3	SENT_145	[p9l1278t17r1719b85],
2	Genotypespeciﬁc	NN	O	genotypespeciﬁc	nn	3	SENT_145	[p9l1755t22r2138b106, p9l11t128r292b217],
3	outcomes	NNS	O	outcome	nsubjpass	5	SENT_145	[p9l326t141r690b196],
4	were	VBD	O	be	auxpass	5	SENT_145	[p9l724t152r904b196],
5	examined	VBN	O	examine	_	0	SENT_145	[p9l939t128r1308b196],
6	after	IN	O	after	_	0	SENT_145	[p9l1341t128r1512b196],
7	stratiﬁcation	NN	O	stratiﬁcation	prep_after	5	SENT_145	[p9l1546t128r2023b196],
8	by	IN	O	by	_	0	SENT_145	[p9l2054t128r2142b217],
9	sex	NN	O	sex	agent	5	SENT_145	[p9l11t261r127b304],
10	and	CC	O	and	_	0	SENT_145	[p9l178t236r318b304],
11	ethnic	JJ	O	ethnic	amod	12	SENT_145	[p9l370t236r605b304],
12	origin	NN	O	origin	agent	5	SENT_145	[p9l658t241r904b326],
13	.	.	O	.	_	0	SENT_145	[p9l658t241r904b326],

1	The	DT	O	the	det	4	SENT_146	[p9l959t236r1104b304],
2	asthma	NN	O	asthma	nn	4	SENT_146	[p9l1158t236r1434b304],
3	control	NN	O	control	nn	4	SENT_146	[p9l1488t236r1754b304],
4	variables	NNS	O	variable	nsubj	10	SENT_146	[p9l1804t236r2137b305],
5	analysed	VBN	O	analyse	partmod	4	SENT_146	[p9l10t345r336b434],
6	were	VBD	O	be	cop	10	SENT_146	[p9l373t369r553b413],
7	mean	JJ	O	mean	amod	10	SENT_146	[p9l593t369r807b413],
8	daily	JJ	SET	daily	amod	10	SENT_146	[p9l847t345r1026b434],
9	symptom	NN	O	symptom	nn	10	SENT_146	[p9l1066t358r1422b434],
10	scores	NNS	O	score	_	0	SENT_146	[p9l1464t369r1694b413],
11	(	RB	O	(	advmod	12	SENT_146	[p9l1742t345r2141b435],
12	measured	VBN	O	measure	partmod	10	SENT_146	[p9l1742t345r2141b435],
13	on	IN	O	on	_	0	SENT_146	[p9l10t479r104b523],
14	a	DT	O	a	det	15	SENT_146	[p9l152t479r189b523],
15	scale	NN	O	scale	prep_on	12	SENT_146	[p9l238t455r418b523],
16	from	IN	O	from	_	0	SENT_146	[p9l465t454r652b523],
17	o	NN	O	o	npadvmod	19	SENT_146	[p9l700t461r740b523],
18	[	CD	NUMBER	[	num	17	SENT_146	[p9l792t455r1077b543],
19	absent	JJ	O	absent	amod	20	SENT_146	[p9l792t455r1077b543],
20	]	NN	O	]	prep_from	12	SENT_146	[p9l792t455r1077b543],
21	to	TO	O	to	dep	20	SENT_146	[p9l1127t468r1197b523],
22	3	CD	NUMBER	3	number	23	SENT_146	[p9l1249t461r1283b523],
23	[	CD	NUMBER	[	num	26	SENT_146	[p9l1339t461r1665b544],
24	severe	JJ	O	severe	amod	26	SENT_146	[p9l1339t461r1665b544],
25	]	NN	O	]	nn	26	SENT_146	[p9l1339t461r1665b544],
26	)	NN	O	)	dep	20	SENT_146	[p9l1339t461r1665b544],
27	,	,	O	,	_	0	SENT_146	[p9l1339t461r1665b544],
28	number	NN	O	number	conj_and	20	SENT_146	[p9l1715t455r2022b523],
29	of	IN	O	of	_	0	SENT_146	[p9l2069t454r2153b523],
30	actuations	NNS	O	actuation	prep_of	28	SENT_146	[p9l10t568r395b631],
31	of	IN	O	of	_	0	SENT_146	[p9l424t563r508b631],
32	rescue	NN	O	rescue	prep_of	30	SENT_146	[p9l519t588r763b631],
33	MDI	NNP	O	MDI	nn	35	SENT_146	[p9l792t570r964b630],
34	(	CD	NUMBER	(	num	35	SENT_146	[p9l999t568r1503b653],
35	ipratropium	NN	O	ipratropium	nsubj	46	SENT_146	[p9l999t568r1503b653],
36	,	,	O	,	_	0	SENT_146	[p9l999t568r1503b653],
37	salbutamol	NN	O	salbutamol	nsubj	46	SENT_146	[p9l1534t563r1972b641],
38	,	,	O	,	_	0	SENT_146	[p9l1534t563r1972b641],
39	and	CC	O	and	_	0	SENT_146	[p9l2002t563r2141b631],
40	the	DT	O	the	det	42	SENT_146	[p9l7t672r125b740],
41	combined	JJ	O	combined	amod	42	SENT_146	[p9l161t672r540b740],
42	total	NN	O	total	nsubj	46	SENT_146	[p9l572t672r737b740],
43	during	IN	O	during	_	0	SENT_146	[p9l773t672r1028b762],
44	treatment	NN	O	treatment	nn	45	SENT_146	[p9l1060t685r1435b740],
45	periods	NNS	O	period	prep_during	42	SENT_146	[p9l1467t672r1796b762],
46	)	VBP	O	)	rcmod	28	SENT_146	[p9l1467t672r1796b762],
47	,	,	O	,	_	0	SENT_146	[p9l1467t672r1796b762],
48	number	NN	O	number	conj_and	20	SENT_146	[p9l1834t672r2141b740],
49	of	IN	O	of	_	0	SENT_146	[p9l10t782r93b851],
50	exacerbations	NNS	O	exacerbation	prep_of	48	SENT_146	[p9l152t783r687b861],
51	,	,	O	,	_	0	SENT_146	[p9l152t783r687b861],
52	and	CC	O	and	_	0	SENT_146	[p9l761t783r900b851],
53	episodes	NNS	O	episode	conj_and	20	SENT_146	[p9l971t783r1294b871],
54	of	IN	O	of	_	0	SENT_146	[p9l1368t782r1452b851],
55	adverse	JJ	O	adverse	amod	57	SENT_146	[p9l1510t783r1792b851],
56	asthma	NN	O	asthma	nn	57	SENT_146	[p9l1863t782r2140b851],
57	control	NN	O	control	prep_of	53	SENT_146	[p9l9t891r294b959],
58	.	.	O	.	_	0	SENT_146	[p9l9t891r294b959],

1	Variables	NNS	O	variable	nsubj	9	SENT_147	[p9l335t891r681b960],
2	measured	VBN	O	measure	partmod	1	SENT_147	[p9l721t891r1098b959],
3	daily	RB	SET	daily	advmod	2	SENT_147	[p9l1135t891r1314b981],
4	from	IN	O	from	_	0	SENT_147	[p9l1350t891r1536b959],
5	the	DT	O	the	det	8	SENT_147	[p9l1572t891r1690b959],
6	participant	NN	O	participant	nn	8	SENT_147	[p9l1728t896r2141b980],
7	diary	NN	O	diary	nn	8	SENT_147	[p9l10t1000r198b1089],
8	cards	NNS	O	card	prep_from	2	SENT_147	[p9l226t1000r622b1090],
9	—	VBP	O	—	ccomp	17	SENT_147	[p9l226t1000r622b1090],
10	eg	FW	O	eg	dobj	9	SENT_147	[p9l226t1000r622b1090],
11	,	,	O	,	_	0	SENT_147	[p9l226t1000r622b1090],
12	PEF	NN	O	pef	nn	15	SENT_147	[p9l660t1004r808b1067],
13	and	CC	O	and	_	0	SENT_147	[p9l842t1000r981b1068],
14	PEF	NN	O	pef	nn	15	SENT_147	[p9l1014t1004r1162b1067],
15	variability	NN	O	variability	nsubjpass	21	SENT_147	[p9l1193t1000r1570b1089],
16	were	VBD	O	be	auxpass	17	SENT_147	[p9l1596t1024r1776b1068],
17	averaged	VBN	O	average	_	0	SENT_147	[p9l1808t1000r2141b1090],
18	between	IN	O	between	_	0	SENT_147	[p9l7t1110r323b1178],
19	visits	NNS	O	visit	prep_between	17	SENT_147	[p9l381t1114r573b1178],
20	and	CC	O	and	_	0	SENT_147	[p9l637t1110r776b1178],
21	weighted	VBN	O	weight	conj_and	17	SENT_147	[p9l833t1110r1180b1199],
22	by	IN	O	by	_	0	SENT_147	[p9l1237t1110r1324b1199],
23	the	DT	O	the	det	24	SENT_147	[p9l1381t1110r1499b1178],
24	inverse	NN	O	inverse	prep_by	21	SENT_147	[p9l1559t1114r1831b1178],
25	of	IN	O	of	_	0	SENT_147	[p9l1892t1109r1976b1178],
26	the	DT	O	the	det	28	SENT_147	[p9l2021t1110r2139b1178],
27	squared	VBN	O	square	amod	28	SENT_147	[p9l11t1218r310b1307],
28	SE	NN	O	se	prep_of	24	SENT_147	[p9l351t1223r465b1286],
29	.	.	O	.	_	0	SENT_147	[p9l351t1223r465b1286],

1	The	DT	O	the	det	2	SENT_148	[p9l504t1218r649b1286],
2	purpose	NN	O	purpose	nsubj	11	SENT_148	[p9l686t1242r992b1307],
3	of	IN	O	of	_	0	SENT_148	[p9l1031t1218r1114b1286],
4	the	DT	O	the	det	6	SENT_148	[p9l1137t1218r1255b1286],
5	weighting	NN	O	weighting	nn	6	SENT_148	[p9l1290t1218r1671b1308],
6	scheme	NN	O	scheme	prep_of	2	SENT_148	[p9l1710t1218r1996b1286],
7	for	IN	O	for	_	0	SENT_148	[p9l2033t1218r2141b1286],
8	diary	NN	O	diary	nn	10	SENT_148	[p9l9t1328r198b1417],
9	card	NN	O	card	nn	10	SENT_148	[p9l234t1328r395b1395],
10	data	NNS	O	datum	prep_for	6	SENT_148	[p9l433t1328r587b1395],
11	was	VBD	O	be	_	0	SENT_148	[p9l622t1352r762b1395],
12	to	TO	O	to	aux	13	SENT_148	[p9l802t1341r871b1395],
13	assign	VB	O	assign	xcomp	11	SENT_148	[p9l911t1332r1150b1418],
14	greater	JJR	O	greater	amod	15	SENT_148	[p9l1188t1341r1454b1418],
15	weight	NN	O	weight	dobj	13	SENT_148	[p9l1488t1328r1745b1418],
16	to	TO	O	to	_	0	SENT_148	[p9l1780t1341r1850b1395],
17	means	NNS	O	means	prep_to	13	SENT_148	[p9l1888t1352r2137b1395],
18	measured	VBN	O	measure	partmod	17	SENT_148	[p9l8t1438r385b1506],
19	with	IN	O	with	_	0	SENT_148	[p9l411t1438r579b1506],
20	low	JJ	O	low	amod	21	SENT_148	[p9l606t1438r741b1506],
21	variability	NN	O	variability	prep_with	18	SENT_148	[p9l766t1438r1143b1527],
22	and	CC	O	and	_	0	SENT_148	[p9l1171t1438r1310b1506],
23	less	JJR	O	less	amod	24	SENT_148	[p9l1337t1438r1476b1506],
24	weight	NN	O	weight	conj_and	21	SENT_148	[p9l1505t1438r1762b1527],
25	to	TO	O	to	_	0	SENT_148	[p9l1789t1451r1859b1506],
26	means	NNS	O	means	prep_to	18	SENT_148	[p9l1888t1462r2137b1506],
27	measured	VBN	O	measure	partmod	26	SENT_148	[p9l8t1546r385b1614],
28	with	IN	O	with	_	0	SENT_148	[p9l409t1546r577b1614],
29	high	JJ	O	high	amod	30	SENT_148	[p9l603t1546r775b1636],
30	variability	NN	O	variability	prep_with	27	SENT_148	[p9l800t1546r1187b1635],
31	.	.	O	.	_	0	SENT_148	[p9l800t1546r1187b1635],

1	Statistical	JJ	O	statistical	dep	100	SENT_149	[p9l10t1765r385b1834],
2	analysis	NN	O	analysis	dep	100	SENT_149	[p9l410t1765r708b1855],
3	With	IN	O	with	dep	100	SENT_149	[p9l7t1874r193b1943],
4	the	DT	O	the	dep	100	SENT_149	[p9l223t1874r342b1942],
5	SD	NN	O	sd	dep	100	SENT_149	[p9l380t1880r487b1942],
6	of	IN	O	of	dep	100	SENT_149	[p9l522t1874r607b1942],
7	the	DT	O	the	dep	100	SENT_149	[p9l624t1874r742b1942],
8	primary	JJ	O	primary	dep	100	SENT_149	[p9l775t1879r1082b1964],
9	comparison	NN	O	comparison	dep	100	SENT_149	[p9l1113t1879r1566b1963],
10	of	IN	O	of	dep	100	SENT_149	[p9l1598t1874r1683b1942],
11	interest	NN	O	interest	dep	100	SENT_149	[p9l1701t1879r1993b1942],
12	(	CD	NUMBER	(	dep	100	SENT_149	[p9l2029t1879r2136b1964],
13	ie	FW	O	ie	dep	100	SENT_149	[p9l2029t1879r2136b1964],
14	,	,	O	,	_	0	SENT_149	[p9l2029t1879r2136b1964],
15	comparing	VBG	O	compare	dep	100	SENT_149	[p9l9t1988r424b2073],
16	the	DT	O	the	dep	100	SENT_149	[p9l481t1983r600b2051],
17	estimate	NN	O	estimate	dep	100	SENT_149	[p9l660t1988r983b2051],
18	at	IN	O	at	dep	100	SENT_149	[p9l1043t1996r1109b2051],
19	the	DT	O	the	dep	100	SENT_149	[p9l1165t1983r1284b2051],
20	end	NN	O	end	dep	100	SENT_149	[p9l1345t1983r1485b2051],
21	of	IN	O	of	dep	100	SENT_149	[p9l1544t1983r1628b2051],
22	the	DT	O	the	dep	100	SENT_149	[p9l1673t1983r1791b2051],
23	placebo	NN	O	placebo	dep	100	SENT_149	[p9l1850t1983r2139b2072],
24	treatment	NN	O	treatment	dep	100	SENT_149	[p9l7t2107r385b2162],
25	period	NN	O	period	dep	100	SENT_149	[p9l427t2094r672b2183],
26	with	IN	O	with	dep	100	SENT_149	[p9l712t2094r881b2162],
27	the	DT	O	the	dep	100	SENT_149	[p9l922t2094r1041b2162],
28	estimate	NN	O	estimate	dep	100	SENT_149	[p9l1086t2098r1409b2162],
29	at	IN	O	at	dep	100	SENT_149	[p9l1454t2107r1520b2162],
30	the	DT	O	the	dep	100	SENT_149	[p9l1560t2094r1679b2162],
31	end	NN	O	end	dep	100	SENT_149	[p9l1724t2094r1864b2162],
32	of	IN	O	of	dep	100	SENT_149	[p9l1907t2094r1992b2162],
33	the	DT	O	the	dep	100	SENT_149	[p9l2020t2094r2139b2162],
34	salmeterol	NN	O	salmeterol	dep	100	SENT_149	[p9l11t2203r410b2271],
35	treatment	NN	O	treatment	dep	100	SENT_149	[p9l448t2217r826b2271],
36	period	NN	O	period	dep	100	SENT_149	[p9l864t2203r1131b2293],
37	)	CD	NUMBER	)	dep	100	SENT_149	[p9l864t2203r1131b2293],
38	with	IN	O	with	dep	100	SENT_149	[p9l1175t2203r1343b2271],
39	respect	NN	O	respect	dep	100	SENT_149	[p9l1382t2217r1655b2292],
40	to	TO	O	to	dep	100	SENT_149	[p9l1692t2217r1762b2271],
41	morning	NN	TIME	morning	dep	100	SENT_149	[p9l1803t2208r2140b2293],
42	PEF	NN	O	pef	dep	100	SENT_149	[p9l13t2317r162b2380],
43	from	IN	O	from	dep	100	SENT_149	[p9l221t2313r408b2381],
44	the	DT	O	the	dep	100	SENT_149	[p9l463t2313r581b2381],
45	ACRN	NNP	O	ACRN	dep	100	SENT_149	[p9l636t2318r880b2381],
46	BARGE	NNP	O	BARGE	dep	100	SENT_149	[p9l943t2317r1232b2381],
47	trial	NN	O	trial	dep	100	SENT_149	[p9l1290t2313r1442b2381],
48	(	CD	NUMBER	(	dep	100	SENT_149	[p9l1504t2319r1614b2403],
49	24	CD	NUMBER	24	dep	100	SENT_149	[p9l1504t2319r1614b2403],
50	L/min	NN	O	l/min	dep	100	SENT_149	[p9l1670t2318r1982b2403],
51	)	CD	NUMBER	)	dep	100	SENT_149	[p9l1670t2318r1982b2403],
52	,6	CD	NUMBER	,6	dep	100	SENT_149	[p9l1670t2318r1982b2403],
53	we	PRP	O	we	dep	100	SENT_149	[p9l2036t2337r2139b2381],
54	calculated	VBD	O	calculate	dep	100	SENT_149	[p9l9t2424r390b2492],
55	that	IN	O	that	dep	100	SENT_149	[p9l440t2424r588b2492],
56	a	DT	O	a	dep	100	SENT_149	[p9l640t2448r677b2492],
57	sample	NN	O	sample	dep	100	SENT_149	[p9l731t2424r1002b2513],
58	size	NN	O	size	dep	100	SENT_149	[p9l1057t2428r1200b2492],
59	of	IN	O	of	dep	100	SENT_149	[p9l1254t2424r1338b2492],
60	24	CD	NUMBER	24	dep	100	SENT_149	[p9l1380t2430r1464b2491],
61	participants	NNS	O	participant	dep	100	SENT_149	[p9l1511t2428r1963b2513],
62	per	IN	O	per	dep	100	SENT_149	[p9l2017t2448r2141b2513],
63	genotype	NN	O	genotype	dep	100	SENT_149	[p9l10t2546r353b2622],
64	was	VBD	O	be	dep	100	SENT_149	[p9l374t2557r515b2600],
65	required	VBN	O	require	dep	100	SENT_149	[p9l540t2532r867b2621],
66	to	TO	O	to	dep	100	SENT_149	[p9l887t2546r957b2600],
67	detect	VB	O	detect	dep	100	SENT_149	[p9l982t2532r1207b2600],
68	a	DT	O	a	dep	100	SENT_149	[p9l1229t2557r1266b2600],
69	difference	NN	O	difference	dep	100	SENT_149	[p9l1290t2532r1672b2600],
70	of	IN	O	of	dep	100	SENT_149	[p9l1696t2532r1780b2600],
71	25	CD	NUMBER	25	dep	100	SENT_149	[p9l1792t2537r1873b2600],
72	L	NN	O	l	dep	100	SENT_149	[p9l1904t2539r1977b2621],
73	/	:	O	/	dep	100	SENT_149	[p9l1904t2539r1977b2621],
74	min	NN	DURATION	min	dep	100	SENT_149	[p9l1984t2537r2140b2599],
75	between	IN	O	between	dep	100	SENT_149	[p9l7t2641r326b2709],
76	Arg/Arg	NN	O	arg/arg	dep	100	SENT_149	[p9l365t2646r686b2731],
77	and	CC	O	and	dep	100	SENT_149	[p9l727t2641r867b2709],
78	Gly/Gly	NN	O	gly/gly	dep	100	SENT_149	[p9l909t2641r1209b2730],
79	with	IN	O	with	dep	100	SENT_149	[p9l1246t2641r1415b2709],
80	a	DT	O	a	dep	100	SENT_149	[p9l1456t2665r1493b2709],
81	two-sided	JJ	O	two-sided	dep	100	SENT_149	[p9l1532t2641r1919b2719],
82	,	,	O	,	_	0	SENT_149	[p9l1532t2641r1919b2719],
83	O-O5	NN	O	o-o5	dep	100	SENT_149	[p9l1964t2645r2136b2709],
84	signiﬁcance	NN	O	signiﬁcance	dep	100	SENT_149	[p9l11t2750r466b2840],
85	level	NN	O	level	dep	100	SENT_149	[p9l537t2751r710b2819],
86	test	NN	O	test	dep	100	SENT_149	[p9l781t2764r935b2829],
87	,	,	O	,	_	0	SENT_149	[p9l781t2764r935b2829],
88	90	CD	PERCENT	90	dep	100	SENT_149	[p9l1012t2755r1174b2822],
89	%	NN	PERCENT	%	dep	100	SENT_149	[p9l1012t2755r1174b2822],
90	statistical	JJ	O	statistical	dep	100	SENT_149	[p9l1250t2751r1606b2819],
91	power	NN	O	power	dep	100	SENT_149	[p9l1678t2775r1924b2839],
92	,	,	O	,	_	0	SENT_149	[p9l1678t2775r1924b2839],
93	and	CC	O	and	dep	100	SENT_149	[p9l2001t2751r2141b2819],
94	accounting	NN	O	accounting	dep	100	SENT_149	[p9l10t2864r432b2949],
95	for	IN	O	for	dep	100	SENT_149	[p9l469t2859r577b2927],
96	a	DT	O	a	dep	100	SENT_149	[p9l614t2884r651b2927],
97	15	CD	PERCENT	15	dep	100	SENT_149	[p9l690t2864r843b2930],
98	%	NN	PERCENT	%	dep	100	SENT_149	[p9l690t2864r843b2930],
99	dropout	NN	O	dropout	dep	100	SENT_149	[p9l882t2859r1184b2948],
100	rate	NN	O	rate	_	0	SENT_149	[p9l1219t2873r1382b2927],
101	.	.	O	.	_	0	SENT_149	[p9l1219t2873r1382b2927],

1	However	RB	O	however	_	0	SENT_150	[p9l1427t2866r1777b2937],
2	,	,	O	,	_	0	SENT_150	[p9l1427t2866r1777b2937],
3	to	TO	O	to	dep	1	SENT_150	[p9l1816t2873r1886b2927],
4	attain	VB	O	attain	dep	3	SENT_150	[p9l1926t2864r2140b2927],
5	www	NN	O	www	dobj	4	SENT_150	[p9l7t3129r540b3180],
6	.	.	O	.	_	0	SENT_150	[p9l7t3129r540b3180],

1	the	DT	O	the	det	2	SENT_151	[p9l7t3129r540b3180],
2	|	NN	O	|	_	0	SENT_151	[p9l7t3129r540b3180],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_151	[p9l7t3129r540b3180],
4	Vol	NNP	O	Vol	dep	2	SENT_151	[p9l583t3129r670b3180],
5	374	CD	NUMBER	374	num	4	SENT_151	[p9l690t3136r792b3188],
6	November	NNP	DATE	November	tmod	4	SENT_151	[p9l840t3129r1132b3180],
7	21	CD	DATE	21	num	6	SENT_151	[p9l1150t3136r1230b3189],
8	,	,	DATE	,	_	0	SENT_151	[p9l1150t3136r1230b3189],
9	2009	CD	DATE	2009	num	6	SENT_151	[p9l1249t3136r1394b3188],

1	474	CD	NUMBER	474	num	2	SENT_152	[p10l728t134r794b167],
2	patients	NNS	O	patient	nsubj	3	SENT_152	[p10l804t132r946b173],
3	screened	VBN	O	screen	_	0	SENT_152	[p10l957t130r1108b163],

1	229	CD	NUMBER	229	_	0	SENT_153	[p10l1324t302r1389b336],
2	ineligible	JJ	O	ineligible	amod	3	SENT_153	[p10l1403t298r1558b342],
3	genotype	NN	O	genotype	dep	1	SENT_153	[p10l1569t304r1733b342],

1	(	NN	O	(	nn	3	SENT_154	[p10l1402t353r1559b397],
2	Arg/Gly	NN	O	arg/gly	nn	3	SENT_154	[p10l1402t353r1559b397],
3	)	NN	O	)	_	0	SENT_154	[p10l1402t353r1559b397],
4	1	CD	NUMBER	1	num	6	SENT_154	[p10l1370t412r1387b441],
5	indeterminate	JJ	O	indeterminate	amod	6	SENT_154	[p10l1400t408r1647b441],
6	genotype	NN	O	genotype	dep	3	SENT_154	[p10l1659t414r1823b452],

1	78	CD	NUMBER	78	num	3	SENT_155	[p10l98t659r141b697],
2	Arg/Arg	NN	O	arg/arg	nn	3	SENT_155	[p10l152t660r289b703],
3	genotype	NN	O	genotype	_	0	SENT_155	[p10l302t665r466b703],
4	166	CD	NUMBER	166	num	6	SENT_155	[p10l1147t659r1214b693],
5	Gly/Gly	NNP	O	Gly/Gly	nn	6	SENT_155	[p10l1226t659r1350b703],
6	genotype	NN	O	genotype	dep	3	SENT_155	[p10l1360t665r1524b703],

1	31	CD	NUMBER	31	nsubj	5	SENT_156	[p10l274t834r314b867],
2	dropped	VBD	O	drop	partmod	1	SENT_156	[p10l325t829r471b873],
3	out	RP	O	out	prt	2	SENT_156	[p10l481t835r540b862],
4	119	CD	NUMBER	119	dobj	2	SENT_156	[p10l1324t834r1386b867],
5	dropped	VBD	O	drop	_	0	SENT_156	[p10l1398t829r1543b873],
6	out	RP	O	out	prt	5	SENT_156	[p10l1554t835r1613b862],

1	2	CD	NUMBER	2	num	2	SENT_157	[p10l342t888r359b917],
2	study	NN	O	study	nsubj	3	SENT_157	[p10l372t884r468b927],
3	ended	VBD	O	end	_	0	SENT_157	[p10l478t884r593b923],
4	;	:	O	;	_	0	SENT_157	[p10l478t884r593b923],
5	no	DT	O	no	det	8	SENT_157	[p10l607t895r649b917],
6	match	NN	O	match	nn	8	SENT_157	[p10l662t884r769b917],
7	26	CD	NUMBER	26	num	8	SENT_157	[p10l1402t884r1444b917],
8	study	NN	O	study	nsubj	9	SENT_157	[p10l1457t884r1552b927],
9	ended	VBD	O	end	parataxis	3	SENT_157	[p10l1562t884r1678b923],
10	;	:	O	;	_	0	SENT_157	[p10l1562t884r1678b923],
11	no	DT	O	no	det	12	SENT_157	[p10l1692t895r1734b917],
12	match	NN	O	match	nsubj	26	SENT_157	[p10l1747t884r1853b917],
13	9	CD	NUMBER	9	nsubj	14	SENT_157	[p10l342t943r362b977],
14	withdrew	VBD	O	withdraw	rcmod	12	SENT_157	[p10l373t939r540b972],
15	consent	NN	O	consent	nsubj	17	SENT_157	[p10l550t945r688b972],
16	42	CD	NUMBER	42	num	15	SENT_157	[p10l1401t943r1443b977],
17	withdrew	VBD	O	withdraw	ccomp	14	SENT_157	[p10l1454t939r1622b972],
18	consent	NN	O	consent	nsubj	20	SENT_157	[p10l1632t945r1769b972],
19	1	CD	NUMBER	1	num	18	SENT_157	[p10l342t998r359b1027],
20	lost	VBD	O	lose	ccomp	17	SENT_157	[p10l372t994r433b1027],
21	to	TO	O	to	aux	22	SENT_157	[p10l442t1000r479b1027],
22	follow	VB	O	follow	xcomp	20	SENT_157	[p10l489t993r659b1037],
23	—	RB	O	—	advmod	22	SENT_157	[p10l489t993r659b1037],
24	up	RB	O	up	advmod	22	SENT_157	[p10l489t993r659b1037],
25	11	CD	NUMBER	11	pobj	24	SENT_157	[p10l1401t998r1440b1027],
26	lost	VBD	O	lose	parataxis	9	SENT_157	[p10l1453t994r1514b1027],
27	to	TO	O	to	aux	28	SENT_157	[p10l1522t1000r1559b1027],
28	follow	VB	O	follow	xcomp	26	SENT_157	[p10l1569t993r1739b1037],
29	—	RB	O	—	advmod	28	SENT_157	[p10l1569t993r1739b1037],
30	up	RB	O	up	advmod	29	SENT_157	[p10l1569t993r1739b1037],
31	11	CD	NUMBER	11	pobj	29	SENT_157	[p10l324t1053r362b1082],
32	ineligible	JJ	O	ineligible	amod	41	SENT_157	[p10l375t1049r531b1093],
33	25	CD	NUMBER	25	tmod	32	SENT_157	[p10l1402t1053r1442b1087],
34	ineligible	JJ	O	ineligible	amod	41	SENT_157	[p10l1456t1049r1611b1093],
35	4	CD	NUMBER	4	number	36	SENT_157	[p10l341t1108r364b1141],
36	non	JJ	O	non	amod	41	SENT_157	[p10l376t1104r636b1147],
37	—	NN	O	—	nn	41	SENT_157	[p10l376t1104r636b1147],
38	compliant	JJ	O	compliant	amod	41	SENT_157	[p10l376t1104r636b1147],
39	2	CD	NUMBER	2	tmod	38	SENT_157	[p10l1423t1108r1440b1137],
40	non	JJ	O	non	amod	41	SENT_157	[p10l1455t1104r1715b1147],
41	—	NN	O	—	dobj	28	SENT_157	[p10l1455t1104r1715b1147],
42	compliant	JJ	O	compliant	amod	41	SENT_157	[p10l1455t1104r1715b1147],
43	4	CD	NUMBER	4	tmod	42	SENT_157	[p10l341t1163r364b1196],
44	other	JJ	O	other	amod	41	SENT_157	[p10l374t1159r468b1192],
45	10	CD	NUMBER	10	number	46	SENT_157	[p10l1402t1163r1442b1192],
46	other	JJ	O	other	amod	41	SENT_157	[p10l1453t1159r1547b1192],

1	3	CD	NUMBER	3	nsubj	2	SENT_158	[p10l1422t1218r1440b1252],
2	terminated	VBN	O	terminate	_	0	SENT_158	[p10l1450t1214r1646b1247],
3	due	JJ	O	due	acomp	2	SENT_158	[p10l1657t1214r1720b1247],
4	to	TO	O	to	_	0	SENT_158	[p10l1729t1220r1765b1247],
5	genotyping	VBG	O	genotype	prepc_to	3	SENT_158	[p10l1453t1271r1652b1312],
6	error	NN	O	error	dobj	5	SENT_158	[p10l1665t1280r1748b1302],

1	47	CD	NUMBER	47	nsubj	2	SENT_159	[p10l99t1453r142b1486],
2	matched	VBN	O	match	_	0	SENT_159	[p10l155t1449r314b1488],
3	,	,	O	,	_	0	SENT_159	[p10l155t1449r314b1488],
4	enrolled	VBN	O	enrol	conj_and	2	SENT_159	[p10l327t1449r476b1488],
5	,	,	O	,	_	0	SENT_159	[p10l327t1449r476b1488],
6	47	CD	NUMBER	47	dobj	4	SENT_159	[p10l1164t1453r1207b1487],
7	matched	VBN	O	match	dep	6	SENT_159	[p10l1220t1449r1379b1488],
8	,	,	O	,	_	0	SENT_159	[p10l1220t1449r1379b1488],
9	enrolled	VBN	O	enrol	dep	6	SENT_159	[p10l1392t1449r1541b1488],
10	,	,	O	,	_	0	SENT_159	[p10l1392t1449r1541b1488],
11	and	CC	O	and	_	0	SENT_159	[p10l155t1503r219b1537],
12	entered	VBD	O	enter	dep	6	SENT_159	[p10l230t1503r363b1537],
13	run	VBN	O	run	dep	12	SENT_159	[p10l376t1506r480b1537],
14	—	RB	O	—	advmod	13	SENT_159	[p10l376t1506r480b1537],
15	in	IN	O	in	prep	13	SENT_159	[p10l376t1506r480b1537],
16	and	CC	O	and	_	0	SENT_159	[p10l1217t1504r1281b1537],
17	entered	VBD	O	enter	conj_and	2	SENT_159	[p10l1292t1504r1425b1537],
18	run	VBN	O	run	dep	17	SENT_159	[p10l1438t1506r1541b1537],
19	—	RB	O	—	advmod	18	SENT_159	[p10l1438t1506r1541b1537],
20	in	IN	O	in	_	0	SENT_159	[p10l1438t1506r1541b1537],
21	period	NN	O	period	nn	22	SENT_159	[p10l155t1558r266b1602],
22	period	NN	O	period	prep_in	18	SENT_159	[p10l1217t1558r1328b1602],

1	2	CD	NUMBER	2	nsubj	2	SENT_160	[p10l263t1721r280b1750],
2	withdrew	VBD	O	withdraw	_	0	SENT_160	[p10l291t1717r458b1750],
3	consent	NN	O	consent	nsubj	5	SENT_160	[p10l469t1723r606b1750],
4	1	CD	NUMBER	1	num	3	SENT_160	[p10l1339t1722r1356b1750],
5	withdrew	VBD	O	withdraw	ccomp	2	SENT_160	[p10l1366t1717r1533b1750],
6	consent	NN	O	consent	nsubj	8	SENT_160	[p10l1543t1723r1681b1750],
7	1	CD	NUMBER	1	num	6	SENT_160	[p10l263t1776r280b1805],
8	lost	VBD	O	lose	ccomp	5	SENT_160	[p10l293t1772r354b1805],
9	1	CD	NUMBER	1	num	11	SENT_160	[p10l1339t1776r1356b1805],
10	non	JJ	O	non	amod	11	SENT_160	[p10l1370t1772r1629b1815],
11	—	NN	O	—	nsubj	15	SENT_160	[p10l1370t1772r1629b1815],
12	compliant	JJ	O	compliant	amod	15	SENT_160	[p10l1370t1772r1629b1815],
13	2	CD	NUMBER	2	tmod	12	SENT_160	[p10l263t1831r280b1860],
14	non	JJ	O	non	amod	15	SENT_160	[p10l295t1827r555b1870],
15	—	NN	O	—	xcomp	8	SENT_160	[p10l295t1827r555b1870],
16	compliant	JJ	O	compliant	amod	15	SENT_160	[p10l295t1827r555b1870],

1	45rand	NN	O	45rand	nsubj	3	SENT_161	[p10l1164t2007r1426b2046],
2	°	CD	NUMBER	°	num	1	SENT_161	[p10l1164t2007r1426b2046],
3	mised	VBN	O	mise	_	0	SENT_161	[p10l1164t2007r1426b2046],

1	23	CD	NUMBER	23	nsubj	2	SENT_162	[p10l110t2264r150b2297],
2	assigned	VBN	O	assign	_	0	SENT_162	[p10l163t2259r312b2303],
3	salmeterol	NN	O	salmeterol	dobj	2	SENT_162	[p10l323t2259r504b2292],
4	19	CD	NUMBER	19	num	3	SENT_162	[p10l604t2264r646b2297],
5	assigned	VBN	O	assign	partmod	3	SENT_162	[p10l658t2259r808b2303],
6	placebo	NN	O	placebo	dobj	5	SENT_162	[p10l819t2259r952b2302],
7	24	CD	NUMBER	24	num	6	SENT_162	[p10l1157t2264r1201b2297],
8	assigned	VBN	O	assign	partmod	6	SENT_162	[p10l1211t2259r1361b2303],
9	salmeterol	NN	O	salmeterol	dobj	8	SENT_162	[p10l1372t2259r1552b2292],
10	21	CD	NUMBER	21	num	9	SENT_162	[p10l1691t2264r1731b2292],
11	assigned	VBN	O	assign	partmod	9	SENT_162	[p10l1742t2259r1892b2303],
12	placebo	NN	O	placebo	dobj	11	SENT_162	[p10l1903t2259r2036b2302],

1	—	NN	O	—	_	0	SENT_163	[p10l1748t2314r1967b2347],
2	>	JJR	O	>	amod	4	SENT_163	[p10l1748t2314r1967b2347],
3	sa	NN	O	sa	nn	4	SENT_163	[p10l1748t2314r1967b2347],
4	|	NN	O	|	dep	1	SENT_163	[p10l1748t2314r1967b2347],
5	metero	NN	O	metero	nn	7	SENT_163	[p10l1748t2314r1967b2347],
6	|	NN	O	|	nn	7	SENT_163	[p10l1748t2314r1967b2347],
7	sequence	NN	O	sequence	dep	1	SENT_163	[p10l1747t2380r1907b2412],

1	23	CD	NUMBER	23	nsubj	2	SENT_164	[p10l110t2536r150b2570],
2	entered	VBD	O	enter	_	0	SENT_164	[p10l163t2532r296b2565],
3	salmeterol	NN	O	salmeterol	nsubj	5	SENT_164	[p10l307t2532r487b2565],
4	19	CD	NUMBER	19	num	3	SENT_164	[p10l604t2536r646b2569],
5	entered	VBD	O	enter	ccomp	2	SENT_164	[p10l658t2531r791b2565],
6	placebo	NN	O	placebo	nsubj	8	SENT_164	[p10l802t2531r935b2575],
7	24	CD	NUMBER	24	num	6	SENT_164	[p10l1157t2536r1201b2570],
8	entered	VBD	O	enter	ccomp	5	SENT_164	[p10l1211t2532r1344b2565],
9	salmeterol	NN	O	salmeterol	nsubj	11	SENT_164	[p10l1355t2532r1536b2565],
10	21	CD	NUMBER	21	num	9	SENT_164	[p10l1691t2536r1731b2565],
11	entered	VBD	O	enter	ccomp	8	SENT_164	[p10l1742t2532r1875b2565],
12	placebo	NN	O	placebo	nn	15	SENT_164	[p10l1886t2532r2019b2575],
13	period	NN	O	period	nn	15	SENT_164	[p10l162t2587r273b2630],
14	period	NN	O	period	nn	15	SENT_164	[p10l657t2586r767b2630],
15	period	NN	O	period	dobj	11	SENT_164	[p10l1209t2587r1319b2630],
16	period	NN	O	period	tmod	11	SENT_164	[p10l1743t2587r1854b2630],

1	3	CD	NUMBER	3	dep	2	SENT_165	[p10l237t2752r256b2786],
2	withdrew	VBD	O	withdraw	_	0	SENT_165	[p10l266t2748r434b2781],
3	2	CD	NUMBER	2	nsubj	4	SENT_165	[p10l752t2752r770b2780],
4	withdrew	VBD	O	withdraw	ccomp	2	SENT_165	[p10l781t2748r948b2781],
5	consent	NN	O	consent	nsubj	7	SENT_165	[p10l958t2754r1095b2781],
6	1	CD	NUMBER	1	num	5	SENT_165	[p10l1283t2752r1301b2780],
7	withdrew	VBD	O	withdraw	ccomp	4	SENT_165	[p10l1310t2748r1478b2781],
8	consent	NN	O	consent	dobj	7	SENT_165	[p10l267t2809r405b2836],
9	1	CD	NUMBER	1	num	11	SENT_165	[p10l752t2807r769b2835],
10	pregnant	JJ	O	pregnant	amod	11	SENT_165	[p10l781t2809r940b2846],
11	consent	NN	O	consent	nsubj	2	SENT_165	[p10l1308t2809r1445b2836],

1	20	CD	NUMBER	20	nsubj	2	SENT_166	[p10l110t2970r152b2999],
2	entered	VBD	O	enter	_	0	SENT_166	[p10l164t2965r297b2999],
3	ﬁrst	NN	O	ﬁrst	nsubj	5	SENT_166	[p10l307t2965r375b2999],
4	16	CD	NUMBER	16	num	3	SENT_166	[p10l604t2965r646b2999],
5	entered	VBD	O	enter	ccomp	2	SENT_166	[p10l658t2965r791b2999],
6	ﬁrst	NN	O	ﬁrst	nsubj	8	SENT_166	[p10l801t2965r869b2999],
7	23	CD	NUMBER	23	num	6	SENT_166	[p10l1157t2970r1197b3004],
8	entered	VBD	O	enter	ccomp	5	SENT_166	[p10l1209t2965r1342b2999],
9	ﬁrst	NN	O	ﬁrst	nsubj	11	SENT_166	[p10l1352t2965r1420b2999],
10	21	CD	NUMBER	21	num	9	SENT_166	[p10l1691t2970r1731b2998],
11	entered	VBD	O	enter	ccomp	8	SENT_166	[p10l1742t2965r1875b2999],
12	ﬁrst	JJ	O	ﬁrst	amod	14	SENT_166	[p10l1885t2965r1953b2999],
13	run	NN	O	run	nn	14	SENT_166	[p10l168t3027r301b3054],
14	—	NN	O	—	nsubj	17	SENT_166	[p10l168t3027r301b3054],
15	out	IN	O	out	_	0	SENT_166	[p10l168t3027r301b3054],
16	period	NN	O	period	prep_out	14	SENT_166	[p10l311t3020r422b3064],
17	run	VBP	O	run	ccomp	11	SENT_166	[p10l659t3027r791b3054],
18	—	CD	NUMBER	—	nsubj	21	SENT_166	[p10l659t3027r791b3054],
19	out	IN	O	out	_	0	SENT_166	[p10l659t3027r791b3054],
20	period	NN	O	period	prep_out	18	SENT_166	[p10l802t3020r912b3064],
21	run	VBP	O	run	ccomp	17	SENT_166	[p10l1211t3027r1344b3054],
22	—	CD	NUMBER	—	nsubj	25	SENT_166	[p10l1211t3027r1344b3054],
23	out	IN	O	out	_	0	SENT_166	[p10l1211t3027r1344b3054],
24	period	NN	O	period	prep_out	22	SENT_166	[p10l1354t3020r1465b3064],
25	run	VBP	O	run	ccomp	21	SENT_166	[p10l1745t3027r1878b3054],
26	—	CD	NUMBER	—	dobj	25	SENT_166	[p10l1745t3027r1878b3054],
27	out	IN	O	out	_	0	SENT_166	[p10l1745t3027r1878b3054],
28	period	NN	O	period	prep_out	25	SENT_166	[p10l1889t3020r1999b3064],

1	1	CD	NUMBER	1	nsubj	2	SENT_167	[p10l1284t3185r1302b3213],
2	lost	VBN	O	lose	_	0	SENT_167	[p10l1315t3180r1376b3213],
3	to	TO	O	to	aux	4	SENT_167	[p10l1384t3186r1421b3213],
4	follow	VB	O	follow	xcomp	2	SENT_167	[p10l1314t3234r1484b3278],
5	—	CD	NUMBER	—	npadvmod	6	SENT_167	[p10l1314t3234r1484b3278],
6	up	IN	O	up	advmod	4	SENT_167	[p10l1314t3234r1484b3278],

1	20	CD	NUMBER	20	nsubj	2	SENT_168	[p10l110t3397r152b3426],
2	entered	VBD	O	enter	_	0	SENT_168	[p10l164t3392r297b3426],
3	placebo	NN	O	placebo	nsubj	5	SENT_168	[p10l308t3392r441b3436],
4	16	CD	NUMBER	16	num	3	SENT_168	[p10l604t3392r646b3426],
5	entered	VBD	O	enter	ccomp	2	SENT_168	[p10l658t3392r791b3426],
6	salmeterol	NN	O	salmeterol	nsubj	8	SENT_168	[p10l802t3392r983b3426],
7	22	CD	NUMBER	22	num	6	SENT_168	[p10l1157t3397r1197b3426],
8	entered	VBD	O	enter	ccomp	5	SENT_168	[p10l1209t3392r1342b3426],
9	placebo	NN	O	placebo	nsubj	11	SENT_168	[p10l1353t3392r1486b3436],
10	21	CD	NUMBER	21	num	9	SENT_168	[p10l1691t3397r1731b3426],
11	entered	VBD	O	enter	ccomp	8	SENT_168	[p10l1742t3392r1875b3426],
12	salmeterol	NN	O	salmeterol	nn	15	SENT_168	[p10l1886t3392r2067b3426],
13	period	NN	O	period	nn	15	SENT_168	[p10l166t3447r277b3491],
14	period	NN	O	period	nn	15	SENT_168	[p10l660t3447r771b3491],
15	period	NN	O	period	dobj	11	SENT_168	[p10l1212t3447r1323b3491],
16	period	NN	O	period	tmod	11	SENT_168	[p10l1743t3447r1854b3491],

1	1	CD	NUMBER	1	nsubj	2	SENT_169	[p10l752t3612r770b3640],
2	withdrew	VBD	O	withdraw	_	0	SENT_169	[p10l779t3608r947b3641],
3	1	CD	NUMBER	1	nsubj	4	SENT_169	[p10l1278t3612r1295b3640],
4	withdrew	VBD	O	withdraw	ccomp	2	SENT_169	[p10l1305t3608r1472b3641],
5	1	CD	NUMBER	1	nsubj	6	SENT_169	[p10l1817t3612r1835b3640],
6	withdrew	VBD	O	withdraw	ccomp	4	SENT_169	[p10l1844t3608r2011b3641],
7	consent	NN	O	consent	nn	9	SENT_169	[p10l776t3669r913b3696],
8	consent	NN	O	consent	nn	9	SENT_169	[p10l1302t3669r1439b3696],
9	consent	NN	O	consent	dobj	6	SENT_169	[p10l1841t3669r1978b3696],

1	—	NN	O	—	dep	8	SENT_170	[p10l167t2314r339b2357],
2	>	JJR	O	>	amod	3	SENT_170	[p10l167t2314r339b2357],
3	p	NN	O	p	dep	1	SENT_170	[p10l167t2314r339b2357],
4	|	CD	NUMBER	|	num	5	SENT_170	[p10l167t2314r339b2357],
5	acebo	NN	O	acebo	dep	8	SENT_170	[p10l167t2314r339b2357],
6	—	CD	NUMBER	—	num	8	SENT_170	[p10l662t2314r880b2347],
7	>	JJR	O	>	amod	8	SENT_170	[p10l662t2314r880b2347],
8	sa	NN	O	sa	dep	14	SENT_170	[p10l662t2314r880b2347],
9	|	NN	O	|	nn	10	SENT_170	[p10l662t2314r880b2347],
10	metero	NN	O	metero	dep	8	SENT_170	[p10l662t2314r880b2347],
11	|	CD	NUMBER	|	number	12	SENT_170	[p10l662t2314r880b2347],
12	—	CD	NUMBER	—	npadvmod	13	SENT_170	[p10l1214t2314r1385b2357],
13	>	JJR	O	>	amod	10	SENT_170	[p10l1214t2314r1385b2357],
14	p	NN	O	p	dep	19	SENT_170	[p10l1214t2314r1385b2357],
15	|	CD	NUMBER	|	num	14	SENT_170	[p10l1214t2314r1385b2357],
16	acebo	NN	O	acebo	nn	19	SENT_170	[p10l1214t2314r1385b2357],
17	sequence	NN	O	sequence	nn	19	SENT_170	[p10l166t2380r326b2412],
18	sequence	NN	O	sequence	nn	19	SENT_170	[p10l660t2380r820b2412],
19	sequence	NN	O	sequence	_	0	SENT_170	[p10l1212t2380r1373b2412],

1	AU	NN	O	au	_	0	SENT_171	[p11l110t6r153b22],
2	El	NNP	O	El	nn	6	SENT_171	[p11l164t6r190b22],
3	ILCI	NNP	O	ILCI	nn	6	SENT_171	[p11l199t6r249b22],
4	CU	NNP	O	CU	nn	6	SENT_171	[p11l257t6r297b22],
5	DCLUI	NNP	O	DCLUI	nn	6	SENT_171	[p11l308t6r392b22],
6	IU	NNP	O	IU	nsubj	7	SENT_171	[p11l401t6r429b22],
7	run	VB	O	run	rcmod	1	SENT_171	[p11l168t50r301b77],
8	—	CD	NUMBER	—	dobj	7	SENT_171	[p11l168t50r301b77],
9	out	IN	O	out	_	0	SENT_171	[p11l168t50r301b77],
10	period	NN	O	period	prep_out	7	SENT_171	[p11l311t44r422b87],

1	20	CD	NUMBER	20	_	0	SENT_172	[p11l110t430r153b458],
2	completed	VBN	O	complete	dep	1	SENT_172	[p11l164t425r349b469],

1	J.	NNP	O	J.	nn	7	SENT_173	[p11l606t6r643b27],
2	)	NNP	O	)	nn	7	SENT_173	[p11l606t6r643b27],
3	Cl	NNP	MISC	Cl	nn	7	SENT_173	[p11l656t6r682b22],
4	ILCI	NNP	MISC	ILCI	nn	7	SENT_173	[p11l691t6r740b22],
5	CU	NNP	MISC	CU	nn	7	SENT_173	[p11l748t6r789b22],
6	DCLUI	NNP	MISC	DCLUI	nn	7	SENT_173	[p11l800t6r883b22],
7	IU	NNP	O	IU	_	0	SENT_173	[p11l892t6r921b22],
8	run	VB	O	run	dep	7	SENT_173	[p11l659t50r791b77],
9	—	CD	NUMBER	—	dobj	8	SENT_173	[p11l659t50r791b77],
10	out	IN	O	out	_	0	SENT_173	[p11l659t50r791b77],
11	period	NN	O	period	prep_out	8	SENT_173	[p11l802t44r913b87],

1	1	CD	NUMBER	1	nsubj	2	SENT_174	[p11l752t226r769b254],
2	lost	VBN	O	lose	_	0	SENT_174	[p11l782t221r844b255],
3	to	TO	O	to	aux	4	SENT_174	[p11l852t228r889b255],
4	follow	VB	O	follow	xcomp	2	SENT_174	[p11l782t276r952b320],
5	—	CD	NUMBER	—	npadvmod	6	SENT_174	[p11l782t276r952b320],
6	up	IN	O	up	advmod	4	SENT_174	[p11l782t276r952b320],

1	14	CD	NUMBER	14	_	0	SENT_175	[p11l604t430r647b463],
2	completed	VBN	O	complete	dep	1	SENT_175	[p11l658t425r843b469],

1	LJ	NNP	ORGANIZATION	LJ	_	0	SENT_176	[p11l1157t6r1196b22],
2	.	.	O	.	_	0	SENT_176	[p11l1157t6r1196b22],

1	CI	NN	O	ci	_	0	SENT_177	[p11l1208t6r1234b22],
2	ILEI	NNP	O	ILEI	nn	5	SENT_177	[p11l1243t6r1292b22],
3	EU	NNP	O	EU	nn	5	SENT_177	[p11l1300t6r1341b22],
4	DELUI	NNP	O	DELUI	nn	5	SENT_177	[p11l1352t6r1435b22],
5	IU	NNP	O	IU	nsubj	6	SENT_177	[p11l1444t6r1473b22],
6	run	VB	O	run	rcmod	1	SENT_177	[p11l1211t50r1344b77],
7	—	CD	NUMBER	—	dobj	6	SENT_177	[p11l1211t50r1344b77],
8	out	IN	O	out	_	0	SENT_177	[p11l1211t50r1344b77],
9	period	NN	O	period	prep_out	6	SENT_177	[p11l1354t44r1465b87],

1	21	CD	NUMBER	21	_	0	SENT_178	[p11l1157t430r1196b458],
2	completed	VBN	O	complete	dep	1	SENT_178	[p11l1208t425r1393b469],

1	AU	NN	O	au	nn	6	SENT_179	[p11l1691t6r1733b22],
2	CI	NN	O	ci	nn	6	SENT_179	[p11l1745t6r1771b22],
3	ILCI	NN	O	ilci	nn	6	SENT_179	[p11l1780t6r1830b22],
4	CU	NNP	O	CU	nn	6	SENT_179	[p11l1838t6r1878b22],
5	DCLUI	NNP	O	DCLUI	nn	6	SENT_179	[p11l1889t6r1972b22],
6	IU	NNP	O	IU	nsubj	7	SENT_179	[p11l1981t6r2010b22],
7	run	VB	O	run	_	0	SENT_179	[p11l1749t50r1881b77],
8	—	CD	NUMBER	—	dobj	7	SENT_179	[p11l1749t50r1881b77],
9	out	IN	O	out	_	0	SENT_179	[p11l1749t50r1881b77],
10	period	NN	O	period	prep_out	7	SENT_179	[p11l1892t44r2003b87],

1	20	CD	NUMBER	20	_	0	SENT_180	[p11l1691t430r1733b458],
2	completed	VBN	O	complete	dep	1	SENT_180	[p11l1745t425r1930b469],

1	Figure	NN	O	figure	_	0	SENT_181	[p11l8t595r123b640],
2	2	CD	NUMBER	2	num	1	SENT_181	[p11l132t598r166b629],
3	:	:	O	:	_	0	SENT_181	[p11l132t598r166b629],
4	Trial	NN	O	trial	nn	5	SENT_181	[p11l175t593r259b629],
5	proﬁle	NN	O	proﬁle	dep	1	SENT_181	[p11l271t593r399b640],

1	I	PRP	O	I	_	0	SENT_182	[p11l6t878r54b1046],
2	Articles	NNPS	O	Articles	dep	1	SENT_182	[p11l101t1010r251b1046],

1	Arg/Arg	NN	O	arg/arg	nn	3	SENT_183	[p11l984t1302r1142b1348],
2	(	CD	NUMBER	(	num	3	SENT_183	[p11l1155t1303r1285b1346],
3	n	NN	O	n	nsubj	9	SENT_183	[p11l1155t1303r1285b1346],
4	=	JJ	O	=	amod	3	SENT_183	[p11l1155t1303r1285b1346],
5	42	CD	NUMBER	42	tmod	4	SENT_183	[p11l1155t1303r1285b1346],
6	)	CD	NUMBER	)	num	9	SENT_183	[p11l1155t1303r1285b1346],
7	Gly/Gly	NN	O	gly/gly	nn	9	SENT_183	[p11l1426t1301r1569b1347],
8	(	NN	O	(	nn	9	SENT_183	[p11l1580t1303r1710b1346],
9	n	NN	O	n	_	0	SENT_183	[p11l1580t1303r1710b1346],
10	=	JJ	O	=	quantmod	11	SENT_183	[p11l1580t1303r1710b1346],
11	45	CD	NUMBER	45	num	15	SENT_183	[p11l1580t1303r1710b1346],
12	)	NN	O	)	nn	15	SENT_183	[p11l1580t1303r1710b1346],
13	p	NN	O	p	nn	15	SENT_183	[p11l1878t1313r1902b1347],
14	value	NN	O	value	nn	15	SENT_183	[p11l1913t1301r2018b1337],
15	Age	NN	O	age	nsubj	18	SENT_183	[p11l70t1400r142b1444],
16	(	CD	NUMBER	(	num	17	SENT_183	[p11l155t1399r276b1443],
17	years	NNS	NUMBER	year	tmod	15	SENT_183	[p11l155t1399r276b1443],
18	)	VBP	O	)	rcmod	9	SENT_183	[p11l155t1399r276b1443],
19	39	CD	NUMBER	39	number	20	SENT_183	[p11l1006t1401r1052b1438],
20	(	CD	NUMBER	(	dobj	18	SENT_183	[p11l1067t1399r1137b1442],
21	11	CD	NUMBER	11	num	22	SENT_183	[p11l1067t1399r1137b1442],
22	)	NN	O	)	dep	20	SENT_183	[p11l1067t1399r1137b1442],
23	42	CD	NUMBER	42	num	24	SENT_183	[p11l1446t1401r1492b1437],
24	(	CD	NUMBER	(	dep	33	SENT_183	[p11l1507t1399r1578b1442],
25	12	CD	NUMBER	12	num	26	SENT_183	[p11l1507t1399r1578b1442],
26	)	NN	O	)	dep	24	SENT_183	[p11l1507t1399r1578b1442],
27	021	CD	NUMBER	021	number	28	SENT_183	[p11l1883t1398r1981b1432],
28	*	CD	NUMBER	*	dep	26	SENT_183	[p11l1883t1398r1981b1432],
29	Male	NN	O	male	dep	33	SENT_183	[p11l71t1476r159b1511],
30	10	CD	PERCENT	10	num	29	SENT_183	[p11l1009t1481r1053b1511],
31	(	CD	PERCENT	(	num	33	SENT_183	[p11l1067t1478r1175b1521],
32	24	CD	PERCENT	24	num	33	SENT_183	[p11l1067t1478r1175b1521],
33	%	NN	PERCENT	%	dep	20	SENT_183	[p11l1067t1478r1175b1521],
34	)	CD	PERCENT	)	num	36	SENT_183	[p11l1067t1478r1175b1521],
35	16	CD	PERCENT	16	num	36	SENT_183	[p11l1448t1475r1492b1511],
36	(	NN	PERCENT	(	dep	33	SENT_183	[p11l1507t1475r1616b1521],
37	36	CD	PERCENT	36	num	38	SENT_183	[p11l1507t1475r1616b1521],
38	%	NN	PERCENT	%	dep	45	SENT_183	[p11l1507t1475r1616b1521],
39	)	CD	NUMBER	)	num	40	SENT_183	[p11l1507t1475r1616b1521],
40	O-07	NN	O	o-07	dep	38	SENT_183	[p11l1883t1479r1985b1516],
41	'	''	O	'	_	0	SENT_183	[p11l1883t1479r1985b1516],
42	l	NN	O	l	dep	40	SENT_183	[p11l1883t1479r1985b1516],
43	Ethnic	JJ	MISC	ethnic	amod	44	SENT_183	[p11l72t1555r186b1591],
44	origin	NN	O	origin	dep	45	SENT_183	[p11l197t1558r304b1602],
45	White	NNP	O	White	dep	52	SENT_183	[p11l109t1634r220b1670],
46	27	CD	PERCENT	27	num	45	SENT_183	[p11l1011t1639r1054b1674],
47	(	CD	PERCENT	(	num	49	SENT_183	[p11l1067t1634r1179b1679],
48	64	CD	PERCENT	64	num	49	SENT_183	[p11l1067t1634r1179b1679],
49	%	NN	PERCENT	%	dep	45	SENT_183	[p11l1067t1634r1179b1679],
50	)	CD	NUMBER	)	num	52	SENT_183	[p11l1067t1634r1179b1679],
51	31	CD	NUMBER	31	num	52	SENT_183	[p11l1450t1639r1494b1675],
52	(	NN	O	(	dep	55	SENT_183	[p11l1507t1634r1619b1679],
53	69	CD	PERCENT	69	num	54	SENT_183	[p11l1507t1634r1619b1679],
54	%	NN	PERCENT	%	dep	52	SENT_183	[p11l1507t1634r1619b1679],
55	)	CD	NUMBER	)	dep	18	SENT_183	[p11l1507t1634r1619b1679],
56	--	:	O	--	_	0	SENT_183	[p11l1887t1637r1925b1672],
57	i	FW	O	i	dep	58	SENT_183	[p11l1887t1637r1925b1672],
58	African	JJ	MISC	african	parataxis	9	SENT_183	[p11l109t1713r437b1749],
59	.	.	O	.	_	0	SENT_183	[p11l109t1713r437b1749],

1	—	NN	O	—	_	0	SENT_184	[p11l109t1713r437b1749],
2	.	.	O	.	_	0	SENT_184	[p11l109t1713r437b1749],

1	American	JJ	O	american	dep	277	SENT_185	[p11l109t1713r437b1749],
2	9	CD	NUMBER	9	dep	277	SENT_185	[p11l1031t1718r1052b1754],
3	(	NN	O	(	dep	277	SENT_185	[p11l1067t1715r1172b1758],
4	21	CD	PERCENT	21	dep	277	SENT_185	[p11l1067t1715r1172b1758],
5	%	NN	PERCENT	%	dep	277	SENT_185	[p11l1067t1715r1172b1758],
6	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1067t1715r1172b1758],
7	8	CD	PERCENT	8	dep	277	SENT_185	[p11l1471t1713r1492b1749],
8	(	NN	PERCENT	(	dep	277	SENT_185	[p11l1507t1713r1615b1758],
9	18	CD	PERCENT	18	dep	277	SENT_185	[p11l1507t1713r1615b1758],
10	%	NN	PERCENT	%	dep	277	SENT_185	[p11l1507t1713r1615b1758],
11	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1507t1713r1615b1758],
12	Asian	JJ	ORGANIZATION	asian	dep	277	SENT_185	[p11l109t1795r210b1828],
13	2	CD	PERCENT	2	dep	277	SENT_185	[p11l1033t1797r1052b1828],
14	(	CD	PERCENT	(	dep	277	SENT_185	[p11l1067t1794r1150b1838],
15	5	CD	PERCENT	5	dep	277	SENT_185	[p11l1067t1794r1150b1838],
16	%	NN	PERCENT	%	dep	277	SENT_185	[p11l1067t1794r1150b1838],
17	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1067t1794r1150b1838],
18	1	CD	NUMBER	1	dep	277	SENT_185	[p11l1475t1797r1494b1828],
19	(	NN	O	(	dep	277	SENT_185	[p11l1507t1794r1590b1838],
20	2	CD	PERCENT	2	dep	277	SENT_185	[p11l1507t1794r1590b1838],
21	%	NN	PERCENT	%	dep	277	SENT_185	[p11l1507t1794r1590b1838],
22	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1507t1794r1590b1838],
23	Hispanic	JJ	O	hispanic	dep	277	SENT_185	[p11l112t1874r267b1918],
24	4	CD	PERCENT	4	dep	277	SENT_185	[p11l1030t1876r1054b1912],
25	(	CD	PERCENT	(	dep	277	SENT_185	[p11l1067t1873r1173b1917],
26	10	CD	PERCENT	10	dep	277	SENT_185	[p11l1067t1873r1173b1917],
27	%	NN	PERCENT	%	dep	277	SENT_185	[p11l1067t1873r1173b1917],
28	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1067t1873r1173b1917],
29	5	CD	NUMBER	5	dep	277	SENT_185	[p11l1473t1877r1492b1912],
30	(	NN	O	(	dep	277	SENT_185	[p11l1507t1873r1610b1917],
31	11	CD	PERCENT	11	dep	277	SENT_185	[p11l1507t1873r1610b1917],
32	%	NN	PERCENT	%	dep	277	SENT_185	[p11l1507t1873r1610b1917],
33	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1507t1873r1610b1917],
34	Positive	JJ	O	positive	dep	277	SENT_185	[p11l72t1953r215b1986],
35	allergy	NN	O	allergy	dep	277	SENT_185	[p11l227t1951r350b1998],
36	skin	NN	O	skin	dep	277	SENT_185	[p11l360t1951r431b1986],
37	test	NN	O	test	dep	277	SENT_185	[p11l443t1957r514b1986],
38	40	CD	NUMBER	40	dep	277	SENT_185	[p11l1005t1955r1053b1991],
39	(	NN	O	(	dep	277	SENT_185	[p11l1067t1953r1220b1996],
40	100	CD	PERCENT	100	dep	277	SENT_185	[p11l1067t1953r1220b1996],
41	%	NN	PERCENT	%	dep	277	SENT_185	[p11l1067t1953r1220b1996],
42	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1067t1953r1220b1996],
43	§	CD	NUMBER	§	dep	277	SENT_185	[p11l1067t1953r1220b1996],
44	40	CD	NUMBER	40	dep	277	SENT_185	[p11l1445t1955r1493b1991],
45	(	NN	O	(	dep	277	SENT_185	[p11l1507t1950r1619b1996],
46	89	CD	PERCENT	89	dep	277	SENT_185	[p11l1507t1950r1619b1996],
47	%	NN	PERCENT	%	dep	277	SENT_185	[p11l1507t1950r1619b1996],
48	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1507t1950r1619b1996],
49	0-03	CD	NUMBER	0-03	dep	277	SENT_185	[p11l1883t1953r1986b1992],
50	’	NN	O	’	dep	277	SENT_185	[p11l1883t1953r1986b1992],
51	r	NN	O	r	dep	277	SENT_185	[p11l1883t1953r1986b1992],
52	Morning	NN	TIME	morning	dep	277	SENT_185	[p11l71t2033r229b2077],
53	PEF	NN	O	pef	dep	277	SENT_185	[p11l245t2033r309b2065],
54	(	CD	NUMBER	(	dep	277	SENT_185	[p11l322t2031r458b2075],
55	L/min	NN	O	l/min	dep	277	SENT_185	[p11l322t2031r458b2075],
56	)	NN	O	)	dep	277	SENT_185	[p11l322t2031r458b2075],
57	405	CD	NUMBER	405	dep	277	SENT_185	[p11l985t2034r1056b2071],
58	(	NN	O	(	dep	277	SENT_185	[p11l1071t2029r1146b2075],
59	85	CD	NUMBER	85	dep	277	SENT_185	[p11l1071t2029r1146b2075],
60	)	NN	O	)	dep	277	SENT_185	[p11l1071t2029r1146b2075],
61	427	CD	NUMBER	427	dep	277	SENT_185	[p11l1425t2034r1495b2070],
62	(	NN	O	(	dep	277	SENT_185	[p11l1508t2032r1605b2075],
63	102	CD	NUMBER	102	dep	277	SENT_185	[p11l1508t2032r1605b2075],
64	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1508t2032r1605b2075],
65	0-27	CD	NUMBER	0-27	dep	277	SENT_185	[p11l1883t2031r1981b2070],
66	*	CD	NUMBER	*	dep	277	SENT_185	[p11l1883t2031r1981b2070],
67	Evening	NNP	TIME	Evening	dep	277	SENT_185	[p11l72t2112r217b2156],
68	PEF	NN	O	pef	dep	277	SENT_185	[p11l233t2112r297b2144],
69	(	CD	NUMBER	(	dep	277	SENT_185	[p11l310t2110r446b2154],
70	L/min	NN	O	l/min	dep	277	SENT_185	[p11l310t2110r446b2154],
71	)	NN	O	)	dep	277	SENT_185	[p11l310t2110r446b2154],
72	403	CD	NUMBER	403	dep	277	SENT_185	[p11l985t2113r1056b2150],
73	(	NN	O	(	dep	277	SENT_185	[p11l1071t2108r1145b2154],
74	87	CD	NUMBER	87	dep	277	SENT_185	[p11l1071t2108r1145b2154],
75	)	NN	O	)	dep	277	SENT_185	[p11l1071t2108r1145b2154],
76	430	CD	NUMBER	430	dep	277	SENT_185	[p11l1425t2114r1497b2150],
77	(	NN	O	(	dep	277	SENT_185	[p11l1511t2111r1607b2154],
78	102	CD	NUMBER	102	dep	277	SENT_185	[p11l1511t2111r1607b2154],
79	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1511t2111r1607b2154],
80	0-19	CD	NUMBER	0-19	dep	277	SENT_185	[p11l1883t2110r1984b2150],
81	*	NN	O	*	dep	277	SENT_185	[p11l1883t2110r1984b2150],
82	FEV1	NN	O	fev1	dep	277	SENT_185	[p11l72t2191r150b2233],
83	(	CD	NUMBER	(	dep	277	SENT_185	[p11l163t2190r209b2233],
84	L	NN	O	l	dep	277	SENT_185	[p11l163t2190r209b2233],
85	)	CD	NUMBER	)	dep	277	SENT_185	[p11l163t2190r209b2233],
86	2-56	CD	NUMBER	2-56	dep	277	SENT_185	[p11l1033t2187r1114b2229],
87	(	NN	O	(	dep	277	SENT_185	[p11l1128t2187r1243b2233],
88	0-66	CD	NUMBER	0-66	dep	277	SENT_185	[p11l1128t2187r1243b2233],
89	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1128t2187r1243b2233],
90	2-66	CD	NUMBER	2-66	dep	277	SENT_185	[p11l1473t2187r1557b2224],
91	(	NN	O	(	dep	277	SENT_185	[p11l1571t2190r1679b2233],
92	0-75	CD	NUMBER	0-75	dep	277	SENT_185	[p11l1571t2190r1679b2233],
93	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1571t2190r1679b2233],
94	0-58	CD	NUMBER	0-58	dep	277	SENT_185	[p11l1883t2187r1986b2229],
95	*	NN	O	*	dep	277	SENT_185	[p11l1883t2187r1986b2229],
96	FEV1	NN	O	fev1	dep	277	SENT_185	[p11l72t2269r207b2312],
97	(	CD	PERCENT	(	dep	277	SENT_185	[p11l72t2269r207b2312],
98	%	NN	PERCENT	%	dep	277	SENT_185	[p11l72t2269r207b2312],
99	predicted	VBD	O	predict	dep	277	SENT_185	[p11l220t2267r408b2313],
100	)	CD	PERCENT	)	dep	277	SENT_185	[p11l220t2267r408b2313],
101	78-6	CD	PERCENT	78-6	dep	277	SENT_185	[p11l1006t2266r1124b2307],
102	%	NN	PERCENT	%	dep	277	SENT_185	[p11l1006t2266r1124b2307],
103	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1138t2269r1246b2312],
104	13-4	CD	NUMBER	13-4	dep	277	SENT_185	[p11l1138t2269r1246b2312],
105	)	NN	O	)	dep	277	SENT_185	[p11l1138t2269r1246b2312],
106	79-6	CD	PERCENT	79-6	dep	277	SENT_185	[p11l1447t2266r1564b2308],
107	%	NN	PERCENT	%	dep	277	SENT_185	[p11l1447t2266r1564b2308],
108	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1578t2269r1684b2312],
109	15-3	CD	NUMBER	15-3	dep	277	SENT_185	[p11l1578t2269r1684b2312],
110	)	NN	O	)	dep	277	SENT_185	[p11l1578t2269r1684b2312],
111	--	:	O	--	_	0	SENT_185	[p11l1887t2270r1925b2305],
112	5	CD	NUMBER	5	dep	277	SENT_185	[p11l1887t2270r1925b2305],
113	;	:	O	;	_	0	SENT_185	[p11l1887t2270r1925b2305],
114	FVC	NN	O	fvc	dep	277	SENT_185	[p11l72t2349r140b2382],
115	(	CD	NUMBER	(	dep	277	SENT_185	[p11l154t2348r200b2391],
116	L	NN	O	l	dep	277	SENT_185	[p11l154t2348r200b2391],
117	)	CD	NUMBER	)	dep	277	SENT_185	[p11l154t2348r200b2391],
118	3-55	CD	NUMBER	3-55	dep	277	SENT_185	[p11l1033t2346r1114b2387],
119	(	NN	O	(	dep	277	SENT_185	[p11l1128t2348r1235b2391],
120	1-03	CD	NUMBER	1-03	dep	277	SENT_185	[p11l1128t2348r1235b2391],
121	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1128t2348r1235b2391],
122	3-69	CD	NUMBER	3-69	dep	277	SENT_185	[p11l1473t2346r1556b2387],
123	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1571t2348r1683b2391],
124	0-95	CD	NUMBER	0-95	dep	277	SENT_185	[p11l1571t2348r1683b2391],
125	)	NN	O	)	dep	277	SENT_185	[p11l1571t2348r1683b2391],
126	052	CD	NUMBER	052	dep	277	SENT_185	[p11l1883t2346r1986b2382],
127	*	CD	NUMBER	*	dep	277	SENT_185	[p11l1883t2346r1986b2382],
128	FEV1	NN	O	fev1	dep	277	SENT_185	[p11l72t2429r150b2470],
129	reversibility	NN	O	reversibility	dep	277	SENT_185	[p11l163t2425r377b2472],
130	with	IN	O	with	dep	277	SENT_185	[p11l386t2425r469b2460],
131	salbutamol	NN	O	salbutamol	dep	277	SENT_185	[p11l483t2425r688b2461],
132	(	CD	PERCENT	(	dep	277	SENT_185	[p11l704t2427r762b2470],
133	%	NN	PERCENT	%	dep	277	SENT_185	[p11l704t2427r762b2470],
134	)	CD	PERCENT	)	dep	277	SENT_185	[p11l704t2427r762b2470],
135	11-2	CD	PERCENT	11-2	dep	277	SENT_185	[p11l1012t2430r1121b2460],
136	%	NN	PERCENT	%	dep	277	SENT_185	[p11l1012t2430r1121b2460],
137	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1135t2425r1221b2470],
138	6-3	CD	NUMBER	6-3	dep	277	SENT_185	[p11l1135t2425r1221b2470],
139	)	NN	O	)	dep	277	SENT_185	[p11l1135t2425r1221b2470],
140	8-9	CD	PERCENT	8-9	dep	277	SENT_185	[p11l1471t2425r1564b2466],
141	%	NN	PERCENT	%	dep	277	SENT_185	[p11l1471t2425r1564b2466],
142	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1578t2425r1667b2470],
143	6-6	CD	NUMBER	6-6	dep	277	SENT_185	[p11l1578t2425r1667b2470],
144	)	NN	O	)	dep	277	SENT_185	[p11l1578t2425r1667b2470],
145	009	CD	NUMBER	009	dep	277	SENT_185	[p11l1883t2427r1987b2466],
146	*	CD	NUMBER	*	dep	277	SENT_185	[p11l1883t2427r1987b2466],
147	FEV1	NN	O	fev1	dep	277	SENT_185	[p11l72t2508r150b2549],
148	reversibility	NN	O	reversibility	dep	277	SENT_185	[p11l163t2504r377b2551],
149	with	IN	O	with	dep	277	SENT_185	[p11l386t2504r469b2540],
150	ipratropium	NN	O	ipratropium	dep	277	SENT_185	[p11l484t2507r705b2551],
151	(	CD	PERCENT	(	dep	277	SENT_185	[p11l720t2506r779b2549],
152	%	NN	PERCENT	%	dep	277	SENT_185	[p11l720t2506r779b2549],
153	)	CD	PERCENT	)	dep	277	SENT_185	[p11l720t2506r779b2549],
154	11-0	CD	PERCENT	11-0	dep	277	SENT_185	[p11l1012t2509r1123b2540],
155	%	NN	PERCENT	%	dep	277	SENT_185	[p11l1012t2509r1123b2540],
156	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1137t2506r1221b2549],
157	7-4	CD	NUMBER	7-4	dep	277	SENT_185	[p11l1137t2506r1221b2549],
158	)	NN	O	)	dep	277	SENT_185	[p11l1137t2506r1221b2549],
159	8-9	CD	PERCENT	8-9	dep	277	SENT_185	[p11l1471t2504r1564b2545],
160	%	NN	PERCENT	%	dep	277	SENT_185	[p11l1471t2504r1564b2545],
161	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1578t2506r1661b2549],
162	5-7	CD	NUMBER	5-7	dep	277	SENT_185	[p11l1578t2506r1661b2549],
163	)	NN	O	)	dep	277	SENT_185	[p11l1578t2506r1661b2549],
164	020	CD	NUMBER	020	dep	277	SENT_185	[p11l1883t2506r1984b2540],
165	*	CD	NUMBER	*	dep	277	SENT_185	[p11l1883t2506r1984b2540],
166	Morning	NN	TIME	morning	dep	277	SENT_185	[p11l71t2586r229b2630],
167	symptom	NN	O	symptom	dep	277	SENT_185	[p11l243t2590r420b2630],
168	score	NN	NUMBER	score	dep	277	SENT_185	[p11l434t2595r529b2619],
169	0-15	CD	NUMBER	0-15	dep	277	SENT_185	[p11l1032t2588r1109b2624],
170	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1124t2583r1235b2629],
171	0-26	CD	NUMBER	0-26	dep	277	SENT_185	[p11l1124t2583r1235b2629],
172	)	NN	O	)	dep	277	SENT_185	[p11l1124t2583r1235b2629],
173	0-18	CD	NUMBER	0-18	dep	277	SENT_185	[p11l1472t2583r1552b2619],
174	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1567t2585r1675b2629],
175	0-22	CD	NUMBER	0-22	dep	277	SENT_185	[p11l1567t2585r1675b2629],
176	)	NN	O	)	dep	277	SENT_185	[p11l1567t2585r1675b2629],
177	0-68	CD	NUMBER	0-68	dep	277	SENT_185	[p11l1883t2583r1988b2619],
178	*	CD	NUMBER	*	dep	277	SENT_185	[p11l1883t2583r1988b2619],
179	Number	NN	O	number	dep	277	SENT_185	[p11l72t2663r224b2698],
180	of	IN	O	of	dep	277	SENT_185	[p11l234t2662r274b2698],
181	puffs	NNS	O	puff	dep	277	SENT_185	[p11l283t2662r374b2709],
182	of	IN	O	of	dep	277	SENT_185	[p11l385t2662r425b2698],
183	salbutamol	NN	O	salbutamol	dep	277	SENT_185	[p11l434t2663r640b2698],
184	per	IN	O	per	dep	277	SENT_185	[p11l653t2674r712b2709],
185	day	NN	DURATION	day	dep	277	SENT_185	[p11l723t2663r788b2709],
186	0-9	CD	NUMBER	0-9	dep	277	SENT_185	[p11l1032t2667r1089b2703],
187	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1104t2664r1188b2708],
188	1-0	CD	NUMBER	1-0	dep	277	SENT_185	[p11l1104t2664r1188b2708],
189	)	NN	O	)	dep	277	SENT_185	[p11l1104t2664r1188b2708],
190	1-1	CD	NUMBER	1-1	dep	277	SENT_185	[p11l1475t2668r1527b2698],
191	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1540t2665r1622b2708],
192	1-5	CD	NUMBER	1-5	dep	277	SENT_185	[p11l1540t2665r1622b2708],
193	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1540t2665r1622b2708],
194	0-39	CD	NUMBER	0-39	dep	277	SENT_185	[p11l1883t2664r1985b2703],
195	*	NN	O	*	dep	277	SENT_185	[p11l1883t2664r1985b2703],
196	Methacholine	NN	O	methacholine	dep	277	SENT_185	[p11l71t2742r326b2777],
197	PC20	NN	O	pc20	dep	277	SENT_185	[p11l340t2744r409b2787],
198	(	CD	NUMBER	(	dep	277	SENT_185	[p11l422t2743r616b2789],
199	mg/mL	NN	O	mg/ml	dep	277	SENT_185	[p11l422t2743r616b2789],
200	)	CD	NUMBER	)	dep	277	SENT_185	[p11l422t2743r616b2789],
201	1T	NN	O	1t	dep	277	SENT_185	[p11l422t2743r616b2789],
202	2-43	CD	NUMBER	2-43	dep	277	SENT_185	[p11l1033t2747r1113b2783],
203	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1128t2743r1342b2787],
204	O-57-9-40	NN	O	o-57-9-40	dep	277	SENT_185	[p11l1128t2743r1342b2787],
205	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1128t2743r1342b2787],
206	1-92	CD	NUMBER	1-92	dep	277	SENT_185	[p11l1475t2747r1553b2783],
207	(	NN	O	(	dep	277	SENT_185	[p11l1568t2741r1784b2787],
208	0-67-3-90	CD	NUMBER	0-67-3-90	dep	277	SENT_185	[p11l1568t2741r1784b2787],
209	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1568t2741r1784b2787],
210	O-19	NN	O	o-19	dep	277	SENT_185	[p11l1883t2743r1984b2783],
211	*	CD	NUMBER	*	dep	277	SENT_185	[p11l1883t2743r1984b2783],
212	Exhaled	VBN	O	exhale	dep	277	SENT_185	[p11l72t2821r214b2857],
213	nitric	JJ	O	nitric	dep	277	SENT_185	[p11l228t2824r321b2857],
214	oxide	NN	O	oxide	dep	277	SENT_185	[p11l332t2821r432b2856],
215	(	NN	O	(	dep	277	SENT_185	[p11l445t2823r552b2867],
216	parts	NNS	O	part	dep	277	SENT_185	[p11l445t2823r552b2867],
217	per	IN	O	per	dep	277	SENT_185	[p11l563t2833r622b2867],
218	billion	CD	NUMBER	billion	dep	277	SENT_185	[p11l635t2821r762b2866],
219	)	CD	NUMBER	)	dep	277	SENT_185	[p11l635t2821r762b2866],
220	16-8	CD	NUMBER	16-8	dep	277	SENT_185	[p11l1008t2820r1090b2857],
221	(	NN	O	(	dep	277	SENT_185	[p11l1104t2820r1313b2866],
222	11-7-28-4	CD	DATE	11-7-28-4	dep	277	SENT_185	[p11l1104t2820r1313b2866],
223	)	CD	NUMBER	)	dep	277	SENT_185	[p11l1104t2820r1313b2866],
224	15-8	CD	NUMBER	15-8	dep	277	SENT_185	[p11l1451t2820r1530b2862],
225	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1544t2823r1754b2866],
226	11-3-24-9	CD	DATE	11-3-24-9	dep	277	SENT_185	[p11l1544t2823r1754b2866],
227	)	NN	O	)	dep	277	SENT_185	[p11l1544t2823r1754b2866],
228	0-69	CD	NUMBER	0-69	dep	277	SENT_185	[p11l1883t2820r1991b2865],
229	|	CD	NUMBER	|	dep	277	SENT_185	[p11l1883t2820r1991b2865],
230	|	NN	O	|	dep	277	SENT_185	[p11l1883t2820r1991b2865],
231	pH	NN	O	ph	dep	277	SENT_185	[p11l70t2903r119b2946],
232	in	IN	O	in	dep	277	SENT_185	[p11l135t2903r165b2935],
233	exhaled	VBN	O	exhale	dep	277	SENT_185	[p11l179t2900r322b2936],
234	breath	NN	O	breath	dep	277	SENT_185	[p11l335t2900r453b2936],
235	condensate	NN	O	condensate	dep	277	SENT_185	[p11l467t2900r680b2936],
236	8-44	CD	NUMBER	8-44	dep	277	SENT_185	[p11l1031t2899r1117b2940],
237	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1130t2899r1343b2945],
238	8-35-8-53	CD	NUMBER	8-35-8-53	dep	277	SENT_185	[p11l1130t2899r1343b2945],
239	)	NN	O	)	dep	277	SENT_185	[p11l1130t2899r1343b2945],
240	8-44	CD	NUMBER	8-44	dep	277	SENT_185	[p11l1471t2899r1557b2940],
241	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1570t2899r1786b2945],
242	8-25-8-59	CD	NUMBER	8-25-8-59	dep	277	SENT_185	[p11l1570t2899r1786b2945],
243	)	NN	O	)	dep	277	SENT_185	[p11l1570t2899r1786b2945],
244	O-74	NN	O	o-74	dep	277	SENT_185	[p11l1883t2899r1984b2944],
245	|	CD	NUMBER	|	dep	277	SENT_185	[p11l1883t2899r1984b2944],
246	|	NN	O	|	dep	277	SENT_185	[p11l1883t2899r1984b2944],
247	Number	NN	O	number	dep	277	SENT_185	[p11l72t2979r224b3015],
248	of	IN	O	of	dep	277	SENT_185	[p11l234t2978r274b3015],
249	positive	JJ	O	positive	dep	277	SENT_185	[p11l283t2982r429b3026],
250	skin	NN	O	skin	dep	277	SENT_185	[p11l441t2979r512b3015],
251	tests	NNS	O	test	dep	277	SENT_185	[p11l523t2986r611b3015],
252	3-7	CD	NUMBER	3-7	dep	277	SENT_185	[p11l1033t2984r1088b3020],
253	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1100t2981r1186b3024],
254	2-4	CD	NUMBER	2-4	dep	277	SENT_185	[p11l1100t2981r1186b3024],
255	)	NN	O	)	dep	277	SENT_185	[p11l1100t2981r1186b3024],
256	3-7	CD	NUMBER	3-7	dep	277	SENT_185	[p11l1473t2984r1528b3020],
257	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1541t2981r1624b3024],
258	2-5	CD	NUMBER	2-5	dep	277	SENT_185	[p11l1541t2981r1624b3024],
259	)	NN	O	)	dep	277	SENT_185	[p11l1541t2981r1624b3024],
260	051	CD	NUMBER	051	dep	277	SENT_185	[p11l1883t2980r1981b3020],
261	*	CD	NUMBER	*	dep	277	SENT_185	[p11l1883t2980r1981b3020],
262	lgE	NN	O	lge	dep	277	SENT_185	[p11l72t3061r125b3105],
263	(	CD	NUMBER	(	dep	277	SENT_185	[p11l139t3059r280b3103],
264	|	CD	NUMBER	|	dep	277	SENT_185	[p11l139t3059r280b3103],
265	U/mL	NN	O	u/ml	dep	277	SENT_185	[p11l139t3059r280b3103],
266	)	NN	O	)	dep	277	SENT_185	[p11l139t3059r280b3103],
267	127	CD	NUMBER	127	dep	277	SENT_185	[p11l988t3063r1054b3098],
268	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1067t3058r1236b3103],
269	43-308	CD	NUMBER	43-308	dep	277	SENT_185	[p11l1067t3058r1236b3103],
270	)	NN	O	)	dep	277	SENT_185	[p11l1067t3058r1236b3103],
271	152	CD	NUMBER	152	dep	277	SENT_185	[p11l1427t3063r1492b3099],
272	(	CD	NUMBER	(	dep	277	SENT_185	[p11l1507t3058r1674b3103],
273	81-282	CD	NUMBER	81-282	dep	277	SENT_185	[p11l1507t3058r1674b3103],
274	)	NN	O	)	dep	277	SENT_185	[p11l1507t3058r1674b3103],
275	093	CD	NUMBER	093	dep	277	SENT_185	[p11l1883t3057r1988b3102],
276	]	CD	NUMBER	]	dep	277	SENT_185	[p11l1883t3057r1988b3102],
277	]	NN	O	]	_	0	SENT_185	[p11l1883t3057r1988b3102],

1	Data	NNS	O	datum	nsubj	3	SENT_186	[p11l52t3179r129b3209],
2	are	VBP	O	be	cop	3	SENT_186	[p11l140t3187r192b3209],
3	n	NN	O	n	_	0	SENT_186	[p11l205t3187r222b3208],
4	(	CD	PERCENT	(	num	5	SENT_186	[p11l236t3177r301b3218],
5	%	NN	PERCENT	%	dep	3	SENT_186	[p11l236t3177r301b3218],
6	)	CD	NUMBER	)	dep	5	SENT_186	[p11l236t3177r301b3218],
7	,	,	O	,	_	0	SENT_186	[p11l236t3177r301b3218],
8	mean	VB	O	mean	ccomp	3	SENT_186	[p11l315t3187r408b3209],
9	(	JJ	O	(	amod	11	SENT_186	[p11l422t3177r503b3218],
10	SD	NN	O	sd	nn	11	SENT_186	[p11l422t3177r503b3218],
11	)	NN	O	)	dobj	8	SENT_186	[p11l422t3177r503b3218],
12	,	,	O	,	_	0	SENT_186	[p11l422t3177r503b3218],
13	or	CC	O	or	_	0	SENT_186	[p11l515t3187r550b3209],
14	median	JJ	O	median	amod	16	SENT_186	[p11l562t3176r689b3209],
15	(	NN	O	(	nn	16	SENT_186	[p11l702t3177r788b3217],
16	IQR	NN	O	iqr	conj_or	11	SENT_186	[p11l702t3177r788b3217],
17	)	CD	NUMBER	)	dep	16	SENT_186	[p11l702t3177r788b3217],
18	unless	IN	O	unless	mark	20	SENT_186	[p11l801t3176r906b3209],
19	otherwise	RB	O	otherwise	advmod	20	SENT_186	[p11l916t3176r1086b3209],
20	indicated	VBN	O	indicate	advcl	8	SENT_186	[p11l1099t3176r1265b3209],
21	.	.	O	.	_	0	SENT_186	[p11l1099t3176r1265b3209],

1	Baseline	NN	O	baseline	nn	2	SENT_187	[p11l1280t3176r1419b3209],
2	data	NNS	O	datum	nsubjpass	4	SENT_187	[p11l1429t3176r1504b3209],
3	was	VBD	O	be	auxpass	4	SENT_187	[p11l1513t3187r1579b3209],
4	obtained	VBN	O	obtain	_	0	SENT_187	[p11l1590t3176r1744b3209],
5	during	IN	O	during	_	0	SENT_187	[p11l1755t3176r1866b3219],
6	the	DT	O	the	det	8	SENT_187	[p11l1876t3176r1933b3209],
7	run	NN	O	run	nn	8	SENT_187	[p11l1946t3178r2049b3209],
8	—	NN	O	—	prep_during	4	SENT_187	[p11l1946t3178r2049b3209],
9	in	IN	O	in	_	0	SENT_187	[p11l1946t3178r2049b3209],
10	phase	NN	O	phase	prep_in	4	SENT_187	[p11l50t3235r158b3278],
11	,	,	O	,	_	0	SENT_187	[p11l50t3235r158b3278],
12	after	IN	O	after	_	0	SENT_187	[p11l170t3235r251b3268],
13	at	IN	DURATION	at	quantmod	15	SENT_187	[p11l261t3241r295b3268],
14	least	JJS	DURATION	least	mwe	13	SENT_187	[p11l307t3235r384b3268],
15	3	CD	DURATION	3	num	16	SENT_187	[p11l395t3240r414b3273],
16	weeks	NNS	NUMBER	week	prep_after	4	SENT_187	[p11l424t3235r530b3268],
17	of	IN	O	of	_	0	SENT_187	[p11l540t3235r577b3268],
18	standard	JJ	O	standard	prep_of	16	SENT_187	[p11l585t3235r737b3268],
19	inhaled	VBN	O	inhale	partmod	18	SENT_187	[p11l749t3235r874b3268],
20	corticosteroid	NN	O	corticosteroid	nn	21	SENT_187	[p11l885t3235r1125b3268],
21	therapy	NN	O	therapy	dobj	19	SENT_187	[p11l1133t3235r1273b3279],
22	.	.	O	.	_	0	SENT_187	[p11l1133t3235r1273b3279],

1	PEF	NN	O	pef	_	0	SENT_188	[p11l1287t3235r1452b3278],
2	=	JJ	O	=	amod	5	SENT_188	[p11l1287t3235r1452b3278],
3	peak	NN	O	peak	nn	5	SENT_188	[p11l1287t3235r1452b3278],
4	expiratory	NN	O	expiratory	nn	5	SENT_188	[p11l1462t3238r1639b3278],
5	ﬂow	NN	O	ﬂow	dep	1	SENT_188	[p11l1648t3235r1731b3268],
6	.	.	O	.	_	0	SENT_188	[p11l1648t3235r1731b3268],

1	FEV1	NN	O	fev1	nn	5	SENT_189	[p11l1745t3235r1950b3277],
2	=	JJ	O	=	amod	5	SENT_189	[p11l1745t3235r1950b3277],
3	forced	JJ	O	forced	amod	5	SENT_189	[p11l1745t3235r1950b3277],
4	expiratory	JJ	O	expiratory	amod	5	SENT_189	[p11l50t3297r227b3338],
5	volume	NN	O	volume	nsubj	10	SENT_189	[p11l236t3295r366b3328],
6	in	IN	O	in	_	0	SENT_189	[p11l378t3297r407b3328],
7	1	CD	NUMBER	1	num	9	SENT_189	[p11l420t3299r437b3328],
8	s.	NN	O	s.	nn	9	SENT_189	[p11l449t3306r471b3328],
9	FVC	NN	O	fvc	prep_in	5	SENT_189	[p11l486t3294r683b3328],
10	=	JJ	O	=	_	0	SENT_189	[p11l486t3294r683b3328],
11	forced	JJ	O	forced	amod	13	SENT_189	[p11l486t3294r683b3328],
12	vital	JJ	O	vital	amod	13	SENT_189	[p11l693t3295r765b3328],
13	capacity	NN	O	capacity	dobj	10	SENT_189	[p11l778t3297r924b3338],
14	.	.	O	.	_	0	SENT_189	[p11l778t3297r924b3338],

1	PC2o	NN	O	pc2o	_	0	SENT_190	[p11l938t3297r1101b3337],
2	=	JJ	O	=	amod	5	SENT_190	[p11l938t3297r1101b3337],
3	20	CD	PERCENT	20	number	4	SENT_190	[p11l938t3297r1101b3337],
4	%	NN	PERCENT	%	amod	5	SENT_190	[p11l938t3297r1101b3337],
5	reduction	NN	O	reduction	dep	1	SENT_190	[p11l1115t3295r1278b3328],
6	in	IN	O	in	_	0	SENT_190	[p11l1292t3297r1320b3328],
7	FEV1	NN	O	fev1	prep_in	5	SENT_190	[p11l1335t3298r1415b3337],
8	.	.	O	.	_	0	SENT_190	[p11l1335t3298r1415b3337],

1	*	NN	O	*	_	0	SENT_191	[p11l1429t3295r1553b3328],
2	Paired	JJ	O	paired	amod	4	SENT_191	[p11l1429t3295r1553b3328],
3	t	NN	O	t	nn	4	SENT_191	[p11l1564t3301r1577b3328],
4	test	NN	O	test	dep	1	SENT_191	[p11l1585t3301r1659b3328],
5	.	.	O	.	_	0	SENT_191	[p11l1585t3301r1659b3328],

1	TMcNemar	JJ	O	tmcnemar	amod	2	SENT_192	[p11l1673t3297r1862b3330],
2	test	NN	O	test	_	0	SENT_192	[p11l1870t3301r1944b3328],
3	.	.	O	.	_	0	SENT_192	[p11l1870t3301r1944b3328],

1	ip	NN	O	ip	nn	2	SENT_193	[p11l51t3357r90b3398],
2	values	NNS	O	value	_	0	SENT_193	[p11l100t3354r208b3387],
3	not	RB	O	not	neg	4	SENT_193	[p11l221t3360r278b3387],
4	shown	VBN	O	show	partmod	2	SENT_193	[p11l289t3354r402b3387],
5	for	IN	O	for	_	0	SENT_193	[p11l413t3354r464b3387],
6	matching	VBG	O	match	amod	7	SENT_193	[p11l476t3354r638b3398],
7	criteria	NNS	O	criterion	prep_for	4	SENT_193	[p11l650t3357r777b3387],
8	.	.	O	.	_	0	SENT_193	[p11l650t3357r777b3387],

1	§	NN	O	§	nsubj	9	SENT_194	[p11l791t3357r881b3393],
2	Two	CD	NUMBER	two	num	3	SENT_194	[p11l791t3357r881b3393],
3	participants	NNS	O	participant	nsubj	6	SENT_194	[p11l892t3357r1097b3398],
4	did	VBD	O	do	aux	6	SENT_194	[p11l1107t3354r1161b3387],
5	not	RB	O	not	neg	6	SENT_194	[p11l1174t3360r1231b3387],
6	have	VB	O	have	rcmod	1	SENT_194	[p11l1244t3354r1323b3387],
7	allergy	NN	O	allergy	nn	8	SENT_194	[p11l1334t3354r1448b3398],
8	skin	NN	O	skin	dobj	6	SENT_194	[p11l1458t3354r1524b3387],
9	tests	VBZ	O	test	_	0	SENT_194	[p11l1534t3360r1616b3387],
10	done	VBN	O	do	acomp	9	SENT_194	[p11l1626t3354r1721b3387],
11	.	.	O	.	_	0	SENT_194	[p11l1626t3354r1721b3387],

1	1lGeometric	JJ	O	1lgeometric	amod	3	SENT_195	[p11l1734t3357r1941b3391],
2	mean	NN	O	mean	nn	3	SENT_195	[p11l1953t3365r2047b3387],
3	(	NN	O	(	_	0	SENT_195	[p11l51t3416r147b3456],
4	IQR	NN	O	iqr	nn	5	SENT_195	[p11l51t3416r147b3456],
5	)	NN	O	)	dep	3	SENT_195	[p11l51t3416r147b3456],
6	.	.	O	.	_	0	SENT_195	[p11l51t3416r147b3456],

1	|	RB	O	|	advmod	6	SENT_196	[p11l162t3414r341b3455],
2	|	CD	NUMBER	|	num	5	SENT_196	[p11l162t3414r341b3455],
3	Wi	NN	O	wus	nn	5	SENT_196	[p11l162t3414r341b3455],
4	|	NN	O	|	nn	5	SENT_196	[p11l162t3414r341b3455],
5	coxon	NN	O	coxon	nsubj	6	SENT_196	[p11l162t3414r341b3455],
6	signed	VBD	O	sign	_	0	SENT_196	[p11l354t3414r559b3458],
7	—	CD	NUMBER	—	num	9	SENT_196	[p11l354t3414r559b3458],
8	rank	NN	O	rank	nn	9	SENT_196	[p11l354t3414r559b3458],
9	test	NN	O	test	dobj	6	SENT_196	[p11l567t3420r642b3447],
10	.	.	O	.	_	0	SENT_196	[p11l567t3420r642b3447],

1	Table	NNP	O	Table	_	0	SENT_197	[p11l50t3524r148b3560],
2	1	CD	NUMBER	1	num	1	SENT_197	[p11l160t3529r192b3560],
3	:	:	O	:	_	0	SENT_197	[p11l160t3529r192b3560],
4	Baseline	NN	O	baseline	nn	5	SENT_197	[p11l206t3524r364b3560],
5	characteristics	NNS	O	characteristic	dep	1	SENT_197	[p11l376t3524r658b3560],
6	of	IN	O	of	_	0	SENT_197	[p11l668t3524r711b3560],
7	randomised	JJ	O	randomised	amod	8	SENT_197	[p11l721t3524r954b3560],
8	participants	NNS	O	participant	prep_of	5	SENT_197	[p11l965t3526r1215b3571],
9	,	,	O	,	_	0	SENT_197	[p11l965t3526r1215b3571],
10	by	IN	O	by	_	0	SENT_197	[p11l1228t3524r1274b3571],
11	genotype	NN	O	genotype	prep_by	5	SENT_197	[p11l1285t3530r1473b3571],

1	90	CD	PERCENT	90	dep	99	SENT_198	[p12l646t69r760b116],
2	%	NN	PERCENT	%	dep	99	SENT_198	[p12l646t69r760b116],
3	statistical	JJ	O	statistical	dep	99	SENT_198	[p12l813t66r1064b114],
4	power	NN	O	power	dep	99	SENT_198	[p12l1114t83r1280b128],
5	for	IN	O	for	dep	99	SENT_198	[p12l1330t66r1406b114],
6	the	DT	O	the	dep	99	SENT_198	[p12l1455t66r1538b114],
7	secondary	JJ	O	secondary	dep	99	SENT_198	[p12l1592t66r1860b129],
8	outcome	NN	O	outcome	dep	99	SENT_198	[p12l1911t76r2142b114],
9	variable	NN	O	variable	dep	99	SENT_198	[p12l643t142r853b189],
10	of	IN	O	of	dep	99	SENT_198	[p12l883t142r942b189],
11	FEV1	NN	O	fev1	dep	99	SENT_198	[p12l965t145r1103b201],
12	,	,	O	,	_	0	SENT_198	[p12l965t145r1103b201],
13	a	DT	O	a	dep	99	SENT_198	[p12l1135t159r1161b189],
14	sample	NN	O	sample	dep	99	SENT_198	[p12l1191t142r1381b204],
15	size	NN	O	size	dep	99	SENT_198	[p12l1412t145r1513b189],
16	of	IN	O	of	dep	99	SENT_198	[p12l1543t142r1602b189],
17	40	CD	NUMBER	40	dep	99	SENT_198	[p12l1621t146r1680b189],
18	participants	NNS	O	participant	dep	99	SENT_198	[p12l1708t145r2026b204],
19	per	IN	O	per	dep	99	SENT_198	[p12l2057t159r2144b204],
20	genotype	NN	O	genotype	dep	99	SENT_198	[p12l645t228r886b282],
21	(	CD	NUMBER	(	dep	99	SENT_198	[p12l950t223r1028b282],
22	80	CD	NUMBER	80	dep	99	SENT_198	[p12l950t223r1028b282],
23	total	JJ	O	total	dep	99	SENT_198	[p12l1087t219r1204b266],
24	randomised	JJ	O	randomised	dep	99	SENT_198	[p12l1263t219r1586b266],
25	participants	NNS	O	participant	dep	99	SENT_198	[p12l1644t222r1980b282],
26	)	VBP	O	)	dep	99	SENT_198	[p12l1644t222r1980b282],
27	was	VBD	O	be	dep	99	SENT_198	[p12l2042t236r2141b266],
28	required	VBN	O	require	dep	99	SENT_198	[p12l644t294r874b356],
29	for	IN	O	for	dep	99	SENT_198	[p12l897t294r973b342],
30	an	DT	O	a	dep	99	SENT_198	[p12l997t311r1061b342],
31	effect	NN	O	effect	dep	99	SENT_198	[p12l1085t295r1230b342],
32	size	NN	O	size	dep	99	SENT_198	[p12l1255t297r1355b342],
33	of	IN	O	of	dep	99	SENT_198	[p12l1381t294r1440b342],
34	0-15	CD	NUMBER	0-15	dep	99	SENT_198	[p12l1455t297r1570b342],
35	L	NN	O	l	dep	99	SENT_198	[p12l1600t299r1629b341],
36	with	IN	O	with	dep	99	SENT_198	[p12l1650t294r1769b342],
37	an	DT	O	a	dep	99	SENT_198	[p12l1793t311r1857b342],
38	estimated	VBN	O	estimate	dep	99	SENT_198	[p12l1881t294r2144b342],
39	SD	NN	O	sd	dep	99	SENT_198	[p12l648t373r723b417],
40	of	IN	O	of	dep	99	SENT_198	[p12l747t370r806b417],
41	0-19	CD	NUMBER	0-19	dep	99	SENT_198	[p12l819t374r936b418],
42	L.	NNP	O	L.	dep	99	SENT_198	[p12l961t375r1003b417],
43	With	IN	O	with	dep	99	SENT_198	[p12l1027t370r1157b418],
44	a	DT	O	a	dep	99	SENT_198	[p12l1179t387r1205b417],
45	sample	NN	O	sample	dep	99	SENT_198	[p12l1228t370r1418b432],
46	size	NN	O	size	dep	99	SENT_198	[p12l1442t373r1543b417],
47	of	IN	O	of	dep	99	SENT_198	[p12l1565t370r1624b417],
48	40	CD	NUMBER	40	dep	99	SENT_198	[p12l1635t374r1694b417],
49	participants	NNS	O	participant	dep	99	SENT_198	[p12l1716t373r2034b432],
50	per	IN	O	per	dep	99	SENT_198	[p12l2057t387r2144b432],
51	genotype	NN	O	genotype	dep	99	SENT_198	[p12l645t456r901b509],
52	,	,	O	,	_	0	SENT_198	[p12l645t456r901b509],
53	the	DT	O	the	dep	99	SENT_198	[p12l929t447r1013b494],
54	actual	JJ	O	actual	dep	99	SENT_198	[p12l1041t447r1198b494],
55	eﬁ	NN	O	eﬁ	dep	99	SENT_198	[p12l1225t447r1371b494],
56	'	''	O	'	_	0	SENT_198	[p12l1225t447r1371b494],
57	ect	NN	O	ect	dep	99	SENT_198	[p12l1225t447r1371b494],
58	size	NN	O	size	dep	99	SENT_198	[p12l1398t450r1499b494],
59	for	IN	O	for	dep	99	SENT_198	[p12l1526t446r1602b494],
60	detecting	VBG	O	detect	dep	99	SENT_198	[p12l1629t446r1875b509],
61	betweengenotype	NN	O	betweengenotype	dep	99	SENT_198	[p12l1901t446r2142b494, p12l645t532r886b585],
62	diﬁerences	NNS	O	diﬁerences	dep	99	SENT_198	[p12l917t522r1212b570],
63	with	IN	O	with	dep	99	SENT_198	[p12l1242t522r1361b570],
64	respect	NN	O	respect	dep	99	SENT_198	[p12l1390t532r1582b584],
65	to	TO	O	to	dep	99	SENT_198	[p12l1610t532r1659b570],
66	end-of-treatment	JJ	O	end-of-treatment	dep	99	SENT_198	[p12l1690t522r2144b570],
67	morning	NN	TIME	morning	dep	99	SENT_198	[p12l644t601r881b661],
68	PEF	NN	O	pef	dep	99	SENT_198	[p12l915t601r1020b645],
69	was	VBD	O	be	dep	99	SENT_198	[p12l1052t615r1151b645],
70	15	CD	NUMBER	15	dep	99	SENT_198	[p12l1186t601r1237b645],
71	L/min	NN	O	l/min	dep	99	SENT_198	[p12l1273t601r1453b660],
72	,	,	O	,	_	0	SENT_198	[p12l1273t601r1453b660],
73	and	CC	O	and	dep	99	SENT_198	[p12l1487t598r1586b645],
74	the	DT	O	the	dep	99	SENT_198	[p12l1615t598r1699b645],
75	effect	NN	O	effect	dep	99	SENT_198	[p12l1731t598r1876b645],
76	sizes	NNS	O	size	dep	99	SENT_198	[p12l1908t601r2035b645],
77	for	IN	O	for	dep	99	SENT_198	[p12l2068t598r2144b645],
78	detecting	VBG	O	detect	dep	99	SENT_198	[p12l645t675r892b737],
79	treatment	NN	O	treatment	dep	99	SENT_198	[p12l925t684r1190b722],
80	regimen	NN	O	regimen	dep	99	SENT_198	[p12l1223t678r1450b737],
81	differences	NNS	O	difference	dep	99	SENT_198	[p12l1484t675r1779b722],
82	within	IN	O	within	dep	99	SENT_198	[p12l1813t675r1988b722],
83	each	DT	O	each	dep	99	SENT_198	[p12l2023t675r2143b722],
84	genotype	NN	O	genotype	dep	99	SENT_198	[p12l645t760r886b813],
85	were	VBD	O	be	dep	99	SENT_198	[p12l905t767r1032b798],
86	13	CD	NUMBER	13	dep	99	SENT_198	[p12l1054t754r1128b798],
87	-	:	O	-	_	0	SENT_198	[p12l1054t754r1128b798],
88	3	CD	NUMBER	3	dep	99	SENT_198	[p12l1144t755r1168b798],
89	L/min	NN	O	l/min	dep	99	SENT_198	[p12l1192t753r1358b812],
90	for	IN	O	for	dep	99	SENT_198	[p12l1377t750r1454b798],
91	morning	NN	TIME	morning	dep	99	SENT_198	[p12l1472t753r1709b813],
92	PEF	NN	O	pef	dep	99	SENT_198	[p12l1730t753r1835b797],
93	and	CC	O	and	dep	99	SENT_198	[p12l1857t750r1956b798],
94	o	NN	O	o	dep	99	SENT_198	[p12l1974t754r2024b798],
95	-	:	O	-	_	0	SENT_198	[p12l1974t754r2024b798],
96	13	CD	DATE	13	dep	99	SENT_198	[p12l2039t755r2090b798],
97	L	NN	O	l	dep	99	SENT_198	[p12l2114t755r2144b797],
98	for	IN	O	for	dep	99	SENT_198	[p12l644t827r721b875],
99	FEV1	NN	O	fev1	_	0	SENT_198	[p12l742t830r880b887],
100	.	.	O	.	_	0	SENT_198	[p12l742t830r880b887],

1	Means	NNP	O	Means	nn	3	SENT_199	[p12l696t909r867b951],
2	(	CD	NUMBER	(	num	3	SENT_199	[p12l902t907r1040b967],
3	SDs	NNS	O	sd	nsubjpass	6	SENT_199	[p12l902t907r1040b967],
4	)	CD	NUMBER	)	dep	3	SENT_199	[p12l902t907r1040b967],
5	were	VBD	O	be	auxpass	6	SENT_199	[p12l1071t921r1197b951],
6	calculated	VBN	O	calculate	_	0	SENT_199	[p12l1227t904r1491b951],
7	as	IN	O	as	_	0	SENT_199	[p12l1519t921r1570b951],
8	descriptive	JJ	O	descriptive	amod	9	SENT_199	[p12l1601t904r1885b966],
9	statistics	NNS	O	statistics	prep_as	6	SENT_199	[p12l1916t907r2141b951],
10	for	IN	O	for	_	0	SENT_199	[p12l644t979r720b1027],
11	baseline	NN	O	baseline	nn	12	SENT_199	[p12l747t979r965b1027],
12	variables	NNS	O	variable	prep_for	9	SENT_199	[p12l994t979r1241b1034],
13	,	,	O	,	_	0	SENT_199	[p12l994t979r1241b1034],
14	apart	RB	O	apart	_	0	SENT_199	[p12l1273t989r1407b1041],
15	from	IN	O	from	_	0	SENT_199	[p12l1435t979r1566b1027],
16	those	DT	O	those	det	17	SENT_199	[p12l1594t979r1735b1027],
17	variables	NNS	O	variable	prep_apart_from	6	SENT_199	[p12l1764t979r1996b1027],
18	with	IN	O	with	_	0	SENT_199	[p12l2026t979r2143b1027],
19	skewed	JJ	O	skewed	amod	20	SENT_199	[p12l646t1055r839b1102],
20	distributions	NNS	O	distribution	prep_with	17	SENT_199	[p12l867t1055r1220b1110],
21	,	,	O	,	_	0	SENT_199	[p12l867t1055r1220b1110],
22	for	IN	O	for	_	0	SENT_199	[p12l1250t1055r1326b1102],
23	which	WDT	O	which	rel	28	SENT_199	[p12l1351t1055r1513b1102],
24	medians	NNS	O	median	nn	27	SENT_199	[p12l1540t1055r1766b1102],
25	or	CC	O	or	_	0	SENT_199	[p12l1797t1072r1851b1102],
26	geometric	JJ	O	geometric	nn	27	SENT_199	[p12l1878t1058r2143b1118],
27	means	NNS	O	means	nsubj	28	SENT_199	[p12l644t1149r818b1179],
28	(	VBP	O	(	rcmod	20	SENT_199	[p12l853t1136r995b1194],
29	IQR	NN	O	iqr	nn	30	SENT_199	[p12l853t1136r995b1194],
30	)	NN	O	)	nsubjpass	32	SENT_199	[p12l853t1136r995b1194],
31	were	VBD	O	be	auxpass	32	SENT_199	[p12l1027t1149r1153b1179],
32	calculated	VBN	O	calculate	ccomp	28	SENT_199	[p12l1183t1132r1459b1179],
33	.	.	O	.	_	0	SENT_199	[p12l1183t1132r1459b1179],

1	Paired	JJ	O	paired	amod	3	SENT_200	[p12l1494t1132r1660b1179],
2	t	NN	O	t	nn	3	SENT_200	[p12l1689t1141r1705b1179],
3	tests	NNS	O	test	_	0	SENT_200	[p12l1732t1141r1865b1186],
4	,	,	O	,	_	0	SENT_200	[p12l1732t1141r1865b1186],
5	Wilcoxon	NNP	PERSON	Wilcoxon	nsubj	6	SENT_200	[p12l1896t1132r2143b1179],
6	signed	VBD	O	sign	dep	3	SENT_200	[p12l646t1207r820b1270],
7	rank	NN	O	rank	nn	8	SENT_200	[p12l855t1207r976b1255],
8	tests	NNS	O	test	dobj	6	SENT_200	[p12l1010t1217r1143b1262],
9	,	,	O	,	_	0	SENT_200	[p12l1010t1217r1143b1262],
10	and	CC	O	and	_	0	SENT_200	[p12l1183t1207r1280b1255],
11	McNemar	NN	O	mcnemar	nn	12	SENT_200	[p12l1318t1212r1582b1255],
12	tests	NNS	O	test	nsubjpass	14	SENT_200	[p12l1617t1217r1734b1255],
13	were	VBD	O	be	auxpass	14	SENT_200	[p12l1771t1224r1896b1255],
14	applied	VBN	O	apply	conj_and	6	SENT_200	[p12l1934t1207r2140b1269],
15	,	,	O	,	_	0	SENT_200	[p12l1934t1207r2140b1269],
16	corresponding	VBG	O	correspond	partmod	3	SENT_200	[p12l645t1283r1030b1346],
17	with	IN	O	with	_	0	SENT_200	[p12l1058t1283r1175b1330],
18	the	DT	O	the	det	19	SENT_200	[p12l1203t1283r1285b1330],
19	type	NN	O	type	prep_with	16	SENT_200	[p12l1314t1293r1423b1346],
20	of	IN	O	of	_	0	SENT_200	[p12l1454t1283r1512b1330],
21	descriptive	JJ	O	descriptive	amod	22	SENT_200	[p12l1533t1283r1818b1345],
22	statistic	NN	O	statistic	prep_of	19	SENT_200	[p12l1849t1286r2062b1338],
23	,	,	O	,	_	0	SENT_200	[p12l1849t1286r2062b1338],
24	to	TO	O	to	aux	25	SENT_200	[p12l2093t1292r2142b1330],
25	compare	VB	O	compare	xcomp	16	SENT_200	[p12l645t1377r873b1421],
26	genotypic	JJ	O	genotypic	amod	27	SENT_200	[p12l918t1363r1173b1422],
27	groups	NNS	O	group	dobj	25	SENT_200	[p12l1217t1377r1397b1422],
28	with	IN	O	with	_	0	SENT_200	[p12l1441t1360r1558b1407],
29	respect	NN	O	respect	_	0	SENT_200	[p12l1601t1369r1790b1421],
30	to	TO	O	to	_	0	SENT_200	[p12l1832t1369r1881b1407],
31	baseline	NN	O	baseline	nn	32	SENT_200	[p12l1924t1360r2142b1407],
32	variables	NNS	O	variable	prep_with_respect_to	25	SENT_200	[p12l643t1435r875b1483],
33	while	IN	O	while	_	0	SENT_200	[p12l892t1435r1036b1483],
34	accounting	VBG	O	account	prepc_while	25	SENT_200	[p12l1054t1438r1346b1498],
35	for	IN	O	for	_	0	SENT_200	[p12l1362t1435r1438b1483],
36	matched	VBN	O	match	amod	37	SENT_200	[p12l1453t1435r1682b1483],
37	pairs	NNS	O	pair	prep_for	34	SENT_200	[p12l1697t1438r1841b1497],
38	.	.	O	.	_	0	SENT_200	[p12l1697t1438r1841b1497],

1	Because	IN	O	because	_	0	SENT_201	[p12l1863t1440r2075b1483],
2	of	IN	O	of	_	0	SENT_201	[p12l2093t1435r2152b1483],
3	repeated	VBN	O	repeat	amod	4	SENT_201	[p12l644t1512r871b1574],
4	measurements	NNS	O	measurement	prep_because_of	15	SENT_201	[p12l921t1522r1315b1559],
5	of	IN	O	of	_	0	SENT_201	[p12l1368t1512r1427b1559],
6	primary	JJ	O	primary	amod	10	SENT_201	[p12l1468t1515r1681b1574],
7	and	CC	O	and	_	0	SENT_201	[p12l1730t1512r1828b1559],
8	secondary	JJ	O	secondary	amod	10	SENT_201	[p12l1879t1512r2144b1574],
9	response	NN	O	response	nn	10	SENT_201	[p12l644t1606r881b1650],
10	variables	NNS	O	variable	prep_of	4	SENT_201	[p12l902t1589r1134b1636],
11	over	IN	O	over	_	0	SENT_201	[p12l1159t1606r1270b1636],
12	time	NN	O	time	prep_over	10	SENT_201	[p12l1290t1592r1424b1643],
13	,	,	O	,	_	0	SENT_201	[p12l1290t1592r1424b1643],
14	we	PRP	O	we	nsubj	15	SENT_201	[p12l1447t1606r1520b1636],
15	used	VBD	O	use	_	0	SENT_201	[p12l1542t1589r1667b1636],
16	longitudinal	JJ	O	longitudinal	amod	18	SENT_201	[p12l1687t1589r2012b1651],
17	data	NN	O	datum	nn	18	SENT_201	[p12l2035t1589r2143b1636],
18	analysis	NN	O	analysis	dobj	15	SENT_201	[p12l645t1664r867b1727],
19	,	,	O	,	_	0	SENT_201	[p12l645t1664r867b1727],
20	incorporating	VBG	O	incorporate	partmod	15	SENT_201	[p12l889t1667r1250b1727],
21	all	DT	O	all	det	22	SENT_201	[p12l1270t1664r1330b1712],
22	data	NNS	O	datum	dobj	20	SENT_201	[p12l1349t1664r1457b1712],
23	from	IN	O	from	_	0	SENT_201	[p12l1475t1664r1606b1712],
24	study	NN	O	study	nn	25	SENT_201	[p12l1626t1664r1767b1727],
25	participants	NNS	O	participant	prep_from	20	SENT_201	[p12l1784t1667r2111b1726],
26	.	.	O	.	_	0	SENT_201	[p12l1784t1667r2111b1726],

1	For	IN	O	for	_	0	SENT_202	[p12l697t1744r782b1788],
2	the	DT	O	the	det	4	SENT_202	[p12l803t1741r885b1788],
3	primary	JJ	O	primary	amod	4	SENT_202	[p12l908t1744r1120b1803],
4	outcome	NN	O	outcome	prep_for	18	SENT_202	[p12l1142t1750r1369b1788],
5	variable	JJ	O	variable	amod	9	SENT_202	[p12l1392t1741r1596b1788],
6	(	NN	O	(	nn	9	SENT_202	[p12l1624t1744r1872b1804],
7	morning	NN	TIME	morning	nn	9	SENT_202	[p12l1624t1744r1872b1804],
8	PEF	NN	O	pef	nn	9	SENT_202	[p12l1898t1744r2019b1804],
9	)	NN	O	)	dep	4	SENT_202	[p12l1898t1744r2019b1804],
10	and	CC	O	and	_	0	SENT_202	[p12l2047t1741r2144b1788],
11	several	JJ	O	several	prep_for	18	SENT_202	[p12l646t1816r824b1864],
12	of	IN	O	of	_	0	SENT_202	[p12l846t1816r904b1864],
13	the	DT	O	the	det	15	SENT_202	[p12l916t1817r998b1864],
14	secondary	JJ	O	secondary	amod	15	SENT_202	[p12l1021t1816r1284b1879],
15	outcomes	NNS	O	outcome	prep_of	11	SENT_202	[p12l1305t1826r1572b1871],
16	,	,	O	,	_	0	SENT_202	[p12l1305t1826r1572b1871],
17	we	PRP	O	we	nsubj	18	SENT_202	[p12l1594t1833r1667b1864],
18	invoked	VBD	O	invoke	_	0	SENT_202	[p12l1688t1816r1896b1864],
19	a	DT	O	a	det	20	SENT_202	[p12l1917t1833r1943b1864],
20	mixedeffects	NNS	O	mixedeffect	nsubj	24	SENT_202	[p12l1964t1816r2141b1864, p12l645t1892r811b1940],
21	linear	JJ	O	linear	amod	22	SENT_202	[p12l843t1892r996b1940],
22	model	NN	O	model	dep	20	SENT_202	[p12l1026t1892r1263b1940],
23	“‘	CD	NUMBER	“‘	num	24	SENT_202	[p12l1026t1892r1263b1940],
24	“	NN	O	“	xcomp	18	SENT_202	[p12l1026t1892r1263b1940],
25	that	WDT	O	that	nsubj	26	SENT_202	[p12l1295t1892r1397b1940],
26	included	VBD	O	include	rcmod	24	SENT_202	[p12l1427t1892r1656b1940],
27	an	DT	O	a	dobj	26	SENT_202	[p12l1688t1909r1750b1940],
28	intercept	VB	O	intercept	dep	27	SENT_202	[p12l1782t1895r2016b1954],
29	and	CC	O	and	_	0	SENT_202	[p12l2047t1892r2144b1940],
30	three	CD	NUMBER	three	num	31	SENT_202	[p12l8t2300r199b2368],
31	slopes	NNS	O	slope	nsubj	51	SENT_202	[p12l275t2300r501b2389],
32	for	IN	O	for	_	0	SENT_202	[p12l576t2300r682b2368],
33	the	DT	O	the	det	36	SENT_202	[p12l752t2300r869b2368],
34	first	JJ	ORDINAL	first	amod	36	SENT_202	[p12l942t2300r1091b2368],
35	treatment	NN	O	treatment	nn	36	SENT_202	[p12l1161t2314r1530b2368],
36	period	NN	O	period	prep_for	31	SENT_202	[p12l1601t2300r1841b2389],
37	(	CD	NUMBER	(	num	39	SENT_202	[p12l1918t2300r2142b2390],
38	study	NN	O	study	nn	39	SENT_202	[p12l1918t2300r2142b2390],
39	weeks	NNS	DURATION	week	dep	36	SENT_202	[p12l7t2410r232b2477],
40	8-10	CD	NUMBER	8-10	dep	36	SENT_202	[p12l291t2416r476b2488],
41	,	,	O	,	_	0	SENT_202	[p12l291t2416r476b2488],
42	weeks	NNS	DURATION	week	conj_and	36	SENT_202	[p12l533t2410r759b2477],
43	10-14	CD	NUMBER	10-14	dep	42	SENT_202	[p12l819t2416r1034b2488],
44	,	,	O	,	_	0	SENT_202	[p12l819t2416r1034b2488],
45	and	CC	O	and	_	0	SENT_202	[p12l1094t2410r1232b2477],
46	weeks	NNS	DURATION	week	conj_and	36	SENT_202	[p12l1284t2410r1509b2477],
47	14-26	CD	NUMBER	14-26	num	46	SENT_202	[p12l1570t2416r1797b2500],
48	)	NN	O	)	dep	46	SENT_202	[p12l1570t2416r1797b2500],
49	and	CC	O	and	_	0	SENT_202	[p12l1859t2410r1996b2477],
50	an	DT	O	a	conj_and	48	SENT_202	[p12l2051t2434r2140b2477],
51	intercept	VB	O	intercept	conj_and	28	SENT_202	[p12l9t2524r341b2608],
52	and	CC	O	and	_	0	SENT_202	[p12l397t2519r535b2588],
53	three	CD	NUMBER	three	num	54	SENT_202	[p12l589t2519r780b2588],
54	slopes	NNS	O	slope	conj_and	24	SENT_202	[p12l840t2519r1066b2608],
55	for	IN	O	for	_	0	SENT_202	[p12l1125t2519r1231b2588],
56	the	DT	O	the	det	59	SENT_202	[p12l1285t2519r1400b2588],
57	second	JJ	ORDINAL	second	amod	59	SENT_202	[p12l1460t2519r1719b2588],
58	treatment	NN	O	treatment	nn	59	SENT_202	[p12l1772t2533r2141b2588],
59	period	NN	O	period	prep_for	54	SENT_202	[p12l8t2628r248b2717],
60	(	CD	NUMBER	(	num	62	SENT_202	[p12l353t2628r577b2718],
61	study	NN	O	study	nn	62	SENT_202	[p12l353t2628r577b2718],
62	weeks	NNS	DURATION	week	dep	59	SENT_202	[p12l672t2628r898b2696],
63	34-36	CD	NUMBER	34-36	dep	59	SENT_202	[p12l1004t2634r1235b2706],
64	,	,	O	,	_	0	SENT_202	[p12l1004t2634r1235b2706],
65	weeks	NNS	DURATION	week	conj_and	59	SENT_202	[p12l1336t2628r1562b2696],
66	36-40	CD	NUMBER	36-40	dep	65	SENT_202	[p12l1668t2634r1899b2706],
67	,	,	O	,	_	0	SENT_202	[p12l1668t2634r1899b2706],
68	and	CC	O	and	_	0	SENT_202	[p12l2003t2628r2141b2696],
69	weeks	NNS	DURATION	week	prep_for	54	SENT_202	[p12l7t2738r232b2805],
70	40-52	CD	NUMBER	40-52	num	71	SENT_202	[p12l263t2742r527b2828],
71	)	NN	O	)	dep	69	SENT_202	[p12l263t2742r527b2828],
72	.	.	O	.	_	0	SENT_202	[p12l263t2742r527b2828],

1	Because	IN	O	because	mark	5	SENT_203	[p12l564t2745r864b2805],
2	we	PRP	O	we	nsubj	5	SENT_203	[p12l893t2762r996b2805],
3	were	VBD	O	be	cop	5	SENT_203	[p12l1024t2762r1202b2805],
4	mainly	RB	O	mainly	advmod	5	SENT_203	[p12l1232t2738r1492b2827],
5	interested	JJ	O	interested	advcl	28	SENT_203	[p12l1520t2738r1892b2805],
6	in	IN	O	in	_	0	SENT_203	[p12l1921t2742r1995b2804],
7	the	DT	O	the	det	9	SENT_203	[p12l2023t2738r2139b2805],
8	genotype-stratiﬁed	JJ	O	genotype-stratiﬁed	amod	9	SENT_203	[p12l10t2846r705b2936],
9	response	NN	O	response	prep_in	5	SENT_203	[p12l752t2871r1086b2935],
10	to	TO	O	to	_	0	SENT_203	[p12l1134t2860r1203b2914],
11	18	CD	DURATION	18	num	12	SENT_203	[p12l1255t2853r1330b2914],
12	weeks	NNS	NUMBER	week	prep_to	5	SENT_203	[p12l1377t2846r1603b2915],
13	of	IN	O	of	_	0	SENT_203	[p12l1655t2846r1738b2914],
14	treatment	NN	O	treatment	prep_of	12	SENT_203	[p12l1772t2860r2141b2915],
15	with	IN	O	with	_	0	SENT_203	[p12l7t2956r172b3024],
16	salmeterol	NN	O	salmeterol	prep_with	5	SENT_203	[p12l220t2956r609b3024],
17	versus	CC	O	versus	prep	16	SENT_203	[p12l653t2980r891b3024],
18	placebo	NN	O	placebo	dep	17	SENT_203	[p12l939t2956r1241b3045],
19	,	,	O	,	_	0	SENT_203	[p12l939t2956r1241b3045],
20	data	NNS	O	datum	nsubjpass	28	SENT_203	[p12l1292t2956r1444b3024],
21	from	IN	O	from	_	0	SENT_203	[p12l1490t2956r1674b3024],
22	run-in	NN	O	run-in	nn	25	SENT_203	[p12l1721t2961r1957b3024],
23	and	CC	O	and	_	0	SENT_203	[p12l2003t2956r2141b3024],
24	run-out	NN	O	run-out	nn	25	SENT_203	[p12l9t3080r292b3134],
25	periods	NNS	O	period	prep_from	20	SENT_203	[p12l337t3067r612b3154],
26	were	VBD	O	be	auxpass	28	SENT_203	[p12l660t3091r838b3134],
27	not	RB	O	not	neg	28	SENT_203	[p12l886t3080r1008b3134],
28	included	VBN	O	include	_	0	SENT_203	[p12l1054t3067r1380b3134],
29	because	IN	O	because	mark	31	SENT_203	[p12l1430t3067r1726b3134],
30	treatment	NN	O	treatment	nsubj	31	SENT_203	[p12l1773t3080r2141b3134],
31	altered	VBD	O	alter	advcl	28	SENT_203	[p12l10t3174r262b3243],
32	substantially	RB	O	substantially	advmod	31	SENT_203	[p12l291t3174r761b3264],
33	when	WRB	O	when	advmod	35	SENT_203	[p12l785t3174r991b3243],
34	participants	NNS	O	participant	nsubj	35	SENT_203	[p12l1017t3179r1457b3263],
35	went	VBD	O	go	conj_and	35	SENT_203	[p12l1484t3188r1668b3243],
36	from	IN	O	from	_	0	SENT_203	[p12l1693t3174r1878b3242],
37	run-in	NN	O	run-in	prep_from	35	SENT_203	[p12l1904t3179r2140b3242],
38	to	TO	O	to	_	0	SENT_203	[p12l8t3298r76b3352],
39	treatment	NN	O	treatment	nn	40	SENT_203	[p12l96t3298r465b3352],
40	period	NN	O	period	prep_to	35	SENT_203	[p12l483t3284r723b3373],
41	and	CC	O	and	_	0	SENT_203	[p12l743t3284r880b3352],
42	from	IN	O	from	_	0	SENT_203	[p12l899t3284r1083b3352],
43	treatment	NN	O	treatment	prep_from	35	SENT_203	[p12l1102t3297r1470b3352],
44	to	TO	O	to	_	0	SENT_203	[p12l1487t3297r1556b3352],
45	run-out	JJ	O	run-out	amod	46	SENT_203	[p12l1577t3297r1861b3352],
46	period	NN	O	period	prep_to	35	SENT_203	[p12l1879t3284r2136b3373],
47	.	.	O	.	_	0	SENT_203	[p12l1879t3284r2136b3373],

1	Inclusion	NN	O	inclusion	nsubj	9	SENT_204	[p12l13t3394r365b3462],
2	of	IN	O	of	_	0	SENT_204	[p12l395t3393r478b3462],
3	either	DT	O	either	prep_of	1	SENT_204	[p12l495t3394r712b3462],
4	of	IN	O	of	_	0	SENT_204	[p12l741t3393r823b3462],
5	these	DT	O	these	det	6	SENT_204	[p12l838t3394r1034b3462],
6	phases	NNS	O	phase	prep_of	3	SENT_204	[p12l1063t3394r1314b3482],
7	could	MD	O	could	aux	9	SENT_204	[p12l1347t3394r1551b3462],
8	artiﬁcially	RB	O	artiﬁcially	advmod	9	SENT_204	[p12l1580t3393r1950b3483],
9	alter	VB	O	alter	_	0	SENT_204	[p12l1977t3394r2141b3462],
10	the	DT	O	the	det	12	SENT_204	[p12l8t3502r123b3570],
11	longitudinal	JJ	O	longitudinal	amod	12	SENT_204	[p12l162t3502r621b3592],
12	model	NN	O	model	dobj	9	SENT_204	[p12l659t3502r912b3580],
13	,	,	O	,	_	0	SENT_204	[p12l659t3502r912b3580],
14	and	CC	O	and	_	0	SENT_204	[p12l956t3502r1093b3570],
15	not	RB	O	not	conj_and	9	SENT_204	[p12l1131t3516r1253b3570],
16	reﬂect	VB	O	reﬂect	dep	9	SENT_204	[p12l1291t3502r1524b3570],
17	true	JJ	O	true	amod	19	SENT_204	[p12l1559t3516r1709b3570],
18	treatmentrelated	JJ	O	treatmentrelated	amod	19	SENT_204	[p12l1748t3516r2138b3570, p12l9t3612r262b3680],
19	effects	NNS	O	effect	dobj	16	SENT_204	[p12l347t3612r603b3680],
20	.	.	O	.	_	0	SENT_204	[p12l347t3612r603b3680],

1	Model	NNP	O	Model	nn	2	SENT_205	[p12l694t3612r925b3680],
2	parameters	NNS	O	parameter	nsubjpass	10	SENT_205	[p12l1009t3626r1428b3701],
3	were	VBD	O	be	auxpass	4	SENT_205	[p12l1513t3636r1691b3680],
4	estimated	VBN	O	estimate	_	0	SENT_205	[p12l1777t3612r2141b3680],
5	separately	RB	O	separately	advmod	4	SENT_205	[p12l12t3722r383b3811],
6	for	IN	O	for	_	0	SENT_205	[p12l445t3721r552b3790],
7	each	DT	O	each	det	8	SENT_205	[p12l616t3722r784b3790],
8	genotype	NN	O	genotype	prep_for	4	SENT_205	[p12l849t3735r1185b3811],
9	and	CC	O	and	_	0	SENT_205	[p12l1251t3722r1388b3790],
10	randomised	VBN	O	randomise	conj_and	4	SENT_205	[p12l1452t3722r1902b3790],
11	drug	NN	O	drug	nn	13	SENT_205	[p12l1966t3722r2140b3811],
12	sequence	NN	O	sequence	nn	13	SENT_205	[p13l11t40r355b105],
13	(	NN	O	(	dobj	10	SENT_205	[p13l380t21r484b106],
14	ie	FW	O	ie	dep	13	SENT_205	[p13l380t21r484b106],
15	,	,	O	,	_	0	SENT_205	[p13l380t21r484b106],
16	placebo	NN	O	placebo	appos	13	SENT_205	[p13l506t16r788b105],
17	followed	VBN	O	follow	partmod	16	SENT_205	[p13l807t16r1125b84],
18	by	IN	O	by	_	0	SENT_205	[p13l1141t16r1228b105],
19	salmeterol	NN	O	salmeterol	agent	17	SENT_205	[p13l1247t16r1636b84],
20	or	CC	O	or	_	0	SENT_205	[p13l1655t41r1732b84],
21	salmeterol	NN	O	salmeterol	conj_or	19	SENT_205	[p13l1751t16r2140b84],
22	followed	VBN	O	follow	partmod	19	SENT_205	[p13l9t126r327b193],
23	by	IN	O	by	_	0	SENT_205	[p13l359t126r446b215],
24	placebo	NN	O	placebo	nn	25	SENT_205	[p13l478t126r808b216],
25	)	NN	O	)	agent	22	SENT_205	[p13l478t126r808b216],
26	.	.	O	.	_	0	SENT_205	[p13l478t126r808b216],

1	Outcome	NNP	O	Outcome	nn	2	SENT_206	[p13l849t132r1191b193],
2	Variables	NNP	O	Variables	nsubjpass	9	SENT_206	[p13l1225t126r1552b193],
3	based	VBN	O	base	_	0	SENT_206	[p13l1588t126r1803b193],
4	on	IN	O	on	prepc_based_on	2	SENT_206	[p13l1838t150r1931b193],
5	daily	JJ	SET	daily	amod	7	SENT_206	[p13l1966t126r2142b215],
6	diary	NN	O	diary	nn	7	SENT_206	[p13l10t235r195b324],
7	records	NNS	O	record	pobj	2	SENT_206	[p13l222t235r495b303],
8	were	VBD	O	be	auxpass	9	SENT_206	[p13l525t259r703b303],
9	averaged	VBN	O	average	_	0	SENT_206	[p13l734t235r1062b324],
10	over	IN	O	over	_	0	SENT_206	[p13l1091t259r1249b303],
11	all	DT	O	all	prep_over	9	SENT_206	[p13l1278t235r1362b303],
12	of	IN	O	of	_	0	SENT_206	[p13l1393t234r1476b303],
13	the	DT	DURATION	the	det	14	SENT_206	[p13l1491t235r1607b303],
14	days	NNS	DURATION	day	prep_of	11	SENT_206	[p13l1638t235r1798b324],
15	between	IN	O	between	_	0	SENT_206	[p13l1828t235r2140b303],
16	clinic	NN	O	clinic	nn	17	SENT_206	[p13l9t343r209b411],
17	Visits	NNS	O	visit	prep_between	14	SENT_206	[p13l265t348r454b411],
18	before	IN	O	before	_	0	SENT_206	[p13l512t343r747b411],
19	data	NN	O	datum	nn	20	SENT_206	[p13l806t343r959b411],
20	analysis	NN	O	analysis	prep_before	9	SENT_206	[p13l1017t343r1330b433],
21	.	.	O	.	_	0	SENT_206	[p13l1017t343r1330b433],

1	For	IN	O	for	_	0	SENT_207	[p13l1395t348r1516b411],
2	most	JJS	O	most	amod	4	SENT_207	[p13l1572t357r1759b411],
3	outcome	NN	O	outcome	nn	4	SENT_207	[p13l1817t357r2139b411],
4	Variables	NNS	O	variable	prep_for	8	SENT_207	[p13l7t453r355b531],
5	,	,	O	,	_	0	SENT_207	[p13l7t453r355b531],
6	values	NNS	O	value	nsubjpass	8	SENT_207	[p13l389t453r620b520],
7	were	VBD	O	be	auxpass	8	SENT_207	[p13l652t477r830b520],
8	estimated	VBN	O	estimate	_	0	SENT_207	[p13l864t453r1228b520],
9	from	IN	O	from	_	0	SENT_207	[p13l1258t453r1442b520],
10	the	DT	O	the	det	11	SENT_207	[p13l1473t453r1589b520],
11	model	NN	O	model	prep_from	8	SENT_207	[p13l1621t453r1856b520],
12	for	IN	O	for	_	0	SENT_207	[p13l1887t453r1994b520],
13	the	DT	O	the	det	14	SENT_207	[p13l2023t453r2139b520],
14	beginning	NN	O	beginning	prep_for	11	SENT_207	[p13l7t561r392b651],
15	and	CC	O	and	_	0	SENT_207	[p13l460t561r597b629],
16	end	NN	O	end	prep_for	11	SENT_207	[p13l664t561r802b629],
17	of	IN	O	of	_	0	SENT_207	[p13l869t561r952b629],
18	each	DT	O	each	det	20	SENT_207	[p13l1007t561r1175b629],
19	treatment	NN	O	treatment	nn	20	SENT_207	[p13l1241t575r1609b629],
20	period	NN	O	period	prep_of	14	SENT_207	[p13l1674t561r1932b650],
21	,	,	O	,	_	0	SENT_207	[p13l1674t561r1932b650],
22	and	CC	O	and	_	0	SENT_207	[p13l2003t561r2141b629],
23	appropriate	JJ	O	appropriate	nsubj	24	SENT_207	[p13l10t675r438b759],
24	contrasts	VBZ	O	contrast	conj_and	8	SENT_207	[p13l500t684r833b738],
25	comparing	VBG	O	compare	xcomp	24	SENT_207	[p13l896t675r1301b760],
26	treatment	NN	O	treatment	nn	27	SENT_207	[p13l1359t684r1728b738],
27	regimens	NNS	O	regimen	nsubjpass	29	SENT_207	[p13l1787t675r2138b760],
28	were	VBD	O	be	auxpass	29	SENT_207	[p13l7t805r184b849],
29	calculated	VBN	O	calculate	ccomp	25	SENT_207	[p13l219t781r607b849],
30	.	.	O	.	_	0	SENT_207	[p13l219t781r607b849],

1	Run-out	NN	O	run-out	nn	2	SENT_208	[p13l647t788r948b849],
2	data	NNS	O	datum	nsubjpass	4	SENT_208	[p13l980t781r1132b849],
3	were	VBD	O	be	auxpass	4	SENT_208	[p13l1162t805r1340b849],
4	modelled	VBN	O	model	_	0	SENT_208	[p13l1373t781r1722b849],
5	separately	RB	O	separately	advmod	4	SENT_208	[p13l1755t781r2136b870],
6	,	,	O	,	_	0	SENT_208	[p13l1755t781r2136b870],
7	ﬁtting	VBG	O	ﬁtting	xcomp	4	SENT_208	[p13l9t889r235b979],
8	an	DT	O	a	dobj	7	SENT_208	[p13l276t914r365b957],
9	intercept	VB	O	intercept	dep	8	SENT_208	[p13l406t894r739b978],
10	and	CC	O	and	_	0	SENT_208	[p13l779t889r917b957],
11	one	CD	NUMBER	one	num	12	SENT_208	[p13l957t914r1091b957],
12	slope	NN	O	slope	nsubj	24	SENT_208	[p13l1136t889r1326b978],
13	for	IN	O	for	_	0	SENT_208	[p13l1367t889r1473b957],
14	the	DT	O	the	det	19	SENT_208	[p13l1511t889r1628b957],
15	ﬁrst	JJ	O	ﬁrst	amod	19	SENT_208	[p13l1669t889r1819b957],
16	run-out	NN	O	run-out	nn	19	SENT_208	[p13l1858t903r2141b957],
17	(	NN	O	(	nn	19	SENT_208	[p13l14t998r238b1088],
18	study	NN	O	study	nn	19	SENT_208	[p13l14t998r238b1088],
19	weeks	NNS	DURATION	week	prep_for	12	SENT_208	[p13l268t998r493b1066],
20	26-34	CD	NUMBER	26-34	dep	19	SENT_208	[p13l532t1004r768b1088],
21	)	NN	O	)	dep	20	SENT_208	[p13l532t1004r768b1088],
22	and	CC	O	and	_	0	SENT_208	[p13l809t998r947b1066],
23	an	DT	O	a	conj_and	21	SENT_208	[p13l980t1022r1069b1066],
24	intercept	VB	O	intercept	conj_and	9	SENT_208	[p13l1102t1003r1435b1087],
25	and	CC	O	and	_	0	SENT_208	[p13l1468t998r1606b1066],
26	one	CD	NUMBER	one	num	27	SENT_208	[p13l1640t1022r1774b1066],
27	slope	NN	O	slope	dep	37	SENT_208	[p13l1811t998r2001b1087],
28	for	IN	O	for	_	0	SENT_208	[p13l2035t998r2141b1066],
29	the	DT	O	the	det	32	SENT_208	[p13l8t1108r123b1175],
30	second	JJ	ORDINAL	second	amod	32	SENT_208	[p13l152t1108r409b1175],
31	run-out	NN	O	run-out	nn	32	SENT_208	[p13l433t1121r716b1175],
32	period	NN	O	period	prep_for	27	SENT_208	[p13l738t1108r979b1197],
33	(	CD	NUMBER	(	num	35	SENT_208	[p13l1007t1108r1231b1198],
34	study	NN	O	study	nn	35	SENT_208	[p13l1007t1108r1231b1198],
35	weeks	NNS	DURATION	week	dep	32	SENT_208	[p13l1252t1108r1477b1175],
36	52-62	CD	NUMBER	52-62	num	37	SENT_208	[p13l1508t1112r1771b1198],
37	)	NN	O	)	conj_and	4	SENT_208	[p13l1508t1112r1771b1198],
38	.	.	O	.	_	0	SENT_208	[p13l1508t1112r1771b1198],

1	Different	JJ	O	different	amod	3	SENT_209	[p13l1803t1108r2141b1175],
2	model	NN	O	model	nn	3	SENT_209	[p13l9t1216r243b1285],
3	speciﬁcations	NNS	O	speciﬁcations	nsubjpass	5	SENT_209	[p13l329t1216r831b1305],
4	were	VBD	O	be	auxpass	5	SENT_209	[p13l915t1241r1093b1285],
5	required	VBN	O	require	dep	17	SENT_209	[p13l1176t1216r1496b1305],
6	for	IN	O	for	_	0	SENT_209	[p13l1577t1216r1684b1284],
7	secondary	JJ	O	secondary	amod	9	SENT_209	[p13l1769t1216r2142b1306],
8	outcome	NN	O	outcome	nn	9	SENT_209	[p13l9t1340r333b1394],
9	Variables	NNS	O	variable	prep_for	5	SENT_209	[p13l377t1326r704b1394],
10	that	WDT	O	that	nsubjpass	13	SENT_209	[p13l751t1326r896b1394],
11	were	VBD	O	be	auxpass	13	SENT_209	[p13l938t1350r1116b1394],
12	not	RB	O	not	neg	13	SENT_209	[p13l1162t1339r1285b1394],
13	obtained	VBN	O	obtain	rcmod	9	SENT_209	[p13l1331t1326r1654b1394],
14	at	IN	O	at	_	0	SENT_209	[p13l1699t1340r1764b1394],
15	all	DT	O	all	det	16	SENT_209	[p13l1809t1326r1895b1394],
16	study	NN	O	study	prep_at	13	SENT_209	[p13l1942t1326r2142b1415],
17	Visits	VBZ	O	visit	_	0	SENT_209	[p13l7t1441r195b1505],
18	(	CD	NUMBER	(	dobj	17	SENT_209	[p13l246t1443r370b1526],
19	eg	FW	O	eg	nsubj	17	SENT_209	[p13l246t1443r370b1526],
20	,	,	O	,	_	0	SENT_209	[p13l246t1443r370b1526],
21	methacholine	JJ	O	methacholine	amod	22	SENT_209	[p13l416t1437r930b1505],
22	PCZO	NN	ORGANIZATION	pczo	appos	19	SENT_209	[p13l976t1442r1128b1523],
23	was	VBD	O	be	auxpass	24	SENT_209	[p13l1168t1461r1306b1505],
24	obtained	VBN	O	obtain	rcmod	22	SENT_209	[p13l1352t1437r1676b1505],
25	only	RB	O	only	advmod	24	SENT_209	[p13l1718t1437r1877b1526],
26	at	IN	O	at	_	0	SENT_209	[p13l1918t1451r1983b1505],
27	the	DT	O	the	det	28	SENT_209	[p13l2023t1437r2139b1505],
28	beginning	NN	O	beginning	prep_at	24	SENT_209	[p13l7t1546r392b1635],
29	and	CC	O	and	_	0	SENT_209	[p13l416t1546r554b1613],
30	end	NN	O	end	conj_and	28	SENT_209	[p13l577t1546r715b1613],
31	of	IN	O	of	_	0	SENT_209	[p13l737t1546r820b1613],
32	each	DT	O	each	det	34	SENT_209	[p13l831t1546r999b1613],
33	treatment	NN	O	treatment	nn	34	SENT_209	[p13l1021t1559r1390b1613],
34	period	NN	O	period	prep_of	28	SENT_209	[p13l1411t1546r1668b1634],
35	,	,	O	,	_	0	SENT_209	[p13l1411t1546r1668b1634],
36	allowing	VBG	O	allow	xcomp	24	SENT_209	[p13l1696t1546r2012b1635],
37	for	IN	O	for	_	0	SENT_209	[p13l2035t1546r2141b1613],
38	estimation	NN	O	estimation	prep_for	36	SENT_209	[p13l10t1659r407b1723],
39	of	IN	O	of	_	0	SENT_209	[p13l446t1654r529b1723],
40	only	RB	O	only	advmod	45	SENT_209	[p13l555t1654r713b1744],
41	one	CD	NUMBER	one	num	43	SENT_209	[p13l750t1679r884b1722],
42	treatment	NN	O	treatment	nn	43	SENT_209	[p13l921t1668r1290b1722],
43	period	NN	O	period	pobj	40	SENT_209	[p13l1327t1654r1567b1743],
44	slope	NN	O	slope	nn	45	SENT_209	[p13l1606t1654r1843b1744],
45	)	NN	O	)	prep_of	38	SENT_209	[p13l1606t1654r1843b1744],
46	.	.	O	.	_	0	SENT_209	[p13l1606t1654r1843b1744],

1	Use	NN	O	use	nsubj	7	SENT_210	[p13l1889t1661r2030b1723],
2	of	IN	O	of	_	0	SENT_210	[p13l2070t1654r2153b1722],
3	rescue	NN	O	rescue	nn	4	SENT_210	[p13l9t1788r249b1832],
4	therapy	NN	O	therapy	prep_of	1	SENT_210	[p13l291t1764r573b1853],
5	and	CC	O	and	_	0	SENT_210	[p13l615t1764r752b1832],
6	symptom	NN	O	symptom	prep_of	1	SENT_210	[p13l796t1778r1147b1853],
7	score	VBP	NUMBER	score	_	0	SENT_210	[p13l1192t1788r1382b1832],
8	data	NNS	O	datum	nsubj	9	SENT_210	[p13l1426t1764r1579b1832],
9	showed	VBD	O	show	ccomp	7	SENT_210	[p13l1624t1764r1905b1832],
10	scant	JJ	O	scant	amod	11	SENT_210	[p13l1949t1778r2141b1832],
11	Variability	NN	O	variability	dobj	9	SENT_210	[p13l7t1875r387b1964],
12	,	,	O	,	_	0	SENT_210	[p13l7t1875r387b1964],
13	and	CC	O	and	_	0	SENT_210	[p13l434t1875r571b1943],
14	Values	NNS	O	value	nsubj	20	SENT_210	[p13l611t1875r842b1943],
15	were	VBD	O	be	cop	20	SENT_210	[p13l885t1899r1063b1943],
16	generally	RB	O	generally	advmod	20	SENT_210	[p13l1108t1875r1448b1964],
17	Very	RB	O	very	advmod	20	SENT_210	[p13l1487t1899r1642b1964],
18	small	JJ	O	small	amod	20	SENT_210	[p13l1686t1875r1886b1943],
19	(	NN	O	(	nn	20	SENT_210	[p13l1934t1875r2139b1964],
20	close	NN	O	close	conj_and	7	SENT_210	[p13l1934t1875r2139b1964],
21	to	TO	O	to	_	0	SENT_210	[p13l8t1997r76b2051],
22	o	NN	O	o	nn	23	SENT_210	[p13l112t1990r199b2073],
23	)	NN	O	)	prep_to	20	SENT_210	[p13l112t1990r199b2073],
24	.	.	O	.	_	0	SENT_210	[p13l112t1990r199b2073],

1	Therefore	RB	O	therefore	advmod	7	SENT_211	[p13l235t1983r623b2061],
2	,	,	O	,	_	0	SENT_211	[p13l235t1983r623b2061],
3	these	DT	O	these	det	5	SENT_211	[p13l659t1983r854b2051],
4	outcome	NN	O	outcome	nn	5	SENT_211	[p13l890t1997r1212b2051],
5	Variables	NNS	O	variable	nsubjpass	7	SENT_211	[p13l1245t1983r1572b2052],
6	were	VBD	O	be	auxpass	7	SENT_211	[p13l1606t2008r1784b2052],
7	analysed	VBN	O	analyse	_	0	SENT_211	[p13l1819t1983r2141b2073],
8	Via	NNP	O	Via	nn	9	SENT_211	[p13l7t2097r111b2160],
9	Wilcoxon	NNP	PERSON	Wilcoxon	nsubj	10	SENT_211	[p13l145t2092r494b2160],
10	signed	VBD	O	sign	ccomp	7	SENT_211	[p13l531t2092r776b2182],
11	rank	NN	O	rank	nn	12	SENT_211	[p13l810t2092r981b2160],
12	tests	NNS	O	test	dobj	10	SENT_211	[p13l1013t2105r1179b2160],
13	and	CC	O	and	_	0	SENT_211	[p13l1217t2092r1355b2160],
14	Wilcoxon	NNP	PERSON	Wilcoxon	nn	17	SENT_211	[p13l1387t2092r1736b2160],
15	rank	NN	O	rank	nn	17	SENT_211	[p13l1771t2092r1942b2160],
16	sum	NN	O	sum	nn	17	SENT_211	[p13l1978t2116r2140b2160],
17	tests	NNS	O	test	dobj	10	SENT_211	[p13l8t2215r194b2270],
18	.	.	O	.	_	0	SENT_211	[p13l8t2215r194b2270],

1	I-Iodges	NNS	O	i-iodge	_	0	SENT_212	[p13l228t2202r921b2291],
2	.	.	O	.	_	0	SENT_212	[p13l228t2202r921b2291],

1	—	NN	O	—	_	0	SENT_213	[p13l228t2202r921b2291],
2	.	.	O	.	_	0	SENT_213	[p13l228t2202r921b2291],

1	Lehmann	NNP	PERSON	Lehmann	nsubj	2	SENT_214	[p13l228t2202r921b2291],
2	estimates	VBZ	O	estimate	_	0	SENT_214	[p13l947t2206r1297b2270],
3	for	IN	O	for	mark	18	SENT_214	[p13l1326t2201r1432b2270],
4	the	DT	O	the	det	8	SENT_214	[p13l1455t2202r1570b2270],
5	median	JJ	O	median	amod	8	SENT_214	[p13l1597t2202r1880b2270],
6	paired	JJ	O	paired	amod	8	SENT_214	[p13l1905t2202r2141b2290],
7	difference	NN	O	difference	nn	8	SENT_214	[p13l10t2310r383b2378],
8	(	NN	O	(	nsubj	18	SENT_214	[p13l455t2310r718b2400],
9	within	IN	O	within	_	0	SENT_214	[p13l455t2310r718b2400],
10	genotype	NN	O	genotype	nn	11	SENT_214	[p13l784t2317r1142b2400],
11	)	NN	O	)	prep_within	8	SENT_214	[p13l784t2317r1142b2400],
12	and	CC	O	and	_	0	SENT_214	[p13l1214t2310r1352b2378],
13	median	NN	O	median	nn	15	SENT_214	[p13l1416t2310r1700b2378],
14	difference	NN	O	difference	nn	15	SENT_214	[p13l1766t2310r2139b2378],
15	(	NN	O	(	conj_and	11	SENT_214	[p13l14t2419r347b2509],
16	between	IN	O	between	_	0	SENT_214	[p13l14t2419r347b2509],
17	genotypes	NNS	O	genotype	prep_between	11	SENT_214	[p13l386t2426r782b2509],
18	)	VBP	O	)	advcl	2	SENT_214	[p13l386t2426r782b2509],
19	with	IN	O	with	mark	24	SENT_214	[p13l823t2419r989b2487],
20	95	CD	PERCENT	95	number	21	SENT_214	[p13l1028t2424r1188b2490],
21	%	NN	PERCENT	%	amod	22	SENT_214	[p13l1028t2424r1188b2490],
22	CIs	NNS	O	ci	nsubjpass	24	SENT_214	[p13l1230t2424r1352b2487],
23	are	VBP	O	be	auxpass	24	SENT_214	[p13l1394t2443r1505b2487],
24	presented	VBN	O	present	advcl	18	SENT_214	[p13l1543t2419r1974b2508],
25	.	.	O	.	_	0	SENT_214	[p13l1543t2419r1974b2508],

1	“	NN	O	“	nsubj	2	SENT_215	[p13l1543t2419r1974b2508],
2	See	VB	O	see	_	0	SENT_215	[p13l2018t2424r2139b2487],
3	webappendix	NN	O	webappendix	nn	4	SENT_215	[p13l7t2530r503b2619],
4	p	NN	O	p	dobj	2	SENT_215	[p13l529t2554r573b2619],
5	1	CD	NUMBER	1	num	4	SENT_215	[p13l606t2536r637b2596],
6	for	IN	O	for	_	0	SENT_215	[p13l665t2530r772b2598],
7	more	JJR	O	more	amod	9	SENT_215	[p13l799t2554r995b2598],
8	detailed	JJ	O	detailed	amod	9	SENT_215	[p13l1025t2530r1318b2598],
9	explanations	NNS	O	explanation	prep_for	2	SENT_215	[p13l1346t2530r1814b2619],
10	of	IN	O	of	_	0	SENT_215	[p13l1846t2530r1929b2598],
11	these	DT	O	these	det	13	SENT_215	[p13l1944t2530r2139b2598],
12	statistical	JJ	O	statistical	amod	13	SENT_215	[p13l11t2638r357b2707],
13	analyses	NNS	O	analysis	prep_of	9	SENT_215	[p13l384t2638r712b2728],
14	.	.	O	.	_	0	SENT_215	[p13l384t2638r712b2728],

1	PROC	NNP	O	PROC	nn	2	SENT_216	[p13l83t2753r312b2816],
2	MIXED	NNP	O	MIXED	_	0	SENT_216	[p13l370t2753r653b2815],
3	of	IN	O	of	_	0	SENT_216	[p13l709t2748r791b2816],
4	the	DT	O	the	det	8	SENT_216	[p13l830t2748r946b2816],
5	SAS/STAT	NNP	O	SAS/STAT	nn	8	SENT_216	[p13l1004t2753r1394b2837],
6	statistical	JJ	O	statistical	amod	8	SENT_216	[p13l1447t2748r1793b2816],
7	analysis	NN	O	analysis	nn	8	SENT_216	[p13l1845t2748r2137b2837],
8	software	NN	O	software	prep_of	2	SENT_216	[p13l12t2857r322b2926],
9	(	CD	NUMBER	(	num	12	SENT_216	[p13l363t2862r657b2947],
10	Version	NNP	O	Version	nn	12	SENT_216	[p13l363t2862r657b2947],
11	9.1	CD	NUMBER	9.1	num	12	SENT_216	[p13l693t2864r813b2947],
12	)	NN	O	)	nsubjpass	14	SENT_216	[p13l693t2864r813b2947],
13	was	VBD	O	be	auxpass	14	SENT_216	[p13l852t2882r990b2926],
14	used	VBN	O	use	dep	2	SENT_216	[p13l1025t2858r1203b2926],
15	for	IN	O	for	_	0	SENT_216	[p13l1236t2857r1343b2926],
16	all	DT	O	all	det	19	SENT_216	[p13l1376t2858r1461b2926],
17	longitudinal	JJ	O	longitudinal	amod	19	SENT_216	[p13l1494t2858r1952b2947],
18	data	NN	O	datum	nn	19	SENT_216	[p13l1988t2858r2140b2926],
19	analyses	NNS	O	analysis	prep_for	14	SENT_216	[p13l10t2966r339b3056],
20	,	,	O	,	_	0	SENT_216	[p13l10t2966r339b3056],
21	with	IN	O	with	_	0	SENT_216	[p13l405t2966r571b3035],
22	other	JJ	O	other	amod	24	SENT_216	[p13l636t2966r832b3034],
23	SAS	NNP	O	SAS	nn	24	SENT_216	[p13l900t2972r1047b3035],
24	procedures	NNS	O	procedure	prep_with	2	SENT_216	[p13l1116t2966r1531b3055],
25	for	IN	O	for	_	0	SENT_216	[p13l1597t2966r1704b3035],
26	additional	JJ	O	additional	amod	28	SENT_216	[p13l1768t2966r2140b3035],
27	statistical	JJ	O	statistical	amod	28	SENT_216	[p13l11t3075r357b3143],
28	analyses	NNS	O	analysis	prep_for	24	SENT_216	[p13l403t3075r732b3164],
29	.	.	O	.	_	0	SENT_216	[p13l403t3075r732b3164],

1	S-plus	NN	O	s-plus	nsubjpass	3	SENT_217	[p13l788t3075r1012b3164],
2	was	VBD	O	be	auxpass	3	SENT_217	[p13l1059t3099r1197b3143],
3	used	VBN	O	use	_	0	SENT_217	[p13l1244t3075r1421b3143],
4	to	TO	O	to	aux	5	SENT_217	[p13l1465t3089r1533b3143],
5	generate	VB	O	generate	xcomp	3	SENT_217	[p13l1581t3088r1899b3165],
6	highlevel	JJ	O	highlevel	amod	7	SENT_217	[p13l1945t3075r2138b3165, p13l7t3186r176b3254],
7	graphics	NNS	O	graphic	dobj	5	SENT_217	[p13l213t3186r547b3275],
8	.	.	O	.	_	0	SENT_217	[p13l213t3186r547b3275],

1	p	NN	O	p	nn	2	SENT_218	[p13l586t3210r631b3274],
2	Values	NNS	O	value	nsubjpass	7	SENT_218	[p13l665t3186r896b3254],
3	less	JJR	O	less	amod	2	SENT_218	[p13l933t3186r1070b3254],
4	than	IN	O	than	_	0	SENT_218	[p13l1107t3186r1276b3254],
5	0-05	CD	NUMBER	0-05	prep_than	3	SENT_218	[p13l1311t3190r1481b3254],
6	were	VBD	O	be	auxpass	7	SENT_218	[p13l1518t3210r1696b3254],
7	considered	VBN	O	consider	_	0	SENT_218	[p13l1733t3186r2141b3254],
8	statistically	RB	O	statistically	acomp	7	SENT_218	[p13l11t3294r422b3383],
9	signiﬁcant	NN	O	signiﬁcant	dep	8	SENT_218	[p13l479t3294r888b3384],
10	;	:	O	;	_	0	SENT_218	[p13l479t3294r888b3384],
11	no	DT	O	no	det	12	SENT_218	[p13l948t3319r1041b3362],
12	adjustment	NN	O	adjustment	nsubjpass	14	SENT_218	[p13l1098t3294r1525b3384],
13	was	VBD	O	be	auxpass	14	SENT_218	[p13l1577t3318r1715b3362],
14	made	VBN	O	make	parataxis	7	SENT_218	[p13l1773t3294r1978b3362],
15	for	IN	O	for	_	0	SENT_218	[p13l2035t3294r2141b3362],
16	analysis	NN	O	analysis	prep_for	14	SENT_218	[p13l10t3404r302b3493],
17	of	IN	O	of	_	0	SENT_218	[p13l331t3404r414b3472],
18	multiple	JJ	O	multiple	amod	20	SENT_218	[p13l427t3404r743b3493],
19	secondary	JJ	O	secondary	amod	20	SENT_218	[p13l772t3404r1145b3493],
20	outcomes	NNS	O	outcome	prep_of	16	SENT_218	[p13l1170t3418r1550b3472],
21	.	.	O	.	_	0	SENT_218	[p13l1170t3418r1550b3472],

1	As	IN	O	as	_	0	SENT_219	[p13l78t3519r172b3582],
2	part	NN	O	part	prep_as	15	SENT_219	[p13l213t3527r364b3602],
3	of	IN	O	of	_	0	SENT_219	[p13l402t3513r485b3582],
4	an	DT	O	a	det	6	SENT_219	[p13l512t3538r601b3582],
5	intention-to-treat	JJ	O	intention-to-treat	amod	6	SENT_219	[p13l639t3518r1289b3582],
6	analysis	NN	O	analysis	prep_of	2	SENT_219	[p13l1327t3514r1646b3603],
7	,	,	O	,	_	0	SENT_219	[p13l1327t3514r1646b3603],
8	all	DT	O	all	det	10	SENT_219	[p13l1688t3514r1775b3582],
9	available	JJ	O	available	amod	10	SENT_219	[p13l1814t3514r2139b3582],
10	data	NNS	O	datum	nsubj	35	SENT_219	[p13l9t3623r164b3691],
11	on	IN	O	on	_	0	SENT_219	[p13l204t3648r298b3691],
12	randomised	JJ	O	randomised	amod	13	SENT_219	[p13l338t3623r794b3691],
13	participants	NNS	O	participant	prep_on	10	SENT_219	[p13l831t3628r1279b3712],
14	were	VBD	O	be	auxpass	15	SENT_219	[p13l1319t3648r1499b3692],
15	included	VBN	O	include	_	0	SENT_219	[p13l1539t3623r1870b3691],
16	in	IN	O	in	_	0	SENT_219	[p13l1909t3628r1983b3690],
17	the	DT	O	the	det	19	SENT_219	[p13l2021t3623r2139b3691],
18	statistical	JJ	O	statistical	amod	19	SENT_219	[p14l11t18r364b86],
19	analysis	NN	O	analysis	prep_in	15	SENT_219	[p14l419t18r738b107],
20	,	,	O	,	_	0	SENT_219	[p14l419t18r738b107],
21	whether	IN	O	whether	complm	26	SENT_219	[p14l794t18r1107b86],
22	or	CC	O	or	_	0	SENT_219	[p14l1161t42r1238b86],
23	not	RB	O	not	conj_or	26	SENT_219	[p14l1290t31r1414b86],
24	they	PRP	O	they	nsubj	26	SENT_219	[p14l1466t18r1627b107],
25	had	VBD	O	have	aux	26	SENT_219	[p14l1678t18r1818b86],
26	missed	VBN	O	miss	ccomp	15	SENT_219	[p14l1870t18r2141b86],
27	some	DT	O	some	det	28	SENT_219	[p14l11t152r210b195],
28	visits	NNS	O	visit	dobj	26	SENT_219	[p14l252t132r467b206],
29	,	,	O	,	_	0	SENT_219	[p14l252t132r467b206],
30	dropped	VBD	O	drop	dep	26	SENT_219	[p14l515t128r829b215],
31	out	RP	O	out	prt	30	SENT_219	[p14l872t141r1012b206],
32	,	,	O	,	_	0	SENT_219	[p14l872t141r1012b206],
33	or	CC	O	or	_	0	SENT_219	[p14l1060t152r1137b195],
34	been	VBN	O	be	cop	35	SENT_219	[p14l1177t128r1360b195],
35	non-compliant	JJ	O	non-compliant	conj_or	15	SENT_219	[p14l1404t128r1983b215],
36	.	.	O	.	_	0	SENT_219	[p14l1404t128r1983b215],

1	An	DT	O	a	det	2	SENT_220	[p14l2029t133r2140b194],
2	exception	NN	O	exception	nsubjpass	4	SENT_220	[p14l10t240r370b324],
3	was	VBD	O	be	auxpass	4	SENT_220	[p14l401t259r540b303],
4	made	VBN	O	make	_	0	SENT_220	[p14l575t235r782b303],
5	for	IN	O	for	_	0	SENT_220	[p14l816t235r923b303],
6	three	CD	NUMBER	three	num	9	SENT_220	[p14l953t235r1148b303],
7	B16	NN	O	b16	nn	9	SENT_220	[p14l1185t241r1315b303],
8	Arg/Gly	NN	O	arg/gly	nn	9	SENT_220	[p14l1348t235r1660b325],
9	participants	NNS	O	participant	prep_for	4	SENT_220	[p14l1690t240r2138b324],
10	who	WP	O	who	nsubjpass	13	SENT_220	[p14l7t345r165b412],
11	were	VBD	O	be	auxpass	13	SENT_220	[p14l188t369r367b412],
12	incorrectly	RB	O	incorrectly	advmod	13	SENT_220	[p14l392t345r797b434],
13	categorised	VBN	O	categorise	rcmod	9	SENT_220	[p14l819t345r1248b434],
14	as	IN	O	as	_	0	SENT_220	[p14l1271t369r1344b412],
15	Gly/Gly	NN	O	gly/gly	prep_as	13	SENT_220	[p14l1372t345r1671b434],
16	and	CC	O	and	_	0	SENT_220	[p14l1693t345r1832b412],
17	initially	RB	O	initially	advmod	18	SENT_220	[p14l1854t345r2142b434],
18	randomised	VBN	O	randomise	rcmod	9	SENT_220	[p14l9t454r464b523],
19	in	IN	O	in	_	0	SENT_220	[p14l487t459r562b522],
20	the	DT	O	the	det	21	SENT_220	[p14l584t454r702b523],
21	trial	NN	O	trial	prep_in	18	SENT_220	[p14l725t454r896b523],
22	.	.	O	.	_	0	SENT_220	[p14l725t454r896b523],

1	Data	NNS	O	datum	nsubjpass	7	SENT_221	[p14l927t461r1098b523],
2	for	IN	O	for	_	0	SENT_221	[p14l1121t454r1229b523],
3	these	DT	O	these	det	5	SENT_221	[p14l1250t454r1448b523],
4	three	CD	NUMBER	three	num	5	SENT_221	[p14l1472t454r1666b523],
5	participants	NNS	O	participant	prep_for	1	SENT_221	[p14l1690t459r2137b543],
6	were	VBD	O	be	auxpass	7	SENT_221	[p14l7t588r187b631],
7	removed	VBN	O	remove	_	0	SENT_221	[p14l263t563r594b631],
8	from	IN	O	from	_	0	SENT_221	[p14l669t563r855b631],
9	all	DT	O	all	det	11	SENT_221	[p14l932t563r1018b631],
10	reported	VBN	O	report	amod	11	SENT_221	[p14l1094t563r1415b652],
11	analyses	NNS	O	analysis	prep_from	7	SENT_221	[p14l1491t563r1804b653],
12	(	CD	NUMBER	(	num	13	SENT_221	[p14l1888t568r2140b653],
13	action	NN	O	action	nsubjpass	7	SENT_221	[p14l1888t568r2140b653],
14	approved	VBN	O	approve	partmod	13	SENT_221	[p14l10t673r357b761],
15	by	IN	O	by	_	0	SENT_221	[p14l380t673r468b762],
16	the	DT	O	the	det	17	SENT_221	[p14l490t673r608b740],
17	data	NNS	O	datum	agent	14	SENT_221	[p14l635t673r790b740],
18	and	CC	O	and	_	0	SENT_221	[p14l816t673r955b740],
19	safety	NN	O	safety	nn	22	SENT_221	[p14l982t673r1198b762],
20	monitoring	NN	O	monitoring	nn	22	SENT_221	[p14l1222t677r1656b762],
21	board	NN	O	board	nn	22	SENT_221	[p14l1680t673r1944b763],
22	)	NN	O	)	agent	14	SENT_221	[p14l1680t673r1944b763],
23	.	.	O	.	_	0	SENT_221	[p14l1680t673r1944b763],

1	This	DT	O	this	det	2	SENT_222	[p14l1972t673r2138b740],
2	trial	NN	O	trial	nsubjpass	4	SENT_222	[p14l8t781r159b849],
3	is	VBZ	O	be	auxpass	4	SENT_222	[p14l238t786r297b850],
4	registered	VBN	O	register	_	0	SENT_222	[p14l378t781r758b871],
5	with	IN	O	with	_	0	SENT_222	[p14l834t781r1001b850],
6	ClinicalTrials	NNS	O	clinicaltrial	prep_with	4	SENT_222	[p14l1083t781r1752b871],
7	.	.	O	.	_	0	SENT_222	[p14l1083t781r1752b871],

1	gov	NN	O	gov	_	0	SENT_223	[p14l1083t781r1752b871],
2	,	,	O	,	_	0	SENT_223	[p14l1083t781r1752b871],
3	number	NN	O	number	nn	4	SENT_223	[p14l1834t781r2141b850],
4	NCT00200967	NN	O	nct00200967	appos	1	SENT_223	[p14l11t895r548b961],
5	.	.	O	.	_	0	SENT_223	[p14l11t895r548b961],

1	www	NN	O	www	_	0	SENT_224	[p14l724t1141r1256b1192],
2	.	.	O	.	_	0	SENT_224	[p14l724t1141r1256b1192],

1	the	DT	O	the	det	2	SENT_225	[p14l724t1141r1256b1192],
2	|	NN	O	|	_	0	SENT_225	[p14l724t1141r1256b1192],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_225	[p14l724t1141r1256b1192],
4	Vol	NNP	O	Vol	dep	2	SENT_225	[p14l1299t1141r1386b1192],
5	374	CD	NUMBER	374	num	6	SENT_225	[p14l1406t1148r1508b1200],
6	November	NNP	DATE	November	dep	2	SENT_225	[p14l1556t1141r1849b1192],
7	21,2009	CD	DATE	21,2009	num	6	SENT_225	[p14l1866t1148r2110b1201],

1	Articles	NNPS	O	Articles	_	0	SENT_226	[p14l6t1408r156b1444],
2	I	PRP	O	I	dep	1	SENT_226	[p14l205t1276r252b1444],

1	Arg/Arg	NN	O	arg/arg	nn	2	SENT_227	[p14l490t1654r579b1681],
2	Gly/Gly	NN	O	gly/gly	_	0	SENT_227	[p14l1127t1654r1208b1681],
3	Arg/Arg	NN	O	arg/arg	nn	4	SENT_227	[p14l1762t1654r1851b1681],
4	difference	NN	O	difference	dep	2	SENT_227	[p14l1857t1653r1967b1674],
5	minus	CC	O	minus	advmod	4	SENT_227	[p14l1974t1655r2042b1674],

1	Gly/Gly	RB	O	gly/gly	dep	2	SENT_228	[p14l1763t1688r1843b1715],
2	difference	NN	O	difference	_	0	SENT_228	[p14l1848t1688r1959b1709],

1	Placebo	NNP	O	Placebo	nn	3	SENT_229	[p14l491t1743r570b1764],
2	Salmeterol	NNP	O	Salmeterol	nn	3	SENT_229	[p14l596t1743r707b1764],
3	Difference	NNP	O	Difference	_	0	SENT_229	[p14l736t1743r840b1764],
4	(	CD	PERCENT	(	number	5	SENT_229	[p14l847t1744r901b1769],
5	95	CD	PERCENT	95	num	6	SENT_229	[p14l847t1744r901b1769],
6	%	NN	PERCENT	%	dep	3	SENT_229	[p14l847t1744r901b1769],
7	CI	NN	O	ci	nn	8	SENT_229	[p14l907t1744r934b1769],
8	)	NN	O	)	dep	6	SENT_229	[p14l907t1744r934b1769],
9	p	NN	O	p	nn	13	SENT_229	[p14l999t1750r1011b1770],
10	value	NN	O	value	nn	13	SENT_229	[p14l1017t1743r1072b1764],
11	Placebo	NNP	ORGANIZATION	Placebo	nn	13	SENT_229	[p14l1128t1743r1207b1764],
12	Salmeterol	NNP	ORGANIZATION	Salmeterol	nn	13	SENT_229	[p14l1236t1743r1348b1764],
13	Difference	NNP	ORGANIZATION	Difference	dep	3	SENT_229	[p14l1375t1743r1480b1764],
14	(	CD	PERCENT	(	number	15	SENT_229	[p14l1487t1744r1541b1769],
15	95	CD	PERCENT	95	dep	16	SENT_229	[p14l1487t1744r1541b1769],
16	%	NN	PERCENT	%	dep	18	SENT_229	[p14l1487t1744r1541b1769],
17	CI	NN	O	ci	nn	18	SENT_229	[p14l1547t1744r1573b1769],
18	)	NN	O	)	nn	21	SENT_229	[p14l1547t1744r1573b1769],
19	p	NN	O	p	nn	21	SENT_229	[p14l1637t1750r1649b1770],
20	value	NN	O	value	nn	21	SENT_229	[p14l1655t1743r1710b1764],
21	Estimate	NNP	O	Estimate	dep	13	SENT_229	[p14l1763t1745r1854b1764],
22	(	CD	PERCENT	(	number	23	SENT_229	[p14l1861t1744r1915b1769],
23	95	CD	PERCENT	95	num	24	SENT_229	[p14l1861t1744r1915b1769],
24	%	NN	PERCENT	%	dep	3	SENT_229	[p14l1861t1744r1915b1769],
25	CI	NN	O	ci	nn	30	SENT_229	[p14l1921t1744r1948b1769],
26	)	NN	O	)	nn	30	SENT_229	[p14l1921t1744r1948b1769],
27	p	NN	O	p	nn	30	SENT_229	[p14l2024t1750r2036b1770],
28	value	NN	O	value	nn	30	SENT_229	[p14l2042t1743r2097b1764],
29	Morning	NN	TIME	morning	nn	30	SENT_229	[p14l43t1800r132b1825],
30	PEF	NN	O	pef	dep	24	SENT_229	[p14l141t1800r177b1819],
31	(	CD	NUMBER	(	num	32	SENT_229	[p14l184t1799r272b1824],
32	L/min	NN	O	l/min	dep	3	SENT_229	[p14l184t1799r272b1824],
33	)	CD	NUMBER	)	num	34	SENT_229	[p14l184t1799r272b1824],
34	*	NN	O	*	dep	32	SENT_229	[p14l184t1799r272b1824],
35	401	CD	NUMBER	401	number	36	SENT_229	[p14l490t1801r530b1822],
36	423	CD	NUMBER	423	dep	3	SENT_229	[p14l599t1801r638b1822],
37	21-4	CD	NUMBER	21-4	num	38	SENT_229	[p14l729t1801r776b1822],
38	(	NN	O	(	dep	36	SENT_229	[p14l783t1798r836b1824],
39	11-8	CD	NUMBER	11-8	num	41	SENT_229	[p14l783t1798r836b1824],
40	to	TO	O	to	dep	41	SENT_229	[p14l842t1802r865b1819],
41	31-1	CD	NUMBER	31-1	dep	3	SENT_229	[p14l872t1799r924b1824],
42	)	CD	NUMBER	)	num	43	SENT_229	[p14l872t1799r924b1824],
43	<	JJR	O	<	dep	41	SENT_229	[p14l1000t1801r1088b1819],
44	0	CD	NUMBER	0	num	45	SENT_229	[p14l1000t1801r1088b1819],
45	~	NN	O	~	dep	3	SENT_229	[p14l1000t1801r1088b1819],
46	0001 405 426	CD	NUMBER	0001 405 426	num	47	SENT_229	[p14l1236t1798r1278b1822],[p14l1000t1801r1088b1819],
47	21-5	CD	NUMBER	21-5	dep	45	SENT_229	[p14l1373t1801r1417b1822],
48	(	NN	O	(	dep	3	SENT_229	[p14l1425t1799r1478b1824],
49	11-0	CD	NUMBER	11-0	num	48	SENT_229	[p14l1425t1799r1478b1824],
50	to	TO	O	to	_	0	SENT_229	[p14l1484t1802r1507b1819],
51	32-1	CD	NUMBER	32-1	num	52	SENT_229	[p14l1513t1799r1567b1824],
52	)	CD	NUMBER	)	prep_to	48	SENT_229	[p14l1513t1799r1567b1824],
53	<	JJR	O	<	dep	3	SENT_229	[p14l1638t1801r1726b1819],
54	0	CD	NUMBER	0	num	55	SENT_229	[p14l1638t1801r1726b1819],
55	~	NN	O	~	dep	53	SENT_229	[p14l1638t1801r1726b1819],
56	0001	CD	DATE	0001	number	57	SENT_229	[p14l1638t1801r1726b1819],
57	-0	CD	NUMBER	-0	dep	3	SENT_229	[p14l1757t1799r1875b1824],
58	-1	CD	NUMBER	-1	num	59	SENT_229	[p14l1757t1799r1875b1824],
59	(	NN	O	(	dep	57	SENT_229	[p14l1757t1799r1875b1824],
60	.	.	O	.	_	0	SENT_229	[p14l1757t1799r1875b1824],

1	—	NN	O	—	_	0	SENT_230	[p14l1757t1799r1875b1824],
2	.	.	O	.	_	0	SENT_230	[p14l1757t1799r1875b1824],

1	14-4	CD	NUMBER	14-4	dep	544	SENT_231	[p14l1757t1799r1875b1824],
2	to	TO	O	to	dep	544	SENT_231	[p14l1880t1802r1903b1819],
3	14-2	CD	NUMBER	14-2	dep	544	SENT_231	[p14l1910t1799r1965b1824],
4	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1910t1799r1965b1824],
5	0-99	CD	NUMBER	0-99	dep	544	SENT_231	[p14l2024t1801r2072b1822],
6	Evening	NNP	TIME	Evening	dep	544	SENT_231	[p14l43t1846r125b1871],
7	PEF	NN	O	pef	dep	544	SENT_231	[p14l134t1846r170b1864],
8	(	CD	NUMBER	(	dep	544	SENT_231	[p14l177t1845r265b1870],
9	L/min	NN	O	l/min	dep	544	SENT_231	[p14l177t1845r265b1870],
10	)	CD	NUMBER	)	dep	544	SENT_231	[p14l177t1845r265b1870],
11	*	NN	O	*	dep	544	SENT_231	[p14l177t1845r265b1870],
12	394	CD	NUMBER	394	dep	544	SENT_231	[p14l490t1847r532b1867],
13	420	CD	NUMBER	420	dep	544	SENT_231	[p14l598t1847r639b1867],
14	25-2	CD	NUMBER	25-2	dep	544	SENT_231	[p14l728t1847r773b1867],
15	(	NN	O	(	dep	544	SENT_231	[p14l781t1844r838b1870],
16	16-4	CD	NUMBER	16-4	dep	544	SENT_231	[p14l781t1844r838b1870],
17	to	TO	O	to	dep	544	SENT_231	[p14l843t1848r866b1865],
18	34-1	CD	NUMBER	34-1	dep	544	SENT_231	[p14l873t1845r927b1870],
19	)	CD	NUMBER	)	dep	544	SENT_231	[p14l873t1845r927b1870],
20	<	JJR	O	<	dep	544	SENT_231	[p14l1000t1847r1088b1864],
21	0-0001	CD	NUMBER	0-0001	dep	544	SENT_231	[p14l1000t1847r1088b1864],
22	400	CD	NUMBER	400	dep	544	SENT_231	[p14l1128t1847r1170b1867],
23	424	CD	NUMBER	424	dep	544	SENT_231	[p14l1236t1847r1278b1867],
24	23-8	CD	NUMBER	23-8	dep	544	SENT_231	[p14l1372t1844r1418b1867],
25	(	NN	O	(	dep	544	SENT_231	[p14l1427t1845r1480b1870],
26	13-9	CD	NUMBER	13-9	dep	544	SENT_231	[p14l1427t1845r1480b1870],
27	to	TO	O	to	dep	544	SENT_231	[p14l1487t1848r1510b1865],
28	33-6	CD	NUMBER	33-6	dep	544	SENT_231	[p14l1517t1844r1572b1870],
29	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1517t1844r1572b1870],
30	<	JJR	O	<	dep	544	SENT_231	[p14l1638t1847r1726b1864],
31	0-0001	CD	NUMBER	0-0001	dep	544	SENT_231	[p14l1638t1847r1726b1864],
32	1-5	CD	NUMBER	1-5	dep	544	SENT_231	[p14l1771t1847r1801b1867],
33	(	NN	O	(	dep	544	SENT_231	[p14l1809t1845r1872b1870],
34	-11	CD	NUMBER	-11	dep	544	SENT_231	[p14l1809t1845r1872b1870],
35	-7	CD	NUMBER	-7	dep	544	SENT_231	[p14l1809t1845r1872b1870],
36	to	TO	O	to	dep	544	SENT_231	[p14l1877t1848r1900b1865],
37	14-7	CD	NUMBER	14-7	dep	544	SENT_231	[p14l1907t1845r1961b1870],
38	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1907t1845r1961b1870],
39	0-82	CD	NUMBER	0-82	dep	544	SENT_231	[p14l2024t1844r2070b1864],
40	Peak	JJ	O	peak	dep	544	SENT_231	[p14l43t1889r91b1910],
41	ﬂow	NN	O	ﬂow	dep	544	SENT_231	[p14l96t1889r143b1910],
42	variability	NN	O	variability	dep	544	SENT_231	[p14l148t1889r261b1917],
43	*	CD	NUMBER	*	dep	544	SENT_231	[p14l148t1889r261b1917],
44	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l506t1892r550b1913],
45	-9	CD	NUMBER	-9	dep	544	SENT_231	[p14l506t1892r550b1913],
46	-1	CD	NUMBER	-1	dep	544	SENT_231	[p14l617t1892r659b1910],
47	-	:	O	-	_	0	SENT_231	[p14l617t1892r659b1910],
48	O	NN	O	o	dep	544	SENT_231	[p14l617t1892r659b1910],
49	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l729t1892r773b1910],
50	-2	CD	NUMBER	-2	dep	544	SENT_231	[p14l729t1892r773b1910],
51	(	NN	O	(	dep	544	SENT_231	[p14l781t1891r832b1916],
52	-1	CD	NUMBER	-1	dep	544	SENT_231	[p14l781t1891r832b1916],
53	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l781t1891r832b1916],
54	to	TO	O	to	dep	544	SENT_231	[p14l838t1893r861b1910],
55	0-6	CD	NUMBER	0-6	dep	544	SENT_231	[p14l868t1889r911b1916],
56	)	CD	NUMBER	)	dep	544	SENT_231	[p14l868t1889r911b1916],
57	0-67	CD	NUMBER	0-67	dep	544	SENT_231	[p14l1014t1889r1061b1913],
58	o-o	NN	O	o-o	dep	544	SENT_231	[p14l1158t1892r1191b1910],
59	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1252t1892r1295b1913],
60	-7	CD	NUMBER	-7	dep	544	SENT_231	[p14l1252t1892r1295b1913],
61	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1373t1892r1417b1913],
62	-7	CD	NUMBER	-7	dep	544	SENT_231	[p14l1373t1892r1417b1913],
63	(	NN	O	(	dep	544	SENT_231	[p14l1424t1891r1476b1916],
64	-1	CD	NUMBER	-1	dep	544	SENT_231	[p14l1424t1891r1476b1916],
65	-4	CD	NUMBER	-4	dep	544	SENT_231	[p14l1424t1891r1476b1916],
66	to	TO	O	to	dep	544	SENT_231	[p14l1481t1893r1504b1910],
67	—	CD	NUMBER	—	dep	544	SENT_231	[p14l1510t1891r1564b1916],
68	o-o	NN	O	o-o	dep	544	SENT_231	[p14l1510t1891r1564b1916],
69	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1510t1891r1564b1916],
70	0-04	CD	NUMBER	0-04	dep	544	SENT_231	[p14l1652t1892r1700b1913],
71	0-6	CD	NUMBER	0-6	dep	544	SENT_231	[p14l1769t1889r1803b1910],
72	(	NN	O	(	dep	544	SENT_231	[p14l1811t1891r1862b1916],
73	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1811t1891r1862b1916],
74	-5	CD	NUMBER	-5	dep	544	SENT_231	[p14l1811t1891r1862b1916],
75	to	TO	O	to	dep	544	SENT_231	[p14l1868t1893r1891b1910],
76	1-6	CD	NUMBER	1-6	dep	544	SENT_231	[p14l1898t1889r1939b1916],
77	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1898t1889r1939b1916],
78	0-31	CD	NUMBER	0-31	dep	544	SENT_231	[p14l2024t1892r2068b1913],
79	FEV	NN	O	fev	dep	544	SENT_231	[p14l43t1937r88b1961],
80	,	,	O	,	_	0	SENT_231	[p14l43t1937r88b1961],
81	(	CD	NUMBER	(	dep	544	SENT_231	[p14l94t1936r132b1961],
82	L	NN	O	l	dep	544	SENT_231	[p14l94t1936r132b1961],
83	)	CD	NUMBER	)	dep	544	SENT_231	[p14l94t1936r132b1961],
84	*	CD	NUMBER	*	dep	544	SENT_231	[p14l94t1936r132b1961],
85	2-53	CD	NUMBER	2-53	dep	544	SENT_231	[p14l518t1938r562b1959],
86	2-60	CD	NUMBER	2-60	dep	544	SENT_231	[p14l628t1935r674b1956],
87	0-08	CD	NUMBER	0-08	dep	544	SENT_231	[p14l741t1935r789b1956],
88	(	NN	O	(	dep	544	SENT_231	[p14l798t1937r853b1961],
89	0-03	CD	NUMBER	0-03	dep	544	SENT_231	[p14l798t1937r853b1961],
90	to	TO	O	to	dep	544	SENT_231	[p14l859t1939r882b1956],
91	0-13	CD	NUMBER	0-13	dep	544	SENT_231	[p14l889t1936r943b1961],
92	)	CD	NUMBER	)	dep	544	SENT_231	[p14l889t1936r943b1961],
93	0-0022	CD	NUMBER	0-0022	dep	544	SENT_231	[p14l1014t1938r1087b1956],
94	2-65	CD	NUMBER	2-65	dep	544	SENT_231	[p14l1159t1935r1205b1959],
95	2-69	CD	NUMBER	2-69	dep	544	SENT_231	[p14l1264t1935r1311b1959],
96	0-04	CD	NUMBER	0-04	dep	544	SENT_231	[p14l1385t1938r1434b1959],
97	(	SYM	O	(	dep	544	SENT_231	[p14l1441t1936r1508b1961],
98	-	:	O	-	_	0	SENT_231	[p14l1441t1936r1508b1961],
99	o-oo	NN	O	o-oo	dep	544	SENT_231	[p14l1441t1936r1508b1961],
100	to	TO	O	to	dep	544	SENT_231	[p14l1514t1939r1537b1956],
101	0-09	CD	NUMBER	0-09	dep	544	SENT_231	[p14l1544t1937r1601b1961],
102	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1544t1937r1601b1961],
103	0-06	CD	NUMBER	0-06	dep	544	SENT_231	[p14l1652t1935r1699b1956],
104	0-03	CD	NUMBER	0-03	dep	544	SENT_231	[p14l1769t1938r1816b1959],
105	(	NN	O	(	dep	544	SENT_231	[p14l1824t1937r1890b1961],
106	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1824t1937r1890b1961],
107	-03	CD	NUMBER	-03	dep	544	SENT_231	[p14l1824t1937r1890b1961],
108	to	TO	O	to	dep	544	SENT_231	[p14l1896t1939r1919b1956],
109	0-10	CD	NUMBER	0-10	dep	544	SENT_231	[p14l1926t1936r1981b1961],
110	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1926t1936r1981b1961],
111	0-34	CD	NUMBER	0-34	dep	544	SENT_231	[p14l2024t1938r2071b1959],
112	FVC	NN	O	fvc	dep	544	SENT_231	[p14l43t1983r83b2002],
113	(	CD	NUMBER	(	dep	544	SENT_231	[p14l89t1982r127b2007],
114	L	NN	O	l	dep	544	SENT_231	[p14l89t1982r127b2007],
115	)	CD	NUMBER	)	dep	544	SENT_231	[p14l89t1982r127b2007],
116	*	NN	O	*	dep	544	SENT_231	[p14l89t1982r127b2007],
117	3	CD	NUMBER	3	dep	544	SENT_231	[p14l518t1984r562b2005],
118	'57	CD	NUMBER	'57	dep	544	SENT_231	[p14l518t1984r562b2005],
119	361	CD	NUMBER	361	dep	544	SENT_231	[p14l627t1981r673b2005],
120	0-04	CD	NUMBER	0-04	dep	544	SENT_231	[p14l741t1984r790b2005],
121	(	CD	NUMBER	(	dep	544	SENT_231	[p14l797t1982r863b2007],
122	~	NN	O	~	dep	544	SENT_231	[p14l797t1982r863b2007],
123	0-01	CD	NUMBER	0-01	dep	544	SENT_231	[p14l797t1982r863b2007],
124	to	TO	O	to	dep	544	SENT_231	[p14l868t1985r892b2002],
125	0-08	CD	NUMBER	0-08	dep	544	SENT_231	[p14l899t1981r956b2007],
126	)	CD	NUMBER	)	dep	544	SENT_231	[p14l899t1981r956b2007],
127	0-12	CD	NUMBER	0-12	dep	544	SENT_231	[p14l1014t1984r1057b2002],
128	3-67	CD	NUMBER	3-67	dep	544	SENT_231	[p14l1159t1981r1205b2005],
129	3-71	CD	NUMBER	3-71	dep	544	SENT_231	[p14l1264t1984r1307b2005],
130	0-03	CD	NUMBER	0-03	dep	544	SENT_231	[p14l1385t1984r1431b2005],
131	(	NN	O	(	dep	544	SENT_231	[p14l1440t1982r1505b2007],
132	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1440t1982r1505b2007],
133	-03	CD	NUMBER	-03	dep	544	SENT_231	[p14l1440t1982r1505b2007],
134	to	TO	O	to	dep	544	SENT_231	[p14l1512t1985r1535b2002],
135	0-09	CD	NUMBER	0-09	dep	544	SENT_231	[p14l1542t1982r1599b2007],
136	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1542t1982r1599b2007],
137	0-29	CD	NUMBER	0-29	dep	544	SENT_231	[p14l1652t1984r1698b2005],
138	o-oo	NN	O	o-oo	dep	544	SENT_231	[p14l1769t1984r1817b2002],
139	(	CD	NUMBER	(	dep	544	SENT_231	[p14l1825t1982r1891b2007],
140	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1825t1982r1891b2007],
141	-07	CD	NUMBER	-07	dep	544	SENT_231	[p14l1825t1982r1891b2007],
142	to	TO	O	to	dep	544	SENT_231	[p14l1896t1985r1919b2002],
143	0-08	CD	NUMBER	0-08	dep	544	SENT_231	[p14l1926t1981r1984b2007],
144	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1926t1981r1984b2007],
145	0-91	CD	NUMBER	0-91	dep	544	SENT_231	[p14l2024t1984r2070b2005],
146	Spirometry	NNP	O	Spirometry	dep	544	SENT_231	[p14l43t2028r160b2054],
147	PEF	NN	O	pef	dep	544	SENT_231	[p14l167t2029r203b2047],
148	(	CD	NUMBER	(	dep	544	SENT_231	[p14l210t2027r298b2053],
149	|	NN	O	|	dep	544	SENT_231	[p14l210t2027r298b2053],
150	Jmin	NN	O	jmin	dep	544	SENT_231	[p14l210t2027r298b2053],
151	)	CD	NUMBER	)	dep	544	SENT_231	[p14l210t2027r298b2053],
152	*	NN	O	*	dep	544	SENT_231	[p14l210t2027r298b2053],
153	409	CD	NUMBER	409	dep	544	SENT_231	[p14l490t2029r532b2050],
154	426	CD	NUMBER	426	dep	544	SENT_231	[p14l597t2027r638b2050],
155	17-2	CD	NUMBER	17-2	dep	544	SENT_231	[p14l730t2029r773b2050],
156	(	NN	O	(	dep	544	SENT_231	[p14l781t2027r822b2053],
157	7-6	CD	NUMBER	7-6	dep	544	SENT_231	[p14l781t2027r822b2053],
158	to	TO	O	to	dep	544	SENT_231	[p14l828t2030r851b2047],
159	26-7	JJ	O	26-7	dep	544	SENT_231	[p14l858t2027r913b2053],
160	)	NN	O	)	dep	544	SENT_231	[p14l858t2027r913b2053],
161	0-0005	CD	NUMBER	0-0005	dep	544	SENT_231	[p14l1014t2029r1088b2050],
162	429	CD	NUMBER	429	dep	544	SENT_231	[p14l1129t2029r1170b2050],
163	446	CD	NUMBER	446	dep	544	SENT_231	[p14l1236t2027r1279b2050],
164	16-5	CD	NUMBER	16-5	dep	544	SENT_231	[p14l1371t2027r1417b2050],
165	(	NN	O	(	dep	544	SENT_231	[p14l1425t2027r1466b2053],
166	5-8	CD	NUMBER	5-8	dep	544	SENT_231	[p14l1425t2027r1466b2053],
167	to	TO	O	to	dep	544	SENT_231	[p14l1472t2030r1495b2047],
168	27-3	CD	NUMBER	27-3	dep	544	SENT_231	[p14l1503t2028r1556b2053],
169	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1503t2028r1556b2053],
170	0-0027	CD	NUMBER	0-0027	dep	544	SENT_231	[p14l1652t2029r1726b2050],
171	0-6	CD	NUMBER	0-6	dep	544	SENT_231	[p14l1769t2027r1803b2047],
172	(	NN	O	(	dep	544	SENT_231	[p14l1811t2027r1876b2053],
173	-13	CD	NUMBER	-13	dep	544	SENT_231	[p14l1811t2027r1876b2053],
174	-8	CD	NUMBER	-8	dep	544	SENT_231	[p14l1811t2027r1876b2053],
175	to	TO	O	to	dep	544	SENT_231	[p14l1882t2030r1905b2047],
176	15-0	CD	NUMBER	15-0	dep	544	SENT_231	[p14l1912t2028r1966b2053],
177	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1912t2028r1966b2053],
178	0-93	CD	NUMBER	0-93	dep	544	SENT_231	[p14l2024t2029r2070b2050],
179	Exhaled	VBN	O	exhale	dep	544	SENT_231	[p14l43t2072r124b2093],
180	NO	NN	O	no	dep	544	SENT_231	[p14l131t2074r163b2093],
181	(	CD	NUMBER	(	dep	544	SENT_231	[p14l171t2072r217b2100],
182	loge	NN	O	loge	dep	544	SENT_231	[p14l171t2072r217b2100],
183	parts	NNS	O	part	dep	544	SENT_231	[p14l223t2076r275b2099],
184	per	IN	O	per	dep	544	SENT_231	[p14l281t2079r315b2099],
185	billion	CD	NUMBER	billion	dep	544	SENT_231	[p14l321t2072r404b2099],
186	)	CD	NUMBER	)	dep	544	SENT_231	[p14l321t2072r404b2099],
187	*	NN	O	*	dep	544	SENT_231	[p14l321t2072r404b2099],
188	2-68	CD	NUMBER	2-68	dep	544	SENT_231	[p14l518t2072r565b2093],
189	2-56	CD	NUMBER	2-56	dep	544	SENT_231	[p14l628t2072r673b2096],
190	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l729t2075r786b2093],
191	-12	CD	NUMBER	-12	dep	544	SENT_231	[p14l729t2075r786b2093],
192	(	NN	O	(	dep	544	SENT_231	[p14l794t2074r862b2099],
193	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l794t2074r862b2099],
194	-24	CD	NUMBER	-24	dep	544	SENT_231	[p14l794t2074r862b2099],
195	to	TO	O	to	dep	544	SENT_231	[p14l867t2076r890b2093],
196	o-oo	JJ	O	o-oo	dep	544	SENT_231	[p14l897t2074r953b2099],
197	)	NN	O	)	dep	544	SENT_231	[p14l897t2074r953b2099],
198	0-06	CD	NUMBER	0-06	dep	544	SENT_231	[p14l1014t2072r1061b2093],
199	2-70	CD	NUMBER	2-70	dep	544	SENT_231	[p14l1159t2075r1204b2096],
200	2-72	CD	NUMBER	2-72	dep	544	SENT_231	[p14l1264t2075r1307b2096],
201	0-02	CD	NUMBER	0-02	dep	544	SENT_231	[p14l1385t2075r1431b2093],
202	(	NN	O	(	dep	544	SENT_231	[p14l1440t2074r1504b2098],
203	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1440t2074r1504b2098],
204	-11	CD	NUMBER	-11	dep	544	SENT_231	[p14l1440t2074r1504b2098],
205	to	TO	O	to	dep	544	SENT_231	[p14l1509t2076r1532b2093],
206	0-15	CD	NUMBER	0-15	dep	544	SENT_231	[p14l1539t2074r1593b2099],
207	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1539t2074r1593b2099],
208	0-76	CD	NUMBER	0-76	dep	544	SENT_231	[p14l1652t2072r1698b2096],
209	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1757t2075r1816b2096],
210	-14	CD	NUMBER	-14	dep	544	SENT_231	[p14l1757t2075r1816b2096],
211	(	NN	O	(	dep	544	SENT_231	[p14l1824t2074r1888b2099],
212	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1824t2074r1888b2099],
213	-31	CD	NUMBER	-31	dep	544	SENT_231	[p14l1824t2074r1888b2099],
214	to	TO	O	to	dep	544	SENT_231	[p14l1893t2076r1917b2093],
215	0-04	CD	NUMBER	0-04	dep	544	SENT_231	[p14l1924t2074r1981b2099],
216	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1924t2074r1981b2099],
217	0-13	CD	NUMBER	0-13	dep	544	SENT_231	[p14l2024t2075r2068b2096],
218	pH	NN	O	ph	dep	544	SENT_231	[p14l42t2120r71b2145],
219	in	IN	O	in	dep	544	SENT_231	[p14l79t2120r96b2139],
220	exhaled	VBN	O	exhale	dep	544	SENT_231	[p14l103t2118r184b2139],
221	breath	NN	O	breath	dep	544	SENT_231	[p14l191t2118r257b2139],
222	condensatet	NN	O	condensatet	dep	544	SENT_231	[p14l264t2118r397b2140],
223	797	CD	NUMBER	797	dep	544	SENT_231	[p14l518t2121r564b2142],
224	8-07	CD	NUMBER	8-07	dep	544	SENT_231	[p14l626t2118r673b2141],
225	0-10	CD	NUMBER	0-10	dep	544	SENT_231	[p14l741t2121r787b2139],
226	(	NN	O	(	dep	544	SENT_231	[p14l795t2118r862b2144],
227	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l795t2118r862b2144],
228	-26	CD	NUMBER	-26	dep	544	SENT_231	[p14l795t2118r862b2144],
229	to	TO	O	to	dep	544	SENT_231	[p14l868t2122r891b2139],
230	0-45	CD	NUMBER	0-45	dep	544	SENT_231	[p14l898t2119r954b2144],
231	)	CD	NUMBER	)	dep	544	SENT_231	[p14l898t2119r954b2144],
232	0-60	CD	NUMBER	0-60	dep	544	SENT_231	[p14l1014t2118r1061b2139],
233	8-13	CD	NUMBER	8-13	dep	544	SENT_231	[p14l1158t2118r1202b2142],
234	8-16	CD	NUMBER	8-16	dep	544	SENT_231	[p14l1263t2118r1309b2139],
235	0-03	CD	NUMBER	0-03	dep	544	SENT_231	[p14l1385t2121r1431b2142],
236	(	NN	O	(	dep	544	SENT_231	[p14l1440t2119r1504b2144],
237	-031	CD	NUMBER	-031	dep	544	SENT_231	[p14l1440t2119r1504b2144],
238	to	TO	O	to	dep	544	SENT_231	[p14l1510t2122r1533b2139],
239	0-37	CD	NUMBER	0-37	dep	544	SENT_231	[p14l1540t2119r1594b2144],
240	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1540t2119r1594b2144],
241	0-87	CD	NUMBER	0-87	dep	544	SENT_231	[p14l1652t2118r1698b2141],
242	0-07	CD	NUMBER	0-07	dep	544	SENT_231	[p14l1769t2121r1816b2142],
243	(	NN	O	(	dep	544	SENT_231	[p14l1823t2119r1890b2144],
244	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1823t2119r1890b2144],
245	-43	CD	NUMBER	-43	dep	544	SENT_231	[p14l1823t2119r1890b2144],
246	to	TO	O	to	dep	544	SENT_231	[p14l1896t2122r1919b2139],
247	0-56	CD	NUMBER	0-56	dep	544	SENT_231	[p14l1926t2118r1982b2144],
248	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1926t2118r1982b2144],
249	0-79	CD	NUMBER	0-79	dep	544	SENT_231	[p14l2024t2121r2070b2142],
250	Methacholine	NNP	O	Methacholine	dep	544	SENT_231	[p14l43t2164r187b2185],
251	PC	NNP	O	PC	dep	544	SENT_231	[p14l194t2165r233b2190],
252	,	,	O	,	_	0	SENT_231	[p14l194t2165r233b2190],
253	“	CD	NUMBER	“	dep	544	SENT_231	[p14l194t2165r233b2190],
254	(	CD	NUMBER	(	dep	544	SENT_231	[p14l240t2164r287b2191],
255	log	NN	O	log	dep	544	SENT_231	[p14l240t2164r287b2191],
256	,	,	O	,	_	0	SENT_231	[p14l240t2164r287b2191],
257	mg/mL	NN	O	mg/ml	dep	544	SENT_231	[p14l294t2165r390b2191],
258	)	NN	O	)	dep	544	SENT_231	[p14l294t2165r390b2191],
259	i	FW	O	i	dep	544	SENT_231	[p14l294t2165r390b2191],
260	1-40	CD	NUMBER	1-40	dep	544	SENT_231	[p14l519t2167r565b2187],
261	1-35	CD	NUMBER	1-35	dep	544	SENT_231	[p14l628t2167r671b2188],
262	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l729t2164r790b2185],
263	-06	CD	NUMBER	-06	dep	544	SENT_231	[p14l729t2164r790b2185],
264	(	NN	O	(	dep	544	SENT_231	[p14l798t2165r862b2190],
265	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l798t2165r862b2190],
266	-71	CD	NUMBER	-71	dep	544	SENT_231	[p14l798t2165r862b2190],
267	to	TO	O	to	dep	544	SENT_231	[p14l867t2168r890b2185],
268	0-60	CD	NUMBER	0-60	dep	544	SENT_231	[p14l897t2164r955b2190],
269	)	CD	NUMBER	)	dep	544	SENT_231	[p14l897t2164r955b2190],
270	0-87	CD	NUMBER	0-87	dep	544	SENT_231	[p14l1014t2164r1060b2187],
271	1-03	CD	NUMBER	1-03	dep	544	SENT_231	[p14l1160t2167r1204b2188],
272	2-30	CD	NUMBER	2-30	dep	544	SENT_231	[p14l1264t2167r1309b2188],
273	1-27	CD	NUMBER	1-27	dep	544	SENT_231	[p14l1386t2167r1431b2187],
274	(	NN	O	(	dep	544	SENT_231	[p14l1438t2164r1496b2190],
275	0-66	CD	NUMBER	0-66	dep	544	SENT_231	[p14l1438t2164r1496b2190],
276	to	TO	O	to	dep	544	SENT_231	[p14l1502t2168r1525b2185],
277	1-87	CD	NUMBER	1-87	dep	544	SENT_231	[p14l1532t2164r1586b2190],
278	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1532t2164r1586b2190],
279	<	JJR	O	<	dep	544	SENT_231	[p14l1638t2167r1726b2185],
280	0	CD	NUMBER	0	dep	544	SENT_231	[p14l1638t2167r1726b2185],
281	~	NN	O	~	dep	544	SENT_231	[p14l1638t2167r1726b2185],
282	0001	CD	DATE	0001	dep	544	SENT_231	[p14l1638t2167r1726b2185],
283	-1	CD	NUMBER	-1	dep	544	SENT_231	[p14l1759t2167r1815b2188],
284	-32	CD	NUMBER	-32	dep	544	SENT_231	[p14l1759t2167r1815b2188],
285	(	NN	O	(	dep	544	SENT_231	[p14l1823t2165r1887b2190],
286	-2	CD	NUMBER	-2	dep	544	SENT_231	[p14l1823t2165r1887b2190],
287	-21	CD	NUMBER	-21	dep	544	SENT_231	[p14l1823t2165r1887b2190],
288	to	TO	O	to	dep	544	SENT_231	[p14l1892t2168r1915b2185],
289	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1921t2165r1989b2190],
290	-43	CD	NUMBER	-43	dep	544	SENT_231	[p14l1921t2165r1989b2190],
291	)	NN	O	)	dep	544	SENT_231	[p14l1921t2165r1989b2190],
292	0-0038	CD	NUMBER	0-0038	dep	544	SENT_231	[p14l2024t2164r2099b2188],
293	FEV	NN	O	fev	dep	544	SENT_231	[p14l43t2211r88b2236],
294	,	,	O	,	_	0	SENT_231	[p14l43t2211r88b2236],
295	reversibility	NN	O	reversibility	dep	544	SENT_231	[p14l95t2210r214b2237],
296	with	IN	O	with	dep	544	SENT_231	[p14l219t2210r266b2230],
297	salbutamol	NN	O	salbutamol	dep	544	SENT_231	[p14l273t2210r389b2230],
298	(	CD	PERCENT	(	dep	544	SENT_231	[p14l397t2211r442b2236],
299	%	NN	PERCENT	%	dep	544	SENT_231	[p14l397t2211r442b2236],
300	)	CD	NUMBER	)	dep	544	SENT_231	[p14l397t2211r442b2236],
301	§	NN	O	§	dep	544	SENT_231	[p14l397t2211r442b2236],
302	103	CD	PERCENT	103	dep	544	SENT_231	[p14l505t2212r568b2233],
303	%	NN	PERCENT	%	dep	544	SENT_231	[p14l505t2212r568b2233],
304	6-7	CD	PERCENT	6-7	dep	544	SENT_231	[p14l626t2209r677b2233],
305	%	NN	PERCENT	%	dep	544	SENT_231	[p14l626t2209r677b2233],
306	-3	CD	PERCENT	-3	dep	544	SENT_231	[p14l730t2209r795b2233],
307	-6	CD	PERCENT	-6	dep	544	SENT_231	[p14l730t2209r795b2233],
308	%	NN	PERCENT	%	dep	544	SENT_231	[p14l730t2209r795b2233],
309	(	CD	NUMBER	(	dep	544	SENT_231	[p14l803t2211r853b2236],
310	-5	CD	NUMBER	-5	dep	544	SENT_231	[p14l803t2211r853b2236],
311	-7	CD	NUMBER	-7	dep	544	SENT_231	[p14l803t2211r853b2236],
312	to	TO	O	to	dep	544	SENT_231	[p14l858t2213r881b2230],
313	—	CD	NUMBER	—	dep	544	SENT_231	[p14l887t2211r938b2236],
314	1-5	CD	NUMBER	1-5	dep	544	SENT_231	[p14l887t2211r938b2236],
315	)	NN	O	)	dep	544	SENT_231	[p14l887t2211r938b2236],
316	00010	CD	PERCENT	00010	dep	544	SENT_231	[p14l1014t2212r1088b2230],
317	108	CD	PERCENT	108	dep	544	SENT_231	[p14l1146t2209r1211b2230],
318	%	NN	PERCENT	%	dep	544	SENT_231	[p14l1146t2209r1211b2230],
319	8-5	CD	PERCENT	8-5	dep	544	SENT_231	[p14l1263t2209r1314b2233],
320	%	NN	PERCENT	%	dep	544	SENT_231	[p14l1263t2209r1314b2233],
321	-2	CD	PERCENT	-2	dep	544	SENT_231	[p14l1374t2212r1436b2233],
322	-3	CD	PERCENT	-3	dep	544	SENT_231	[p14l1374t2212r1436b2233],
323	%	NN	PERCENT	%	dep	544	SENT_231	[p14l1374t2212r1436b2233],
324	(	CD	NUMBER	(	dep	544	SENT_231	[p14l1445t2211r1499b2236],
325	-4	CD	NUMBER	-4	dep	544	SENT_231	[p14l1445t2211r1499b2236],
326	-4	CD	NUMBER	-4	dep	544	SENT_231	[p14l1445t2211r1499b2236],
327	to	TO	O	to	dep	544	SENT_231	[p14l1504t2213r1526b2230],
328	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1533t2211r1584b2236],
329	-1	CD	NUMBER	-1	dep	544	SENT_231	[p14l1533t2211r1584b2236],
330	)	NN	O	)	dep	544	SENT_231	[p14l1533t2211r1584b2236],
331	0-04	CD	PERCENT	0-04	dep	544	SENT_231	[p14l1652t2212r1700b2233],
332	-1	CD	PERCENT	-1	dep	544	SENT_231	[p14l1759t2212r1821b2233],
333	-3	CD	PERCENT	-3	dep	544	SENT_231	[p14l1759t2212r1821b2233],
334	%	NN	PERCENT	%	dep	544	SENT_231	[p14l1759t2212r1821b2233],
335	(	CD	NUMBER	(	dep	544	SENT_231	[p14l1829t2211r1880b2236],
336	-4	CD	NUMBER	-4	dep	544	SENT_231	[p14l1829t2211r1880b2236],
337	-3	CD	NUMBER	-3	dep	544	SENT_231	[p14l1829t2211r1880b2236],
338	to	TO	O	to	dep	544	SENT_231	[p14l1886t2213r1909b2230],
339	1-7	CD	NUMBER	1-7	dep	544	SENT_231	[p14l1916t2211r1955b2236],
340	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1916t2211r1955b2236],
341	0-38	CD	NUMBER	0-38	dep	544	SENT_231	[p14l2024t2209r2070b2233],
342	FEV	NN	O	fev	dep	544	SENT_231	[p14l43t2257r88b2282],
343	,	,	O	,	_	0	SENT_231	[p14l43t2257r88b2282],
344	after	IN	O	after	dep	544	SENT_231	[p14l93t2255r143b2276],
345	salbutamol	NN	O	salbutamol	dep	544	SENT_231	[p14l148t2255r264b2276],
346	(	CD	NUMBER	(	dep	544	SENT_231	[p14l272t2256r310b2281],
347	L	NN	O	l	dep	544	SENT_231	[p14l272t2256r310b2281],
348	)	CD	NUMBER	)	dep	544	SENT_231	[p14l272t2256r310b2281],
349	§	CD	NUMBER	§	dep	544	SENT_231	[p14l272t2256r310b2281],
350	2-82	CD	NUMBER	2-82	dep	544	SENT_231	[p14l518t2255r564b2276],
351	2-77	CD	NUMBER	2-77	dep	544	SENT_231	[p14l628t2258r671b2279],
352	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l729t2258r790b2279],
353	-04	CD	NUMBER	-04	dep	544	SENT_231	[p14l729t2258r790b2279],
354	(	NN	O	(	dep	544	SENT_231	[p14l797t2256r863b2282],
355	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l797t2256r863b2282],
356	-10	CD	NUMBER	-10	dep	544	SENT_231	[p14l797t2256r863b2282],
357	to	TO	O	to	dep	544	SENT_231	[p14l868t2259r892b2276],
358	0-01	CD	NUMBER	0-01	dep	544	SENT_231	[p14l899t2257r953b2281],
359	)	CD	NUMBER	)	dep	544	SENT_231	[p14l899t2257r953b2281],
360	0-11	CD	NUMBER	0-11	dep	544	SENT_231	[p14l1014t2258r1057b2276],
361	2-93	CD	NUMBER	2-93	dep	544	SENT_231	[p14l1159t2258r1205b2279],
362	2-90	CD	NUMBER	2-90	dep	544	SENT_231	[p14l1264t2258r1311b2279],
363	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1373t2258r1431b2279],
364	-03	CD	NUMBER	-03	dep	544	SENT_231	[p14l1373t2258r1431b2279],
365	(	NN	O	(	dep	544	SENT_231	[p14l1440t2255r1507b2281],
366	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1440t2255r1507b2281],
367	-08	CD	NUMBER	-08	dep	544	SENT_231	[p14l1440t2255r1507b2281],
368	to	TO	O	to	dep	544	SENT_231	[p14l1513t2259r1536b2276],
369	0-03	CD	NUMBER	0-03	dep	544	SENT_231	[p14l1543t2256r1599b2281],
370	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1543t2256r1599b2281],
371	0-40	CD	NUMBER	0-40	dep	544	SENT_231	[p14l1652t2258r1699b2279],
372	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1757t2258r1816b2276],
373	-02	CD	NUMBER	-02	dep	544	SENT_231	[p14l1757t2258r1816b2276],
374	(	NN	O	(	dep	544	SENT_231	[p14l1824t2257r1889b2281],
375	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1824t2257r1889b2281],
376	-10	CD	NUMBER	-10	dep	544	SENT_231	[p14l1824t2257r1889b2281],
377	to	TO	O	to	dep	544	SENT_231	[p14l1895t2259r1918b2276],
378	0-06	CD	NUMBER	0-06	dep	544	SENT_231	[p14l1925t2255r1983b2282],
379	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1925t2255r1983b2282],
380	0-64	CD	NUMBER	0-64	dep	544	SENT_231	[p14l2024t2255r2073b2279],
381	FEV	NN	O	fev	dep	544	SENT_231	[p14l43t2303r88b2327],
382	,	,	O	,	_	0	SENT_231	[p14l43t2303r88b2327],
383	reversibility	NN	O	reversibility	dep	544	SENT_231	[p14l95t2301r214b2328],
384	with	IN	O	with	dep	544	SENT_231	[p14l219t2301r266b2322],
385	ipratropium	NN	O	ipratropium	dep	544	SENT_231	[p14l274t2303r398b2328],
386	(	CD	PERCENT	(	dep	544	SENT_231	[p14l406t2302r456b2327],
387	%	NN	PERCENT	%	dep	544	SENT_231	[p14l406t2302r456b2327],
388	)	CD	PERCENT	)	dep	544	SENT_231	[p14l406t2302r456b2327],
389	1i	NN	PERCENT	1us	dep	544	SENT_231	[p14l406t2302r456b2327],
390	101	CD	PERCENT	101	dep	544	SENT_231	[p14l505t2304r567b2322],
391	%	NN	PERCENT	%	dep	544	SENT_231	[p14l505t2304r567b2322],
392	9-4	CD	PERCENT	9-4	dep	544	SENT_231	[p14l626t2304r679b2325],
393	%	NN	PERCENT	%	dep	544	SENT_231	[p14l626t2304r679b2325],
394	-0	CD	PERCENT	-0	dep	544	SENT_231	[p14l729t2301r794b2322],
395	-8	CD	PERCENT	-8	dep	544	SENT_231	[p14l729t2301r794b2322],
396	%	NN	PERCENT	%	dep	544	SENT_231	[p14l729t2301r794b2322],
397	(	CD	NUMBER	(	dep	544	SENT_231	[p14l803t2302r854b2327],
398	-2	CD	NUMBER	-2	dep	544	SENT_231	[p14l803t2302r854b2327],
399	-9	CD	NUMBER	-9	dep	544	SENT_231	[p14l803t2302r854b2327],
400	to	TO	O	to	dep	544	SENT_231	[p14l861t2305r883b2322],
401	1-4	CD	PERCENT	1-4	dep	544	SENT_231	[p14l891t2302r931b2327],
402	)	CD	PERCENT	)	dep	544	SENT_231	[p14l891t2302r931b2327],
403	0-47	CD	PERCENT	0-47	dep	544	SENT_231	[p14l1014t2304r1060b2325],
404	84	CD	PERCENT	84	dep	544	SENT_231	[p14l1158t2301r1210b2325],
405	%	NN	PERCENT	%	dep	544	SENT_231	[p14l1158t2301r1210b2325],
406	76	CD	PERCENT	76	dep	544	SENT_231	[p14l1264t2301r1316b2324],
407	%	NN	PERCENT	%	dep	544	SENT_231	[p14l1264t2301r1316b2324],
408	-0	CD	PERCENT	-0	dep	544	SENT_231	[p14l1373t2304r1438b2325],
409	-9	CD	PERCENT	-9	dep	544	SENT_231	[p14l1373t2304r1438b2325],
410	%	NN	PERCENT	%	dep	544	SENT_231	[p14l1373t2304r1438b2325],
411	(	CD	NUMBER	(	dep	544	SENT_231	[p14l1446t2301r1498b2327],
412	-2	CD	NUMBER	-2	dep	544	SENT_231	[p14l1446t2301r1498b2327],
413	-8	CD	NUMBER	-8	dep	544	SENT_231	[p14l1446t2301r1498b2327],
414	to	TO	O	to	dep	544	SENT_231	[p14l1504t2305r1527b2322],
415	1-1	CD	PERCENT	1-1	dep	544	SENT_231	[p14l1534t2302r1573b2327],
416	)	CD	PERCENT	)	dep	544	SENT_231	[p14l1534t2302r1573b2327],
417	0-38	CD	PERCENT	0-38	dep	544	SENT_231	[p14l1652t2301r1698b2325],
418	0-1	CD	PERCENT	0-1	dep	544	SENT_231	[p14l1769t2304r1820b2322],
419	%	NN	PERCENT	%	dep	544	SENT_231	[p14l1769t2304r1820b2322],
420	(	CD	NUMBER	(	dep	544	SENT_231	[p14l1828t2301r1880b2327],
421	-2	CD	NUMBER	-2	dep	544	SENT_231	[p14l1828t2301r1880b2327],
422	-8	CD	NUMBER	-8	dep	544	SENT_231	[p14l1828t2301r1880b2327],
423	to	TO	O	to	dep	544	SENT_231	[p14l1886t2305r1909b2322],
424	2-9	CD	NUMBER	2-9	dep	544	SENT_231	[p14l1916t2302r1958b2327],
425	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1916t2302r1958b2327],
426	0-96	CD	NUMBER	0-96	dep	544	SENT_231	[p14l2024t2301r2072b2325],
427	FEV	NN	O	fev	dep	544	SENT_231	[p14l43t2349r88b2373],
428	,	,	O	,	_	0	SENT_231	[p14l43t2349r88b2373],
429	after	IN	O	after	dep	544	SENT_231	[p14l93t2347r143b2368],
430	ipratropium	NN	O	ipratropium	dep	544	SENT_231	[p14l149t2349r274b2374],
431	(	CD	NUMBER	(	dep	544	SENT_231	[p14l281t2348r324b2373],
432	L	NN	O	l	dep	544	SENT_231	[p14l281t2348r324b2373],
433	)	CD	NUMBER	)	dep	544	SENT_231	[p14l281t2348r324b2373],
434	1l	NN	O	1l	dep	544	SENT_231	[p14l281t2348r324b2373],
435	2-77	CD	NUMBER	2-77	dep	544	SENT_231	[p14l518t2350r562b2370],
436	2-82	CD	NUMBER	2-82	dep	544	SENT_231	[p14l628t2347r673b2368],
437	0-05	CD	NUMBER	0-05	dep	544	SENT_231	[p14l741t2350r788b2371],
438	(	NN	O	(	dep	544	SENT_231	[p14l796t2348r862b2373],
439	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l796t2348r862b2373],
440	-02	CD	NUMBER	-02	dep	544	SENT_231	[p14l796t2348r862b2373],
441	to	TO	O	to	dep	544	SENT_231	[p14l868t2351r891b2368],
442	0-11	CD	NUMBER	0-11	dep	544	SENT_231	[p14l898t2348r951b2373],
443	)	CD	NUMBER	)	dep	544	SENT_231	[p14l898t2348r951b2373],
444	0-14	CD	NUMBER	0-14	dep	544	SENT_231	[p14l1014t2350r1060b2370],
445	2-83	CD	NUMBER	2-83	dep	544	SENT_231	[p14l1159t2347r1204b2371],
446	2-89	CD	NUMBER	2-89	dep	544	SENT_231	[p14l1264t2347r1311b2371],
447	0-05	CD	NUMBER	0-05	dep	544	SENT_231	[p14l1385t2350r1432b2371],
448	(	NN	O	(	dep	544	SENT_231	[p14l1440t2348r1505b2373],
449	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1440t2348r1505b2373],
450	-01	CD	NUMBER	-01	dep	544	SENT_231	[p14l1440t2348r1505b2373],
451	to	TO	O	to	dep	544	SENT_231	[p14l1511t2351r1534b2368],
452	0-12	CD	NUMBER	0-12	dep	544	SENT_231	[p14l1541t2348r1595b2373],
453	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1541t2348r1595b2373],
454	0-09	CD	NUMBER	0-09	dep	544	SENT_231	[p14l1652t2350r1699b2371],
455	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1757t2350r1815b2368],
456	-01	CD	NUMBER	-01	dep	544	SENT_231	[p14l1757t2350r1815b2368],
457	(	NN	O	(	dep	544	SENT_231	[p14l1823t2348r1888b2373],
458	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1823t2348r1888b2373],
459	-10	CD	NUMBER	-10	dep	544	SENT_231	[p14l1823t2348r1888b2373],
460	to	TO	O	to	dep	544	SENT_231	[p14l1894t2351r1917b2368],
461	0-09	CD	NUMBER	0-09	dep	544	SENT_231	[p14l1924t2348r1982b2373],
462	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1924t2348r1982b2373],
463	0-90	CD	NUMBER	0-90	dep	544	SENT_231	[p14l2024t2350r2072b2371],
464	Daily	NNP	SET	Daily	dep	544	SENT_231	[p14l43t2393r94b2419],
465	symptomsll	NN	O	symptomsll	dep	544	SENT_231	[p14l99t2392r223b2420],
466	0-06	CD	NUMBER	0-06	dep	544	SENT_231	[p14l517t2392r565b2413],
467	0-04	CD	NUMBER	0-04	dep	544	SENT_231	[p14l627t2395r675b2416],
468	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l729t2395r790b2416],
469	-04	CD	NUMBER	-04	dep	544	SENT_231	[p14l729t2395r790b2416],
470	(	NN	O	(	dep	544	SENT_231	[p14l797t2394r861b2419],
471	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l797t2394r861b2419],
472	-12	CD	NUMBER	-12	dep	544	SENT_231	[p14l797t2394r861b2419],
473	to	TO	O	to	dep	544	SENT_231	[p14l867t2396r890b2413],
474	-	:	O	-	_	0	SENT_231	[p14l897t2394r965b2419],
475	o-oo	JJ	O	o-oo	dep	544	SENT_231	[p14l897t2394r965b2419],
476	)	NN	O	)	dep	544	SENT_231	[p14l897t2394r965b2419],
477	0-02	CD	NUMBER	0-02	dep	544	SENT_231	[p14l1014t2395r1059b2413],
478	0-11	CD	NUMBER	0-11	dep	544	SENT_231	[p14l1158t2395r1202b2413],
479	0-04	CD	NUMBER	0-04	dep	544	SENT_231	[p14l1263t2395r1312b2416],
480	-	:	O	-	_	0	SENT_231	[p14l1373t2395r1433b2413],
481	o-oo	JJ	O	o-oo	dep	544	SENT_231	[p14l1373t2395r1433b2413],
482	(	NN	O	(	dep	544	SENT_231	[p14l1441t2394r1506b2419],
483	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1441t2394r1506b2419],
484	-02	CD	NUMBER	-02	dep	544	SENT_231	[p14l1441t2394r1506b2419],
485	to	TO	O	to	dep	544	SENT_231	[p14l1513t2396r1536b2413],
486	0-01	CD	NUMBER	0-01	dep	544	SENT_231	[p14l1543t2394r1597b2419],
487	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1543t2394r1597b2419],
488	0-67	CD	NUMBER	0-67	dep	544	SENT_231	[p14l1652t2392r1699b2416],
489	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1757t2395r1815b2413],
490	-02	CD	NUMBER	-02	dep	544	SENT_231	[p14l1757t2395r1815b2413],
491	(	NN	O	(	dep	544	SENT_231	[p14l1824t2394r1890b2419],
492	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1824t2394r1890b2419],
493	-	:	O	-	_	0	SENT_231	[p14l1824t2394r1890b2419],
494	O7	CD	NUMBER	o7	dep	544	SENT_231	[p14l1824t2394r1890b2419],
495	to	TO	O	to	dep	544	SENT_231	[p14l1895t2396r1918b2413],
496	-	:	O	-	_	0	SENT_231	[p14l1924t2394r1993b2419],
497	ooo	NN	O	ooo	dep	544	SENT_231	[p14l1924t2394r1993b2419],
498	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1924t2394r1993b2419],
499	0-09	CD	NUMBER	0-09	dep	544	SENT_231	[p14l2024t2395r2071b2416],
500	Rescue	NN	O	rescue	dep	544	SENT_231	[p14l43t2440r113b2459],
501	ipratropium	NN	O	ipratropium	dep	544	SENT_231	[p14l120t2440r245b2465],
502	and	CC	O	and	dep	544	SENT_231	[p14l252t2438r291b2459],
503	salbutamol	NN	O	salbutamol	dep	544	SENT_231	[p14l297t2438r413b2459],
504	0-2	CD	NUMBER	0-2	dep	544	SENT_231	[p14l517t2441r548b2459],
505	o-o	NN	O	o-o	dep	544	SENT_231	[p14l627t2441r659b2459],
506	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l729t2441r773b2459],
507	-2	CD	NUMBER	-2	dep	544	SENT_231	[p14l729t2441r773b2459],
508	(	NN	O	(	dep	544	SENT_231	[p14l781t2439r833b2464],
509	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l781t2439r833b2464],
510	-5	CD	NUMBER	-5	dep	544	SENT_231	[p14l781t2439r833b2464],
511	to	TO	O	to	dep	544	SENT_231	[p14l839t2442r862b2459],
512	-	:	O	-	_	0	SENT_231	[p14l868t2440r921b2464],
513	o-O	NN	O	o-o	dep	544	SENT_231	[p14l868t2440r921b2464],
514	)	CD	NUMBER	)	dep	544	SENT_231	[p14l868t2440r921b2464],
515	0-01	CD	NUMBER	0-01	dep	544	SENT_231	[p14l1014t2441r1059b2459],
516	o-o	NN	O	o-o	dep	544	SENT_231	[p14l1158t2441r1191b2459],
517	o-o	SYM	O	o-o	dep	544	SENT_231	[p14l1263t2441r1296b2459],
518	-	:	O	-	_	0	SENT_231	[p14l1373t2441r1418b2459],
519	o-o	NN	O	o-o	dep	544	SENT_231	[p14l1373t2441r1418b2459],
520	(	CD	NUMBER	(	dep	544	SENT_231	[p14l1426t2439r1477b2464],
521	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1426t2439r1477b2464],
522	-2	CD	NUMBER	-2	dep	544	SENT_231	[p14l1426t2439r1477b2464],
523	to	TO	O	to	dep	544	SENT_231	[p14l1483t2442r1506b2459],
524	-	:	O	-	_	0	SENT_231	[p14l1512t2440r1566b2464],
525	o-o	NN	O	o-o	dep	544	SENT_231	[p14l1512t2440r1566b2464],
526	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1512t2440r1566b2464],
527	0-09	CD	NUMBER	0-09	dep	544	SENT_231	[p14l1652t2441r1699b2462],
528	-	:	O	-	_	0	SENT_231	[p14l1757t2441r1802b2459],
529	o-o	JJ	O	o-o	dep	544	SENT_231	[p14l1757t2441r1802b2459],
530	(	NN	O	(	dep	544	SENT_231	[p14l1810t2439r1861b2465],
531	-0	CD	NUMBER	-0	dep	544	SENT_231	[p14l1810t2439r1861b2465],
532	-2	CD	NUMBER	-2	dep	544	SENT_231	[p14l1810t2439r1861b2465],
533	to	TO	O	to	dep	544	SENT_231	[p14l1867t2442r1891b2459],
534	-	:	O	-	_	0	SENT_231	[p14l1896t2440r1950b2464],
535	o-o	NN	O	o-o	dep	544	SENT_231	[p14l1896t2440r1950b2464],
536	)	CD	NUMBER	)	dep	544	SENT_231	[p14l1896t2440r1950b2464],
537	0-25	CD	NUMBER	0-25	dep	544	SENT_231	[p14l2024t2441r2069b2462],
538	(	NN	O	(	dep	544	SENT_231	[p14l43t2473r103b2500],
539	puffs	NNS	O	puff	dep	544	SENT_231	[p14l43t2473r103b2500],
540	per	IN	O	per	dep	544	SENT_231	[p14l109t2480r142b2500],
541	day	NN	DURATION	day	dep	544	SENT_231	[p14l147t2472r204b2500],
542	)	CD	NUMBER	)	dep	544	SENT_231	[p14l147t2472r204b2500],
543	|	CD	NUMBER	|	dep	544	SENT_231	[p14l147t2472r204b2500],
544	|	IN	O	|	_	0	SENT_231	[p14l147t2472r204b2500],

1	Data	NNS	O	datum	nsubj	3	SENT_232	[p14l32t2543r77b2560],
2	are	VBP	O	be	cop	3	SENT_232	[p14l83t2547r113b2560],
3	mean	JJ	O	mean	_	0	SENT_232	[p14l120t2547r174b2560],
4	unless	IN	O	unless	mark	6	SENT_232	[p14l182t2541r242b2560],
5	otherwise	RB	O	otherwise	advmod	6	SENT_232	[p14l248t2541r347b2560],
6	indicated	VBN	O	indicate	dep	3	SENT_232	[p14l354t2541r450b2560],
7	,	,	O	,	_	0	SENT_232	[p14l354t2541r450b2560],
8	PEF	NN	O	pef	appos	3	SENT_232	[p14l458t2541r554b2566],
9	=	JJ	O	=	amod	12	SENT_232	[p14l458t2541r554b2566],
10	peak	NN	O	peak	nn	12	SENT_232	[p14l458t2541r554b2566],
11	expiratory	NN	O	expiratory	nn	12	SENT_232	[p14l560t2542r662b2566],
12	ﬂow	NN	O	ﬂow	dep	8	SENT_232	[p14l667t2541r715b2560],
13	.	.	O	.	_	0	SENT_232	[p14l667t2541r715b2560],

1	FEV	NN	O	fev	_	0	SENT_233	[p14l723t2541r842b2565],
2	,	,	O	,	_	0	SENT_233	[p14l723t2541r842b2565],
3	=	JJ	O	=	amod	6	SENT_233	[p14l723t2541r842b2565],
4	forced	JJ	O	forced	amod	6	SENT_233	[p14l723t2541r842b2565],
5	expiratory	JJ	O	expiratory	amod	6	SENT_233	[p14l848t2542r950b2566],
6	volume	NN	O	volume	appos	1	SENT_233	[p14l955t2541r1031b2560],
7	in	IN	O	in	_	0	SENT_233	[p14l1038t2542r1054b2560],
8	1	CD	NUMBER	1	num	10	SENT_233	[p14l1062t2543r1072b2560],
9	s.	NN	O	s.	nn	10	SENT_233	[p14l1078t2547r1092b2560],
10	FVC	NN	O	fvc	prep_in	6	SENT_233	[p14l1100t2541r1214b2560],
11	=	JJ	O	=	amod	10	SENT_233	[p14l1100t2541r1214b2560],
12	forced	JJ	O	forced	amod	14	SENT_233	[p14l1100t2541r1214b2560],
13	vital	JJ	O	vital	amod	14	SENT_233	[p14l1219t2541r1261b2560],
14	capacity	NN	O	capacity	tmod	11	SENT_233	[p14l1268t2542r1353b2566],
15	,	,	O	,	_	0	SENT_233	[p14l1268t2542r1353b2566],
16	NO	NN	O	no	nn	19	SENT_233	[p14l1361t2542r1458b2560],
17	=	JJ	O	=	amod	19	SENT_233	[p14l1361t2542r1458b2560],
18	nitric	JJ	O	nitric	amod	19	SENT_233	[p14l1361t2542r1458b2560],
19	oxide	NN	O	oxide	appos	14	SENT_233	[p14l1464t2541r1523b2560],
20	.	.	O	.	_	0	SENT_233	[p14l1464t2541r1523b2560],

1	PC	NN	O	pc	_	0	SENT_234	[p14l1531t2542r1625b2565],
2	,	,	O	,	_	0	SENT_234	[p14l1531t2542r1625b2565],
3	,	,	O	,	_	0	SENT_234	[p14l1531t2542r1625b2565],
4	,	,	O	,	_	0	SENT_234	[p14l1531t2542r1625b2565],
5	=	JJ	O	=	dep	8	SENT_234	[p14l1531t2542r1625b2565],
6	20	CD	PERCENT	20	number	7	SENT_234	[p14l1531t2542r1625b2565],
7	%	NN	PERCENT	%	amod	8	SENT_234	[p14l1531t2542r1625b2565],
8	reduction	NN	O	reduction	dep	17	SENT_234	[p14l1633t2541r1727b2560],
9	in	IN	O	in	_	0	SENT_234	[p14l1735t2542r1752b2560],
10	FEV	NNP	O	FEV	prep_in	8	SENT_234	[p14l1760t2542r1807b2565],
11	,	,	O	,	_	0	SENT_234	[p14l1760t2542r1807b2565],
12	*	NNP	O	*	nn	14	SENT_234	[p14l1814t2541r1886b2560],
13	Mixed	NNP	O	Mixed	nn	14	SENT_234	[p14l1814t2541r1886b2560],
14	Ion	NNP	O	Ion	appos	10	SENT_234	[p14l1893t2541r1922b2560],
15	i	FW	O	i	dep	14	SENT_234	[p14l1938t2542r1941b2560],
16	udinal	JJ	O	udinal	amod	17	SENT_234	[p14l1953t2541r2013b2560],
17	model	NN	O	model	dep	23	SENT_234	[p14l2021t2541r2082b2560],
18	(	CD	NUMBER	(	dep	17	SENT_234	[p14l31t2575r152b2600],
19	three-slope	JJ	O	three-slope	amod	21	SENT_234	[p14l31t2575r152b2600],
20	treatment	NN	O	treatment	nn	21	SENT_234	[p14l157t2579r260b2595],
21	period	NN	O	period	dep	17	SENT_234	[p14l266t2575r335b2600],
22	,	,	O	,	_	0	SENT_234	[p14l266t2575r335b2600],
23	weeks	NNS	DURATION	week	appos	1	SENT_234	[p14l341t2575r402b2595],
24	0-2	CD	NUMBER	0-2	dep	23	SENT_234	[p14l409t2578r448b2598],
25	,	,	O	,	_	0	SENT_234	[p14l409t2578r448b2598],
26	2-6	CD	NUMBER	2-6	appos	1	SENT_234	[p14l456t2575r496b2598],
27	,	,	O	,	_	0	SENT_234	[p14l456t2575r496b2598],
28	6-18	CD	NUMBER	6-18	num	29	SENT_234	[p14l504t2575r560b2599],
29	)	NN	O	)	appos	1	SENT_234	[p14l504t2575r560b2599],
30	without	IN	O	without	_	0	SENT_234	[p14l566t2575r647b2595],
31	run-in	NN	O	run-in	prep_without	29	SENT_234	[p14l654t2577r714b2594],
32	or	CC	O	or	_	0	SENT_234	[p14l720t2582r741b2594],
33	run-outs	NNS	O	run-out	conj_or	31	SENT_234	[p14l748t2579r838b2595],
34	.	.	O	.	_	0	SENT_234	[p14l748t2579r838b2595],

1	‘	NN	O	‘	nsubj	2	SENT_235	[p14l846t2575r918b2596],
2	rMixed	VBD	O	rmix	_	0	SENT_235	[p14l846t2575r918b2596],
3	longitudinal	JJ	O	longitudinal	amod	10	SENT_235	[p14l925t2575r1045b2601],
4	model	NN	O	model	nn	10	SENT_235	[p14l1054t2575r1115b2595],
5	(	CD	NUMBER	(	num	10	SENT_235	[p14l1123t2575r1231b2600],
6	t	NN	O	t	nn	10	SENT_235	[p14l1123t2575r1231b2600],
7	\	CD	NUMBER	\	num	10	SENT_235	[p14l1123t2575r1231b2600],
8	No-slope	JJ	O	no-slope	amod	10	SENT_235	[p14l1123t2575r1231b2600],
9	treatment	NN	O	treatment	nn	10	SENT_235	[p14l1236t2579r1339b2595],
10	period	NN	O	period	dep	12	SENT_235	[p14l1344t2575r1413b2600],
11	,	,	O	,	_	0	SENT_235	[p14l1344t2575r1413b2600],
12	weeks	NNS	DURATION	week	dep	2	SENT_235	[p14l1419t2575r1480b2595],
13	0-10	CD	NUMBER	0-10	dep	12	SENT_235	[p14l1487t2578r1540b2598],
14	,	,	O	,	_	0	SENT_235	[p14l1487t2578r1540b2598],
15	10-18	CD	NUMBER	10-18	num	16	SENT_235	[p14l1547t2575r1614b2600],
16	)	NN	O	)	dep	12	SENT_235	[p14l1547t2575r1614b2600],
17	without	IN	O	without	dep	16	SENT_235	[p14l1620t2575r1701b2594],
18	ru	NN	O	ru	nn	19	SENT_235	[p14l1708t2582r1726b2595],
19	n-in	NN	O	n-in	pobj	17	SENT_235	[p14l1730t2577r1768b2594],
20	or	CC	O	or	_	0	SENT_235	[p14l1775t2582r1795b2594],
21	run-outs	NNS	O	run-out	conj_or	19	SENT_235	[p14l1802t2579r1893b2595],
22	.	.	O	.	_	0	SENT_235	[p14l1802t2579r1893b2595],

1	ixed	JJ	O	ixed	amod	3	SENT_236	[p14l1933t2575r1973b2595],
2	longitudinal	JJ	O	longitudinal	amod	3	SENT_236	[p14l1980t2575r2100b2601],
3	model	NN	O	model	_	0	SENT_236	[p14l32t2610r93b2629],
4	(	CD	NUMBER	(	num	7	SENT_236	[p14l101t2610r207b2635],
5	one-slope	JJ	O	one-slope	amod	7	SENT_236	[p14l101t2610r207b2635],
6	treatment	NN	O	treatment	nn	7	SENT_236	[p14l212t2613r315b2629],
7	period	NN	O	period	dep	3	SENT_236	[p14l321t2610r390b2635],
8	,	,	O	,	_	0	SENT_236	[p14l321t2610r390b2635],
9	weeks	NNS	DURATION	week	appos	7	SENT_236	[p14l396t2610r457b2629],
10	0-18	CD	NUMBER	0-18	num	11	SENT_236	[p14l463t2609r519b2634],
11	)	NN	O	)	dep	3	SENT_236	[p14l463t2609r519b2634],
12	without	IN	O	without	_	0	SENT_236	[p14l525t2610r606b2629],
13	run-in	NN	O	run-in	prep_without	11	SENT_236	[p14l613t2611r673b2629],
14	or	CC	O	or	_	0	SENT_236	[p14l679t2616r700b2629],
15	run-outs	NNS	O	run-out	prep_without	11	SENT_236	[p14l707t2613r797b2629],
16	,	,	O	,	_	0	SENT_236	[p14l707t2613r797b2629],
17	SMixed	JJ	O	smixed	amod	19	SENT_236	[p14l805t2610r877b2632],
18	longitudinal	JJ	O	longitudinal	amod	19	SENT_236	[p14l884t2610r1004b2635],
19	model	NN	O	model	appos	3	SENT_236	[p14l1012t2610r1073b2629],
20	(	CD	NUMBER	(	num	23	SENT_236	[p14l1081t2610r1187b2635],
21	one-slope	JJ	O	one-slope	amod	23	SENT_236	[p14l1081t2610r1187b2635],
22	treatment	NN	O	treatment	nn	23	SENT_236	[p14l1192t2613r1295b2629],
23	period	NN	O	period	dep	19	SENT_236	[p14l1301t2610r1370b2635],
24	,	,	O	,	_	0	SENT_236	[p14l1301t2610r1370b2635],
25	weeks	NNS	DATE	week	appos	3	SENT_236	[p14l1376t2610r1437b2629],
26	-2	CD	DATE	-2	num	25	SENT_236	[p14l1442t2612r1464b2629],
27	to	TO	DATE	to	_	0	SENT_236	[p14l1470t2613r1491b2629],
28	14	CD	DATE	14	number	29	SENT_236	[p14l1498t2611r1529b2634],
29	)	CD	NUMBER	)	prep_to	25	SENT_236	[p14l1498t2611r1529b2634],
30	without	IN	O	without	_	0	SENT_236	[p14l1536t2610r1616b2629],
31	ru	NN	O	ru	nn	32	SENT_236	[p14l1623t2616r1641b2629],
32	n-in	NN	O	n-in	prep_without	25	SENT_236	[p14l1645t2611r1683b2629],
33	or	CC	O	or	_	0	SENT_236	[p14l1690t2616r1710b2629],
34	run-outs	NNS	O	run-out	prep_without	25	SENT_236	[p14l1717t2613r1808b2629],
35	.	.	O	.	_	0	SENT_236	[p14l1717t2613r1808b2629],

1	1lMixed	VBN	O	1lmix	_	0	SENT_237	[p14l1815t2610r1892b2631],
2	longitudinal	JJ	O	longitudinal	amod	3	SENT_237	[p14l1899t2610r2019b2635],
3	model	NN	O	model	dobj	1	SENT_237	[p14l2027t2610r2088b2629],
4	(	CD	NUMBER	(	num	7	SENT_237	[p14l31t2644r138b2669],
5	one-slope	JJ	O	one-slope	amod	7	SENT_237	[p14l31t2644r138b2669],
6	treatment	NN	O	treatment	nn	7	SENT_237	[p14l142t2648r246b2663],
7	period	NN	O	period	dep	3	SENT_237	[p14l251t2644r320b2669],
8	,	,	O	,	_	0	SENT_237	[p14l251t2644r320b2669],
9	weeks	NNS	DATE	week	appos	3	SENT_237	[p14l326t2644r387b2663],
10	-5	CD	DATE	-5	dep	9	SENT_237	[p14l393t2647r414b2666],
11	to	TO	DATE	to	_	0	SENT_237	[p14l420t2648r441b2663],
12	10	CD	DATE	10	number	13	SENT_237	[p14l448t2645r479b2668],
13	)	CD	NUMBER	)	prep_to	1	SENT_237	[p14l448t2645r479b2668],
14	without	IN	O	without	_	0	SENT_237	[p14l485t2644r566b2663],
15	run-in	NN	O	run-in	prep_without	1	SENT_237	[p14l573t2646r633b2663],
16	or	CC	O	or	_	0	SENT_237	[p14l640t2651r660b2663],
17	run-outs	NNS	O	run-out	prep_without	1	SENT_237	[p14l667t2648r758b2663],
18	.	.	O	.	_	0	SENT_237	[p14l667t2648r758b2663],

1	|	NN	O	|	nsubj	4	SENT_238	[p14l767t2644r939b2669],
2	|	SYM	O	|	dep	4	SENT_238	[p14l767t2644r939b2669],
3	Non-parametric	JJ	O	non-parametric	amod	4	SENT_238	[p14l767t2644r939b2669],
4	analysis	NN	O	analysis	_	0	SENT_238	[p14l945t2644r1027b2669],
5	.	.	O	.	_	0	SENT_238	[p14l945t2644r1027b2669],

1	Table	NNP	O	Table	_	0	SENT_239	[p14l31t2708r88b2729],
2	2	CD	NUMBER	2	num	1	SENT_239	[p14l93t2711r113b2729],
3	:	:	O	:	_	0	SENT_239	[p14l93t2711r113b2729],
4	Outcomes	NNS	O	outcome	dep	1	SENT_239	[p14l119t2709r234b2729],
5	after	IN	O	after	_	0	SENT_239	[p14l241t2708r296b2729],
6	18	CD	DURATION	18	num	7	SENT_239	[p14l302t2708r329b2729],
7	weeks	NNS	NUMBER	week	prep_after	4	SENT_239	[p14l335t2708r406b2729],
8	of	IN	O	of	_	0	SENT_239	[p14l412t2708r437b2729],
9	treatment	NN	O	treatment	prep_of	7	SENT_239	[p14l440t2711r559b2729],
10	with	IN	O	with	dep	1	SENT_239	[p14l564t2708r616b2729],
11	inhaled	VBN	O	inhale	pcomp	10	SENT_239	[p14l624t2708r708b2729],
12	corticosteroid	NN	O	corticosteroid	dobj	11	SENT_239	[p14l714t2708r873b2729],
13	plus	CC	O	plus	prep	11	SENT_239	[p14l879t2708r926b2735],
14	placebo	NN	O	placebo	dep	13	SENT_239	[p14l932t2708r1019b2735],
15	or	CC	O	or	_	0	SENT_239	[p14l1026t2715r1049b2729],
16	salmeterol	NN	O	salmeterol	conj_or	14	SENT_239	[p14l1055t2708r1174b2729],
17	in	IN	O	in	_	0	SENT_239	[p14l1182t2709r1202b2728],
18	B16	NN	O	b16	nn	19	SENT_239	[p14l1210t2708r1252b2729],
19	Arg/Arg	NN	O	arg/arg	prep_in	11	SENT_239	[p14l1259t2709r1349b2735],
20	and	CC	O	and	_	0	SENT_239	[p14l1357t2708r1399b2729],
21	B16	NN	O	b16	nn	23	SENT_239	[p14l1406t2708r1449b2729],
22	Gly/Gly	NN	O	gly/gly	nn	23	SENT_239	[p14l1455t2708r1538b2735],
23	participants	NNS	O	participant	prep_in	11	SENT_239	[p14l1544t2709r1682b2735],

1	Role	NN	O	role	nsubj	17	SENT_240	[p14l12t2933r169b3002],
2	of	IN	O	of	_	0	SENT_240	[p14l191t2933r272b3002],
3	the	DT	O	the	det	5	SENT_240	[p14l285t2933r412b3002],
4	funding	NN	O	funding	nn	5	SENT_240	[p14l432t2933r736b3024],
5	sources	NNS	O	source	prep_of	1	SENT_240	[p14l761t2956r1041b3002],
6	A	DT	O	a	det	9	SENT_240	[p14l6t3049r66b3110],
7	protocol	NN	O	protocol	nn	9	SENT_240	[p14l98t3044r409b3133],
8	review	NN	O	review	nn	9	SENT_240	[p14l443t3048r691b3112],
9	committee	NN	O	committee	dep	5	SENT_240	[p14l723t3048r1130b3112],
10	appointed	VBN	O	appoint	partmod	5	SENT_240	[p14l1165t3044r1546b3133],
11	by	IN	O	by	_	0	SENT_240	[p14l1577t3044r1665b3133],
12	the	DT	O	the	det	13	SENT_240	[p14l1695t3044r1814b3112],
13	sponsor	NN	O	sponsor	agent	10	SENT_240	[p14l1850t3068r2152b3133],
14	of	IN	O	of	_	0	SENT_240	[p14l9t3152r93b3220],
15	the	DT	O	the	det	16	SENT_240	[p14l102t3152r220b3221],
16	study	NN	O	study	prep_of	13	SENT_240	[p14l247t3152r450b3242],
17	approved	VBD	O	approve	_	0	SENT_240	[p14l473t3152r822b3241],
18	the	DT	O	the	det	20	SENT_240	[p14l842t3152r961b3220],
19	study	NN	O	study	nn	20	SENT_240	[p14l988t3152r1191b3242],
20	design	NN	O	design	dobj	17	SENT_240	[p14l1213t3152r1483b3242],
21	.	.	O	.	_	0	SENT_240	[p14l1213t3152r1483b3242],

1	A	DT	O	a	det	2	SENT_241	[p14l1509t3158r1569b3219],
2	data	NNS	O	datum	nsubj	7	SENT_241	[p14l1592t3152r1748b3221],
3	and	CC	O	and	_	0	SENT_241	[p14l1771t3152r1911b3220],
4	safety	NN	O	safety	nn	6	SENT_241	[p14l1936t3152r2153b3242],
5	monitoring	NN	O	monitoring	nn	6	SENT_241	[p14l8t3266r444b3351],
6	board	NN	O	board	nsubj	7	SENT_241	[p14l487t3261r705b3329],
7	appointed	VBN	O	appoint	_	0	SENT_241	[p14l750t3261r1131b3350],
8	by	IN	O	by	_	0	SENT_241	[p14l1173t3261r1261b3350],
9	the	DT	O	the	det	10	SENT_241	[p14l1302t3261r1420b3329],
10	sponsor	NN	O	sponsor	prep_by	7	SENT_241	[p14l1468t3285r1770b3350],
11	reviewed	VBN	O	review	partmod	10	SENT_241	[p14l1813t3261r2152b3329],
12	the	DT	O	the	det	14	SENT_241	[p14l7t3371r125b3439],
13	ﬁnal	JJ	O	ﬁnal	amod	14	SENT_241	[p14l159t3370r329b3439],
14	manuscript	NN	O	manuscript	dobj	11	SENT_241	[p14l362t3375r821b3459],
15	.	.	O	.	_	0	SENT_241	[p14l362t3375r821b3459],

1	Neither	DT	O	neither	det	2	SENT_242	[p14l861t3371r1146b3439],
2	group	NN	O	group	nsubj	3	SENT_242	[p14l1179t3395r1402b3460],
3	had	VBD	O	have	_	0	SENT_242	[p14l1435t3371r1577b3439],
4	any	DT	O	any	det	6	SENT_242	[p14l1610t3395r1743b3460],
5	other	JJ	O	other	amod	6	SENT_242	[p14l1775t3371r1975b3439],
6	role	NN	O	role	dobj	3	SENT_242	[p14l2006t3371r2150b3439],
7	in	IN	O	in	_	0	SENT_242	[p14l8t3484r83b3546],
8	the	DT	O	the	det	9	SENT_242	[p14l115t3479r233b3547],
9	study	NN	O	study	prep_in	6	SENT_242	[p14l269t3479r483b3569],
10	.	.	O	.	_	0	SENT_242	[p14l269t3479r483b3569],

1	The	DT	O	the	det	2	SENT_243	[p14l519t3479r664b3547],
2	companies	NNS	O	company	nsubj	7	SENT_243	[p14l699t3484r1110b3568],
3	providing	VBG	O	provide	partmod	2	SENT_243	[p14l1145t3479r1513b3569],
4	the	DT	O	the	det	6	SENT_243	[p14l1545t3479r1663b3547],
5	study	NN	O	study	nn	6	SENT_243	[p14l1699t3479r1903b3569],
6	drugs	NNS	O	drug	dobj	3	SENT_243	[p14l1935t3479r2148b3569],
7	had	VBD	O	have	_	0	SENT_243	[p14l6t3588r147b3656],
8	no	DT	O	no	det	9	SENT_243	[p14l167t3612r261b3656],
9	role	NN	O	role	dobj	7	SENT_243	[p14l283t3588r426b3656],
10	in	IN	O	in	_	0	SENT_243	[p14l446t3593r522b3655],
11	study	NN	O	study	nn	12	SENT_243	[p14l545t3588r749b3677],
12	design	NN	O	design	nsubj	23	SENT_243	[p14l768t3588r1038b3678],
13	,	,	O	,	_	0	SENT_243	[p14l768t3588r1038b3678],
14	data	NNS	O	datum	nn	15	SENT_243	[p14l1063t3588r1218b3656],
15	collection	NN	O	collection	appos	12	SENT_243	[p14l1239t3588r1625b3666],
16	,	,	O	,	_	0	SENT_243	[p14l1239t3588r1625b3666],
17	data	NN	O	datum	nn	18	SENT_243	[p14l1650t3588r1805b3656],
18	analysis	NN	O	analysis	appos	12	SENT_243	[p14l1826t3588r2147b3677],
19	,	,	O	,	_	0	SENT_243	[p14l1826t3588r2147b3677],
20	data	NNS	O	datum	nn	21	SENT_243	[p14l9t3698r164b3766],
21	interpretation	NN	O	interpretation	appos	12	SENT_243	[p14l220t3702r769b3786],
22	,	,	O	,	_	0	SENT_243	[p14l220t3702r769b3786],
23	writing	VBG	O	write	prepc_in	7	SENT_243	[p14l826t3702r1103b3787],
24	of	IN	O	of	_	0	SENT_243	[p14l1159t3697r1243b3766],
25	the	DT	O	the	det	26	SENT_243	[p14l1285t3698r1403b3766],
26	report	NN	O	report	prep_of	23	SENT_243	[p14l1460t3711r1710b3786],
27	,	,	O	,	_	0	SENT_243	[p14l1460t3711r1710b3786],
28	or	CC	O	or	_	0	SENT_243	[p14l1770t3722r1848b3766],
29	in	IN	O	in	_	0	SENT_243	[p14l1902t3702r1977b3764],
30	the	DT	O	the	det	31	SENT_243	[p14l2031t3698r2150b3766],
31	decision	NN	O	decision	conj_or	23	SENT_243	[p15l9t17r325b85],
32	to	TO	O	to	aux	33	SENT_243	[p15l385t31r455b85],
33	submit	VB	O	submit	infmod	31	SENT_243	[p15l520t17r788b85],
34	the	DT	O	the	det	35	SENT_243	[p15l847t17r966b85],
35	report	NN	O	report	dobj	33	SENT_243	[p15l1028t31r1261b106],
36	for	IN	O	for	_	0	SENT_243	[p15l1321t17r1429b85],
37	publication	NN	O	publication	prep_for	35	SENT_243	[p15l1489t17r1940b106],
38	.	.	O	.	_	0	SENT_243	[p15l1489t17r1940b106],

1	The	DT	O	the	det	3	SENT_244	[p15l2005t17r2150b85],
2	corresponding	JJ	O	corresponding	amod	3	SENT_244	[p15l8t126r563b216],
3	author	NN	O	author	nsubj	15	SENT_244	[p15l600t126r852b194],
4	had	VBD	O	have	_	0	SENT_244	[p15l885t126r1027b194],
5	full	JJ	O	full	amod	6	SENT_244	[p15l1061t126r1189b194],
6	access	NN	O	access	dobj	4	SENT_244	[p15l1227t150r1460b194],
7	to	TO	O	to	_	0	SENT_244	[p15l1497t140r1567b194],
8	all	PDT	O	all	predet	10	SENT_244	[p15l1606t126r1692b194],
9	the	DT	O	the	det	10	SENT_244	[p15l1728t126r1846b194],
10	data	NNS	O	datum	prep_to	4	SENT_244	[p15l1884t126r2039b194],
11	in	IN	O	in	_	0	SENT_244	[p15l2076t131r2151b193],
12	the	DT	O	the	det	13	SENT_244	[p15l7t236r125b304],
13	study	NN	O	study	prep_in	10	SENT_244	[p15l155t236r359b325],
14	and	CC	O	and	_	0	SENT_244	[p15l385t236r525b304],
15	had	VBD	O	have	conj_and	4	SENT_244	[p15l549t236r690b304],
16	ﬁnal	JJ	O	ﬁnal	amod	17	SENT_244	[p15l716t235r885b304],
17	responsibility	NN	O	responsibility	dobj	15	SENT_244	[p15l912t236r1433b325],
18	for	IN	O	for	_	0	SENT_244	[p15l1458t235r1566b304],
19	the	DT	O	the	det	20	SENT_244	[p15l1591t236r1709b304],
20	decision	NN	O	decision	prep_for	17	SENT_244	[p15l1738t236r2054b304],
21	to	TO	O	to	aux	22	SENT_244	[p15l2079t249r2150b304],
22	submit	VB	O	submit	infmod	20	SENT_244	[p15l11t345r278b413],
23	for	IN	O	for	_	0	SENT_244	[p15l304t345r413b413],
24	publication	NN	O	publication	prep_for	22	SENT_244	[p15l438t345r889b434],
25	.	.	O	.	_	0	SENT_244	[p15l438t345r889b434],

1	Results	NNS	O	result	nsubj	4	SENT_245	[p15l13t554r321b633],
2	Figure	NN	O	figure	dep	1	SENT_245	[p15l12t679r252b764],
3	2	CD	NUMBER	2	num	2	SENT_245	[p15l284t681r320b741],
4	shows	VBZ	O	show	_	0	SENT_245	[p15l353t674r582b743],
5	the	DT	O	the	det	7	SENT_245	[p15l611t674r728b742],
6	trial	NN	O	trial	nn	7	SENT_245	[p15l756t674r907b743],
7	proﬁle	NN	O	proﬁle	dobj	4	SENT_245	[p15l934t674r1198b763],
8	.	.	O	.	_	0	SENT_245	[p15l934t674r1198b763],

1	Between	IN	O	between	_	0	SENT_246	[p15l1234t681r1554b743],
2	2004	CD	DATE	2004	prep_between	9	SENT_246	[p15l1584t681r1759b743],
3	and	CC	DATE	and	_	0	SENT_246	[p15l1783t674r1922b742],
4	2006	CD	DATE	2006	conj_and	2	SENT_246	[p15l1952t680r2147b753],
5	,	,	O	,	_	0	SENT_246	[p15l1952t680r2147b753],
6	474	CD	NUMBER	474	num	7	SENT_246	[p15l6t789r129b855],
7	patients	NNS	O	patient	nsubjpass	9	SENT_246	[p15l157t789r455b873],
8	were	VBD	O	be	auxpass	9	SENT_246	[p15l490t808r669b852],
9	screened	VBN	O	screen	_	0	SENT_246	[p15l706t784r1040b852],
10	for	IN	O	for	_	0	SENT_246	[p15l1072t784r1180b852],
11	the	DT	O	the	det	12	SENT_246	[p15l1211t784r1329b852],
12	trial	NN	O	trial	prep_for	9	SENT_246	[p15l1362t784r1531b852],
13	.	.	O	.	_	0	SENT_246	[p15l1362t784r1531b852],

1	The	DT	O	the	det	3	SENT_247	[p15l1568t784r1713b852],
2	B16	NN	O	b16	nn	3	SENT_247	[p15l1751t790r1881b852],
3	alleles	NNS	O	allele	nsubj	4	SENT_247	[p15l1918t784r2147b852],
4	were	VBD	O	be	_	0	SENT_247	[p15l6t918r186b961],
5	in	IN	O	in	_	0	SENT_247	[p15l226t898r301b960],
6	Hardy	NNP	LOCATION	Hardy	prep_in	4	SENT_247	[p15l345t894r992b983],
7	.	.	O	.	_	0	SENT_247	[p15l345t894r992b983],

1	—	NN	O	—	_	0	SENT_248	[p15l345t894r992b983],
2	.	.	O	.	_	0	SENT_248	[p15l345t894r992b983],

1	Weinberg	NNP	PERSON	Weinberg	nn	4	SENT_249	[p15l345t894r992b983],
2	equilibrium	NN	O	equilibrium	nn	4	SENT_249	[p15l1033t894r1485b983],
3	(	NN	O	(	nn	4	SENT_249	[p15l1531t898r1851b984],
4	p	NN	O	p	_	0	SENT_249	[p15l1531t898r1851b984],
5	=	JJ	O	=	amod	7	SENT_249	[p15l1531t898r1851b984],
6	O-95	NN	O	o-95	nn	7	SENT_249	[p15l1531t898r1851b984],
7	)	NN	O	)	dep	4	SENT_249	[p15l1531t898r1851b984],
8	in	IN	O	in	_	0	SENT_249	[p15l1896t898r1971b960],
9	this	DT	O	this	det	10	SENT_249	[p15l2010t894r2148b961],
10	population	NN	O	population	prep_in	7	SENT_249	[p15l7t1002r436b1091],
11	.	.	O	.	_	0	SENT_249	[p15l7t1002r436b1091],

1	244	CD	NUMBER	244	num	2	SENT_250	[p15l476t1009r601b1069],
2	patients	NNS	O	patient	nsubj	3	SENT_250	[p15l630t1007r928b1091],
3	had	VBD	O	have	_	0	SENT_250	[p15l963t1002r1104b1070],
4	eligible	JJ	O	eligible	amod	5	SENT_250	[p15l1137t1002r1409b1092],
5	genotypes	NNS	O	genotype	dobj	3	SENT_250	[p15l1445t1016r1843b1092],
6	.	.	O	.	_	0	SENT_250	[p15l1445t1016r1843b1092],

1	Several	JJ	O	several	nsubj	18	SENT_251	[p15l1886t1002r2151b1070],
2	of	IN	O	of	_	0	SENT_251	[p15l9t1111r92b1179],
3	these	DT	O	these	det	4	SENT_251	[p15l101t1111r299b1179],
4	patients	NNS	O	patient	prep_of	1	SENT_251	[p15l321t1116r619b1200],
5	(	IN	O	(	_	0	SENT_251	[p15l650t1116r1009b1201],
6	Arg/Arg	NN	O	arg/arg	prep_(	4	SENT_251	[p15l650t1116r1009b1201],
7	,	,	O	,	_	0	SENT_251	[p15l650t1116r1009b1201],
8	n	NN	O	n	appos	6	SENT_251	[p15l1035t1117r1198b1189],
9	=	JJ	O	=	amod	8	SENT_251	[p15l1035t1117r1198b1189],
10	9	CD	NUMBER	9	tmod	9	SENT_251	[p15l1035t1117r1198b1189],
11	;	:	O	;	_	0	SENT_251	[p15l1035t1117r1198b1189],
12	Gly/Gly	NNP	O	Gly/Gly	dep	8	SENT_251	[p15l1227t1111r1535b1200],
13	,	,	O	,	_	0	SENT_251	[p15l1227t1111r1535b1200],
14	n	NN	O	n	appos	12	SENT_251	[p15l1561t1117r1768b1201],
15	=	JJ	O	=	amod	14	SENT_251	[p15l1561t1117r1768b1201],
16	42	CD	NUMBER	42	number	17	SENT_251	[p15l1561t1117r1768b1201],
17	)	CD	NUMBER	)	dep	15	SENT_251	[p15l1561t1117r1768b1201],
18	withdrew	VBD	O	withdraw	_	0	SENT_251	[p15l1794t1111r2152b1179],
19	consent	NN	O	consent	dobj	18	SENT_251	[p15l8t1234r304b1289],
20	after	IN	O	after	_	0	SENT_251	[p15l344t1220r514b1289],
21	screening	VBG	O	screen	prepc_after	18	SENT_251	[p15l556t1225r922b1310],
22	because	IN	O	because	mark	27	SENT_251	[p15l961t1221r1261b1289],
23	no	DT	O	no	det	25	SENT_251	[p15l1302t1245r1396b1289],
24	appropriate	JJ	O	appropriate	amod	25	SENT_251	[p15l1439t1225r1873b1309],
25	match	NN	O	match	nsubjpass	27	SENT_251	[p15l1914t1221r2151b1289],
26	was	VBD	O	be	auxpass	27	SENT_251	[p15l6t1354r146b1397],
27	identiﬁed	VBN	O	identiﬁed	advcl	21	SENT_251	[p15l181t1329r544b1397],
28	and	CC	O	and	_	0	SENT_251	[p15l577t1329r716b1397],
29	they	PRP	O	they	nsubj	32	SENT_251	[p15l747t1329r908b1419],
30	no	RB	O	no	advmod	31	SENT_251	[p15l939t1354r1033b1397],
31	longer	RB	O	longer	advmod	32	SENT_251	[p15l1066t1329r1311b1419],
32	wanted	VBD	O	want	advcl	21	SENT_251	[p15l1341t1329r1616b1398],
33	to	TO	O	to	aux	34	SENT_251	[p15l1647t1343r1716b1397],
34	participate	VB	O	participate	xcomp	32	SENT_251	[p15l1751t1334r2150b1418],
35	in	IN	O	in	_	0	SENT_251	[p15l8t1444r83b1506],
36	the	DT	O	the	det	38	SENT_251	[p15l142t1439r259b1507],
37	pre-match	JJ	O	pre-match	amod	38	SENT_251	[p15l319t1439r707b1528],
38	protocol	NN	O	protocol	prep_in	34	SENT_251	[p15l765t1439r1093b1528],
39	.	.	O	.	_	0	SENT_251	[p15l765t1439r1093b1528],

1	42	CD	NUMBER	42	num	2	SENT_252	[p15l1155t1445r1237b1506],
2	participants	NNS	O	participant	nsubjpass	17	SENT_252	[p15l1299t1444r1745b1528],
3	with	IN	O	with	_	0	SENT_252	[p15l1806t1439r1974b1507],
4	the	DT	O	the	det	7	SENT_252	[p15l2032t1439r2150b1507],
5	B16	NN	O	b16	nn	7	SENT_252	[p15l12t1556r142b1618],
6	Arg/Arg	NN	O	arg/arg	nn	7	SENT_252	[p15l194t1555r512b1639],
7	genotype	NN	O	genotype	prep_with	2	SENT_252	[p15l564t1563r904b1639],
8	and	CC	O	and	_	0	SENT_252	[p15l957t1550r1096b1618],
9	45	CD	NUMBER	45	conj_and	2	SENT_252	[p15l1144t1554r1225b1617],
10	with	IN	O	with	_	0	SENT_252	[p15l1278t1550r1445b1618],
11	the	DT	O	the	det	14	SENT_252	[p15l1495t1550r1613b1618],
12	B16	NN	O	b16	nn	14	SENT_252	[p15l1668t1556r1799b1618],
13	Gly/Gly	NN	O	gly/gly	nn	14	SENT_252	[p15l1854t1550r2152b1639],
14	genotype	NN	O	genotype	prep_with	9	SENT_252	[p15l9t1672r349b1748],
15	were	VBD	O	be	auxpass	17	SENT_252	[p15l374t1683r554b1726],
16	randomly	RB	O	randomly	advmod	17	SENT_252	[p15l581t1658r947b1748],
17	assigned	VBN	O	assign	_	0	SENT_252	[p15l973t1658r1303b1748],
18	to	TO	O	to	aux	19	SENT_252	[p15l1327t1672r1397b1726],
19	study	VB	O	study	xcomp	17	SENT_252	[p15l1427t1658r1630b1748],
20	treatment	NN	O	treatment	dobj	19	SENT_252	[p15l1653t1672r2044b1726],
21	.	.	O	.	_	0	SENT_252	[p15l1653t1672r2044b1726],

1	Table	NNP	O	Table	nsubj	3	SENT_253	[p15l77t1767r276b1835],
2	1	CD	NUMBER	1	num	1	SENT_253	[p15l317t1773r347b1834],
3	shows	VBZ	O	show	_	0	SENT_253	[p15l387t1767r616b1835],
4	the	DT	O	the	det	5	SENT_253	[p15l656t1767r773b1835],
5	demographic	JJ	O	demographic	dobj	3	SENT_253	[p15l812t1767r1331b1857],
6	,	,	O	,	_	0	SENT_253	[p15l812t1767r1331b1857],
7	clinical	JJ	O	clinical	dobj	3	SENT_253	[p15l1373t1767r1661b1845],
8	,	,	O	,	_	0	SENT_253	[p15l1373t1767r1661b1845],
9	and	CC	O	and	_	0	SENT_253	[p15l1703t1767r1842b1835],
10	physiological	JJ	O	physiological	amod	11	SENT_253	[p15l1877t1767r2149b1856, p15l6t1877r252b1966],
11	characteristics	NNS	O	characteristic	dobj	3	SENT_253	[p15l316t1877r855b1945],
12	of	IN	O	of	_	0	SENT_253	[p15l922t1876r1005b1945],
13	randomised	JJ	O	randomised	amod	14	SENT_253	[p15l1056t1877r1511b1945],
14	participants	NNS	O	participant	prep_of	11	SENT_253	[p15l1573t1881r2019b1965],
15	at	IN	O	at	_	0	SENT_253	[p15l2086t1890r2152b1945],
16	enrolment	NN	O	enrolment	prep_at	14	SENT_253	[p15l9t1985r407b2053],
17	in	IN	O	in	_	0	SENT_253	[p15l438t1990r513b2052],
18	the	DT	O	the	det	20	SENT_253	[p15l543t1985r661b2053],
19	run-in	JJ	O	run-in	amod	20	SENT_253	[p15l693t1990r933b2053],
20	period	NN	O	period	prep_in	16	SENT_253	[p15l964t1985r1206b2074],
21	of	IN	O	of	_	0	SENT_253	[p15l1238t1985r1322b2053],
22	the	DT	O	the	det	25	SENT_253	[p15l1339t1985r1457b2053],
23	main	JJ	O	main	amod	25	SENT_253	[p15l1490t1990r1686b2053],
24	study	NN	O	study	nn	25	SENT_253	[p15l1721t1985r1922b2075],
25	(	NN	O	(	prep_of	20	SENT_253	[p15l1958t1985r2152b2075],
26	after	IN	O	after	_	0	SENT_253	[p15l1958t1985r2152b2075],
27	at	IN	DURATION	at	quantmod	29	SENT_253	[p15l9t2108r75b2162],
28	least	JJS	DURATION	least	mwe	27	SENT_253	[p15l134t2095r307b2162],
29	3	CD	DURATION	3	num	30	SENT_253	[p15l372t2101r406b2162],
30	weeks	NNS	NUMBER	week	prep_after	3	SENT_253	[p15l470t2095r698b2162],
31	of	IN	O	of	_	0	SENT_253	[p15l764t2095r848b2162],
32	standard	JJ	O	standard	prep_of	30	SENT_253	[p15l900t2095r1228b2162],
33	inhaled	VBN	O	inhale	partmod	32	SENT_253	[p15l1289t2095r1573b2162],
34	corticosteroid	NN	O	corticosteroid	nn	36	SENT_253	[p15l1635t2095r2152b2162],
35	therapy	NN	O	therapy	nn	36	SENT_253	[p15l7t2205r313b2294],
36	)	NN	O	)	dobj	33	SENT_253	[p15l7t2205r313b2294],
37	by	IN	O	by	_	0	SENT_253	[p15l370t2205r458b2294],
38	genotype	NN	O	genotype	agent	33	SENT_253	[p15l510t2218r869b2294],
39	.	.	O	.	_	0	SENT_253	[p15l510t2218r869b2294],

1	Matching	VBG	O	match	amod	2	SENT_254	[p15l929t2205r1287b2294],
2	participants	NNS	O	participant	nsubj	7	SENT_254	[p15l1339t2209r1786b2293],
3	by	IN	O	by	_	0	SENT_254	[p15l1840t2205r1928b2294],
4	lung	NN	O	lung	nn	5	SENT_254	[p15l1977t2205r2151b2294],
5	function	NN	O	function	prep_by	2	SENT_254	[p15l8t2313r329b2381],
6	was	VBD	O	be	cop	7	SENT_254	[p15l430t2337r569b2381],
7	successful	JJ	O	successful	_	0	SENT_254	[p15l678t2313r1083b2381],
8	.	.	O	.	_	0	SENT_254	[p15l678t2313r1083b2381],

1	Arg/Arg	NN	O	arg/arg	_	0	SENT_255	[p15l1189t2318r1507b2403],
2	and	CC	O	and	_	0	SENT_255	[p15l1611t2313r1750b2381],
3	Gly/Gly	NN	O	gly/gly	conj_and	1	SENT_255	[p15l1854t2313r2152b2403],
4	www	NN	O	www	dep	1	SENT_255	[p15l6t2584r542b2635],
5	.	.	O	.	_	0	SENT_255	[p15l6t2584r542b2635],

1	the	DT	O	the	det	2	SENT_256	[p15l6t2584r542b2635],
2	|	NN	O	|	_	0	SENT_256	[p15l6t2584r542b2635],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_256	[p15l6t2584r542b2635],
4	Vol	NNP	O	Vol	dep	2	SENT_256	[p15l585t2584r673b2635],
5	374	CD	NUMBER	374	num	6	SENT_256	[p15l693t2591r795b2643],
6	November	NNP	DATE	November	dep	2	SENT_256	[p15l843t2584r1138b2635],
7	21,2009	CD	DATE	21,2009	num	6	SENT_256	[p15l1155t2591r1400b2644],

1	participants	NNS	O	participant	nsubj	4	SENT_257	[p15l9t2775r325b2835],
2	did	VBD	O	do	aux	4	SENT_257	[p15l349t2772r434b2820],
3	not	RB	O	not	neg	4	SENT_257	[p15l455t2781r542b2820],
4	differ	VB	O	differ	_	0	SENT_257	[p15l564t2772r709b2820],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	4	SENT_257	[p15l731t2772r1060b2836],
6	at	IN	O	at	_	0	SENT_257	[p15l1081t2781r1128b2820],
7	the	DT	O	the	det	8	SENT_257	[p15l1147t2772r1231b2820],
8	beginning	NN	O	beginning	prep_at	4	SENT_257	[p15l1252t2772r1528b2836],
9	of	IN	O	of	_	0	SENT_257	[p15l10t2849r69b2898],
10	each	DT	O	each	det	12	SENT_257	[p15l85t2849r206b2898],
11	treatment	NN	O	treatment	nn	12	SENT_257	[p15l230t2859r494b2898],
12	period	NN	O	period	prep_of	8	SENT_257	[p15l518t2850r690b2912],
13	with	IN	O	with	_	0	SENT_257	[p15l712t2850r831b2898],
14	respect	NN	O	respect	prep_with	12	SENT_257	[p15l856t2859r1047b2912],
15	to	TO	O	to	_	0	SENT_257	[p15l1070t2859r1119b2898],
16	any	DT	O	any	prep_to	4	SENT_257	[p15l1145t2867r1239b2913],
17	measured	VBN	O	measure	partmod	16	SENT_257	[p15l1262t2850r1529b2898],
18	baseline	NN	O	baseline	nsubj	23	SENT_257	[p15l8t2927r229b2976],
19	characteristic	JJ	O	characteristic	dep	23	SENT_257	[p15l249t2927r606b2976],
20	(	CD	NUMBER	(	num	21	SENT_257	[p15l629t2927r755b2991],
21	data	NNS	O	datum	npadvmod	22	SENT_257	[p15l629t2927r755b2991],
22	not	RB	O	not	neg	23	SENT_257	[p15l774t2937r862b2975],
23	shown	VBN	O	show	xcomp	17	SENT_257	[p15l881t2927r1089b2991],
24	)	NN	O	)	dobj	23	SENT_257	[p15l881t2927r1089b2991],
25	.	.	O	.	_	0	SENT_257	[p15l881t2927r1089b2991],

1	Of	IN	O	of	_	0	SENT_258	[p15l61t3006r135b3054],
2	1910	CD	DATE	1910	prep_of	14	SENT_258	[p15l163t3010r275b3054],
3	scheduled	VBN	O	schedule	partmod	2	SENT_258	[p15l312t3006r583b3054],
4	main	JJ	O	main	amod	6	SENT_258	[p15l617t3009r757b3054],
5	study	NN	O	study	nn	6	SENT_258	[p15l794t3006r937b3069],
6	visits	NNS	O	visit	dobj	3	SENT_258	[p15l970t3009r1121b3061],
7	,	,	O	,	_	0	SENT_258	[p15l970t3009r1121b3061],
8	1901	CD	DATE	1901	nsubjpass	14	SENT_258	[p15l1161t3010r1273b3054],
9	(	CD	PERCENT	(	num	11	SENT_258	[p15l1313t3009r1524b3070],
10	99-5	CD	PERCENT	99-5	num	11	SENT_258	[p15l1313t3009r1524b3070],
11	%	NN	PERCENT	%	dep	8	SENT_258	[p15l1313t3009r1524b3070],
12	)	CD	NUMBER	)	dep	8	SENT_258	[p15l1313t3009r1524b3070],
13	were	VBD	O	be	auxpass	14	SENT_258	[p15l8t3101r135b3132],
14	completed	VBN	O	complete	_	0	SENT_258	[p15l179t3083r472b3146],
15	.	.	O	.	_	0	SENT_258	[p15l179t3083r472b3146],

1	During	IN	O	during	_	0	SENT_259	[p15l520t3086r712b3147],
2	the	DT	O	the	det	5	SENT_259	[p15l754t3083r837b3132],
3	double-blind	JJ	O	double-blind	amod	5	SENT_259	[p15l882t3083r1223b3132],
4	treatment	NN	O	treatment	nn	5	SENT_259	[p15l1264t3093r1529b3132],
5	periods	NNS	O	period	prep_during	8	SENT_259	[p15l9t3161r221b3224],
6	,	,	O	,	_	0	SENT_259	[p15l9t3161r221b3224],
7	participants	NNS	O	participant	nsubj	8	SENT_259	[p15l250t3164r566b3224],
8	recorded	VBD	O	record	_	0	SENT_259	[p15l595t3161r830b3210],
9	their	PRP$	O	they	poss	11	SENT_259	[p15l854t3161r982b3210],
10	morning	NN	TIME	morning	nn	11	SENT_259	[p15l1008t3164r1244b3225],
11	PEF	NN	O	pef	tmod	8	SENT_259	[p15l1274t3164r1379b3209],
12	on	IN	O	on	_	0	SENT_259	[p15l1408t3179r1475b3209],
13	a	DT	O	a	det	14	SENT_259	[p15l1502t3179r1528b3209],
14	median	NN	O	median	prep_on	8	SENT_259	[p15l9t3240r213b3288],
15	of	IN	O	of	_	0	SENT_259	[p15l245t3240r304b3288],
16	95-7	CD	PERCENT	95-7	num	17	SENT_259	[p15l328t3243r500b3290],
17	%	NN	PERCENT	%	prep_of	14	SENT_259	[p15l328t3243r500b3290],
18	(	CD	NUMBER	(	num	19	SENT_259	[p15l537t3244r666b3304],
19	IQR	NN	O	iqr	dep	17	SENT_259	[p15l537t3244r666b3304],
20	90-1-98-4	CD	NUMBER	90-1-98-4	num	21	SENT_259	[p15l698t3244r987b3304],
21	)	NN	O	)	dep	19	SENT_259	[p15l698t3244r987b3304],
22	of	IN	O	of	_	0	SENT_259	[p15l1024t3240r1083b3288],
23	days	NNS	DURATION	day	prep_of	21	SENT_259	[p15l1106t3240r1236b3303],
24	.	.	O	.	_	0	SENT_259	[p15l1106t3240r1236b3303],

1	Based	VBN	O	base	_	0	SENT_260	[p15l1273t3240r1430b3288],
2	on	IN	O	on	pcomp	1	SENT_260	[p15l1462t3257r1528b3288],
3	data	NNS	O	datum	pobj	2	SENT_260	[p15l10t3316r119b3364],
4	from	IN	O	from	_	0	SENT_260	[p15l177t3316r309b3364],
5	the	DT	O	the	det	6	SENT_260	[p15l367t3316r450b3364],
6	DOSER	NN	O	doser	prep_from	3	SENT_260	[p15l512t3319r718b3364],
7	and	CC	O	and	_	0	SENT_260	[p15l776t3316r875b3364],
8	the	DT	O	the	det	10	SENT_260	[p15l932t3316r1015b3364],
9	Diskus	NNP	MISC	Diskus	nn	10	SENT_260	[p15l1077t3316r1259b3364],
10	devices	NNS	O	device	prep_from	3	SENT_260	[p15l1320t3316r1526b3372],
11	,	,	O	,	_	0	SENT_260	[p15l1320t3316r1526b3372],

1	participants	NNS	O	participant	nsubj	2	SENT_261	[p16l9t21r325b81],
2	took	VBD	O	take	_	0	SENT_261	[p16l351t18r468b66],
3	95-1	CD	PERCENT	95-1	num	4	SENT_261	[p16l493t21r665b69],
4	%	NN	PERCENT	%	iobj	2	SENT_261	[p16l493t21r665b69],
5	(	CD	NUMBER	(	num	7	SENT_261	[p16l695t21r1000b82],
6	90-1-97-9	CD	NUMBER	90-1-97-9	num	7	SENT_261	[p16l695t21r1000b82],
7	)	NN	O	)	dobj	2	SENT_261	[p16l695t21r1000b82],
8	of	IN	O	of	_	0	SENT_261	[p16l1031t18r1090b66],
9	their	PRP$	O	they	poss	19	SENT_261	[p16l1105t18r1233b66],
10	scheduled	VBN	O	schedule	amod	19	SENT_261	[p16l1259t18r1529b66],
11	inhaled	VBN	O	inhale	dep	10	SENT_261	[p16l9t97r211b145],
12	corticosteroid	NN	O	corticosteroid	nn	13	SENT_261	[p16l238t97r604b145],
13	puffs	NNS	O	puff	dobj	11	SENT_261	[p16l631t97r766b160],
14	and	CC	O	and	_	0	SENT_261	[p16l796t97r895b145],
15	94-9	CD	PERCENT	94-9	num	16	SENT_261	[p16l923t100r1097b147],
16	%	NN	PERCENT	%	conj_and	13	SENT_261	[p16l923t100r1097b147],
17	(	CD	NUMBER	(	number	18	SENT_261	[p16l1130t101r1446b161],
18	88-2-98-6	CD	NUMBER	88-2-98-6	num	19	SENT_261	[p16l1130t101r1446b161],
19	)	NN	O	)	prep_of	7	SENT_261	[p16l1130t101r1446b161],
20	of	IN	O	of	_	0	SENT_261	[p16l1478t97r1537b145],
21	their	PRP$	O	they	poss	23	SENT_261	[p16l8t173r136b222],
22	scheduled	VBN	O	schedule	amod	23	SENT_261	[p16l155t173r426b222],
23	salmeterol	NN	O	salmeterol	prep_of	19	SENT_261	[p16l446t173r725b222],
24	or	CC	O	or	_	0	SENT_261	[p16l745t191r799b222],
25	placebo	NN	O	placebo	nn	26	SENT_261	[p16l817t173r1019b236],
26	puﬁs	NNS	O	puﬁs	prep_of	19	SENT_261	[p16l1039t174r1189b236],
27	.	.	O	.	_	0	SENT_261	[p16l1039t174r1189b236],

1	After	IN	O	after	_	0	SENT_262	[p16l59t251r199b299],
2	18	CD	DURATION	18	num	3	SENT_262	[p16l242t255r296b299],
3	weeks	NNS	NUMBER	week	prep_after	13	SENT_262	[p16l338t251r520b307],
4	,	,	O	,	_	0	SENT_262	[p16l338t251r520b307],
5	mean	VB	O	mean	csubj	13	SENT_262	[p16l565t268r719b299],
6	morning	NN	TIME	morning	nn	7	SENT_262	[p16l761t254r1005b315],
7	PEF	NN	O	pef	tmod	5	SENT_262	[p16l1049t254r1157b298],
8	in	IN	O	in	_	0	SENT_262	[p16l1201t254r1256b298],
9	Arg/Arg	NN	O	arg/arg	nn	10	SENT_262	[p16l1297t254r1529b315],
10	participants	NNS	O	participant	prep_in	5	SENT_262	[p16l9t332r337b392],
11	was	VBD	O	be	cop	13	SENT_262	[p16l387t346r488b378],
12	21-4	CD	NUMBER	21-4	num	13	SENT_262	[p16l543t334r662b377],
13	L/min	NN	O	l/min	_	0	SENT_262	[p16l712t332r883b392],
14	(	CD	PERCENT	(	num	17	SENT_262	[p16l937t332r1072b393],
15	95	CD	PERCENT	95	number	16	SENT_262	[p16l937t332r1072b393],
16	%	NN	PERCENT	%	amod	17	SENT_262	[p16l937t332r1072b393],
17	CI	NN	O	ci	npadvmod	20	SENT_262	[p16l1125t333r1186b378],
18	11-8-31-1	CD	DATE	11-8-31-1	number	19	SENT_262	[p16l1241t333r1524b393],
19	)	CD	NUMBER	)	num	17	SENT_262	[p16l1241t333r1524b393],
20	greater	JJR	O	greater	amod	13	SENT_262	[p16l10t418r204b472],
21	when	WRB	O	when	advmod	24	SENT_262	[p16l240t408r391b457],
22	participants	NNS	O	participant	nsubjpass	24	SENT_262	[p16l430t411r758b471],
23	were	VBD	O	be	auxpass	24	SENT_262	[p16l797t426r928b457],
24	assigned	VBN	O	assign	ccomp	20	SENT_262	[p16l968t408r1209b472],
25	to	TO	O	to	aux	26	SENT_262	[p16l1246t418r1297b457],
26	receive	VB	O	receive	xcomp	24	SENT_262	[p16l1336t411r1528b457],
27	salmeterol	NN	O	salmeterol	dobj	26	SENT_262	[p16l11t486r300b534],
28	than	IN	O	than	_	0	SENT_262	[p16l371t486r496b534],
29	when	WRB	O	when	advmod	30	SENT_262	[p16l532t486r684b534],
30	assigned	VBN	O	assign	prepc_than	26	SENT_262	[p16l723t486r964b550],
31	to	TO	O	to	aux	32	SENT_262	[p16l1000t496r1050b534],
32	receive	VB	O	receive	xcomp	30	SENT_262	[p16l1089t489r1280b534],
33	placebo	NN	O	placebo	nn	35	SENT_262	[p16l1319t486r1528b549],
34	(	NN	O	(	nn	35	SENT_262	[p16l13t568r305b627],
35	p	NN	O	p	dep	36	SENT_262	[p16l13t568r305b627],
36	<	JJR	O	<	dobj	32	SENT_262	[p16l13t568r305b627],
37	0-0001	CD	NUMBER	0-0001	dep	36	SENT_262	[p16l13t568r305b627],
38	;	:	O	;	_	0	SENT_262	[p16l13t568r305b627],
39	table	NN	O	table	nn	41	SENT_262	[p16l330t564r462b612],
40	2	CD	NUMBER	2	num	41	SENT_262	[p16l488t568r551b627],
41	)	NN	O	)	dep	36	SENT_262	[p16l488t568r551b627],
42	.	.	O	.	_	0	SENT_262	[p16l488t568r551b627],

1	Similarly	RB	O	similarly	advmod	11	SENT_263	[p16l581t564r838b627],
2	,	,	O	,	_	0	SENT_263	[p16l581t564r838b627],
3	in	IN	O	in	_	0	SENT_263	[p16l863t567r918b611],
4	Gly/Gly	NN	O	gly/gly	nn	5	SENT_263	[p16l943t564r1160b627],
5	participants	NNS	O	participant	prep_in	11	SENT_263	[p16l1182t567r1526b626],
6	,	,	O	,	_	0	SENT_263	[p16l1182t567r1526b626],
7	morning	NN	TIME	morning	nn	8	SENT_263	[p16l9t644r252b705],
8	PEF	NN	O	pef	nsubj	11	SENT_263	[p16l292t644r400b689],
9	was	VBD	O	be	cop	11	SENT_263	[p16l471t658r572b689],
10	21-5	CD	NUMBER	21-5	num	11	SENT_263	[p16l614t644r731b689],
11	L/min	NN	O	l/min	_	0	SENT_263	[p16l774t644r944b704],
12	(	CD	NUMBER	(	number	13	SENT_263	[p16l985t645r1293b705],
13	11-0-32-1	CD	NUMBER	11-0-32-1	num	14	SENT_263	[p16l985t645r1293b705],
14	)	NN	O	)	npadvmod	15	SENT_263	[p16l985t645r1293b705],
15	greater	JJR	O	greater	amod	11	SENT_263	[p16l1336t651r1529b705],
16	when	WRB	O	when	advmod	19	SENT_263	[p16l8t720r159b768],
17	participants	NNS	O	participant	nsubjpass	19	SENT_263	[p16l182t723r509b783],
18	were	VBD	O	be	auxpass	19	SENT_263	[p16l532t737r663b768],
19	assigned	VBN	O	assign	ccomp	15	SENT_263	[p16l687t720r928b784],
20	to	TO	O	to	aux	21	SENT_263	[p16l949t730r1000b768],
21	receive	VB	O	receive	xcomp	19	SENT_263	[p16l1023t723r1214b768],
22	salmeterol	NN	O	salmeterol	dobj	21	SENT_263	[p16l1240t720r1529b768],
23	than	IN	O	than	_	0	SENT_263	[p16l8t798r133b846],
24	when	WRB	O	when	advmod	27	SENT_263	[p16l175t798r326b846],
25	they	PRP	O	they	nsubjpass	27	SENT_263	[p16l370t798r487b861],
26	were	VBD	O	be	auxpass	27	SENT_263	[p16l528t815r659b846],
27	assigned	VBN	O	assign	prepc_than	22	SENT_263	[p16l704t798r945b861],
28	to	TO	O	to	aux	29	SENT_263	[p16l988t807r1038b846],
29	receive	VB	O	receive	xcomp	27	SENT_263	[p16l1083t801r1274b846],
30	placebo	NN	O	placebo	nn	32	SENT_263	[p16l1319t798r1528b860],
31	(	NN	O	(	nn	32	SENT_263	[p16l13t879r326b939],
32	p	NN	O	p	nsubj	33	SENT_263	[p16l13t879r326b939],
33	<	JJR	O	<	xcomp	29	SENT_263	[p16l13t879r326b939],
34	0-0001	CD	NUMBER	0-0001	num	35	SENT_263	[p16l13t879r326b939],
35	)	NN	O	)	dep	22	SENT_263	[p16l13t879r326b939],
36	.	.	O	.	_	0	SENT_263	[p16l13t879r326b939],

1	The	DT	O	the	det	2	SENT_264	[p16l369t875r474b924],
2	difference	NN	O	difference	nsubj	5	SENT_264	[p16l516t875r792b924],
3	between	IN	O	between	_	0	SENT_264	[p16l833t875r1063b924],
4	genotypes	NNS	O	genotype	prep_between	2	SENT_264	[p16l1104t885r1379b939],
5	(	VBP	O	(	_	0	SENT_264	[p16l1426t875r1528b939],
6	the	DT	O	the	det	9	SENT_264	[p16l1426t875r1528b939],
7	eﬁ	NN	O	eﬁ	nn	9	SENT_264	[p16l10t954r159b1002],
8	’	NN	O	’	nn	9	SENT_264	[p16l10t954r159b1002],
9	ect	NN	O	ect	nsubj	24	SENT_264	[p16l10t954r159b1002],
10	of	IN	O	of	_	0	SENT_264	[p16l180t954r240b1002],
11	treatment	NN	O	treatment	prep_of	9	SENT_264	[p16l252t963r525b1002],
12	in	IN	O	in	_	0	SENT_264	[p16l545t957r600b1001],
13	Arg/Arg	NN	O	arg/arg	nn	14	SENT_264	[p16l620t957r852b1018],
14	participants	NNS	O	participant	prep_in	11	SENT_264	[p16l873t957r1200b1017],
15	minus	CC	O	minus	advmod	11	SENT_264	[p16l1224t957r1400b1002],
16	that	IN	O	that	nsubj	20	SENT_264	[p16l1422t954r1529b1002],
17	in	IN	O	in	_	0	SENT_264	[p16l9t1034r64b1078],
18	Gly/Gly	NN	O	gly/gly	nn	19	SENT_264	[p16l110t1031r328b1094],
19	participants	NNS	O	participant	prep_in	20	SENT_264	[p16l372t1034r718b1094],
20	)	VBP	O	)	rcmod	11	SENT_264	[p16l372t1034r718b1094],
21	was	VBD	O	be	cop	24	SENT_264	[p16l766t1048r867b1079],
22	-0	CD	NUMBER	-0	num	24	SENT_264	[p16l913t1035r1036b1079],
23	-1	CD	NUMBER	-1	num	24	SENT_264	[p16l913t1035r1036b1079],
24	(	NN	O	(	ccomp	5	SENT_264	[p16l1086t1035r1254b1094],
25	-14	CD	NUMBER	-14	num	26	SENT_264	[p16l1086t1035r1254b1094],
26	-4	CD	NUMBER	-4	dep	24	SENT_264	[p16l1086t1035r1254b1094],
27	to	TO	O	to	_	0	SENT_264	[p16l1296t1040r1346b1079],
28	14-2	CD	NUMBER	14-2	prep_to	26	SENT_264	[p16l1395t1035r1526b1086],
29	;	:	O	;	_	0	SENT_264	[p16l1395t1035r1526b1086],
30	p	NN	O	p	dep	26	SENT_264	[p16l9t1112r224b1171],
31	=	JJ	O	=	amod	30	SENT_264	[p16l9t1112r224b1171],
32	0-99	CD	NUMBER	0-99	tmod	31	SENT_264	[p16l9t1112r224b1171],
33	;	:	O	;	_	0	SENT_264	[p16l9t1112r224b1171],
34	ﬁgure	NN	O	ﬁgure	dep	26	SENT_264	[p16l257t1108r419b1172],
35	3	CD	NUMBER	3	num	36	SENT_264	[p16l453t1113r516b1172],
36	)	NN	O	)	dep	34	SENT_264	[p16l453t1113r516b1172],
37	.	.	O	.	_	0	SENT_264	[p16l453t1113r516b1172],

1	Correspondingly	RB	O	correspondingly	advmod	17	SENT_265	[p16l551t1108r1024b1172],
2	,	,	O	,	_	0	SENT_265	[p16l551t1108r1024b1172],
3	morning	NN	TIME	morning	nn	4	SENT_265	[p16l1057t1111r1300b1172],
4	PEF	NN	O	pef	nsubj	17	SENT_265	[p16l1334t1111r1441b1156],
5	in	IN	O	in	_	0	SENT_265	[p16l1474t1111r1529b1156],
6	the	DT	O	the	det	8	SENT_265	[p16l8t1187r94b1235],
7	run-out	NN	O	run-out	nn	8	SENT_265	[p16l168t1196r378b1235],
8	periods	NNS	O	period	prep_in	4	SENT_265	[p16l450t1187r653b1250],
9	following	VBG	O	follow	_	0	SENT_265	[p16l729t1187r989b1251],
10	treatment	NN	O	treatment	prep_following	8	SENT_265	[p16l1062t1196r1335b1235],
11	with	IN	O	with	_	0	SENT_265	[p16l1407t1187r1529b1235],
12	salmeterol	NN	O	salmeterol	prep_with	10	SENT_265	[p16l11t1264r300b1313],
13	or	CC	O	or	_	0	SENT_265	[p16l324t1282r380b1313],
14	placebo	NN	O	placebo	conj_or	12	SENT_265	[p16l402t1264r611b1327],
15	did	VBD	O	do	aux	17	SENT_265	[p16l636t1264r722b1313],
16	not	RB	O	not	neg	17	SENT_265	[p16l745t1274r835b1313],
17	differ	VB	O	differ	_	0	SENT_265	[p16l858t1264r1008b1313],
18	signiﬁcantly	RB	O	signiﬁcantly	advmod	19	SENT_265	[p16l1032t1264r1372b1328],
19	(	JJ	O	(	amod	20	SENT_265	[p16l1398t1264r1528b1328],
20	data	NNS	O	datum	dobj	17	SENT_265	[p16l1398t1264r1528b1328],
21	not	RB	O	not	neg	22	SENT_265	[p16l9t1352r99b1390],
22	shown	VBN	O	show	rcmod	20	SENT_265	[p16l121t1342r335b1406],
23	)	NN	O	)	dobj	22	SENT_265	[p16l121t1342r335b1406],
24	.	.	O	.	_	0	SENT_265	[p16l121t1342r335b1406],

1	Table	NNP	O	Table	nsubj	3	SENT_266	[p16l59t1420r199b1468],
2	2	CD	NUMBER	2	num	1	SENT_266	[p16l254t1424r280b1467],
3	shows	VBZ	O	show	_	0	SENT_266	[p16l336t1420r499b1468],
4	the	DT	O	the	det	5	SENT_266	[p16l552t1420r635b1468],
5	analyses	NNS	O	analysis	dobj	3	SENT_266	[p16l689t1420r910b1483],
6	of	IN	O	of	_	0	SENT_266	[p16l965t1420r1024b1468],
7	the	DT	O	the	det	10	SENT_266	[p16l1067t1420r1150b1468],
8	prespeciﬁed	JJ	O	prespeciﬁed	amod	10	SENT_266	[p16l1202t1420r1529b1483],
9	secondary	JJ	O	secondary	amod	10	SENT_266	[p16l11t1497r278b1561],
10	outcomes	NNS	O	outcome	prep_of	5	SENT_266	[p16l344t1507r615b1546],
11	.	.	O	.	_	0	SENT_266	[p16l344t1507r615b1546],

1	There	EX	O	there	expl	2	SENT_267	[p16l683t1497r839b1546],
2	were	VBD	O	be	_	0	SENT_267	[p16l903t1515r1030b1546],
3	within-genotype	NN	O	within-genotype	nn	4	SENT_267	[p16l1095t1497r1528b1561],
4	differences	NNS	O	difference	nsubj	2	SENT_267	[p16l10t1574r302b1622],
5	between	IN	O	between	_	0	SENT_267	[p16l371t1574r593b1622],
6	the	DT	O	the	det	10	SENT_267	[p16l661t1574r744b1622],
7	salmeterol	NN	O	salmeterol	nn	10	SENT_267	[p16l815t1574r1092b1622],
8	and	CC	O	and	_	0	SENT_267	[p16l1161t1574r1259b1622],
9	placebo	NN	O	placebo	nn	10	SENT_267	[p16l1327t1574r1528b1637],
10	treatments	NNS	O	treatment	prep_between	4	SENT_267	[p16l8t1662r295b1701],
11	with	IN	O	with	_	0	SENT_267	[p16l340t1653r457b1701],
12	respect	NN	O	respect	prep_with	2	SENT_267	[p16l501t1662r691b1716],
13	to	TO	O	to	_	0	SENT_267	[p16l732t1662r782b1701],
14	evening	NN	TIME	evening	nn	15	SENT_267	[p16l827t1656r1036b1717],
15	PEF	NN	O	pef	prep_to	2	SENT_267	[p16l1082t1656r1203b1708],
16	,	,	O	,	_	0	SENT_267	[p16l1082t1656r1203b1708],
17	peak	NN	O	peak	nn	18	SENT_267	[p16l1249t1653r1374b1716],
18	ﬂow	NN	O	ﬂow	appos	15	SENT_267	[p16l1416t1653r1530b1701],

1	I	PRP	O	I	_	0	SENT_268	[p16l6t1957r54b2125],
2	Articles	NNPS	O	Articles	dep	1	SENT_268	[p16l101t2089r251b2125],

1	A	DT	O	a	det	2	SENT_269	[p17l192t113r227b152],
2	P	NN	O	p	_	0	SENT_269	[p17l1128t109r1253b148],
3	=	JJ	O	=	amod	4	SENT_269	[p17l1128t109r1253b148],
4	0	CD	NUMBER	0	dep	2	SENT_269	[p17l1128t109r1253b148],
5	'99	CD	NUMBER	'99	dep	2	SENT_269	[p17l1128t109r1253b148],

1	450	CD	NUMBER	450	_	0	SENT_270	[p17l160t183r228b217],
2	I	PRP	O	I	nsubj	3	SENT_270	[p17l1861t200r1915b234],
3	Placebo	VBP	O	placebo	rcmod	1	SENT_270	[p17l1939t200r2070b234],

1	I	PRP	O	I	nsubj	2	SENT_271	[p17l569t232r900b322],
2	}	VBP	O	}	_	0	SENT_271	[p17l569t232r900b322],
3	all	DT	O	all	det	5	SENT_271	[p17l1495t232r1826b322],
4	“	CD	NUMBER	“	num	5	SENT_271	[p17l1495t232r1826b322],
5	I	PRP	O	I	dobj	2	SENT_271	[p17l1861t255r1915b290],
6	Salmeterol	NNP	O	Salmeterol	dep	5	SENT_271	[p17l1937t255r2122b289],

1	E	NN	O	e	nn	2	SENT_272	[p17l83t442r124b486],
2	E	NN	O	e	_	0	SENT_272	[p17l83t491r119b538],
3	425	CD	NUMBER	425	num	5	SENT_272	[p17l160t486r226b520],
4	:	:	O	:	_	0	SENT_272	[p17l83t539r124b570],
5	|	CD	NUMBER	|	dep	2	SENT_272	[p17l83t539r124b570],
6	/	:	O	/	punct	2	SENT_272	[p17l83t539r124b570],
7	U.	NNP	O	U.	nn	12	SENT_272	[p17l84t582r114b598],
8	LIJ	NNP	O	LIJ	nn	12	SENT_272	[p17l84t603r114b619],
9	D.	NNP	O	D.	nn	12	SENT_272	[p17l84t623r114b642],
10	E	NNP	O	E	nn	12	SENT_272	[p17l84t656r125b707],
11	‘	NN	O	‘	nn	12	SENT_272	[p17l84t656r125b707],
12	C	NN	O	c	dep	2	SENT_272	[p17l93t713r115b730],
13	'	''	O	'	_	0	SENT_272	[p17l92t734r115b769],
14	6	CD	NUMBER	6	num	15	SENT_272	[p17l92t734r115b769],
15	E	NN	O	e	dep	12	SENT_272	[p17l93t773r114b836],
16	400	CD	NUMBER	400	number	17	SENT_272	[p17l160t789r229b822],
17	8	CD	NUMBER	8	dep	18	SENT_272	[p17l93t840r115b877],
18	E	NN	O	e	dep	15	SENT_272	[p17l84t881r114b912],

1	Arg/Arg	NN	O	arg/arg	nn	2	SENT_273	[p17l664t1247r801b1289],
2	Gly/Gly	NN	O	gly/gly	_	0	SENT_273	[p17l1601t1245r1726b1289],

1	Study	NNP	O	Study	_	0	SENT_274	[p17l1093t1305r1193b1349],
2	group	NN	O	group	dep	1	SENT_274	[p17l1203t1316r1306b1349],

1	B	NN	O	b	_	0	SENT_275	[p17l195t1348r222b1387],

1	460	CD	NUMBER	460	num	2	SENT_276	[p17l159t1425r229b1464],
2	Arg/Arg	NN	O	arg/arg	_	0	SENT_276	[p17l312t1448r458b1491],
3	:	:	O	:	_	0	SENT_276	[p17l945t1462r1025b1467],
4	Salmeterol	NNP	ORGANIZATION	Salmeterol	nsubj	5	SENT_276	[p17l1047t1445r1231b1479],
5	modelled	VBD	O	model	dep	2	SENT_276	[p17l1246t1445r1406b1479],
6	data	NN	O	datum	nsubj	9	SENT_276	[p17l1416t1445r1492b1479],
7	+	CC	O	+	_	0	SENT_276	[p17l1583t1462r1663b1467],
8	Placebo	NN	O	placebo	conj_+	6	SENT_276	[p17l1686t1445r1818b1479],
9	modelled	VBD	O	model	ccomp	5	SENT_276	[p17l1830t1445r1991b1479],
10	data	NNS	O	datum	dobj	9	SENT_276	[p17l2001t1445r2077b1479],

1	—	NN	O	—	_	0	SENT_277	[p17l945t1518r1025b1521],
2	Salmeterol	NNP	O	Salmeterol	nn	4	SENT_277	[p17l1047t1500r1231b1534],
3	raw	JJ	O	raw	amod	4	SENT_277	[p17l1246t1511r1308b1534],
4	data	NNS	O	datum	dep	1	SENT_277	[p17l1317t1500r1393b1534],
5	----	CD	NUMBER	----	num	6	SENT_277	[p17l1583t1517r1663b1521],
6	l	NN	O	l	tmod	4	SENT_277	[p17l1583t1517r1663b1521],
7	Placebo	NNP	O	Placebo	nn	9	SENT_277	[p17l1686t1500r1818b1534],
8	raw	JJ	O	raw	amod	9	SENT_277	[p17l1830t1511r1892b1534],
9	data	NNS	O	datum	dep	1	SENT_277	[p17l1901t1500r1977b1534],

1	Mean	NN	O	mean	nn	3	SENT_278	[p17l91t2403r121b2496],
2	morning	NN	TIME	morning	nn	3	SENT_278	[p17l91t2241r132b2388],
3	PEF	NN	O	pef	_	0	SENT_278	[p17l91t2167r121b2226],
4	(	CD	NUMBER	(	num	6	SENT_278	[p17l89t2027r130b2155],
5	L/min	NN	O	l/min	nn	6	SENT_278	[p17l89t2027r130b2155],
6	)	NN	O	)	dep	3	SENT_278	[p17l89t2027r130b2155],

1	380	CD	NUMBER	380	num	2	SENT_279	[p17l161t2915r229b2954],
2	p	NN	O	p	_	0	SENT_279	[p17l1908t2890r2076b2930],
3	<	JJR	O	<	dep	2	SENT_279	[p17l1908t2890r2076b2930],
4	O-0001	CD	NUMBER	o-0001	dep	2	SENT_279	[p17l1908t2890r2076b2930],

1	o	NN	O	o	nn	3	SENT_280	[p17l205t3063r226b3093],
2	1P	NN	O	1p	nn	3	SENT_280	[p17l242t3009r2080b3110],
3	o	NN	O	o	_	0	SENT_280	[p17l263t3136r283b3165],
4	2	CD	NUMBER	2	number	5	SENT_280	[p17l467t3136r485b3165],
5	6	CD	DATE	6	dep	3	SENT_280	[p17l867t3131r887b3165],
6	10	CD	DATE	10	dep	5	SENT_280	[p17l1256t3136r1297b3165],
7	14	CD	DATE	14	num	8	SENT_280	[p17l1656t3136r1699b3170],
8	18	CD	DATE	18	dep	3	SENT_280	[p17l2056t3131r2097b3165],

1	Weeks	NNS	DURATION	week	_	0	SENT_281	[p17l1119t3187r1230b3221],

1	Figure	NNP	O	Figure	_	0	SENT_282	[p17l8t3315r122b3361],
2	3	CD	NUMBER	3	num	1	SENT_282	[p17l130t3319r165b3355],
3	:	:	O	:	_	0	SENT_282	[p17l130t3319r165b3355],
4	Morning	NN	TIME	morning	nn	5	SENT_282	[p17l179t3315r348b3361],
5	PEF	NN	O	pef	dep	1	SENT_282	[p17l362t3317r431b3349],
6	in	IN	O	in	_	0	SENT_282	[p17l443t3315r477b3349],
7	participants	NNS	O	participant	prep_in	5	SENT_282	[p17l489t3315r728b3361],
8	while	IN	O	while	mark	9	SENT_282	[p17l738t3314r845b3350],
9	assigned	VBN	O	assign	dep	7	SENT_282	[p17l857t3314r1029b3361],
10	to	TO	O	to	aux	11	SENT_282	[p17l1037t3320r1080b3350],
11	receive	VB	O	receive	xcomp	9	SENT_282	[p17l1094t3315r1229b3350],
12	treatment	NN	O	treatment	dobj	11	SENT_282	[p17l1238t3320r1444b3350],
13	with	IN	O	with	_	0	SENT_282	[p17l1453t3314r1544b3350],
14	inhaled	VBN	O	inhale	prepc_with	11	SENT_282	[p17l1558t3314r1703b3350],
15	corticosteroid	NN	O	corticosteroid	dobj	14	SENT_282	[p17l1714t3314r1990b3350],
16	plus	CC	O	plus	prep	15	SENT_282	[p17l2001t3314r2081b3361],
17	salmeterol	NN	O	salmeterol	dep	16	SENT_282	[p17l8t3375r214b3411],
18	or	CC	O	or	_	0	SENT_282	[p17l227t3387r267b3411],
19	placebo	NN	O	placebo	conj_or	17	SENT_282	[p17l277t3375r441b3422],
20	,	,	O	,	_	0	SENT_282	[p17l277t3375r441b3422],
21	by	IN	O	by	_	0	SENT_282	[p17l454t3375r501b3422],
22	genotype	NN	O	genotype	prep_by	14	SENT_282	[p17l511t3381r700b3422],
23	(	CD	NUMBER	(	num	22	SENT_282	[p17l9t3437r63b3480],
24	A	DT	O	a	det	27	SENT_282	[p17l9t3437r63b3480],
25	)	NN	O	)	nn	27	SENT_282	[p17l9t3437r63b3480],
26	Morning	NN	TIME	morning	nn	27	SENT_282	[p17l78t3438r236b3482],
27	PEF	NN	O	pef	npadvmod	9	SENT_282	[p17l252t3438r316b3470],
28	at	IN	O	at	_	0	SENT_282	[p17l328t3441r364b3471],
29	18	CD	DURATION	18	num	31	SENT_282	[p17l375t3435r420b3471],
30	weeks	NNS	NUMBER	week	nn	31	SENT_282	[p17l431t3435r546b3471],
31	oftreatment	NN	O	oftreatment	prep_at	9	SENT_282	[p17l557t3435r805b3471],
32	.	.	O	.	_	0	SENT_282	[p17l557t3435r805b3471],

1	Error	NN	O	error	nn	2	SENT_283	[p17l820t3438r909b3471],
2	bars	NNS	O	bar	nsubj	3	SENT_283	[p17l921t3435r996b3471],
3	represent	VBP	O	represent	_	0	SENT_283	[p17l1010t3441r1184b3481],
4	95	CD	PERCENT	95	number	5	SENT_283	[p17l1197t3440r1276b3476],
5	%	NN	PERCENT	%	amod	6	SENT_283	[p17l1197t3440r1276b3476],
6	Cls	NNS	O	cl	dobj	3	SENT_283	[p17l1289t3438r1349b3471],
7	.	.	O	.	_	0	SENT_283	[p17l1289t3438r1349b3471],

1	(	NN	O	(	nn	2	SENT_284	[p17l1364t3437r1415b3480],
2	B	NN	O	b	_	0	SENT_284	[p17l1364t3437r1415b3480],
3	)	CD	NUMBER	)	num	5	SENT_284	[p17l1364t3437r1415b3480],
4	Morning	NN	TIME	morning	nn	5	SENT_284	[p17l1430t3438r1588b3482],
5	PEF	NN	O	pef	npadvmod	6	SENT_284	[p17l1604t3438r1668b3470],
6	from	IN	O	from	advmod	7	SENT_284	[p17l1678t3435r1769b3471],
7	beginning	VBG	O	begin	partmod	2	SENT_284	[p17l1783t3435r1971b3482],
8	to	TO	O	to	aux	9	SENT_284	[p17l1981t3441r2021b3471],
9	end	VB	DURATION	end	xcomp	7	SENT_284	[p17l2034t3435r2103b3471],
10	of	IN	DURATION	of	_	0	SENT_284	[p17l2113t3435r2153b3471],
11	18-week	JJ	DURATION	18-week	amod	13	SENT_284	[p17l8t3495r169b3531],
12	treatment	NN	O	treatment	nn	13	SENT_284	[p17l177t3501r370b3531],
13	periods	NNS	O	period	prep_of	9	SENT_284	[p17l381t3495r528b3541],
14	.	.	O	.	_	0	SENT_284	[p17l381t3495r528b3541],

1	Modelled	NNP	O	Modelled	nn	2	SENT_285	[p17l542t3495r715b3531],
2	data	NNS	O	datum	nsubj	3	SENT_285	[p17l726t3495r807b3531],
3	account	VBP	O	account	_	0	SENT_285	[p17l819t3501r967b3531],
4	for	IN	O	for	_	0	SENT_285	[p17l977t3495r1032b3531],
5	repeated	VBN	O	repeat	amod	6	SENT_285	[p17l1045t3495r1207b3541],
6	measurements	NNS	O	measurement	prep_for	3	SENT_285	[p17l1221t3501r1497b3531],
7	for	IN	O	for	_	0	SENT_285	[p17l1507t3495r1562b3531],
8	each	DT	O	each	det	9	SENT_285	[p17l1573t3495r1656b3531],
9	participant	NN	O	participant	prep_for	6	SENT_285	[p17l1669t3498r1882b3541],
10	.	.	O	.	_	0	SENT_285	[p17l1669t3498r1882b3541],

1	p	NN	O	p	nn	2	SENT_286	[p17l1895t3507r1917b3541],
2	values	NNS	O	value	nsubjpass	4	SENT_286	[p17l1928t3495r2044b3531],
3	are	VBP	O	be	auxpass	4	SENT_286	[p17l2056t3507r2111b3531],
4	shown	VBN	O	show	_	0	SENT_286	[p17l8t3555r130b3590],
5	for	IN	O	for	_	0	SENT_286	[p17l142t3554r196b3590],
6	the	DT	O	the	det	8	SENT_286	[p17l205t3555r266b3590],
7	18-week	JJ	DURATION	18-week	amod	8	SENT_286	[p17l279t3554r440b3590],
8	comparison	NN	O	comparison	prep_for	4	SENT_286	[p17l451t3558r670b3601],
9	within	IN	O	within	_	0	SENT_286	[p17l681t3555r801b3590],
10	genotype	NN	O	genotype	prep_within	8	SENT_286	[p17l814t3561r1001b3602],
11	.	.	O	.	_	0	SENT_286	[p17l814t3561r1001b3602],

1	PEF	NN	O	pef	_	0	SENT_287	[p17l1016t3555r1194b3601],
2	=	JJ	O	=	amod	5	SENT_287	[p17l1016t3555r1194b3601],
3	peak	NN	O	peak	nn	5	SENT_287	[p17l1016t3555r1194b3601],
4	expiratory	NN	O	expiratory	nn	5	SENT_287	[p17l1205t3558r1397b3601],
5	ﬂow	NN	O	ﬂow	dep	1	SENT_287	[p17l1406t3554r1496b3590],
6	.	.	O	.	_	0	SENT_287	[p17l1406t3554r1496b3590],

1	variability	NN	O	variability	nn	3	SENT_288	[p18l645t54r913b117],
2	,	,	O	,	_	0	SENT_288	[p18l645t54r913b117],
3	FEV	NN	O	fev	_	0	SENT_288	[p18l965t57r1101b114],
4	,	,	O	,	_	0	SENT_288	[p18l965t57r1101b114],
5	,	,	O	,	_	0	SENT_288	[p18l965t57r1101b114],
6	FEV1	NN	O	fev1	nn	7	SENT_288	[p18l1153t57r1277b114],
7	reversibility	NN	O	reversibility	appos	3	SENT_288	[p18l1323t54r1634b117],
8	with	IN	O	with	_	0	SENT_288	[p18l1678t54r1795b102],
9	salbutamol	NN	O	salbutamol	prep_with	7	SENT_288	[p18l1844t54r2148b109],
10	,	,	O	,	_	0	SENT_288	[p18l1844t54r2148b109],
11	asthma	NN	O	asthma	nn	12	SENT_288	[p18l647t130r839b177],
12	symptoms	NNS	O	symptom	appos	3	SENT_288	[p18l908t140r1196b193],
13	,	,	O	,	_	0	SENT_288	[p18l908t140r1196b193],
14	use	NN	O	use	appos	3	SENT_288	[p18l1265t147r1355b177],
15	of	IN	O	of	_	0	SENT_288	[p18l1424t130r1482b177],
16	rescue	NN	O	rescue	nn	17	SENT_288	[p18l1541t147r1710b177],
17	therapy	NN	O	therapy	prep_of	14	SENT_288	[p18l1778t130r1983b192],
18	,	,	O	,	_	0	SENT_288	[p18l1778t130r1983b192],
19	and	CC	O	and	_	0	SENT_288	[p18l2054t130r2151b177],
20	responsiveness	NN	O	responsiveness	appos	3	SENT_288	[p18l646t210r1046b269],
21	to	TO	O	to	_	0	SENT_288	[p18l1065t216r1114b254],
22	methacholine	NN	O	methacholine	prep_to	20	SENT_288	[p18l1132t207r1495b254],
23	(	NN	O	(	nn	24	SENT_288	[p18l1517t207r1657b270],
24	table	NN	O	table	dep	3	SENT_288	[p18l1517t207r1657b270],
25	2	CD	NUMBER	2	num	26	SENT_288	[p18l1678t211r1738b270],
26	)	NN	O	)	dep	24	SENT_288	[p18l1678t211r1738b270],
27	.	.	O	.	_	0	SENT_288	[p18l1678t211r1738b270],

1	In	IN	O	in	_	0	SENT_289	[p18l699t287r754b329],
2	Gly/Gly	JJ	O	gly/gly	amod	3	SENT_289	[p18l814t282r1021b345],
3	participants	NNS	O	participant	prep_in	10	SENT_289	[p18l1078t285r1404b344],
4	,	,	O	,	_	0	SENT_289	[p18l1078t285r1404b344],
5	methacholine	NN	O	methacholine	nn	6	SENT_289	[p18l1464t282r1826b330],
6	PCZO	NN	ORGANIZATION	pczo	nsubj	10	SENT_289	[p18l1888t286r1995b342],
7	was	VBD	O	be	cop	10	SENT_289	[p18l2051t299r2149b330],
8	2-4	CD	NUMBER	2-4	num	9	SENT_289	[p18l648t362r737b405],
9	times	NNS	O	time	npadvmod	10	SENT_289	[p18l767t361r912b405],
10	higher	JJR	O	higher	_	0	SENT_289	[p18l947t358r1122b421],
11	when	WRB	O	when	advmod	14	SENT_289	[p18l1153t358r1300b405],
12	participants	NNS	O	participant	nsubjpass	14	SENT_289	[p18l1333t361r1644b420],
13	were	VBD	O	be	auxpass	14	SENT_289	[p18l1678t375r1804b406],
14	assigned	VBN	O	assign	ccomp	10	SENT_289	[p18l1839t358r2069b421],
15	to	TO	O	to	_	0	SENT_289	[p18l2101t368r2150b405],
16	salmeterol	NN	O	salmeterol	prep_to	14	SENT_289	[p18l648t435r922b482],
17	than	IN	O	than	mark	38	SENT_289	[p18l952t435r1072b482],
18	when	WRB	O	when	advmod	19	SENT_289	[p18l1100t435r1247b482],
19	assigned	VBN	O	assign	advcl	38	SENT_289	[p18l1278t435r1508b498],
20	to	TO	O	to	_	0	SENT_289	[p18l1536t444r1585b482],
21	placebo	NN	O	placebo	nn	23	SENT_289	[p18l1616t435r1815b497],
22	(	NN	O	(	nn	23	SENT_289	[p18l1850t439r2148b498],
23	p	NN	O	p	dep	24	SENT_289	[p18l1850t439r2148b498],
24	<	JJR	O	<	prep_to	19	SENT_289	[p18l1850t439r2148b498],
25	0-0001	CD	NUMBER	0-0001	num	26	SENT_289	[p18l1850t439r2148b498],
26	)	NN	O	)	dep	24	SENT_289	[p18l1850t439r2148b498],
27	;	:	O	;	_	0	SENT_289	[p18l1850t439r2148b498],
28	however	RB	O	however	advmod	24	SENT_289	[p18l645t510r875b565],
29	,	,	O	,	_	0	SENT_289	[p18l645t510r875b565],
30	in	IN	O	in	_	0	SENT_289	[p18l897t513r949b557],
31	Arg/Arg	NN	O	arg/arg	nn	32	SENT_289	[p18l968t514r1190b573],
32	participants	NNS	O	participant	prep_in	19	SENT_289	[p18l1209t513r1534b572],
33	,	,	O	,	_	0	SENT_289	[p18l1209t513r1534b572],
34	methacholine	NN	O	methacholine	nn	35	SENT_289	[p18l1556t510r1919b558],
35	PC20	NN	O	pc20	nsubj	38	SENT_289	[p18l1941t514r2049b570],
36	did	VBD	O	do	aux	38	SENT_289	[p18l2068t510r2151b558],
37	not	RB	O	not	neg	38	SENT_289	[p18l646t595r732b633],
38	differ	VB	O	differ	advcl	10	SENT_289	[p18l765t586r908b633],
39	between	IN	O	between	_	0	SENT_289	[p18l939t586r1159b634],
40	treatments	NNS	O	treatment	prep_between	38	SENT_289	[p18l1191t595r1476b633],
41	(	CD	NUMBER	(	num	42	SENT_289	[p18l1515t589r1730b649],
42	p	NN	O	p	dobj	38	SENT_289	[p18l1515t589r1730b649],
43	=	JJ	O	=	amod	44	SENT_289	[p18l1515t589r1730b649],
44	O-87	NN	O	o-87	dep	42	SENT_289	[p18l1515t589r1730b649],
45	;	:	O	;	_	0	SENT_289	[p18l1515t589r1730b649],
46	ﬁgure	NN	O	ﬁgure	nn	48	SENT_289	[p18l1766t586r1922b649],
47	4	CD	NUMBER	4	num	48	SENT_289	[p18l1954t590r2014b649],
48	)	NN	O	)	dep	42	SENT_289	[p18l1954t590r2014b649],
49	.	.	O	.	_	0	SENT_289	[p18l1954t590r2014b649],

1	The	DT	O	the	det	6	SENT_290	[p18l2049t586r2150b633],
2	2-5	CD	NUMBER	2-5	number	3	SENT_290	[p18l648t666r735b710],
3	times	NNS	O	time	dep	6	SENT_290	[p18l757t666r903b710],
4	higher	JJR	O	higher	dep	3	SENT_290	[p18l924t663r1099b726],
5	genotype-speciﬁc	NN	O	genotype-speciﬁc	nn	6	SENT_290	[p18l1119t663r1574b726],
6	difference	NN	O	difference	nsubj	13	SENT_290	[p18l1595t663r1858b710],
7	in	IN	O	in	_	0	SENT_290	[p18l1880t666r1932b710],
8	responsiveness	NN	O	responsiveness	prep_in	6	SENT_290	[p18l1953t680r2149b725, p18l648t741r863b786],
9	to	TO	O	to	_	0	SENT_290	[p18l884t748r932b786],
10	methacholine	NN	O	methacholine	prep_to	8	SENT_290	[p18l953t738r1315b786],
11	was	VBD	O	be	cop	13	SENT_290	[p18l1334t755r1432b786],
12	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_290	[p18l1455t738r1732b801],
13	(	NN	O	(	dep	41	SENT_290	[p18l1755t743r1885b801],
14	1-32	CD	NUMBER	1-32	num	13	SENT_290	[p18l1755t743r1885b801],
15	doubling	VBG	O	double	partmod	13	SENT_290	[p18l1908t738r2151b801],
16	dose	NN	O	dose	nn	17	SENT_290	[p18l10t1148r181b1216],
17	difference	NN	O	difference	dobj	15	SENT_290	[p18l211t1148r596b1216],
18	between	IN	O	between	_	0	SENT_290	[p18l622t1148r943b1216],
19	genotypes	NNS	O	genotype	prep_between	17	SENT_290	[p18l972t1161r1378b1238],
20	,	,	O	,	_	0	SENT_290	[p18l972t1161r1378b1238],
21	95	CD	PERCENT	95	number	22	SENT_290	[p18l1411t1152r1574b1219],
22	%	NN	PERCENT	%	amod	23	SENT_290	[p18l1411t1152r1574b1219],
23	CI	NN	O	ci	appos	19	SENT_290	[p18l1605t1153r1690b1216],
24	0-43-2	CD	NUMBER	0-43-2	dep	23	SENT_290	[p18l1722t1154r1986b1216],
25	-	:	O	-	_	0	SENT_290	[p18l2007t1187r2018b1198],
26	21	CD	DATE	21	dep	23	SENT_290	[p18l2039t1154r2136b1226],
27	,	,	O	,	_	0	SENT_290	[p18l2039t1154r2136b1226],
28	p	NN	O	p	appos	26	SENT_290	[p18l8t1264r400b1347],
29	=	JJ	O	=	amod	28	SENT_290	[p18l8t1264r400b1347],
30	0-0038	CD	NUMBER	0-0038	tmod	29	SENT_290	[p18l8t1264r400b1347],
31	;	:	O	;	_	0	SENT_290	[p18l8t1264r400b1347],
32	table	NN	O	table	dep	23	SENT_290	[p18l437t1258r620b1325],
33	2	CD	NUMBER	2	num	34	SENT_290	[p18l658t1264r746b1348],
34	)	NN	O	)	dep	32	SENT_290	[p18l658t1264r746b1348],
35	;	:	O	;	_	0	SENT_290	[p18l658t1264r746b1348],
36	plots	NNS	O	plot	dep	23	SENT_290	[p18l784t1258r966b1347],
37	of	IN	O	of	_	0	SENT_290	[p18l1004t1258r1088b1325],
38	individual	JJ	O	individual	amod	39	SENT_290	[p18l1109t1258r1498b1325],
39	participants	NNS	O	participant	prep_of	36	SENT_290	[p18l1532t1262r1988b1347],
40	are	VBP	O	be	auxpass	41	SENT_290	[p18l2025t1282r2139b1325],
41	shown	VBN	O	show	_	0	SENT_290	[p18l11t1366r261b1435],
42	in	IN	O	in	_	0	SENT_290	[p18l296t1371r372b1433],
43	ﬁgure	NN	O	ﬁgure	nn	45	SENT_290	[p18l407t1366r633b1456],
44	4	CD	NUMBER	4	num	45	SENT_290	[p18l668t1373r710b1433],
45	(	NN	O	(	prep_in	41	SENT_290	[p18l748t1366r913b1456],
46	and	CC	O	and	_	0	SENT_290	[p18l748t1366r913b1456],
47	webappendix	NN	O	webappendix	nn	48	SENT_290	[p18l945t1366r1455b1455],
48	p	NN	O	p	prep_in	41	SENT_290	[p18l1489t1391r1533b1455],
49	3	CD	NUMBER	3	num	50	SENT_290	[p18l1574t1373r1660b1456],
50	)	NN	O	)	nsubjpass	41	SENT_290	[p18l1574t1373r1660b1456],
51	.	.	O	.	_	0	SENT_290	[p18l1574t1373r1660b1456],

1	There	EX	O	there	expl	2	SENT_291	[p18l1698t1366r1922b1434],
2	were	VBD	O	be	_	0	SENT_291	[p18l1957t1391r2139b1435],
3	no	DT	O	no	det	5	SENT_291	[p18l9t1499r103b1543],
4	genotype-speciﬁc	JJ	O	genotype-speciﬁc	amod	5	SENT_291	[p18l207t1475r871b1565],
5	differences	NNS	O	difference	nsubj	2	SENT_291	[p18l973t1475r1394b1543],
6	for	IN	O	for	_	0	SENT_291	[p18l1498t1475r1607b1543],
7	any	DT	O	any	det	9	SENT_291	[p18l1707t1499r1841b1564],
8	other	JJ	O	other	amod	9	SENT_291	[p18l1940t1475r2141b1543],
9	outcomes	NNS	O	outcome	prep_for	5	SENT_291	[p18l10t1573r401b1627],
10	.	.	O	.	_	0	SENT_291	[p18l10t1573r401b1627],

1	Both	DT	O	both	det	3	SENT_292	[p18l83t1668r257b1736],
2	genotype	NN	O	genotype	nn	3	SENT_292	[p18l286t1682r624b1758],
3	groups	NNS	O	group	nsubj	4	SENT_292	[p18l653t1693r910b1758],
4	had	VBD	O	have	_	0	SENT_292	[p18l938t1668r1078b1736],
5	a	DT	O	a	det	8	SENT_292	[p18l1105t1693r1142b1736],
6	fairly	RB	O	fairly	advmod	7	SENT_292	[p18l1169t1668r1362b1758],
7	high	JJ	O	high	amod	8	SENT_292	[p18l1387t1668r1558b1758],
8	degree	NN	O	degree	dobj	4	SENT_292	[p18l1587t1668r1835b1758],
9	of	IN	O	of	_	0	SENT_292	[p18l1863t1668r1947b1736],
10	FEV1	NN	O	fev1	nn	11	SENT_292	[p18l1965t1673r2141b1753],
11	reversibility	NN	O	reversibility	prep_of	8	SENT_292	[p18l9t1777r453b1866],
12	to	TO	O	to	_	0	SENT_292	[p18l496t1790r566b1845],
13	four	CD	NUMBER	four	num	14	SENT_292	[p18l613t1777r772b1845],
14	puffs	NNS	O	puff	prep_to	4	SENT_292	[p18l816t1777r1005b1866],
15	of	IN	O	of	_	0	SENT_292	[p18l1055t1777r1138b1845],
16	ipratropium	NN	O	ipratropium	prep_of	14	SENT_292	[p18l1172t1782r1630b1866],
17	(	CD	NUMBER	(	num	19	SENT_292	[p18l1683t1781r2134b1867],
18	7-6-10-1	CD	PERCENT	7-6-10-1	num	19	SENT_292	[p18l1683t1781r2134b1867],
19	%	NN	PERCENT	%	dep	16	SENT_292	[p18l1683t1781r2134b1867],
20	)	CD	NUMBER	)	dep	19	SENT_292	[p18l1683t1781r2134b1867],
21	and	CC	O	and	_	0	SENT_292	[p18l10t1887r148b1954],
22	to	TO	O	to	_	0	SENT_292	[p18l189t1900r259b1954],
23	four	CD	NUMBER	four	num	24	SENT_292	[p18l304t1887r462b1954],
24	puffs	NNS	O	puff	conj_and	14	SENT_292	[p18l504t1887r693b1976],
25	of	IN	O	of	_	0	SENT_292	[p18l741t1887r823b1954],
26	salbutamol	NN	O	salbutamol	prep_of	24	SENT_292	[p18l857t1887r1272b1954],
27	(	CD	NUMBER	(	num	29	SENT_292	[p18l1321t1891r1777b1977],
28	6-7-10-8	CD	PERCENT	6-7-10-8	num	29	SENT_292	[p18l1321t1891r1777b1977],
29	%	NN	PERCENT	%	dep	26	SENT_292	[p18l1321t1891r1777b1977],
30	;	:	O	;	_	0	SENT_292	[p18l1321t1891r1777b1977],
31	table	NN	O	table	nn	33	SENT_292	[p18l1824t1887r2003b1954],
32	2	CD	NUMBER	2	num	33	SENT_292	[p18l2050t1893r2135b1977],
33	)	NN	O	)	dep	26	SENT_292	[p18l2050t1893r2135b1977],
34	.	.	O	.	_	0	SENT_292	[p18l2050t1893r2135b1977],

1	There	EX	O	there	expl	2	SENT_293	[p18l7t1995r227b2063],
2	was	VBD	O	be	_	0	SENT_293	[p18l295t2020r433b2063],
3	no	DT	O	no	det	5	SENT_293	[p18l505t2020r598b2063],
4	genotype-speciﬁc	NN	O	genotype-speciﬁc	nn	5	SENT_293	[p18l669t1995r1318b2085],
5	advantage	NN	O	advantage	nsubj	2	SENT_293	[p18l1387t1995r1761b2085],
6	for	IN	O	for	_	0	SENT_293	[p18l1830t1995r1937b2063],
7	one	CD	NUMBER	one	num	8	SENT_293	[p18l2005t2020r2139b2063],
8	bronchodilator	NN	O	bronchodilator	prep_for	5	SENT_293	[p18l7t2105r569b2173],
9	over	IN	O	over	_	0	SENT_293	[p18l610t2129r768b2173],
10	another	DT	O	another	prep_over	8	SENT_293	[p18l809t2105r1110b2173],
11	.	.	O	.	_	0	SENT_293	[p18l809t2105r1110b2173],

1	I-Iowever	NNP	O	I-Iowever	_	0	SENT_294	[p18l1160t2112r1504b2183],
2	,	,	O	,	_	0	SENT_294	[p18l1160t2112r1504b2183],
3	independent	JJ	O	independent	nsubj	15	SENT_294	[p18l1550t2105r2028b2194],
4	of	IN	O	of	_	0	SENT_294	[p18l2069t2105r2152b2173],
5	genotype	NN	O	genotype	prep_of	3	SENT_294	[p18l10t2228r368b2304],
6	,	,	O	,	_	0	SENT_294	[p18l10t2228r368b2304],
7	the	DT	O	the	det	8	SENT_294	[p18l394t2215r511b2283],
8	degree	NN	O	degree	appos	5	SENT_294	[p18l537t2215r785b2304],
9	of	IN	O	of	_	0	SENT_294	[p18l811t2214r895b2283],
10	bronchodilation	NN	O	bronchodilation	prep_of	8	SENT_294	[p18l905t2215r1509b2283],
11	with	IN	O	with	_	0	SENT_294	[p18l1531t2215r1697b2283],
12	salbutamol	NN	O	salbutamol	prep_with	10	SENT_294	[p18l1724t2215r2139b2283],
13	was	VBD	O	be	cop	15	SENT_294	[p18l7t2348r146b2392],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	15	SENT_294	[p18l172t2323r633b2413],
15	higher	JJR	O	higher	dep	1	SENT_294	[p18l651t2323r900b2413],
16	when	WRB	O	when	advmod	19	SENT_294	[p18l917t2323r1125b2392],
17	participants	NNS	O	participant	nsubjpass	19	SENT_294	[p18l1145t2328r1589b2412],
18	were	VBD	O	be	auxpass	19	SENT_294	[p18l1611t2348r1790b2392],
19	assigned	VBN	O	assign	ccomp	15	SENT_294	[p18l1813t2323r2141b2413],
20	to	TO	O	to	aux	21	SENT_294	[p18l7t2445r77b2500],
21	receive	VB	O	receive	xcomp	19	SENT_294	[p18l147t2437r407b2500],
22	placebo	NN	O	placebo	dobj	21	SENT_294	[p18l476t2432r760b2521],
23	than	IN	O	than	_	0	SENT_294	[p18l829t2432r999b2500],
24	when	WRB	O	when	advmod	25	SENT_294	[p18l1067t2432r1275b2500],
25	assigned	VBN	O	assign	prepc_than	21	SENT_294	[p18l1345t2432r1673b2522],
26	to	TO	O	to	aux	27	SENT_294	[p18l1740t2445r1809b2500],
27	receive	VB	O	receive	xcomp	25	SENT_294	[p18l1879t2437r2139b2500],
28	salmeterol	NN	O	salmeterol	nn	30	SENT_294	[p18l11t2543r403b2611],
29	(	NN	O	(	nn	30	SENT_294	[p18l473t2548r829b2632],
30	Arg/Arg	NN	O	arg/arg	dobj	27	SENT_294	[p18l473t2548r829b2632],
31	,	,	O	,	_	0	SENT_294	[p18l473t2548r829b2632],
32	p	NN	O	p	nn	34	SENT_294	[p18l896t2549r1207b2631],
33	=	JJ	O	=	amod	34	SENT_294	[p18l896t2549r1207b2631],
34	O-001	NN	O	o-001	conj_and	30	SENT_294	[p18l896t2549r1207b2631],
35	and	CC	O	and	_	0	SENT_294	[p18l1271t2543r1410b2611],
36	Gly/Gly	NN	O	gly/gly	conj_and	30	SENT_294	[p18l1475t2543r1781b2632],
37	,	,	O	,	_	0	SENT_294	[p18l1475t2543r1781b2632],
38	p	NN	O	p	appos	1	SENT_294	[p18l1848t2549r2136b2631],
39	=	JJ	O	=	amod	38	SENT_294	[p18l1848t2549r2136b2631],
40	0-04	CD	NUMBER	0-04	tmod	39	SENT_294	[p18l1848t2549r2136b2631],
41	;	:	O	;	_	0	SENT_294	[p18l1848t2549r2136b2631],
42	table	NN	O	table	dep	1	SENT_294	[p18l7t2651r187b2719],
43	2	CD	NUMBER	2	num	44	SENT_294	[p18l233t2658r318b2741],
44	)	NN	O	)	dep	42	SENT_294	[p18l233t2658r318b2741],
45	.	.	O	.	_	0	SENT_294	[p18l233t2658r318b2741],

1	For	IN	O	for	_	0	SENT_295	[p18l370t2656r492b2719],
2	both	DT	O	both	det	3	SENT_295	[p18l531t2651r701b2719],
3	genotypes	NNS	O	genotype	prep_for	9	SENT_295	[p18l746t2665r1142b2741],
4	,	,	O	,	_	0	SENT_295	[p18l746t2665r1142b2741],
5	response	NN	O	response	nsubj	9	SENT_295	[p18l1188t2675r1525b2740],
6	to	TO	O	to	_	0	SENT_295	[p18l1567t2665r1636b2719],
7	ipratropium	NN	O	ipratropium	prep_to	5	SENT_295	[p18l1681t2656r2140b2740],
8	was	VBD	O	be	cop	9	SENT_295	[p18l7t2785r146b2829],
9	similar	JJ	O	similar	_	0	SENT_295	[p18l177t2761r442b2829],
10	for	IN	O	for	_	0	SENT_295	[p18l466t2761r574b2829],
11	salmeterol	NN	O	salmeterol	nn	14	SENT_295	[p18l602t2761r993b2829],
12	and	CC	O	and	_	0	SENT_295	[p18l1021t2761r1159b2829],
13	placebo	NN	O	placebo	conj_and	11	SENT_295	[p18l1185t2761r1468b2850],
14	treatments	NNS	O	treatment	prep_for	9	SENT_295	[p18l1495t2774r1922b2829],
15	.	.	O	.	_	0	SENT_295	[p18l1495t2774r1922b2829],

1	Seven	CD	NUMBER	seven	num	3	SENT_296	[p18l85t2877r301b2940],
2	Arg/Arg	NN	O	arg/arg	nn	3	SENT_296	[p18l331t2877r647b2961],
3	participants	NNS	O	participant	nsubj	4	SENT_296	[p18l678t2876r1122b2960],
4	(	VBP	O	(	_	0	SENT_296	[p18l1162t2872r1489b2961],
5	placebo	NN	O	placebo	nsubj	21	SENT_296	[p18l1162t2872r1489b2961],
6	,	,	O	,	_	0	SENT_296	[p18l1162t2872r1489b2961],
7	n	NN	O	n	appos	5	SENT_296	[p18l1523t2876r1686b2950],
8	=	JJ	O	=	amod	7	SENT_296	[p18l1523t2876r1686b2950],
9	5	CD	NUMBER	5	tmod	8	SENT_296	[p18l1523t2876r1686b2950],
10	;	:	O	;	_	0	SENT_296	[p18l1523t2876r1686b2950],
11	salmeterol	NN	O	salmeterol	dep	7	SENT_296	[p18l1725t2872r2136b2950],
12	,	,	O	,	_	0	SENT_296	[p18l1725t2872r2136b2950],
13	n	NN	O	n	conj_and	11	SENT_296	[p18l9t2987r175b3070],
14	=	JJ	O	=	amod	16	SENT_296	[p18l9t2987r175b3070],
15	2	CD	NUMBER	2	tmod	14	SENT_296	[p18l9t2987r175b3070],
16	)	NN	O	)	dep	13	SENT_296	[p18l9t2987r175b3070],
17	and	CC	O	and	_	0	SENT_296	[p18l261t2980r400b3048],
18	six	CD	NUMBER	six	num	20	SENT_296	[p18l480t2985r579b3048],
19	Gly/Gly	NN	O	gly/gly	nn	20	SENT_296	[p18l659t2980r955b3070],
20	participants	NNS	O	participant	dep	7	SENT_296	[p18l1033t2985r1476b3069],
21	(	VBP	O	(	ccomp	4	SENT_296	[p18l1564t2980r1890b3070],
22	placebo	NN	O	placebo	dobj	21	SENT_296	[p18l1564t2980r1890b3070],
23	,	,	O	,	_	0	SENT_296	[p18l1564t2980r1890b3070],
24	n	NN	O	n	appos	22	SENT_296	[p18l1973t2987r2135b3058],
25	=	JJ	O	=	amod	24	SENT_296	[p18l1973t2987r2135b3058],
26	3	CD	NUMBER	3	tmod	25	SENT_296	[p18l1973t2987r2135b3058],
27	;	:	O	;	_	0	SENT_296	[p18l1973t2987r2135b3058],
28	salmeterol	NN	O	salmeterol	nsubj	34	SENT_296	[p18l11t3090r422b3168],
29	,	,	O	,	_	0	SENT_296	[p18l11t3090r422b3168],
30	n	NN	O	n	appos	28	SENT_296	[p18l478t3096r644b3180],
31	=	JJ	O	=	amod	33	SENT_296	[p18l478t3096r644b3180],
32	3	CD	NUMBER	3	tmod	31	SENT_296	[p18l478t3096r644b3180],
33	)	NN	O	)	dep	30	SENT_296	[p18l478t3096r644b3180],
34	had	VBD	O	have	parataxis	4	SENT_296	[p18l701t3090r840b3157],
35	an	DT	O	a	det	36	SENT_296	[p18l893t3114r982b3157],
36	exacerbation	NN	O	exacerbation	dobj	34	SENT_296	[p18l1035t3090r1508b3157],
37	of	IN	O	of	_	0	SENT_296	[p18l1561t3090r1644b3157],
38	asthma	NN	O	asthma	prep_of	36	SENT_296	[p18l1685t3090r1977b3157],
39	.	.	O	.	_	0	SENT_296	[p18l1685t3090r1977b3157],

1	No	DT	O	no	det	3	SENT_297	[p18l2036t3096r2139b3157],
2	genotype-speciﬁc	NN	O	genotype-speciﬁc	nn	3	SENT_297	[p18l10t3198r659b3288],
3	differences	NNS	O	difference	nsubjpass	8	SENT_297	[p18l691t3199r1104b3267],
4	in	IN	O	in	_	0	SENT_297	[p18l1138t3203r1213b3265],
5	exacerbation	NN	O	exacerbation	nn	6	SENT_297	[p18l1246t3198r1719b3267],
6	rates	NNS	O	rate	prep_in	3	SENT_297	[p18l1751t3212r1927b3267],
7	were	VBD	O	be	auxpass	8	SENT_297	[p18l1960t3223r2139b3267],
8	seen	VBN	O	see	_	0	SENT_297	[p18l11t3332r198b3377],
9	.	.	O	.	_	0	SENT_297	[p18l11t3332r198b3377],

1	Five	CD	NUMBER	five	dep	107	SENT_298	[p18l240t3313r389b3377],
2	serious	JJ	O	serious	dep	107	SENT_298	[p18l426t3313r693b3377],
3	adverse	JJ	O	adverse	dep	107	SENT_298	[p18l731t3308r1010b3376],
4	events	NNS	O	event	dep	107	SENT_298	[p18l1047t3322r1281b3377],
5	were	VBD	O	be	dep	107	SENT_298	[p18l1316t3333r1495b3377],
6	reported	VBN	O	report	dep	107	SENT_298	[p18l1530t3308r1867b3397],
7	:	:	O	:	_	0	SENT_298	[p18l1530t3308r1867b3397],
8	severe	JJ	O	severe	dep	107	SENT_298	[p18l1909t3332r2139b3377],
9	postoperative	JJ	O	postoperative	dep	107	SENT_298	[p19l8t22r510b107],
10	pain	NN	O	pain	dep	107	SENT_298	[p19l567t22r732b107],
11	after	IN	O	after	dep	107	SENT_298	[p19l789t18r958b85],
12	loop	NN	O	loop	dep	107	SENT_298	[p19l1011t18r1172b107],
13	electrosurgical	JJ	O	electrosurgical	dep	107	SENT_298	[p19l1230t18r1779b108],
14	excision	NN	O	excision	dep	107	SENT_298	[p19l1837t22r2140b85],
15	procedure/cone	NN	O	procedure/cone	dep	107	SENT_298	[p19l8t126r605b215],
16	biopsy	NN	O	biopsy	dep	107	SENT_298	[p19l656t126r901b216],
17	for	IN	O	for	dep	107	SENT_298	[p19l951t126r1058b194],
18	cervical	JJ	O	cervical	dep	107	SENT_298	[p19l1109t126r1390b195],
19	dysplasia	NN	O	dysplasium	dep	107	SENT_298	[p19l1442t126r1783b216],
20	needing	VBG	O	need	dep	107	SENT_298	[p19l1835t126r2140b216],
21	hospital	NN	O	hospital	dep	107	SENT_298	[p19l7t235r308b324],
22	stay	VB	O	stay	dep	107	SENT_298	[p19l353t249r495b325],
23	(	RB	O	(	dep	107	SENT_298	[p19l542t235r949b325],
24	pre-match	JJ	O	pre-match	dep	107	SENT_298	[p19l542t235r949b325],
25	inhaled	VBN	O	inhale	dep	107	SENT_298	[p19l991t235r1273b303],
26	corticosteroid	NN	O	corticosteroid	dep	107	SENT_298	[p19l1316t235r1830b303],
27	phase	NN	O	phase	dep	107	SENT_298	[p19l1871t235r2135b325],
28	)	NN	O	)	dep	107	SENT_298	[p19l1871t235r2135b325],
29	;	:	O	;	_	0	SENT_298	[p19l1871t235r2135b325],
30	hospital	NN	O	hospital	dep	107	SENT_298	[p19l7t345r308b434],
31	admission	NN	O	admission	dep	107	SENT_298	[p19l354t345r744b412],
32	after	IN	O	after	dep	107	SENT_298	[p19l790t345r959b412],
33	scheduled	VBN	O	schedule	dep	107	SENT_298	[p19l1005t345r1384b412],
34	outpatient	NN	O	outpatient	dep	107	SENT_298	[p19l1429t349r1814b434],
35	surgery	NN	O	surgery	dep	107	SENT_298	[p19l1860t369r2141b435],
36	for	IN	O	for	dep	107	SENT_298	[p19l8t453r116b521],
37	repair	NN	O	repair	dep	107	SENT_298	[p19l212t458r436b542],
38	of	IN	O	of	dep	107	SENT_298	[p19l533t453r616b521],
39	umbilical	JJ	O	umbilical	dep	107	SENT_298	[p19l700t453r1057b521],
40	hernia	NN	O	hernia	dep	107	SENT_298	[p19l1152t453r1397b521],
41	(	NN	O	(	dep	107	SENT_298	[p19l1501t458r1761b543],
42	run-in	NN	O	run-in	dep	107	SENT_298	[p19l1501t458r1761b543],
43	inhaled	VBD	O	inhale	dep	107	SENT_298	[p19l1858t453r2141b521],
44	corticosteroid	NN	O	corticosteroid	dep	107	SENT_298	[p19l9t562r523b630],
45	phase	NN	O	phase	dep	107	SENT_298	[p19l549t562r814b652],
46	)	NN	O	)	dep	107	SENT_298	[p19l549t562r814b652],
47	;	:	O	;	_	0	SENT_298	[p19l549t562r814b652],
48	hospital	NN	O	hospital	dep	107	SENT_298	[p19l844t562r1144b651],
49	admission	NN	O	admission	dep	107	SENT_298	[p19l1173t562r1563b630],
50	for	IN	O	for	dep	107	SENT_298	[p19l1590t562r1697b630],
51	cellulitis	NNS	O	cellulitis	dep	107	SENT_298	[p19l1723t562r2038b630],
52	of	IN	O	of	dep	107	SENT_298	[p19l2069t562r2152b630],
53	the	DT	O	the	dep	107	SENT_298	[p19l7t672r124b739],
54	right	JJ	O	right	dep	107	SENT_298	[p19l167t672r350b762],
55	leg	NN	O	leg	dep	107	SENT_298	[p19l389t672r499b762],
56	(	CD	NUMBER	(	dep	107	SENT_298	[p19l547t672r1049b762],
57	double-blind	JJ	O	double-blind	dep	107	SENT_298	[p19l547t672r1049b762],
58	treatment	NN	O	treatment	dep	107	SENT_298	[p19l1089t685r1461b739],
59	with	IN	O	with	dep	107	SENT_298	[p19l1500t672r1666b740],
60	salmeterol	NN	O	salmeterol	dep	107	SENT_298	[p19l1711t672r2137b761],
61	/	:	O	/	dep	107	SENT_298	[p19l1711t672r2137b761],
62	inhaled	VBN	O	inhale	dep	107	SENT_298	[p19l8t780r291b848],
63	corticosteroid	NN	O	corticosteroid	dep	107	SENT_298	[p19l336t780r896b870],
64	)	NN	O	)	dep	107	SENT_298	[p19l336t780r896b870],
65	;	:	O	;	_	0	SENT_298	[p19l336t780r896b870],
66	hospital	NN	O	hospital	dep	107	SENT_298	[p19l943t780r1244b869],
67	admission	NN	O	admission	dep	107	SENT_298	[p19l1290t780r1680b848],
68	for	IN	O	for	dep	107	SENT_298	[p19l1725t780r1832b848],
69	bipolar	JJ	O	bipolar	dep	107	SENT_298	[p19l1874t780r2141b869],
70	disorder	NN	O	disorder	dep	107	SENT_298	[p19l9t889r323b957],
71	mood	NN	O	mood	dep	107	SENT_298	[p19l374t889r591b957],
72	event	NN	O	event	dep	107	SENT_298	[p19l644t902r845b957],
73	(	CD	NUMBER	(	dep	107	SENT_298	[p19l902t894r1160b979],
74	manic	JJ	O	manic	dep	107	SENT_298	[p19l902t894r1160b979],
75	episode	NN	O	episode	dep	107	SENT_298	[p19l1213t889r1498b978],
76	during	IN	O	during	dep	107	SENT_298	[p19l1553t889r1806b979],
77	doubleblind	NN	O	doubleblind	dep	107	SENT_298	[p19l1861t889r2138b957, p19l7t1000r204b1068],
78	treatment	NN	O	treatment	dep	107	SENT_298	[p19l232t1013r604b1068],
79	with	IN	O	with	dep	107	SENT_298	[p19l631t1000r797b1068],
80	salmeterol	NN	O	salmeterol	dep	107	SENT_298	[p19l830t1000r1223b1068],
81	/	:	O	/	dep	107	SENT_298	[p19l1229t1006r1257b1088],
82	inhaled	VBN	O	inhale	dep	107	SENT_298	[p19l1264t1000r1546b1068],
83	corticosteroid	NN	O	corticosteroid	dep	107	SENT_298	[p19l1576t1000r2135b1089],
84	)	NN	O	)	dep	107	SENT_298	[p19l1576t1000r2135b1089],
85	;	:	O	;	_	0	SENT_298	[p19l1576t1000r2135b1089],
86	and	CC	O	and	dep	107	SENT_298	[p19l10t1108r148b1176],
87	hospital	NN	O	hospital	dep	107	SENT_298	[p19l199t1108r499b1197],
88	admission	NN	O	admission	dep	107	SENT_298	[p19l554t1108r944b1176],
89	for	IN	O	for	dep	107	SENT_298	[p19l998t1108r1105b1176],
90	vaginal	JJ	O	vaginal	dep	107	SENT_298	[p19l1155t1108r1424b1198],
91	hysterectomy	NN	O	hysterectomy	dep	107	SENT_298	[p19l1477t1108r1982b1198],
92	for	IN	O	for	dep	107	SENT_298	[p19l2034t1108r2141b1176],
93	treatment	NN	O	treatment	dep	107	SENT_298	[p19l7t1230r379b1285],
94	of	IN	O	of	dep	107	SENT_298	[p19l413t1217r497b1285],
95	abdominopelvic	JJ	O	abdominopelvic	dep	107	SENT_298	[p19l519t1217r1120b1306],
96	pain	NN	O	pain	dep	107	SENT_298	[p19l1154t1222r1319b1306],
97	secondary	JJ	O	secondary	dep	107	SENT_298	[p19l1356t1217r1733b1306],
98	to	TO	O	to	dep	107	SENT_298	[p19l1764t1230r1833b1285],
99	uterine	JJ	O	uterine	dep	107	SENT_298	[p19l1867t1222r2139b1285],
100	ﬁbroids	NNS	O	ﬁbroids	dep	107	SENT_298	[p19l9t1326r294b1395],
101	(	VBP	O	(	dep	107	SENT_298	[p19l352t1327r854b1416],
102	double-blind	JJ	O	double-blind	dep	107	SENT_298	[p19l352t1327r854b1416],
103	treatment	NN	O	treatment	dep	107	SENT_298	[p19l900t1340r1272b1395],
104	with	IN	O	with	dep	107	SENT_298	[p19l1317t1327r1484b1395],
105	placebo/inhaled	VBN	O	placebo/inhaled	dep	107	SENT_298	[p19l1533t1327r2141b1415],
106	corticosteroid	NN	O	corticosteroid	dep	107	SENT_298	[p19l9t1435r569b1525],
107	)	NN	O	)	_	0	SENT_298	[p19l9t1435r569b1525],
108	.	.	O	.	_	0	SENT_298	[p19l9t1435r569b1525],

1	None	NN	O	none	nsubjpass	9	SENT_299	[p19l608t1442r806b1503],
2	of	IN	O	of	_	0	SENT_299	[p19l840t1435r924b1503],
3	the	DT	O	the	det	5	SENT_299	[p19l942t1435r1059b1503],
4	serious	JJ	O	serious	amod	5	SENT_299	[p19l1095t1440r1362b1503],
5	events	NNS	O	event	prep_of	1	SENT_299	[p19l1398t1449r1632b1503],
6	was	VBD	O	be	auxpass	7	SENT_299	[p19l1666t1459r1804b1503],
7	asthmarelated	VBN	O	asthmarelate	_	0	SENT_299	[p19l1840t1435r2138b1503, p19l8t1544r265b1612],
8	or	CC	O	or	_	0	SENT_299	[p19l319t1568r396b1612],
9	related	VBN	O	relate	conj_or	7	SENT_299	[p19l449t1544r705b1612],
10	to	TO	O	to	aux	11	SENT_299	[p19l757t1557r827b1612],
11	study	VB	O	study	xcomp	7	SENT_299	[p19l885t1544r1086b1633],
12	drugs	NNS	O	drug	dobj	11	SENT_299	[p19l1139t1544r1350b1634],
13	or	CC	O	or	_	0	SENT_299	[p19l1407t1568r1484b1612],
14	procedures	NNS	O	procedure	dobj	11	SENT_299	[p19l1537t1544r1975b1633],
15	.	.	O	.	_	0	SENT_299	[p19l1537t1544r1975b1633],

1	All	DT	O	all	det	2	SENT_300	[p19l2033t1544r2140b1611],
2	participants	NNS	O	participant	nsubj	3	SENT_300	[p19l8t1659r452b1742],
3	recovered	VBD	O	recover	_	0	SENT_300	[p19l489t1655r871b1722],
4	.	.	O	.	_	0	SENT_300	[p19l489t1655r871b1722],

1	The	DT	O	the	det	6	SENT_301	[p19l908t1655r1052b1722],
2	most	RBS	O	most	advmod	3	SENT_301	[p19l1088t1668r1277b1722],
3	prevalent	JJ	O	prevalent	amod	6	SENT_301	[p19l1309t1655r1660b1742],
4	non-serious	JJ	O	non-serious	amod	6	SENT_301	[p19l1692t1659r2137b1722],
5	adverse	JJ	O	adverse	amod	6	SENT_301	[p19l10t1763r290b1831],
6	events	NNS	O	event	nsubjpass	9	SENT_301	[p19l316t1777r550b1831],
7	reported	VBN	O	report	partmod	6	SENT_301	[p19l577t1763r896b1852],
8	were	VBD	O	be	auxpass	9	SENT_301	[p19l918t1788r1096b1831],
9	expected	VBN	O	expect	_	0	SENT_301	[p19l1123t1763r1447b1852],
10	and	CC	O	and	_	0	SENT_301	[p19l1472t1763r1610b1831],
11	respiratory	JJ	O	respiratory	conj_and	9	SENT_301	[p19l1633t1768r2043b1853],
12	in	IN	O	in	_	0	SENT_301	[p19l2065t1768r2140b1830],
13	nature	NN	O	nature	prep_in	11	SENT_301	[p19l9t1886r273b1951],
14	,	,	O	,	_	0	SENT_301	[p19l9t1886r273b1951],
15	with	IN	O	with	conj_and	9	SENT_301	[p19l306t1873r473b1940],
16	94	CD	NUMBER	94	num	17	SENT_301	[p19l506t1879r591b1941],
17	events	NNS	O	event	pobj	15	SENT_301	[p19l620t1886r853b1940],
18	occurring	VBG	O	occur	partmod	17	SENT_301	[p19l889t1877r1252b1963],
19	during	IN	O	during	_	0	SENT_301	[p19l1285t1873r1538b1963],
20	the	DT	O	the	det	36	SENT_301	[p19l1569t1873r1686b1940],
21	pre-match	JJ	O	pre-match	amod	36	SENT_301	[p19l1718t1873r2137b1962],
22	/	:	O	/	punct	30	SENT_301	[p19l1718t1873r2137b1962],
23	run-in/run-out	JJ	O	run-in/run-out	amod	24	SENT_301	[p19l8t1986r573b2070],
24	phases	NNS	O	phase	nsubj	30	SENT_301	[p19l602t1981r855b2070],
25	of	IN	O	of	_	0	SENT_301	[p19l889t1981r972b2050],
26	the	DT	O	the	det	27	SENT_301	[p19l989t1982r1106b2050],
27	study	NN	O	study	prep_of	24	SENT_301	[p19l1139t1982r1351b2071],
28	,	,	O	,	_	0	SENT_301	[p19l1139t1982r1351b2071],
29	74	CD	NUMBER	74	appos	27	SENT_301	[p19l1384t1986r1465b2052],
30	occurring	VBG	O	occur	dep	36	SENT_301	[p19l1492t1986r1855b2071],
31	during	IN	O	during	_	0	SENT_301	[p19l1886t1982r2140b2071],
32	double-blind	JJ	O	double-blind	amod	33	SENT_301	[p19l9t2091r488b2159],
33	treatment	NN	O	treatment	prep_during	30	SENT_301	[p19l544t2105r917b2159],
34	with	IN	O	with	_	0	SENT_301	[p19l972t2091r1138b2160],
35	placebo/inhaled	VBN	O	placebo/inhaled	prepc_with	30	SENT_301	[p19l1196t2091r1805b2180],
36	corticosteroid	NN	O	corticosteroid	prep_during	18	SENT_301	[p19l1863t2096r2138b2159, p19l11t2201r285b2279],
37	,	,	O	,	_	0	SENT_301	[p19l1863t2096r2138b2159, p19l11t2201r285b2279],
38	and	CC	O	and	_	0	SENT_301	[p19l317t2201r456b2268],
39	57	CD	NUMBER	57	prep_during	18	SENT_301	[p19l487t2205r564b2271],
40	occurring	VBG	O	occur	partmod	39	SENT_301	[p19l592t2205r955b2291],
41	during	IN	O	during	_	0	SENT_301	[p19l983t2201r1237b2291],
42	double-blind	JJ	O	double-blind	amod	43	SENT_301	[p19l1265t2201r1744b2268],
43	treatment	NN	O	treatment	prep_during	40	SENT_301	[p19l1769t2214r2141b2268],
44	with	IN	O	with	_	0	SENT_301	[p19l7t2310r173b2379],
45	salmeterol/inhaled	VBN	O	salmeterol/inhaled	prepc_with	40	SENT_301	[p19l198t2310r913b2399],
46	corticosteroid	NN	O	corticosteroid	dobj	45	SENT_301	[p19l935t2310r1466b2379],
47	.	.	O	.	_	0	SENT_301	[p19l935t2310r1466b2379],

1	Most	JJS	O	most	amod	2	SENT_302	[p19l1496t2317r1681b2379],
2	events	NNS	O	event	nsubj	5	SENT_302	[p19l1703t2324r1937b2379],
3	were	VBD	O	be	cop	5	SENT_302	[p19l1960t2335r2139b2379],
4	acute	JJ	O	acute	amod	5	SENT_302	[p19l10t2435r205b2489],
5	nasopharyngitis	NN	O	nasopharyngitis	_	0	SENT_302	[p19l232t2421r834b2511],
6	and	CC	O	and	_	0	SENT_302	[p19l865t2421r1003b2489],
7	acute	JJ	O	acute	amod	8	SENT_302	[p19l1029t2435r1225b2489],
8	pharyngitis	NN	O	pharyngitis	conj_and	5	SENT_302	[p19l1252t2421r1698b2511],
9	.	.	O	.	_	0	SENT_302	[p19l1252t2421r1698b2511],

1	Results	NNS	O	result	nsubj	6	SENT_303	[p19l83t2531r353b2599],
2	in	IN	O	in	_	0	SENT_303	[p19l389t2535r464b2597],
3	white	JJ	O	white	amod	4	SENT_303	[p19l495t2531r704b2599],
4	participants	NNS	O	participant	prep_in	1	SENT_303	[p19l737t2535r1185b2620],
5	alone	RB	O	alone	advmod	6	SENT_303	[p19l1222t2531r1423b2599],
6	mirrored	VBD	O	mirror	_	0	SENT_303	[p19l1457t2531r1801b2599],
7	those	DT	O	those	dobj	6	SENT_303	[p19l1832t2531r2034b2599],
8	of	IN	O	of	_	0	SENT_303	[p19l2069t2531r2153b2599],
9	the	DT	O	the	det	12	SENT_303	[p19l7t2639r125b2707],
10	entire	JJ	O	entire	amod	12	SENT_303	[p19l175t2644r394b2707],
11	study	NN	O	study	nn	12	SENT_303	[p19l446t2639r648b2729],
12	population	NN	O	population	prep_of	7	SENT_303	[p19l694t2639r1124b2728],
13	.	.	O	.	_	0	SENT_303	[p19l694t2639r1124b2728],

1	However	RB	O	however	advmod	10	SENT_304	[p19l1180t2646r1527b2717],
2	,	,	O	,	_	0	SENT_304	[p19l1180t2646r1527b2717],
3	an	DT	O	a	det	7	SENT_304	[p19l1580t2664r1670b2707],
4	exploratory	JJ	O	exploratory	amod	7	SENT_304	[p19l1718t2639r2142b2729],
5	post-hoc	JJ	O	post-hoc	amod	7	SENT_304	[p19l8t2748r329b2837],
6	subgroup	NN	O	subgroup	nn	7	SENT_304	[p19l419t2748r777b2838],
7	analysis	NN	O	analysis	nsubj	10	SENT_304	[p19l867t2748r1164b2838],
8	in	IN	O	in	_	0	SENT_304	[p19l1254t2753r1330b2815],
9	African-Americans	NNPS	MISC	African-Americans	prep_in	7	SENT_304	[p19l1416t2748r2138b2816],
10	showed	VBD	O	show	_	0	SENT_304	[p19l11t2858r297b2925],
11	that	IN	O	that	complm	23	SENT_304	[p19l342t2858r489b2925],
12	in	IN	O	in	_	0	SENT_304	[p19l535t2862r610b2924],
13	the	DT	O	the	det	16	SENT_304	[p19l657t2858r774b2925],
14	eight	CD	NUMBER	eight	num	16	SENT_304	[p19l824t2858r1014b2948],
15	Gly/Gly	NN	O	gly/gly	nn	16	SENT_304	[p19l1063t2858r1361b2947],
16	participants	NNS	O	participant	prep_in	23	SENT_304	[p19l1406t2862r1876b2947],
17	,	,	O	,	_	0	SENT_304	[p19l1406t2862r1876b2947],
18	mean	VB	O	mean	csubj	23	SENT_304	[p19l1927t2882r2140b2925],
19	morning	NN	TIME	morning	nn	22	SENT_304	[p19l8t2971r343b3056],
20	and	CC	O	and	_	0	SENT_304	[p19l371t2966r510b3034],
21	evening	NN	TIME	evening	conj_and	19	SENT_304	[p19l537t2971r834b3056],
22	PEF	NN	O	pef	dobj	18	SENT_304	[p19l865t2971r1013b3033],
23	were	VBD	O	be	ccomp	10	SENT_304	[p19l1041t2991r1221b3034],
24	29	CD	NUMBER	29	num	25	SENT_304	[p19l1250t2973r1333b3035],
25	L/min	NN	O	l/min	npadvmod	29	SENT_304	[p19l1365t2971r1600b3055],
26	and	CC	O	and	_	0	SENT_304	[p19l1628t2966r1767b3034],
27	45	CD	NUMBER	45	num	28	SENT_304	[p19l1790t2971r1871b3034],
28	L/min	NN	O	l/min	conj_and	25	SENT_304	[p19l1905t2971r2140b3055],
29	higher	JJR	O	higher	advmod	23	SENT_304	[p19l7t3075r259b3165],
30	when	WRB	O	when	advmod	33	SENT_304	[p19l297t3075r505b3143],
31	participants	NNS	O	participant	nsubjpass	33	SENT_304	[p19l547t3080r994b3164],
32	were	VBD	O	be	auxpass	33	SENT_304	[p19l1036t3099r1216b3143],
33	assigned	VBN	O	assign	dep	29	SENT_304	[p19l1260t3075r1590b3165],
34	to	TO	O	to	_	0	SENT_304	[p19l1630t3088r1699b3143],
35	salmeterol	NN	O	salmeterol	prep_to	33	SENT_304	[p19l1745t3075r2140b3143],
36	than	IN	O	than	_	0	SENT_304	[p19l7t3186r179b3254],
37	when	WRB	O	when	advmod	38	SENT_304	[p19l220t3186r429b3254],
38	assigned	VBN	O	assign	prepc_than	33	SENT_304	[p19l474t3186r804b3275],
39	to	TO	O	to	_	0	SENT_304	[p19l845t3199r914b3254],
40	placebo	NN	O	placebo	prep_to	38	SENT_304	[p19l959t3186r1266b3274],
41	,	,	O	,	_	0	SENT_304	[p19l959t3186r1266b3274],
42	respectively	RB	O	respectively	advmod	40	SENT_304	[p19l1313t3186r1758b3275],
43	(	CD	NUMBER	(	num	44	SENT_304	[p19l1805t3192r2136b3275],
44	p	NN	O	p	dep	40	SENT_304	[p19l1805t3192r2136b3275],
45	=	JJ	O	=	amod	46	SENT_304	[p19l1805t3192r2136b3275],
46	O-O13	NN	O	o-o13	dep	44	SENT_304	[p19l1805t3192r2136b3275],
47	and	CC	O	and	_	0	SENT_304	[p19l10t3294r149b3362],
48	p	NN	O	p	nn	50	SENT_304	[p19l178t3299r564b3383],
49	=	JJ	O	=	amod	50	SENT_304	[p19l178t3299r564b3383],
50	O-0005	NN	O	o-0005	conj_and	46	SENT_304	[p19l178t3299r564b3383],
51	,	,	O	,	_	0	SENT_304	[p19l178t3299r564b3383],
52	respectively	RB	O	respectively	dep	53	SENT_304	[p19l597t3294r1088b3384],
53	)	CD	NUMBER	)	dep	40	SENT_304	[p19l597t3294r1088b3384],
54	.	.	O	.	_	0	SENT_304	[p19l597t3294r1088b3384],

1	Morning	NN	TIME	morning	nn	4	SENT_305	[p19l1125t3299r1457b3384],
2	and	CC	O	and	_	0	SENT_305	[p19l1487t3294r1627b3362],
3	evening	NN	TIME	evening	conj_and	1	SENT_305	[p19l1657t3299r1954b3384],
4	PEF	NN	O	pef	nsubj	7	SENT_305	[p19l1989t3299r2136b3361],
5	did	VBD	O	do	aux	7	SENT_305	[p19l10t3404r129b3472],
6	not	RB	O	not	neg	7	SENT_305	[p19l146t3417r270b3472],
7	differ	VB	O	differ	_	0	SENT_305	[p19l288t3404r493b3472],
8	between	IN	O	between	_	0	SENT_305	[p19l508t3404r825b3472],
9	treatments	NNS	O	treatment	prep_between	7	SENT_305	[p19l842t3417r1251b3472],
10	in	IN	O	in	_	0	SENT_305	[p19l1272t3409r1348b3471],
11	the	DT	O	the	det	13	SENT_305	[p19l1365t3404r1483b3472],
12	nine	CD	NUMBER	nine	num	13	SENT_305	[p19l1502t3409r1671b3472],
13	participants	NNS	O	participant	prep_in	9	SENT_305	[p19l1690t3409r2138b3493],
14	with	IN	O	with	_	0	SENT_305	[p20l7t18r175b86],
15	the	DT	O	the	det	21	SENT_305	[p20l235t18r353b86],
16	Arg/Arg	NN	O	arg/arg	nn	21	SENT_305	[p20l415t23r734b107],
17	genotype	NN	O	genotype	nn	21	SENT_305	[p20l798t31r1138b107],
18	(	NN	O	(	nn	21	SENT_305	[p20l1207t18r1610b107],
19	difference	NN	O	difference	nn	21	SENT_305	[p20l1207t18r1610b107],
20	[	CD	NUMBER	[	num	21	SENT_305	[p20l1678t18r2142b106],
21	salmeterol	NN	O	salmeterol	prep_with	13	SENT_305	[p20l1678t18r2142b106],
22	—	CD	NUMBER	—	num	23	SENT_305	[p20l1678t18r2142b106],
23	placebo	NN	O	placebo	dobj	7	SENT_305	[p20l8t127r315b216],
24	]	CD	NUMBER	]	num	26	SENT_305	[p20l8t127r315b216],
25	-12	CD	NUMBER	-12	num	26	SENT_305	[p20l358t133r482b194],
26	L/min	NN	O	l/min	dep	23	SENT_305	[p20l530t132r785b216],
27	,	,	O	,	_	0	SENT_305	[p20l530t132r785b216],
28	p	NN	O	p	appos	23	SENT_305	[p20l829t132r1100b216],
29	=	JJ	O	=	amod	28	SENT_305	[p20l829t132r1100b216],
30	0-57	CD	NUMBER	0-57	tmod	29	SENT_305	[p20l829t132r1100b216],
31	and	CC	O	and	_	0	SENT_305	[p20l1141t127r1280b195],
32	-2	CD	NUMBER	-2	conj_and	30	SENT_305	[p20l1319t134r1494b194],
33	-2	CD	NUMBER	-2	num	34	SENT_305	[p20l1319t134r1494b194],
34	L/min	NN	O	l/min	dep	28	SENT_305	[p20l1542t132r1796b216],
35	,	,	O	,	_	0	SENT_305	[p20l1542t132r1796b216],
36	p	NN	O	p	appos	23	SENT_305	[p20l1842t133r2136b216],
37	=	JJ	O	=	amod	38	SENT_305	[p20l1842t133r2136b216],
38	0-92	CD	NUMBER	0-92	dep	36	SENT_305	[p20l1842t133r2136b216],
39	,	,	O	,	_	0	SENT_305	[p20l1842t133r2136b216],
40	respectively	RB	O	respectively	advmod	36	SENT_305	[p20l8t236r469b325],
41	;	:	O	;	_	0	SENT_305	[p20l8t236r469b325],
42	ﬁgure	NN	O	ﬁgure	dep	23	SENT_305	[p20l521t236r744b326],
43	5	CD	NUMBER	5	num	44	SENT_305	[p20l798t240r882b326],
44	)	NN	O	)	dep	42	SENT_305	[p20l798t240r882b326],
45	.	.	O	.	_	0	SENT_305	[p20l798t240r882b326],

1	Mean	NN	O	mean	nn	2	SENT_306	[p20l938t243r1148b304],
2	PEF	NN	O	pef	nsubj	11	SENT_306	[p20l1199t240r1348b303],
3	measured	VBN	O	measure	partmod	2	SENT_306	[p20l1399t236r1775b304],
4	at	IN	O	at	_	0	SENT_306	[p20l1824t249r1889b304],
5	clinic	NN	O	clinic	nn	6	SENT_306	[p20l1936t236r2140b304],
6	visits	NNS	O	visit	prep_at	3	SENT_306	[p20l7t351r199b415],
7	during	IN	O	during	_	0	SENT_306	[p20l290t347r546b436],
8	spirometry	NN	O	spirometry	prep_during	3	SENT_306	[p20l635t351r1050b436],
9	was	VBD	O	be	cop	11	SENT_306	[p20l1133t371r1273b415],
10	also	RB	O	also	advmod	11	SENT_306	[p20l1364t347r1509b415],
11	higher	JJR	O	higher	_	0	SENT_306	[p20l1596t347r1847b436],
12	when	WRB	O	when	advmod	13	SENT_306	[p20l1931t347r2140b415],
13	www	NN	O	www	advcl	11	SENT_306	[p20l724t616r1256b667],
14	.	.	O	.	_	0	SENT_306	[p20l724t616r1256b667],

1	the	DT	O	the	det	2	SENT_307	[p20l724t616r1256b667],
2	|	NN	O	|	_	0	SENT_307	[p20l724t616r1256b667],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_307	[p20l724t616r1256b667],
4	Vol	NNP	O	Vol	dep	2	SENT_307	[p20l1299t616r1386b667],
5	374	CD	NUMBER	374	num	6	SENT_307	[p20l1406t623r1508b675],
6	November	NNP	DATE	November	dep	2	SENT_307	[p20l1556t616r1849b667],
7	21,2009	CD	DATE	21,2009	num	6	SENT_307	[p20l1866t623r2110b676],

1	Articles	NNPS	O	Articles	_	0	SENT_308	[p20l6t883r156b919],
2	I	PRP	O	I	dep	1	SENT_308	[p20l204t751r252b919],

1	participants	NNS	O	participant	nsubjpass	3	SENT_309	[p20l8t1183r456b1267],
2	were	VBD	O	be	auxpass	3	SENT_309	[p20l511t1202r692b1246],
3	assigned	VBN	O	assign	dep	29	SENT_309	[p20l748t1178r1078b1268],
4	to	TO	O	to	_	0	SENT_309	[p20l1131t1191r1200b1246],
5	salmeterol	NN	O	salmeterol	prep_to	3	SENT_309	[p20l1259t1178r1654b1246],
6	than	IN	O	than	_	0	SENT_309	[p20l1708t1178r1879b1246],
7	when	WRB	O	when	advmod	15	SENT_309	[p20l1931t1178r2140b1246],
8	assigned	VBN	O	assign	csubj	15	SENT_309	[p20l10t1288r340b1378],
9	to	TO	O	to	_	0	SENT_309	[p20l415t1301r485b1355],
10	placebo	NN	O	placebo	prep_to	8	SENT_309	[p20l563t1288r849b1377],
11	in	IN	O	in	_	0	SENT_309	[p20l927t1292r1002b1354],
12	African-American	JJ	MISC	african-american	amod	14	SENT_309	[p20l1078t1288r1764b1355],
13	Gly/Gly	NN	O	gly/gly	nn	14	SENT_309	[p20l1844t1288r2142b1377],
14	participants	NNS	O	participant	prep_in	10	SENT_309	[p20l8t1401r456b1485],
15	(	VBP	O	(	prepc_than	3	SENT_309	[p20l495t1396r898b1486],
16	difference	NN	O	difference	nn	18	SENT_309	[p20l495t1396r898b1486],
17	39	CD	NUMBER	39	num	18	SENT_309	[p20l933t1403r1015b1465],
18	L/min	NN	O	l/min	dobj	15	SENT_309	[p20l1052t1401r1306b1485],
19	,	,	O	,	_	0	SENT_309	[p20l1052t1401r1306b1485],
20	p	NN	O	p	appos	18	SENT_309	[p20l1340t1402r1721b1486],
21	=	JJ	O	=	amod	23	SENT_309	[p20l1340t1402r1721b1486],
22	O-0016	NN	O	o-0016	nn	23	SENT_309	[p20l1340t1402r1721b1486],
23	)	NN	O	)	dep	20	SENT_309	[p20l1340t1402r1721b1486],
24	but	CC	O	but	dep	25	SENT_309	[p20l1756t1396r1883b1464],
25	not	RB	O	not	dep	15	SENT_309	[p20l1911t1410r2036b1464],
26	in	IN	O	in	dep	25	SENT_309	[p20l2065t1401r2140b1463],
27	Arg/Arg	NN	O	arg/arg	nn	28	SENT_309	[p20l7t1510r326b1595],
28	participants	NNS	O	participant	pobj	26	SENT_309	[p20l371t1510r818b1594],
29	(	VBP	O	(	_	0	SENT_309	[p20l872t1511r1064b1595],
30	-4	CD	NUMBER	-4	num	31	SENT_309	[p20l872t1511r1064b1595],
31	-8	CD	NUMBER	-8	dobj	29	SENT_309	[p20l872t1511r1064b1595],
32	L/min	NN	O	l/min	nsubj	29	SENT_309	[p20l1115t1510r1369b1594],
33	,	,	O	,	_	0	SENT_309	[p20l1115t1510r1369b1594],
34	p	NN	O	p	appos	32	SENT_309	[p20l1418t1509r1734b1595],
35	=	JJ	O	=	amod	37	SENT_309	[p20l1418t1509r1734b1595],
36	O-73	NN	O	o-73	nn	37	SENT_309	[p20l1418t1509r1734b1595],
37	)	NN	O	)	dep	34	SENT_309	[p20l1418t1509r1734b1595],
38	.	.	O	.	_	0	SENT_309	[p20l1418t1509r1734b1595],

1	Although	IN	O	although	mark	5	SENT_310	[p20l1782t1505r2140b1595],
2	these	DT	O	these	det	3	SENT_310	[p20l7t1615r206b1683],
3	subgroups	NNS	O	subgroup	nsubj	5	SENT_310	[p20l280t1615r675b1704],
4	were	VBD	O	be	cop	5	SENT_310	[p20l746t1639r926b1683],
5	small	JJ	O	small	advcl	28	SENT_310	[p20l1000t1615r1223b1693],
6	,	,	O	,	_	0	SENT_310	[p20l1000t1615r1223b1693],
7	the	DT	O	the	det	9	SENT_310	[p20l1296t1614r1413b1683],
8	genotype-speciﬁc	JJ	O	genotype-speciﬁc	amod	9	SENT_310	[p20l1486t1614r2140b1704],
9	differences	NNS	O	difference	dep	17	SENT_310	[p20l9t1723r426b1791],
10	in	IN	O	in	_	0	SENT_310	[p20l459t1728r535b1790],
11	morning	NN	TIME	morning	nn	12	SENT_310	[p20l566t1728r901b1813],
12	PEF	NN	O	pef	prep_in	9	SENT_310	[p20l937t1728r1085b1790],
13	(	CD	NUMBER	(	num	14	SENT_310	[p20l1125t1729r1446b1813],
14	p	NN	O	p	dep	17	SENT_310	[p20l1125t1729r1446b1813],
15	=	JJ	O	=	amod	17	SENT_310	[p20l1125t1729r1446b1813],
16	0-O9	NN	O	0-o9	nn	17	SENT_310	[p20l1125t1729r1446b1813],
17	)	NN	O	)	dep	28	SENT_310	[p20l1125t1729r1446b1813],
18	and	CC	O	and	_	0	SENT_310	[p20l1485t1723r1624b1791],
19	evening	NN	TIME	evening	nn	20	SENT_310	[p20l1655t1728r1953b1813],
20	PEF	NN	O	pef	dep	28	SENT_310	[p20l1989t1728r2136b1790],
21	(	CD	NUMBER	(	num	22	SENT_310	[p20l14t1838r177b1922],
22	p	NN	O	p	dep	17	SENT_310	[p20l14t1838r177b1922],
23	=	JJ	O	=	amod	24	SENT_310	[p20l14t1838r177b1922],
24	o	NN	O	o	dep	22	SENT_310	[p20l14t1838r177b1922],
25	-	:	O	-	_	0	SENT_310	[p20l196t1871r207b1883],
26	07	CD	DATE	07	dep	22	SENT_310	[p20l226t1836r328b1922],
27	)	NN	O	)	nsubj	28	SENT_310	[p20l226t1836r328b1922],
28	approached	VBD	O	approach	_	0	SENT_310	[p20l365t1832r804b1921],
29	signiﬁcance	NN	O	signiﬁcance	dobj	28	SENT_310	[p20l835t1832r1307b1922],
30	,	,	O	,	_	0	SENT_310	[p20l835t1832r1307b1922],
31	while	IN	O	while	mark	37	SENT_310	[p20l1338t1832r1544b1900],
32	the	DT	O	the	det	33	SENT_310	[p20l1572t1832r1690b1900],
33	differences	NNS	O	difference	nsubj	37	SENT_310	[p20l1722t1832r2137b1900],
34	in	IN	O	in	_	0	SENT_310	[p20l8t1946r84b2008],
35	clinic-measured	JJ	O	clinic-measured	amod	36	SENT_310	[p20l122t1942r731b2010],
36	PEF	NN	O	pef	prep_in	33	SENT_310	[p20l771t1946r919b2008],
37	reached	VBD	O	reach	advcl	28	SENT_310	[p20l960t1942r1257b2010],
38	signiﬁcance	NN	O	signiﬁcance	nn	40	SENT_310	[p20l1296t1941r1746b2031],
39	(	NN	O	(	nn	40	SENT_310	[p20l1790t1948r2136b2031],
40	p	NN	O	p	dobj	37	SENT_310	[p20l1790t1948r2136b2031],
41	=	JJ	O	=	amod	43	SENT_310	[p20l1790t1948r2136b2031],
42	O-02	NN	O	o-02	nn	43	SENT_310	[p20l1790t1948r2136b2031],
43	)	NN	O	)	dep	40	SENT_310	[p20l1790t1948r2136b2031],
44	.	.	O	.	_	0	SENT_310	[p20l1790t1948r2136b2031],

1	Differences	NNS	O	difference	nsubj	6	SENT_311	[p20l13t2052r444b2120],
2	in	IN	O	in	_	0	SENT_311	[p20l559t2056r634b2118],
3	responsiveness	NN	O	responsiveness	prep_in	1	SENT_311	[p20l746t2056r1321b2140],
4	to	TO	O	to	_	0	SENT_311	[p20l1435t2065r1505b2119],
5	methacholine	NN	O	methacholine	prep_to	3	SENT_311	[p20l1618t2051r2139b2120],
6	paralleled	VBD	O	parallel	_	0	SENT_311	[p20l8t2160r379b2249],
7	the	DT	O	the	det	9	SENT_311	[p20l406t2160r524b2228],
8	genotype-speciﬁc	JJ	O	genotype-speciﬁc	amod	9	SENT_311	[p20l555t2160r1209b2250],
9	trend	NN	O	trend	dobj	6	SENT_311	[p20l1236t2160r1440b2228],
10	seen	VBN	O	see	partmod	9	SENT_311	[p20l1471t2184r1640b2228],
11	in	IN	O	in	_	0	SENT_311	[p20l1668t2165r1744b2227],
12	the	DT	O	the	det	15	SENT_311	[p20l1771t2160r1889b2228],
13	entire	JJ	O	entire	amod	15	SENT_311	[p20l1920t2165r2139b2228],
14	study	NN	O	study	nn	15	SENT_311	[p20l11t2271r213b2360],
15	cohort	NN	O	cohort	prep_in	10	SENT_311	[p20l240t2271r499b2339],
16	.	.	O	.	_	0	SENT_311	[p20l240t2271r499b2339],

1	There	EX	O	there	expl	2	SENT_312	[p20l78t2379r297b2447],
2	were	VBD	O	be	_	0	SENT_312	[p20l359t2404r536b2447],
3	only	RB	O	only	advmod	2	SENT_312	[p20l601t2379r760b2468],
4	two	CD	NUMBER	two	num	6	SENT_312	[p20l820t2393r952b2447],
5	Asian	JJ	MISC	asian	amod	6	SENT_312	[p20l1015t2384r1230b2447],
6	participants	NNS	O	participant	pobj	3	SENT_312	[p20l1292t2384r1732b2468],
7	with	IN	O	with	_	0	SENT_312	[p20l1796t2379r1961b2447],
8	the	DT	O	the	det	10	SENT_312	[p20l2023t2379r2139b2447],
9	Arg/Arg	NN	O	arg/arg	nn	10	SENT_312	[p20l7t2494r322b2579],
10	genotype	NN	O	genotype	prep_with	3	SENT_312	[p20l349t2502r684b2579],
11	(	CD	NUMBER	(	npadvmod	12	SENT_312	[p20l717t2489r899b2579],
12	only	RB	O	only	advmod	3	SENT_312	[p20l717t2489r899b2579],
13	one	CD	NUMBER	one	nsubj	2	SENT_312	[p20l924t2513r1058b2556],
14	of	IN	O	of	_	0	SENT_312	[p20l1086t2489r1169b2556],
15	whom	WP	O	whom	nsubj	16	SENT_312	[p20l1180t2489r1418b2556],
16	completed	VBD	O	complete	prepc_of	13	SENT_312	[p20l1445t2489r1835b2578],
17	a	DT	O	a	det	18	SENT_312	[p20l1861t2513r1898b2556],
18	phase	NN	O	phase	dobj	16	SENT_312	[p20l1923t2489r2139b2578],
19	of	IN	O	of	_	0	SENT_312	[p20l10t2597r92b2666],
20	the	DT	O	the	det	22	SENT_312	[p20l146t2598r262b2666],
21	trial	NN	O	trial	nn	22	SENT_312	[p20l329t2598r525b2687],
22	)	NN	O	)	prep_of	18	SENT_312	[p20l329t2598r525b2687],
23	,	,	O	,	_	0	SENT_312	[p20l329t2598r525b2687],
24	and	CC	O	and	_	0	SENT_312	[p20l597t2598r735b2666],
25	one	CD	NUMBER	one	conj_and	18	SENT_312	[p20l802t2622r936b2666],
26	with	IN	O	with	_	0	SENT_312	[p20l1002t2597r1167b2666],
27	the	DT	O	the	det	29	SENT_312	[p20l1234t2598r1350b2666],
28	Gly/Gly	NNP	O	Gly/Gly	nn	29	SENT_312	[p20l1421t2598r1715b2687],
29	genotype	NN	O	genotype	prep_with	25	SENT_312	[p20l1782t2611r2135b2687],
30	.	.	O	.	_	0	SENT_312	[p20l1782t2611r2135b2687],

1	Additionally	RB	O	additionally	advmod	4	SENT_313	[p20l7t2706r475b2796],
2	,	,	O	,	_	0	SENT_313	[p20l7t2706r475b2796],
3	there	EX	O	there	expl	4	SENT_313	[p20l532t2706r723b2774],
4	were	VBD	O	be	_	0	SENT_313	[p20l777t2731r955b2774],
5	only	RB	O	only	quantmod	6	SENT_313	[p20l1011t2706r1170b2796],
6	four	CD	NUMBER	four	num	9	SENT_313	[p20l1223t2706r1381b2774],
7	Hispanic	JJ	MISC	hispanic	amod	9	SENT_313	[p20l1438t2711r1773b2795],
8	Arg/Arg	NN	O	arg/arg	nn	9	SENT_313	[p20l1826t2711r2140b2796],
9	participants	NNS	O	participant	nsubj	4	SENT_313	[p20l8t2821r448b2906],
10	and	CC	O	and	_	0	SENT_313	[p20l485t2817r623b2885],
11	ﬁve	NN	O	ﬁve	nsubj	4	SENT_313	[p20l655t2817r784b2885],
12	Hispanic	JJ	MISC	hispanic	amod	14	SENT_313	[p20l823t2821r1157b2906],
13	Gly/Gly	NN	O	gly/gly	nn	14	SENT_313	[p20l1193t2817r1487b2906],
14	participants	NNS	O	participant	dep	11	SENT_313	[p20l1518t2821r1979b2906],
15	.	.	O	.	_	0	SENT_313	[p20l1518t2821r1979b2906],

1	For	IN	O	for	_	0	SENT_314	[p20l2020t2821r2141b2885],
2	such	JJ	O	such	amod	4	SENT_314	[p20l11t2925r184b2993],
3	small	JJ	O	small	amod	4	SENT_314	[p20l211t2925r411b2993],
4	groups	NNS	O	group	prep_for	11	SENT_314	[p20l437t2950r713b3015],
5	,	,	O	,	_	0	SENT_314	[p20l437t2950r713b3015],
6	model-derived	JJ	O	model-derived	amod	7	SENT_314	[p20l742t2925r1278b2993],
7	estimates	NNS	O	estimate	nsubjpass	11	SENT_314	[p20l1303t2930r1654b2993],
8	could	MD	O	could	aux	11	SENT_314	[p20l1682t2925r1886b2993],
9	not	RB	O	not	neg	11	SENT_314	[p20l1909t2939r2031b2993],
10	be	VB	O	be	auxpass	11	SENT_314	[p20l2053t2925r2139b2993],
11	obtained	VBN	O	obtain	_	0	SENT_314	[p20l10t3035r351b3103],
12	.	.	O	.	_	0	SENT_314	[p20l10t3035r351b3103],

1	It	PRP	O	it	nsubj	4	SENT_315	[p20l413t3042r468b3103],
2	is	VBZ	O	be	cop	4	SENT_315	[p20l520t3040r578b3103],
3	more	RBR	O	more	advmod	4	SENT_315	[p20l635t3060r831b3103],
4	appropriate	JJ	O	appropriate	_	0	SENT_315	[p20l887t3040r1315b3124],
5	to	TO	O	to	aux	6	SENT_315	[p20l1369t3049r1437b3103],
6	assess	VB	O	assess	xcomp	4	SENT_315	[p20l1494t3059r1721b3103],
7	genotypespeciﬁc	NN	O	genotypespeciﬁc	nn	8	SENT_315	[p20l1779t3049r2138b3125, p20l11t3145r288b3234],
8	differences	NNS	O	difference	dobj	6	SENT_315	[p20l340t3145r749b3212],
9	within	IN	O	within	_	0	SENT_315	[p20l801t3145r1044b3213],
10	ethnic	JJ	O	ethnic	amod	11	SENT_315	[p20l1096t3145r1327b3212],
11	groups	NNS	O	group	prep_within	6	SENT_315	[p20l1380t3169r1634b3235],
12	if	IN	O	if	mark	20	SENT_315	[p20l1688t3145r1752b3211],
13	suﬂ	NN	O	suﬂ	npadvmod	15	SENT_315	[p20l1793t3145r2141b3212],
14	‘	CD	NUMBER	‘	num	13	SENT_315	[p20l1793t3145r2141b3212],
15	1cient	JJ	O	1cient	amod	16	SENT_315	[p20l1793t3145r2141b3212],
16	numbers	NNS	O	number	nsubj	20	SENT_315	[p20l8t3253r346b3321],
17	of	IN	O	of	_	0	SENT_315	[p20l375t3253r458b3321],
18	participants	NNS	O	participant	prep_of	16	SENT_315	[p20l470t3258r910b3342],
19	are	VBP	O	be	cop	20	SENT_315	[p20l939t3278r1051b3321],
20	available	JJ	O	available	ccomp	4	SENT_315	[p20l1078t3253r1398b3322],
21	for	IN	O	for	_	0	SENT_315	[p20l1424t3253r1531b3321],
22	analysis	NN	O	analysis	prep_for	20	SENT_315	[p20l1556t3253r1868b3343],
23	.	.	O	.	_	0	SENT_315	[p20l1556t3253r1868b3343],

1	There	EX	O	there	expl	2	SENT_316	[p20l78t3362r299b3430],
2	were	VBD	O	be	_	0	SENT_316	[p20l361t3386r541b3430],
3	no	DT	O	no	det	7	SENT_316	[p20l604t3386r698b3430],
4	other	JJ	O	other	amod	7	SENT_316	[p20l762t3362r961b3430],
5	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_316	[p20l1025t3362r1424b3452],
6	genotype-speciﬁc	NN	O	genotype-speciﬁc	nn	7	SENT_316	[p20l1486t3362r2140b3452],
7	differences	NNS	O	difference	nsubj	2	SENT_316	[p20l9t3472r426b3539],
8	in	IN	O	in	_	0	SENT_316	[p20l469t3476r545b3538],
9	other	JJ	O	other	amod	10	SENT_316	[p20l587t3472r785b3539],
10	subgroups	NNS	O	subgroup	prep_in	2	SENT_316	[p20l828t3472r1223b3562],
11	analysed	VBN	O	analyse	partmod	10	SENT_316	[p20l1269t3472r1614b3561],
12	,	,	O	,	_	0	SENT_316	[p20l1269t3472r1614b3561],
13	including	VBG	O	include	prep	2	SENT_316	[p20l1659t3472r2024b3562],
14	in	IN	O	in	pcomp	13	SENT_316	[p20l2065t3476r2140b3538],
15	preplanned	JJ	O	preplanned	amod	16	SENT_316	[p20l8t3580r443b3669],
16	subanalyses	NNS	O	subanalys	pobj	14	SENT_316	[p20l465t3580r915b3670],
17	of	IN	O	of	_	0	SENT_316	[p20l939t3580r1023b3648],
18	those	DT	O	those	prep_of	16	SENT_316	[p20l1029t3580r1231b3648],
19	who	WP	O	who	nsubj	20	SENT_316	[p20l1251t3580r1409b3649],
20	reversed	VBD	O	reverse	rcmod	18	SENT_316	[p20l1431t3580r1751b3649],
21	by	IN	O	by	_	0	SENT_316	[p20l1769t3580r1856b3670],
22	greater	JJR	O	greater	amod	66	SENT_316	[p20l1876t3594r2141b3670],
23	than	IN	O	than	mark	62	SENT_316	[p20l7t3690r178b3758],
24	or	CC	O	or	_	0	SENT_316	[p20l217t3714r294b3758],
25	less	JJR	O	less	nsubj	62	SENT_316	[p20l329t3690r468b3758],
26	than	IN	O	than	_	0	SENT_316	[p20l507t3690r678b3758],
27	12	CD	PERCENT	12	num	28	SENT_316	[p20l718t3695r870b3761],
28	%	NN	PERCENT	%	prep_than	25	SENT_316	[p20l718t3695r870b3761],
29	with	IN	O	with	_	0	SENT_316	[p20l907t3690r1075b3758],
30	salbutamol	NN	O	salbutamol	prep_with	28	SENT_316	[p20l1114t3690r1552b3768],
31	,	,	O	,	_	0	SENT_316	[p20l1114t3690r1552b3768],
32	or	CC	O	or	_	0	SENT_316	[p20l1595t3714r1672b3758],
33	in	IN	O	in	_	0	SENT_316	[p20l1708t3695r1783b3757],
34	post-hoc	JJ	O	post-hoc	amod	35	SENT_316	[p20l1820t3690r2140b3779],
35	subanalyses	NNS	O	subanalys	prep_in	25	SENT_316	[p21l11t18r461b107],
36	including	VBG	O	include	_	0	SENT_316	[p21l510t18r875b107],
37	only	RB	O	only	advmod	38	SENT_316	[p21l922t18r1083b107],
38	those	DT	O	those	prep_including	35	SENT_316	[p21l1126t18r1329b86],
39	who	WP	O	who	nsubj	40	SENT_316	[p21l1375t18r1533b86],
40	completed	VBD	O	complete	rcmod	38	SENT_316	[p21l1582t18r1977b106],
41	the	DT	O	the	det	43	SENT_316	[p21l2021t18r2139b86],
42	entire	JJ	O	entire	amod	43	SENT_316	[p21l10t131r229b194],
43	trial	NN	O	trial	dobj	40	SENT_316	[p21l285t126r457b204],
44	,	,	O	,	_	0	SENT_316	[p21l285t126r457b204],
45	those	DT	O	those	conj_or	25	SENT_316	[p21l515t126r718b194],
46	who	WP	O	who	nsubj	47	SENT_316	[p21l773t126r932b194],
47	were	VBD	O	be	rcmod	45	SENT_316	[p21l987t151r1168b194],
48	on	IN	O	on	_	0	SENT_316	[p21l1226t151r1320b194],
49	a	DT	O	a	det	50	SENT_316	[p21l1377t151r1414b194],
50	controller	NN	O	controller	prep_on	47	SENT_316	[p21l1472t126r1841b194],
51	within	IN	O	within	_	0	SENT_316	[p21l1894t126r2140b194],
52	6	CD	DURATION	6	num	53	SENT_316	[p21l10t241r49b303],
53	weeks	NNS	NUMBER	week	prep_within	50	SENT_316	[p21l77t235r305b303],
54	of	IN	O	of	_	0	SENT_316	[p21l338t235r421b303],
55	study	NN	O	study	nn	56	SENT_316	[p21l440t235r643b324],
56	initiation	NN	O	initiation	prep_of	53	SENT_316	[p21l669t240r1038b313],
57	,	,	O	,	_	0	SENT_316	[p21l669t240r1038b313],
58	or	CC	O	or	_	0	SENT_316	[p21l1071t259r1148b303],
59	men	NNS	O	man	nsubj	62	SENT_316	[p21l1175t259r1347b303],
60	versus	CC	O	versus	prep	59	SENT_316	[p21l1373t259r1615b303],
61	women	NNS	O	woman	dep	60	SENT_316	[p21l1644t259r1927b303],
62	(	VBP	O	(	ccomp	22	SENT_316	[p21l1962t235r2140b325],
63	data	NNS	O	datum	dobj	62	SENT_316	[p21l1962t235r2140b325],
64	not	RB	O	not	neg	65	SENT_316	[p21l8t359r133b414],
65	shown	VBN	O	show	partmod	63	SENT_316	[p21l161t346r455b435],
66	)	NN	O	)	prep_by	20	SENT_316	[p21l161t346r455b435],
67	.	.	O	.	_	0	SENT_316	[p21l161t346r455b435],

1	Discussion	NN	O	discussion	_	0	SENT_317	[p21l14t557r467b634],

1	Over	IN	O	over	_	0	SENT_318	[p21l11t681r189b743],
2	the	DT	DATE	the	det	4	SENT_318	[p21l225t675r341b743],
3	past	JJ	DATE	past	amod	4	SENT_318	[p21l380t688r533b764],
4	decade	NN	DATE	decade	prep_over	9	SENT_318	[p21l571t675r844b753],
5	,	,	O	,	_	0	SENT_318	[p21l571t675r844b753],
6	several	JJ	O	several	amod	7	SENT_318	[p21l888t675r1142b743],
7	studies	NNS	O	study	nsubj	9	SENT_318	[p21l1183t675r1442b743],
8	have	VBP	O	have	aux	9	SENT_318	[p21l1483t675r1653b743],
9	investigated	VBN	O	investigate	_	0	SENT_318	[p21l1692t675r2141b765],
10	the	DT	O	the	det	11	SENT_318	[p21l7t785r124b853],
11	effect	NN	O	effect	dobj	9	SENT_318	[p21l186t785r388b853],
12	of	IN	O	of	_	0	SENT_318	[p21l448t785r531b852],
13	speciﬁc	NN	O	speciﬁc	nn	14	SENT_318	[p21l581t785r858b874],
14	mutations	NNS	O	mutation	prep_of	11	SENT_318	[p21l918t790r1297b853],
15	of	IN	O	of	_	0	SENT_318	[p21l1362t785r1445b853],
16	the	DT	O	the	det	19	SENT_318	[p21l1491t785r1607b853],
17	B-adrenergic	JJ	MISC	b-adrenergic	amod	19	SENT_318	[p21l1674t785r2140b875],
18	receptor	NN	O	receptor	nn	19	SENT_318	[p21l8t907r317b982],
19	gene	NN	O	gene	prep_of	14	SENT_318	[p21l356t918r531b983],
20	on	IN	O	on	_	0	SENT_318	[p21l573t918r667b961],
21	response	NN	O	response	prep_on	19	SENT_318	[p21l707t918r1040b982],
22	to	TO	O	to	_	0	SENT_318	[p21l1080t907r1149b961],
23	[	CD	NUMBER	[	number	24	SENT_318	[p21l1196t893r1259b981],
24	3	CD	NUMBER	3	prep_to	9	SENT_318	[p21l1196t893r1259b981],
25	,	,	O	,	_	0	SENT_318	[p21l1196t893r1259b981],
26	agonists	NNS	O	agonist	xcomp	9	SENT_318	[p21l1301t897r1685b983],
27	.	.	O	.	_	0	SENT_318	[p21l1301t897r1685b983],

1	“	NN	O	“	nn	2	SENT_319	[p21l1301t897r1685b983],
2	A	NN	O	a	_	0	SENT_319	[p21l1722t899r1782b960],
3	previous	JJ	O	previous	amod	5	SENT_319	[p21l1820t898r2137b982],
4	retrospective	JJ	O	retrospective	amod	5	SENT_319	[p21l8t1007r485b1091],
5	analysis	NN	O	analysis	nsubj	9	SENT_319	[p21l545t1002r837b1091],
6	of	IN	O	of	_	0	SENT_319	[p21l898t1002r981b1070],
7	ACRN	NN	O	acrn	nn	8	SENT_319	[p21l1024t1007r1265b1070],
8	trials	NNS	O	trial	prep_of	5	SENT_319	[p21l1324t1002r1508b1070],
9	suggested	VBD	O	suggest	rcmod	2	SENT_319	[p21l1571t1002r1941b1092],
10	that	IN	O	that	complm	20	SENT_319	[p21l1996t1002r2141b1070],
11	individuals	NNS	O	individual	nsubj	20	SENT_319	[p21l8t1112r420b1180],
12	with	IN	O	with	_	0	SENT_319	[p21l441t1112r607b1180],
13	the	DT	O	the	det	17	SENT_319	[p21l626t1112r742b1179],
14	ADRB2	NN	O	adrb2	nn	17	SENT_319	[p21l762t1117r1052b1178],
15	B16	NN	O	b16	nn	17	SENT_319	[p21l1072t1118r1202b1179],
16	Arg/Arg	NN	O	arg/arg	nn	17	SENT_319	[p21l1223t1117r1537b1202],
17	genotype	NN	O	genotype	prep_with	11	SENT_319	[p21l1559t1125r1894b1202],
18	might	MD	O	might	aux	20	SENT_319	[p21l1915t1112r2141b1202],
19	not	RB	O	not	neg	20	SENT_319	[p21l8t1234r131b1288],
20	beneﬁt	VB	O	beneﬁt	ccomp	9	SENT_319	[p21l164t1220r425b1288],
21	from	IN	O	from	_	0	SENT_319	[p21l458t1220r642b1288],
22	treatment	NN	O	treatment	prep_from	20	SENT_319	[p21l676t1234r1045b1288],
23	with	IN	O	with	_	0	SENT_319	[p21l1077t1220r1242b1288],
24	longacting	VBG	O	longact	prepc_with	20	SENT_319	[p21l1276t1220r1671b1310],
25	[	NN	O	[	dobj	24	SENT_319	[p21l1711t1220r1774b1308],
26	3	CD	NUMBER	3	num	25	SENT_319	[p21l1711t1220r1774b1308],
27	,	,	O	,	_	0	SENT_319	[p21l1711t1220r1774b1308],
28	agonists	NNS	O	agonist	appos	25	SENT_319	[p21l1810t1225r2136b1310],
29	,	,	O	,	_	0	SENT_319	[p21l1810t1225r2136b1310],
30	with	IN	O	with	_	0	SENT_319	[p21l7t1329r172b1397],
31	or	CC	O	or	_	0	SENT_319	[p21l197t1353r274b1397],
32	without	IN	O	without	_	0	SENT_319	[p21l295t1329r585b1397],
33	inhaled	VBN	O	inhale	prepc_without	24	SENT_319	[p21l609t1329r889b1397],
34	corticosteroids	NNS	O	corticosteroid	dobj	33	SENT_319	[p21l913t1329r1504b1397],
35	?	.	O	?	_	0	SENT_319	[p21l913t1329r1504b1397],

1	However	RB	O	however	advmod	26	SENT_320	[p21l1533t1336r1875b1407],
2	,	,	O	,	_	0	SENT_320	[p21l1533t1336r1875b1407],
3	in	IN	O	in	_	0	SENT_320	[p21l1903t1334r1978b1396],
4	this	DT	O	this	det	9	SENT_320	[p21l2001t1329r2137b1397],
5	prospective	JJ	O	prospective	amod	9	SENT_320	[p21l8t1444r451b1529],
6	,	,	O	,	_	0	SENT_320	[p21l8t1444r451b1529],
7	randomised	JJ	O	randomised	amod	9	SENT_320	[p21l487t1440r937b1508],
8	controlled	JJ	O	controlled	amod	9	SENT_320	[p21l969t1440r1345b1508],
9	trial	NN	O	trial	prep_in	26	SENT_320	[p21l1375t1440r1543b1518],
10	,	,	O	,	_	0	SENT_320	[p21l1375t1440r1543b1518],
11	the	DT	O	the	det	12	SENT_320	[p21l1578t1440r1695b1508],
12	addition	NN	O	addition	appos	9	SENT_320	[p21l1729t1440r2036b1508],
13	of	IN	O	of	_	0	SENT_320	[p21l2070t1440r2153b1508],
14	a	DT	O	a	det	16	SENT_320	[p21l10t1573r47b1616],
15	longacting	VBG	O	longact	amod	16	SENT_320	[p21l102t1548r497b1638],
16	[	NN	O	[	prep_of	12	SENT_320	[p21l559t1548r621b1636],
17	3	CD	NUMBER	3	dep	16	SENT_320	[p21l559t1548r621b1636],
18	,	,	O	,	_	0	SENT_320	[p21l559t1548r621b1636],
19	agonist	NN	O	agonist	nsubj	26	SENT_320	[p21l680t1553r951b1638],
20	to	TO	O	to	aux	21	SENT_320	[p21l1005t1562r1075b1616],
21	inhaled	VBN	O	inhale	infmod	19	SENT_320	[p21l1133t1548r1413b1616],
22	corticosteroid	NN	O	corticosteroid	dobj	21	SENT_320	[p21l1470t1548r1979b1616],
23	for	IN	O	for	_	0	SENT_320	[p21l2035t1548r2141b1616],
24	18	CD	DURATION	18	num	25	SENT_320	[p21l12t1663r85b1725],
25	weeks	NNS	NUMBER	week	prep_for	22	SENT_320	[p21l143t1657r369b1725],
26	produced	VBD	O	produce	_	0	SENT_320	[p21l429t1657r782b1746],
27	similar	JJ	O	similar	amod	28	SENT_320	[p21l841t1657r1104b1725],
28	improvements	NNS	O	improvement	dobj	26	SENT_320	[p21l1161t1662r1705b1746],
29	in	IN	O	in	_	0	SENT_320	[p21l1766t1662r1841b1724],
30	airway	NN	O	airway	nn	31	SENT_320	[p21l1900t1662r2142b1747],
31	function	NN	O	function	prep_in	26	SENT_320	[p21l9t1767r326b1834],
32	as	IN	O	as	mark	33	SENT_320	[p21l361t1791r433b1834],
33	shown	VBN	O	show	advcl	26	SENT_320	[p21l472t1767r716b1835],
34	by	IN	O	by	_	0	SENT_320	[p21l749t1767r836b1856],
35	morning	NN	TIME	morning	nn	36	SENT_320	[p21l868t1771r1198b1857],
36	PEF	NN	O	pef	prep_by	33	SENT_320	[p21l1236t1771r1383b1833],
37	in	IN	O	in	_	0	SENT_320	[p21l1420t1771r1495b1833],
38	individuals	NNS	O	individual	prep_in	33	SENT_320	[p21l1529t1767r1940b1835],
39	with	IN	O	with	_	0	SENT_320	[p21l1975t1767r2140b1835],
40	the	DT	O	the	det	42	SENT_320	[p21l7t1875r123b1943],
41	B16	NN	O	b16	nn	42	SENT_320	[p21l148t1881r277b1943],
42	Arg/Arg	NN	O	arg/arg	prep_with	33	SENT_320	[p21l296t1881r610b1965],
43	and	CC	O	and	_	0	SENT_320	[p21l630t1875r768b1943],
44	B16	NN	O	b16	nn	46	SENT_320	[p21l790t1881r919b1943],
45	Gly/Gly	NN	O	gly/gly	nn	46	SENT_320	[p21l943t1875r1236b1965],
46	genotypes	NNS	O	genotype	prep_with	33	SENT_320	[p21l1255t1889r1647b1965],
47	.	.	O	.	_	0	SENT_320	[p21l1255t1889r1647b1965],

1	Additionally	RB	O	additionally	advmod	6	SENT_321	[p21l1669t1875r2136b1965],
2	,	,	O	,	_	0	SENT_321	[p21l1669t1875r2136b1965],
3	PEF	NN	O	pef	nsubj	6	SENT_321	[p21l13t1988r159b2051],
4	did	VBD	O	do	aux	6	SENT_321	[p21l203t1984r321b2052],
5	not	RB	O	not	neg	6	SENT_321	[p21l360t1997r482b2052],
6	decline	VB	O	decline	_	0	SENT_321	[p21l522t1984r787b2052],
7	during	IN	O	during	_	0	SENT_321	[p21l829t1984r1081b2074],
8	the	DT	O	the	det	10	SENT_321	[p21l1119t1984r1235b2052],
9	run-out	NN	O	run-out	nn	10	SENT_321	[p21l1276t1997r1559b2052],
10	period	NN	O	period	prep_during	6	SENT_321	[p21l1597t1984r1855b2073],
11	,	,	O	,	_	0	SENT_321	[p21l1597t1984r1855b2073],
12	as	IN	O	as	mark	15	SENT_321	[p21l1899t2008r1971b2052],
13	has	VBZ	O	have	aux	15	SENT_321	[p21l2012t1984r2137b2052],
14	been	VBN	O	be	auxpass	15	SENT_321	[p21l7t2094r188b2161],
15	seen	VBN	O	see	advcl	6	SENT_321	[p21l221t2118r388b2161],
16	in	IN	O	in	_	0	SENT_321	[p21l419t2098r493b2160],
17	trials	NNS	O	trial	prep_in	15	SENT_321	[p21l523t2093r706b2161],
18	with	IN	O	with	_	0	SENT_321	[p21l738t2094r904b2161],
19	shortacting	VBG	O	shortact	prepc_with	15	SENT_321	[p21l937t2094r1355b2183],
20	8	CD	NUMBER	8	dobj	19	SENT_321	[p21l1391t2093r1454b2181],
21	,	,	O	,	_	0	SENT_321	[p21l1391t2093r1454b2181],
22	agonists	NNS	O	agonist	appos	20	SENT_321	[p21l1486t2098r1889b2184],
23	.	.	O	.	_	0	SENT_321	[p21l1486t2098r1889b2184],

1	”	NN	O	”	_	0	SENT_322	[p21l1486t2098r1889b2184],
2	These	DT	O	these	det	3	SENT_322	[p21l1917t2094r2139b2162],
3	ﬁndings	NNS	O	ﬁndings	nsubj	5	SENT_322	[p21l8t2202r316b2292],
4	are	VBP	O	be	cop	5	SENT_322	[p21l343t2227r454b2270],
5	reassuring	VBG	O	reassure	rcmod	1	SENT_322	[p21l479t2207r876b2292],
6	and	CC	O	and	_	0	SENT_322	[p21l901t2202r1038b2270],
7	accord	NN	O	accord	rcmod	1	SENT_322	[p21l1062t2202r1304b2270],
8	with	IN	O	with	_	0	SENT_322	[p21l1325t2202r1490b2271],
9	those	DT	O	those	prep_with	7	SENT_322	[p21l1513t2202r1712b2270],
10	from	IN	O	from	_	0	SENT_322	[p21l1736t2202r1921b2270],
11	other	JJ	O	other	amod	13	SENT_322	[p21l1946t2202r2141b2270],
12	retrospective	JJ	O	retrospective	amod	13	SENT_322	[p21l9t2316r485b2400],
13	studies	NNS	O	study	prep_from	9	SENT_322	[p21l522t2311r781b2379],
14	that	WDT	O	that	nsubj	38	SENT_322	[p21l816t2311r961b2379],
15	generally	RB	O	generally	advmod	16	SENT_322	[p21l994t2311r1334b2401],
16	failed	VBD	O	fail	rcmod	7	SENT_322	[p21l1366t2311r1572b2379],
17	to	TO	O	to	aux	18	SENT_322	[p21l1603t2324r1672b2379],
18	show	VB	O	show	xcomp	16	SENT_322	[p21l1709t2311r1903b2379],
19	a	DT	O	a	det	22	SENT_322	[p21l1935t2335r1972b2379],
20	B16	NN	O	b16	nn	22	SENT_322	[p21l2009t2317r2138b2379],
21	genotype-speciﬁc	NN	O	genotype-speciﬁc	nn	22	SENT_322	[p21l10t2420r653b2510],
22	difference	NN	O	difference	dobj	18	SENT_322	[p21l749t2421r1122b2489],
23	in	IN	O	in	_	0	SENT_322	[p21l1217t2425r1291b2487],
24	PEF	NN	O	pef	nn	27	SENT_322	[p21l1390t2425r1537b2487],
25	and	CC	O	and	_	0	SENT_322	[p21l1635t2421r1773b2489],
26	asthma	NN	O	asthma	nn	27	SENT_322	[p21l1867t2421r2140b2489],
27	symptoms	NNS	O	symptom	prep_in	22	SENT_322	[p21l11t2543r397b2619],
28	with	IN	O	with	_	0	SENT_322	[p21l432t2529r596b2598],
29	combined	VBN	O	combine	amod	30	SENT_322	[p21l631t2529r1005b2597],
30	use	NN	O	use	prep_with	18	SENT_322	[p21l1036t2554r1163b2597],
31	of	IN	O	of	_	0	SENT_322	[p21l1199t2529r1282b2597],
32	longacting	VBG	O	longact	prepc_of	30	SENT_322	[p21l1302t2529r1696b2619],
33	[	NN	O	[	dobj	32	SENT_322	[p21l1735t2529r1798b2617],
34	3	CD	NUMBER	3	num	33	SENT_322	[p21l1735t2529r1798b2617],
35	,	,	O	,	_	0	SENT_322	[p21l1735t2529r1798b2617],
36	agonists	NNS	O	agonist	appos	33	SENT_322	[p21l1832t2534r2137b2619],
37	and	CC	O	and	_	0	SENT_322	[p21l9t2638r147b2706],
38	inhaled	VBD	O	inhale	conj_and	16	SENT_322	[p21l172t2638r452b2706],
39	corticosteroidsfg	NN	O	corticosteroidsfg	nn	40	SENT_322	[p21l478t2638r1138b2706],
40	”	NN	O	”	dobj	38	SENT_322	[p21l478t2638r1138b2706],

1	A	DT	O	a	det	3	SENT_323	[p21l78t2753r138b2814],
2	genotype-speciﬁc	JJ	O	genotype-speciﬁc	amod	3	SENT_323	[p21l189t2748r827b2838],
3	eﬁect	NN	O	eﬁect	nsubj	14	SENT_323	[p21l879t2748r1080b2815],
4	was	VBD	O	be	auxpass	5	SENT_323	[p21l1128t2772r1266b2815],
5	noted	VBN	O	note	rcmod	3	SENT_323	[p21l1320t2748r1530b2815],
6	in	IN	O	in	_	0	SENT_323	[p21l1580t2752r1654b2814],
7	one	CD	NUMBER	one	prep_in	5	SENT_323	[p21l1706t2772r1840b2815],
8	of	IN	O	of	_	0	SENT_323	[p21l1893t2748r1975b2815],
9	our	PRP$	O	we	poss	13	SENT_323	[p21l2015t2772r2141b2815],
10	prespeciﬁed	JJ	O	prespeciﬁed	amod	13	SENT_323	[p21l8t2856r459b2945],
11	secondary	JJ	O	secondary	amod	13	SENT_323	[p21l481t2856r852b2946],
12	outcome	NN	O	outcome	nn	13	SENT_323	[p21l871t2870r1192b2924],
13	variables	NNS	O	variable	prep_of	7	SENT_323	[p21l1211t2856r2140b2925],
14	—	VBP	O	—	_	0	SENT_323	[p21l1211t2856r2140b2925],
15	methacholine	JJ	O	methacholine	amod	16	SENT_323	[p21l1211t2856r2140b2925],
16	PCZO	NN	O	pczo	dobj	14	SENT_323	[p21l13t2970r181b3050],
17	.	.	O	.	_	0	SENT_323	[p21l13t2970r181b3050],

1	The	DT	O	the	det	3	SENT_324	[p21l216t2965r359b3033],
2	discrepant	JJ	O	discrepant	amod	3	SENT_324	[p21l393t2965r780b3054],
3	effects	NNS	O	effect	nsubjpass	19	SENT_324	[p21l812t2965r1046b3033],
4	of	IN	O	of	_	0	SENT_324	[p21l1083t2965r1165b3033],
5	longacting	VBG	O	longact	prepc_of	3	SENT_324	[p21l1183t2965r1575b3055],
6	B	NN	O	b	dobj	5	SENT_324	[p21l1612t2965r1674b3052],
7	,	,	O	,	_	0	SENT_324	[p21l1612t2965r1674b3052],
8	agonists	NNS	O	agonist	appos	6	SENT_324	[p21l1709t2970r2011b3055],
9	on	IN	O	on	_	0	SENT_324	[p21l2048t2989r2140b3033],
10	airway	NN	O	airway	nn	11	SENT_324	[p21l10t3080r250b3165],
11	function	NN	O	function	prep_on	8	SENT_324	[p21l299t3076r614b3144],
12	compared	VBN	O	compare	_	0	SENT_324	[p21l665t3076r1035b3165],
13	with	IN	O	with	prepc_compared_with	5	SENT_324	[p21l1083t3076r1247b3144],
14	airway	NN	O	airway	nn	15	SENT_324	[p21l1299t3080r1539b3165],
15	reactivity	NN	O	reactivity	pobj	5	SENT_324	[p21l1588t3080r1923b3165],
16	have	VBP	O	have	aux	19	SENT_324	[p21l1971t3076r2140b3144],
17	been	VBN	O	be	auxpass	19	SENT_324	[p21l7t3184r187b3252],
18	previously	RB	DATE	previously	advmod	19	SENT_324	[p21l218t3184r601b3274],
19	noted	VBN	O	note	_	0	SENT_324	[p21l631t3184r906b3252],
20	.	.	O	.	_	0	SENT_324	[p21l631t3184r906b3252],

1	”	NN	O	”	nsubj	27	SENT_325	[p21l631t3184r906b3252],
2	Furthermore	RB	O	furthermore	advmod	27	SENT_325	[p21l942t3184r1435b3263],
3	,	,	O	,	_	0	SENT_325	[p21l942t3184r1435b3263],
4	B16	NNP	O	B16	nn	5	SENT_325	[p21l1474t3190r1603b3252],
5	Arg	NN	O	arg	nsubjpass	8	SENT_325	[p21l1636t3190r1773b3274],
6	has	VBZ	O	have	aux	8	SENT_325	[p21l1803t3184r1928b3252],
7	been	VBN	O	be	auxpass	8	SENT_325	[p21l1961t3184r2140b3252],
8	associated	VBN	O	associate	parataxis	27	SENT_325	[p21l10t3293r386b3361],
9	with	IN	O	with	_	0	SENT_325	[p21l407t3293r571b3361],
10	greater	JJR	O	greater	amod	11	SENT_325	[p21l597t3306r856b3383],
11	decreases	NNS	O	decrease	prep_with	8	SENT_325	[p21l879t3293r1230b3361],
12	in	IN	O	in	_	0	SENT_325	[p21l1257t3298r1331b3360],
13	bronchoprotection	NN	O	bronchoprotection	prep_in	11	SENT_325	[p21l1353t3293r2043b3382],
14	in	IN	O	in	_	0	SENT_325	[p21l2067t3298r2141b3360],
15	response	NN	O	response	prep_in	13	SENT_325	[p21l9t3427r340b3492],
16	to	TO	O	to	_	0	SENT_325	[p21l377t3416r445b3471],
17	regular	JJ	O	regular	amod	18	SENT_325	[p21l484t3403r751b3493],
18	use	NN	O	use	prep_to	8	SENT_325	[p21l786t3427r912b3471],
19	of	IN	O	of	_	0	SENT_325	[p21l952t3403r1034b3470],
20	a	DT	O	a	det	22	SENT_325	[p21l1060t3427r1097b3471],
21	longacting	VBG	O	longact	amod	22	SENT_325	[p21l1133t3403r1525b3493],
22	[	NN	O	[	prep_of	18	SENT_325	[p21l1567t3403r1629b3490],
23	3	CD	NUMBER	3	dep	22	SENT_325	[p21l1567t3403r1629b3490],
24	,	,	O	,	_	0	SENT_325	[p21l1567t3403r1629b3490],
25	agonist	NN	O	agonist	nsubj	27	SENT_325	[p21l1668t3408r1938b3493],
26	than	IN	O	than	advmod	27	SENT_325	[p21l1972t3403r2140b3470],
27	has	VBZ	O	have	_	0	SENT_325	[p21l7t3511r132b3579],
28	B16	NN	O	b16	nn	29	SENT_325	[p21l179t3517r308b3579],
29	Gly	NN	O	gly	dobj	27	SENT_325	[p21l353t3511r533b3601],
30	.	.	O	.	_	0	SENT_325	[p21l353t3511r533b3601],

1	“	NN	O	“	_	0	SENT_326	[p21l353t3511r533b3601],
2	In	IN	O	in	dep	1	SENT_326	[p21l578t3518r656b3578],
3	all	DT	O	all	predet	5	SENT_326	[p21l697t3511r782b3579],
4	these	DT	O	these	det	5	SENT_326	[p21l821t3511r1015b3579],
5	cases	NNS	O	case	pobj	2	SENT_326	[p21l1058t3536r1267b3589],
6	,	,	O	,	_	0	SENT_326	[p21l1058t3536r1267b3589],
7	the	DT	O	the	det	10	SENT_326	[p21l1311t3511r1427b3579],
8	bronchoprotective	JJ	O	bronchoprotective	amod	10	SENT_326	[p21l1467t3511r2140b3600],
9	www.thelancet.com	NNP	O	www.thelancet.com	nn	10	SENT_326	[p22l7t97r540b149],
10	Vol	NNP	O	Vol	appos	5	SENT_326	[p22l583t97r670b149],
11	374	CD	NUMBER	374	num	10	SENT_326	[p22l689t104r792b156],
12	November	NNP	DATE	November	tmod	10	SENT_326	[p22l840t97r1133b149],
13	21,2009	CD	DATE	21,2009	num	12	SENT_326	[p22l1150t104r1394b157],

1	A	DT	O	a	_	0	SENT_327	[p22l138t338r173b378],

1	p	NN	O	p	_	0	SENT_328	[p22l1075t412r1244b456],
2	=	JJ	O	=	amod	1	SENT_328	[p22l1075t412r1244b456],
3	0-0038	CD	NUMBER	0-0038	tmod	2	SENT_328	[p22l1075t412r1244b456],

1	p	NN	O	p	nsubj	2	SENT_329	[p22l592t528r715b572],
2	=	JJ	O	=	_	0	SENT_329	[p22l592t528r715b572],
3	O_87	NN	O	o_87	nn	4	SENT_329	[p22l592t528r715b572],
4	p	NN	O	p	dobj	2	SENT_329	[p22l1520t533r1688b572],
5	<	VBG	O	<	partmod	4	SENT_329	[p22l1520t533r1688b572],
6	0.0001	CD	NUMBER	0.0001	dobj	5	SENT_329	[p22l1520t533r1688b572],
7	-	:	O	-	_	0	SENT_329	[p22l1808t507r1861b542],
8	Placebo	NN	O	placebo	dep	6	SENT_329	[p22l1885t508r2016b542],

1	I	PRP	O	I	nsubj	2	SENT_330	[p22l1808t563r1861b597],
2	Salmeterol	VBP	O	salmeterol	_	0	SENT_330	[p22l1883t563r2068b596],

1	[	NN	O	[	_	0	SENT_331	[p22l515t590r846b630],
2	TI	NNP	O	TI	dep	4	SENT_331	[p22l515t590r846b630],
3	IT	NNP	O	IT	nn	4	SENT_331	[p22l1441t590r1772b630],
4	‘	NN	O	‘	dep	1	SENT_331	[p22l1441t590r1772b630],
5	,	,	O	,	_	0	SENT_331	[p22l1793t610r1797b611],

1	Ch	NN	O	ch	nn	2	SENT_332	[p22l148t857r168b891],
2	PC20	NN	O	pc20	_	0	SENT_332	[p22l79t1272r125b1340],
3	(	CD	NUMBER	(	num	5	SENT_332	[p22l79t1070r121b1260],
4	geometric	JJ	O	geometric	amod	5	SENT_332	[p22l79t1070r121b1260],
5	mean	NN	O	mean	dep	2	SENT_332	[p22l88t953r116b1057],
6	;	:	O	;	_	0	SENT_332	[p22l88t953r116b1057],
7	mg/mL	NN	O	mg/ml	dep	2	SENT_332	[p22l78t801r121b939],
8	)	CD	NUMBER	)	num	9	SENT_332	[p22l78t801r121b939],
9	N	NN	O	n	dep	7	SENT_332	[p22l149t1241r167b1270],
10	-	:	O	-	_	0	SENT_332	[p22l148t1051r171b1084],
11	I	PRP	O	I	dep	12	SENT_332	[p22l148t1051r171b1084],
12	>	JJR	O	>	dep	9	SENT_332	[p22l148t1051r171b1084],

1	Arg/Arg	NN	O	arg/arg	nn	2	SENT_333	[p22l610t1485r747b1528],
2	Gly/Gly	NN	O	gly/gly	_	0	SENT_333	[p22l1547t1484r1672b1528],

1	Study	NNP	O	Study	_	0	SENT_334	[p22l1040t1556r1139b1600],
2	group	NN	O	group	dep	1	SENT_334	[p22l1150t1568r1252b1600],

1	O	NN	O	o	_	0	SENT_335	[p22l1622t1765r1646b1790],

1	(	NN	O	(	nn	2	SENT_336	[p22l1622t2099r1646b2175],
2	o	NN	O	o	_	0	SENT_336	[p22l1622t2099r1646b2175],
3	)	CD	NUMBER	)	num	5	SENT_336	[p22l1622t2099r1646b2175],
4	o	NN	O	o	nn	5	SENT_336	[p22l1622t2099r1646b2175],
5	GDOOCQDO	NN	PERSON	gdoocqdo	dep	2	SENT_336	[p22l1622t1903r1646b2064],

1	Doubling	VBG	O	double	_	0	SENT_337	[p22l77t2401r121b2557],
2	dilution	NN	O	dilution	nn	4	SENT_337	[p22l77t2255r110b2389],
3	difference	NN	O	difference	nn	4	SENT_337	[p22l77t2072r110b2243],
4	o	NN	O	o	dobj	1	SENT_337	[p22l146t2297r167b2326],

1	Between	IN	O	between	_	0	SENT_338	[p22l802t2906r1133b2947],
2	—	CD	NUMBER	—	num	5	SENT_338	[p22l802t2906r1133b2947],
3	genotype	NN	O	genotype	nn	5	SENT_338	[p22l802t2906r1133b2947],
4	difference	NN	O	difference	nn	5	SENT_338	[p22l1144t2902r1315b2936],
5	p	NN	O	p	pobj	1	SENT_338	[p22l1326t2902r1496b2946],
6	=	JJ	O	=	amod	5	SENT_338	[p22l1326t2902r1496b2946],
7	0-0038	CD	NUMBER	0-0038	tmod	6	SENT_338	[p22l1326t2902r1496b2946],

1	Arg/Arg	NN	O	arg/arg	nn	2	SENT_339	[p22l583t3077r720b3120],
2	Gly/Gly	NN	O	gly/gly	_	0	SENT_339	[p22l1570t3076r1695b3120],

1	Study	NNP	O	Study	_	0	SENT_340	[p22l1042t3145r1142b3189],
2	group	NN	O	group	dep	1	SENT_340	[p22l1152t3157r1254b3189],

1	Figure	NNP	O	Figure	_	0	SENT_341	[p22l8t3284r123b3330],
2	4	CD	NUMBER	4	num	1	SENT_341	[p22l131t3288r166b3324],
3	:	:	O	:	_	0	SENT_341	[p22l131t3288r166b3324],
4	Methacholine	NN	O	methacholine	nn	5	SENT_341	[p22l180t3283r451b3319],
5	responsiveness	NN	O	responsiveness	dep	1	SENT_341	[p22l464t3284r760b3330],
6	in	IN	O	in	_	0	SENT_341	[p22l773t3284r807b3318],
7	participants	NNS	O	participant	prep_in	5	SENT_341	[p22l819t3284r1058b3330],
8	while	IN	O	while	mark	9	SENT_341	[p22l1068t3283r1176b3319],
9	assigned	VBN	O	assign	dep	7	SENT_341	[p22l1187t3283r1359b3330],
10	to	TO	O	to	aux	11	SENT_341	[p22l1367t3289r1410b3319],
11	receive	VB	O	receive	xcomp	9	SENT_341	[p22l1424t3284r1559b3319],
12	treatment	NN	O	treatment	dobj	11	SENT_341	[p22l1567t3289r1774b3319],
13	with	IN	O	with	_	0	SENT_341	[p22l1783t3283r1874b3319],
14	inhaled	VBN	O	inhale	prepc_with	11	SENT_341	[p22l1888t3283r2032b3319],
15	corticosteroid	NN	O	corticosteroid	dobj	14	SENT_341	[p22l8t3344r284b3380],
16	plus	CC	O	plus	prep	15	SENT_341	[p22l295t3344r376b3391],
17	salmeterol	NN	O	salmeterol	dep	16	SENT_341	[p22l387t3344r594b3380],
18	or	CC	O	or	_	0	SENT_341	[p22l606t3356r647b3380],
19	placebo	NN	O	placebo	dep	16	SENT_341	[p22l657t3344r820b3391],
20	,	,	O	,	_	0	SENT_341	[p22l657t3344r820b3391],
21	by	IN	O	by	_	0	SENT_341	[p22l833t3344r880b3391],
22	genotype	NN	O	genotype	prep_by	14	SENT_341	[p22l891t3350r1079b3391],
23	(	CD	NUMBER	(	num	22	SENT_341	[p22l10t3406r64b3449],
24	A	DT	O	a	det	28	SENT_341	[p22l10t3406r64b3449],
25	)	NN	O	)	nn	28	SENT_341	[p22l10t3406r64b3449],
26	20	CD	PERCENT	20	num	28	SENT_341	[p22l78t3409r157b3440],
27	%	NN	PERCENT	%	nn	28	SENT_341	[p22l78t3409r157b3440],
28	reduction	NN	O	reduction	nsubj	36	SENT_341	[p22l172t3404r348b3440],
29	in	IN	O	in	_	0	SENT_341	[p22l363t3407r393b3439],
30	forced	JJ	O	forced	amod	32	SENT_341	[p22l406t3404r524b3440],
31	expiratory	JJ	O	expiratory	amod	32	SENT_341	[p22l536t3407r727b3451],
32	volume	NN	O	volume	prep_in	28	SENT_341	[p22l737t3404r877b3440],
33	in	IN	O	in	_	0	SENT_341	[p22l891t3407r922b3439],
34	1	CD	NUMBER	1	num	35	SENT_341	[p22l936t3409r955b3439],
35	s	NNS	O	s	prep_in	32	SENT_341	[p22l967t3416r982b3440],
36	[	VBP	O	[	rcmod	22	SENT_341	[p22l995t3406r1094b3450],
37	PC20	NN	O	pc20	nn	38	SENT_341	[p22l995t3406r1094b3450],
38	]	NN	O	]	dobj	36	SENT_341	[p22l995t3406r1094b3450],
39	in	IN	O	in	_	0	SENT_341	[p22l1109t3407r1140b3439],
40	response	NN	O	response	prep_in	38	SENT_341	[p22l1156t3416r1319b3451],
41	to	TO	O	to	_	0	SENT_341	[p22l1328t3411r1368b3440],
42	methacholine	NN	O	methacholine	prep_to	36	SENT_341	[p22l1382t3404r1638b3440],
43	at	IN	O	at	_	0	SENT_341	[p22l1650t3411r1686b3440],
44	18	CD	DURATION	18	num	45	SENT_341	[p22l1698t3404r1743b3440],
45	weeks	NNS	NUMBER	week	prep_at	9	SENT_341	[p22l1754t3404r1869b3440],
46	of	IN	O	of	_	0	SENT_341	[p22l1880t3404r1920b3440],
47	treatment	NN	O	treatment	prep_of	45	SENT_341	[p22l1926t3411r2127b3440],
48	.	.	O	.	_	0	SENT_341	[p22l1926t3411r2127b3440],

1	Data	NNS	O	datum	nsubj	2	SENT_342	[p22l10t3467r94b3500],
2	log	VBP	O	log	_	0	SENT_342	[p22l108t3464r162b3511],
3	transformed	VBN	O	transform	dep	2	SENT_342	[p22l173t3464r407b3500],
4	for	IN	O	for	_	0	SENT_342	[p22l418t3464r472b3500],
5	analysis	NN	O	analysis	prep_for	3	SENT_342	[p22l483t3464r636b3511],
6	.	.	O	.	_	0	SENT_342	[p22l483t3464r636b3511],

1	Bars	NNS	O	bar	nsubj	2	SENT_343	[p22l652t3467r727b3500],
2	represent	VBP	O	represent	_	0	SENT_343	[p22l741t3471r916b3511],
3	back	RB	O	back	advmod	2	SENT_343	[p22l928t3464r1260b3500],
4	—	RB	O	—	advmod	5	SENT_343	[p22l928t3464r1260b3500],
5	transformed	VBN	O	transform	dep	2	SENT_343	[p22l928t3464r1260b3500],
6	95	CD	PERCENT	95	number	7	SENT_343	[p22l1273t3469r1353b3505],
7	%	NN	PERCENT	%	amod	8	SENT_343	[p22l1273t3469r1353b3505],
8	Cls	NNS	O	cl	dobj	5	SENT_343	[p22l1365t3467r1426b3500],
9	.	.	O	.	_	0	SENT_343	[p22l1365t3467r1426b3500],

1	(	NN	O	(	nn	2	SENT_344	[p22l1440t3466r1492b3509],
2	B	NN	O	b	nsubj	7	SENT_344	[p22l1440t3466r1492b3509],
3	)	CD	NUMBER	)	num	6	SENT_344	[p22l1440t3466r1492b3509],
4	Individual	NNP	O	Individual	nn	6	SENT_344	[p22l1507t3464r1687b3500],
5	raw	JJ	O	raw	amod	6	SENT_344	[p22l1702t3476r1769b3500],
6	data	NNS	O	datum	dep	2	SENT_344	[p22l1779t3464r1860b3500],
7	forthe	VBP	O	forthe	_	0	SENT_344	[p22l1871t3464r1995b3500],
8	doubling	VBG	O	double	xcomp	7	SENT_344	[p22l8t3524r174b3571],
9	dilution	NN	O	dilution	nn	10	SENT_344	[p22l186t3524r331b3560],
10	difference	NN	O	difference	dobj	8	SENT_344	[p22l344t3524r528b3560],
11	in	IN	O	in	_	0	SENT_344	[p22l541t3527r572b3559],
12	methacholine	NN	O	methacholine	nn	13	SENT_344	[p22l587t3524r844b3560],
13	PCZO	NN	O	pczo	prep_in	8	SENT_344	[p22l858t3527r937b3569],
14	,	,	O	,	_	0	SENT_344	[p22l858t3527r937b3569],
15	at	IN	O	at	_	0	SENT_344	[p22l950t3531r986b3560],
16	the	DT	O	the	det	26	SENT_344	[p22l994t3524r1056b3560],
17	end	NN	O	end	dep	26	SENT_344	[p22l1068t3524r1137b3560],
18	of	IN	O	of	_	0	SENT_344	[p22l1148t3524r1188b3560],
19	each	DT	O	each	det	23	SENT_344	[p22l1197t3524r1279b3560],
20	treatment	NN	O	treatment	nn	23	SENT_344	[p22l1290t3530r1483b3560],
21	period	NN	O	period	nn	23	SENT_344	[p22l1494t3524r1613b3570],
22	(	CD	NUMBER	(	num	23	SENT_344	[p22l1626t3524r2026b3570],
23	sa	NN	O	sa	prep_of	17	SENT_344	[p22l1626t3524r2026b3570],
24	|	NN	O	|	nn	26	SENT_344	[p22l1626t3524r2026b3570],
25	metero	NN	O	metero	nn	26	SENT_344	[p22l1626t3524r2026b3570],
26	|	NN	O	|	prep_at	8	SENT_344	[p22l1626t3524r2026b3570],
27	.	.	O	.	_	0	SENT_344	[p22l1626t3524r2026b3570],

1	—	NN	O	—	_	0	SENT_345	[p22l1626t3524r2026b3570],
2	.	.	O	.	_	0	SENT_345	[p22l1626t3524r2026b3570],

1	p	NN	O	p	_	0	SENT_346	[p22l1626t3524r2026b3570],
2	|	CD	NUMBER	|	num	4	SENT_346	[p22l1626t3524r2026b3570],
3	acebo	NN	O	acebo	nn	4	SENT_346	[p22l1626t3524r2026b3570],
4	)	NN	O	)	dep	1	SENT_346	[p22l1626t3524r2026b3570],
5	.	.	O	.	_	0	SENT_346	[p22l1626t3524r2026b3570],

1	Mean	NN	O	mean	nn	2	SENT_347	[p22l2041t3527r2142b3560],
2	values	NNS	O	value	nsubjpass	4	SENT_347	[p22l7t3584r123b3620],
3	are	VBP	O	be	auxpass	4	SENT_347	[p22l135t3596r191b3620],
4	shown	VBN	O	show	_	0	SENT_347	[p22l203t3584r325b3620],
5	as	IN	O	as	_	0	SENT_347	[p22l338t3596r375b3620],
6	horizontal	JJ	O	horizontal	amod	7	SENT_347	[p22l389t3584r576b3620],
7	lines	NNS	O	line	prep_as	4	SENT_347	[p22l592t3584r683b3620],
8	.	.	O	.	_	0	SENT_347	[p22l592t3584r683b3620],

1	71	CD	PERCENT	71	num	2	SENT_348	[p22l695t3589r772b3624],
2	%	NN	PERCENT	%	nsubj	6	SENT_348	[p22l695t3589r772b3624],
3	of	IN	O	of	_	0	SENT_348	[p22l784t3584r824b3620],
4	Gly/Gly	NN	O	gly/gly	nn	5	SENT_348	[p22l832t3584r966b3630],
5	participants	NNS	O	participant	prep_of	2	SENT_348	[p22l977t3587r1198b3630],
6	had	VBD	O	have	_	0	SENT_348	[p22l1212t3584r1279b3620],
7	an	DT	O	a	det	9	SENT_348	[p22l1290t3596r1333b3620],
8	improved	VBN	O	improve	amod	9	SENT_348	[p22l1348t3584r1527b3630],
9	PCZO	NN	O	pczo	dobj	6	SENT_348	[p22l1540t3587r1610b3629],
10	when	WRB	O	when	advmod	11	SENT_348	[p22l1624t3584r1727b3620],
11	assigned	VBN	O	assign	dep	9	SENT_348	[p22l1740t3584r1901b3631],
12	to	TO	O	to	aux	13	SENT_348	[p22l1910t3590r1950b3620],
13	receive	VB	O	receive	xcomp	11	SENT_348	[p22l1964t3587r2091b3620],
14	salmeterol	NN	O	salmeterol	dobj	13	SENT_348	[p22l8t3644r203b3680],
15	compared	VBN	O	compare	_	0	SENT_348	[p22l216t3644r404b3690],
16	with	IN	O	with	prepc_compared_with	13	SENT_348	[p22l413t3644r496b3679],
17	56	CD	PERCENT	56	number	18	SENT_348	[p22l510t3644r591b3685],
18	%	NN	PERCENT	%	amod	20	SENT_348	[p22l510t3644r591b3685],
19	ofArg/Arg	NN	O	ofarg/arg	nn	20	SENT_348	[p22l603t3644r798b3691],
20	participants	NNS	O	participant	pobj	13	SENT_348	[p22l811t3647r1043b3690],
21	.	.	O	.	_	0	SENT_348	[p22l811t3647r1043b3690],

1	effect	NN	O	effect	nsubjpass	8	SENT_349	[p23l9t40r150b88],
2	of	IN	O	of	_	0	SENT_349	[p23l169t40r228b88],
3	the	DT	O	the	det	6	SENT_349	[p23l237t40r318b88],
4	longacting	VBG	O	longact	amod	6	SENT_349	[p23l337t40r614b103],
5	B2	NN	O	b2	nn	6	SENT_349	[p23l636t40r680b101],
6	agonist	NN	O	agonist	prep_of	1	SENT_349	[p23l700t43r890b103],
7	was	VBD	O	be	auxpass	8	SENT_349	[p23l907t57r1004b88],
8	assessed	VBN	O	assess	_	0	SENT_349	[p23l1026t40r1250b88],
9	at	IN	O	at	_	0	SENT_349	[p23l1269t49r1314b88],
10	12	CD	NUMBER	12	num	11	SENT_349	[p23l1335t44r1386b87],
11	h	NN	O	h	prep_at	8	SENT_349	[p23l1406t40r1440b87],
12	or	CC	O	or	_	0	SENT_349	[p23l1460t57r1514b88],
13	less	JJR	O	less	prep_at	8	SENT_349	[p23l7t117r103b164],
14	after	IN	O	after	_	0	SENT_349	[p23l129t117r246b164],
15	administration	NN	O	administration	prep_after	8	SENT_349	[p23l270t117r672b164],
16	.	.	O	.	_	0	SENT_349	[p23l270t117r672b164],

1	Somewhat	RB	O	somewhat	advmod	9	SENT_350	[p23l702t117r975b164],
2	surprisingly	RB	O	surprisingly	advmod	9	SENT_350	[p23l999t117r1322b180],
3	,	,	O	,	_	0	SENT_350	[p23l999t117r1322b180],
4	in	IN	O	in	_	0	SENT_350	[p23l1348t120r1400b164],
5	our	PRP$	O	we	poss	6	SENT_350	[p23l1425t134r1514b164],
6	study	NN	O	study	prep_in	9	SENT_350	[p23l10t192r157b255],
7	,	,	O	,	_	0	SENT_350	[p23l10t192r157b255],
8	we	PRP	O	we	nsubj	9	SENT_350	[p23l182t209r254b240],
9	found	VBD	O	find	_	0	SENT_350	[p23l279t192r435b240],
10	that	IN	O	that	complm	19	SENT_350	[p23l458t192r560b240],
11	salmeterol	NN	O	salmeterol	nsubj	19	SENT_350	[p23l584t192r870b247],
12	,	,	O	,	_	0	SENT_350	[p23l584t192r870b247],
13	when	WRB	O	when	advmod	14	SENT_350	[p23l895t192r1041b240],
14	added	VBN	O	add	dep	11	SENT_350	[p23l1065t192r1221b240],
15	to	TO	O	to	aux	16	SENT_350	[p23l1244t202r1292b240],
16	inhaled	VBN	O	inhale	xcomp	14	SENT_350	[p23l1317t192r1514b240],
17	corticosteroid	NN	O	corticosteroid	dobj	16	SENT_350	[p23l9t268r377b324],
18	,	,	O	,	_	0	SENT_350	[p23l9t268r377b324],
19	enhanced	VBD	O	enhance	ccomp	9	SENT_350	[p23l442t268r696b316],
20	bronchoprotection	NN	O	bronchoprotection	dobj	19	SENT_350	[p23l755t268r1243b331],
21	in	IN	O	in	_	0	SENT_350	[p23l1304t271r1357b316],
22	B16	NNP	O	B16	nn	23	SENT_350	[p23l1421t272r1512b316],
23	Gly	NNP	O	Gly	prep_in	19	SENT_350	[p23l10t345r121b408],
24	/	:	O	/	punct	23	SENT_350	[p23l10t345r121b408],
25	Gly	NN	O	gly	nn	26	SENT_350	[p23l127t345r216b408],
26	participants	NNS	O	participant	nsubj	27	SENT_350	[p23l229t348r537b408],
27	(	VBP	O	(	dep	23	SENT_350	[p23l558t345r808b408],
28	doubling	VBG	O	double	xcomp	27	SENT_350	[p23l558t345r808b408],
29	dose	NN	O	dose	nn	30	SENT_350	[p23l823t345r941b393],
30	shift	NN	O	shift	dobj	28	SENT_350	[p23l957t345r1072b393],
31	in	IN	O	in	_	0	SENT_350	[p23l1086t348r1139b392],
32	methacholine	NN	O	methacholine	nn	34	SENT_350	[p23l1153t345r1513b393],
33	reactivity	NN	O	reactivity	nn	34	SENT_350	[p23l8t424r258b484],
34	)	NN	O	)	prep_in	28	SENT_350	[p23l8t424r258b484],
35	but	CC	O	but	_	0	SENT_350	[p23l277t421r365b469],
36	not	RB	O	not	_	0	SENT_350	[p23l380t431r467b469],
37	in	IN	O	in	_	0	SENT_350	[p23l482t424r534b468],
38	B16	NN	O	b16	nn	40	SENT_350	[p23l553t425r644b469],
39	Arg/Arg	NN	O	arg/arg	nn	40	SENT_350	[p23l661t425r882b484],
40	participants	NNS	O	participant	conj_negcc	23	SENT_350	[p23l897t424r1220b483],
41	.	.	O	.	_	0	SENT_350	[p23l897t424r1220b483],

1	This	DT	O	this	det	2	SENT_351	[p23l1238t421r1353b469],
2	effect	NN	O	effect	nsubj	4	SENT_351	[p23l1372t422r1514b469],
3	was	VBD	O	be	cop	4	SENT_351	[p23l7t514r104b545],
4	unlikely	JJ	O	unlikely	_	0	SENT_351	[p23l130t497r342b560],
5	to	TO	O	to	aux	7	SENT_351	[p23l365t506r414b545],
6	be	VB	O	be	auxpass	7	SENT_351	[p23l438t497r499b545],
7	caused	VBN	O	cause	xcomp	4	SENT_351	[p23l525t497r703b545],
8	by	IN	O	by	_	0	SENT_351	[p23l726t497r788b560],
9	persistent	JJ	O	persistent	amod	11	SENT_351	[p23l811t500r1070b559],
10	bronchodilating	JJ	O	bronchodilating	amod	11	SENT_351	[p23l1093t497r1513b560],
11	eﬁects	NNS	O	eﬁects	agent	7	SENT_351	[p23l9t574r174b621],
12	of	IN	O	of	_	0	SENT_351	[p23l201t573r259b621],
13	salmeterol	NN	O	salmeterol	prep_of	11	SENT_351	[p23l276t573r562b628],
14	,	,	O	,	_	0	SENT_351	[p23l276t573r562b628],
15	since	IN	O	since	mark	20	SENT_351	[p23l590t576r723b621],
16	the	DT	O	the	det	18	SENT_351	[p23l746t573r828b621],
17	methacholine	NN	O	methacholine	nn	18	SENT_351	[p23l853t573r1213b621],
18	challenges	NNS	O	challenge	nsubjpass	20	SENT_351	[p23l1238t573r1511b636],
19	were	VBD	O	be	auxpass	20	SENT_351	[p23l7t666r131b697],
20	done	VBN	O	do	advcl	7	SENT_351	[p23l164t649r291b697],
21	after	IN	O	after	_	0	SENT_351	[p23l324t649r441b697],
22	withholding	VBG	O	withhold	prepc_after	20	SENT_351	[p23l470t649r790b712],
23	salmeterol	NN	O	salmeterol	dobj	22	SENT_351	[p23l822t649r1095b697],
24	or	CC	O	or	_	0	SENT_351	[p23l1126t666r1181b697],
25	placebo	NN	O	placebo	conj_or	23	SENT_351	[p23l1210t649r1407b711],
26	for	IN	O	for	_	0	SENT_351	[p23l1439t649r1514b697],
27	24	CD	NUMBER	24	num	28	SENT_351	[p23l10t729r69b772],
28	h.	NN	O	h.	prep_for	23	SENT_351	[p23l106t725r153b772],
29	Some	DT	O	some	det	30	SENT_351	[p23l202t728r346b773],
30	in-Vitro	FW	O	in-vitro	tmod	22	SENT_351	[p23l388t728r576b773],
31	data	NNS	O	datum	nsubj	32	SENT_351	[p23l619t725r726b773],
32	suggest	VBP	O	suggest	rcmod	30	SENT_351	[p23l769t734r966b788],
33	that	IN	O	that	complm	47	SENT_351	[p23l1005t725r1107b773],
34	longacting	VBG	O	longact	csubj	47	SENT_351	[p23l1147t725r1423b788],
35	B2	NN	O	b2	nn	36	SENT_351	[p23l1468t725r1513b786],
36	agonists	NNS	O	agonist	dobj	34	SENT_351	[p23l9t805r223b865],
37	and	CC	O	and	_	0	SENT_351	[p23l249t802r346b849],
38	inhaled	VBD	O	inhale	csubj	47	SENT_351	[p23l369t802r566b849],
39	corticosteroids	NNS	O	corticosteroid	nsubj	40	SENT_351	[p23l590t802r970b849],
40	produce	VB	O	produce	ccomp	38	SENT_351	[p23l995t802r1208b864],
41	synergistic	JJ	O	synergistic	amod	42	SENT_351	[p23l1234t805r1513b865],
42	effects	NNS	O	effect	dobj	40	SENT_351	[p23l9t878r174b925],
43	through	IN	O	through	_	0	SENT_351	[p23l218t877r430b940],
44	multiple	JJ	O	multiple	amod	46	SENT_351	[p23l473t877r695b939],
45	molecular	JJ	O	molecular	amod	46	SENT_351	[p23l738t877r1002b925],
46	mechanisms	NNS	O	mechanism	prep_through	40	SENT_351	[p23l1044t877r1379b925],
47	(	VBP	O	(	ccomp	32	SENT_351	[p23l1428t880r1511b940, p23l6t1183r54b1351],
48	inI	NN	O	inus	dobj	47	SENT_351	[p23l1428t880r1511b940, p23l6t1183r54b1351],

1	Articles	NNPS	O	Articles	_	0	SENT_352	[p23l101t1315r251b1351],

1	A	DT	O	a	det	2	SENT_353	[p23l134t1596r169b1635],
2	Morning	NN	TIME	morning	_	0	SENT_353	[p23l220t1606r376b1648],
3	B	NN	O	b	nn	5	SENT_353	[p23l1137t1598r1164b1637],
4	Evening	NN	TIME	evening	nn	5	SENT_353	[p23l1208t1606r1352b1648],
5	K	NN	O	k	dep	2	SENT_353	[p23l1850t1647r1902b1682],

1	_	NN	O	_	nn	2	SENT_354	[p23l567t1686r585b1689],
2	_	NN	O	_	_	0	SENT_354	[p23l614t1689r619b1694],
3	=	JJ	O	=	dep	2	SENT_354	[p23l1553t1687r1571b1697],
4	_	CD	NUMBER	_	num	5	SENT_354	[p23l1599t1690r1604b1695],
5	Placebo	NN	O	placebo	dep	2	SENT_354	[p23l1927t1648r2057b1682],

1	ITIFLO	NNP	ORGANIZATION	ITIFLO	_	0	SENT_355	[p23l396t1674r785b1762],
2	09	CD	NUMBER	09	num	1	SENT_355	[p23l623t1674r667b1707],
3	lap	NN	O	lap	dep	1	SENT_355	[p23l1385t1682r1777b1763],
4	007	CD	NUMBER	007	num	3	SENT_355	[p23l1575t1675r1651b1708],
5	-	:	O	-	_	0	SENT_355	[p23l1850t1703r1902b1737],
6	Salmeterol	NNP	ORGANIZATION	Salmeterol	nn	7	SENT_355	[p23l1925t1703r2109b1736],
7	p	NN	O	p	dep	3	SENT_355	[p23l340t1787r460b1826],
8	=	JJ	O	=	dep	7	SENT_355	[p23l340t1787r460b1826],
9	0-57	CD	NUMBER	0-57	num	10	SENT_355	[p23l340t1787r460b1826],
10	p	NN	O	p	iobj	8	SENT_355	[p23l716t1787r858b1826],
11	=	JJ	O	=	amod	13	SENT_355	[p23l716t1787r858b1826],
12	0-013	CD	NUMBER	0-013	tmod	11	SENT_355	[p23l716t1787r858b1826],
13	p	NN	O	p	dobj	8	SENT_355	[p23l1327t1787r1450b1826],
14	=	JJ	O	=	amod	13	SENT_355	[p23l1327t1787r1450b1826],
15	0-92	CD	NUMBER	0-92	tmod	14	SENT_355	[p23l1327t1787r1450b1826],
16	p	NN	O	p	nn	18	SENT_355	[p23l1676t1787r1844b1826],
17	=	JJ	O	=	amod	18	SENT_355	[p23l1676t1787r1844b1826],
18	O-0005	NN	O	o-0005	dep	1	SENT_355	[p23l1676t1787r1844b1826],

1	A	DT	O	a	det	2	SENT_356	[p23l39t2150r79b2160],
2	400	CD	NUMBER	400	_	0	SENT_356	[p23l103t2129r172b2162],
3	400	CD	NUMBER	400	num	4	SENT_356	[p23l1094t2129r1163b2162],
4	E	NN	O	e	dep	2	SENT_356	[p23l40t2165r70b2193],
5	E	NN	O	e	rcmod	4	SENT_356	[p23l38t2198r75b2245],
6	:	:	O	:	_	0	SENT_356	[p23l39t2246r79b2277],
7	L	NN	O	l	advmod	5	SENT_356	[p23l39t2246r79b2277],
8	u.	NN	O	u.	dep	5	SENT_356	[p23l40t2289r70b2305],
9	360	CD	NUMBER	360	number	10	SENT_356	[p23l103t2271r171b2309],
10	360	CD	NUMBER	360	dep	8	SENT_356	[p23l1094t2271r1162b2309],
11	El	NNP	O	El	dep	10	SENT_356	[p23l40t2309r70b2348],
12	.	.	O	.	_	0	SENT_356	[p23l40t2309r70b2348],
13	"	''	O	"	punct	5	SENT_356	[p23l40t2309r70b2348],

1	C	NN	O	c	_	0	SENT_357	[p23l48t2363r70b2380],
2	8	CD	NUMBER	8	num	3	SENT_357	[p23l48t2384r70b2422],
3	E	NN	O	e	dep	1	SENT_357	[p23l40t2426r70b2456],
4	320	CD	NUMBER	320	number	5	SENT_357	[p23l103t2433r168b2467],
5	320	CD	NUMBER	320	dep	3	SENT_357	[p23l1094t2433r1159b2467],

1	O	NN	O	o	nn	2	SENT_358	[p23l152t2746r172b2775],
2	O	NN	O	o	_	0	SENT_358	[p23l1143t2746r1163b2775],

1	Arg/Arg	NN	O	arg/arg	nn	4	SENT_359	[p23l326t2809r463b2852],
2	Gly/Gly	NN	O	gly/gly	nn	4	SENT_359	[p23l738t2808r862b2851],
3	Arg/Arg	NN	O	arg/arg	nn	4	SENT_359	[p23l1314t2809r1451b2852],
4	Gly/Gly	NN	O	gly/gly	_	0	SENT_359	[p23l1713t2808r1837b2851],

1	Study	NNP	O	Study	nn	3	SENT_360	[p23l483t2884r582b2928],
2	group	NN	O	group	nn	3	SENT_360	[p23l592t2895r695b2928],
3	Study	NNP	O	Study	_	0	SENT_360	[p23l1467t2884r1566b2928],
4	group	NN	O	group	dep	3	SENT_360	[p23l1576t2895r1678b2928],

1	Figure	NNP	O	Figure	_	0	SENT_361	[p23l8t3017r122b3062],
2	5	CD	NUMBER	5	num	1	SENT_361	[p23l131t3021r165b3056],
3	:	:	O	:	_	0	SENT_361	[p23l131t3021r165b3056],
4	Morning	NN	TIME	morning	nn	7	SENT_361	[p23l179t3017r347b3062],
5	and	CC	O	and	_	0	SENT_361	[p23l360t3015r433b3051],
6	evening	NN	TIME	evening	nn	7	SENT_361	[p23l444t3017r600b3062],
7	PEF	NN	O	pef	dep	1	SENT_361	[p23l615t3018r683b3050],
8	in	IN	O	in	_	0	SENT_361	[p23l694t3017r728b3051],
9	African-American	JJ	MISC	african-american	amod	10	SENT_361	[p23l739t3015r1085b3051],
10	participants	NNS	O	participant	prep_in	7	SENT_361	[p23l1097t3017r1336b3062],
11	while	IN	O	while	mark	12	SENT_361	[p23l1345t3015r1453b3051],
12	assigned	VBN	O	assign	dep	7	SENT_361	[p23l1464t3015r1635b3062],
13	to	TO	O	to	aux	14	SENT_361	[p23l1643t3021r1687b3051],
14	receive	VB	O	receive	xcomp	12	SENT_361	[p23l1700t3017r1834b3051],
15	treatment	NN	O	treatment	dobj	14	SENT_361	[p23l1843t3021r2048b3051],
16	with	IN	O	with	_	0	SENT_361	[p23l7t3076r98b3112],
17	inhaled	VBN	O	inhale	prepc_with	14	SENT_361	[p23l112t3076r256b3112],
18	corticosteroid	NN	O	corticosteroid	dobj	17	SENT_361	[p23l267t3076r542b3112],
19	plus	CC	O	plus	prep	18	SENT_361	[p23l553t3076r633b3123],
20	salmeterol	NN	O	salmeterol	dep	19	SENT_361	[p23l645t3076r850b3112],
21	or	CC	O	or	_	0	SENT_361	[p23l863t3088r903b3112],
22	placebo	NN	O	placebo	dep	19	SENT_361	[p23l913t3076r1076b3123],
23	,	,	O	,	_	0	SENT_361	[p23l913t3076r1076b3123],
24	by	IN	O	by	_	0	SENT_361	[p23l1089t3076r1136b3123],
25	genotype	NN	O	genotype	nn	27	SENT_361	[p23l1146t3082r1334b3123],
26	B16	NN	O	b16	nn	27	SENT_361	[p23l10t3137r80b3173],
27	Arg/Arg	NN	O	arg/arg	prep_by	17	SENT_361	[p23l91t3139r249b3184],
28	,	,	O	,	_	0	SENT_361	[p23l91t3139r249b3184],
29	n	NN	O	n	dep	17	SENT_361	[p23l264t3142r346b3179],
30	=	JJ	O	=	amod	29	SENT_361	[p23l264t3142r346b3179],
31	9	CD	NUMBER	9	tmod	30	SENT_361	[p23l264t3142r346b3179],
32	;	:	O	;	_	0	SENT_361	[p23l264t3142r346b3179],
33	B16	CD	NUMBER	b16	num	34	SENT_361	[p23l361t3137r430b3173],
34	Gly/Gly	NN	O	gly/gly	dep	1	SENT_361	[p23l442t3137r583b3184],
35	,	,	O	,	_	0	SENT_361	[p23l442t3137r583b3184],
36	n	NN	O	n	appos	34	SENT_361	[p23l598t3137r679b3173],
37	=	JJ	O	=	amod	36	SENT_361	[p23l598t3137r679b3173],
38	8	CD	NUMBER	8	tmod	37	SENT_361	[p23l598t3137r679b3173],
39	.	.	O	.	_	0	SENT_361	[p23l598t3137r679b3173],

1	Error	NN	O	error	nn	2	SENT_362	[p23l694t3141r782b3173],
2	bars	NNS	O	bar	nsubj	3	SENT_362	[p23l794t3137r869b3173],
3	represent	VBP	O	represent	_	0	SENT_362	[p23l883t3144r1057b3184],
4	95	CD	PERCENT	95	number	5	SENT_362	[p23l1069t3142r1148b3178],
5	%	NN	PERCENT	%	amod	6	SENT_362	[p23l1069t3142r1148b3178],
6	Cls	NNS	O	cl	dobj	3	SENT_362	[p23l1161t3140r1221b3173],
7	.	.	O	.	_	0	SENT_362	[p23l1161t3140r1221b3173],

1	PEF	NN	O	pef	_	0	SENT_363	[p23l1236t3137r1413b3184],
2	=	JJ	O	=	amod	5	SENT_363	[p23l1236t3137r1413b3184],
3	peak	NN	O	peak	nn	5	SENT_363	[p23l1236t3137r1413b3184],
4	expiratory	NN	O	expiratory	nn	5	SENT_363	[p23l1425t3140r1615b3184],
5	flow	NN	O	flow	dep	1	SENT_363	[p23l1624t3137r1714b3173],
6	.	.	O	.	_	0	SENT_363	[p23l1624t3137r1714b3173],

1	cluding	VBG	O	clude	csubj	32	SENT_364	[p24l645t40r841b103],
2	facilitating	VBG	O	facilitate	conj_and	2	SENT_364	[p24l857t40r1134b103],
3	the	DT	O	the	det	4	SENT_364	[p24l1149t40r1230b87],
4	transcription	NN	O	transcription	dobj	2	SENT_364	[p24l1246t43r1584b102],
5	of	IN	O	of	_	0	SENT_364	[p24l1601t40r1659b87],
6	anti-inﬂammatory	JJ	O	anti-inﬂammatory	amod	7	SENT_364	[p24l1667t40r2145b102],
7	genes	NNS	O	gene	prep_of	2	SENT_364	[p24l645t132r793b178],
8	and	CC	O	and	_	0	SENT_364	[p24l810t115r907b163],
9	by	IN	O	by	_	0	SENT_364	[p24l920t115r981b178],
10	acting	VBG	O	act	prepc_by	2	SENT_364	[p24l995t118r1152b178],
11	as	IN	O	as	_	0	SENT_364	[p24l1168t132r1218b163],
12	allosteric	JJ	O	allosteric	amod	13	SENT_364	[p24l1236t115r1469b163],
13	modulators	NNS	O	modulator	prep_as	10	SENT_364	[p24l1483t115r1796b170],
14	,	,	O	,	_	0	SENT_364	[p24l1483t115r1796b170],
15	which	WDT	O	which	nsubj	17	SENT_364	[p24l1812t115r1971b163],
16	might	MD	O	might	aux	17	SENT_364	[p24l1986t115r2144b178],
17	modify	VB	O	modify	rcmod	13	SENT_364	[p24l644t191r830b254],
18	the	DT	O	the	det	19	SENT_364	[p24l895t191r977b238],
19	conformation	NN	O	conformation	dobj	17	SENT_364	[p24l1046t191r1402b238],
20	of	IN	O	of	_	0	SENT_364	[p24l1471t191r1529b238],
21	glucocorticoid-bound	JJ	O	glucocorticoid-bound	amod	23	SENT_364	[p24l1589t191r2144b254],
22	glucocorticoid	NN	O	glucocorticoid	nn	23	SENT_364	[p24l645t267r1014b330],
23	receptor	NN	O	receptor	prep_of	19	SENT_364	[p24l1059t277r1273b330],
24	or	CC	O	or	_	0	SENT_364	[p24l1320t285r1373b315],
25	the	DT	O	the	det	26	SENT_364	[p24l1417t267r1499b315],
26	binding	NN	O	binding	dobj	17	SENT_364	[p24l1544t267r1749b330],
27	of	IN	O	of	_	0	SENT_364	[p24l1796t267r1854b315],
28	necessary	JJ	O	necessary	amod	29	SENT_364	[p24l1892t284r2145b330],
29	cofactors	NNS	O	cofactor	prep_of	26	SENT_364	[p24l645t343r875b391],
30	and	CC	O	and	_	0	SENT_364	[p24l897t343r994b391],
31	coactivators	NNS	O	coactivator	prep_of	26	SENT_364	[p24l1014t346r1422b406],
32	)	VBP	O	)	_	0	SENT_364	[p24l1014t346r1422b406],
33	.2	NN	NUMBER	.2	nsubj	65	SENT_364	[p24l1014t346r1422b406],
34	“	CD	NUMBER	“	num	33	SENT_364	[p24l1014t346r1422b406],
35	3	CD	NUMBER	3	dep	40	SENT_364	[p24l1014t346r1422b406],
36	Whether	IN	O	whether	dep	40	SENT_364	[p24l1442t343r1672b391],
37	such	JJ	O	such	amod	38	SENT_364	[p24l1693t343r1814b391],
38	interactions	NNS	O	interaction	nsubjpass	40	SENT_364	[p24l1834t346r2141b391],
39	are	VBP	O	be	auxpass	40	SENT_364	[p24l645t436r723b466],
40	affected	VBN	O	affect	dep	33	SENT_364	[p24l750t419r953b466],
41	by	IN	O	by	_	0	SENT_364	[p24l978t419r1039b481],
42	polymorphisms	NNS	O	polymorphism	agent	40	SENT_364	[p24l1064t419r1475b481],
43	in	IN	O	in	_	0	SENT_364	[p24l1503t422r1555b466],
44	ADRB2	NN	O	adrb2	prep_in	42	SENT_364	[p24l1581t422r1783b466],
45	and	CC	O	and	_	0	SENT_364	[p24l1808t419r1904b466],
46	whether	IN	O	whether	dep	50	SENT_364	[p24l1928t419r2144b466],
47	such	PDT	O	such	predet	49	SENT_364	[p24l646t496r767b543],
48	a	DT	O	a	det	49	SENT_364	[p24l797t513r823b543],
49	ﬁnding	NN	O	ﬁnding	nsubj	50	SENT_364	[p24l852t496r1042b559],
50	translates	VBZ	O	translate	dep	33	SENT_364	[p24l1071t496r1320b543],
51	into	IN	O	into	_	0	SENT_364	[p24l1351t499r1453b543],
52	increased	VBN	O	increase	amod	53	SENT_364	[p24l1483t496r1732b543],
53	efﬁcacy	NN	O	efﬁcacy	prep_into	50	SENT_364	[p24l1761t496r1955b558],
54	of	IN	O	of	_	0	SENT_364	[p24l1984t496r2042b543],
55	the	DT	O	the	det	57	SENT_364	[p24l2061t496r2143b543],
56	drug	NN	O	drug	nn	57	SENT_364	[p24l645t571r767b634],
57	combination	NN	O	combination	prep_of	53	SENT_364	[p24l789t571r1120b619],
58	in	IN	O	in	_	0	SENT_364	[p24l1141t574r1193b618],
59	patients	NNS	O	patient	prep_in	57	SENT_364	[p24l1214t574r1419b633],
60	with	IN	O	with	_	0	SENT_364	[p24l1441t571r1557b619],
61	the	DT	O	the	det	63	SENT_364	[p24l1577t571r1659b619],
62	Gly/Gly	NNP	O	Gly/Gly	nn	63	SENT_364	[p24l1682t571r1888b634],
63	genotype	NN	O	genotype	prep_with	59	SENT_364	[p24l1909t581r2143b634],
64	are	VBP	O	be	cop	65	SENT_364	[p24l645t664r723b694],
65	unclear	JJ	O	unclear	ccomp	32	SENT_364	[p24l735t647r938b694],
66	.	.	O	.	_	0	SENT_364	[p24l735t647r938b694],

1	Another	DT	O	another	det	3	SENT_365	[p24l951t647r1168b694],
2	potential	JJ	O	potential	amod	3	SENT_365	[p24l1179t647r1408b709],
3	explanation	NN	O	explanation	nsubj	8	SENT_365	[p24l1420t647r1722b709],
4	for	IN	O	for	_	0	SENT_365	[p24l1734t647r1808b694],
5	the	DT	O	the	det	7	SENT_365	[p24l1818t647r1900b694],
6	observed	VBN	O	observe	amod	7	SENT_365	[p24l1913t647r2144b694],
7	difference	NN	O	difference	prep_for	3	SENT_365	[p24l645t723r905b771],
8	relates	VBZ	O	relate	_	0	SENT_365	[p24l941t723r1108b771],
9	to	TO	O	to	_	0	SENT_365	[p24l1143t733r1192b771],
10	the	DT	O	the	prep_to	8	SENT_365	[p24l1226t723r1307b771],
11	ﬁnding	VBG	O	ﬁnding	amod	10	SENT_365	[p24l1342t723r1532b786],
12	that	IN	O	that	complm	26	SENT_365	[p24l1566t723r1667b771],
13	Arg/Arg	NN	O	arg/arg	nn	15	SENT_365	[p24l1699t727r1919b786],
14	human	JJ	O	human	amod	15	SENT_365	[p24l1952t723r2143b771],
15	airway	NN	O	airway	nsubj	26	SENT_365	[p24l645t802r814b862],
16	smooth	JJ	O	smooth	amod	18	SENT_365	[p24l837t799r1033b847],
17	muscle	NN	O	muscle	nn	18	SENT_365	[p24l1056t799r1243b847],
18	cells	NNS	O	cell	npadvmod	20	SENT_365	[p24l1267t799r1378b847],
19	(	RB	O	(	advmod	18	SENT_365	[p24l1407t804r1473b862],
20	as	IN	O	as	advmod	21	SENT_365	[p24l1407t804r1473b862],
21	compared	VBN	O	compare	partmod	15	SENT_365	[p24l1499t799r1759b861],
22	with	IN	O	with	_	0	SENT_365	[p24l1780t799r1896b847],
23	Gly/Gly	JJ	O	gly/gly	amod	24	SENT_365	[p24l1920t799r2139b862],
24	)	NN	O	)	prep_with	21	SENT_365	[p24l1920t799r2139b862],
25	can	MD	O	can	aux	26	SENT_365	[p24l645t892r734b922],
26	produce	VB	O	produce	dep	10	SENT_365	[p24l778t875r989b937],
27	increased	VBN	O	increase	amod	28	SENT_365	[p24l1034t875r1284b922],
28	amounts	NNS	O	amount	dobj	26	SENT_365	[p24l1328t884r1556b922],
29	of	IN	O	of	_	0	SENT_365	[p24l1603t875r1661b922],
30	proinﬂammatory	JJ	O	proinﬂammatory	amod	31	SENT_365	[p24l1696t875r2145b937],
31	mediators	NNS	O	mediator	prep_of	28	SENT_365	[p24l644t951r904b999],
32	in	IN	O	in	_	0	SENT_365	[p24l930t955r982b998],
33	response	NN	O	response	prep_in	28	SENT_365	[p24l1006t968r1239b1014],
34	to	TO	O	to	_	0	SENT_365	[p24l1262t961r1311b999],
35	B2-agonist	JJ	O	b2-agonist	amod	36	SENT_365	[p24l1339t951r1592b1015],
36	stimulation	NN	O	stimulation	prep_to	28	SENT_365	[p24l1617t952r1963b1007],
37	,	,	O	,	_	0	SENT_365	[p24l1617t952r1963b1007],
38	“	NN	O	“	appos	28	SENT_365	[p24l1617t952r1963b1007],
39	which	WDT	O	which	nsubj	41	SENT_365	[p24l1984t952r2143b999],
40	might	MD	O	might	aux	41	SENT_365	[p24l644t1027r802b1090],
41	counteract	VB	O	counteract	rcmod	38	SENT_365	[p24l826t1037r1100b1075],
42	the	DT	O	the	det	45	SENT_365	[p24l1123t1027r1204b1075],
43	increased	VBN	O	increase	amod	45	SENT_365	[p24l1229t1027r1478b1075],
44	anti-inﬂammatory	JJ	O	anti-inﬂammatory	amod	45	SENT_365	[p24l1502t1027r1979b1090],
45	effect	NN	O	effect	dobj	41	SENT_365	[p24l2003t1028r2144b1075],
46	of	IN	O	of	_	0	SENT_365	[p24l645t1103r703b1150],
47	the	DT	O	the	det	51	SENT_365	[p24l711t1103r792b1150],
48	B,-agonist	JJ	O	b,-agonist	amod	51	SENT_365	[p24l814t1103r1449b1166],
49	/	:	O	/	punct	50	SENT_365	[p24l814t1103r1449b1166],
50	corticosteroid	NN	O	corticosteroid	dep	51	SENT_365	[p24l814t1103r1449b1166],
51	synergy	NN	O	synergy	prep_of	45	SENT_365	[p24l1468t1120r1674b1166],
52	.	.	O	.	_	0	SENT_365	[p24l1468t1120r1674b1166],

1	In	IN	O	in	_	0	SENT_366	[p24l697t1185r753b1226],
2	a	DT	O	a	det	4	SENT_366	[p24l811t1197r838b1227],
3	post-hoc	JJ	O	post-hoc	amod	4	SENT_366	[p24l895t1180r1122b1242],
4	subanalysis	NN	O	subanalysis	prep_in	17	SENT_366	[p24l1182t1180r1489b1242],
5	of	IN	O	of	_	0	SENT_366	[p24l1550t1180r1609b1227],
6	African-American	JJ	MISC	african-american	amod	7	SENT_366	[p24l1657t1180r2143b1227],
7	individuals	NNS	O	individual	prep_of	4	SENT_366	[p24l644t1255r941b1303],
8	(	VBP	O	(	rcmod	7	SENT_366	[p24l974t1258r1105b1318],
9	20	CD	PERCENT	20	num	10	SENT_366	[p24l974t1258r1105b1318],
10	%	NN	PERCENT	%	dobj	8	SENT_366	[p24l974t1258r1105b1318],
11	of	IN	O	of	_	0	SENT_366	[p24l1133t1255r1192b1303],
12	the	DT	O	the	det	14	SENT_366	[p24l1209t1255r1292b1303],
13	cohort	NN	O	cohort	nn	14	SENT_366	[p24l1320t1255r1524b1318],
14	)	NN	O	)	prep_of	10	SENT_366	[p24l1320t1255r1524b1318],
15	,	,	O	,	_	0	SENT_366	[p24l1320t1255r1524b1318],
16	we	PRP	O	we	nsubj	17	SENT_366	[p24l1552t1272r1625b1303],
17	noted	VBD	O	note	_	0	SENT_366	[p24l1652t1255r1804b1303],
18	a	DT	O	a	det	20	SENT_366	[p24l1830t1272r1856b1303],
19	genotypespeciﬁc	NN	O	genotypespeciﬁc	nn	20	SENT_366	[p24l1883t1265r2141b1318, p24l646t1331r845b1393],
20	difference	NN	O	difference	dobj	17	SENT_366	[p24l869t1331r1137b1378],
21	in	IN	O	in	_	0	SENT_366	[p24l1161t1334r1214b1378],
22	morning	NN	TIME	morning	nn	24	SENT_366	[p24l1236t1334r1473b1394],
23	PEF	NN	O	pef	nn	24	SENT_366	[p24l1499t1334r1604b1378],
24	(	NN	O	(	prep_in	17	SENT_366	[p24l1633t1331r1722b1394],
25	for	IN	O	for	_	0	SENT_366	[p24l1633t1331r1722b1394],
26	both	CC	O	both	dep	31	SENT_366	[p24l1743t1331r1864b1379],
27	the	DT	O	the	det	31	SENT_366	[p24l1886t1331r1969b1378],
28	mean	JJ	O	mean	amod	31	SENT_366	[p24l1993t1348r2143b1378],
29	daily	JJ	SET	daily	amod	31	SENT_366	[p24l645t1408r771b1470],
30	home	NN	O	home	nn	31	SENT_366	[p24l832t1408r985b1455],
31	measurements	NNS	O	measurement	prep_for	17	SENT_366	[p24l1048t1417r1448b1455],
32	and	CC	O	and	_	0	SENT_366	[p24l1514t1408r1625b1462],
33	,	,	O	,	_	0	SENT_366	[p24l1514t1408r1625b1462],
34	separately	RB	O	separately	dep	31	SENT_366	[p24l1692t1408r1968b1470],
35	,	,	O	,	_	0	SENT_366	[p24l1692t1408r1968b1470],
36	PEF	NN	O	pef	conj_and	31	SENT_366	[p24l2036t1410r2141b1454],
37	measured	VBN	O	measure	partmod	31	SENT_366	[p24l644t1483r911b1531],
38	at	IN	O	at	_	0	SENT_366	[p24l930t1493r976b1531],
39	clinic	NN	O	clinic	nn	40	SENT_366	[p24l995t1483r1139b1531],
40	visits	NNS	O	visit	prep_at	37	SENT_366	[p24l1156t1486r1311b1546],
41	)	CD	NUMBER	)	dep	40	SENT_366	[p24l1156t1486r1311b1546],
42	and	CC	O	and	_	0	SENT_366	[p24l1334t1483r1433b1531],
43	in	IN	O	in	conj_and	41	SENT_366	[p24l1451t1486r1504b1530],
44	evening	NN	TIME	evening	nn	45	SENT_366	[p24l1523t1486r1734b1546],
45	PEF	NN	O	pef	pobj	43	SENT_366	[p24l1756t1486r1876b1531],
46	.	.	O	.	_	0	SENT_366	[p24l1756t1486r1876b1531],

1	The	DT	O	the	det	2	SENT_367	[p24l1897t1483r1999b1531],
2	Arg	NN	O	arg	_	0	SENT_367	[p24l2018t1487r2141b1546],
3	/	:	O	/	punct	2	SENT_367	[p24l2018t1487r2141b1546],
4	Arg	NN	O	arg	nn	5	SENT_367	[p24l643t1562r742b1622],
5	group	NN	O	group	nsubj	6	SENT_367	[p24l768t1576r924b1622],
6	did	VBD	O	do	dep	2	SENT_367	[p24l951t1559r1035b1606],
7	not	RB	O	not	neg	8	SENT_367	[p24l1059t1568r1147b1606],
8	beneﬁt	NN	O	beneﬁt	dobj	6	SENT_367	[p24l1170t1559r1357b1606],
9	when	WRB	O	when	advmod	12	SENT_367	[p24l1379t1559r1527b1607],
10	salmeterol	NN	O	salmeterol	nsubjpass	12	SENT_367	[p24l1554t1559r1834b1607],
11	was	VBD	O	be	auxpass	12	SENT_367	[p24l1858t1576r1957b1606],
12	added	VBN	O	add	advcl	6	SENT_367	[p24l1984t1559r2144b1606],
13	to	TO	O	to	aux	14	SENT_367	[p24l644t1645r693b1683],
14	inhaled	VBN	O	inhale	xcomp	12	SENT_367	[p24l725t1636r927b1683],
15	corticosteroid	NN	O	corticosteroid	dobj	14	SENT_367	[p24l959t1636r1340b1690],
16	,	,	O	,	_	0	SENT_367	[p24l959t1636r1340b1690],
17	whereas	IN	O	whereas	mark	21	SENT_367	[p24l1373t1636r1592b1683],
18	the	DT	O	the	det	20	SENT_367	[p24l1625t1636r1709b1683],
19	Gly/Gly	JJ	O	gly/gly	amod	20	SENT_367	[p24l1743t1636r1954b1698],
20	group	NN	O	group	nsubj	21	SENT_367	[p24l1985t1653r2142b1698],
21	did	VBD	O	do	advcl	12	SENT_367	[p24l645t1711r742b1766],
22	;	:	O	;	_	0	SENT_367	[p24l645t1711r742b1766],
23	neither	DT	O	neither	det	24	SENT_367	[p24l774t1711r968b1759],
24	group	NN	O	group	nsubj	25	SENT_367	[p24l997t1728r1154b1774],
25	had	VBD	O	have	parataxis	21	SENT_367	[p24l1182t1711r1281b1759],
26	any	DT	O	any	det	28	SENT_367	[p24l1310t1728r1403b1774],
27	adverse	JJ	O	adverse	amod	28	SENT_367	[p24l1431t1711r1631b1759],
28	effects	NNS	O	effect	dobj	25	SENT_367	[p24l1661t1711r1846b1759],
29	.	.	O	.	_	0	SENT_367	[p24l1661t1711r1846b1759],

1	Since	IN	O	since	mark	6	SENT_368	[p24l1882t1714r2023b1759],
2	our	PRP$	O	we	poss	4	SENT_368	[p24l2053t1728r2144b1759],
3	African-American	JJ	MISC	african-american	amod	4	SENT_368	[p24l643t1787r1129b1834],
4	subpopulation	NN	O	subpopulation	nsubj	6	SENT_368	[p24l1197t1787r1585b1849],
5	was	VBD	O	be	cop	6	SENT_368	[p24l1649t1804r1748b1834],
6	small	JJ	O	small	advcl	12	SENT_368	[p24l1818t1787r1975b1842],
7	,	,	O	,	_	0	SENT_368	[p24l1818t1787r1975b1842],
8	this	DT	O	this	det	9	SENT_368	[p24l2043t1787r2141b1834],
9	ﬁnding	NN	O	ﬁnding	nsubjpass	12	SENT_368	[p24l644t1863r840b1926],
10	might	MD	O	might	aux	12	SENT_368	[p24l868t1863r1030b1926],
11	be	VB	O	be	auxpass	12	SENT_368	[p24l1056t1863r1117b1911],
12	caused	VBN	O	cause	_	0	SENT_368	[p24l1147t1863r1330b1911],
13	by	IN	O	by	_	0	SENT_368	[p24l1356t1863r1418b1926],
14	beta	NN	O	beta	nn	15	SENT_368	[p24l1444t1863r1555b1911],
15	error	NN	O	error	agent	12	SENT_368	[p24l1584t1881r1718b1911],
16	and	CC	O	and	_	0	SENT_368	[p24l1746t1863r1844b1911],
17	should	MD	O	should	aux	19	SENT_368	[p24l1873t1863r2055b1911],
18	be	VB	O	be	auxpass	19	SENT_368	[p24l2081t1863r2142b1911],
19	considered	VBN	O	consider	conj_and	12	SENT_368	[p24l645t1939r939b1987],
20	exploratory	NN	O	exploratory	dobj	19	SENT_368	[p24l984t1939r1295b2002],
21	;	:	O	;	_	0	SENT_368	[p24l984t1939r1295b2002],
22	however	RB	O	however	advmod	30	SENT_368	[p24l1342t1939r1576b1994],
23	,	,	O	,	_	0	SENT_368	[p24l1342t1939r1576b1994],
24	if	IN	O	if	mark	25	SENT_368	[p24l1623t1939r1669b1986],
25	conﬁrmed	VBN	O	conﬁrmed	advcl	30	SENT_368	[p24l1706t1939r1996b1994],
26	,	,	O	,	_	0	SENT_368	[p24l1706t1939r1996b1994],
27	this	DT	O	this	det	28	SENT_368	[p24l2043t1939r2141b1987],
28	ﬁnding	NN	O	ﬁnding	nsubj	30	SENT_368	[p24l644t2016r839b2079],
29	might	MD	O	might	aux	30	SENT_368	[p24l862t2016r1025b2079],
30	have	VB	O	have	parataxis	12	SENT_368	[p24l1046t2016r1168b2063],
31	important	JJ	O	important	amod	32	SENT_368	[p24l1191t2019r1463b2078],
32	implications	NNS	O	implication	dobj	30	SENT_368	[p24l1484t2016r1834b2078],
33	.	.	O	.	_	0	SENT_368	[p24l1484t2016r1834b2078],

1	If	IN	O	if	mark	4	SENT_369	[p24l1863t2016r1912b2063],
2	AfricanAmerican	JJ	MISC	africanamerican	amod	3	SENT_369	[p24l1925t2016r2142b2063, p24l643t2095r909b2139],
3	individuals	NNS	O	individual	nsubj	4	SENT_369	[p24l932t2091r1229b2139],
4	do	VBP	O	do	advcl	24	SENT_369	[p24l1255t2091r1317b2139],
5	not	RB	O	not	neg	4	SENT_369	[p24l1341t2101r1429b2139],
6	beneﬁt	VBN	O	beneﬁt	dep	4	SENT_369	[p24l1450t2091r1637b2139],
7	from	IN	O	from	_	0	SENT_369	[p24l1660t2091r1791b2139],
8	the	DT	O	the	det	9	SENT_369	[p24l1814t2091r1897b2139],
9	addition	NN	O	addition	prep_from	6	SENT_369	[p24l1922t2091r2143b2139],
10	of	IN	O	of	_	0	SENT_369	[p24l645t2167r704b2215],
11	longacting	VBG	O	longact	prepc_of	9	SENT_369	[p24l711t2167r996b2230],
12	[	NN	O	[	dobj	11	SENT_369	[p24l1017t2167r1061b2228],
13	5	CD	NUMBER	5	num	12	SENT_369	[p24l1017t2167r1061b2228],
14	,	,	O	,	_	0	SENT_369	[p24l1017t2167r1061b2228],
15	agonists	NNS	O	agonist	appos	12	SENT_369	[p24l1079t2170r1299b2230],
16	to	TO	O	to	aux	17	SENT_369	[p24l1317t2177r1366b2215],
17	inhaled	VBN	O	inhale	infmod	15	SENT_369	[p24l1384t2167r1586b2215],
18	corticosteroids	NNS	O	corticosteroid	dobj	17	SENT_369	[p24l1603t2167r2012b2222],
19	,	,	O	,	_	0	SENT_369	[p24l1603t2167r2012b2222],
20	they	PRP	O	they	nsubj	24	SENT_369	[p24l2030t2167r2144b2230],
21	might	MD	O	might	aux	24	SENT_369	[p24l644t2243r806b2306],
22	be	VB	O	be	cop	24	SENT_369	[p24l830t2243r891b2290],
23	less	RBR	O	less	advmod	24	SENT_369	[p24l916t2243r1014b2290],
24	likely	JJ	O	likely	_	0	SENT_369	[p24l1040t2243r1185b2306],
25	to	TO	O	to	aux	26	SENT_369	[p24l1208t2252r1257b2290],
26	comply	VB	O	comply	xcomp	24	SENT_369	[p24l1284t2243r1480b2305],
27	with	IN	O	with	_	0	SENT_369	[p24l1502t2243r1621b2291],
28	such	JJ	O	such	amod	29	SENT_369	[p24l1648t2243r1772b2291],
29	medications	NNS	O	medication	prep_with	26	SENT_369	[p24l1797t2243r2140b2291],
30	.	.	O	.	_	0	SENT_369	[p24l1797t2243r2140b2291],

1	Furthermore	RB	O	furthermore	advmod	13	SENT_370	[p24l647t2320r1004b2374],
2	,	,	O	,	_	0	SENT_370	[p24l647t2320r1004b2374],
3	a	DT	O	a	det	5	SENT_370	[p24l1039t2337r1065b2367],
4	recent	JJ	O	recent	amod	5	SENT_370	[p24l1096t2329r1264b2367],
5	meta-analysis	NN	O	meta-analysis	nsubj	13	SENT_370	[p24l1294t2320r1659b2382],
6	by	IN	O	by	_	0	SENT_370	[p24l1691t2320r1753b2382],
7	the	DT	O	the	det	9	SENT_370	[p24l1782t2320r1865b2367],
8	US	NNP	ORGANIZATION	US	nn	9	SENT_370	[p24l1900t2323r1977b2367],
9	Food	NNP	ORGANIZATION	Food	prep_by	5	SENT_370	[p24l2015t2320r2144b2367],
10	and	CC	ORGANIZATION	and	_	0	SENT_370	[p24l645t2395r743b2443],
11	Drug	NNP	ORGANIZATION	Drug	nn	12	SENT_370	[p24l772t2400r908b2458],
12	Administration	NNP	ORGANIZATION	Administration	conj_and	9	SENT_370	[p24l933t2395r1348b2443],
13	suggested	VBD	O	suggest	_	0	SENT_370	[p24l1377t2395r1643b2458],
14	an	DT	O	a	det	16	SENT_370	[p24l1670t2412r1733b2443],
15	increased	VBN	O	increase	amod	16	SENT_370	[p24l1760t2395r2017b2443],
16	risk	NN	O	risk	nsubj	21	SENT_370	[p24l2043t2395r2144b2443],
17	of	IN	O	of	_	0	SENT_370	[p24l645t2471r704b2518],
18	serious	JJ	O	serious	amod	20	SENT_370	[p24l760t2474r950b2519],
19	adverse	JJ	O	adverse	amod	20	SENT_370	[p24l1015t2471r1215b2519],
20	outcomes	NNS	O	outcome	prep_of	16	SENT_370	[p24l1279t2480r1537b2519],
21	(	VBP	O	(	ccomp	13	SENT_370	[p24l1605t2471r1890b2534],
22	combined	JJ	O	combined	amod	23	SENT_370	[p24l1605t2471r1890b2534],
23	deaths	NNS	O	death	nsubj	30	SENT_370	[p24l1953t2471r2140b2526],
24	,	,	O	,	_	0	SENT_370	[p24l1953t2471r2140b2526],
25	intubations	NNS	O	intubation	nsubj	30	SENT_370	[p24l644t2547r967b2602],
26	,	,	O	,	_	0	SENT_370	[p24l644t2547r967b2602],
27	and	CC	O	and	_	0	SENT_370	[p24l1016t2547r1115b2595],
28	hospital	NN	O	hospital	nn	29	SENT_370	[p24l1159t2547r1374b2610],
29	admissions	NNS	O	admission	nsubj	30	SENT_370	[p24l1420t2547r1742b2610],
30	)	VBP	O	)	ccomp	21	SENT_370	[p24l1420t2547r1742b2610],
31	with	IN	O	with	_	0	SENT_370	[p24l1791t2547r1909b2595],
32	use	NN	O	use	prep_with	30	SENT_370	[p24l1954t2564r2046b2595],
33	of	IN	O	of	_	0	SENT_370	[p24l2093t2547r2152b2595],
34	longacting	VBG	O	longact	prepc_of	32	SENT_370	[p24l643t2623r928b2686],
35	[	NN	O	[	dep	34	SENT_370	[p24l942t2623r987b2684],
36	3	CD	NUMBER	3	num	35	SENT_370	[p24l942t2623r987b2684],
37	,	,	O	,	_	0	SENT_370	[p24l942t2623r987b2684],
38	agonists	NNS	O	agonist	appos	35	SENT_370	[p24l999t2626r1234b2686],
39	,	,	O	,	_	0	SENT_370	[p24l999t2626r1234b2686],
40	especially	RB	O	especially	advmod	35	SENT_370	[p24l1249t2623r1508b2686],
41	in	IN	O	in	dep	35	SENT_370	[p24l1517t2626r1571b2670],
42	African-Americans	NNPS	MISC	African-Americans	pobj	41	SENT_370	[p24l1580t2623r2142b2671],
43	.	.	O	.	_	0	SENT_370	[p24l1580t2623r2142b2671],

1	“	NN	O	“	_	0	SENT_371	[p24l1580t2623r2142b2671],

1	Therefore	RB	O	therefore	advmod	5	SENT_372	[p24l7t3031r405b3109],
2	,	,	O	,	_	0	SENT_372	[p24l7t3031r405b3109],
3	physicians	NNS	O	physician	nsubj	5	SENT_372	[p24l479t3031r880b3120],
4	might	MD	O	might	aux	5	SENT_372	[p24l953t3031r1184b3121],
5	consider	VB	O	consider	_	0	SENT_372	[p24l1253t3031r1580b3099],
6	not	RB	O	not	neg	7	SENT_372	[p24l1649t3045r1774b3099],
7	treating	VBG	O	treat	xcomp	5	SENT_372	[p24l1842t3036r2140b3121],
8	African-Americans	NNPS	MISC	African-Americans	dobj	7	SENT_372	[p24l7t3141r735b3208],
9	with	IN	O	with	_	0	SENT_372	[p24l793t3141r961b3208],
10	the	DT	O	the	det	12	SENT_372	[p24l1017t3141r1136b3208],
11	Arg/Arg	NN	O	arg/arg	nn	12	SENT_372	[p24l1193t3146r1514b3231],
12	genotype	NN	O	genotype	prep_with	7	SENT_372	[p24l1572t3154r1915b3231],
13	with	IN	O	with	_	0	SENT_372	[p24l1972t3141r2140b3208],
14	longacting	VBG	O	longact	prepc_with	7	SENT_372	[p24l7t3249r412b3339],
15	[	NN	O	[	dobj	14	SENT_372	[p24l474t3249r537b3337],
16	3	CD	NUMBER	3	num	15	SENT_372	[p24l474t3249r537b3337],
17	,	,	O	,	_	0	SENT_372	[p24l474t3249r537b3337],
18	agonists	NNS	O	agonist	appos	15	SENT_372	[p24l595t3254r907b3339],
19	in	IN	O	in	_	0	SENT_372	[p24l967t3254r1043b3316],
20	the	DT	O	the	det	21	SENT_372	[p24l1098t3249r1217b3317],
21	context	NN	O	context	prep_in	18	SENT_372	[p24l1276t3263r1550b3317],
22	of	IN	O	of	_	0	SENT_372	[p24l1606t3249r1690b3317],
23	a	DT	O	a	det	25	SENT_372	[p24l1735t3274r1771b3317],
24	possible	JJ	O	possible	amod	25	SENT_372	[p24l1828t3249r2139b3338],
25	increase	NN	O	increase	prep_of	21	SENT_372	[p24l9t3363r323b3426],
26	in	IN	O	in	_	0	SENT_372	[p24l352t3363r427b3425],
27	serious	JJ	O	serious	amod	29	SENT_372	[p24l458t3363r729b3426],
28	adverse	JJ	O	adverse	amod	29	SENT_372	[p24l760t3358r1045b3426],
29	outcomes	NNS	O	outcome	prep_in	25	SENT_372	[p24l1074t3371r1462b3426],
30	.	.	O	.	_	0	SENT_372	[p24l1074t3371r1462b3426],

1	A	DT	O	a	det	4	SENT_373	[p24l78t3474r138b3535],
2	recent	JJ	O	recent	amod	4	SENT_373	[p24l169t3482r402b3537],
3	prospective	JJ	O	prospective	amod	4	SENT_373	[p24l433t3473r856b3558],
4	study	NN	O	study	nsubj	9	SENT_373	[p24l893t3469r1092b3558],
5	in	IN	O	in	_	0	SENT_373	[p24l1123t3473r1197b3536],
6	475	CD	NUMBER	475	num	7	SENT_373	[p24l1229t3473r1347b3540],
7	African-Americans	NNPS	MISC	African-Americans	prep_in	4	SENT_373	[p24l1382t3469r2140b3537],
8	“	RB	O	“	advmod	9	SENT_373	[p24l1382t3469r2140b3537],
9	found	VBD	O	find	_	0	SENT_373	[p24l8t3577r232b3645],
10	no	DT	O	no	det	12	SENT_373	[p24l277t3602r370b3645],
11	signiﬁcant	NN	O	signiﬁcant	nn	12	SENT_373	[p24l421t3577r813b3667],
12	difference	NN	O	difference	dobj	9	SENT_373	[p24l859t3577r1233b3645],
13	in	IN	O	in	_	0	SENT_373	[p24l1280t3582r1354b3644],
14	the	DT	O	the	det	15	SENT_373	[p24l1399t3577r1515b3645],
15	rate	NN	O	rate	prep_in	9	SENT_373	[p24l1563t3591r1702b3645],
16	of	IN	O	of	_	0	SENT_373	[p24l1750t3577r1833b3645],
17	asthma	NN	O	asthma	nn	18	SENT_373	[p24l1868t3577r2140b3645],
18	exacerbations	NNS	O	exacerbation	prep_of	15	SENT_373	[p24l9t3686r514b3754],
19	when	WRB	O	when	advmod	25	SENT_373	[p24l551t3686r758b3754],
20	longacting	VBG	O	longact	partmod	25	SENT_373	[p24l793t3686r1187b3776],
21	B	NN	O	b	dobj	20	SENT_373	[p24l1230t3686r1292b3773],
22	,	,	O	,	_	0	SENT_373	[p24l1230t3686r1292b3773],
23	agonist	NN	O	agonist	nsubjpass	25	SENT_373	[p24l1331t3691r1601b3776],
24	was	VBD	O	be	auxpass	25	SENT_373	[p24l1635t3710r1773b3754],
25	added	VBN	O	add	advcl	9	SENT_373	[p24l1813t3686r2036b3754],
26	to	TO	O	to	_	0	SENT_373	[p24l2070t3699r2139b3754],
27	inhaled	VBN	O	inhale	amod	28	SENT_373	[p25l9t17r289b85],
28	corticosteroid	NN	O	corticosteroid	prep_to	25	SENT_373	[p25l311t17r821b85],
29	and	CC	O	and	_	0	SENT_373	[p25l843t17r980b85],
30	only	RB	O	only	advmod	33	SENT_373	[p25l1003t17r1162b106],
31	a	DT	O	a	det	33	SENT_373	[p25l1183t41r1221b85],
32	small	JJ	O	small	amod	33	SENT_373	[p25l1245t17r1446b85],
33	difference	NN	O	difference	prep_to	25	SENT_373	[p25l1469t17r1842b85],
34	in	IN	O	in	_	0	SENT_373	[p25l1866t21r1940b84],
35	FEV	NNP	O	FEV	prep_in	33	SENT_373	[p25l1966t21r2141b102],
36	,	,	O	,	_	0	SENT_373	[p25l1966t21r2141b102],
37	(	CD	NUMBER	(	appos	35	SENT_373	[p25l14t132r74b215],
38	3	LS	NUMBER	3	dep	37	SENT_373	[p25l14t132r74b215],
39	-	:	O	-	_	0	SENT_373	[p25l95t165r106b176],
40	5	CD	PERCENT	5	num	41	SENT_373	[p25l128t130r241b196],
41	%	NN	PERCENT	%	dep	33	SENT_373	[p25l128t130r241b196],
42	between	IN	O	between	_	0	SENT_373	[p25l270t125r582b193],
43	treatment	NN	O	treatment	nn	44	SENT_373	[p25l610t139r979b193],
44	groups	NNS	O	group	prep_between	41	SENT_373	[p25l1009t150r1264b215],
45	despite	IN	O	despite	_	0	SENT_373	[p25l1297t125r1561b214],
46	the	DT	O	the	det	47	SENT_373	[p25l1590t125r1707b193],
47	fact	NN	O	fact	prep_despite	25	SENT_373	[p25l1737t125r1871b193],
48	that	IN	O	that	nsubj	50	SENT_373	[p25l1898t125r2043b193],
49	to	TO	O	to	aux	50	SENT_373	[p25l2070t139r2139b193],
50	enter	VB	O	enter	infmod	47	SENT_373	[p25l10t248r202b303],
51	the	DT	O	the	det	52	SENT_373	[p25l221t235r337b303],
52	study	NN	O	study	dobj	50	SENT_373	[p25l362t235r561b324],
53	all	DT	O	all	det	54	SENT_373	[p25l582t235r667b303],
54	patients	NNS	O	patient	nsubj	55	SENT_373	[p25l688t240r981b324],
55	needed	VBD	O	need	rcmod	52	SENT_373	[p25l1005t235r1275b303],
56	to	TO	O	to	aux	57	SENT_373	[p25l1295t248r1363b303],
57	demonstrate	VB	O	demonstrate	xcomp	55	SENT_373	[p25l1387t235r1855b303],
58	a	DT	O	a	det	62	SENT_373	[p25l1878t259r1915b303],
59	>	JJR	O	>	amod	62	SENT_373	[p25l1938t240r2139b306],
60	12	CD	PERCENT	12	number	61	SENT_373	[p25l1938t240r2139b306],
61	%	NN	PERCENT	%	amod	62	SENT_373	[p25l1938t240r2139b306],
62	improvement	NN	O	improvement	dobj	57	SENT_373	[p25l8t349r520b433],
63	in	IN	O	in	_	0	SENT_373	[p25l557t349r632b411],
64	FEV	NNP	O	FEV	prep_in	62	SENT_373	[p25l675t349r850b429],
65	,	,	O	,	_	0	SENT_373	[p25l675t349r850b429],
66	while	IN	O	while	dep	25	SENT_373	[p25l886t345r1089b413],
67	on	IN	O	on	_	0	SENT_373	[p25l1130t369r1223b412],
68	inhaled	VBN	O	inhale	amod	70	SENT_373	[p25l1262t345r1543b412],
69	corticosteroid	NN	O	corticosteroid	nn	70	SENT_373	[p25l1582t345r2136b435],
70	)	NN	O	)	prep_on	25	SENT_373	[p25l1582t345r2136b435],
71	.	.	O	.	_	0	SENT_373	[p25l1582t345r2136b435],

1	Furthermore	RB	O	furthermore	advmod	14	SENT_374	[p25l13t453r509b531],
2	,	,	O	,	_	0	SENT_374	[p25l13t453r509b531],
3	although	IN	O	although	mark	5	SENT_374	[p25l540t453r872b543],
4	there	EX	O	there	expl	5	SENT_374	[p25l897t453r1089b521],
5	was	VBD	O	be	advcl	14	SENT_374	[p25l1114t478r1253b521],
6	a	DT	O	a	det	8	SENT_374	[p25l1283t478r1320b521],
7	substantial	JJ	O	substantial	amod	8	SENT_374	[p25l1349t453r1755b521],
8	reduction	NN	O	reduction	nsubj	5	SENT_374	[p25l1781t453r2140b521],
9	in	IN	O	in	_	0	SENT_374	[p25l8t567r83b629],
10	nocturnal	JJ	O	nocturnal	amod	11	SENT_374	[p25l104t562r466b630],
11	asthma	NN	O	asthma	prep_in	8	SENT_374	[p25l489t562r780b640],
12	,	,	O	,	_	0	SENT_374	[p25l489t562r780b640],
13	there	EX	O	there	expl	14	SENT_374	[p25l804t562r996b630],
14	was	VBD	O	be	_	0	SENT_374	[p25l1016t586r1155b630],
15	no	DT	O	no	det	16	SENT_374	[p25l1179t586r1271b630],
16	difference	NN	O	difference	nsubj	14	SENT_374	[p25l1296t562r1668b630],
17	in	IN	O	in	_	0	SENT_374	[p25l1691t567r1765b629],
18	symptom	NN	O	symptom	nn	19	SENT_374	[p25l1789t575r2140b652],
19	scores	NNS	O	score	prep_in	16	SENT_374	[p25l11t696r259b750],
20	,	,	O	,	_	0	SENT_374	[p25l11t696r259b750],
21	symptom-free	JJ	O	symptom-free	amod	22	SENT_374	[p25l280t671r800b761],
22	days	NNS	DURATION	day	conj_or	19	SENT_374	[p25l817t672r998b761],
23	,	,	O	,	_	0	SENT_374	[p25l817t672r998b761],
24	salbutamol	NN	O	salbutamol	nn	25	SENT_374	[p25l1019t672r1431b740],
25	use	NN	O	use	prep_in	16	SENT_374	[p25l1444t696r1592b750],
26	,	,	O	,	_	0	SENT_374	[p25l1444t696r1592b750],
27	or	CC	O	or	_	0	SENT_374	[p25l1611t696r1688b740],
28	salbutamolfree	NN	O	salbutamolfree	nn	29	SENT_374	[p25l1704t672r2138b740, p25l8t780r150b848],
29	days	NNS	DURATION	day	prep_in	16	SENT_374	[p25l199t780r359b870],
30	between	IN	O	between	_	0	SENT_374	[p25l407t780r719b849],
31	treatment	NN	O	treatment	nn	32	SENT_374	[p25l765t794r1134b848],
32	groups	NNS	O	group	prep_between	29	SENT_374	[p25l1181t805r1457b870],
33	.	.	O	.	_	0	SENT_374	[p25l1181t805r1457b870],

1	It	PRP	O	it	nsubj	3	SENT_375	[p25l1513t787r1567b848],
2	is	VBZ	O	be	cop	3	SENT_375	[p25l1613t785r1670b848],
3	possible	JJ	O	possible	dep	16	SENT_375	[p25l1720t780r2023b869],
4	to	TO	O	to	aux	5	SENT_375	[p25l2070t794r2139b848],
5	speculate	VB	O	speculate	xcomp	3	SENT_375	[p25l11t889r355b978],
6	that	IN	O	that	complm	10	SENT_375	[p25l384t889r529b957],
7	the	DT	O	the	det	9	SENT_375	[p25l556t889r673b957],
8	Arg/Arg	NN	O	arg/arg	nn	9	SENT_375	[p25l702t894r1016b979],
9	participants	NNS	O	participant	nsubj	10	SENT_375	[p25l1045t894r1485b978],
10	(	VBP	O	(	ccomp	5	SENT_375	[p25l1523t894r1707b979],
11	20	CD	PERCENT	20	num	12	SENT_375	[p25l1523t894r1707b979],
12	%	NN	PERCENT	%	dobj	10	SENT_375	[p25l1523t894r1707b979],
13	of	IN	O	of	_	0	SENT_375	[p25l1739t889r1822b957],
14	AfricanAmericans	NNPS	MISC	AfricanAmericans	prep_of	12	SENT_375	[p25l1837t889r2138b957, p25l7t1003r437b1088],
15	)	CD	NUMBER	)	nsubj	16	SENT_375	[p25l1837t889r2138b957, p25l7t1003r437b1088],
16	contributed	VBD	O	contribute	_	0	SENT_375	[p25l537t999r970b1067],
17	to	TO	O	to	_	0	SENT_375	[p25l1061t1012r1130b1067],
18	the	DT	O	the	det	20	SENT_375	[p25l1222t999r1339b1067],
19	small	JJ	O	small	amod	20	SENT_375	[p25l1435t999r1635b1067],
20	degree	NN	O	degree	prep_to	16	SENT_375	[p25l1729t999r1975b1088],
21	of	IN	O	of	_	0	SENT_375	[p25l2070t998r2153b1067],
22	improvement	NN	O	improvement	prep_of	20	SENT_375	[p25l9t1112r520b1196],
23	seen	VBN	O	see	partmod	22	SENT_375	[p25l547t1131r713b1175],
24	in	IN	O	in	_	0	SENT_375	[p25l739t1112r814b1174],
25	this	DT	O	this	det	26	SENT_375	[p25l838t1107r974b1175],
26	study	NN	O	study	prep_in	23	SENT_375	[p25l1005t1107r1213b1197],
27	.	.	O	.	_	0	SENT_375	[p25l1005t1107r1213b1197],

1	We	PRP	O	we	nsubj	2	SENT_376	[p25l78t1223r196b1284],
2	used	VBD	O	use	_	0	SENT_376	[p25l210t1216r387b1284],
3	a	DT	O	a	det	6	SENT_376	[p25l402t1240r438b1284],
4	moderately	RB	O	moderately	advmod	5	SENT_376	[p25l453t1216r871b1306],
5	high	JJ	O	high	amod	6	SENT_376	[p25l883t1216r1054b1306],
6	dose	NN	O	dose	dobj	2	SENT_376	[p25l1070t1216r1236b1284],
7	of	IN	O	of	_	0	SENT_376	[p25l1253t1216r1336b1284],
8	inhaled	VBN	O	inhale	prepc_of	6	SENT_376	[p25l1338t1216r1618b1284],
9	corticosteroid	NN	O	corticosteroid	dobj	8	SENT_376	[p25l1632t1216r2141b1284],
10	in	IN	O	in	_	0	SENT_376	[p25l8t1330r83b1392],
11	this	DT	O	this	det	17	SENT_376	[p25l119t1326r256b1394],
12	study	NN	O	study	nn	17	SENT_376	[p25l298t1326r498b1415],
13	(	NN	O	(	nn	17	SENT_376	[p25l539t1332r687b1415],
14	480	CD	NUMBER	480	num	17	SENT_376	[p25l539t1332r687b1415],
15	pg	NN	O	pg	nn	17	SENT_376	[p25l724t1350r819b1415],
16	hydroﬂuoroalkane	NN	O	hydroﬂuoroalkane	nn	17	SENT_376	[p25l855t1325r1543b1415],
17	beclometasone	NN	O	beclometasone	prep_in	9	SENT_376	[p25l1580t1326r2139b1394],
18	per	IN	O	per	_	0	SENT_376	[p25l8t1459r130b1523],
19	day	NN	DURATION	day	prep_per	17	SENT_376	[p25l166t1434r336b1524],
20	)	CD	NUMBER	)	num	19	SENT_376	[p25l166t1434r336b1524],
21	.	.	O	.	_	0	SENT_376	[p25l166t1434r336b1524],

1	It	PRP	O	it	nsubj	3	SENT_377	[p25l380t1441r434b1502],
2	is	VBZ	O	be	cop	3	SENT_377	[p25l469t1439r526b1502],
3	unclear	JJ	O	unclear	_	0	SENT_377	[p25l563t1434r845b1502],
4	whether	IN	O	whether	complm	8	SENT_377	[p25l877t1434r1186b1502],
5	genotype-speciﬁc	JJ	O	genotype-speciﬁc	amod	6	SENT_377	[p25l1222t1434r1865b1524],
6	effects	NNS	O	effect	nsubj	8	SENT_377	[p25l1902t1435r2138b1502],
7	become	VBP	O	become	cop	8	SENT_377	[p25l7t1544r298b1611],
8	evident	JJ	O	evident	ccomp	3	SENT_377	[p25l333t1544r605b1611],
9	at	IN	O	at	_	0	SENT_377	[p25l638t1557r703b1611],
10	lower	JJR	O	lower	amod	11	SENT_377	[p25l734t1544r941b1611],
11	doses	NNS	O	dose	prep_at	8	SENT_377	[p25l974t1544r1178b1611],
12	of	IN	O	of	_	0	SENT_377	[p25l1215t1544r1298b1611],
13	inhaled	VBN	O	inhale	prepc_of	11	SENT_377	[p25l1318t1544r1599b1611],
14	corticosteroid	NN	O	corticosteroid	dobj	13	SENT_377	[p25l1632t1544r2141b1611],
15	often	RB	O	often	advmod	16	SENT_377	[p25l9t1652r199b1721],
16	used	VBN	O	use	partmod	14	SENT_377	[p25l233t1653r411b1721],
17	in	IN	O	in	_	0	SENT_377	[p25l445t1657r520b1719],
18	combination	NN	O	combination	nn	19	SENT_377	[p25l556t1652r1031b1721],
19	therapy	NN	O	therapy	prep_in	16	SENT_377	[p25l1066t1653r1454b1742],
20	.	.	O	.	_	0	SENT_377	[p25l1066t1653r1454b1742],

1	“‘	NN	O	“‘	ccomp	7	SENT_378	[p25l1066t1653r1454b1742],
2	”	CD	NUMBER	”	num	1	SENT_378	[p25l1066t1653r1454b1742],
3	Additionally	RB	O	additionally	advmod	1	SENT_378	[p25l1488t1653r1956b1742],
4	,	,	O	,	_	0	SENT_378	[p25l1488t1653r1956b1742],
5	it	PRP	O	it	nsubj	7	SENT_378	[p25l1995t1658r2046b1721],
6	is	VBZ	O	be	cop	7	SENT_378	[p25l2080t1658r2137b1721],
7	important	JJ	O	important	_	0	SENT_378	[p25l8t1766r386b1850],
8	to	TO	O	to	aux	9	SENT_378	[p25l429t1775r498b1829],
9	distinguish	VB	O	distinguish	xcomp	7	SENT_378	[p25l546t1761r967b1851],
10	our	PRP$	O	we	poss	11	SENT_378	[p25l1015t1786r1142b1829],
11	study	NN	O	study	nsubj	16	SENT_378	[p25l1189t1761r1388b1851],
12	of	IN	O	of	_	0	SENT_378	[p25l1433t1761r1516b1829],
13	a	DT	O	a	det	15	SENT_378	[p25l1550t1786r1587b1829],
14	longacting	VBG	O	longact	amod	15	SENT_378	[p25l1631t1761r2026b1851],
15	[	NN	O	[	prep_of	11	SENT_378	[p25l2077t1761r2140b1849],
16	3	CD	NUMBER	3	xcomp	9	SENT_378	[p25l2077t1761r2140b1849],
17	,	,	O	,	_	0	SENT_378	[p25l2077t1761r2140b1849],
18	agonist	NN	O	agonist	appos	16	SENT_378	[p25l10t1875r281b1960],
19	from	IN	O	from	_	0	SENT_378	[p25l366t1870r550b1938],
20	studies	NNS	O	study	prep_from	18	SENT_378	[p25l640t1870r899b1938],
21	of	IN	O	of	_	0	SENT_378	[p25l989t1870r1072b1938],
22	shortacting	VBG	O	shortact	prepc_of	20	SENT_378	[p25l1149t1870r1567b1960],
23	[	NN	O	[	dobj	22	SENT_378	[p25l1660t1870r1722b1957],
24	3	CD	NUMBER	3	num	23	SENT_378	[p25l1660t1870r1722b1957],
25	,	,	O	,	_	0	SENT_378	[p25l1660t1870r1722b1957],
26	agonists	NNS	O	agonist	appos	23	SENT_378	[p25l1810t1875r2136b1960],
27	.	.	O	.	_	0	SENT_378	[p25l1810t1875r2136b1960],

1	Retrospective	JJ	O	retrospective	amod	4	SENT_379	[p25l13t1985r508b2069],
2	and	CC	O	and	_	0	SENT_379	[p25l550t1980r688b2047],
3	prospective	JJ	O	prospective	amod	4	SENT_379	[p25l727t1985r1150b2069],
4	studies	NNS	O	study	nsubj	12	SENT_379	[p25l1195t1980r1454b2048],
5	of	IN	O	of	_	0	SENT_379	[p25l1499t1980r1582b2047],
6	shortacting	VBG	O	shortact	prepc_of	4	SENT_379	[p25l1612t1980r2031b2070],
7	[	NN	O	[	dobj	6	SENT_379	[p25l2077t1980r2140b2067],
8	3	CD	NUMBER	3	num	7	SENT_379	[p25l2077t1980r2140b2067],
9	,	,	O	,	_	0	SENT_379	[p25l2077t1980r2140b2067],
10	agonists	NNS	O	agonist	appos	7	SENT_379	[p25l10t2093r315b2178],
11	have	VBP	O	have	aux	12	SENT_379	[p25l359t2088r529b2156],
12	shown	VBN	O	show	_	0	SENT_379	[p25l575t2088r819b2157],
13	genotype-speciﬁc	JJ	O	genotype-speciﬁc	amod	14	SENT_379	[p25l863t2088r1506b2178],
14	effects	NNS	O	effect	dobj	12	SENT_379	[p25l1549t2089r1785b2156],
15	on	IN	O	on	_	0	SENT_379	[p25l1831t2113r1924b2156],
16	peak	NN	O	peak	nn	17	SENT_379	[p25l1966t2088r2142b2177],
17	ﬂow	NN	O	ﬂow	prep_on	12	SENT_379	[p25l9t2197r178b2275],
18	,	,	O	,	_	0	SENT_379	[p25l9t2197r178b2275],
19	drug	NN	O	drug	nn	20	SENT_379	[p25l252t2197r427b2287],
20	use	NN	O	use	prep_on	12	SENT_379	[p25l495t2221r642b2275],
21	,	,	O	,	_	0	SENT_379	[p25l495t2221r642b2275],
22	asthma	NN	O	asthma	nn	23	SENT_379	[p25l717t2197r989b2265],
23	exacerbations	NNS	O	exacerbation	prep_on	12	SENT_379	[p25l1060t2197r1586b2275],
24	,	,	O	,	_	0	SENT_379	[p25l1060t2197r1586b2275],
25	and	CC	O	and	_	0	SENT_379	[p25l1660t2197r1798b2265],
26	asthma	NN	O	asthma	nn	27	SENT_379	[p25l1868t2197r2140b2265],
27	symptoms	NNS	O	symptom	prep_on	12	SENT_379	[p25l11t2310r488b2396],
28	,	,	O	,	_	0	SENT_379	[p25l11t2310r488b2396],
29	”	NN	O	”	appos	27	SENT_379	[p25l11t2310r488b2396],
30	suggesting	VBG	O	suggest	dep	12	SENT_379	[p25l516t2311r919b2397],
31	either	CC	O	either	dep	30	SENT_379	[p25l946t2307r1163b2374],
32	that	IN	O	that	dep	34	SENT_379	[p25l1188t2307r1333b2374],
33	there	EX	O	there	expl	34	SENT_379	[p25l1357t2307r1549b2374],
34	is	VBZ	O	be	conj_and	30	SENT_379	[p25l1576t2311r1634b2374],
35	a	DT	O	a	det	37	SENT_379	[p25l1664t2331r1701b2374],
36	differential	JJ	O	differential	amod	37	SENT_379	[p25l1729t2307r2140b2374],
37	response	NN	O	response	nsubj	34	SENT_379	[p25l8t2441r342b2505],
38	between	IN	O	between	_	0	SENT_379	[p25l368t2416r680b2485],
39	shortacting	NN	O	shortacting	prep_between	37	SENT_379	[p25l709t2416r1127b2506],
40	and	CC	O	and	_	0	SENT_379	[p25l1155t2416r1292b2484],
41	longacting	VBG	O	longact	conj_and	30	SENT_379	[p25l1316t2416r1710b2506],
42	[	CD	NUMBER	[	number	43	SENT_379	[p25l1742t2416r1805b2504],
43	3	CD	NUMBER	3	dobj	41	SENT_379	[p25l1742t2416r1805b2504],
44	,	,	O	,	_	0	SENT_379	[p25l1742t2416r1805b2504],
45	agonists	NNS	O	agonist	dobj	41	SENT_379	[p25l1832t2421r2137b2506],
46	or	CC	O	or	_	0	SENT_379	[p25l10t2549r86b2593],
47	that	IN	O	that	complm	51	SENT_379	[p25l167t2525r312b2593],
48	inhaled	VBN	O	inhale	csubj	51	SENT_379	[p25l395t2525r675b2593],
49	corticosteroid	NN	O	corticosteroid	dobj	48	SENT_379	[p25l759t2525r1268b2593],
50	might	MD	O	might	aux	51	SENT_379	[p25l1351t2525r1577b2615],
51	prevent	VB	O	prevent	conj_or	45	SENT_379	[p25l1659t2538r1941b2614],
52	the	DT	O	the	det	54	SENT_379	[p25l2023t2525r2139b2593],
53	detrimental	JJ	O	detrimental	amod	54	SENT_379	[p25l9t2635r445b2703],
54	response	NN	O	response	dobj	51	SENT_379	[p25l480t2659r814b2724],
55	seen	VBN	O	see	partmod	54	SENT_379	[p25l852t2659r1018b2703],
56	with	IN	O	with	_	0	SENT_379	[p25l1051t2635r1216b2703],
57	shortacting	VBG	O	shortact	prepc_with	55	SENT_379	[p25l1253t2635r1672b2725],
58	[	NN	O	[	dobj	57	SENT_379	[p25l1711t2635r1774b2722],
59	3	CD	NUMBER	3	num	58	SENT_379	[p25l1711t2635r1774b2722],
60	,	,	O	,	_	0	SENT_379	[p25l1711t2635r1774b2722],
61	agonists	NNS	O	agonist	appos	58	SENT_379	[p25l1810t2640r2136b2725],
62	.	.	O	.	_	0	SENT_379	[p25l1810t2640r2136b2725],

1	Additionally	RB	O	additionally	advmod	9	SENT_380	[p25l7t2743r475b2833],
2	,	,	O	,	_	0	SENT_380	[p25l7t2743r475b2833],
3	the	DT	O	the	det	5	SENT_380	[p25l536t2743r652b2811],
4	Arg/Arg	NN	O	arg/arg	nn	5	SENT_380	[p25l710t2749r1024b2833],
5	associations	NNS	O	association	nsubj	9	SENT_380	[p25l1084t2748r1531b2811],
6	might	MD	O	might	aux	9	SENT_380	[p25l1592t2743r1818b2833],
7	not	RB	O	not	neg	9	SENT_380	[p25l1875t2757r1998b2811],
8	be	VB	O	be	cop	9	SENT_380	[p25l2053t2743r2139b2811],
9	causative	JJ	O	causative	_	0	SENT_380	[p25l9t2857r366b2920],
10	.	.	O	.	_	0	SENT_380	[p25l9t2857r366b2920],

1	These	DT	O	these	det	2	SENT_381	[p25l419t2852r642b2920],
2	polymorphisms	NNS	O	polymorphism	nsubj	4	SENT_381	[p25l692t2852r1282b2941],
3	might	MD	O	might	aux	4	SENT_381	[p25l1334t2852r1561b2942],
4	be	VB	O	be	_	0	SENT_381	[p25l1607t2852r1694b2920],
5	in	IN	O	in	_	0	SENT_381	[p25l1744t2857r1818b2919],
6	linkage	NN	O	linkage	nn	7	SENT_381	[p25l1867t2852r2139b2942],
7	disequilibrium	NN	O	disequilibrium	prep_in	4	SENT_381	[p25l10t2963r567b3051],
8	with	IN	O	with	_	0	SENT_381	[p25l610t2963r776b3030],
9	other	JJ	O	other	amod	10	SENT_381	[p25l822t2963r1017b3031],
10	polymorphisms	NNS	O	polymorphism	prep_with	4	SENT_381	[p25l1060t2963r1650b3052],
11	that	WDT	O	that	nsubj	18	SENT_381	[p25l1697t2963r1842b3031],
12	are	VBP	O	be	cop	18	SENT_381	[p25l1886t2987r2017b3041],
13	,	,	O	,	_	0	SENT_381	[p25l1886t2987r2017b3041],
14	in	IN	O	in	advmod	18	SENT_381	[p25l2065t2967r2140b3029],
15	fact	NN	O	fact	dep	14	SENT_381	[p25l8t3071r160b3149],
16	,	,	O	,	_	0	SENT_381	[p25l8t3071r160b3149],
17	biologically	RB	O	biologically	advmod	18	SENT_381	[p25l180t3071r605b3161],
18	important	JJ	O	important	rcmod	10	SENT_381	[p25l621t3076r1015b3160],
19	.	.	O	.	_	0	SENT_381	[p25l621t3076r1015b3160],

1	Since	IN	O	since	mark	5	SENT_382	[p25l1043t3076r1239b3139],
2	our	PRP$	O	we	poss	3	SENT_382	[p25l1259t3096r1387b3139],
3	study	NN	O	study	nsubjpass	5	SENT_382	[p25l1406t3071r1605b3161],
4	was	VBD	O	be	auxpass	5	SENT_382	[p25l1619t3096r1757b3139],
5	genotypestratiﬁed	VBN	O	genotypestratiﬁed	advcl	10	SENT_382	[p25l1779t3085r2138b3161, p25l11t3181r357b3259],
6	,	,	O	,	_	0	SENT_382	[p25l1779t3085r2138b3161, p25l11t3181r357b3259],
7	we	PRP	O	we	nsubj	10	SENT_382	[p25l431t3205r534b3249],
8	could	MD	O	could	aux	10	SENT_382	[p25l608t3181r811b3249],
9	not	RB	O	not	neg	10	SENT_382	[p25l882t3194r1004b3249],
10	assess	VB	O	assess	_	0	SENT_382	[p25l1076t3205r1302b3249],
11	whether	IN	O	whether	complm	16	SENT_382	[p25l1375t3181r1684b3249],
12	haplotypic	JJ	O	haplotypic	amod	13	SENT_382	[p25l1753t3181r2140b3270],
13	combinations	NNS	O	combination	nsubj	16	SENT_382	[p25l9t3291r519b3359],
14	of	IN	O	of	_	0	SENT_382	[p25l571t3290r654b3359],
15	polymorphisms	NNS	O	polymorphism	prep_of	13	SENT_382	[p25l688t3290r1278b3380],
16	showed	VBD	O	show	ccomp	10	SENT_382	[p25l1332t3291r1613b3359],
17	even	RB	O	even	advmod	18	SENT_382	[p25l1661t3315r1832b3359],
18	greater	JJR	O	greater	amod	19	SENT_382	[p25l1881t3304r2141b3380],
19	associations	NNS	O	association	dobj	16	SENT_382	[p25l10t3404r457b3467],
20	than	IN	O	than	_	0	SENT_382	[p25l484t3399r653b3467],
21	those	DT	O	those	prep_than	16	SENT_382	[p25l678t3399r877b3467],
22	we	PRP	O	we	nsubj	23	SENT_382	[p25l902t3424r1004b3467],
23	detected	VBD	O	detect	dep	16	SENT_382	[p25l1032t3399r1358b3467],
24	.	.	O	.	_	0	SENT_382	[p25l1032t3399r1358b3467],

1	Thus	RB	O	thus	advmod	6	SENT_383	[p25l78t3508r289b3586],
2	,	,	O	,	_	0	SENT_383	[p25l78t3508r289b3586],
3	the	DT	O	the	det	5	SENT_383	[p25l321t3508r437b3576],
4	LARGE	NNP	O	LARGE	nn	5	SENT_383	[p25l471t3512r747b3576],
5	study	NN	O	study	nsubj	6	SENT_383	[p25l782t3508r982b3597],
6	showed	VBD	O	show	_	0	SENT_383	[p25l1012t3508r1294b3576],
7	that	IN	O	that	_	0	SENT_383	[p25l1322t3508r1466b3576],
8	B16	NN	O	b16	nn	9	SENT_383	[p25l1499t3514r1628b3576],
9	Arg/Arg	NN	O	arg/arg	prep_that	6	SENT_383	[p25l1658t3513r1972b3598],
10	and	CC	O	and	advmod	6	SENT_383	[p25l2003t3508r2141b3576],

1	B16	NN	O	b16	nn	3	SENT_384	[p26l13t23r142b85],
2	Gly/Gly	NN	O	gly/gly	nn	3	SENT_384	[p26l208t17r502b106],
3	patients	NNS	O	patient	nsubj	6	SENT_384	[p26l561t21r855b105],
4	with	IN	O	with	_	0	SENT_384	[p26l918t17r1083b85],
5	asthma	NN	O	asthma	prep_with	3	SENT_384	[p26l1145t17r1418b85],
6	had	VBD	O	have	_	0	SENT_384	[p26l1478t17r1617b85],
7	similar	JJ	O	similar	amod	10	SENT_384	[p26l1680t17r1942b85],
8	and	CC	O	and	_	0	SENT_384	[p26l2003t17r2141b85],
9	substantial	JJ	O	substantial	amod	10	SENT_384	[p26l11t125r416b193],
10	improvements	NNS	O	improvement	dobj	6	SENT_384	[p26l484t130r1029b214],
11	in	IN	O	in	_	0	SENT_384	[p26l1099t130r1174b192],
12	airway	NN	O	airway	nn	13	SENT_384	[p26l1242t130r1484b215],
13	function	NN	O	function	prep_in	10	SENT_384	[p26l1550t125r1867b193],
14	when	WRB	O	when	advmod	17	SENT_384	[p26l1934t125r2140b193],
15	salmeterol	NN	O	salmeterol	nsubjpass	17	SENT_384	[p26l11t236r400b304],
16	was	VBD	O	be	auxpass	17	SENT_384	[p26l436t260r574b304],
17	added	VBN	O	add	dep	10	SENT_384	[p26l616t236r838b304],
18	to	TO	O	to	aux	19	SENT_384	[p26l874t249r943b304],
19	inhaled	VBN	O	inhale	xcomp	17	SENT_384	[p26l982t236r1263b304],
20	corticosteroid	NN	O	corticosteroid	nn	21	SENT_384	[p26l1300t236r1809b304],
21	therapy	NN	O	therapy	dobj	19	SENT_384	[p26l1845t236r2135b325],
22	.	.	O	.	_	0	SENT_384	[p26l1845t236r2135b325],

1	These	DT	O	these	det	2	SENT_385	[p26l7t345r230b413],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_385	[p26l265t344r572b434],
3	provide	VBP	O	provide	ccomp	26	SENT_385	[p26l610t344r887b433],
4	reassurance	NN	O	reassurance	dobj	3	SENT_385	[p26l923t369r1369b413],
5	that	IN	O	that	complm	14	SENT_385	[p26l1403t345r1566b423],
6	,	,	O	,	_	0	SENT_385	[p26l1403t345r1566b423],
7	in	IN	O	in	_	0	SENT_385	[p26l1604t349r1678b411],
8	the	DT	O	the	det	10	SENT_385	[p26l1712t345r1828b413],
9	general	JJ	O	general	amod	10	SENT_385	[p26l1865t345r2140b434],
10	population	NN	O	population	prep_in	14	SENT_385	[p26l8t454r432b543],
11	,	,	O	,	_	0	SENT_385	[p26l8t454r432b543],
12	patients	NNS	O	patient	nsubj	14	SENT_385	[p26l471t459r765b543],
13	should	MD	O	should	aux	14	SENT_385	[p26l806t454r1058b523],
14	continue	VB	O	continue	ccomp	3	SENT_385	[p26l1094t459r1422b523],
15	to	TO	O	to	aux	17	SENT_385	[p26l1458t468r1527b522],
16	be	VB	O	be	auxpass	17	SENT_385	[p26l1562t454r1648b523],
17	treated	VBN	O	treat	xcomp	14	SENT_385	[p26l1684t454r1942b522],
18	with	IN	O	with	_	0	SENT_385	[p26l1975t454r2140b523],
19	longacting	VBG	O	longact	prepc_with	17	SENT_385	[p26l7t563r402b653],
20	[	NN	O	[	dobj	19	SENT_385	[p26l482t563r545b650],
21	3	CD	NUMBER	3	num	20	SENT_385	[p26l482t563r545b650],
22	,	,	O	,	_	0	SENT_385	[p26l482t563r545b650],
23	agonists	NNS	O	agonist	nsubj	26	SENT_385	[p26l621t568r925b653],
24	plus	CC	O	plus	prep	23	SENT_385	[p26l1003t563r1158b652],
25	moderate-dose	NN	O	moderate-dose	dep	24	SENT_385	[p26l1235t563r1785b631],
26	inhaled	VBD	O	inhale	_	0	SENT_385	[p26l1861t563r2141b631],
27	corticosteroids	NNS	O	corticosteroid	dobj	26	SENT_385	[p26l9t673r553b740],
28	irrespective	RB	O	irrespective	_	0	SENT_385	[p26l578t677r1008b762],
29	of	IN	O	of	_	0	SENT_385	[p26l1032t673r1115b740],
30	B16	NN	O	b16	nn	31	SENT_385	[p26l1129t679r1258b740],
31	genotype	NN	O	genotype	prep_irrespective_of	26	SENT_385	[p26l1284t686r1639b763],
32	.	.	O	.	_	0	SENT_385	[p26l1284t686r1639b763],

1	I-Iowever	NNP	O	I-Iowever	nsubj	4	SENT_386	[p26l1669t679r2012b751],
2	,	,	O	,	_	0	SENT_386	[p26l1669t679r2012b751],
3	we	PRP	O	we	nsubj	4	SENT_386	[p26l2037t697r2139b741],
4	need	VBP	O	need	_	0	SENT_386	[p26l8t781r189b849],
5	to	TO	O	to	aux	7	SENT_386	[p26l256t795r325b849],
6	further	RB	O	further	advmod	7	SENT_386	[p26l396t781r662b849],
7	investigate	VB	O	investigate	xcomp	4	SENT_386	[p26l730t786r1129b871],
8	the	DT	O	the	det	9	SENT_386	[p26l1198t781r1314b849],
9	importance	NN	O	importance	dobj	7	SENT_386	[p26l1385t786r1813b870],
10	of	IN	O	of	_	0	SENT_386	[p26l1884t781r1968b849],
11	the	DT	O	the	det	13	SENT_386	[p26l2023t781r2139b849],
12	genotype-differentiated	JJ	O	genotype-differentiated	amod	13	SENT_386	[p26l10t891r880b981],
13	response	NN	O	response	prep_of	9	SENT_386	[p26l947t915r1281b980],
14	in	IN	O	in	_	0	SENT_386	[p26l1351t896r1425b958],
15	airway	NN	O	airway	nn	16	SENT_386	[p26l1496t896r1737b980],
16	reactivity	NN	O	reactivity	prep_in	13	SENT_386	[p26l1805t896r2142b981],
17	favouring	VBG	O	favour	partmod	16	SENT_386	[p26l9t1000r369b1090],
18	Gly/Gly	NN	O	gly/gly	nn	19	SENT_386	[p26l394t1000r688b1090],
19	participants	NNS	O	participant	dobj	17	SENT_386	[p26l708t1005r1169b1089],
20	,	,	O	,	_	0	SENT_386	[p26l708t1005r1169b1089],
21	as	RB	O	as	_	0	SENT_386	[p26l1197t1025r1269b1069],
22	well	RB	O	well	_	0	SENT_386	[p26l1292t1000r1443b1069],
23	as	IN	O	as	_	0	SENT_386	[p26l1467t1025r1539b1069],
24	the	DT	O	the	det	25	SENT_386	[p26l1563t1001r1679b1069],
25	ﬁnding	NN	O	ﬁnding	dobj	7	SENT_386	[p26l1703t1000r1975b1090],
26	that	WDT	O	that	dobj	35	SENT_386	[p26l1996t1000r2141b1069],
27	African-Americans	NNPS	MISC	African-Americans	nsubj	35	SENT_386	[p26l7t1109r717b1177],
28	with	IN	O	with	_	0	SENT_386	[p26l743t1109r908b1177],
29	the	DT	O	the	predet	32	SENT_386	[p26l932t1109r1048b1177],
30	the	DT	O	the	det	32	SENT_386	[p26l1073t1109r1189b1177],
31	Arg/Arg	NN	O	arg/arg	nn	32	SENT_386	[p26l1214t1115r1528b1199],
32	genotype	NN	O	genotype	prep_with	27	SENT_386	[p26l1554t1123r1890b1199],
33	might	MD	O	might	aux	35	SENT_386	[p26l1915t1109r2141b1199],
34	not	RB	O	not	neg	35	SENT_386	[p26l9t1231r131b1285],
35	beneﬁt	VB	O	beneﬁt	rcmod	25	SENT_386	[p26l154t1218r415b1286],
36	from	IN	O	from	_	0	SENT_386	[p26l439t1218r623b1285],
37	treatment	NN	O	treatment	prep_from	35	SENT_386	[p26l648t1231r1017b1286],
38	with	IN	O	with	_	0	SENT_386	[p26l1039t1218r1204b1286],
39	salmeterol	NN	O	salmeterol	prep_with	35	SENT_386	[p26l1232t1218r1640b1286],
40	.	.	O	.	_	0	SENT_386	[p26l1232t1218r1640b1286],

1	Contributors	NNS	O	contributor	nn	2	SENT_387	[p26l9t1363r368b1414],
2	MEW	NN	O	mew	_	0	SENT_387	[p26l10t1451r181b1509],
3	,	,	O	,	_	0	SENT_387	[p26l10t1451r181b1509],
4	SIK	NNP	O	SIK	nn	8	SENT_387	[p26l208t1452r325b1516],
5	,	,	O	,	_	0	SENT_387	[p26l208t1452r325b1516],
6	VMC	NNP	ORGANIZATION	VMC	appos	8	SENT_387	[p26l346t1452r514b1509],
7	,	,	O	,	_	0	SENT_387	[p26l346t1452r514b1509],
8	EB	NNP	O	EB	appos	2	SENT_387	[p26l539t1451r633b1509],
9	,	,	O	,	_	0	SENT_387	[p26l539t1451r633b1509],
10	I	PRP	O	I	dep	8	SENT_387	[p26l658t1452r816b1509],
11	.	.	O	.	_	0	SENT_387	[p26l658t1452r816b1509],

1	—	NN	O	—	_	0	SENT_388	[p26l658t1452r816b1509],
2	.	.	O	.	_	0	SENT_388	[p26l658t1452r816b1509],

1	IAB	NNP	ORGANIZATION	IAB	nn	15	SENT_389	[p26l658t1452r816b1509],
2	,	,	O	,	_	0	SENT_389	[p26l658t1452r816b1509],
3	BTA	NNP	ORGANIZATION	BTA	appos	15	SENT_389	[p26l841t1451r975b1509],
4	,	,	O	,	_	0	SENT_389	[p26l841t1451r975b1509],
5	MC	NNP	O	MC	appos	15	SENT_389	[p26l999t1452r1118b1509],
6	,	,	O	,	_	0	SENT_389	[p26l999t1452r1118b1509],
7	TIC	NNP	O	TIC	appos	15	SENT_389	[p26l1139t1451r1266b1516],
8	,	,	O	,	_	0	SENT_389	[p26l1139t1451r1266b1516],
9	IVF	NNP	O	IVF	appos	15	SENT_389	[p26l1289t1451r1411b1516],
10	,	,	O	,	_	0	SENT_389	[p26l1289t1451r1411b1516],
11	NI	NNP	O	NI	appos	15	SENT_389	[p26l1435t1453r1521b1516],
12	,	,	O	,	_	0	SENT_389	[p26l1435t1453r1521b1516],
13	SKa	NNP	O	SKa	appos	15	SENT_389	[p26l1548t1452r1672b1509],
14	,	,	O	,	_	0	SENT_389	[p26l1548t1452r1672b1509],
15	MK	NNP	O	MK	nsubj	39	SENT_389	[p26l1696t1453r1814b1509],
16	,	,	O	,	_	0	SENT_389	[p26l1696t1453r1814b1509],
17	SCL	NN	ORGANIZATION	scl	nsubj	39	SENT_389	[p26l1840t1452r1970b1509],
18	,	,	O	,	_	0	SENT_389	[p26l1840t1452r1970b1509],
19	RFL	NNP	ORGANIZATION	RFL	nn	35	SENT_389	[p26l1995t1451r2127b1509],
20	,	,	O	,	_	0	SENT_389	[p26l1995t1451r2127b1509],
21	RIM	NNP	O	RIM	appos	35	SENT_389	[p26l12t1540r153b1602],
22	,	,	O	,	_	0	SENT_389	[p26l12t1540r153b1602],
23	SPP	NNP	O	SPP	appos	35	SENT_389	[p26l180t1539r310b1595],
24	,	,	O	,	_	0	SENT_389	[p26l180t1539r310b1595],
25	IR	NNP	O	IR	appos	35	SENT_389	[p26l334t1540r415b1602],
26	,	,	O	,	_	0	SENT_389	[p26l334t1540r415b1602],
27	CAS	NNP	ORGANIZATION	CAS	appos	35	SENT_389	[p26l439t1538r582b1595],
28	,	,	O	,	_	0	SENT_389	[p26l439t1538r582b1595],
29	ERS	NNP	O	ERS	appos	35	SENT_389	[p26l606t1538r740b1595],
30	,	,	O	,	_	0	SENT_389	[p26l606t1538r740b1595],
31	SIS	NNP	O	SIS	appos	35	SENT_389	[p26l767t1538r877b1602],
32	,	,	O	,	_	0	SENT_389	[p26l767t1538r877b1602],
33	MIW	NNP	O	MIW	appos	35	SENT_389	[p26l902t1540r1058b1602],
34	,	,	O	,	_	0	SENT_389	[p26l902t1540r1058b1602],
35	SW	NNP	O	SW	conj_and	15	SENT_389	[p26l1084t1539r1188b1595],
36	,	,	O	,	_	0	SENT_389	[p26l1084t1539r1188b1595],
37	and	CC	O	and	_	0	SENT_389	[p26l1212t1534r1318b1587],
38	EI	NN	O	eus	conj_and	15	SENT_389	[p26l1340t1538r1398b1586],
39	participated	VBD	O	participate	_	0	SENT_389	[p26l1419t1534r1761b1603],
40	in	IN	O	in	_	0	SENT_389	[p26l1779t1538r1837b1586],
41	the	DT	O	the	det	44	SENT_389	[p26l1855t1534r1945b1587],
42	design	NN	O	design	nn	44	SENT_389	[p26l9t1620r199b1691],
43	ofthe	NN	O	ofthe	nn	44	SENT_389	[p26l219t1620r382b1673],
44	study	NN	O	study	prep_in	39	SENT_389	[p26l403t1620r565b1690],
45	.	.	O	.	_	0	SENT_389	[p26l403t1620r565b1690],

1	MEW	NNP	O	MEW	nn	21	SENT_390	[p26l590t1624r760b1682],
2	,	,	O	,	_	0	SENT_390	[p26l590t1624r760b1682],
3	SIK	NNP	O	SIK	appos	21	SENT_390	[p26l786t1625r904b1689],
4	,	,	O	,	_	0	SENT_390	[p26l786t1625r904b1689],
5	VMC	NNP	ORGANIZATION	VMC	appos	21	SENT_390	[p26l925t1625r1093b1681],
6	,	,	O	,	_	0	SENT_390	[p26l925t1625r1093b1681],
7	EB	NNP	O	EB	appos	21	SENT_390	[p26l1118t1624r1212b1682],
8	,	,	O	,	_	0	SENT_390	[p26l1118t1624r1212b1682],
9	HAB	NNP	O	HAB	appos	21	SENT_390	[p26l1237t1625r1395b1682],
10	,	,	O	,	_	0	SENT_390	[p26l1237t1625r1395b1682],
11	WIC	NNP	LOCATION	WIC	appos	21	SENT_390	[p26l1416t1625r1566b1689],
12	,	,	O	,	_	0	SENT_390	[p26l1416t1625r1566b1689],
13	BTA	NNP	ORGANIZATION	BTA	appos	21	SENT_390	[p26l1591t1624r1725b1682],
14	,	,	O	,	_	0	SENT_390	[p26l1591t1624r1725b1682],
15	MC	NNP	O	MC	appos	21	SENT_390	[p26l1749t1625r1868b1682],
16	,	,	O	,	_	0	SENT_390	[p26l1749t1625r1868b1682],
17	IVF	NNP	O	IVF	appos	21	SENT_390	[p26l1892t1624r2013b1689],
18	,	,	O	,	_	0	SENT_390	[p26l1892t1624r2013b1689],
19	NI	NNP	O	NI	appos	21	SENT_390	[p26l2038t1626r2124b1689],
20	,	,	O	,	_	0	SENT_390	[p26l2038t1626r2124b1689],
21	SKa	NNP	O	SKa	nsubj	51	SENT_390	[p26l13t1712r136b1769],
22	,	,	O	,	_	0	SENT_390	[p26l13t1712r136b1769],
23	SKi	NNS	O	ski	appos	21	SENT_390	[p26l163t1711r274b1769],
24	,	,	O	,	_	0	SENT_390	[p26l163t1711r274b1769],
25	SCL	NN	ORGANIZATION	scl	appos	21	SENT_390	[p26l301t1712r431b1769],
26	,	,	O	,	_	0	SENT_390	[p26l301t1712r431b1769],
27	RFL	NNP	ORGANIZATION	RFL	nn	41	SENT_390	[p26l456t1711r587b1769],
28	,	,	O	,	_	0	SENT_390	[p26l456t1711r587b1769],
29	AM	NNP	O	AM	appos	41	SENT_390	[p26l608t1711r731b1769],
30	,	,	O	,	_	0	SENT_390	[p26l608t1711r731b1769],
31	RIM	NNP	O	RIM	appos	41	SENT_390	[p26l756t1713r898b1776],
32	,	,	O	,	_	0	SENT_390	[p26l756t1713r898b1776],
33	PP	NNP	O	PP	appos	41	SENT_390	[p26l924t1713r1016b1769],
34	,	,	O	,	_	0	SENT_390	[p26l924t1713r1016b1769],
35	SPP	NNP	O	SPP	appos	41	SENT_390	[p26l1042t1712r1172b1769],
36	,	,	O	,	_	0	SENT_390	[p26l1042t1712r1172b1769],
37	IR	NNP	O	IR	appos	41	SENT_390	[p26l1196t1713r1277b1776],
38	,	,	O	,	_	0	SENT_390	[p26l1196t1713r1277b1776],
39	CAS	NNP	ORGANIZATION	CAS	appos	41	SENT_390	[p26l1301t1711r1443b1769],
40	,	,	O	,	_	0	SENT_390	[p26l1301t1711r1443b1769],
41	ERS	NNP	O	ERS	appos	21	SENT_390	[p26l1468t1711r1603b1769],
42	,	,	O	,	_	0	SENT_390	[p26l1468t1711r1603b1769],
43	sis	NN	O	si	appos	21	SENT_390	[p26l1629t1712r1740b1776],
44	,	,	O	,	_	0	SENT_390	[p26l1629t1712r1740b1776],
45	MIW	NN	O	miw	conj_and	43	SENT_390	[p26l1764t1713r1920b1776],
46	,	,	O	,	_	0	SENT_390	[p26l1764t1713r1920b1776],
47	sw	NN	O	sw	conj_and	43	SENT_390	[p26l1946t1712r2051b1769],
48	,	,	O	,	_	0	SENT_390	[p26l1946t1712r2051b1769],
49	and	CC	O	and	_	0	SENT_390	[p26l9t1794r116b1847],
50	EI	NN	O	eus	conj_and	43	SENT_390	[p26l137t1798r195b1847],
51	participated	VBD	O	participate	_	0	SENT_390	[p26l217t1794r559b1864],
52	in	IN	O	in	_	0	SENT_390	[p26l577t1798r634b1847],
53	the	DT	O	the	det	54	SENT_390	[p26l653t1794r743b1847],
54	running	NN	O	running	prep_in	51	SENT_390	[p26l763t1798r1002b1864],
55	of	IN	O	of	_	0	SENT_390	[p26l1022t1794r1086b1847],
56	the	DT	O	the	det	57	SENT_390	[p26l1095t1794r1185b1847],
57	study	NN	O	study	prep_of	54	SENT_390	[p26l1207t1794r1368b1864],
58	.	.	O	.	_	0	SENT_390	[p26l1207t1794r1368b1864],

1	MEW	NNP	O	MEW	_	0	SENT_391	[p26l1393t1798r1563b1855],
2	,	,	O	,	_	0	SENT_391	[p26l1393t1798r1563b1855],
3	SIK	NNP	O	SIK	nn	7	SENT_391	[p26l1589t1798r1707b1863],
4	,	,	O	,	_	0	SENT_391	[p26l1589t1798r1707b1863],
5	VMC	NNP	ORGANIZATION	VMC	appos	7	SENT_391	[p26l1728t1798r1896b1855],
6	,	,	O	,	_	0	SENT_391	[p26l1728t1798r1896b1855],
7	HAB	NNP	O	HAB	appos	1	SENT_391	[p26l1921t1798r2079b1855],
8	,	,	O	,	_	0	SENT_391	[p26l1921t1798r2079b1855],

1	www	NN	O	www	_	0	SENT_392	[p26l724t2045r1256b2096],
2	.	.	O	.	_	0	SENT_392	[p26l724t2045r1256b2096],

1	the	DT	O	the	det	2	SENT_393	[p26l724t2045r1256b2096],
2	|	NN	O	|	_	0	SENT_393	[p26l724t2045r1256b2096],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_393	[p26l724t2045r1256b2096],
4	Vol	NNP	O	Vol	dep	2	SENT_393	[p26l1299t2045r1386b2096],
5	374	CD	NUMBER	374	num	6	SENT_393	[p26l1406t2052r1508b2104],
6	November	NNP	DATE	November	dep	2	SENT_393	[p26l1556t2045r1849b2096],
7	21,2009	CD	DATE	21,2009	num	6	SENT_393	[p26l1866t2052r2110b2105],

1	Articles	NNPS	O	Articles	_	0	SENT_394	[p26l6t2312r156b2348],
2	I	PRP	O	I	dep	1	SENT_394	[p26l204t2180r252b2348],

1	WIC	NNP	LOCATION	WIC	nn	7	SENT_395	[p26l6t2608r157b2672],
2	,	,	O	,	_	0	SENT_395	[p26l6t2608r157b2672],
3	BTA	NNP	ORGANIZATION	BTA	appos	7	SENT_395	[p26l183t2608r317b2665],
4	,	,	O	,	_	0	SENT_395	[p26l183t2608r317b2665],
5	MC	NNP	O	MC	appos	7	SENT_395	[p26l342t2608r462b2666],
6	,	,	O	,	_	0	SENT_395	[p26l342t2608r462b2666],
7	LD	NNP	O	LD	nsubj	35	SENT_395	[p26l487t2609r585b2666],
8	,	,	O	,	_	0	SENT_395	[p26l487t2609r585b2666],
9	SKi	NNS	O	ski	nsubj	35	SENT_395	[p26l612t2608r724b2666],
10	,	,	O	,	_	0	SENT_395	[p26l612t2608r724b2666],
11	MK	NNP	O	MK	nn	31	SENT_395	[p26l748t2609r867b2666],
12	,	,	O	,	_	0	SENT_395	[p26l748t2609r867b2666],
13	sCL	NNP	ORGANIZATION	sCL	appos	31	SENT_395	[p26l894t2608r1024b2666],
14	,	,	O	,	_	0	SENT_395	[p26l894t2608r1024b2666],
15	RFL	NNP	ORGANIZATION	RFL	appos	31	SENT_395	[p26l1050t2608r1182b2665],
16	,	,	O	,	_	0	SENT_395	[p26l1050t2608r1182b2665],
17	AM	NNP	O	AM	appos	31	SENT_395	[p26l1203t2608r1326b2666],
18	,	,	O	,	_	0	SENT_395	[p26l1203t2608r1326b2666],
19	RIM	NNP	O	RIM	appos	31	SENT_395	[p26l1352t2609r1495b2672],
20	,	,	O	,	_	0	SENT_395	[p26l1352t2609r1495b2672],
21	PP	NNP	O	PP	appos	31	SENT_395	[p26l1520t2609r1613b2666],
22	,	,	O	,	_	0	SENT_395	[p26l1520t2609r1613b2666],
23	IR	NNP	O	IR	appos	31	SENT_395	[p26l1637t2609r1719b2672],
24	,	,	O	,	_	0	SENT_395	[p26l1637t2609r1719b2672],
25	CAS	NNP	ORGANIZATION	CAS	appos	31	SENT_395	[p26l1743t2608r1886b2665],
26	,	,	O	,	_	0	SENT_395	[p26l1743t2608r1886b2665],
27	ERS	NNP	O	ERS	appos	31	SENT_395	[p26l1912t2608r2046b2665],
28	,	,	O	,	_	0	SENT_395	[p26l1912t2608r2046b2665],
29	SIS	NNP	O	SIS	appos	31	SENT_395	[p26l12t2694r123b2759],
30	,	,	O	,	_	0	SENT_395	[p26l12t2694r123b2759],
31	SW	NNP	O	SW	nsubj	35	SENT_395	[p26l150t2694r255b2752],
32	,	,	O	,	_	0	SENT_395	[p26l150t2694r255b2752],
33	and	CC	O	and	_	0	SENT_395	[p26l278t2691r386b2744],
34	EI	NN	O	eus	nsubj	35	SENT_395	[p26l407t2694r465b2743],
35	participated	VBD	O	participate	_	0	SENT_395	[p26l488t2691r831b2760],
36	in	IN	O	in	_	0	SENT_395	[p26l850t2694r908b2743],
37	analysis	NN	O	analysis	prep_in	35	SENT_395	[p26l928t2691r1155b2760],
38	of	IN	O	of	_	0	SENT_395	[p26l1177t2691r1242b2744],
39	the	DT	O	the	det	40	SENT_395	[p26l1250t2691r1341b2744],
40	data	NNS	O	datum	prep_of	37	SENT_395	[p26l1362t2691r1494b2744],
41	.	.	O	.	_	0	SENT_395	[p26l1362t2691r1494b2744],

1	MEW	NNP	O	MEW	dep	23	SENT_396	[p26l1519t2694r1691b2752],
2	,	,	O	,	_	0	SENT_396	[p26l1519t2694r1691b2752],
3	SIK	NNP	O	SIK	appos	1	SENT_396	[p26l1718t2694r1836b2759],
4	,	,	O	,	_	0	SENT_396	[p26l1718t2694r1836b2759],
5	VMC	NNP	ORGANIZATION	VMC	appos	1	SENT_396	[p26l1857t2694r2026b2752],
6	,	,	O	,	_	0	SENT_396	[p26l1857t2694r2026b2752],
7	EB	NNP	O	EB	appos	1	SENT_396	[p26l2052t2694r2146b2752],
8	,	,	O	,	_	0	SENT_396	[p26l2052t2694r2146b2752],
9	I-IAB	NN	O	i-iab	appos	1	SENT_396	[p26l11t2782r170b2839],
10	,	,	O	,	_	0	SENT_396	[p26l11t2782r170b2839],
11	WIC	NNP	LOCATION	WIC	nn	19	SENT_396	[p26l191t2782r342b2846],
12	,	,	O	,	_	0	SENT_396	[p26l191t2782r342b2846],
13	BTA	NNP	ORGANIZATION	BTA	appos	19	SENT_396	[p26l367t2781r502b2839],
14	,	,	O	,	_	0	SENT_396	[p26l367t2781r502b2839],
15	MC	NNP	O	MC	appos	19	SENT_396	[p26l526t2782r646b2839],
16	,	,	O	,	_	0	SENT_396	[p26l526t2782r646b2839],
17	TIC	NNP	O	TIC	appos	19	SENT_396	[p26l667t2781r794b2846],
18	,	,	O	,	_	0	SENT_396	[p26l667t2781r794b2846],
19	LD	NNP	O	LD	appos	1	SENT_396	[p26l820t2783r918b2839],
20	,	,	O	,	_	0	SENT_396	[p26l820t2783r918b2839],
21	}	CD	NUMBER	}	num	22	SENT_396	[p26l942t2781r1064b2846],
22	v1	NN	O	v1	dep	23	SENT_396	[p26l942t2781r1064b2846],
23	=	JJ	O	=	dep	53	SENT_396	[p26l942t2781r1064b2846],
24	,	,	O	,	_	0	SENT_396	[p26l942t2781r1064b2846],
25	NI	NNP	O	NI	conj_and	23	SENT_396	[p26l1088t2783r1175b2846],
26	,	,	O	,	_	0	SENT_396	[p26l1088t2783r1175b2846],
27	SKa	NNP	O	SKa	conj_and	23	SENT_396	[p26l1202t2782r1326b2839],
28	,	,	O	,	_	0	SENT_396	[p26l1202t2782r1326b2839],
29	SKi	NNS	O	ski	conj_and	23	SENT_396	[p26l1353t2782r1465b2839],
30	,	,	O	,	_	0	SENT_396	[p26l1353t2782r1465b2839],
31	MK	NN	O	mk	conj_and	23	SENT_396	[p26l1490t2783r1609b2839],
32	,	,	O	,	_	0	SENT_396	[p26l1490t2783r1609b2839],
33	SCL	NN	ORGANIZATION	scl	conj_and	23	SENT_396	[p26l1635t2782r1766b2839],
34	,	,	O	,	_	0	SENT_396	[p26l1635t2782r1766b2839],
35	RFL	NNP	ORGANIZATION	RFL	nn	49	SENT_396	[p26l1791t2781r1923b2839],
36	,	,	O	,	_	0	SENT_396	[p26l1791t2781r1923b2839],
37	AM	NNP	O	AM	appos	49	SENT_396	[p26l1944t2782r2068b2839],
38	,	,	O	,	_	0	SENT_396	[p26l1944t2782r2068b2839],
39	RIM	NNP	O	RIM	appos	49	SENT_396	[p26l11t2870r153b2933],
40	,	,	O	,	_	0	SENT_396	[p26l11t2870r153b2933],
41	PP	NNP	O	PP	appos	49	SENT_396	[p26l179t2870r272b2926],
42	,	,	O	,	_	0	SENT_396	[p26l179t2870r272b2926],
43	SPP	NNP	O	SPP	appos	49	SENT_396	[p26l299t2869r429b2925],
44	,	,	O	,	_	0	SENT_396	[p26l299t2869r429b2925],
45	ERS	NNP	O	ERS	appos	49	SENT_396	[p26l455t2868r589b2926],
46	,	,	O	,	_	0	SENT_396	[p26l455t2868r589b2926],
47	SIS	NNP	O	SIS	appos	49	SENT_396	[p26l616t2869r728b2933],
48	,	,	O	,	_	0	SENT_396	[p26l616t2869r728b2933],
49	SW	NNP	O	SW	dep	53	SENT_396	[p26l754t2869r860b2926],
50	,	,	O	,	_	0	SENT_396	[p26l754t2869r860b2926],
51	and	CC	O	and	_	0	SENT_396	[p26l883t2864r990b2917],
52	EI	NN	O	eus	dep	53	SENT_396	[p26l1012t2868r1070b2917],
53	contributed	VBD	O	contribute	_	0	SENT_396	[p26l1094t2864r1430b2917],
54	to	TO	O	to	_	0	SENT_396	[p26l1447t2875r1501b2917],
55	the	DT	O	the	det	56	SENT_396	[p26l1520t2864r1611b2917],
56	writing	NN	O	writing	prep_to	53	SENT_396	[p26l1630t2868r1841b2935],
57	of	IN	O	of	_	0	SENT_396	[p26l1861t2864r1925b2918],
58	the	DT	O	the	det	59	SENT_396	[p26l1934t2864r2024b2917],
59	report	NN	O	report	prep_of	56	SENT_396	[p26l7t2962r197b3021],
60	.	.	O	.	_	0	SENT_396	[p26l7t2962r197b3021],

1	All	DT	O	all	det	2	SENT_397	[p26l219t2951r301b3004],
2	authors	NNS	O	author	nsubj	6	SENT_397	[p26l322t2951r540b3005],
3	have	VBP	O	have	aux	4	SENT_397	[p26l560t2951r693b3005],
4	seen	VBN	O	see	_	0	SENT_397	[p26l715t2970r845b3005],
5	and	CC	O	and	_	0	SENT_397	[p26l865t2951r972b3005],
6	approved	VBN	O	approve	conj_and	4	SENT_397	[p26l992t2951r1258b3021],
7	the	DT	O	the	det	9	SENT_397	[p26l1276t2951r1366b3005],
8	ﬁnal	JJ	O	ﬁnal	amod	9	SENT_397	[p26l1386t2951r1516b3005],
9	version	NN	O	version	dobj	4	SENT_397	[p26l1534t2955r1747b3005],
10	of	IN	O	of	_	0	SENT_397	[p26l1767t2951r1832b3005],
11	the	DT	O	the	det	12	SENT_397	[p26l1840t2951r1930b3005],
12	report	NN	O	report	prep_of	9	SENT_397	[p26l1951t2962r2141b3021],
13	.	.	O	.	_	0	SENT_397	[p26l1951t2962r2141b3021],

1	The	DT	O	the	det	3	SENT_398	[p26l6t3083r110b3134],
2	National	NNP	O	National	nn	3	SENT_398	[p26l129t3084r368b3134],
3	Heart	NNP	O	Heart	_	0	SENT_398	[p26l389t3088r558b3143],
4	,	,	O	,	_	0	SENT_398	[p26l389t3088r558b3143],
5	Lung	NN	O	lung	conj_and	3	SENT_398	[p26l578t3088r731b3150],
6	,	,	O	,	_	0	SENT_398	[p26l578t3088r731b3150],
7	and	CC	O	and	_	0	SENT_398	[p26l749t3084r854b3134],
8	Blood	NNP	ORGANIZATION	Blood	nn	9	SENT_398	[p26l873t3083r1033b3135],
9	Institute	NNP	ORGANIZATION	Institute	poss	11	SENT_398	[p26l1051t3085r1335b3134],
10	's	POS	O	's	_	0	SENT_398	[p26l1051t3085r1335b3134],
11	Asthma	NNP	ORGANIZATION	Asthma	conj_and	3	SENT_398	[p26l1348t3083r1570b3134],
12	Clinical	JJ	ORGANIZATION	clinical	amod	16	SENT_398	[p26l1585t3083r1781b3134],
13	Research	NNP	ORGANIZATION	Research	nn	16	SENT_398	[p26l11t3169r251b3221],
14	Network	NNP	ORGANIZATION	Network	nn	16	SENT_398	[p26l272t3169r519b3221],
15	research	NN	O	research	nn	16	SENT_398	[p26l537t3169r764b3221],
16	coordinators	NNS	O	coordinator	dep	3	SENT_398	[p26l782t3169r1142b3221],
17	and	CC	O	and	_	0	SENT_398	[p26l1158t3169r1263b3221],
18	staff	NN	O	staff	dep	3	SENT_398	[p26l1278t3169r1409b3221],

1	Linda	NNP	PERSON	Linda	nn	3	SENT_399	[p27l11t24r169b77],
2	L	NNP	PERSON	L	nn	3	SENT_399	[p27l190t29r223b76],
3	Engle	NNP	PERSON	Engle	dep	10	SENT_399	[p27l243t24r417b94],
4	,	,	O	,	_	0	SENT_399	[p27l243t24r417b94],
5	Kelly	NNP	PERSON	Kelly	nn	6	SENT_399	[p27l441t24r579b94],
6	Bixler	NNP	PERSON	Bixler	appos	3	SENT_399	[p27l599t24r769b85],
7	,	,	O	,	_	0	SENT_399	[p27l599t24r769b85],
8	Aimee	NNP	PERSON	Aimee	appos	3	SENT_399	[p27l789t27r977b77],
9	I	PRP	PERSON	I	dep	10	SENT_399	[p27l998t29r1016b92],
10	Merchlinski	NNP	PERSON	Merchlinski	dep	19	SENT_399	[p27l1040t24r1396b85],
11	,	,	O	,	_	0	SENT_399	[p27l1040t24r1396b85],
12	Kerrie	NNP	PERSON	Kerrie	nn	13	SENT_399	[p27l1420t27r1592b77],
13	Sheaffer	NNP	PERSON	Sheaffer	appos	10	SENT_399	[p27l1615t24r1859b85],
14	,	,	O	,	_	0	SENT_399	[p27l1615t24r1859b85],
15	Ronald	NNP	PERSON	Ronald	nn	18	SENT_399	[p27l11t110r210b164],
16	R	NNP	PERSON	R	nn	18	SENT_399	[p27l231t116r272b163],
17	Zimmerman	NNP	PERSON	Zimmerman	nn	18	SENT_399	[p27l292t114r664b163],
18	Jr	NNP	PERSON	Jr	appos	10	SENT_399	[p27l683t116r732b179],
19	(	VBD	O	(	_	0	SENT_399	[p27l754t116r919b181],
20	Penn	NNP	ORGANIZATION	Penn	nn	22	SENT_399	[p27l754t116r919b181],
21	State	NNP	ORGANIZATION	State	nn	22	SENT_399	[p27l942t115r1077b164],
22	College	NNP	ORGANIZATION	College	dobj	19	SENT_399	[p27l1098t110r1306b181],
23	of	IN	ORGANIZATION	of	_	0	SENT_399	[p27l1326t110r1390b163],
24	Medicine	NNP	ORGANIZATION	Medicine	nn	26	SENT_399	[p27l1401t110r1679b172],
25	,	,	O	,	_	0	SENT_399	[p27l1401t110r1679b172],
26	Hershey	NNP	PERSON	Hershey	prep_of	22	SENT_399	[p27l1703t110r1950b180],
27	,	,	O	,	_	0	SENT_399	[p27l1703t110r1950b180],
28	PA	NN	LOCATION	pa	nn	29	SENT_399	[p27l1974t115r2092b181],
29	)	NN	O	)	appos	26	SENT_399	[p27l1974t115r2092b181],
30	.	.	O	.	_	0	SENT_399	[p27l1974t115r2092b181],

1	Sreedhar	NNP	O	Sreedhar	nn	2	SENT_400	[p27l12t197r267b250],
2	Bunga	NNP	O	Bunga	_	0	SENT_400	[p27l287t203r483b268],
3	,	,	O	,	_	0	SENT_400	[p27l287t203r483b268],
4	Gautham	NNP	PERSON	Gautham	nn	7	SENT_400	[p27l507t197r775b251],
5	Marigowda	NNP	PERSON	Marigowda	nn	7	SENT_400	[p27l796t197r1115b268],
6	(	NNP	O	(	nn	7	SENT_400	[p27l1138t197r1407b268],
7	Brigham	NNP	ORGANIZATION	Brigham	appos	2	SENT_400	[p27l1138t197r1407b268],
8	and	CC	ORGANIZATION	and	_	0	SENT_400	[p27l1426t197r1533b250],
9	Women	NNP	ORGANIZATION	Women	poss	12	SENT_400	[p27l1549t202r1817b251],
10	’s	POS	ORGANIZATION	’s	_	0	SENT_400	[p27l1549t202r1817b251],
11	Medical	NNP	ORGANIZATION	Medical	nn	12	SENT_400	[p27l1840t197r2062b250],
12	Hospital	NNP	ORGANIZATION	Hospital	appos	2	SENT_400	[p27l11t284r265b354],
13	,	,	O	,	_	0	SENT_400	[p27l11t284r265b354],
14	Boston	NNP	LOCATION	Boston	appos	2	SENT_400	[p27l289t290r500b345],
15	,	,	O	,	_	0	SENT_400	[p27l289t290r500b345],
16	MA	NNP	LOCATION	MA	nn	17	SENT_400	[p27l524t288r663b355],
17	)	NNP	O	)	appos	2	SENT_400	[p27l524t288r663b355],
18	.	.	O	.	_	0	SENT_400	[p27l524t288r663b355],

1	Iennifer	NNP	PERSON	Iennifer	nn	2	SENT_401	[p27l686t284r916b353],
2	Brandorff	NNP	PERSON	Brandorff	_	0	SENT_401	[p27l936t284r1227b346],
3	,	,	O	,	_	0	SENT_401	[p27l936t284r1227b346],
4	Mary	NNP	PERSON	Mary	nn	5	SENT_401	[p27l1250t290r1395b354],
5	Gill	NNP	PERSON	Gill	appos	2	SENT_401	[p27l1414t284r1529b345],
6	,	,	O	,	_	0	SENT_401	[p27l1414t284r1529b345],
7	]	CD	NUMBER	]	num	9	SENT_401	[p27l1552t290r1683b353],
8	uno	NN	O	uno	nn	9	SENT_401	[p27l1552t290r1683b353],
9	Pak	NNP	O	Pak	appos	5	SENT_401	[p27l1706t284r1821b346],
10	,	,	O	,	_	0	SENT_401	[p27l1706t284r1821b346],
11	Allen	NNP	PERSON	Allen	nn	18	SENT_401	[p27l6t371r159b424],
12	Stevens	NNP	PERSON	Stevens	nn	18	SENT_401	[p27l182t375r395b424],
13	(	NNP	O	(	nn	18	SENT_401	[p27l420t371r678b442],
14	National	NNP	ORGANIZATION	National	nn	18	SENT_401	[p27l420t371r678b442],
15	Iewish	NNP	ORGANIZATION	Iewish	nn	18	SENT_401	[p27l698t371r884b440],
16	Medical	NNP	ORGANIZATION	Medical	nn	18	SENT_401	[p27l905t371r1128b424],
17	Research	NNP	ORGANIZATION	Research	nn	18	SENT_401	[p27l1149t371r1405b424],
18	Center	NNP	ORGANIZATION	Center	appos	5	SENT_401	[p27l1425t375r1623b432],
19	,	,	O	,	_	0	SENT_401	[p27l1425t375r1623b432],
20	Denver	NNP	LOCATION	Denver	appos	5	SENT_401	[p27l1648t377r1862b433],
21	,	,	O	,	_	0	SENT_401	[p27l1648t377r1862b433],
22	CO	NNP	LOCATION	CO	nn	23	SENT_401	[p27l1884t375r2012b442],
23	)	NNP	O	)	appos	5	SENT_401	[p27l1884t375r2012b442],
24	.	.	O	.	_	0	SENT_401	[p27l1884t375r2012b442],

1	Barbara	NNP	PERSON	Barbara	nn	3	SENT_402	[p27l11t458r230b511],
2	A	NNP	PERSON	A	nn	3	SENT_402	[p27l248t462r294b511],
3	Miller	NNP	PERSON	Miller	_	0	SENT_402	[p27l314t458r492b520],
4	,	,	O	,	_	0	SENT_402	[p27l314t458r492b520],
5	Ann	NNP	PERSON	Ann	nn	8	SENT_402	[p27l512t462r638b511],
6	Sexton	NNP	PERSON	Sexton	nn	8	SENT_402	[p27l660t462r847b511],
7	(	NNP	O	(	nn	8	SENT_402	[p27l871t462r1185b529],
8	University	NNP	ORGANIZATION	University	appos	3	SENT_402	[p27l871t462r1185b529],
9	of	IN	ORGANIZATION	of	_	0	SENT_402	[p27l1203t458r1267b511],
10	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	11	SENT_402	[p27l1274t462r1576b512],
11	School	NNP	ORGANIZATION	School	prep_of	8	SENT_402	[p27l1598t458r1787b511],
12	of	IN	ORGANIZATION	of	_	0	SENT_402	[p27l1806t458r1870b511],
13	Medicine	NNP	ORGANIZATION	Medicine	nn	16	SENT_402	[p27l1880t458r2144b511],
14	and	CC	ORGANIZATION	and	_	0	SENT_402	[p27l8t546r114b599],
15	Public	NNP	ORGANIZATION	Public	nn	16	SENT_402	[p27l135t546r312b599],
16	Health	NNP	ORGANIZATION	Health	prep_of	11	SENT_402	[p27l333t546r539b608],
17	,	,	O	,	_	0	SENT_402	[p27l333t546r539b608],
18	Madison	NNP	PERSON	Madison	appos	3	SENT_402	[p27l562t546r823b607],
19	,	,	O	,	_	0	SENT_402	[p27l562t546r823b607],
20	WI	NNP	O	WI	nn	21	SENT_402	[p27l843t551r968b616],
21	)	NNP	O	)	appos	3	SENT_402	[p27l843t551r968b616],
22	.	.	O	.	_	0	SENT_402	[p27l843t551r968b616],

1	Peggy	NNP	PERSON	Peggy	nn	2	SENT_403	[p27l992t551r1159b616],
2	Cadbury	NNP	PERSON	Cadbury	_	0	SENT_403	[p27l1178t546r1426b616],
3	,	,	O	,	_	0	SENT_403	[p27l1178t546r1426b616],
4	]	CD	NUMBER	]	num	5	SENT_403	[p27l1449t552r1571b614],
5	ean	NN	PERSON	ean	appos	2	SENT_403	[p27l1449t552r1571b614],
6	Schenkkan	NNP	PERSON	Schenkkan	nn	8	SENT_403	[p27l1594t546r1907b599],
7	(	NNP	O	(	nn	8	SENT_403	[p27l12t636r327b703],
8	University	NNP	ORGANIZATION	University	dep	5	SENT_403	[p27l12t636r327b703],
9	of	IN	ORGANIZATION	of	_	0	SENT_403	[p27l344t633r408b686],
10	Califomia	NNP	ORGANIZATION	Califomia	prep_of	8	SENT_403	[p27l419t633r713b695],
11	,	,	O	,	_	0	SENT_403	[p27l419t633r713b695],
12	San	NNP	ORGANIZATION	San	nn	15	SENT_403	[p27l739t637r841b686],
13	Francisco	NNP	ORGANIZATION	Francisco	nn	15	SENT_403	[p27l863t636r1130b686],
14	Medical	NNP	ORGANIZATION	Medical	nn	15	SENT_403	[p27l1152t633r1375b686],
15	Center	NNP	ORGANIZATION	Center	appos	2	SENT_403	[p27l1395t637r1593b694],
16	,	,	O	,	_	0	SENT_403	[p27l1395t637r1593b694],
17	San	NNP	LOCATION	San	nn	18	SENT_403	[p27l1618t637r1721b686],
18	Francisco	NNP	LOCATION	Francisco	appos	2	SENT_403	[p27l1742t636r2024b694],
19	,	,	O	,	_	0	SENT_403	[p27l1742t636r2024b694],
20	CA	NNP	LOCATION	CA	nn	21	SENT_403	[p27l9t723r133b790],
21	)	NNP	O	)	appos	2	SENT_403	[p27l9t723r133b790],
22	.	.	O	.	_	0	SENT_403	[p27l9t723r133b790],

1	Elise	NNP	PERSON	Elise	nn	2	SENT_404	[p27l157t720r289b773],
2	Bender	NNP	PERSON	Bender	_	0	SENT_404	[p27l311t720r524b781],
3	,	,	O	,	_	0	SENT_404	[p27l311t720r524b781],
4	Steve	NNP	PERSON	Steve	nn	5	SENT_404	[p27l549t724r694b773],
5	DeMartino	NNP	PERSON	DeMartino	appos	2	SENT_404	[p27l717t723r1040b781],
6	,	,	O	,	_	0	SENT_404	[p27l717t723r1040b781],
7	Pamela	NNP	PERSON	Pamela	nn	11	SENT_404	[p27l1065t720r1272b773],
8	Kemp	NNP	PERSON	Kemp	nn	11	SENT_404	[p27l1294t725r1461b789],
9	(	NNP	O	(	nn	11	SENT_404	[p27l1485t720r1848b790],
10	Washington	NNP	ORGANIZATION	Washington	nn	11	SENT_404	[p27l1485t720r1848b790],
11	University	NNP	ORGANIZATION	University	appos	2	SENT_404	[p27l11t810r312b877],
12	,	,	ORGANIZATION	,	_	0	SENT_404	[p27l11t810r312b877],
13	School	NNP	ORGANIZATION	School	appos	2	SENT_404	[p27l338t807r527b860],
14	of	IN	ORGANIZATION	of	_	0	SENT_404	[p27l546t807r610b860],
15	Medicine	NNP	ORGANIZATION	Medicine	prep_of	13	SENT_404	[p27l620t807r898b868],
16	,	,	O	,	_	0	SENT_404	[p27l620t807r898b868],
17	St	NNP	LOCATION	St	nn	18	SENT_404	[p27l924t811r977b860],
18	Louis	NNP	LOCATION	Louis	appos	2	SENT_404	[p27l998t810r1165b868],
19	,	,	O	,	_	0	SENT_404	[p27l998t810r1165b868],
20	MO	NNP	DURATION	MO	nn	21	SENT_404	[p27l1189t812r1333b877],
21	)	NNP	O	)	appos	2	SENT_404	[p27l1189t812r1333b877],
22	.	.	O	.	_	0	SENT_404	[p27l1189t812r1333b877],

1	Paul	NNP	PERSON	Paul	nn	4	SENT_405	[p27l1358t807r1481b860],
2	Ferguson	NNP	PERSON	Ferguson	nn	4	SENT_405	[p27l1502t810r1769b877],
3	(	NNP	O	(	nn	4	SENT_405	[p27l1791t810r2106b877],
4	University	NNP	ORGANIZATION	University	_	0	SENT_405	[p27l1791t810r2106b877],
5	of	IN	ORGANIZATION	of	_	0	SENT_405	[p27l8t894r72b947],
6	Califomia	NNP	ORGANIZATION	Califomia	prep_of	4	SENT_405	[p27l83t894r377b955],
7	,	,	O	,	_	0	SENT_405	[p27l83t894r377b955],
8	San	NNP	ORGANIZATION	San	nn	11	SENT_405	[p27l403t898r505b947],
9	Diego	NNP	ORGANIZATION	Diego	nn	11	SENT_405	[p27l526t897r692b964],
10	Medical	NNP	ORGANIZATION	Medical	nn	11	SENT_405	[p27l713t894r936b947],
11	Center	NNP	ORGANIZATION	Center	appos	4	SENT_405	[p27l956t898r1154b955],
12	,	,	O	,	_	0	SENT_405	[p27l956t898r1154b955],
13	San	NNP	LOCATION	San	nn	14	SENT_405	[p27l1180t898r1282b947],
14	Diego	NNP	LOCATION	Diego	appos	4	SENT_405	[p27l1303t897r1484b964],
15	,	,	O	,	_	0	SENT_405	[p27l1303t897r1484b964],
16	CA	NNP	LOCATION	CA	nn	17	SENT_405	[p27l1507t898r1630b964],
17	)	NNP	O	)	appos	4	SENT_405	[p27l1507t898r1630b964],
18	.	.	O	.	_	0	SENT_405	[p27l1507t898r1630b964],

1	Bob	NNP	PERSON	Bob	nn	2	SENT_406	[p27l1655t894r1764b947],
2	Hmieleski	NNP	PERSON	Hmieleski	nsubj	15	SENT_406	[p27l1786t894r2098b955],
3	,	,	O	,	_	0	SENT_406	[p27l1786t894r2098b955],
4	Bill	NNP	PERSON	Bill	nn	5	SENT_406	[p27l11t981r103b1033],
5	Kahn	NNP	PERSON	Kahn	appos	2	SENT_406	[p27l124t981r289b1042],
6	,	,	O	,	_	0	SENT_406	[p27l124t981r289b1042],
7	Ieffrey	NNP	PERSON	Ieffrey	nn	8	SENT_406	[p27l312t981r494b1051],
8	Krings	NNP	PERSON	Krings	appos	2	SENT_406	[p27l514t984r717b1051],
9	,	,	O	,	_	0	SENT_406	[p27l514t984r717b1051],
10	Susan	NNP	PERSON	Susan	nn	11	SENT_406	[p27l742t984r912b1034],
11	Trahan	NNP	PERSON	Trahan	appos	2	SENT_406	[p27l930t981r1145b1042],
12	,	,	O	,	_	0	SENT_406	[p27l930t981r1145b1042],
13	Cheryl	NNP	PERSON	Cheryl	nn	14	SENT_406	[p27l1167t981r1354b1051],
14	Wilmoth	NNP	PERSON	Wilmoth	appos	2	SENT_406	[p27l1372t981r1625b1034],
15	(	VBD	O	(	_	0	SENT_406	[p27l1648t981r1821b1051],
16	Wake	NNP	ORGANIZATION	Wake	nn	20	SENT_406	[p27l1648t981r1821b1051],
17	Forest	NNP	ORGANIZATION	Forest	nn	20	SENT_406	[p27l1843t984r2016b1034],
18	University	NNP	ORGANIZATION	University	nn	20	SENT_406	[p27l11t1071r312b1138],
19	,	,	O	,	_	0	SENT_406	[p27l11t1071r312b1138],
20	School	NNP	ORGANIZATION	School	dobj	15	SENT_406	[p27l338t1068r527b1121],
21	of	IN	ORGANIZATION	of	_	0	SENT_406	[p27l546t1068r610b1121],
22	Medicine	NNP	ORGANIZATION	Medicine	nn	27	SENT_406	[p27l620t1068r898b1129],
23	,	,	O	,	_	0	SENT_406	[p27l620t1068r898b1129],
24	Winston-Salem	NNP	LOCATION	Winston-Salem	appos	27	SENT_406	[p27l918t1068r1374b1129],
25	,	,	O	,	_	0	SENT_406	[p27l918t1068r1374b1129],
26	NC	NNP	O	NC	appos	27	SENT_406	[p27l1397t1071r1524b1138],
27	)	NNP	O	)	prep_of	20	SENT_406	[p27l1397t1071r1524b1138],
28	.	.	O	.	_	0	SENT_406	[p27l1397t1071r1524b1138],

1	Conﬂicts	NNS	O	conﬂicts	_	0	SENT_407	[p27l8t1199r253b1251],
2	of	IN	O	of	_	0	SENT_407	[p27l269t1199r329b1251],
3	interest	NN	O	interest	prep_of	1	SENT_407	[p27l344t1201r561b1251],

1	HAB	NNP	O	HAB	nsubj	18	SENT_408	[p27l11t1289r170b1346],
2	,	,	O	,	_	0	SENT_408	[p27l11t1289r170b1346],
3	RFL	NNP	ORGANIZATION	RFL	conj_and	1	SENT_408	[p27l196t1288r329b1346],
4	,	,	O	,	_	0	SENT_408	[p27l196t1288r329b1346],
5	RIM	NNP	O	RIM	conj_and	1	SENT_408	[p27l355t1290r499b1353],
6	,	,	O	,	_	0	SENT_408	[p27l355t1290r499b1353],
7	their	PRP$	O	they	poss	8	SENT_408	[p27l521t1285r660b1338],
8	institutions	NNS	O	institution	conj_and	1	SENT_408	[p27l679t1288r1030b1346],
9	,	,	O	,	_	0	SENT_408	[p27l679t1288r1030b1346],
10	and	CC	O	and	_	0	SENT_408	[p27l1054t1285r1162b1338],
11	the	DT	O	the	det	12	SENT_408	[p27l1180t1285r1271b1338],
12	Brigham	NNP	LOCATION	Brigham	conj_and	1	SENT_408	[p27l1295t1285r1550b1355],
13	and	CC	O	and	_	0	SENT_408	[p27l1571t1285r1679b1338],
14	Women	NNP	O	Women	poss	16	SENT_408	[p27l1697t1290r1970b1338],
15	’s	POS	O	’s	_	0	SENT_408	[p27l1697t1290r1970b1338],
16	Hospital	NN	O	hospital	nsubj	18	SENT_408	[p27l11t1372r257b1441],
17	are	VBP	O	be	cop	18	SENT_408	[p27l277t1391r364b1425],
18	inventors	NNS	O	inventor	_	0	SENT_408	[p27l385t1375r658b1425],
19	on	IN	O	on	_	0	SENT_408	[p27l682t1391r754b1425],
20	a	DT	O	a	det	21	SENT_408	[p27l775t1391r804b1425],
21	patent	NN	O	patent	prep_on	18	SENT_408	[p27l824t1382r1008b1441],
22	concerning	VBG	O	concern	_	0	SENT_408	[p27l1028t1375r1357b1442],
23	the	DT	O	the	det	24	SENT_408	[p27l1376t1372r1468b1425],
24	use	NN	O	use	prep_concerning	21	SENT_408	[p27l1487t1390r1587b1425],
25	of	IN	O	of	_	0	SENT_408	[p27l1608t1372r1673b1425],
26	genotype	NN	O	genotype	prep_of	24	SENT_408	[p27l1684t1382r1947b1442],
27	at	IN	O	at	_	0	SENT_408	[p27l1969t1382r2019b1425],
28	the	DT	O	the	det	30	SENT_408	[p27l2037t1372r2129b1425],
29	B,-adrenergic	JJ	O	b,-adrenergic	amod	30	SENT_408	[p27l12t1458r394b1529],
30	receptor	NN	O	receptor	prep_at	26	SENT_408	[p27l414t1470r655b1528],
31	and	CC	O	and	_	0	SENT_408	[p27l675t1459r783b1512],
32	effects	NNS	O	effect	prep_of	24	SENT_408	[p27l803t1459r987b1512],
33	of	IN	O	of	_	0	SENT_408	[p27l1010t1459r1075b1512],
34	regular	JJ	O	regular	amod	36	SENT_408	[p27l1085t1459r1296b1529],
35	salbutamol	NN	O	salbutamol	nn	36	SENT_408	[p27l1317t1459r1639b1512],
36	use	NN	O	use	prep_of	32	SENT_408	[p27l1659t1477r1773b1512],
37	.	.	O	.	_	0	SENT_408	[p27l1659t1477r1773b1512],

1	MEW	NN	O	mew	nn	2	SENT_409	[p27l9t1549r176b1599],
2	reports	NNS	O	report	nsubj	15	SENT_409	[p27l195t1556r400b1615],
3	that	IN	O	that	complm	6	SENT_409	[p27l421t1546r535b1599],
4	he	PRP	O	he	nsubj	9	SENT_409	[p27l553t1546r623b1599],
5	has	VBZ	O	have	aux	6	SENT_409	[p27l643t1546r741b1599],
6	consulted	VBN	O	consult	dep	2	SENT_409	[p27l764t1546r1047b1599],
7	for	IN	O	for	prep	6	SENT_409	[p27l1066t1546r1149b1599],
8	or	CC	O	or	_	0	SENT_409	[p27l1169t1565r1229b1599],
9	participated	VBD	O	participate	dep	2	SENT_409	[p27l1248t1546r1594b1615],
10	in	IN	O	in	_	0	SENT_409	[p27l1613t1549r1672b1598],
11	advisory	JJ	O	advisory	amod	12	SENT_409	[p27l1693t1546r1934b1615],
12	boards	NNS	O	board	prep_in	9	SENT_409	[p27l1951t1546r2146b1599],
13	or	CC	O	or	_	0	SENT_409	[p27l8t1651r68b1685],
14	speaker	NN	O	speaker	conj_or	12	SENT_409	[p27l89t1632r312b1702],
15	bureaus	NN	O	bureau	_	0	SENT_409	[p27l330t1632r564b1686],
16	for	IN	O	for	_	0	SENT_409	[p27l586t1632r670b1685],
17	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_for	15	SENT_409	[p27l688t1636r1070b1694],
18	,	,	O	,	_	0	SENT_409	[p27l688t1636r1070b1694],
19	G1axoSmithKline	NN	O	g1axosmithkline	prep_for	15	SENT_409	[p27l1095t1632r1615b1694],
20	,	,	O	,	_	0	SENT_409	[p27l1095t1632r1615b1694],
21	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	nn	29	SENT_409	[p27l1642t1632r2146b1703],
22	,	,	O	,	_	0	SENT_409	[p27l1642t1632r2146b1703],
23	Novartis	NNP	ORGANIZATION	Novartis	appos	29	SENT_409	[p27l9t1723r265b1781],
24	,	,	O	,	_	0	SENT_409	[p27l9t1723r265b1781],
25	Genentech	NNP	ORGANIZATION	Genentech	appos	29	SENT_409	[p27l290t1719r621b1781],
26	,	,	O	,	_	0	SENT_409	[p27l290t1719r621b1781],
27	Merck	NNP	PERSON	Merck	appos	29	SENT_409	[p27l647t1719r843b1781],
28	,	,	O	,	_	0	SENT_409	[p27l647t1719r843b1781],
29	Medicinova	NNP	PERSON	Medicinova	prep_for	15	SENT_409	[p27l868t1719r1219b1781],
30	,	,	O	,	_	0	SENT_409	[p27l868t1719r1219b1781],
31	and	CC	O	and	_	0	SENT_409	[p27l1242t1719r1351b1773],
32	Sepracor	NNP	O	Sepracor	conj_and	17	SENT_409	[p27l1374t1724r1635b1789],
33	.	.	O	.	_	0	SENT_409	[p27l1374t1724r1635b1789],

1	EB	NNP	O	EB	nsubj	2	SENT_410	[p27l1661t1723r1738b1772],
2	reports	VBZ	O	report	_	0	SENT_410	[p27l1761t1730r1966b1789],
3	serving	VBG	O	serve	ccomp	2	SENT_410	[p27l9t1810r221b1877],
4	as	IN	O	as	_	0	SENT_410	[p27l242t1825r298b1859],
5	a	DT	O	a	det	6	SENT_410	[p27l321t1825r350b1860],
6	consultant	NN	O	consultant	prep_as	3	SENT_410	[p27l371t1806r692b1868],
7	,	,	O	,	_	0	SENT_410	[p27l371t1806r692b1868],
8	giving	VBG	O	give	conj_and	3	SENT_410	[p27l716t1810r895b1877],
9	presentations	NNS	O	presentation	dobj	8	SENT_410	[p27l914t1810r1310b1876],
10	and	CC	O	and	_	0	SENT_410	[p27l1333t1806r1441b1860],
11	performing	VBG	O	perform	conj_and	3	SENT_410	[p27l1460t1806r1798b1877],
12	clinical	JJ	O	clinical	amod	13	SENT_410	[p27l1818t1806r2025b1860],
13	trials	NNS	O	trial	dobj	11	SENT_410	[p27l6t1893r151b1946],
14	that	WDT	O	that	nsubjpass	16	SENT_410	[p27l171t1893r285b1946],
15	were	VBD	O	be	auxpass	16	SENT_410	[p27l303t1912r442b1946],
16	administered	VBN	O	administer	rcmod	13	SENT_410	[p27l464t1893r852b1946],
17	by	IN	O	by	_	0	SENT_410	[p27l871t1893r939b1963],
18	Wake	NNP	ORGANIZATION	Wake	nn	22	SENT_410	[p27l956t1893r1116b1947],
19	Forest	NNP	ORGANIZATION	Forest	nn	22	SENT_410	[p27l1140t1896r1317b1946],
20	University	NNP	ORGANIZATION	University	nn	22	SENT_410	[p27l1339t1897r1642b1963],
21	Health	NNP	ORGANIZATION	Health	nn	22	SENT_410	[p27l1664t1893r1860b1946],
22	Sciences	NNPS	ORGANIZATION	Sciences	agent	16	SENT_410	[p27l1884t1897r2130b1946],
23	for	IN	ORGANIZATION	for	_	0	SENT_410	[p27l7t1980r91b2033],
24	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_for	22	SENT_410	[p27l108t1984r492b2042],
25	,	,	O	,	_	0	SENT_410	[p27l108t1984r492b2042],
26	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	conj_and	24	SENT_410	[p27l517t1980r1036b2042],
27	,	,	O	,	_	0	SENT_410	[p27l517t1980r1036b2042],
28	and	CC	O	and	_	0	SENT_410	[p27l1060t1980r1168b2033],
29	Novartis	NNP	ORGANIZATION	Novartis	prep_for	22	SENT_410	[p27l1189t1984r1445b2033],
30	.	.	O	.	_	0	SENT_410	[p27l1189t1984r1445b2033],

1	HAB	NN	O	hab	nn	2	SENT_411	[p27l1471t1984r1612b2033],
2	reports	NNS	O	report	tmod	59	SENT_411	[p27l1636t1991r1841b2050],
3	research	NN	O	research	nn	5	SENT_411	[p27l1863t1980r2110b2033],
4	project	NN	O	project	nn	5	SENT_411	[p27l7t2072r209b2138],
5	support	NN	O	support	nsubj	44	SENT_411	[p27l230t2079r454b2138],
6	from	IN	O	from	_	0	SENT_411	[p27l473t2068r618b2121],
7	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	prep_from	5	SENT_411	[p27l640t2068r1159b2129],
8	,	,	O	,	_	0	SENT_411	[p27l640t2068r1159b2129],
9	participating	VBG	O	participate	partmod	5	SENT_411	[p27l1182t2071r1554b2138],
10	on	IN	O	on	_	0	SENT_411	[p27l1576t2087r1648b2121],
11	a	DT	O	a	det	14	SENT_411	[p27l1669t2087r1698b2121],
12	scientific	JJ	O	scientific	amod	14	SENT_411	[p27l1720t2068r1981b2121],
13	advisory	JJ	O	advisory	amod	14	SENT_411	[p27l8t2155r250b2225],
14	committee	NN	O	committee	prep_on	9	SENT_411	[p27l269t2159r581b2208],
15	for	IN	O	for	_	0	SENT_411	[p27l602t2155r686b2208],
16	Glaxo	NNP	ORGANIZATION	Glaxo	nn	17	SENT_411	[p27l706t2155r870b2208],
17	SmithKline	NNP	ORGANIZATION	SmithKline	prep_for	14	SENT_411	[p27l878t2155r1226b2217],
18	;	:	O	;	_	0	SENT_411	[p27l878t2155r1226b2217],
19	ad-hoc	JJ	O	ad-hoc	amod	20	SENT_411	[p27l1250t2155r1441b2208],
20	consulting	NN	O	consulting	dep	5	SENT_411	[p27l1461t2155r1771b2225],
21	for	IN	O	for	_	0	SENT_411	[p27l1790t2155r1874b2208],
22	Altana	NNP	ORGANIZATION	Altana	prep_for	20	SENT_411	[p27l1892t2155r2098b2217],
23	,	,	O	,	_	0	SENT_411	[p27l1892t2155r2098b2217],
24	Boehringer	NNP	PERSON	Boehringer	nn	35	SENT_411	[p27l11t2242r340b2312],
25	Ingelheim	NNP	PERSON	Ingelheim	nn	35	SENT_411	[p27l362t2242r679b2312],
26	,	,	O	,	_	0	SENT_411	[p27l362t2242r679b2312],
27	Genentech	NNP	ORGANIZATION	Genentech	appos	35	SENT_411	[p27l704t2242r1035b2303],
28	,	,	O	,	_	0	SENT_411	[p27l704t2242r1035b2303],
29	Nanomix	NNP	PERSON	Nanomix	appos	35	SENT_411	[p27l1060t2245r1341b2303],
30	,	,	O	,	_	0	SENT_411	[p27l1060t2245r1341b2303],
31	Novartis	NNP	ORGANIZATION	Novartis	appos	35	SENT_411	[p27l1366t2246r1622b2303],
32	,	,	O	,	_	0	SENT_411	[p27l1366t2246r1622b2303],
33	Sumitomo	NNP	ORGANIZATION	Sumitomo	appos	35	SENT_411	[p27l1649t2246r1971b2303],
34	,	,	O	,	_	0	SENT_411	[p27l1649t2246r1971b2303],
35	Theravance	NNP	O	Theravance	nsubj	44	SENT_411	[p27l6t2329r359b2390],
36	,	,	O	,	_	0	SENT_411	[p27l6t2329r359b2390],
37	and	CC	O	and	_	0	SENT_411	[p27l383t2329r491b2382],
38	Watermark	NNP	ORGANIZATION	Watermark	nn	39	SENT_411	[p27l509t2329r839b2382],
39	Research	NNP	ORGANIZATION	Research	conj_and	35	SENT_411	[p27l860t2329r1137b2389],
40	;	:	O	;	_	0	SENT_411	[p27l860t2329r1137b2389],
41	and	CC	O	and	_	0	SENT_411	[p27l1161t2329r1269b2382],
42	honoraria	NN	O	honorarium	nsubj	44	SENT_411	[p27l1287t2329r1575b2382],
43	for	IN	O	for	prep	42	SENT_411	[p27l1594t2329r1677b2382],
44	lectures	VBZ	O	lecture	rcmod	2	SENT_411	[p27l1695t2329r1923b2382],
45	and	CC	O	and	_	0	SENT_411	[p27l1946t2329r2054b2382],
46	presentations	NNS	O	presentation	rcmod	2	SENT_411	[p27l7t2418r402b2484],
47	from	IN	O	from	_	0	SENT_411	[p27l424t2415r569b2468],
48	Merck	NNP	ORGANIZATION	Merck	prep_from	46	SENT_411	[p27l590t2415r787b2476],
49	,	,	O	,	_	0	SENT_411	[p27l590t2415r787b2476],
50	Novartis	NNP	ORGANIZATION	Novartis	conj_and	44	SENT_411	[p27l812t2418r1068b2476],
51	,	,	O	,	_	0	SENT_411	[p27l812t2418r1068b2476],
52	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	conj_and	44	SENT_411	[p27l1095t2415r1526b2477],
53	,	,	O	,	_	0	SENT_411	[p27l1095t2415r1526b2477],
54	and	CC	O	and	_	0	SENT_411	[p27l1550t2415r1658b2468],
55	Genentech	NNP	ORGANIZATION	Genentech	conj_and	44	SENT_411	[p27l1679t2415r2010b2468],
56	,	,	O	,	_	0	SENT_411	[p27l1679t2415r2010b2468],
57	BTA	NNP	ORGANIZATION	BTA	nsubj	59	SENT_411	[p27l11t2505r132b2554],
58	has	VBZ	O	have	aux	59	SENT_411	[p27l150t2502r248b2555],
59	received	VBN	O	receive	_	0	SENT_411	[p27l270t2502r511b2555],
60	consulting	VBG	O	consult	amod	61	SENT_411	[p27l531t2502r840b2572],
61	fees	NNS	O	fee	dobj	59	SENT_411	[p27l860t2502r972b2555],
62	from	IN	O	from	_	0	SENT_411	[p27l994t2502r1139b2555],
63	Sepracor	NNP	O	Sepracor	prep_from	61	SENT_411	[p27l1163t2506r1424b2571],
64	.	.	O	.	_	0	SENT_411	[p27l1163t2506r1424b2571],

1	TIC	NN	O	tic	nn	2	SENT_412	[p27l1446t2505r1557b2570],
2	reports	NNS	O	report	nsubj	3	SENT_412	[p27l1579t2513r1784b2571],
3	performing	VBG	O	perform	_	0	SENT_412	[p27l1806t2502r2144b2572],
4	research	NN	O	research	dobj	3	SENT_412	[p27l7t2589r254b2642],
5	with	IN	O	with	_	0	SENT_412	[p27l273t2589r402b2642],
6	Schering	NNP	ORGANIZATION	Schering	prep_with	3	SENT_412	[p27l427t2589r700b2659],
7	,	,	O	,	_	0	SENT_412	[p27l427t2589r700b2659],
8	Merck	NNP	PERSON	Merck	prep_with	3	SENT_412	[p27l725t2589r921b2650],
9	,	,	O	,	_	0	SENT_412	[p27l725t2589r921b2650],
10	G1aXoSmithKline	NN	O	g1axosmithkline	prep_with	3	SENT_412	[p27l946t2589r1466b2650],
11	,	,	O	,	_	0	SENT_412	[p27l946t2589r1466b2650],
12	Boehringer	NNP	PERSON	Boehringer	nn	13	SENT_412	[p27l1492t2589r1821b2659],
13	Ingelheim	NNP	PERSON	Ingelheim	prep_with	3	SENT_412	[p27l11t2675r328b2746],
14	,	,	O	,	_	0	SENT_412	[p27l11t2675r328b2746],
15	Altana	NNP	ORGANIZATION	Altana	conj_and	6	SENT_412	[p27l349t2675r555b2737],
16	,	,	O	,	_	0	SENT_412	[p27l349t2675r555b2737],
17	Genentech/Novartis	NNP	O	Genentech/Novartis	conj_and	6	SENT_412	[p27l579t2675r1185b2745],
18	,	,	O	,	_	0	SENT_412	[p27l579t2675r1185b2745],
19	and	CC	O	and	_	0	SENT_412	[p27l1209t2675r1317b2729],
20	Forrest	NNP	PERSON	Forrest	conj_and	6	SENT_412	[p27l1339t2679r1557b2737],
21	;	:	O	;	_	0	SENT_412	[p27l1339t2679r1557b2737],
22	grants	NNS	O	grant	nsubj	25	SENT_412	[p27l1581t2686r1761b2746],
23	for	IN	O	for	_	0	SENT_412	[p27l1783t2675r1866b2728],
24	investigator	NN	O	investigator	prep_for	22	SENT_412	[p27l7t2766r351b2833],
25	initiated	VBD	O	initiate	parataxis	3	SENT_412	[p27l370t2762r612b2816],
26	research	NN	O	research	dobj	25	SENT_412	[p27l632t2762r879b2816],
27	from	IN	O	from	_	0	SENT_412	[p27l899t2762r1043b2815],
28	Viropharma	NNP	ORGANIZATION	Viropharma	prep_from	25	SENT_412	[p27l1062t2762r1432b2832],
29	,	,	O	,	_	0	SENT_412	[p27l1062t2762r1432b2832],
30	CSL	NNP	ORGANIZATION	CSL	nn	31	SENT_412	[p27l1456t2767r1576b2816],
31	Mehring	NNP	ORGANIZATION	Mehring	prep_from	25	SENT_412	[p27l1598t2762r1865b2833],
32	,	,	O	,	_	0	SENT_412	[p27l1598t2762r1865b2833],
33	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	prep_from	25	SENT_412	[p27l9t2849r529b2910],
34	,	,	O	,	_	0	SENT_412	[p27l9t2849r529b2910],
35	and	CC	O	and	_	0	SENT_412	[p27l553t2849r660b2902],
36	Merck	NNP	PERSON	Merck	prep_from	25	SENT_412	[p27l682t2849r878b2910],
37	;	:	O	;	_	0	SENT_412	[p27l682t2849r878b2910],
38	honorarium	NN	O	honorarium	prep_from	25	SENT_412	[p27l900t2849r1258b2902],
39	for	IN	O	for	_	0	SENT_412	[p27l1278t2849r1361b2902],
40	consultative	JJ	O	consultative	amod	41	SENT_412	[p27l1381t2849r1729b2903],
41	services	NNS	O	service	prep_for	38	SENT_412	[p27l1752t2853r1977b2903],
42	from	IN	O	from	_	0	SENT_412	[p27l1999t2849r2143b2902],
43	Teva	NNP	ORGANIZATION	Teva	nn	54	SENT_412	[p27l6t2938r150b2996],
44	,	,	O	,	_	0	SENT_412	[p27l6t2938r150b2996],
45	Alcon	NNP	ORGANIZATION	Alcon	appos	54	SENT_412	[p27l172t2935r358b2996],
46	,	,	O	,	_	0	SENT_412	[p27l172t2935r358b2996],
47	Novartis	NNP	ORGANIZATION	Novartis	appos	54	SENT_412	[p27l383t2939r639b2996],
48	,	,	O	,	_	0	SENT_412	[p27l383t2939r639b2996],
49	Genentech	NNP	ORGANIZATION	Genentech	appos	54	SENT_412	[p27l664t2935r995b2996],
50	,	,	O	,	_	0	SENT_412	[p27l664t2935r995b2996],
51	Dyax	NNP	ORGANIZATION	Dyax	appos	54	SENT_412	[p27l1020t2941r1176b3005],
52	,	,	O	,	_	0	SENT_412	[p27l1020t2941r1176b3005],
53	CSL	NNP	ORGANIZATION	CSL	appos	54	SENT_412	[p27l1201t2939r1321b2988],
54	Behring	NNP	ORGANIZATION	Behring	prep_from	41	SENT_412	[p27l1343t2935r1592b3005],
55	,	,	O	,	_	0	SENT_412	[p27l1343t2935r1592b3005],
56	Viropharma	NNP	ORGANIZATION	Viropharma	prep_from	41	SENT_412	[p27l1614t2935r1983b3005],
57	,	,	O	,	_	0	SENT_412	[p27l1614t2935r1983b3005],
58	Shire	NNP	PERSON	Shire	prep_from	41	SENT_412	[p27l12t3022r177b3083],
59	,	,	O	,	_	0	SENT_412	[p27l12t3022r177b3083],
60	and	CC	O	and	_	0	SENT_412	[p27l201t3022r309b3075],
61	Pharming	NNP	ORGANIZATION	Pharming	prep_from	41	SENT_412	[p27l331t3022r640b3092],
62	;	:	O	;	_	0	SENT_412	[p27l331t3022r640b3092],
63	and	CC	O	and	_	0	SENT_412	[p27l664t3022r771b3075],
64	honorarium	NN	O	honorarium	prep_from	25	SENT_412	[p27l789t3022r1147b3075],
65	for	IN	O	for	_	0	SENT_412	[p27l1166t3022r1251b3075],
66	speaking	VBG	O	speak	prepc_for	25	SENT_412	[p27l1271t3022r1530b3092],
67	from	IN	O	from	_	0	SENT_412	[p27l1550t3022r1695b3075],
68	Teva	NNP	ORGANIZATION	Teva	nn	77	SENT_412	[p27l1714t3026r1843b3075],
69	Schering	NNP	ORGANIZATION	Schering	nn	77	SENT_412	[p27l1867t3022r2140b3092],
70	,	,	O	,	_	0	SENT_412	[p27l1867t3022r2140b3092],
71	Merck	NNP	PERSON	Merck	appos	77	SENT_412	[p27l9t3110r206b3171],
72	,	,	O	,	_	0	SENT_412	[p27l9t3110r206b3171],
73	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	appos	77	SENT_412	[p27l228t3113r611b3171],
74	,	,	O	,	_	0	SENT_412	[p27l228t3113r611b3171],
75	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	appos	77	SENT_412	[p27l638t3110r1069b3171],
76	,	,	O	,	_	0	SENT_412	[p27l638t3110r1069b3171],
77	Genentech	NNP	ORGANIZATION	Genentech	prep_from	66	SENT_412	[p27l1094t3110r1425b3171],
78	,	,	O	,	_	0	SENT_412	[p27l1094t3110r1425b3171],
79	and	CC	O	and	_	0	SENT_412	[p27l1448t3110r1557b3163],
80	Novartis	NNP	ORGANIZATION	Novartis	prep_from	66	SENT_412	[p27l1578t3113r1834b3163],
81	.	.	O	.	_	0	SENT_412	[p27l1578t3113r1834b3163],

1	LD	NN	O	ld	_	0	SENT_413	[p27l1860t3115r1941b3162],

1	reports	NNS	O	report	_	0	SENT_414	[p28l7t30r212b89],
2	receiving	VBG	O	receive	partmod	1	SENT_414	[p28l234t22r500b89],
3	consultation	NN	O	consultation	nn	4	SENT_414	[p28l521t19r883b72],
4	honoraria	NN	O	honorarium	dobj	2	SENT_414	[p28l902t19r1189b72],
5	from	IN	O	from	_	0	SENT_414	[p28l1209t19r1354b72],
6	Merck	NNP	PERSON	Merck	prep_from	2	SENT_414	[p28l1376t19r1572b72],
7	.	.	O	.	_	0	SENT_414	[p28l1376t19r1572b72],

1	IVE	NN	O	ive	nn	2	SENT_415	[p28l1597t22r1703b88],
2	reports	NNS	O	report	_	0	SENT_415	[p28l1725t30r1930b89],
3	providing	VBG	O	provide	partmod	2	SENT_415	[p28l7t107r289b177],
4	consulting	NN	O	consulting	nn	5	SENT_415	[p28l310t107r619b177],
5	services	NNS	O	service	dobj	3	SENT_415	[p28l641t111r866b160],
6	for	IN	O	for	_	0	SENT_415	[p28l888t107r971b160],
7	Abgenix	NNP	ORGANIZATION	Abgenix	nn	21	SENT_415	[p28l989t107r1243b177],
8	,	,	O	,	_	0	SENT_415	[p28l989t107r1243b177],
9	Aerovance	NNP	O	Aerovance	appos	21	SENT_415	[p28l1265t111r1585b168],
10	,	,	O	,	_	0	SENT_415	[p28l1265t111r1585b168],
11	Amira	NNP	PERSON	Amira	appos	21	SENT_415	[p28l1607t110r1808b168],
12	,	,	O	,	_	0	SENT_415	[p28l1607t110r1808b168],
13	Biogen	NNP	ORGANIZATION	Biogen	appos	21	SENT_415	[p28l1834t111r2050b177],
14	,	,	O	,	_	0	SENT_415	[p28l1834t111r2050b177],
15	Cytokinetics	NNP	ORGANIZATION	Cytokinetics	appos	21	SENT_415	[p28l9t194r382b264],
16	,	,	O	,	_	0	SENT_415	[p28l9t194r382b264],
17	Gilead	NNP	ORGANIZATION	Gilead	appos	21	SENT_415	[p28l406t194r607b255],
18	,	,	O	,	_	0	SENT_415	[p28l406t194r607b255],
19	Merck	NNP	PERSON	Merck	appos	21	SENT_415	[p28l632t194r829b255],
20	,	,	O	,	_	0	SENT_415	[p28l632t194r829b255],
21	Oxagen	NNP	LOCATION	Oxagen	prep_for	3	SENT_415	[p28l854t199r1088b264],
22	,	,	O	,	_	0	SENT_415	[p28l854t199r1088b264],
23	and	CC	O	and	_	0	SENT_415	[p28l1112t194r1219b247],
24	Roche	NNP	LOCATION	Roche	prep_for	3	SENT_415	[p28l1242t194r1433b255],
25	;	:	O	;	_	0	SENT_415	[p28l1242t194r1433b255],
26	grants	NNS	O	grant	dep	2	SENT_415	[p28l1457t205r1637b264],
27	for	IN	O	for	_	0	SENT_415	[p28l1659t194r1742b247],
28	research	NN	O	research	prep_for	26	SENT_415	[p28l1762t194r2009b247],
29	from	IN	O	from	_	0	SENT_415	[p28l7t281r152b334],
30	Aerovance	NNP	LOCATION	Aerovance	nn	34	SENT_415	[p28l171t285r490b342],
31	,	,	O	,	_	0	SENT_415	[p28l171t285r490b342],
32	Roche	NNP	PERSON	Roche	appos	34	SENT_415	[p28l517t281r708b342],
33	,	,	O	,	_	0	SENT_415	[p28l517t281r708b342],
34	Genentech	NNP	ORGANIZATION	Genentech	prep_from	28	SENT_415	[p28l733t281r1064b342],
35	,	,	O	,	_	0	SENT_415	[p28l733t281r1064b342],
36	and	CC	O	and	_	0	SENT_415	[p28l1088t281r1195b334],
37	Boehringer	NNP	PERSON	Boehringer	nn	38	SENT_415	[p28l1218t281r1547b351],
38	Ingelheim	NNP	PERSON	Ingelheim	prep_from	28	SENT_415	[p28l1570t281r1886b351],
39	.	.	O	.	_	0	SENT_415	[p28l1570t281r1886b351],

1	N	NN	O	n	_	0	SENT_416	[p28l1912t286r1981b349],
2	]	CD	NUMBER	]	num	3	SENT_416	[p28l1912t286r1981b349],
3	reports	NNS	O	report	dep	1	SENT_416	[p28l7t378r212b437],
4	receiving	VBG	O	receive	partmod	1	SENT_416	[p28l234t371r500b438],
5	advisory	JJ	O	advisory	amod	7	SENT_416	[p28l521t368r763b438],
6	board	NN	O	board	nn	7	SENT_416	[p28l780t368r948b421],
7	honorarium	NN	O	honorarium	dobj	4	SENT_416	[p28l966t368r1323b421],
8	and	CC	O	and	_	0	SENT_416	[p28l1344t368r1452b421],
9	clinical	JJ	O	clinical	amod	11	SENT_416	[p28l1472t368r1680b421],
10	trial	NN	O	trial	nn	11	SENT_416	[p28l1699t368r1815b421],
11	support	NN	O	support	conj_and	7	SENT_416	[p28l1837t378r2062b437],
12	from	IN	O	from	_	0	SENT_416	[p28l7t455r152b508],
13	GlaXoSmithKline	NNP	ORGANIZATION	GlaXoSmithKline	prep_from	11	SENT_416	[p28l173t455r693b516],
14	;	:	O	;	_	0	SENT_416	[p28l173t455r693b516],
15	consulting	NN	O	consulting	nn	16	SENT_416	[p28l717t455r1026b525],
16	fees	NNS	O	fee	conj_and	7	SENT_416	[p28l1046t455r1159b508],
17	from	IN	O	from	_	0	SENT_416	[p28l1181t455r1325b508],
18	Asthmatx	NN	LOCATION	asthmatx	prep_from	16	SENT_416	[p28l1344t455r1641b516],
19	;	:	O	;	_	0	SENT_416	[p28l1344t455r1641b516],
20	advisory	JJ	O	advisory	amod	22	SENT_416	[p28l1665t455r1906b525],
21	board	NN	O	board	nn	22	SENT_416	[p28l1923t455r2091b508],
22	compensation	NN	O	compensation	conj_and	11	SENT_416	[p28l8t545r437b611],
23	,	,	O	,	_	0	SENT_416	[p28l8t545r437b611],
24	lecture	NN	O	lecture	nn	25	SENT_416	[p28l459t541r658b595],
25	honorarium	NN	O	honorarium	conj_and	11	SENT_416	[p28l678t541r1035b595],
26	and	CC	O	and	_	0	SENT_416	[p28l1056t541r1164b595],
27	clinical	JJ	O	clinical	amod	29	SENT_416	[p28l1184t541r1392b595],
28	trial	NN	O	trial	nn	29	SENT_416	[p28l1411t541r1527b595],
29	support	NN	O	support	conj_and	11	SENT_416	[p28l1549t552r1774b611],
30	from	IN	O	from	_	0	SENT_416	[p28l1793t541r1937b595],
31	Genentech-Novartis	NNP	LOCATION	Genentech-Novartis	prep_from	29	SENT_416	[p28l9t628r605b690],
32	;	:	O	;	_	0	SENT_416	[p28l9t628r605b690],
33	trial	NN	O	trial	nn	34	SENT_416	[p28l627t628r744b682],
34	support	NN	O	support	conj_and	11	SENT_416	[p28l766t639r991b698],
35	from	IN	O	from	_	0	SENT_416	[p28l1010t628r1154b682],
36	Medlmmune	NNP	LOCATION	Medlmmune	prep_from	34	SENT_416	[p28l1177t628r1581b690],
37	;	:	O	;	_	0	SENT_416	[p28l1177t628r1581b690],
38	and	CC	O	and	_	0	SENT_416	[p28l1605t628r1713b682],
39	clinical	JJ	O	clinical	amod	41	SENT_416	[p28l1733t628r1941b682],
40	trial	NN	O	trial	nn	41	SENT_416	[p28l1959t628r2076b682],
41	support	NN	O	support	conj_and	11	SENT_416	[p28l9t726r234b785],
42	and	CC	O	and	_	0	SENT_416	[p28l254t715r362b769],
43	lecture	NN	O	lecture	nn	44	SENT_416	[p28l380t715r579b769],
44	honorarium	NN	O	honorarium	conj_and	11	SENT_416	[p28l599t715r956b769],
45	from	IN	O	from	_	0	SENT_416	[p28l976t715r1121b769],
46	Merck	NNP	PERSON	Merck	prep_from	41	SENT_416	[p28l1143t715r1339b769],
47	.	.	O	.	_	0	SENT_416	[p28l1143t715r1339b769],

1	MK	NN	O	mk	nn	2	SENT_417	[p28l1365t721r1471b768],
2	reports	NNS	O	report	_	0	SENT_417	[p28l1489t726r1694b785],
3	speaker	NN	O	speaker	poss	5	SENT_417	[p28l1718t715r1984b785],
4	’s	POS	O	’s	_	0	SENT_417	[p28l1718t715r1984b785],
5	bureau	NN	O	bureau	dep	2	SENT_417	[p28l6t802r213b855],
6	for	IN	O	for	_	0	SENT_417	[p28l232t802r316b855],
7	Glaxo	NNP	ORGANIZATION	Glaxo	nn	8	SENT_417	[p28l337t802r501b855],
8	SmithKline	NNP	ORGANIZATION	SmithKline	prep_for	5	SENT_417	[p28l509t802r857b864],
9	;	:	O	;	_	0	SENT_417	[p28l509t802r857b864],
10	advisory	JJ	O	advisory	amod	11	SENT_417	[p28l881t802r1122b872],
11	board	NN	O	board	dep	2	SENT_417	[p28l1140t802r1307b855],
12	/	:	O	/	punct	13	SENT_417	[p28l1311t808r1333b872],
13	consultation	NN	O	consultation	dep	11	SENT_417	[p28l1338t802r1700b855],
14	for	IN	O	for	_	0	SENT_417	[p28l1720t802r1804b855],
15	Glaxo	NNP	ORGANIZATION	Glaxo	nn	16	SENT_417	[p28l9t889r173b942],
16	SmithKline	NNP	ORGANIZATION	SmithKline	prep_for	13	SENT_417	[p28l181t889r529b950],
17	,	,	O	,	_	0	SENT_417	[p28l181t889r529b950],
18	Merck	NNP	PERSON	Merck	conj_and	16	SENT_417	[p28l554t889r751b951],
19	,	,	O	,	_	0	SENT_417	[p28l554t889r751b951],
20	Novartis	NNP	ORGANIZATION	Novartis	conj_and	16	SENT_417	[p28l776t893r1031b951],
21	,	,	O	,	_	0	SENT_417	[p28l776t893r1031b951],
22	and	CC	O	and	_	0	SENT_417	[p28l1055t889r1163b942],
23	Amira	NNP	PERSON	Amira	conj_and	16	SENT_417	[p28l1181t893r1382b950],
24	;	:	O	;	_	0	SENT_417	[p28l1181t893r1382b950],
25	and	CC	O	and	_	0	SENT_417	[p28l1406t889r1514b942],
26	research	NN	O	research	nn	27	SENT_417	[p28l1533t889r1781b942],
27	funding	NN	O	funding	conj_and	11	SENT_417	[p28l1800t889r2035b959],
28	from	IN	O	from	_	0	SENT_417	[p28l7t977r152b1030],
29	GlaXoSmithKline	NNP	ORGANIZATION	GlaXoSmithKline	prep_from	27	SENT_417	[p28l173t977r693b1038],
30	,	,	O	,	_	0	SENT_417	[p28l173t977r693b1038],
31	Bronchus	NNP	O	Bronchus	prep_from	27	SENT_417	[p28l719t977r1016b1038],
32	,	,	O	,	_	0	SENT_417	[p28l719t977r1016b1038],
33	GE	NNP	ORGANIZATION	GE	nn	34	SENT_417	[p28l1041t980r1127b1030],
34	Healthcare	NNP	ORGANIZATION	Healthcare	prep_from	27	SENT_417	[p28l1152t977r1484b1038],
35	,	,	O	,	_	0	SENT_417	[p28l1152t977r1484b1038],
36	Asthmatx	NNP	O	Asthmatx	conj_and	29	SENT_417	[p28l1506t977r1803b1038],
37	,	,	O	,	_	0	SENT_417	[p28l1506t977r1803b1038],
38	Novartis	NNP	ORGANIZATION	Novartis	conj_and	29	SENT_417	[p28l1828t980r2084b1038],
39	,	,	O	,	_	0	SENT_417	[p28l1828t980r2084b1038],
40	and	CC	O	and	_	0	SENT_417	[p28l8t1063r116b1116],
41	Genentech	NNP	ORGANIZATION	Genentech	prep_from	27	SENT_417	[p28l137t1063r468b1116],
42	.	.	O	.	_	0	SENT_417	[p28l137t1063r468b1116],

1	RFL	NN	ORGANIZATION	rfl	nn	2	SENT_418	[p28l494t1066r613b1115],
2	reports	NNS	O	report	_	0	SENT_418	[p28l632t1074r837b1133],
3	receiving	VBG	O	receive	dep	2	SENT_418	[p28l859t1066r1125b1133],
4	speaker	NN	O	speaker	nn	5	SENT_418	[p28l1147t1063r1370b1133],
5	honorarium	NN	O	honorarium	dobj	3	SENT_418	[p28l1388t1063r1746b1116],
6	from	IN	O	from	_	0	SENT_418	[p28l1765t1063r1910b1116],
7	Merck	NNP	PERSON	Merck	nn	16	SENT_418	[p28l1932t1063r2129b1124],
8	,	,	O	,	_	0	SENT_418	[p28l1932t1063r2129b1124],
9	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	appos	16	SENT_418	[p28l6t1153r389b1212],
10	,	,	O	,	_	0	SENT_418	[p28l6t1153r389b1212],
11	Medicus	NNP	ORGANIZATION	Medicus	appos	16	SENT_418	[p28l414t1150r659b1203],
12	Group	NNP	ORGANIZATION	Group	nn	16	SENT_418	[p28l683t1154r883b1220],
13	,	,	O	,	_	0	SENT_418	[p28l683t1154r883b1220],
14	Park	NNP	ORGANIZATION	Park	appos	16	SENT_418	[p28l909t1150r1040b1203],
15	Nicolet	NNP	ORGANIZATION	Nicolet	nn	16	SENT_418	[p28l1060t1150r1265b1203],
16	Institute	NNP	ORGANIZATION	Institute	prep_from	3	SENT_418	[p28l1287t1154r1547b1211],
17	;	:	O	;	_	0	SENT_418	[p28l1287t1154r1547b1211],
18	consultant	NN	O	consultant	nn	19	SENT_418	[p28l1571t1150r1879b1203],
19	honorarium	NN	O	honorarium	dep	16	SENT_418	[p28l6t1237r364b1290],
20	from	IN	O	from	_	0	SENT_418	[p28l384t1237r528b1290],
21	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	19	SENT_418	[p28l547t1240r930b1298],
22	,	,	O	,	_	0	SENT_418	[p28l547t1240r930b1298],
23	MAP	NN	ORGANIZATION	map	nn	24	SENT_418	[p28l955t1241r1101b1289],
24	Pharmaceuticals	NNS	ORGANIZATION	pharmaceutical	prep_from	19	SENT_418	[p28l1126t1237r1624b1298],
25	,	,	O	,	_	0	SENT_418	[p28l1126t1237r1624b1298],
26	Gray	NNP	ORGANIZATION	Gray	nn	27	SENT_418	[p28l1649t1241r1786b1307],
27	Consulting	NNP	ORGANIZATION	Consulting	prep_from	19	SENT_418	[p28l1807t1237r2144b1307],
28	,	,	O	,	_	0	SENT_418	[p28l1807t1237r2144b1307],
29	Smith	NNP	ORGANIZATION	Smith	nn	30	SENT_418	[p28l12t1324r187b1377],
30	Research	NNP	ORGANIZATION	Research	prep_from	19	SENT_418	[p28l210t1324r487b1385],
31	,	,	O	,	_	0	SENT_418	[p28l210t1324r487b1385],
32	Merck	NNP	ORGANIZATION	Merck	nn	35	SENT_418	[p28l512t1324r695b1377],
33	Childhood	NNP	ORGANIZATION	Childhood	nn	35	SENT_418	[p28l716t1324r1023b1377],
34	Asthma	NNP	ORGANIZATION	Asthma	nn	35	SENT_418	[p28l1041t1324r1272b1377],
35	Network	NNP	ORGANIZATION	Network	prep_from	19	SENT_418	[p28l1294t1324r1555b1385],
36	,	,	O	,	_	0	SENT_418	[p28l1294t1324r1555b1385],
37	Novartis	NNP	ORGANIZATION	Novartis	prep_from	19	SENT_418	[p28l1580t1327r1836b1385],
38	,	,	O	,	_	0	SENT_418	[p28l1580t1327r1836b1385],
39	Quintiles/ANOVAS	NNP	O	Quintiles/ANOVAS	prep_from	19	SENT_418	[p28l9t1410r595b1479],
40	,	,	O	,	_	0	SENT_418	[p28l9t1410r595b1479],
41	and	CC	O	and	_	0	SENT_418	[p28l619t1410r727b1463],
42	RCHorowitz	NNP	ORGANIZATION	RCHorowitz	prep_from	19	SENT_418	[p28l749t1413r1113b1463],
43	&	CC	ORGANIZATION	&	_	0	SENT_418	[p28l1135t1410r1182b1463],
44	Company	NNP	ORGANIZATION	Company	conj_and	42	SENT_418	[p28l1203t1413r1497b1479],
45	;	:	O	;	_	0	SENT_418	[p28l1203t1413r1497b1479],
46	and	CC	O	and	_	0	SENT_418	[p28l1520t1410r1629b1463],
47	serving	VBG	O	serve	conj_and	3	SENT_418	[p28l1650t1413r1861b1480],
48	as	IN	O	as	_	0	SENT_418	[p28l1882t1428r1939b1463],
49	an	DT	O	a	det	50	SENT_418	[p28l1961t1429r2031b1463],
50	author	NN	O	author	prep_as	47	SENT_418	[p28l8t1497r201b1550],
51	of	IN	O	of	_	0	SENT_418	[p28l220t1497r286b1550],
52	UpToDate	NNP	O	UpToDate	prep_of	50	SENT_418	[p28l299t1500r608b1566],
53	.	.	O	.	_	0	SENT_418	[p28l299t1500r608b1566],

1	RIM	NN	O	rim	nn	2	SENT_419	[p28l635t1502r761b1565],
2	reports	NNS	O	report	_	0	SENT_419	[p28l784t1508r989b1566],
3	serving	VBG	O	serve	partmod	2	SENT_419	[p28l1013t1500r1224b1567],
4	as	IN	O	as	_	0	SENT_419	[p28l1245t1515r1301b1550],
5	a	DT	O	a	det	6	SENT_419	[p28l1324t1516r1353b1550],
6	consultant/lecturer	NN	O	consultant/lecturer	prep_as	3	SENT_419	[p28l1374t1497r1939b1566],
7	for	IN	O	for	_	0	SENT_419	[p28l1957t1497r2041b1550],
8	Adelphi	NNP	ORGANIZATION	Adelphi	nn	24	SENT_419	[p28l6t1583r251b1653],
9	,	,	O	,	_	0	SENT_419	[p28l6t1583r251b1653],
10	Abbott	NNP	PERSON	Abbott	appos	24	SENT_419	[p28l273t1583r482b1645],
11	,	,	O	,	_	0	SENT_419	[p28l273t1583r482b1645],
12	Schering	NNP	ORGANIZATION	Schering	appos	24	SENT_419	[p28l509t1583r782b1654],
13	,	,	O	,	_	0	SENT_419	[p28l509t1583r782b1654],
14	Novartis	NNP	ORGANIZATION	Novartis	appos	24	SENT_419	[p28l807t1587r1063b1644],
15	,	,	O	,	_	0	SENT_419	[p28l807t1587r1063b1644],
16	Genentech	NNP	ORGANIZATION	Genentech	appos	24	SENT_419	[p28l1088t1583r1419b1645],
17	,	,	O	,	_	0	SENT_419	[p28l1088t1583r1419b1645],
18	Nitec	NNP	ORGANIZATION	Nitec	appos	24	SENT_419	[p28l1444t1587r1608b1645],
19	,	,	O	,	_	0	SENT_419	[p28l1444t1587r1608b1645],
20	Covidien	NNP	ORGANIZATION	Covidien	appos	24	SENT_419	[p28l1633t1583r1905b1644],
21	,	,	O	,	_	0	SENT_419	[p28l1633t1583r1905b1644],
22	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	appos	24	SENT_419	[p28l6t1674r389b1732],
23	,	,	O	,	_	0	SENT_419	[p28l6t1674r389b1732],
24	KaloBios	NNP	O	KaloBios	prep_for	6	SENT_419	[p28l415t1670r684b1732],
25	,	,	O	,	_	0	SENT_419	[p28l415t1670r684b1732],
26	and	CC	O	and	_	0	SENT_419	[p28l708t1670r816b1724],
27	Sepracor	NNP	O	Sepracor	conj_and	6	SENT_419	[p28l840t1675r1100b1740],
28	.	.	O	.	_	0	SENT_419	[p28l840t1675r1100b1740],

1	SPP	NN	O	spp	nn	2	SENT_420	[p28l1128t1675r1243b1724],
2	reports	NNS	O	report	_	0	SENT_420	[p28l1265t1681r1470b1740],
3	pharmaceutical	JJ	O	pharmaceutical	amod	5	SENT_420	[p28l1491t1670r1945b1740],
4	trial	NN	O	trial	nn	5	SENT_420	[p28l1964t1670r2081b1724],
5	support	NN	O	support	dep	2	SENT_420	[p28l9t1768r234b1827],
6	as	IN	O	as	_	0	SENT_420	[p28l254t1776r310b1811],
7	a	DT	O	a	det	8	SENT_420	[p28l333t1776r362b1811],
8	member	NN	O	member	prep_as	5	SENT_420	[p28l382t1757r633b1811],
9	of	IN	O	of	_	0	SENT_420	[p28l653t1757r717b1811],
10	the	DT	O	the	det	13	SENT_420	[p28l726t1757r818b1811],
11	Wake	NNP	ORGANIZATION	Wake	nn	13	SENT_420	[p28l837t1757r997b1811],
12	Forest	NNP	ORGANIZATION	Forest	nn	13	SENT_420	[p28l1020t1761r1199b1811],
13	University	NNP	ORGANIZATION	University	prep_of	8	SENT_420	[p28l1220t1761r1523b1827],
14	Clinical	JJ	ORGANIZATION	clinical	amod	2	SENT_420	[p28l1544t1757r1766b1811],
15	Trials	NNPS	ORGANIZATION	Trials	nn	16	SENT_420	[p28l1785t1757r1944b1811],
16	Group	NNP	ORGANIZATION	Group	dep	2	SENT_420	[p28l1968t1762r2153b1827],
17	sponsored	VBN	O	sponsor	partmod	16	SENT_420	[p28l9t1844r311b1914],
18	by	IN	O	by	_	0	SENT_420	[p28l329t1844r397b1914],
19	Abaris	NNP	PERSON	Abaris	nn	40	SENT_420	[p28l414t1844r617b1905],
20	,	,	O	,	_	0	SENT_420	[p28l414t1844r617b1905],
21	Amgen	NNP	ORGANIZATION	Amgen	appos	40	SENT_420	[p28l639t1848r870b1914],
22	,	,	O	,	_	0	SENT_420	[p28l639t1848r870b1914],
23	Altana	NNP	ORGANIZATION	Altana	appos	40	SENT_420	[p28l893t1844r1098b1906],
24	,	,	O	,	_	0	SENT_420	[p28l893t1844r1098b1906],
25	Boehringer	NNP	PERSON	Boehringer	appos	40	SENT_420	[p28l1124t1844r1453b1914],
26	Ingelheim	NNP	PERSON	Ingelheim	nn	40	SENT_420	[p28l1475t1844r1792b1915],
27	,	,	O	,	_	0	SENT_420	[p28l1475t1844r1792b1915],
28	Contocor	NNP	O	Contocor	appos	40	SENT_420	[p28l1817t1848r2092b1905],
29	,	,	O	,	_	0	SENT_420	[p28l1817t1848r2092b1905],
30	Genentech	NNP	ORGANIZATION	Genentech	appos	40	SENT_420	[p28l9t1931r340b1992],
31	,	,	O	,	_	0	SENT_420	[p28l9t1931r340b1992],
32	GlaXoSmithKline	NNP	ORGANIZATION	GlaXoSmithKline	appos	40	SENT_420	[p28l365t1931r885b1992],
33	,	,	O	,	_	0	SENT_420	[p28l365t1931r885b1992],
34	Medimmune	NNP	ORGANIZATION	Medimmune	appos	40	SENT_420	[p28l910t1931r1309b1993],
35	,	,	O	,	_	0	SENT_420	[p28l910t1931r1309b1993],
36	Novartis	NNP	ORGANIZATION	Novartis	appos	40	SENT_420	[p28l1334t1935r1589b1992],
37	,	,	O	,	_	0	SENT_420	[p28l1334t1935r1589b1992],
38	Pﬁzer	NNP	O	Pﬁzer	appos	40	SENT_420	[p28l1616t1931r1794b1992],
39	,	,	O	,	_	0	SENT_420	[p28l1616t1931r1794b1992],
40	Schering	NNP	ORGANIZATION	Schering	agent	17	SENT_420	[p28l1821t1931r2094b2001],
41	,	,	O	,	_	0	SENT_420	[p28l1821t1931r2094b2001],
42	and	CC	O	and	_	0	SENT_420	[p28l8t2019r116b2072],
43	Wyeth	NN	LOCATION	wyeth	agent	17	SENT_420	[p28l134t2019r338b2089],
44	;	:	O	;	_	0	SENT_420	[p28l134t2019r338b2089],
45	consulting	VBG	O	consult	dep	2	SENT_420	[p28l362t2019r671b2089],
46	under	IN	O	under	_	0	SENT_420	[p28l690t2019r867b2072],
47	the	DT	O	the	det	48	SENT_420	[p28l884t2019r976b2072],
48	auspices	NNS	O	auspices	prep_under	45	SENT_420	[p28l997t2023r1243b2089],
49	of	IN	O	of	_	0	SENT_420	[p28l1266t2019r1331b2072],
50	Adelphi	NNP	ORGANIZATION	Adelphi	prep_of	48	SENT_420	[p28l1341t2019r1586b2089],
51	,	,	O	,	_	0	SENT_420	[p28l1341t2019r1586b2089],
52	Exocrine	NN	O	exocrine	dep	2	SENT_420	[p28l1612t2022r1877b2080],
53	,	,	O	,	_	0	SENT_420	[p28l1612t2022r1877b2080],
54	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	conj_and	52	SENT_420	[p28l6t2109r389b2168],
55	,	,	O	,	_	0	SENT_420	[p28l6t2109r389b2168],
56	Bristol-Meyers	NNP	O	Bristol-Meyers	nn	57	SENT_420	[p28l415t2106r836b2176],
57	Squibb	NNP	O	Squibb	conj_and	52	SENT_420	[p28l863t2106r1081b2176],
58	,	,	O	,	_	0	SENT_420	[p28l863t2106r1081b2176],
59	Ception	NNP	ORGANIZATION	Ception	nn	60	SENT_420	[p28l1106t2110r1334b2176],
60	Therapeutics	NNPS	ORGANIZATION	Therapeutics	conj_and	52	SENT_420	[p28l1353t2106r1750b2176],
61	,	,	O	,	_	0	SENT_420	[p28l1353t2106r1750b2176],
62	Dey	NNP	PERSON	Dey	conj_and	52	SENT_420	[p28l1776t2112r1895b2176],
63	,	,	O	,	_	0	SENT_420	[p28l1776t2112r1895b2176],
64	Dyson	NNP	PERSON	Dyson	conj_and	52	SENT_420	[p28l1921t2112r2119b2176],
65	,	,	O	,	_	0	SENT_420	[p28l1921t2112r2119b2176],
66	Genentech	NNP	ORGANIZATION	Genentech	conj_and	52	SENT_420	[p28l9t2193r340b2254],
67	,	,	O	,	_	0	SENT_420	[p28l9t2193r340b2254],
68	Johnson	NNP	ORGANIZATION	Johnson	conj_and	52	SENT_420	[p28l365t2193r606b2262],
69	&	CC	ORGANIZATION	&	_	0	SENT_420	[p28l627t2193r675b2246],
70	Iohnson	NNP	ORGANIZATION	Iohnson	conj_and	52	SENT_420	[p28l695t2193r951b2261],
71	,	,	O	,	_	0	SENT_420	[p28l695t2193r951b2261],
72	Merck	NNP	ORGANIZATION	Merck	conj_and	52	SENT_420	[p28l976t2193r1173b2255],
73	,	,	O	,	_	0	SENT_420	[p28l976t2193r1173b2255],
74	Novartis	NNP	ORGANIZATION	Novartis	conj_and	52	SENT_420	[p28l1197t2197r1454b2255],
75	,	,	O	,	_	0	SENT_420	[p28l1197t2197r1454b2255],
76	RAD	NN	O	rad	nn	77	SENT_420	[p28l1479t2197r1617b2245],
77	Foundation	NNP	O	Foundation	conj_and	16	SENT_420	[p28l1642t2193r1992b2255],
78	,	,	O	,	_	0	SENT_420	[p28l1642t2193r1992b2255],
79	Respiratory	NNP	ORGANIZATION	Respiratory	nn	80	SENT_420	[p28l11t2283r343b2350],
80	Medicine	NNP	ORGANIZATION	Medicine	conj_and	16	SENT_420	[p28l364t2280r648b2341],
81	,	,	O	,	_	0	SENT_420	[p28l364t2280r648b2341],
82	Respiratory	NNP	ORGANIZATION	Respiratory	nn	83	SENT_420	[p28l674t2283r1007b2350],
83	Research	NNP	ORGANIZATION	Research	conj_and	16	SENT_420	[p28l1029t2280r1305b2341],
84	,	,	O	,	_	0	SENT_420	[p28l1029t2280r1305b2341],
85	Sepracor	NNP	O	Sepracor	conj_and	16	SENT_420	[p28l1332t2284r1594b2349],
86	,	,	O	,	_	0	SENT_420	[p28l1332t2284r1594b2349],
87	and	CC	O	and	_	0	SENT_420	[p28l1618t2280r1725b2333],
88	Teva	NNP	ORGANIZATION	Teva	conj_and	16	SENT_420	[p28l1743t2283r1887b2341],
89	;	:	O	;	_	0	SENT_420	[p28l1743t2283r1887b2341],
90	and	CC	O	and	_	0	SENT_420	[p28l1911t2280r2019b2333],
91	www	NN	O	www	conj_and	16	SENT_420	[p28l6t2531r542b2582],
92	.	.	O	.	_	0	SENT_420	[p28l6t2531r542b2582],

1	the	DT	O	the	det	2	SENT_421	[p28l6t2531r542b2582],
2	|	NN	O	|	_	0	SENT_421	[p28l6t2531r542b2582],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_421	[p28l6t2531r542b2582],
4	Vol	NNP	O	Vol	dep	2	SENT_421	[p28l586t2531r673b2582],
5	374	CD	NUMBER	374	num	6	SENT_421	[p28l693t2538r796b2590],
6	November	NNP	DATE	November	dep	2	SENT_421	[p28l844t2531r1139b2582],
7	21,2009	CD	DATE	21,2009	num	6	SENT_421	[p28l1156t2538r1402b2591],

1	participating	VBG	O	participate	csubj	6	SENT_422	[p28l9t2721r272b2768],
2	in	IN	O	in	_	0	SENT_422	[p28l287t2721r328b2756],
3	Physician	NNP	O	Physician	nn	5	SENT_422	[p28l344t2719r542b2768],
4	Education	NNP	O	Education	nn	5	SENT_422	[p28l559t2719r766b2756],
5	Programs	NNP	O	Programs	prep_in	1	SENT_422	[p28l782t2722r982b2768],
6	sponsored	VBN	O	sponsor	_	0	SENT_422	[p28l999t2719r1213b2767],
7	by	IN	O	by	_	0	SENT_422	[p28l1225t2719r1274b2768],
8	AdvanceMed	NNP	O	AdvanceMed	nn	27	SENT_422	[p28l8t2780r288b2823],
9	,	,	O	,	_	0	SENT_422	[p28l8t2780r288b2823],
10	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	appos	27	SENT_422	[p28l303t2782r574b2823],
11	,	,	O	,	_	0	SENT_422	[p28l303t2782r574b2823],
12	Creative	NNP	O	Creative	appos	27	SENT_422	[p28l592t2782r758b2818],
13	Educational	NNP	O	Educational	nn	27	SENT_422	[p28l775t2780r1018b2818],
14	Concepts	NNP	O	Concepts	nn	27	SENT_422	[p28l1033t2782r1233b2829],
15	,	,	O	,	_	0	SENT_422	[p28l1033t2782r1233b2829],
16	DIME	NNP	O	DIME	appos	27	SENT_422	[p28l1252t2782r1388b2823],
17	,	,	O	,	_	0	SENT_422	[p28l1252t2782r1388b2823],
18	Merck	NNP	ORGANIZATION	Merck	appos	27	SENT_422	[p28l10t2842r140b2880],
19	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	27	SENT_422	[p28l156t2842r508b2885],
20	,	,	O	,	_	0	SENT_422	[p28l156t2842r508b2885],
21	Genentech	NNP	ORGANIZATION	Genentech	appos	27	SENT_422	[p28l526t2842r760b2885],
22	,	,	O	,	_	0	SENT_422	[p28l526t2842r760b2885],
23	Novartis	NNP	ORGANIZATION	Novartis	appos	27	SENT_422	[p28l778t2844r959b2885],
24	,	,	O	,	_	0	SENT_422	[p28l778t2844r959b2885],
25	Practicome	NNP	O	Practicome	appos	27	SENT_422	[p28l978t2844r1219b2885],
26	,	,	O	,	_	0	SENT_422	[p28l978t2844r1219b2885],
27	Pri-Med	NNP	O	Pri-Med	prep_by	6	SENT_422	[p28l1238t2842r1422b2891],
28	/	:	O	/	punct	29	SENT_422	[p28l1238t2842r1422b2891],
29	SCIOS	NNP	LOCATION	SCIOS	dep	27	SENT_422	[p28l12t2906r162b2946],
30	,	,	O	,	_	0	SENT_422	[p28l12t2906r162b2946],
31	Respiratory	JJ	O	respiratory	amod	35	SENT_422	[p28l180t2906r416b2952],
32	and	CC	O	and	_	0	SENT_422	[p28l430t2903r506b2941],
33	Allergic	JJ	ORGANIZATION	allergic	conj_and	31	SENT_422	[p28l519t2903r681b2953],
34	Disease	NN	ORGANIZATION	disease	nn	35	SENT_422	[p28l697t2906r854b2941],
35	(	NN	O	(	conj_and	29	SENT_422	[p28l872t2906r997b2953],
36	RAD	NN	O	rad	nn	38	SENT_422	[p28l872t2906r997b2953],
37	)	CD	NUMBER	)	num	38	SENT_422	[p28l872t2906r997b2953],
38	Foundation	NNP	O	Foundation	dep	35	SENT_422	[p28l1017t2903r1264b2946],
39	,	,	O	,	_	0	SENT_422	[p28l1017t2903r1264b2946],
40	and	CC	O	and	_	0	SENT_422	[p28l1281t2903r1358b2941],
41	UpToDate	NNP	O	UpToDate	conj_and	29	SENT_422	[p28l11t2967r230b3013],
42	.	.	O	.	_	0	SENT_422	[p28l11t2967r230b3013],

1	CAS	NNP	ORGANIZATION	CAS	nsubj	2	SENT_423	[p28l248t2967r337b3002],
2	reports	VBZ	O	report	_	0	SENT_423	[p28l354t2972r499b3013],
3	receiving	VBG	O	receive	dep	2	SENT_423	[p28l514t2967r703b3014],
4	honorarium	NN	O	honorarium	dobj	3	SENT_423	[p28l717t2964r970b3002],
5	for	IN	O	for	_	0	SENT_423	[p28l984t2964r1043b3002],
6	speaker	NN	O	speaker	poss	8	SENT_423	[p28l1057t2964r1246b3013],
7	's	POS	O	's	_	0	SENT_423	[p28l1057t2964r1246b3013],
8	bureau	NN	O	bureau	prep_for	4	SENT_423	[p28l1261t2964r1408b3002],
9	and	CC	O	and	_	0	SENT_423	[p28l1422t2964r1498b3002],
10	consultation	NN	O	consultation	prep_for	4	SENT_423	[p28l9t3025r266b3063],
11	from	IN	O	from	_	0	SENT_423	[p28l280t3025r382b3063],
12	Glaxo	NNP	ORGANIZATION	Glaxo	nn	13	SENT_423	[p28l398t3025r514b3063],
13	SmithKline	NNP	ORGANIZATION	SmithKline	prep_from	3	SENT_423	[p28l520t3025r766b3068],
14	;	:	O	;	_	0	SENT_423	[p28l520t3025r766b3068],
15	and	CC	O	and	_	0	SENT_423	[p28l782t3025r859b3063],
16	receiving	VBG	O	receive	conj_and	3	SENT_423	[p28l872t3028r1061b3075],
17	research	NN	O	research	nn	18	SENT_423	[p28l1075t3025r1250b3063],
18	support	NN	O	support	dobj	16	SENT_423	[p28l1266t3033r1425b3074],
19	from	IN	O	from	_	0	SENT_423	[p28l9t3086r111b3124],
20	Pharmaxis	NNP	LOCATION	Pharmaxis	prep_from	16	SENT_423	[p28l127t3086r345b3124],
21	and	CC	O	and	_	0	SENT_423	[p28l361t3086r438b3124],
22	Schering	NNP	ORGANIZATION	Schering	prep_from	16	SENT_423	[p28l454t3086r647b3136],
23	.	.	O	.	_	0	SENT_423	[p28l454t3086r647b3136],

1	ERS	NNS	O	er	nn	2	SENT_424	[p28l666t3088r749b3124],
2	reports	NNS	O	report	nsubj	3	SENT_424	[p28l765t3094r911b3135],
3	serving	VBG	O	serve	_	0	SENT_424	[p28l928t3089r1077b3136],
4	as	IN	O	as	_	0	SENT_424	[p28l1092t3099r1132b3124],
5	an	DT	O	a	det	6	SENT_424	[p28l1148t3100r1198b3124],
6	adviser	NN	O	adviser	prep_as	3	SENT_424	[p28l1212t3086r1359b3124],
7	or	CC	O	or	_	0	SENT_424	[p28l1373t3100r1415b3124],
8	consultant	NN	O	consultant	prep_as	3	SENT_424	[p28l9t3147r227b3185],
9	to	TO	O	to	_	0	SENT_424	[p28l240t3155r278b3185],
10	Dey	NNP	PERSON	Dey	prep_to	3	SENT_424	[p28l295t3151r380b3196],
11	,	,	O	,	_	0	SENT_424	[p28l295t3151r380b3196],
12	Glaxo	NNP	ORGANIZATION	Glaxo	nn	13	SENT_424	[p28l397t3147r513b3185],
13	SmithKline	NNP	ORGANIZATION	SmithKline	conj_and	10	SENT_424	[p28l519t3147r766b3190],
14	,	,	O	,	_	0	SENT_424	[p28l519t3147r766b3190],
15	and	CC	O	and	_	0	SENT_424	[p28l782t3147r859b3185],
16	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	conj_and	10	SENT_424	[p28l875t3147r1232b3197],
17	;	:	O	;	_	0	SENT_424	[p28l875t3147r1232b3197],
18	and	CC	O	and	_	0	SENT_424	[p28l1249t3147r1325b3185],
19	receiving	VBG	O	receive	partmod	31	SENT_424	[p28l1339t3150r1528b3197],
20	grant	NN	O	grant	nn	21	SENT_424	[p28l10t3216r118b3258],
21	funding	NN	O	funding	dobj	19	SENT_424	[p28l132t3209r298b3258],
22	from	IN	O	from	_	0	SENT_424	[p28l312t3209r414b3246],
23	National	NNP	ORGANIZATION	National	nn	24	SENT_424	[p28l430t3209r604b3246],
24	Institutes	NNPS	ORGANIZATION	Institutes	prep_from	19	SENT_424	[p28l620t3211r814b3246],
25	of	IN	ORGANIZATION	of	_	0	SENT_424	[p28l831t3209r877b3246],
26	Health	NNP	ORGANIZATION	Health	prep_of	24	SENT_424	[p28l886t3209r1025b3246],
27	and	CC	O	and	_	0	SENT_424	[p28l1039t3209r1116b3246],
28	Novartis	NNP	ORGANIZATION	Novartis	conj_and	26	SENT_424	[p28l1131t3211r1312b3246],
29	,	,	O	,	_	0	SENT_424	[p28l1131t3211r1312b3246],
30	SIS	NNP	O	SIS	nsubj	31	SENT_424	[p28l1331t3212r1398b3257],
31	reports	VBZ	O	report	conj_and	3	SENT_424	[p28l9t3277r154b3319],
32	serving	VBG	O	serve	xcomp	31	SENT_424	[p28l171t3272r321b3319],
33	as	IN	O	as	_	0	SENT_424	[p28l335t3283r375b3307],
34	a	DT	O	a	det	35	SENT_424	[p28l392t3283r412b3307],
35	consultant	NN	O	consultant	prep_as	32	SENT_424	[p28l427t3270r645b3307],
36	for	IN	O	for	_	0	SENT_424	[p28l658t3270r717b3307],
37	GlaXoSmithKline	NNP	ORGANIZATION	GlaXoSmithKline	prep_for	35	SENT_424	[p28l732t3270r1100b3313],
38	,	,	O	,	_	0	SENT_424	[p28l732t3270r1100b3313],
39	Genentech	NNP	ORGANIZATION	Genentech	prep_for	35	SENT_424	[p28l1118t3270r1352b3313],
40	,	,	O	,	_	0	SENT_424	[p28l1118t3270r1352b3313],
41	and	CC	O	and	_	0	SENT_424	[p28l1369t3270r1445b3307],
42	Merck	NNP	PERSON	Merck	conj_and	37	SENT_424	[p28l10t3331r150b3374],
43	;	:	O	;	_	0	SENT_424	[p28l10t3331r150b3374],
44	and	CC	O	and	_	0	SENT_424	[p28l167t3331r243b3368],
45	research	NN	O	research	nn	46	SENT_424	[p28l256t3331r432b3368],
46	funding	NN	O	funding	conj_and	3	SENT_424	[p28l446t3331r612b3380],
47	from	IN	O	from	dep	46	SENT_424	[p28l626t3331r728b3368],
48	Ross	NNP	PERSON	Ross	pobj	47	SENT_424	[p28l745t3334r838b3368],
49	and	CC	O	and	_	0	SENT_424	[p28l854t3331r930b3368],
50	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	pobj	47	SENT_424	[p28l945t3331r1313b3368],
51	.	.	O	.	_	0	SENT_424	[p28l945t3331r1313b3368],

1	SW	NN	O	sw	nn	4	SENT_425	[p28l1333t3333r1403b3368],
2	reports	NNS	O	report	nn	4	SENT_425	[p28l9t3399r154b3440],
3	grant	NN	O	grant	nn	4	SENT_425	[p28l170t3399r279b3441],
4	support	NN	O	support	_	0	SENT_425	[p28l294t3399r453b3441],
5	from	IN	O	from	dep	4	SENT_425	[p28l467t3392r569b3429],
6	Merck	NNP	PERSON	Merck	pobj	5	SENT_425	[p28l584t3392r715b3429],
7	and	CC	O	and	_	0	SENT_425	[p28l728t3392r804b3429],
8	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	pobj	5	SENT_425	[p28l821t3392r1178b3441],
9	;	:	O	;	_	0	SENT_425	[p28l821t3392r1178b3441],
10	and	CC	O	and	_	0	SENT_425	[p28l1195t3392r1271b3429],
11	serving	VBG	O	serve	conj_and	5	SENT_425	[p28l1286t3394r1436b3441],
12	as	IN	O	as	_	0	SENT_425	[p28l1451t3405r1491b3429],
13	a	DT	O	a	det	14	SENT_425	[p28l1507t3405r1527b3429],
14	consultant	NN	O	consultant	prep_as	11	SENT_425	[p28l9t3453r227b3490],
15	for	IN	O	for	_	0	SENT_425	[p28l241t3453r300b3490],
16	Amylin	NNP	ORGANIZATION	Amylin	prep_for	14	SENT_425	[p28l312t3453r477b3502],
17	.	.	O	.	_	0	SENT_425	[p28l312t3453r477b3502],

1	EI	NN	O	eus	nsubj	2	SENT_426	[p28l496t3455r537b3490],
2	conducted	VBD	O	conduct	_	0	SENT_426	[p28l554t3453r768b3490],
3	sponsored	VBN	O	sponsor	dep	2	SENT_426	[p28l783t3453r997b3502],
4	research	NN	O	research	dobj	3	SENT_426	[p28l1010t3453r1186b3490],
5	with	IN	O	with	_	0	SENT_426	[p28l1199t3453r1290b3490],
6	Aerovance	NN	PERSON	aerovance	prep_with	3	SENT_426	[p28l8t3516r235b3557],
7	,	,	O	,	_	0	SENT_426	[p28l8t3516r235b3557],
8	Asthmatx	NN	O	asthmatx	prep_with	3	SENT_426	[p28l250t3514r460b3557],
9	,	,	O	,	_	0	SENT_426	[p28l250t3514r460b3557],
10	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_with	3	SENT_426	[p28l476t3516r747b3557],
11	,	,	O	,	_	0	SENT_426	[p28l476t3516r747b3557],
12	Boehringer	NNP	PERSON	Boehringer	nn	13	SENT_426	[p28l765t3514r999b3563],
13	Ingelheim	NNP	PERSON	Ingelheim	prep_with	3	SENT_426	[p28l1015t3514r1239b3563],
14	,	,	O	,	_	0	SENT_426	[p28l1015t3514r1239b3563],
15	Centocor	NNP	ORGANIZATION	Centocor	conj_and	6	SENT_426	[p28l1257t3516r1449b3557],
16	,	,	O	,	_	0	SENT_426	[p28l1257t3516r1449b3557],
17	Ception	NNP	ORGANIZATION	Ception	nn	18	SENT_426	[p28l10t3577r172b3623],
18	Therapeutics	NNPS	ORGANIZATION	Therapeutics	conj_and	6	SENT_426	[p28l185t3575r466b3623],
19	,	,	O	,	_	0	SENT_426	[p28l185t3575r466b3623],
20	Genentech	NNP	ORGANIZATION	Genentech	conj_and	6	SENT_426	[p28l484t3575r719b3617],
21	,	,	O	,	_	0	SENT_426	[p28l484t3575r719b3617],
22	GlaXoSmithKline	NNP	ORGANIZATION	GlaXoSmithKline	conj_and	6	SENT_426	[p28l736t3575r1104b3618],
23	,	,	O	,	_	0	SENT_426	[p28l736t3575r1104b3618],
24	Icagen	NNP	ORGANIZATION	Icagen	conj_and	6	SENT_426	[p28l1123t3578r1269b3624],
25	,	,	O	,	_	0	SENT_426	[p28l1123t3578r1269b3624],
26	Iohnson	NNP	ORGANIZATION	Iohnson	conj_and	6	SENT_426	[p28l1286t3575r1457b3622],
27	&	CC	ORGANIZATION	&	_	0	SENT_426	[p28l1472t3574r1505b3612],
28	Iohnson	NNP	ORGANIZATION	Iohnson	conj_and	6	SENT_426	[p28l10t3635r192b3683],
29	,	,	O	,	_	0	SENT_426	[p28l10t3635r192b3683],
30	Medlmmune	NNP	O	Medlmmune	nn	36	SENT_426	[p28l209t3635r496b3678],
31	,	,	O	,	_	0	SENT_426	[p28l209t3635r496b3678],
32	Merck	NNP	PERSON	Merck	appos	36	SENT_426	[p28l514t3635r653b3678],
33	,	,	O	,	_	0	SENT_426	[p28l514t3635r653b3678],
34	Novartis	NNP	ORGANIZATION	Novartis	appos	36	SENT_426	[p28l671t3638r852b3678],
35	,	,	O	,	_	0	SENT_426	[p28l671t3638r852b3678],
36	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	prep_with	3	SENT_426	[p28l871t3635r1228b3685],
37	,	,	O	,	_	0	SENT_426	[p28l871t3635r1228b3685],
38	and	CC	O	and	_	0	SENT_426	[p28l1245t3635r1321b3673],
39	Wyeth	NN	LOCATION	wyeth	conj_and	6	SENT_426	[p28l1334t3635r1479b3684],
40	;	:	O	;	_	0	SENT_426	[p28l1334t3635r1479b3684],
41	consulted	VBN	O	consult	dep	6	SENT_426	[p28l9t3696r210b3734],
42	and	CC	O	and	advmod	41	SENT_426	[p28l224t3696r319b3745],
43	/	:	O	/	punct	41	SENT_426	[p28l224t3696r319b3745],
44	or	CC	O	or	_	0	SENT_426	[p28l323t3710r365b3734],
45	served	VBN	O	serve	dep	2	SENT_426	[p28l380t3696r512b3734],
46	on	IN	O	on	_	0	SENT_426	[p28l526t3710r577b3734],
47	advisory	JJ	O	advisory	amod	48	SENT_426	[p28l592t3696r763b3746],
48	boards	NNS	O	board	prep_on	45	SENT_426	[p28l775t3696r913b3734],
49	for	IN	O	for	_	0	SENT_426	[p28l929t3696r988b3734],
50	Abbott	NNP	PERSON	Abbott	nn	56	SENT_426	[p28l1000t3696r1148b3739],
51	,	,	O	,	_	0	SENT_426	[p28l1000t3696r1148b3739],
52	Amgen	NNP	ORGANIZATION	Amgen	conj_and	56	SENT_426	[p28l1164t3699r1328b3746],
53	,	,	O	,	_	0	SENT_426	[p28l1164t3699r1328b3746],
54	Astellas	NNP	ORGANIZATION	Astellas	conj_and	56	SENT_426	[p28l1343t3696r1503b3734],
55	Pharma	NNP	ORGANIZATION	Pharma	nn	56	SENT_426	[p28l11t3757r174b3795],
56	US	NNP	ORGANIZATION	US	prep_for	48	SENT_426	[p28l190t3760r263b3801],
57	,	,	O	,	_	0	SENT_426	[p28l190t3760r263b3801],
58	Asthmatx	NNP	O	Asthmatx	conj_and	56	SENT_426	[p28l278t3757r489b3801],
59	,	,	O	,	_	0	SENT_426	[p28l278t3757r489b3801],
60	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	conj_and	56	SENT_426	[p28l504t3759r775b3801],
61	,	,	O	,	_	0	SENT_426	[p28l504t3759r775b3801],
62	Aventis	NNP	ORGANIZATION	Aventis	conj_and	56	SENT_426	[p28l791t3760r954b3801],
63	,	,	O	,	_	0	SENT_426	[p28l791t3760r954b3801],
64	Cowen	NNP	ORGANIZATION	Cowen	conj_and	56	SENT_426	[p28l971t3760r1112b3795],
65	&	CC	ORGANIZATION	&	_	0	SENT_426	[p28l1127t3757r1161b3795],
66	Co	NNP	ORGANIZATION	Co	conj_and	56	SENT_426	[p28l1175t3760r1239b3801],
67	,	,	O	,	_	0	SENT_426	[p28l1175t3760r1239b3801],
68	Critical	JJ	O	critical	appos	56	SENT_426	[p28l1257t3757r1404b3795],

1	Therapeutics	NNS	O	therapeutics	_	0	SENT_427	[p29l8t16r290b65],
2	,	,	O	,	_	0	SENT_427	[p29l8t16r290b65],
3	Genentech	NNP	ORGANIZATION	Genentech	nn	28	SENT_427	[p29l307t16r541b59],
4	,	,	O	,	_	0	SENT_427	[p29l307t16r541b59],
5	Icagen	NNP	ORGANIZATION	Icagen	appos	28	SENT_427	[p29l560t20r706b66],
6	,	,	O	,	_	0	SENT_427	[p29l560t20r706b66],
7	IDEC	NNP	ORGANIZATION	IDEC	appos	28	SENT_427	[p29l724t18r848b59],
8	,	,	O	,	_	0	SENT_427	[p29l724t18r848b59],
9	Medlmmune	NNP	O	Medlmmune	appos	28	SENT_427	[p29l866t16r1153b59],
10	,	,	O	,	_	0	SENT_427	[p29l866t16r1153b59],
11	Merck	NNP	PERSON	Merck	appos	28	SENT_427	[p29l1171t16r1310b59],
12	,	,	O	,	_	0	SENT_427	[p29l1171t16r1310b59],
13	newMentor	NNP	O	newMentor	appos	28	SENT_427	[p29l9t81r255b120],
14	,	,	O	,	_	0	SENT_427	[p29l9t81r255b120],
15	Novartis	NNP	ORGANIZATION	Novartis	appos	28	SENT_427	[p29l272t80r454b120],
16	,	,	O	,	_	0	SENT_427	[p29l272t80r454b120],
17	Pﬁzer	NNP	O	Pﬁzer	appos	28	SENT_427	[p29l472t77r599b120],
18	,	,	O	,	_	0	SENT_427	[p29l472t77r599b120],
19	PDL	NNP	ORGANIZATION	PDL	appos	28	SENT_427	[p29l617t81r707b114],
20	Biopharma	NNP	ORGANIZATION	Biopharma	nn	28	SENT_427	[p29l722t77r962b126],
21	,	,	O	,	_	0	SENT_427	[p29l722t77r962b126],
22	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	appos	28	SENT_427	[p29l981t77r1338b127],
23	,	,	O	,	_	0	SENT_427	[p29l981t77r1338b127],
24	Sepracor	NNP	O	Sepracor	appos	28	SENT_427	[p29l12t142r197b188],
25	,	,	O	,	_	0	SENT_427	[p29l12t142r197b188],
26	Teva	NNP	ORGANIZATION	Teva	appos	28	SENT_427	[p29l212t141r304b176],
27	Specialty	NNP	ORGANIZATION	Specialty	nn	28	SENT_427	[p29l321t139r504b188],
28	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	appos	1	SENT_427	[p29l519t139r872b182],
29	,	,	O	,	_	0	SENT_427	[p29l519t139r872b182],
30	USB	JJ	O	usb	appos	1	SENT_427	[p29l890t142r995b182],
31	,	,	O	,	_	0	SENT_427	[p29l890t142r995b182],
32	Wyeth	NN	PERSON	wyeth	appos	1	SENT_427	[p29l1010t139r1155b188],
33	;	:	O	;	_	0	SENT_427	[p29l1010t139r1155b188],
34	and	CC	O	and	cc	35	SENT_427	[p29l1172t139r1248b176],
35	received	VBD	O	receive	dep	1	SENT_427	[p29l1262t139r1432b176],
36	speaker	NN	O	speaker	poss	38	SENT_427	[p29l10t200r199b249],
37	's	POS	O	's	_	0	SENT_427	[p29l10t200r199b249],
38	fees	NNS	O	fee	dobj	35	SENT_427	[p29l214t200r294b237],
39	from	IN	O	from	_	0	SENT_427	[p29l309t200r412b237],
40	Genentech	NNP	ORGANIZATION	Genentech	nn	44	SENT_427	[p29l427t200r662b243],
41	,	,	O	,	_	0	SENT_427	[p29l427t200r662b243],
42	Merck	NNP	PERSON	Merck	appos	44	SENT_427	[p29l679t200r819b243],
43	,	,	O	,	_	0	SENT_427	[p29l679t200r819b243],
44	Novartis	NNP	ORGANIZATION	Novartis	prep_from	35	SENT_427	[p29l836t202r1018b243],
45	,	,	O	,	_	0	SENT_427	[p29l836t202r1018b243],
46	and	CC	O	and	_	0	SENT_427	[p29l1034t200r1111b237],
47	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	prep_from	35	SENT_427	[p29l1128t200r1484b249],
48	.	.	O	.	_	0	SENT_427	[p29l1128t200r1484b249],

1	SIK	NNP	O	SIK	nn	9	SENT_428	[p29l12t263r96b309],
2	,	,	O	,	_	0	SENT_428	[p29l12t263r96b309],
3	VMC	NNP	ORGANIZATION	VMC	appos	9	SENT_428	[p29l112t264r232b304],
4	,	,	O	,	_	0	SENT_428	[p29l112t264r232b304],
5	WIC	NNP	LOCATION	WIC	appos	9	SENT_428	[p29l247t264r355b309],
6	,	,	O	,	_	0	SENT_428	[p29l247t264r355b309],
7	MC	NNP	O	MC	appos	9	SENT_428	[p29l373t264r458b304],
8	,	,	O	,	_	0	SENT_428	[p29l373t264r458b304],
9	SKa	NNP	O	SKa	_	0	SENT_428	[p29l477t264r566b304],
10	,	,	O	,	_	0	SENT_428	[p29l477t264r566b304],
11	SKi	NNS	O	ski	appos	9	SENT_428	[p29l585t263r665b304],
12	,	,	O	,	_	0	SENT_428	[p29l585t263r665b304],
13	SCL	NN	ORGANIZATION	scl	appos	9	SENT_428	[p29l685t263r778b304],
14	,	,	O	,	_	0	SENT_428	[p29l685t263r778b304],
15	AM	NNP	O	AM	appos	9	SENT_428	[p29l793t264r881b304],
16	,	,	O	,	_	0	SENT_428	[p29l793t264r881b304],
17	PP	NNP	O	PP	nsubj	23	SENT_428	[p29l899t265r966b304],
18	,	,	O	,	_	0	SENT_428	[p29l899t265r966b304],
19	IR	NNP	O	IR	conj_and	17	SENT_428	[p29l983t264r1041b309],
20	,	,	O	,	_	0	SENT_428	[p29l983t264r1041b309],
21	and	CC	O	and	_	0	SENT_428	[p29l1058t261r1134b299],
22	MIW	NNP	O	MIW	conj_and	17	SENT_428	[p29l1149t264r1257b309],
23	declare	VB	O	declare	dep	9	SENT_428	[p29l1271t261r1417b299],
24	that	IN	O	that	complm	26	SENT_428	[p29l1431t261r1511b299],
25	they	PRP	O	they	nsubj	26	SENT_428	[p29l8t323r96b372],
26	have	VBP	O	have	ccomp	23	SENT_428	[p29l109t323r203b360],
27	no	DT	O	no	det	28	SENT_428	[p29l218t336r269b360],
28	conﬂicts	NNS	O	conﬂicts	dobj	26	SENT_428	[p29l285t323r457b360],
29	of	IN	O	of	_	0	SENT_428	[p29l473t323r519b360],
30	interest	NN	O	interest	prep_of	28	SENT_428	[p29l526t325r693b360],
31	.	.	O	.	_	0	SENT_428	[p29l526t325r693b360],

1	Acknowledgments	NNS	O	acknowledgment	nsubjpass	5	SENT_429	[p29l9t416r378b464],
2	The	DT	O	the	det	3	SENT_429	[p29l8t477r88b514],
3	study	NN	O	study	dep	1	SENT_429	[p29l105t477r218b526],
4	was	VBD	O	be	auxpass	5	SENT_429	[p29l230t490r308b514],
5	funded	VBN	O	fund	_	0	SENT_429	[p29l324t477r475b514],
6	by	IN	O	by	_	0	SENT_429	[p29l488t477r537b526],
7	the	DT	O	the	det	9	SENT_429	[p29l550t477r615b514],
8	National	NNP	ORGANIZATION	National	nn	9	SENT_429	[p29l632t477r809b514],
9	Heart	NNP	ORGANIZATION	Heart	agent	5	SENT_429	[p29l826t481r955b520],
10	,	,	O	,	_	0	SENT_429	[p29l826t481r955b520],
11	Lung	NN	O	lung	agent	5	SENT_429	[p29l974t481r1090b526],
12	,	,	O	,	_	0	SENT_429	[p29l974t481r1090b526],
13	and	CC	O	and	_	0	SENT_429	[p29l1107t477r1185b514],
14	Blood	NNP	ORGANIZATION	Blood	nn	15	SENT_429	[p29l1201t477r1320b514],
15	Institute	NNP	ORGANIZATION	Institute	agent	5	SENT_429	[p29l1336t479r1514b514],
16	(	CD	NUMBER	(	num	17	SENT_429	[p29l12t542r192b587],
17	NHLBI	NNP	ORGANIZATION	NHLBI	nn	28	SENT_429	[p29l12t542r192b587],
18	)	CD	NUMBER	)	num	17	SENT_429	[p29l12t542r192b587],
19	of	IN	O	of	_	0	SENT_429	[p29l211t538r257b575],
20	the	DT	O	the	det	27	SENT_429	[p29l264t538r330b575],
21	US	NNP	ORGANIZATION	US	nn	27	SENT_429	[p29l347t541r408b575],
22	National	NNP	ORGANIZATION	National	dep	27	SENT_429	[p29l427t538r604b575],
23	Institutes	NNPS	ORGANIZATION	Institutes	dep	22	SENT_429	[p29l621t540r819b575],
24	of	IN	ORGANIZATION	of	_	0	SENT_429	[p29l835t538r882b575],
25	Health	NNP	ORGANIZATION	Health	prep_of	22	SENT_429	[p29l892t538r1033b575],
26	(	CD	NUMBER	(	num	25	SENT_429	[p29l1051t542r1186b587],
27	NIH	NNP	ORGANIZATION	NIH	prep_of	28	SENT_429	[p29l1051t542r1186b587],
28	)	NN	O	)	dep	15	SENT_429	[p29l1051t542r1186b587],
29	.	.	O	.	_	0	SENT_429	[p29l1051t542r1186b587],

1	An	DT	O	a	det	5	SENT_430	[p29l1202t541r1264b575],
2	NHLBIappointed	JJ	MISC	nhlbiappointed	amod	5	SENT_430	[p29l1281t542r1447b575, p29l9t599r220b648],
3	protocol	NN	O	protocol	nn	5	SENT_430	[p29l234t599r406b647],
4	review	NN	O	review	nn	5	SENT_430	[p29l420t601r558b636],
5	committee	NN	O	committee	nsubj	6	SENT_430	[p29l572t601r797b636],
6	approved	VBD	O	approve	_	0	SENT_430	[p29l813t599r1005b647],
7	the	DT	O	the	det	9	SENT_430	[p29l1019t599r1084b636],
8	study	NN	O	study	nn	9	SENT_430	[p29l1101t599r1214b648],
9	design	NN	O	design	dobj	6	SENT_430	[p29l1228t599r1366b648],
10	and	CC	O	and	_	0	SENT_430	[p29l1382t599r1459b636],
11	reviewed	VBN	O	review	conj_and	6	SENT_430	[p29l9t660r196b697],
12	the	DT	O	the	det	14	SENT_430	[p29l209t660r275b697],
13	ﬁnal	JJ	O	ﬁnal	amod	14	SENT_430	[p29l290t660r384b697],
14	manuscript	NN	O	manuscript	dobj	11	SENT_430	[p29l399t662r652b708],
15	.	.	O	.	_	0	SENT_430	[p29l399t662r652b708],

1	Funding	NNP	O	Funding	_	0	SENT_431	[p29l671t660r848b709],
2	references	NNS	O	reference	dep	1	SENT_431	[p29l863t660r1092b697],
3	:	:	O	:	_	0	SENT_431	[p29l863t660r1092b697],
4	US	NNP	LOCATION	US	nn	5	SENT_431	[p29l1111t662r1172b697],
5	NIH/NHLBI	NNP	O	NIH/NHLBI	dep	1	SENT_431	[p29l1191t663r1470b709],
6	:	:	O	:	_	0	SENT_431	[p29l1191t663r1470b709],
7	K23-I-IL04285	NN	O	k23-i-il04285	nn	15	SENT_431	[p29l11t722r308b763],
8	,	,	O	,	_	0	SENT_431	[p29l11t722r308b763],
9	U10-HL74227	NN	O	u10-hl74227	dep	15	SENT_431	[p29l327t722r618b763],
10	,	,	O	,	_	0	SENT_431	[p29l327t722r618b763],
11	U10-HL74231	NN	O	u10-hl74231	dep	15	SENT_431	[p29l637t722r928b763],
12	,	,	O	,	_	0	SENT_431	[p29l637t722r928b763],
13	U10-I-IL074204	NN	O	u10-i-il074204	dep	15	SENT_431	[p29l947t722r1264b763],
14	,	,	O	,	_	0	SENT_431	[p29l947t722r1264b763],
15	U10HL74212	NN	O	u10hl74212	dep	5	SENT_431	[p29l1283t723r1377b758, p29l11t783r202b824],
16	,	,	O	,	_	0	SENT_431	[p29l1283t723r1377b758, p29l11t783r202b824],

1	U10-HL74073	NN	O	u10-hl74073	nn	7	SENT_432	[p29l221t783r512b824],
2	,	,	O	,	_	0	SENT_432	[p29l221t783r512b824],
3	U10-I-IL074206	NN	O	u10-i-il074206	dep	7	SENT_432	[p29l532t783r852b824],
4	,	,	O	,	_	0	SENT_432	[p29l532t783r852b824],
5	U10-I-IL074208	NN	O	u10-i-il074208	dep	7	SENT_432	[p29l871t783r1191b824],
6	,	,	O	,	_	0	SENT_432	[p29l871t783r1191b824],
7	U10-HL74225	NN	O	u10-hl74225	_	0	SENT_432	[p29l1223t783r1518b824],
8	,	,	O	,	_	0	SENT_432	[p29l1223t783r1518b824],
9	U10-HL74218	NN	O	u10-hl74218	dep	7	SENT_432	[p29l11t845r301b881],
10	.	.	O	.	_	0	SENT_432	[p29l11t845r301b881],

1	Open-label	JJ	O	open-label	amod	3	SENT_433	[p29l319t843r548b891],
2	ipratropium	NN	O	ipratropium	nn	3	SENT_433	[p29l563t845r819b891],
3	bromide	NN	O	bromide	nsubjpass	5	SENT_433	[p29l833t843r1012b880],
4	was	VBD	O	be	auxpass	5	SENT_433	[p29l1026t856r1104b880],
5	provided	VBN	O	provide	_	0	SENT_433	[p29l1120t843r1304b891],
6	by	IN	O	by	_	0	SENT_433	[p29l1318t843r1367b892],
7	Boehringer	NNP	ORGANIZATION	Boehringer	nn	11	SENT_433	[p29l11t903r248b953],
8	Ingelheim	NNP	ORGANIZATION	Ingelheim	nn	11	SENT_433	[p29l265t903r482b953],
9	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	11	SENT_433	[p29l499t903r845b941],
10	(	NNP	O	(	nn	11	SENT_433	[p29l865t903r1103b953],
11	Ridgeﬁeld	NNP	PERSON	Ridgeﬁeld	agent	5	SENT_433	[p29l865t903r1103b953],
12	,	,	O	,	_	0	SENT_433	[p29l865t903r1103b953],
13	CT	NNP	O	CT	nn	15	SENT_433	[p29l1121t906r1187b946],
14	,	,	O	,	_	0	SENT_433	[p29l1121t906r1187b946],
15	USA	NNP	LOCATION	USA	appos	11	SENT_433	[p29l1206t906r1330b953],
16	)	CD	NUMBER	)	num	15	SENT_433	[p29l1206t906r1330b953],
17	,	,	O	,	_	0	SENT_433	[p29l1206t906r1330b953],
18	and	CC	O	and	_	0	SENT_433	[p29l1347t903r1425b941],
19	open-label	JJ	O	open-label	amod	21	SENT_433	[p29l10t964r227b1013],
20	beclometasone	NN	O	beclometasone	nn	21	SENT_433	[p29l241t964r556b1002],
21	hydroﬂuoroalkane	NN	O	hydroﬂuoroalkane	nsubjpass	23	SENT_433	[p29l570t964r958b1013],
22	was	VBD	O	be	auxpass	23	SENT_433	[p29l972t977r1050b1002],
23	provided	VBN	O	provide	conj_and	5	SENT_433	[p29l1066t964r1250b1013],
24	by	IN	O	by	_	0	SENT_433	[p29l1264t964r1313b1013],
25	Teva	NNP	ORGANIZATION	Teva	nn	30	SENT_433	[p29l1326t967r1419b1002],
26	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	30	SENT_433	[p29l11t1025r357b1063],
27	Industry	NNP	ORGANIZATION	Industry	nn	30	SENT_433	[p29l376t1025r555b1074],
28	(	NNP	O	(	nn	30	SENT_433	[p29l572t1025r724b1075],
29	Petach	NNP	ORGANIZATION	Petach	nn	30	SENT_433	[p29l572t1025r724b1075],
30	Tikva	NNP	ORGANIZATION	Tikva	agent	23	SENT_433	[p29l738t1025r861b1068],
31	,	,	O	,	_	0	SENT_433	[p29l738t1025r861b1068],
32	Israel	NNP	LOCATION	Israel	nn	33	SENT_433	[p29l881t1025r1022b1075],
33	)	NNP	O	)	appos	30	SENT_433	[p29l881t1025r1022b1075],
34	.	.	O	.	_	0	SENT_433	[p29l881t1025r1022b1075],

1	The	DT	O	the	det	4	SENT_434	[p29l1039t1025r1119b1063],
2	ACRN	NNP	O	ACRN	nn	4	SENT_434	[p29l1134t1028r1269b1063],
3	data	NNS	O	datum	nn	4	SENT_434	[p29l1286t1025r1371b1063],
4	safety	NN	O	safety	nsubj	7	SENT_434	[p29l10t1086r130b1135],
5	monitoring	NN	O	monitoring	nn	6	SENT_434	[p29l144t1089r385b1136],
6	board	NN	O	board	dep	4	SENT_434	[p29l399t1086r519b1124],
7	reviewed	VBD	O	review	_	0	SENT_434	[p29l533t1086r721b1124],
8	the	DT	O	the	det	10	SENT_434	[p29l734t1086r800b1124],
9	ﬁnal	JJ	O	ﬁnal	amod	10	SENT_434	[p29l815t1086r908b1124],
10	version	NN	O	version	dobj	7	SENT_434	[p29l922t1089r1077b1124],
11	of	IN	O	of	_	0	SENT_434	[p29l1092t1086r1139b1124],
12	the	DT	O	the	det	13	SENT_434	[p29l1146t1086r1211b1124],
13	report	NN	O	report	prep_of	10	SENT_434	[p29l1227t1094r1365b1135],
14	.	.	O	.	_	0	SENT_434	[p29l1227t1094r1365b1135],

1	We	PRP	O	we	nsubj	2	SENT_435	[p29l1381t1090r1447b1124],
2	thank	VBP	O	thank	_	0	SENT_435	[p29l8t1147r130b1185],
3	the	DT	O	the	det	9	SENT_435	[p29l143t1147r209b1185],
4	Asthma	NNP	ORGANIZATION	Asthma	nn	9	SENT_435	[p29l223t1147r388b1185],
5	Clinical	JJ	ORGANIZATION	clinical	amod	9	SENT_435	[p29l405t1147r565b1185],
6	Research	NNP	ORGANIZATION	Research	nn	9	SENT_435	[p29l583t1147r771b1185],
7	Network	NNP	ORGANIZATION	Network	nn	9	SENT_435	[p29l787t1147r965b1185],
8	research	NN	O	research	nn	9	SENT_435	[p29l979t1147r1157b1185],
9	coordinators	NNS	O	coordinator	dep	2	SENT_435	[p29l1172t1147r1435b1185],
10	and	CC	O	and	_	0	SENT_435	[p29l10t1210r87b1247],
11	study	NN	O	study	nn	12	SENT_435	[p29l103t1210r215b1259],
12	staff	NN	O	staff	conj_and	9	SENT_435	[p29l230t1210r328b1247],
13	.	.	O	.	_	0	SENT_435	[p29l230t1210r328b1247],

1	References	NNS	O	reference	_	0	SENT_436	[p29l11t1303r217b1339],

1	1	CD	NUMBER	1	num	3	SENT_437	[p29l10t1362r28b1396],
2	Pauwels	NNP	ORGANIZATION	Pauwels	nn	3	SENT_437	[p29l112t1359r282b1397],
3	RA	NN	ORGANIZATION	ra	_	0	SENT_437	[p29l301t1362r375b1403],
4	,	,	O	,	_	0	SENT_437	[p29l301t1362r375b1403],
5	Lofdahl	NNP	PERSON	Lofdahl	nn	6	SENT_437	[p29l394t1359r552b1397],
6	CG	NNP	O	CG	appos	3	SENT_437	[p29l569t1362r648b1403],
7	,	,	O	,	_	0	SENT_437	[p29l569t1362r648b1403],
8	Postma	NNP	PERSON	Postma	nn	9	SENT_437	[p29l667t1363r822b1397],
9	DS	NN	O	d	appos	3	SENT_437	[p29l840t1362r912b1403],
10	,	,	O	,	_	0	SENT_437	[p29l840t1362r912b1403],
11	et	FW	O	et	nn	12	SENT_437	[p29l930t1367r967b1397],
12	al.	FW	O	al.	appos	3	SENT_437	[p29l982t1359r1027b1397],
13	.	.	O	.	_	0	SENT_437	[p29l982t1359r1027b1397],

1	Effect	NN	O	effect	nsubj	3	SENT_438	[p29l1047t1359r1166b1397],
2	of	IN	O	of	prep	1	SENT_438	[p29l1181t1359r1228b1397],
3	inhaled	VBN	O	inhale	_	0	SENT_438	[p29l1236t1359r1395b1397],
4	formoterol	NN	O	formoterol	dobj	3	SENT_438	[p29l109t1416r337b1454],
5	and	CC	O	and	_	0	SENT_438	[p29l353t1416r431b1454],
6	budesonide	NN	O	budesonide	dobj	3	SENT_438	[p29l445t1416r691b1454],
7	on	IN	O	on	_	0	SENT_438	[p29l708t1430r760b1454],
8	exacerbations	NNS	O	exacerbation	prep_on	3	SENT_438	[p29l776t1416r1063b1454],
9	of	IN	O	of	_	0	SENT_438	[p29l1080t1416r1127b1454],
10	asthma	NN	O	asthma	prep_of	8	SENT_438	[p29l1136t1416r1301b1454],
11	.	.	O	.	_	0	SENT_438	[p29l1136t1416r1301b1454],

1	Formoterol	NNP	O	Formoterol	_	0	SENT_439	[p29l112t1472r348b1510],
2	and	CC	O	and	_	0	SENT_439	[p29l364t1472r441b1510],
3	Corticosteroids	NNS	O	corticosteroid	conj_and	1	SENT_439	[p29l457t1472r777b1510],
4	Establishing	VBG	O	establish	partmod	1	SENT_439	[p29l796t1472r1057b1522],
5	Therapy	NN	O	therapy	dobj	4	SENT_439	[p29l1071t1472r1246b1521],
6	(	CD	NUMBER	(	num	5	SENT_439	[p29l1264t1475r1444b1522],
7	FACET	NNP	O	FACET	nn	11	SENT_439	[p29l1264t1475r1444b1522],
8	)	NNP	O	)	nn	11	SENT_439	[p29l1264t1475r1444b1522],
9	International	NNP	O	International	nn	11	SENT_439	[p29l112t1529r390b1566],
10	Study	NNP	O	Study	nn	11	SENT_439	[p29l408t1529r527b1578],
11	Group	NNP	O	Group	dep	5	SENT_439	[p29l542t1532r687b1578],
12	.	.	O	.	_	0	SENT_439	[p29l542t1532r687b1578],

1	N	NN	O	n	nn	3	SENT_440	[p29l707t1533r743b1566],
2	Engl	NNP	O	Engl	nn	3	SENT_440	[p29l758t1529r845b1578],
3	]	NNP	O	]	nsubj	4	SENT_440	[p29l853t1533r879b1578],
4	Med	VBD	O	med	_	0	SENT_440	[p29l893t1529r979b1566],
5	1997	CD	DATE	1997	dobj	4	SENT_440	[p29l995t1531r1095b1572],
6	;	:	O	;	_	0	SENT_440	[p29l995t1531r1095b1572],
7	337	CD	NUMBER	337	num	9	SENT_440	[p29l1114t1531r1198b1567],
8	:	:	O	:	_	0	SENT_440	[p29l1114t1531r1198b1567],
9	1405-11	CD	DATE	1405-11	dep	5	SENT_440	[p29l1217t1531r1386b1566],
10	.	.	O	.	_	0	SENT_440	[p29l1217t1531r1386b1566],

1	2	CD	NUMBER	2	num	3	SENT_441	[p29l10t1595r31b1629],
2	Castle	NNP	O	Castle	nn	3	SENT_441	[p29l111t1592r237b1630],
3	W	NNP	O	W	_	0	SENT_441	[p29l252t1595r303b1635],
4	,	,	O	,	_	0	SENT_441	[p29l252t1595r303b1635],
5	Fuller	NNP	PERSON	Fuller	nn	6	SENT_441	[p29l323t1592r445b1630],
6	R	NNP	O	R	appos	3	SENT_441	[p29l462t1595r502b1635],
7	,	,	O	,	_	0	SENT_441	[p29l462t1595r502b1635],
8	Hall	NNP	O	Hall	nn	12	SENT_441	[p29l521t1592r609b1630],
9	I	PRP	O	I	dep	12	SENT_441	[p29l626t1595r652b1640],
10	,	,	O	,	_	0	SENT_441	[p29l626t1595r652b1640],
11	Palmer	NNP	PERSON	Palmer	dep	12	SENT_441	[p29l672t1592r821b1630],
12	I.	NNP	O	I.	appos	3	SENT_441	[p29l837t1595r863b1640],
13	Serevent	NNP	O	Serevent	nn	16	SENT_441	[p29l884t1594r1064b1630],
14	nationwide	JJ	O	nationwide	amod	16	SENT_441	[p29l1079t1592r1315b1630],
15	surveillance	NN	O	surveillance	nn	16	SENT_441	[p29l111t1648r364b1685],
16	study	NN	O	study	dep	12	SENT_441	[p29l381t1648r503b1697],
17	:	:	O	:	_	0	SENT_441	[p29l381t1648r503b1697],
18	comparison	NN	O	comparison	dep	3	SENT_441	[p29l521t1651r772b1697],
19	of	IN	O	of	_	0	SENT_441	[p29l788t1648r834b1685],
20	salmeterol	NN	O	salmeterol	prep_of	18	SENT_441	[p29l844t1648r1065b1685],
21	with	IN	O	with	_	0	SENT_441	[p29l1079t1648r1173b1685],
22	salbutamol	NN	O	salbutamol	prep_with	20	SENT_441	[p29l1190t1648r1424b1685],
23	in	IN	O	in	_	0	SENT_441	[p29l1439t1651r1481b1685],
24	asthmatic	JJ	O	asthmatic	amod	25	SENT_441	[p29l110t1705r317b1742],
25	patients	NNS	O	patient	prep_in	22	SENT_441	[p29l332t1707r499b1753],
26	who	WP	O	who	nsubj	27	SENT_441	[p29l515t1705r603b1742],
27	require	VBP	O	require	rcmod	18	SENT_441	[p29l619t1707r772b1753],
28	regular	JJ	O	regular	amod	30	SENT_441	[p29l788t1705r941b1754],
29	bronchodilator	NN	O	bronchodilator	nn	30	SENT_441	[p29l955t1705r1271b1742],
30	treatment	NN	O	treatment	dobj	27	SENT_441	[p29l1285t1712r1505b1742],
31	.	.	O	.	_	0	SENT_441	[p29l1285t1712r1505b1742],

1	BM	NN	O	bm	_	0	SENT_442	[p29l113t1764r207b1810],
2	]	CD	NUMBER	]	num	3	SENT_442	[p29l113t1764r207b1810],
3	1993	CD	DATE	1993	dep	1	SENT_442	[p29l221t1764r326b1803],
4	;	:	O	;	_	0	SENT_442	[p29l221t1764r326b1803],
5	306	CD	NUMBER	306	num	7	SENT_442	[p29l344t1763r428b1798],
6	:	:	O	:	_	0	SENT_442	[p29l344t1763r428b1798],
7	1034-37	CD	NUMBER	1034-37	dep	1	SENT_442	[p29l447t1762r613b1799],
8	.	.	O	.	_	0	SENT_442	[p29l447t1762r613b1799],

1	3	CD	NUMBER	3	num	3	SENT_443	[p29l11t1827r30b1861],
2	Nelson	NNP	ORGANIZATION	Nelson	nn	3	SENT_443	[p29l111t1824r258b1861],
3	HS	NN	ORGANIZATION	h	_	0	SENT_443	[p29l275t1827r353b1867],
4	,	,	O	,	_	0	SENT_443	[p29l275t1827r353b1867],
5	Weiss	NNP	ORGANIZATION	Weiss	appos	3	SENT_443	[p29l369t1826r492b1861],
6	ST	JJ	ORGANIZATION	st	amod	9	SENT_443	[p29l512t1826r571b1867],
7	,	,	O	,	_	0	SENT_443	[p29l512t1826r571b1867],
8	Bleecker	NNP	O	Bleecker	dep	9	SENT_443	[p29l591t1824r770b1861],
9	ER	NN	O	er	dep	5	SENT_443	[p29l786t1826r856b1867],
10	,	,	O	,	_	0	SENT_443	[p29l786t1826r856b1867],
11	Yancey	NNP	PERSON	Yancey	nn	12	SENT_443	[p29l872t1828r1019b1873],
12	SW	NNP	PERSON	SW	appos	3	SENT_443	[p29l1036t1827r1112b1867],
13	,	,	O	,	_	0	SENT_443	[p29l1036t1827r1112b1867],
14	Dorinsky	NNP	O	Dorinsky	nn	15	SENT_443	[p29l1132t1824r1325b1873],
15	PM	NNP	O	PM	appos	3	SENT_443	[p29l1342t1828r1424b1861],
16	.	.	O	.	_	0	SENT_443	[p29l1342t1828r1424b1861],

1	The	DT	O	the	det	6	SENT_444	[p29l1441t1824r1522b1861],
2	Salmeterol	NNP	O	Salmeterol	nn	6	SENT_444	[p29l113t1880r338b1918],
3	Multicenter	NNP	O	Multicenter	nn	6	SENT_444	[p29l355t1880r602b1918],
4	Asthma	NNP	O	Asthma	nn	6	SENT_444	[p29l616t1880r782b1918],
5	Research	NNP	O	Research	nn	6	SENT_444	[p29l800t1880r989b1918],
6	Trial	NNP	O	Trial	_	0	SENT_444	[p29l1004t1880r1110b1918],
7	:	:	O	:	_	0	SENT_444	[p29l1004t1880r1110b1918],
8	a	DT	O	a	det	9	SENT_444	[p29l1128t1893r1149b1918],
9	comparison	NN	O	comparison	dep	6	SENT_444	[p29l1165t1882r1416b1929],
10	of	IN	O	of	_	0	SENT_444	[p29l1431t1880r1478b1918],
11	usual	JJ	O	usual	amod	12	SENT_444	[p29l109t1936r224b1974],
12	pharmacotherapy	NN	O	pharmacotherapy	prep_of	9	SENT_444	[p29l239t1936r613b1985],
13	for	IN	O	for	_	0	SENT_444	[p29l627t1936r688b1974],
14	asthma	NN	O	asthma	prep_for	12	SENT_444	[p29l703t1936r857b1974],
15	or	CC	O	or	_	0	SENT_444	[p29l873t1950r916b1974],
16	usual	JJ	O	usual	amod	17	SENT_444	[p29l930t1936r1045b1974],
17	pharmacotherapy	NN	O	pharmacotherapy	conj_or	12	SENT_444	[p29l1060t1936r1434b1985],
18	plus	CC	O	plus	prep	17	SENT_444	[p29l109t1993r198b2042],
19	salmeterol	NN	O	salmeterol	dep	18	SENT_444	[p29l216t1993r448b2030],
20	.	.	O	.	_	0	SENT_444	[p29l216t1993r448b2030],

1	Chest	NN	O	chest	_	0	SENT_445	[p29l469t1993r576b2030],
2	2006	CD	DATE	2006	num	1	SENT_445	[p29l591t1996r701b2036],
3	;	:	O	;	_	0	SENT_445	[p29l591t1996r701b2036],
4	129	CD	NUMBER	129	num	6	SENT_445	[p29l719t1996r800b2030],
5	:	:	O	:	_	0	SENT_445	[p29l719t1996r800b2030],
6	15-26	CD	DATE	15-26	dep	1	SENT_445	[p29l819t1995r948b2030],
7	.	.	O	.	_	0	SENT_445	[p29l819t1995r948b2030],

1	4	CD	NUMBER	4	num	3	SENT_446	[p29l8t2059r32b2092],
2	Hawkins	NNP	ORGANIZATION	Hawkins	nn	3	SENT_446	[p29l112t2055r301b2093],
3	GA	NNP	ORGANIZATION	GA	_	0	SENT_446	[p29l321t2058r401b2098],
4	,	,	O	,	_	0	SENT_446	[p29l321t2058r401b2098],
5	Tantisira	NNP	PERSON	Tantisira	nn	6	SENT_446	[p29l419t2058r609b2093],
6	K	NNP	PERSON	K	appos	3	SENT_446	[p29l628t2059r668b2098],
7	,	,	O	,	_	0	SENT_446	[p29l628t2059r668b2098],
8	Meyers	NNP	ORGANIZATION	Meyers	nn	9	SENT_446	[p29l688t2059r841b2104],
9	DA	NNP	ORGANIZATION	DA	appos	3	SENT_446	[p29l861t2058r940b2098],
10	,	,	O	,	_	0	SENT_446	[p29l861t2058r940b2098],
11	et	FW	O	et	nn	12	SENT_446	[p29l959t2063r997b2093],
12	al.	FW	O	al.	appos	3	SENT_446	[p29l1013t2055r1059b2093],
13	.	.	O	.	_	0	SENT_446	[p29l1013t2055r1059b2093],

1	Sequence	NN	O	sequence	_	0	SENT_447	[p29l1081t2058r1297b2104],
2	,	,	O	,	_	0	SENT_447	[p29l1081t2058r1297b2104],
3	haplotype	NN	O	haplotype	conj_and	1	SENT_447	[p29l109t2111r332b2160],
4	,	,	O	,	_	0	SENT_447	[p29l109t2111r332b2160],
5	and	CC	O	and	_	0	SENT_447	[p29l351t2111r430b2148],
6	association	NN	O	association	nn	7	SENT_447	[p29l446t2114r687b2148],
7	analysis	NN	O	analysis	conj_and	1	SENT_447	[p29l704t2111r874b2160],
8	of	IN	O	of	_	0	SENT_447	[p29l893t2111r940b2148],
9	ADRbeta2	NN	O	adrbeta2	prep_of	7	SENT_447	[p29l949t2111r1169b2148],
10	in	IN	O	in	_	0	SENT_447	[p29l1187t2114r1230b2148],
11	a	DT	O	a	det	15	SENT_447	[p29l1247t2124r1267b2148],
12	multiethnic	JJ	O	multiethnic	amod	15	SENT_447	[p29l109t2168r365b2205],
13	asthma	NN	O	asthma	nn	15	SENT_447	[p29l382t2168r539b2205],
14	case-control	JJ	O	case-control	amod	15	SENT_447	[p29l556t2168r816b2205],
15	study	NN	O	study	prep_in	9	SENT_447	[p29l834t2168r956b2217],
16	.	.	O	.	_	0	SENT_447	[p29l834t2168r956b2217],

1	Am	VBP	O	be	cop	2	SENT_448	[p29l974t2171r1048b2205],
2	j	NN	O	j	dep	6	SENT_448	[p29l1059t2171r1084b2217],
3	Respir	NNP	O	Respir	nn	5	SENT_448	[p29l1101t2169r1229b2217],
4	Crit	NNP	O	Crit	nn	5	SENT_448	[p29l1246t2169r1322b2205],
5	Care	NNP	O	Care	nsubj	6	SENT_448	[p29l1341t2170r1434b2205],
6	Med	VBD	O	med	_	0	SENT_448	[p29l111t2224r198b2262],
7	2006	CD	DATE	2006	dobj	6	SENT_448	[p29l215t2227r327b2267],
8	;	:	O	;	_	0	SENT_448	[p29l215t2227r327b2267],
9	174	CD	NUMBER	174	num	11	SENT_448	[p29l346t2226r429b2262],
10	:	:	O	:	_	0	SENT_448	[p29l346t2226r429b2262],
11	1101-09	CD	DATE	1101-09	dep	7	SENT_448	[p29l449t2227r624b2262],
12	.	.	O	.	_	0	SENT_448	[p29l449t2227r624b2262],

1	5	CD	NUMBER	5	num	3	SENT_449	[p29l11t2290r30b2325],
2	Israel	NNP	LOCATION	Israel	nn	3	SENT_449	[p29l112t2288r228b2325],
3	E	NNP	O	E	_	0	SENT_449	[p29l246t2290r282b2331],
4	,	,	O	,	_	0	SENT_449	[p29l246t2290r282b2331],
5	Drazen	NNP	PERSON	Drazen	nn	6	SENT_449	[p29l301t2292r454b2325],
6	IM	NNP	PERSON	IM	appos	3	SENT_449	[p29l470t2292r542b2336],
7	,	,	O	,	_	0	SENT_449	[p29l470t2292r542b2336],
8	Liggett	NNP	ORGANIZATION	Liggett	nn	9	SENT_449	[p29l562t2290r706b2337],
9	SB	NN	O	sb	appos	3	SENT_449	[p29l723t2291r790b2331],
10	,	,	O	,	_	0	SENT_449	[p29l723t2291r790b2331],
11	et	FW	O	et	nn	12	SENT_449	[p29l808t2295r845b2325],
12	al.	FW	O	al.	appos	3	SENT_449	[p29l860t2288r905b2325],
13	.	.	O	.	_	0	SENT_449	[p29l860t2288r905b2325],

1	The	DT	O	the	det	2	SENT_450	[p29l922t2288r1003b2325],
2	effect	NN	O	effect	_	0	SENT_450	[p29l1019t2288r1133b2325],
3	of	IN	O	of	_	0	SENT_450	[p29l1149t2288r1195b2325],
4	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_450	[p29l109t2344r444b2393],
5	of	IN	O	of	_	0	SENT_450	[p29l461t2343r507b2381],
6	the	DT	O	the	det	8	SENT_450	[p29l515t2344r581b2381],
7	beta2-adrenergic	JJ	O	beta2-adrenergic	amod	8	SENT_450	[p29l596t2343r952b2393],
8	receptor	NN	O	receptor	prep_of	4	SENT_450	[p29l967t2351r1142b2392],
9	on	IN	O	on	_	0	SENT_450	[p29l1157t2357r1209b2381],
10	the	DT	O	the	det	11	SENT_450	[p29l1224t2344r1290b2381],
11	response	NN	O	response	prep_on	8	SENT_450	[p29l1305t2357r1495b2392],
12	to	TO	O	to	_	0	SENT_450	[p29l109t2407r148b2437],
13	regular	JJ	O	regular	amod	14	SENT_450	[p29l164t2399r317b2449],
14	use	NN	O	use	prep_to	11	SENT_450	[p29l330t2413r402b2437],
15	of	IN	O	of	_	0	SENT_450	[p29l419t2399r465b2437],
16	albuterol	NN	O	albuterol	prep_of	2	SENT_450	[p29l474t2399r662b2437],
17	in	IN	O	in	_	0	SENT_450	[p29l678t2402r720b2436],
18	asthma	NN	O	asthma	prep_in	2	SENT_450	[p29l736t2399r901b2437],
19	.	.	O	.	_	0	SENT_450	[p29l736t2399r901b2437],

1	Am	VBP	O	be	cop	2	SENT_451	[p29l917t2402r1025b2449],
2	]	CD	NUMBER	]	dep	6	SENT_451	[p29l917t2402r1025b2449],
3	Respir	NNP	O	Respir	nn	5	SENT_451	[p29l1041t2401r1166b2448],
4	Crit	NNP	O	Crit	nn	5	SENT_451	[p29l1182t2401r1256b2437],
5	Care	NNP	O	Care	nsubj	6	SENT_451	[p29l1275t2402r1365b2437],
6	Med	VBD	O	med	_	0	SENT_451	[p29l1381t2399r1467b2437],
7	2000	CD	DATE	2000	dobj	6	SENT_451	[p29l111t2459r220b2499],
8	;	:	O	;	_	0	SENT_451	[p29l111t2459r220b2499],
9	162	CD	NUMBER	162	num	11	SENT_451	[p29l239t2459r319b2493],
10	:	:	O	:	_	0	SENT_451	[p29l239t2459r319b2493],
11	75-80	CD	NUMBER	75-80	dep	7	SENT_451	[p29l336t2458r469b2495],
12	.	.	O	.	_	0	SENT_451	[p29l336t2458r469b2495],

1	6	CD	NUMBER	6	_	0	SENT_452	[p29l10t2522r31b2556],
2	Israel	NNP	LOCATION	Israel	nn	3	SENT_452	[p29l112t2518r228b2556],
3	E	NNP	O	E	dep	1	SENT_452	[p29l246t2521r282b2562],
4	,	,	O	,	_	0	SENT_452	[p29l246t2521r282b2562],
5	Chinchilli	NNP	PERSON	Chinchilli	nn	6	SENT_452	[p29l300t2518r512b2556],
6	VM	NNP	O	VM	appos	3	SENT_452	[p29l526t2522r615b2562],
7	,	,	O	,	_	0	SENT_452	[p29l526t2522r615b2562],
8	Ford	NNP	ORGANIZATION	Ford	nn	9	SENT_452	[p29l634t2518r729b2556],
9	IG	NNP	O	IG	appos	3	SENT_452	[p29l745t2521r809b2567],
10	,	,	O	,	_	0	SENT_452	[p29l745t2521r809b2567],
11	et	FW	O	et	nn	12	SENT_452	[p29l827t2526r864b2556],
12	al	FW	O	al	appos	3	SENT_452	[p29l879t2518r924b2562],
13	,	,	O	,	_	0	SENT_452	[p29l879t2518r924b2562],
14	for	IN	O	for	_	0	SENT_452	[p29l942t2518r1002b2556],
15	The	DT	ORGANIZATION	the	det	17	SENT_452	[p29l1016t2518r1097b2556],
16	National	NNP	ORGANIZATION	National	nn	17	SENT_452	[p29l1114t2518r1292b2556],
17	Heart	NNP	ORGANIZATION	Heart	prep_for	3	SENT_452	[p29l1310t2522r1439b2562],
18	,	,	O	,	_	0	SENT_452	[p29l1310t2522r1439b2562],
19	Lung	NN	O	lung	appos	17	SENT_452	[p29l112t2579r228b2625],
20	,	,	O	,	_	0	SENT_452	[p29l112t2579r228b2625],
21	And	CC	O	and	_	0	SENT_452	[p29l245t2575r335b2613],
22	Blood	NNP	ORGANIZATION	Blood	nn	23	SENT_452	[p29l352t2575r471b2613],
23	Institute	NNP	ORGANIZATION	Institute	poss	25	SENT_452	[p29l488t2578r698b2613],
24	’s	POS	ORGANIZATION	’s	_	0	SENT_452	[p29l488t2578r698b2613],
25	Asthma	NNP	ORGANIZATION	Asthma	dep	1	SENT_452	[p29l714t2575r881b2613],
26	Clinical	JJ	ORGANIZATION	clinical	amod	28	SENT_452	[p29l897t2575r1059b2613],
27	Research	NNP	ORGANIZATION	Research	nn	28	SENT_452	[p29l1077t2575r1267b2613],
28	Network	NNP	ORGANIZATION	Network	dep	25	SENT_452	[p29l1283t2575r1472b2613],
29	.	.	O	.	_	0	SENT_452	[p29l1283t2575r1472b2613],

1	Use	NN	O	use	nsubj	4	SENT_453	[p29l112t2635r191b2669],
2	of	IN	O	of	prep	1	SENT_453	[p29l208t2632r254b2669],
3	regularly	RB	O	regularly	pcomp	2	SENT_453	[p29l263t2632r452b2681],
4	scheduled	VBN	O	schedule	_	0	SENT_453	[p29l468t2632r681b2669],
5	albuterol	NN	O	albuterol	nn	6	SENT_453	[p29l696t2632r885b2669],
6	treatment	NN	O	treatment	tmod	4	SENT_453	[p29l899t2639r1109b2669],
7	in	IN	O	in	_	0	SENT_453	[p29l1123t2634r1165b2669],
8	asthma	NN	O	asthma	prep_in	6	SENT_453	[p29l1181t2632r1346b2669],
9	:	:	O	:	_	0	SENT_453	[p29l1181t2632r1346b2669],
10	genotype-stratiﬁed	JJ	O	genotype-stratiﬁed	amod	16	SENT_453	[p29l110t2687r516b2737],
11	,	,	O	,	_	0	SENT_453	[p29l110t2687r516b2737],
12	randomised	JJ	O	randomised	amod	16	SENT_453	[p29l534t2687r799b2730],
13	,	,	O	,	_	0	SENT_453	[p29l534t2687r799b2730],
14	placebo-controlled	JJ	O	placebo-controlled	amod	16	SENT_453	[p29l816t2687r1208b2736],
15	cross-over	JJ	O	cross-over	amod	16	SENT_453	[p29l1223t2701r1436b2725],
16	trial	NN	O	trial	dep	6	SENT_453	[p29l109t2743r205b2781],
17	.	.	O	.	_	0	SENT_453	[p29l109t2743r205b2781],

1	Lancet	NNP	O	Lancet	_	0	SENT_454	[p29l225t2747r355b2781],
2	2004	CD	DATE	2004	num	1	SENT_454	[p29l371t2747r477b2787],
3	;	:	O	;	_	0	SENT_454	[p29l371t2747r477b2787],
4	364	CD	NUMBER	364	num	6	SENT_454	[p29l496t2746r580b2781],
5	:	:	O	:	_	0	SENT_454	[p29l496t2746r580b2781],
6	1505-12	CD	DATE	1505-12	dep	1	SENT_454	[p29l599t2745r775b2781],
7	.	.	O	.	_	0	SENT_454	[p29l599t2745r775b2781],

1	7	CD	NUMBER	7	num	3	SENT_455	[p29l8t2810r29b2846],
2	Taylor	NNP	ORGANIZATION	Taylor	nn	3	SENT_455	[p29l109t2808r238b2857],
3	DR	NN	ORGANIZATION	dr	_	0	SENT_455	[p29l255t2811r332b2851],
4	,	,	O	,	_	0	SENT_455	[p29l255t2811r332b2851],
5	Drazen	NNP	PERSON	Drazen	nn	6	SENT_455	[p29l352t2811r505b2845],
6	IM	NNP	PERSON	IM	appos	3	SENT_455	[p29l521t2811r593b2855],
7	,	,	O	,	_	0	SENT_455	[p29l521t2811r593b2855],
8	Herbison	NNP	PERSON	Herbison	nn	9	SENT_455	[p29l612t2808r810b2845],
9	GP	NNP	O	GP	appos	6	SENT_455	[p29l827t2810r902b2851],
10	,	,	O	,	_	0	SENT_455	[p29l827t2810r902b2851],
11	Yandava	NNP	O	Yandava	nn	12	SENT_455	[p29l919t2808r1093b2845],
12	CN	NN	O	cn	appos	6	SENT_455	[p29l1109t2810r1188b2851],
13	,	,	O	,	_	0	SENT_455	[p29l1109t2810r1188b2851],
14	Hancox	NNP	PERSON	Hancox	nn	15	SENT_455	[p29l1207t2811r1368b2845],
15	RI	NN	O	rus	appos	6	SENT_455	[p29l1385t2811r1443b2855],
16	,	,	O	,	_	0	SENT_455	[p29l1385t2811r1443b2855],
17	Town	NNP	ORGANIZATION	Town	nn	18	SENT_455	[p29l109t2865r224b2901],
18	GI	NNP	O	GI	appos	6	SENT_455	[p29l241t2866r304b2901],
19	.	.	O	.	_	0	SENT_455	[p29l241t2866r304b2901],

1	Asthma	NN	O	asthma	nn	2	SENT_456	[p29l321t2863r488b2901],
2	exacerbations	NNS	O	exacerbation	_	0	SENT_456	[p29l503t2863r790b2901],
3	during	IN	O	during	_	0	SENT_456	[p29l808t2863r950b2913],
4	long	JJ	O	long	amod	7	SENT_456	[p29l965t2863r1058b2913],
5	term	NN	O	term	nn	7	SENT_456	[p29l1073t2871r1174b2901],
6	beta-agonist	JJ	O	beta-agonist	amod	7	SENT_456	[p29l1189t2863r1447b2913],
7	use	NN	O	use	prep_during	2	SENT_456	[p29l109t2933r192b2957],
8	:	:	O	:	_	0	SENT_456	[p29l109t2933r192b2957],
9	inﬂuence	NN	O	inﬂuence	dep	2	SENT_456	[p29l210t2920r408b2957],
10	of	IN	O	of	_	0	SENT_456	[p29l425t2920r471b2957],
11	beta2	NN	O	beta2	nn	13	SENT_456	[p29l479t2920r590b2957],
12	adrenoceptor	NN	O	adrenoceptor	nn	13	SENT_456	[p29l608t2920r888b2969],
13	polymorphism	NN	O	polymorphism	prep_of	9	SENT_456	[p29l902t2920r1227b2969],
14	.	.	O	.	_	0	SENT_456	[p29l902t2920r1227b2969],

1	Thorax	NNP	O	Thorax	_	0	SENT_457	[p29l1248t2920r1394b2957],
2	2000	CD	DATE	2000	num	1	SENT_457	[p29l1408t2923r1518b2963],
3	;	:	O	;	_	0	SENT_457	[p29l1408t2923r1518b2963],
4	55	CD	NUMBER	55	num	6	SENT_457	[p29l112t2978r169b3014],
5	:	:	O	:	_	0	SENT_457	[p29l112t2978r169b3014],
6	762-67	CD	NUMBER	762-67	dep	1	SENT_457	[p29l186t2978r332b3015],
7	.	.	O	.	_	0	SENT_457	[p29l186t2978r332b3015],

1	8	CD	NUMBER	8	num	3	SENT_458	[p29l10t3043r31b3077],
2	Wechsler	NNP	ORGANIZATION	Wechsler	nn	3	SENT_458	[p29l109t3040r305b3078],
3	ME	NNP	ORGANIZATION	ME	_	0	SENT_458	[p29l322t3042r404b3083],
4	,	,	O	,	_	0	SENT_458	[p29l322t3042r404b3083],
5	Lehman	NNP	ORGANIZATION	Lehman	nn	6	SENT_458	[p29l423t3040r595b3077],
6	E	NNP	ORGANIZATION	E	appos	3	SENT_458	[p29l613t3042r649b3083],
7	,	,	O	,	_	0	SENT_458	[p29l613t3042r649b3083],
8	Lazarus	NNP	PERSON	Lazarus	nn	9	SENT_458	[p29l668t3044r830b3077],
9	SC	NNP	O	SC	appos	3	SENT_458	[p29l850t3043r918b3083],
10	,	,	O	,	_	0	SENT_458	[p29l850t3043r918b3083],
11	et	FW	O	et	nn	12	SENT_458	[p29l936t3047r973b3077],
12	al.	FW	O	al.	appos	3	SENT_458	[p29l988t3040r1033b3077],
13	.	.	O	.	_	0	SENT_458	[p29l988t3040r1033b3077],

1	Beta-adrenergic	JJ	O	beta-adrenergic	amod	3	SENT_459	[p29l1053t3040r1386b3089],
2	receptor	NN	O	receptor	nn	3	SENT_459	[p29l109t3118r285b3159],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_459	[p29l299t3111r633b3160],
4	and	CC	O	and	_	0	SENT_459	[p29l650t3111r728b3148],
5	response	NN	O	response	conj_and	3	SENT_459	[p29l743t3124r932b3159],
6	to	TO	O	to	_	0	SENT_459	[p29l947t3118r986b3148],
7	salmeterol	NN	O	salmeterol	prep_to	3	SENT_459	[p29l1004t3111r1235b3148],
8	.	.	O	.	_	0	SENT_459	[p29l1004t3111r1235b3148],

1	Am	VBP	O	be	cop	2	SENT_460	[p29l109t3170r183b3204],
2	]	CD	NUMBER	]	dep	6	SENT_460	[p29l191t3171r217b3216],
3	Respir	NNP	O	Respir	nn	5	SENT_460	[p29l232t3169r357b3216],
4	Crit	NNP	O	Crit	nn	5	SENT_460	[p29l373t3169r448b3205],
5	Care	NNP	O	Care	nsubj	6	SENT_460	[p29l466t3170r556b3205],
6	Med	VBD	O	med	_	0	SENT_460	[p29l573t3167r658b3205],
7	2006	CD	DATE	2006	dobj	6	SENT_460	[p29l674t3171r783b3210],
8	;	:	O	;	_	0	SENT_460	[p29l674t3171r783b3210],
9	173	CD	NUMBER	173	num	11	SENT_460	[p29l801t3169r882b3205],
10	:	:	O	:	_	0	SENT_460	[p29l801t3169r882b3205],
11	519-26	CD	NUMBER	519-26	dep	7	SENT_460	[p29l902t3170r1056b3205],
12	.	.	O	.	_	0	SENT_460	[p29l902t3170r1056b3205],

1	I	PRP	O	I	_	0	SENT_461	[p29l6t3461r54b3629],
2	Articles	NNPS	O	Articles	dep	1	SENT_461	[p29l101t3593r251b3629],

1	9	CD	NUMBER	9	num	3	SENT_462	[p30l647t74r669b108],
2	Drazen	NNP	PERSON	Drazen	nn	3	SENT_462	[p30l749t74r901b108],
3	IM	NNP	PERSON	IM	_	0	SENT_462	[p30l917t74r988b119],
4	,	,	O	,	_	0	SENT_462	[p30l917t74r988b119],
5	Israel	NNP	LOCATION	Israel	nn	6	SENT_462	[p30l1008t71r1123b108],
6	E	NNP	O	E	appos	3	SENT_462	[p30l1141t73r1177b114],
7	,	,	O	,	_	0	SENT_462	[p30l1141t73r1177b114],
8	Boushey	NNP	LOCATION	Boushey	nn	9	SENT_462	[p30l1196t71r1375b120],
9	HA	NNP	LOCATION	HA	appos	3	SENT_462	[p30l1391t73r1474b114],
10	,	,	O	,	_	0	SENT_462	[p30l1391t73r1474b114],
11	et	FW	O	et	nn	12	SENT_462	[p30l1492t78r1529b108],
12	al.	FW	O	al.	appos	3	SENT_462	[p30l1544t71r1588b108],
13	.	.	O	.	_	0	SENT_462	[p30l1544t71r1588b108],

1	Comparison	NN	O	comparison	nsubj	4	SENT_463	[p30l1607t73r1866b119],
2	of	IN	O	of	prep	1	SENT_463	[p30l1882t71r1928b108],
3	regularly	RB	O	regularly	pcomp	2	SENT_463	[p30l1937t71r2125b120],
4	scheduled	VBN	O	schedule	_	0	SENT_463	[p30l748t126r960b164],
5	with	IN	O	with	_	0	SENT_463	[p30l974t126r1067b164],
6	as-needed	JJ	O	as-needed	amod	7	SENT_463	[p30l1083t126r1293b164],
7	use	NN	O	use	prep_with	4	SENT_463	[p30l1307t139r1378b164],
8	of	IN	O	of	_	0	SENT_463	[p30l1394t126r1441b164],
9	albuterol	NN	O	albuterol	prep_of	7	SENT_463	[p30l1450t126r1637b164],
10	in	IN	O	in	_	0	SENT_463	[p30l1652t129r1693b163],
11	mild	JJ	O	mild	amod	12	SENT_463	[p30l1709t126r1806b164],
12	asthma	NN	O	asthma	prep_in	9	SENT_463	[p30l1822t126r1986b164],
13	.	.	O	.	_	0	SENT_463	[p30l1822t126r1986b164],

1	N	NN	O	n	nn	3	SENT_464	[p30l749t187r785b220],
2	Engl	NNP	O	Engl	nn	3	SENT_464	[p30l800t183r920b232],
3	]	NNP	O	]	nsubj	4	SENT_464	[p30l800t183r920b232],
4	Med	VBD	O	med	_	0	SENT_464	[p30l935t183r1020b220],
5	1996	CD	DATE	1996	dobj	4	SENT_464	[p30l1036t186r1139b226],
6	;	:	O	;	_	0	SENT_464	[p30l1036t186r1139b226],
7	335	CD	NUMBER	335	num	9	SENT_464	[p30l1158t185r1241b220],
8	:	:	O	:	_	0	SENT_464	[p30l1158t185r1241b220],
9	841-47	CD	NUMBER	841-47	dep	5	SENT_464	[p30l1259t185r1397b222],
10	.	.	O	.	_	0	SENT_464	[p30l1259t185r1397b222],

1	Lazarus	NNP	PERSON	Lazarus	nn	2	SENT_465	[p30l749t249r910b283],
2	S	NNP	O	S	_	0	SENT_465	[p30l929t248r963b289],
3	,	,	O	,	_	0	SENT_465	[p30l929t248r963b289],
4	Boushey	NNP	PERSON	Boushey	nn	5	SENT_465	[p30l983t245r1162b295],
5	H	NNP	PERSON	H	appos	2	SENT_465	[p30l1178t249r1227b289],
6	,	,	O	,	_	0	SENT_465	[p30l1178t249r1227b289],
7	Fahy	NNP	PERSON	Fahy	appos	2	SENT_465	[p30l1246t246r1342b295],
8	I	PRP	O	I	dep	7	SENT_465	[p30l1358t249r1384b294],
9	,	,	O	,	_	0	SENT_465	[p30l1358t249r1384b294],
10	et	FW	O	et	nn	11	SENT_465	[p30l1402t253r1439b283],
11	al.	FW	O	al.	appos	2	SENT_465	[p30l1454t246r1498b283],
12	.	.	O	.	_	0	SENT_465	[p30l1454t246r1498b283],

1	Long-acting	JJ	O	long-acting	_	0	SENT_466	[p30l1518t248r1765b295],
2	B2-agonist	JJ	O	b2-agonist	dep	1	SENT_466	[p30l1784t245r2001b295],
3	monotherapy	NN	O	monotherapy	nsubj	8	SENT_466	[p30l747t301r1030b350],
4	vs	CC	O	vs	nsubj	5	SENT_466	[p30l1044t315r1081b338],
5	continued	VBD	O	continue	rcmod	3	SENT_466	[p30l1096t301r1309b338],
6	therapy	NN	O	therapy	dobj	5	SENT_466	[p30l1323t301r1482b350],
7	with	IN	O	with	prep	5	SENT_466	[p30l1495t301r1588b338],
8	inhaled	VBN	O	inhale	ccomp	2	SENT_466	[p30l1603t301r1762b338],
9	corticosteroids	NNS	O	corticosteroid	dobj	8	SENT_466	[p30l1777t301r2084b338],
10	in	IN	O	in	_	0	SENT_466	[p30l2101t304r2143b338],
11	patients	NNS	O	patient	prep_in	9	SENT_466	[p30l747t359r913b405],
12	with	IN	O	with	_	0	SENT_466	[p30l929t357r1022b394],
13	persistent	JJ	O	persistent	amod	14	SENT_466	[p30l1037t359r1246b405],
14	asthma	NN	O	asthma	prep_with	2	SENT_466	[p30l1261t357r1425b394],
15	:	:	O	:	_	0	SENT_466	[p30l1261t357r1425b394],
16	a	DT	O	a	dep	2	SENT_466	[p30l1443t370r1464b394],
17	randomized	VBN	O	randomize	partmod	16	SENT_466	[p30l1479t357r1734b394],
18	controlled	JJ	O	controlled	amod	19	SENT_466	[p30l1750t357r1962b394],
19	trial	NN	O	trial	dep	17	SENT_466	[p30l1976t357r2072b394],
20	.	.	O	.	_	0	SENT_466	[p30l1976t357r2072b394],
21	]	SYM	O	]	dep	1	SENT_466	[p30l741t415r878b462],

1	AMA	NNP	O	AMA	_	0	SENT_467	[p30l741t415r878b462],
2	2001	CD	DATE	2001	num	1	SENT_467	[p30l893t415r997b455],
3	;	:	O	;	_	0	SENT_467	[p30l893t415r997b455],
4	2.85	CD	NUMBER	2.85	num	6	SENT_467	[p30l1016t414r1100b450],
5	:	:	O	:	_	0	SENT_467	[p30l1016t414r1100b450],
6	2583-93	CD	NUMBER	2583-93	dep	1	SENT_467	[p30l1118t414r1302b450],
7	.	.	O	.	_	0	SENT_467	[p30l1118t414r1302b450],

1	11	CD	NUMBER	11	num	3	SENT_468	[p30l648t479r686b513],
2	Lemanske	NN	O	lemanske	nn	3	SENT_468	[p30l749t476r960b513],
3	I	NN	O	i	_	0	SENT_468	[p30l977t480r1003b524],
4	,	,	O	,	_	0	SENT_468	[p30l977t480r1003b524],
5	Sorkness	NN	O	sorkness	nn	6	SENT_468	[p30l1023t476r1208b513],
6	C	NN	O	c	appos	3	SENT_468	[p30l1226t479r1266b519],
7	,	,	O	,	_	0	SENT_468	[p30l1226t479r1266b519],
8	Mauger	NNP	PERSON	Mauger	nn	9	SENT_468	[p30l1284t480r1445b525],
9	E	NNP	O	E	appos	3	SENT_468	[p30l1461t478r1497b519],
10	,	,	O	,	_	0	SENT_468	[p30l1461t478r1497b519],
11	et	FW	O	et	nn	12	SENT_468	[p30l1514t483r1551b513],
12	al.	FW	O	al.	appos	3	SENT_468	[p30l1565t476r1610b513],
13	.	.	O	.	_	0	SENT_468	[p30l1565t476r1610b513],

1	Inhaled	VBN	O	inhale	_	0	SENT_469	[p30l1629t476r1788b513],
2	corticosteroid	NN	O	corticosteroid	nn	3	SENT_469	[p30l1803t476r2089b513],
3	reduction	NN	O	reduction	dobj	1	SENT_469	[p30l747t531r948b568],
4	and	CC	O	and	_	0	SENT_469	[p30l963t531r1040b568],
5	elimination	NN	O	elimination	conj_and	3	SENT_469	[p30l1055t531r1298b568],
6	in	IN	O	in	_	0	SENT_469	[p30l1313t533r1354b567],
7	patients	NNS	O	patient	prep_in	3	SENT_469	[p30l1369t533r1534b579],
8	with	IN	O	with	_	0	SENT_469	[p30l1549t531r1642b568],
9	persistent	JJ	O	persistent	amod	10	SENT_469	[p30l1656t533r1864b579],
10	asthma	NN	O	asthma	prep_with	1	SENT_469	[p30l1879t531r2031b568],
11	receiving	VBG	O	receive	partmod	10	SENT_469	[p30l747t589r938b636],
12	salmeterol	NN	O	salmeterol	dobj	11	SENT_469	[p30l954t586r1182b624],
13	:	:	O	:	_	0	SENT_469	[p30l954t586r1182b624],
14	a	DT	O	a	det	17	SENT_469	[p30l1200t600r1220b624],
15	randomized	VBN	O	randomize	amod	17	SENT_469	[p30l1235t586r1489b624],
16	controlled	JJ	O	controlled	amod	17	SENT_469	[p30l1504t586r1715b624],
17	trial	NN	O	trial	dep	10	SENT_469	[p30l1728t586r1822b624],
18	.	.	O	.	_	0	SENT_469	[p30l1728t586r1822b624],
19	]	SYM	O	]	dep	1	SENT_469	[p30l1834t589r1970b636],

1	AMA	NNP	O	AMA	_	0	SENT_470	[p30l1834t589r1970b636],
2	2001	CD	DATE	2001	num	1	SENT_470	[p30l1985t590r2088b629],
3	;	:	O	;	_	0	SENT_470	[p30l1985t590r2088b629],
4	285	CD	NUMBER	285	num	6	SENT_470	[p30l748t644r831b680],
5	:	:	O	:	_	0	SENT_470	[p30l748t644r831b680],
6	2594-603	CD	NUMBER	2594-603	dep	1	SENT_470	[p30l849t645r1055b680],
7	.	.	O	.	_	0	SENT_470	[p30l849t645r1055b680],

1	Vaughan	NNP	PERSON	Vaughan	nn	2	SENT_471	[p30l746t705r933b755],
2	I	NNP	O	I	_	0	SENT_471	[p30l950t709r976b753],
3	,	,	O	,	_	0	SENT_471	[p30l950t709r976b753],
4	Ngamtrakulpanit	NNP	O	Ngamtrakulpanit	nn	5	SENT_471	[p30l994t705r1358b755],
5	L	NNP	O	L	appos	2	SENT_471	[p30l1374t709r1408b748],
6	,	,	O	,	_	0	SENT_471	[p30l1374t709r1408b748],
7	Pajewski	NNP	O	Pajewski	nn	8	SENT_471	[p30l1427t705r1609b754],
8	TN	NN	O	tn	appos	2	SENT_471	[p30l1624t708r1701b748],
9	,	,	O	,	_	0	SENT_471	[p30l1624t708r1701b748],
10	et	FW	O	et	nn	11	SENT_471	[p30l1719t713r1755b743],
11	al.	FW	O	al.	appos	2	SENT_471	[p30l1770t705r1815b743],
12	.	.	O	.	_	0	SENT_471	[p30l1770t705r1815b743],

1	Exhaled	VBN	O	exhale	dep	10	SENT_472	[p30l1835t705r1998b743],
2	breath	NN	O	breath	nn	4	SENT_472	[p30l2012t705r2147b743],
3	condensate	NN	O	condensate	nn	4	SENT_472	[p30l747t761r984b798],
4	pH	NN	O	ph	nsubj	10	SENT_472	[p30l999t765r1064b810],
5	is	VBZ	O	be	cop	10	SENT_472	[p30l1082t764r1114b798],
6	a	DT	O	a	det	10	SENT_472	[p30l1131t774r1152b798],
7	robust	JJ	O	robust	amod	10	SENT_472	[p30l1167t761r1303b798],
8	and	CC	O	and	_	0	SENT_472	[p30l1317t761r1395b798],
9	reproducible	JJ	O	reproducible	amod	10	SENT_472	[p30l1409t761r1677b810],
10	assay	NN	O	assay	_	0	SENT_472	[p30l1693t774r1804b810],
11	of	IN	O	of	_	0	SENT_472	[p30l1818t761r1865b798],
12	airway	NN	O	airway	nn	13	SENT_472	[p30l1874t764r2010b810],
13	acidity	NN	O	acidity	prep_of	10	SENT_472	[p30l747t818r890b867],
14	.	.	O	.	_	0	SENT_472	[p30l747t818r890b867],

1	Eur	NNP	MISC	Eur	nn	2	SENT_473	[p30l911t820r984b855],
2	Respir	NNP	MISC	Respir	_	0	SENT_473	[p30l998t819r1155b867],
3	]	CD	NUMBER	]	num	4	SENT_473	[p30l998t819r1155b867],
4	2003	CD	DATE	2003	dep	2	SENT_473	[p30l1169t821r1277b861],
5	;	:	O	;	_	0	SENT_473	[p30l1169t821r1277b861],
6	22	CD	NUMBER	22	num	8	SENT_473	[p30l1296t821r1354b855],
7	:	:	O	:	_	0	SENT_473	[p30l1296t821r1354b855],
8	889-94	CD	NUMBER	889-94	dep	2	SENT_473	[p30l1372t821r1529b855],
9	.	.	O	.	_	0	SENT_473	[p30l1372t821r1529b855],

1	Laird	NNP	ORGANIZATION	Laird	nn	2	SENT_474	[p30l749t880r856b918],
2	NM	NNP	ORGANIZATION	NM	_	0	SENT_474	[p30l872t884r961b923],
3	,	,	O	,	_	0	SENT_474	[p30l872t884r961b923],
4	Donnelly	NNP	PERSON	Donnelly	nn	5	SENT_474	[p30l981t880r1173b929],
5	C	NNP	O	C	appos	2	SENT_474	[p30l1188t883r1229b923],
6	,	,	O	,	_	0	SENT_474	[p30l1188t883r1229b923],
7	Ware	NNP	O	Ware	nn	8	SENT_474	[p30l1245t884r1353b918],
8	IH	NN	O	ih	appos	5	SENT_474	[p30l1370t884r1438b928],
9	.	.	O	.	_	0	SENT_474	[p30l1370t884r1438b928],

1	Longitudinal	JJ	O	longitudinal	amod	2	SENT_475	[p30l1457t880r1727b930],
2	studies	NNS	O	study	_	0	SENT_475	[p30l1744t880r1890b918],
3	with	IN	O	with	_	0	SENT_475	[p30l1906t880r1999b918],
4	continuous	JJ	O	continuous	amod	5	SENT_475	[p30l747t939r984b974],
5	responses	NNS	O	response	prep_with	2	SENT_475	[p30l1000t950r1221b986],
6	.	.	O	.	_	0	SENT_475	[p30l1000t950r1221b986],

1	Stat	NN	O	stat	nn	2	SENT_476	[p30l1242t940r1321b974],
2	Methods	NNS	O	method	nsubj	3	SENT_476	[p30l1337t937r1503b974],
3	Med	VBD	O	med	_	0	SENT_476	[p30l1519t937r1605b974],
4	Res	NNP	O	Res	dobj	3	SENT_476	[p30l1622t941r1687b974],
5	1992	CD	DATE	1992	num	4	SENT_476	[p30l1703t940r1806b980],
6	;	:	O	;	_	0	SENT_476	[p30l1703t940r1806b980],
7	1	CD	NUMBER	1	dep	4	SENT_476	[p30l1825t940r1854b974],
8	:	:	O	:	_	0	SENT_476	[p30l1825t940r1854b974],
9	22547	CD	NUMBER	22547	num	17	SENT_476	[p30l1872t939r2017b975],
10	Laird	NNP	ORGANIZATION	Laird	nn	17	SENT_476	[p30l749t999r856b1037],
11	NM	NNP	ORGANIZATION	NM	nn	17	SENT_476	[p30l872t1003r961b1042],
12	,	,	O	,	_	0	SENT_476	[p30l872t1003r961b1042],
13	Ware	NNP	O	Ware	appos	17	SENT_476	[p30l978t1003r1086b1037],
14	]	NNP	O	]	nn	17	SENT_476	[p30l1102t1003r1170b1047],
15	H.	NNP	O	H.	nn	17	SENT_476	[p30l1102t1003r1170b1047],
16	Random-effects	NNP	O	Random-effects	nn	17	SENT_476	[p30l1190t999r1517b1037],
17	models	NNS	O	model	dep	4	SENT_476	[p30l1533t999r1685b1037],
18	for	IN	O	for	_	0	SENT_476	[p30l1702t999r1762b1037],
19	longitudinal	JJ	O	longitudinal	amod	20	SENT_476	[p30l1776t999r2035b1049],
20	data	NNS	O	datum	prep_for	17	SENT_476	[p30l2051t999r2147b1037],
21	.	.	O	.	_	0	SENT_476	[p30l2051t999r2147b1037],

1	Biometrics	NNS	O	biometric	_	0	SENT_477	[p30l750t1056r958b1092],
2	1982	CD	DATE	1982	num	1	SENT_477	[p30l974t1058r1077b1098],
3	;	:	O	;	_	0	SENT_477	[p30l974t1058r1077b1098],
4	38	CD	NUMBER	38	num	6	SENT_477	[p30l1096t1058r1154b1092],
5	:	:	O	:	_	0	SENT_477	[p30l1096t1058r1154b1092],
6	963-74	CD	NUMBER	963-74	dep	1	SENT_477	[p30l1172t1057r1325b1094],
7	.	.	O	.	_	0	SENT_477	[p30l1172t1057r1325b1094],

1	Vonesh	JJ	O	vonesh	amod	2	SENT_478	[p30l746t1119r903b1156],
2	EF	NN	O	ef	_	0	SENT_478	[p30l921t1121r985b1162],
3	,	,	O	,	_	0	SENT_478	[p30l921t1121r985b1162],
4	Carter	NNP	PERSON	Carter	nn	5	SENT_478	[p30l1004t1121r1134b1156],
5	RL	NNP	O	RL	appos	2	SENT_478	[p30l1150t1122r1216b1156],
6	.	.	O	.	_	0	SENT_478	[p30l1150t1122r1216b1156],

1	Mixed-effects	NNS	O	mixed-effect	nsubj	3	SENT_479	[p30l1235t1119r1513b1156],
2	nonlinear	JJ	O	nonlinear	amod	3	SENT_479	[p30l1529t1119r1736b1156],
3	regression	NN	O	regression	_	0	SENT_479	[p30l1750t1121r1971b1168],
4	for	IN	O	for	_	0	SENT_479	[p30l1987t1119r2046b1156],
5	unbalanced	JJ	O	unbalanced	amod	7	SENT_479	[p30l746t1174r992b1211],
6	repeated	VBN	O	repeat	amod	7	SENT_479	[p30l1006t1174r1187b1223],
7	measures	NNS	O	measure	prep_for	3	SENT_479	[p30l1201t1187r1415b1211],
8	.	.	O	.	_	0	SENT_479	[p30l1201t1187r1415b1211],

1	Biometrics	NNS	O	biometric	_	0	SENT_480	[p30l1436t1176r1643b1211],
2	1992	CD	DATE	1992	num	1	SENT_480	[p30l1659t1178r1763b1217],
3	;	:	O	;	_	0	SENT_480	[p30l1659t1178r1763b1217],
4	48	CD	NUMBER	48	num	6	SENT_480	[p30l1780t1177r1840b1211],
5	:	:	O	:	_	0	SENT_480	[p30l1780t1177r1840b1211],
6	1-17	CD	NUMBER	1-17	dep	1	SENT_480	[p30l1858t1176r1945b1213],
7	.	.	O	.	_	0	SENT_480	[p30l1858t1176r1945b1213],

1	Hollander	NNP	PERSON	Hollander	nn	2	SENT_481	[p30l749t1238r961b1275],
2	M	NNP	O	M	_	0	SENT_481	[p30l977t1241r1030b1280],
3	,	,	O	,	_	0	SENT_481	[p30l977t1241r1030b1280],
4	Wolfe	NNP	PERSON	Wolfe	nn	5	SENT_481	[p30l1046t1238r1168b1275],
5	DA	NNP	O	DA	appos	2	SENT_481	[p30l1186t1240r1263b1275],
6	.	.	O	.	_	0	SENT_481	[p30l1186t1240r1263b1275],

1	Nonparametric	JJ	MISC	nonparametric	_	0	SENT_482	[p30l1282t1240r1601b1286],
2	statistical	JJ	O	statistical	amod	3	SENT_482	[p30l1617t1238r1814b1275],
3	methods	NNS	O	method	dep	1	SENT_482	[p30l1829t1238r2023b1275],
4	.	.	O	.	_	0	SENT_482	[p30l1829t1238r2023b1275],

1	2nd	JJ	ORDINAL	2nd	amod	2	SENT_483	[p30l748t1293r827b1331],
2	edn	NN	O	edn	_	0	SENT_483	[p30l842t1293r929b1331],
3	.	.	O	.	_	0	SENT_483	[p30l842t1293r929b1331],

1	New	NNP	LOCATION	New	nn	2	SENT_484	[p30l948t1297r1040b1331],
2	York	NNP	LOCATION	York	_	0	SENT_484	[p30l1054t1293r1160b1331],
3	:	:	O	:	_	0	SENT_484	[p30l1054t1293r1160b1331],
4	Wiley	NNP	PERSON	Wiley	dep	2	SENT_484	[p30l1177t1293r1302b1342],
5	,	,	O	,	_	0	SENT_484	[p30l1177t1293r1302b1342],
6	1999	CD	DATE	1999	appos	4	SENT_484	[p30l1321t1297r1424b1331],
7	.	.	O	.	_	0	SENT_484	[p30l1321t1297r1424b1331],

1	17	CD	NUMBER	17	num	3	SENT_485	[p30l648t1359r687b1395],
2	Israel	NNP	LOCATION	Israel	nn	3	SENT_485	[p30l749t1357r865b1394],
3	E	NNP	O	E	_	0	SENT_485	[p30l882t1359r918b1400],
4	,	,	O	,	_	0	SENT_485	[p30l882t1359r918b1400],
5	Drazen	NNP	PERSON	Drazen	nn	7	SENT_485	[p30l937t1360r1089b1394],
6	]	CD	NUMBER	]	num	7	SENT_485	[p30l1105t1360r1177b1405],
7	M	NN	O	m	appos	3	SENT_485	[p30l1105t1360r1177b1405],
8	,	,	O	,	_	0	SENT_485	[p30l1105t1360r1177b1405],
9	Liggett	NNP	ORGANIZATION	Liggett	nn	10	SENT_485	[p30l1196t1359r1339b1406],
10	SB	NN	O	sb	appos	3	SENT_485	[p30l1357t1359r1423b1400],
11	,	,	O	,	_	0	SENT_485	[p30l1357t1359r1423b1400],
12	et	FW	O	et	nn	13	SENT_485	[p30l1441t1364r1477b1394],
13	al.	FW	O	al.	appos	3	SENT_485	[p30l1493t1357r1537b1394],
14	.	.	O	.	_	0	SENT_485	[p30l1493t1357r1537b1394],

1	Effect	NN	O	effect	_	0	SENT_486	[p30l1557t1357r1675b1394],
2	of	IN	O	of	_	0	SENT_486	[p30l1690t1357r1736b1394],
3	polymorphism	NN	O	polymorphism	prep_of	1	SENT_486	[p30l1745t1357r2057b1406],
4	of	IN	O	of	_	0	SENT_486	[p30l2073t1357r2119b1394],
5	the	DT	O	the	det	7	SENT_486	[p30l746t1413r811b1450],
6	beta	NN	O	beta	nn	7	SENT_486	[p30l826t1413r1212b1462],
7	(	NN	O	(	prep_of	3	SENT_486	[p30l826t1413r1212b1462],
8	2	CD	NUMBER	2	dep	7	SENT_486	[p30l826t1413r1212b1462],
9	)	SYM	O	)	dep	1	SENT_486	[p30l826t1413r1212b1462],
10	-	:	O	-	_	0	SENT_486	[p30l826t1413r1212b1462],
11	adrenergic	JJ	O	adrenergic	amod	12	SENT_486	[p30l826t1413r1212b1462],
12	receptor	NN	O	receptor	dep	1	SENT_486	[p30l1227t1420r1401b1461],
13	on	IN	O	on	_	0	SENT_486	[p30l1416t1426r1468b1450],
14	response	NN	O	response	prep_on	12	SENT_486	[p30l1483t1426r1671b1461],
15	to	TO	O	to	_	0	SENT_486	[p30l1686t1420r1725b1450],
16	regular	JJ	O	regular	amod	17	SENT_486	[p30l1741t1413r1893b1462],
17	use	NN	O	use	prep_to	14	SENT_486	[p30l1907t1426r1978b1450],
18	of	IN	O	of	_	0	SENT_486	[p30l1995t1413r2041b1450],
19	albuterol	NN	O	albuterol	prep_of	17	SENT_486	[p30l747t1468r934b1506],
20	in	IN	O	in	_	0	SENT_486	[p30l949t1471r991b1505],
21	asthma	NN	O	asthma	prep_in	19	SENT_486	[p30l1007t1468r1171b1506],
22	.	.	O	.	_	0	SENT_486	[p30l1007t1468r1171b1506],

1	Int	NNP	O	Int	nn	4	SENT_487	[p30l1191t1472r1249b1505],
2	Arch	NNP	O	Arch	nn	4	SENT_487	[p30l1263t1468r1359b1505],
3	Allergy	NNP	O	Allergy	nn	4	SENT_487	[p30l1373t1468r1512b1518],
4	Immunol	NNP	O	Immunol	_	0	SENT_487	[p30l1529t1468r1715b1505],
5	2001	CD	DATE	2001	num	4	SENT_487	[p30l1731t1471r1834b1511],
6	;	:	O	;	_	0	SENT_487	[p30l1731t1471r1834b1511],
7	124	CD	NUMBER	124	num	9	SENT_487	[p30l1853t1471r1933b1505],
8	:	:	O	:	_	0	SENT_487	[p30l1853t1471r1933b1505],
9	183-86	CD	NUMBER	183-86	dep	4	SENT_487	[p30l1952t1471r2106b1506],
10	.	.	O	.	_	0	SENT_487	[p30l1952t1471r2106b1506],

1	Bleecker	NNP	O	Bleecker	nn	2	SENT_488	[p30l749t1532r927b1569],
2	ER	NN	O	er	_	0	SENT_488	[p30l943t1534r1012b1575],
3	,	,	O	,	_	0	SENT_488	[p30l943t1534r1012b1575],
4	Nelson	NNP	PERSON	Nelson	nn	5	SENT_488	[p30l1031t1532r1177b1569],
5	H	NNP	PERSON	H	appos	2	SENT_488	[p30l1194t1535r1243b1575],
6	,	,	O	,	_	0	SENT_488	[p30l1194t1535r1243b1575],
7	Corren	NNP	O	Corren	appos	2	SENT_488	[p30l1261t1534r1407b1569],
8	I	PRP	O	I	dep	7	SENT_488	[p30l1423t1535r1449b1579],
9	,	,	O	,	_	0	SENT_488	[p30l1423t1535r1449b1579],
10	et	FW	O	et	nn	11	SENT_488	[p30l1467t1539r1504b1569],
11	al.	FW	O	al.	appos	2	SENT_488	[p30l1519t1532r1564b1569],
12	.	.	O	.	_	0	SENT_488	[p30l1519t1532r1564b1569],

1	Arg16Gly	RB	O	arg16gly	dep	2	SENT_489	[p30l1581t1532r1779b1581],
2	polymorphism	NN	O	polymorphism	_	0	SENT_489	[p30l1793t1532r2105b1581],
3	of	IN	O	of	_	0	SENT_489	[p30l747t1587r794b1625],
4	the	DT	O	the	det	6	SENT_489	[p30l801t1587r866b1625],
5	[	NN	O	[	nn	6	SENT_489	[p30l885t1587r1261b1637],
6	beta	NN	O	beta	prep_of	2	SENT_489	[p30l885t1587r1261b1637],
7	]	CD	NUMBER	]	num	10	SENT_489	[p30l885t1587r1261b1637],
8	2-adrenergic	JJ	O	2-adrenergic	amod	10	SENT_489	[p30l885t1587r1261b1637],
9	receptor	NN	O	receptor	nn	10	SENT_489	[p30l1276t1595r1450b1636],
10	gene	NN	O	gene	nsubj	13	SENT_489	[p30l1465t1601r1564b1637],
11	does	VBZ	O	do	aux	13	SENT_489	[p30l1580t1587r1673b1625],
12	not	RB	O	not	neg	13	SENT_489	[p30l1690t1595r1758b1625],
13	modulate	VB	O	modulate	rcmod	6	SENT_489	[p30l1773t1587r1972b1625],
14	cinical	JJ	O	cinical	amod	15	SENT_489	[p30l1988t1587r2124b1625],
15	response	NN	O	response	dobj	13	SENT_489	[p30l747t1657r935b1693],
16	to	TO	O	to	_	0	SENT_489	[p30l950t1651r989b1681],
17	salmeterol	NN	O	salmeterol	prep_to	13	SENT_489	[p30l1006t1644r1226b1681],
18	in	IN	O	in	_	0	SENT_489	[p30l1241t1646r1283b1681],
19	subjects	NNS	O	subject	prep_in	17	SENT_489	[p30l1300t1644r1467b1693],
20	with	IN	O	with	prep	13	SENT_489	[p30l1483t1644r1576b1681],
21	asthma	NN	O	asthma	dep	20	SENT_489	[p30l1592t1644r1756b1681],
22	.	.	O	.	_	0	SENT_489	[p30l1592t1644r1756b1681],
23	]	SYM	O	]	dep	13	SENT_489	[p30l741t1703r766b1749],

1	Allergy	NN	O	allergy	nn	2	SENT_490	[p30l778t1700r917b1749],
2	Clin	NN	O	clin	_	0	SENT_490	[p30l935t1700r1018b1737],
3	Immunol	NNP	O	Immunol	dep	2	SENT_490	[p30l1036t1700r1221b1737],
4	2008	CD	DATE	2008	num	3	SENT_490	[p30l1237t1703r1345b1743],
5	;	:	O	;	_	0	SENT_490	[p30l1237t1703r1345b1743],
6	121	CD	NUMBER	121	num	7	SENT_490	[p30l1364t1703r1429b1736],
7	(	NN	O	(	dep	2	SENT_490	[p30l1448t1703r1482b1749],
8	2	CD	NUMBER	2	num	9	SENT_490	[p30l1448t1703r1482b1749],
9	suppl	NN	O	suppl	dep	7	SENT_490	[p30l1500t1700r1615b1748],
10	1	CD	NUMBER	1	num	11	SENT_490	[p30l1632t1703r1676b1749],
11	)	NN	O	)	dep	7	SENT_490	[p30l1632t1703r1676b1749],
12	:	:	O	:	_	0	SENT_490	[p30l1632t1703r1676b1749],
13	S143	NN	O	s143	dep	7	SENT_490	[p30l1696t1702r1798b1737],
14	.	.	O	.	_	0	SENT_490	[p30l1696t1702r1798b1737],

1	Bleecker	NNP	O	Bleecker	nn	2	SENT_491	[p30l749t1762r927b1799],
2	ER	NN	O	er	_	0	SENT_491	[p30l943t1764r1012b1805],
3	,	,	O	,	_	0	SENT_491	[p30l943t1764r1012b1805],
4	Postma	NNP	PERSON	Postma	nn	5	SENT_491	[p30l1032t1766r1186b1799],
5	DS	NN	O	d	appos	2	SENT_491	[p30l1203t1765r1275b1805],
6	,	,	O	,	_	0	SENT_491	[p30l1203t1765r1275b1805],
7	Lawrance	NNP	PERSON	Lawrance	nn	8	SENT_491	[p30l1295t1766r1493b1799],
8	RM	NN	PERSON	rm	appos	2	SENT_491	[p30l1511t1766r1595b1805],
9	,	,	O	,	_	0	SENT_491	[p30l1511t1766r1595b1805],
10	Meyers	NNP	ORGANIZATION	Meyers	nn	11	SENT_491	[p30l1614t1766r1763b1811],
11	DA	NNP	ORGANIZATION	DA	appos	2	SENT_491	[p30l1782t1765r1859b1805],
12	,	,	O	,	_	0	SENT_491	[p30l1782t1765r1859b1805],
13	Ambrose	NNP	PERSON	Ambrose	nn	15	SENT_491	[p30l1876t1762r2068b1799],
14	H	NNP	O	H	nn	15	SENT_491	[p30l2086t1766r2153b1810],
15	]	NN	O	]	appos	2	SENT_491	[p30l2086t1766r2153b1810],
16	,	,	O	,	_	0	SENT_491	[p30l2086t1766r2153b1810],
17	Goldman	NNP	ORGANIZATION	Goldman	nn	19	SENT_491	[p30l748t1819r944b1856],
18	M.	NNP	ORGANIZATION	M.	nn	19	SENT_491	[p30l960t1822r1013b1856],
19	Effect	NN	ORGANIZATION	effect	appos	2	SENT_491	[p30l1032t1819r1151b1856],
20	of	IN	ORGANIZATION	of	_	0	SENT_491	[p30l1166t1819r1212b1856],
21	ADRB2	NN	ORGANIZATION	adrb2	nn	22	SENT_491	[p30l1219t1821r1381b1856],
22	polymorphisms	NNS	O	polymorphism	prep_of	19	SENT_491	[p30l1394t1819r1726b1868],
23	on	IN	O	on	_	0	SENT_491	[p30l1744t1832r1796b1856],
24	response	NN	O	response	prep_on	2	SENT_491	[p30l1811t1832r1999b1867],
25	to	TO	O	to	_	0	SENT_491	[p30l2015t1826r2053b1856],
26	longacting	VBG	O	longact	prepc_to	2	SENT_491	[p30l746t1874r969b1924],
27	[	CD	NUMBER	[	num	29	SENT_491	[p30l987t1874r1192b1924],
28	3,-agonist	JJ	O	3,-agonist	amod	29	SENT_491	[p30l987t1874r1192b1924],
29	therapy	NN	O	therapy	dobj	26	SENT_491	[p30l1206t1874r1374b1923],
30	:	:	O	:	_	0	SENT_491	[p30l1206t1874r1374b1923],
31	a	DT	O	a	det	33	SENT_491	[p30l1392t1888r1413b1912],
32	pharmacogenetic	JJ	O	pharmacogenetic	amod	33	SENT_491	[p30l1428t1874r1793b1924],
33	analysis	NN	O	analysis	dep	2	SENT_491	[p30l1808t1874r1973b1924],
34	of	IN	O	of	_	0	SENT_491	[p30l1991t1874r2037b1912],
35	two	CD	NUMBER	two	num	37	SENT_491	[p30l2045t1882r2119b1912],
36	randomised	JJ	O	randomised	amod	37	SENT_491	[p30l747t1929r1000b1966],
37	studies	NNS	O	study	prep_of	33	SENT_491	[p30l1016t1929r1175b1966],
38	.	.	O	.	_	0	SENT_491	[p30l1016t1929r1175b1966],

1	Lancet	NNP	O	Lancet	_	0	SENT_492	[p30l1195t1933r1324b1966],
2	2007	CD	DATE	2007	num	1	SENT_492	[p30l1340t1931r1445b1972],
3	;	:	O	;	_	0	SENT_492	[p30l1340t1931r1445b1972],
4	370	CD	NUMBER	370	num	6	SENT_492	[p30l1463t1931r1547b1967],
5	:	:	O	:	_	0	SENT_492	[p30l1463t1931r1547b1967],
6	2118-25	CD	NUMBER	2118-25	dep	1	SENT_492	[p30l1566t1931r1741b1966],
7	.	.	O	.	_	0	SENT_492	[p30l1566t1931r1741b1966],

1	Lipworth	NNP	PERSON	Lipworth	nn	2	SENT_493	[p30l151t2322r409b2391],
2	B	NNP	PERSON	B	_	0	SENT_493	[p30l431t2327r485b2384],
3	,	,	O	,	_	0	SENT_493	[p30l431t2327r485b2384],
4	Tan	NNP	LOCATION	Tan	nn	5	SENT_493	[p30l505t2325r611b2375],
5	S	NNP	LOCATION	S	appos	2	SENT_493	[p30l634t2326r680b2383],
6	,	,	O	,	_	0	SENT_493	[p30l634t2326r680b2383],
7	Devlin	NNP	PERSON	Devlin	nn	13	SENT_493	[p30l705t2322r892b2375],
8	M	NNP	O	M	nn	13	SENT_493	[p30l912t2327r986b2383],
9	,	,	O	,	_	0	SENT_493	[p30l912t2327r986b2383],
10	Aiken	NNP	PERSON	Aiken	appos	13	SENT_493	[p30l1006t2322r1179b2375],
11	"	``	O	"	punct	13	SENT_493	[p30l1196t2325r1243b2383],
12	E	NNP	O	E	nn	13	SENT_493	[p30l1196t2325r1243b2383],
13	Baker	NNP	PERSON	Baker	appos	2	SENT_493	[p30l1268t2322r1433b2375],
14	R	NN	PERSON	r	dep	13	SENT_493	[p30l1453t2327r1508b2383],
15	,	,	O	,	_	0	SENT_493	[p30l1453t2327r1508b2383],
16	Hendrick	NNP	LOCATION	Hendrick	nn	18	SENT_493	[p30l1532t2322r1805b2375],
17	D.	NNP	O	D.	nn	18	SENT_493	[p30l1825t2327r1886b2375],
18	Effects	NNS	O	effect	appos	2	SENT_493	[p30l1910t2322r2098b2375],
19	of	IN	O	of	_	0	SENT_493	[p30l149t2402r214b2456],
20	treatment	NN	O	treatment	prep_of	18	SENT_493	[p30l221t2413r505b2456],
21	with	IN	O	with	_	0	SENT_493	[p30l521t2402r650b2457],
22	formoterol	NN	O	formoterol	prep_with	20	SENT_493	[p30l668t2402r977b2456],
23	on	IN	O	on	_	0	SENT_493	[p30l996t2422r1069b2456],
24	bronchoprotection	NN	O	bronchoprotection	prep_on	22	SENT_493	[p30l1086t2402r1622b2473],
25	against	IN	O	against	_	0	SENT_493	[p30l1641t2406r1847b2474],
26	methacholine	NN	O	methacholine	prep_against	24	SENT_493	[p30l148t2483r559b2536],
27	.	.	O	.	_	0	SENT_493	[p30l148t2483r559b2536],

1	Am	VBP	O	be	cop	2	SENT_494	[p30l579t2487r727b2553],
2	]	CD	NUMBER	]	_	0	SENT_494	[p30l579t2487r727b2553],
3	Med	JJ	O	med	amod	2	SENT_494	[p30l745t2483r864b2536],
4	1998	CD	DATE	1998	tmod	3	SENT_494	[p30l883t2488r1024b2544],
5	;	:	O	;	_	0	SENT_494	[p30l883t2488r1024b2544],
6	104	CD	NUMBER	104	num	8	SENT_494	[p30l1047t2488r1157b2536],
7	:	:	O	:	_	0	SENT_494	[p30l1047t2488r1157b2536],
8	431-38	CD	NUMBER	431-38	dep	2	SENT_494	[p30l1177t2488r1387b2536],
9	.	.	O	.	_	0	SENT_494	[p30l1177t2488r1387b2536],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_495	[p30l151t2579r246b2627],
2	DK	NNP	O	DK	_	0	SENT_495	[p30l268t2579r375b2635],
3	,	,	O	,	_	0	SENT_495	[p30l268t2579r375b2635],
4	Currie	NNP	PERSON	Currie	nn	5	SENT_495	[p30l398t2577r583b2627],
5	GP	NNP	O	GP	appos	2	SENT_495	[p30l604t2577r708b2635],
6	,	,	O	,	_	0	SENT_495	[p30l604t2577r708b2635],
7	Hall	NNP	O	Hall	nn	8	SENT_495	[p30l732t2574r852b2627],
8	IP	NNP	O	IP	appos	2	SENT_495	[p30l874t2579r950b2635],
9	,	,	O	,	_	0	SENT_495	[p30l874t2579r950b2635],
10	Lima	NNP	LOCATION	Lima	appos	2	SENT_495	[p30l975t2577r1119b2627],
11	I	PRP	O	I	nsubj	12	SENT_495	[p30l1139t2579r1200b2642],
12	]	VBP	O	]	rcmod	10	SENT_495	[p30l1139t2579r1200b2642],
13	,	,	O	,	_	0	SENT_495	[p30l1139t2579r1200b2642],
14	Lipworth	NNP	PERSON	Lipworth	nn	16	SENT_495	[p30l1224t2574r1482b2643],
15	B	NNP	O	B	nn	16	SENT_495	[p30l1504t2579r1582b2642],
16	]	NN	O	]	appos	10	SENT_495	[p30l1504t2579r1582b2642],
17	.	.	O	.	_	0	SENT_495	[p30l1504t2579r1582b2642],

1	The	DT	O	the	det	4	SENT_496	[p30l1603t2574r1715b2627],
2	arginine-16	JJ	O	arginine-16	amod	4	SENT_496	[p30l1735t2577r2055b2644],
3	beta2-adrenoceptor	NN	O	beta2-adrenoceptor	nn	4	SENT_496	[p30l147t2653r702b2723],
4	polymorphism	NN	O	polymorphism	nsubj	5	SENT_496	[p30l719t2653r1148b2723],
5	predisposes	VBZ	O	predispose	_	0	SENT_496	[p30l1166t2653r1505b2723],
6	to	TO	O	to	_	0	SENT_496	[p30l1525t2664r1578b2706],
7	bronchoprotective	JJ	O	bronchoprotective	amod	8	SENT_496	[p30l1596t2653r2119b2723],
8	subsensitivity	NN	O	subsensitivity	prep_to	5	SENT_496	[p30l150t2734r542b2804],
9	in	IN	O	in	_	0	SENT_496	[p30l559t2737r617b2786],
10	patients	NNS	O	patient	prep_in	8	SENT_496	[p30l635t2737r862b2803],
11	treated	VBN	O	treat	partmod	10	SENT_496	[p30l882t2734r1080b2787],
12	with	IN	O	with	_	0	SENT_496	[p30l1096t2734r1225b2787],
13	formoterol	NN	O	formoterol	prep_with	11	SENT_496	[p30l1243t2734r1552b2787],
14	and	CC	O	and	_	0	SENT_496	[p30l1571t2734r1678b2787],
15	salmeterol	NN	O	salmeterol	conj_and	13	SENT_496	[p30l1698t2734r2011b2787],
16	.	.	O	.	_	0	SENT_496	[p30l1698t2734r2011b2787],

1	Br	NN	O	br	nn	4	SENT_497	[p30l153t2819r261b2884],
2	]	CD	NUMBER	]	num	4	SENT_497	[p30l153t2819r261b2884],
3	Clin	NNP	O	Clin	nn	4	SENT_497	[p30l282t2814r395b2867],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_497	[p30l417t2814r712b2867],
5	2004	CD	DATE	2004	dep	4	SENT_497	[p30l731t2819r876b2875],
6	;	:	O	;	_	0	SENT_497	[p30l731t2819r876b2875],
7	57	CD	NUMBER	57	num	9	SENT_497	[p30l900t2816r979b2867],
8	:	:	O	:	_	0	SENT_497	[p30l900t2816r979b2867],
9	68-75	CD	NUMBER	68-75	dep	4	SENT_497	[p30l1002t2817r1180b2869],
10	.	.	O	.	_	0	SENT_497	[p30l1002t2817r1180b2869],

1	Giembycz	NNP	PERSON	Giembycz	nn	2	SENT_498	[p30l150t2905r437b2975],
2	MA	NNP	PERSON	MA	_	0	SENT_498	[p30l459t2909r578b2966],
3	,	,	O	,	_	0	SENT_498	[p30l459t2909r578b2966],
4	Kaur	NNP	O	Kaur	nn	5	SENT_498	[p30l603t2910r742b2958],
5	M	NNP	O	M	appos	2	SENT_498	[p30l761t2911r835b2967],
6	,	,	O	,	_	0	SENT_498	[p30l761t2911r835b2967],
7	Leigh	NNP	PERSON	Leigh	nn	8	SENT_498	[p30l859t2905r1017b2975],
8	R	NNP	PERSON	R	appos	5	SENT_498	[p30l1038t2910r1093b2967],
9	,	,	O	,	_	0	SENT_498	[p30l1038t2910r1093b2967],
10	Newton	NNP	ORGANIZATION	Newton	nn	14	SENT_498	[p30l1116t2911r1339b2958],
11	R.	NNP	ORGANIZATION	R.	nn	14	SENT_498	[p30l1361t2911r1415b2958],
12	A	NNP	ORGANIZATION	A	nn	14	SENT_498	[p30l1436t2909r1483b2957],
13	holy	JJ	O	holy	amod	14	SENT_498	[p30l1500t2905r1623b2975],
14	grail	NN	O	grail	appos	5	SENT_498	[p30l1641t2905r1769b2975],
15	of	IN	O	of	_	0	SENT_498	[p30l1788t2905r1853b2958],
16	asthma	NN	O	asthma	nn	17	SENT_498	[p30l1862t2905r2073b2958],
17	management	NN	O	management	prep_of	14	SENT_498	[p30l148t2995r546b3055],
18	:	:	O	:	_	0	SENT_498	[p30l148t2995r546b3055],
19	toward	IN	O	toward	_	0	SENT_498	[p30l567t2985r766b3038],
20	understanding	VBG	O	understand	prepc_toward	5	SENT_498	[p30l783t2985r1209b3055],
21	how	WRB	O	how	advmod	29	SENT_498	[p30l1227t2985r1351b3038],
22	long-acting	JJ	O	long-acting	amod	24	SENT_498	[p30l1367t2985r1690b3055],
23	beta	NN	O	beta	nn	24	SENT_498	[p30l1707t2985r1921b3055, p30l149t3065r529b3136],
24	(	NN	O	(	nsubj	29	SENT_498	[p30l1707t2985r1921b3055, p30l149t3065r529b3136],
25	2	CD	NUMBER	2	num	28	SENT_498	[p30l1707t2985r1921b3055, p30l149t3065r529b3136],
26	)	NN	O	)	nn	28	SENT_498	[p30l1707t2985r1921b3055, p30l149t3065r529b3136],
27	adrenoceptor	NN	O	adrenoceptor	nn	28	SENT_498	[p30l1707t2985r1921b3055, p30l149t3065r529b3136],
28	agonists	NNS	O	agonist	dep	24	SENT_498	[p30l547t3069r782b3137],
29	enhance	VBP	O	enhance	ccomp	20	SENT_498	[p30l803t3065r1045b3119],
30	the	DT	O	the	det	32	SENT_498	[p30l1063t3065r1153b3119],
31	clinical	JJ	O	clinical	amod	32	SENT_498	[p30l1173t3065r1377b3119],
32	efficacy	NN	O	efficacy	dobj	29	SENT_498	[p30l1396t3065r1610b3136],
33	of	IN	O	of	_	0	SENT_498	[p30l1628t3065r1693b3119],
34	inhaled	VBN	O	inhale	prepc_of	32	SENT_498	[p30l1701t3065r1918b3119],
35	corticosteroids	NNS	O	corticosteroid	dobj	34	SENT_498	[p30l149t3146r582b3199],
36	.	.	O	.	_	0	SENT_498	[p30l149t3146r582b3199],

1	Br	NN	O	br	_	0	SENT_499	[p30l608t3152r717b3216],
2	]	CD	NUMBER	]	num	1	SENT_499	[p30l608t3152r717b3216],
3	Pharmacol	NNP	O	Pharmacol	dep	1	SENT_499	[p30l736t3146r1031b3199],
4	2008	CD	DATE	2008	num	3	SENT_499	[p30l1050t3151r1199b3207],
5	;	:	O	;	_	0	SENT_499	[p30l1050t3151r1199b3207],
6	153	CD	NUMBER	153	num	8	SENT_499	[p30l1222t3148r1332b3199],
7	:	:	O	:	_	0	SENT_499	[p30l1222t3148r1332b3199],
8	1090-104	CD	NUMBER	1090-104	dep	1	SENT_499	[p30l1355t3151r1624b3199],
9	.	.	O	.	_	0	SENT_499	[p30l1355t3151r1624b3199],

1	Cockcroft	NNP	PERSON	Cockcroft	nn	2	SENT_500	[p30l150t3238r426b3292],
2	DW	NNP	O	DW	_	0	SENT_500	[p30l447t3243r567b3300],
3	,	,	O	,	_	0	SENT_500	[p30l447t3243r567b3300],
4	Swystun	NNP	ORGANIZATION	Swystun	nn	5	SENT_500	[p30l593t3242r837b3309],
5	VA	NNP	ORGANIZATION	VA	appos	2	SENT_500	[p30l855t3242r958b3300],
6	,	,	O	,	_	0	SENT_500	[p30l855t3242r958b3300],
7	Bhagat	NNP	PERSON	Bhagat	nn	9	SENT_500	[p30l983t3238r1181b3309],
8	R.	NNP	PERSON	R.	nn	9	SENT_500	[p30l1203t3243r1257b3292],
9	Interaction	NN	PERSON	interaction	appos	2	SENT_500	[p30l1283t3242r1600b3292],
10	of	IN	O	of	_	0	SENT_500	[p30l1620t3238r1685b3292],
11	inhaled	VBN	O	inhale	prepc_of	9	SENT_500	[p30l1694t3238r1912b3292],
12	beta	NN	O	beta	nn	14	SENT_500	[p30l1929t3238r2050b3292],
13	2	CD	NUMBER	2	num	14	SENT_500	[p30l2071t3243r2100b3291],
14	agonist	NN	O	agonist	dobj	11	SENT_500	[p30l149t3322r360b3389],
15	and	CC	O	and	_	0	SENT_500	[p30l379t3318r486b3372],
16	inhaled	VBN	O	inhale	conj_and	11	SENT_500	[p30l504t3318r723b3372],
17	corticosteroid	NN	O	corticosteroid	dobj	16	SENT_500	[p30l742t3318r1136b3372],
18	on	IN	O	on	_	0	SENT_500	[p30l1155t3337r1228b3372],
19	airway	NN	O	airway	nn	20	SENT_500	[p30l1248t3322r1436b3389],
20	responsiveness	NN	O	responsiveness	prep_on	17	SENT_500	[p30l1454t3322r1894b3389],
21	to	TO	O	to	_	0	SENT_500	[p30l1914t3329r1968b3372],
22	allergen	NN	O	allergen	prep_to	16	SENT_500	[p30l149t3399r381b3469],
23	and	CC	O	and	_	0	SENT_500	[p30l401t3399r509b3452],
24	methacholine	NN	O	methacholine	prep_to	16	SENT_500	[p30l527t3399r940b3452],
25	.	.	O	.	_	0	SENT_500	[p30l527t3399r940b3452],

1	Am	VBP	O	be	cop	2	SENT_501	[p30l962t3403r1111b3469],
2	]	CD	NUMBER	]	dep	6	SENT_501	[p30l962t3403r1111b3469],
3	Respir	NNP	O	Respir	nn	5	SENT_501	[p30l1131t3401r1302b3468],
4	Crit	NNP	O	Crit	nn	5	SENT_501	[p30l1322t3401r1424b3452],
5	Care	NNP	O	Care	nsubj	6	SENT_501	[p30l1447t3403r1571b3452],
6	Med	VBD	O	med	_	0	SENT_501	[p30l1591t3399r1711b3452],
7	1995	CD	DATE	1995	dobj	6	SENT_501	[p30l1730t3402r1873b3460],
8	;	:	O	;	_	0	SENT_501	[p30l1730t3402r1873b3460],
9	152	CD	NUMBER	152	num	11	SENT_501	[p30l150t3481r260b3532],
10	:	:	O	:	_	0	SENT_501	[p30l150t3481r260b3532],
11	1485-89	CD	NUMBER	1485-89	dep	7	SENT_501	[p30l284t3481r527b3532],
12	.	.	O	.	_	0	SENT_501	[p30l284t3481r527b3532],

1	Shore	NNP	O	Shore	nn	2	SENT_502	[p30l153t3570r317b3623],
2	SA	NNP	O	SA	_	0	SENT_502	[p30l341t3574r434b3631],
3	,	,	O	,	_	0	SENT_502	[p30l341t3574r434b3631],
4	Drazen	NNP	PERSON	Drazen	nn	5	SENT_502	[p30l459t3576r668b3623],
5	IM	NNP	PERSON	IM	appos	2	SENT_502	[p30l687t3576r786b3638],
6	.	.	O	.	_	0	SENT_502	[p30l687t3576r786b3638],

1	Beta-agonists	NNS	O	beta-agonist	_	0	SENT_503	[p30l811t3574r1190b3640],
2	and	CC	O	and	_	0	SENT_503	[p30l1211t3570r1318b3623],
3	asthma	NN	O	asthma	conj_and	1	SENT_503	[p30l1337t3570r1561b3623],
4	:	:	O	:	_	0	SENT_503	[p30l1337t3570r1561b3623],
5	too	RB	O	too	advmod	6	SENT_503	[p30l1582t3581r1671b3623],
6	much	JJ	O	much	dep	1	SENT_503	[p30l1690t3570r1859b3623],
7	of	IN	O	of	prep	6	SENT_503	[p30l1878t3570r1943b3623],
8	a	DT	O	a	det	10	SENT_503	[p30l1952t3589r1982b3623],
9	good	JJ	O	good	amod	10	SENT_503	[p30l2001t3570r2141b3640],
10	thing	NN	O	thing	dep	7	SENT_503	[p30l147t3650r327b3720],
11	?	.	O	?	_	0	SENT_503	[p30l147t3650r327b3720],
12	]	SYM	O	]	dep	1	SENT_503	[p30l340t3655r375b3720],

1	Clin	NNP	O	Clin	nn	2	SENT_504	[p30l396t3650r509b3703],
2	Invest	NNP	O	Invest	_	0	SENT_504	[p30l531t3655r688b3702],
3	2003	CD	DATE	2003	num	2	SENT_504	[p30l707t3655r855b3711],
4	;	:	O	;	_	0	SENT_504	[p30l707t3655r855b3711],
5	112	CD	NUMBER	112	num	7	SENT_504	[p30l878t3655r983b3703],
6	:	:	O	:	_	0	SENT_504	[p30l878t3655r983b3703],
7	495-97	CD	NUMBER	495-97	dep	2	SENT_504	[p30l1003t3653r1203b3705],

1	FDA	NNP	ORGANIZATION	FDA	_	0	SENT_505	[p31l151t21r301b71],
2	.	.	O	.	_	0	SENT_505	[p31l151t21r301b71],

1	Long	JJ	O	long	amod	4	SENT_506	[p31l329t21r677b88],
2	—	NN	O	—	nn	4	SENT_506	[p31l329t21r677b88],
3	acting	NN	O	acting	nn	4	SENT_506	[p31l329t21r677b88],
4	beta	NN	O	beta	_	0	SENT_506	[p31l697t17r1086b88],
5	—	CD	NUMBER	—	num	6	SENT_506	[p31l697t17r1086b88],
6	agonists	NNS	O	agonist	dep	4	SENT_506	[p31l697t17r1086b88],
7	and	CC	O	and	_	0	SENT_506	[p31l1109t17r1219b71],
8	adverse	JJ	O	adverse	amod	11	SENT_506	[p31l1239t17r1460b71],
9	asthma	NN	O	asthma	nn	11	SENT_506	[p31l1483t17r1700b71],
10	events	NNS	O	event	nn	11	SENT_506	[p31l1721t28r1906b71],
11	meta-analysis	NN	O	meta-analysis	conj_and	6	SENT_506	[p31l148t98r568b168],
12	.	.	O	.	_	0	SENT_506	[p31l148t98r568b168],

1	Statistical	JJ	O	statistical	amod	3	SENT_507	[p31l597t98r880b151],
2	brieﬁng	NN	O	brieﬁng	nn	3	SENT_507	[p31l900t98r1135b168],
3	package	NN	O	package	_	0	SENT_507	[p31l1155t98r1392b168],
4	for	IN	O	for	_	0	SENT_507	[p31l1414t98r1498b151],
5	Ioint	NNP	O	Ioint	prep_for	3	SENT_507	[p31l1520t101r1660b166],
6	Meeting	VBG	O	meet	partmod	5	SENT_507	[p31l1681t101r1925b168],
7	of	IN	O	of	_	0	SENT_507	[p31l1946t98r2012b151],
8	the	DT	O	the	det	12	SENT_507	[p31l2022t98r2114b151],
9	Pulmonary-Allergy	NNP	ORGANIZATION	Pulmonary-Allergy	nn	12	SENT_507	[p31l151t178r713b250],
10	Drugs	NNPS	ORGANIZATION	Drugs	nn	12	SENT_507	[p31l736t184r915b250],
11	Advisory	NNP	ORGANIZATION	Advisory	nn	12	SENT_507	[p31l937t178r1198b249],
12	Committee	NNP	ORGANIZATION	Committee	prep_of	6	SENT_507	[p31l1219t182r1566b240],
13	,	,	O	,	_	0	SENT_507	[p31l1219t182r1566b240],
14	Drug	NNP	O	Drug	nn	15	SENT_507	[p31l1593t184r1744b250],
15	Safety	NNP	O	Safety	conj_and	5	SENT_507	[p31l1769t178r1943b249],
16	and	CC	O	and	_	0	SENT_507	[p31l1963t178r2073b232],
17	Risk	NNP	ORGANIZATION	Risk	nn	20	SENT_507	[p31l151t259r280b313],
18	Management	NNP	ORGANIZATION	Management	nn	20	SENT_507	[p31l302t265r695b330],
19	Advisory	NNP	ORGANIZATION	Advisory	nn	20	SENT_507	[p31l714t259r975b330],
20	Committee	NNP	ORGANIZATION	Committee	conj_and	5	SENT_507	[p31l996t263r1343b321],
21	,	,	O	,	_	0	SENT_507	[p31l996t263r1343b321],
22	and	CC	O	and	_	0	SENT_507	[p31l1368t259r1477b313],
23	Pediatric	NNP	ORGANIZATION	Pediatric	nn	25	SENT_507	[p31l1500t259r1758b313],
24	Advisory	NNP	ORGANIZATION	Advisory	nn	25	SENT_507	[p31l1778t259r2039b330],
25	Committee	NNP	ORGANIZATION	Committee	prep_for	3	SENT_507	[p31l150t343r497b393],
26	.	.	O	.	_	0	SENT_507	[p31l150t343r497b393],

1	Nov	NNP	DATE	Nov	_	0	SENT_508	[p31l523t345r638b393],
2	12	CD	DATE	12	num	1	SENT_508	[p31l660t345r735b401],
3	,	,	DATE	,	_	0	SENT_508	[p31l660t345r735b401],
4	2008	CD	DATE	2008	dep	1	SENT_508	[p31l760t345r913b393],
5	.	.	O	.	_	0	SENT_508	[p31l760t345r913b393],

1	http://wvvw.fda.gov/ohrms/doc1	NN	O	http://wvvw.fda.gov/ohrms/doc1	_	0	SENT_509	[p31l936t340r2020b410],
2	<	JJR	O	<	amod	3	SENT_509	[p31l936t340r2020b410],
3	ets	NN	O	et	dep	1	SENT_509	[p31l936t340r2020b410],
4	/	:	O	/	punct	6	SENT_509	[p31l936t340r2020b410],
5	ac/08/brie	NN	O	ac/08/brie	nn	6	SENT_509	[p31l149t420r1347b492],
6	ﬁng	NN	O	ﬁng	dep	3	SENT_509	[p31l149t420r1347b492],
7	/	:	O	/	punct	6	SENT_509	[p31l149t420r1347b492],
8	2008-4398b1-01-FDA	NN	O	2008-4398b1-01-fda	dep	3	SENT_509	[p31l149t420r1347b492],
9	.	.	O	.	_	0	SENT_509	[p31l149t420r1347b492],

1	pdf	NN	O	pdf	nn	2	SENT_510	[p31l149t420r1347b492],
2	(	NN	O	(	nsubj	3	SENT_510	[p31l1362t420r1637b492],
3	accessed	VBD	O	access	_	0	SENT_510	[p31l1362t420r1637b492],
4	Sept	NNP	DATE	Sept	dobj	3	SENT_510	[p31l1661t425r1786b491],
5	2	CD	DATE	2	num	4	SENT_510	[p31l1808t426r1854b482],
6	,	,	DATE	,	_	0	SENT_510	[p31l1808t426r1854b482],
7	2009	CD	DATE	2009	num	4	SENT_510	[p31l1879t425r2055b492],
8	)	NN	O	)	dep	4	SENT_510	[p31l1879t425r2055b492],
9	.	.	O	.	_	0	SENT_510	[p31l1879t425r2055b492],

1	Bailey	NNP	PERSON	Bailey	nn	2	SENT_511	[p31l151t512r323b582],
2	W	NNP	O	W	_	0	SENT_511	[p31l339t517r411b574],
3	,	,	O	,	_	0	SENT_511	[p31l339t517r411b574],
4	Castro	NNP	PERSON	Castro	nn	5	SENT_511	[p31l434t516r616b565],
5	M	NNP	O	M	appos	2	SENT_511	[p31l637t517r711b574],
6	,	,	O	,	_	0	SENT_511	[p31l637t517r711b574],
7	Matz	NNP	PERSON	Matz	appos	2	SENT_511	[p31l734t518r875b565],
8	I	PRP	O	I	dep	7	SENT_511	[p31l896t517r932b581],
9	,	,	O	,	_	0	SENT_511	[p31l896t517r932b581],
10	et	FW	O	et	nn	11	SENT_511	[p31l954t523r1005b565],
11	a1	FW	O	a1	appos	2	SENT_511	[p31l1023t512r1084b565],
12	.	.	O	.	_	0	SENT_511	[p31l1023t512r1084b565],

1	Asthma	NN	O	asthma	nn	2	SENT_512	[p31l1104t512r1333b565],
2	exacerbations	NNS	O	exacerbation	nsubj	6	SENT_512	[p31l1352t512r1740b565],
3	in	IN	O	in	_	0	SENT_512	[p31l1760t515r1819b564],
4	African	JJ	MISC	african	amod	5	SENT_512	[p31l1836t512r2051b565],
5	Americans	NNPS	MISC	Americans	prep_in	2	SENT_512	[p31l147t595r460b645],
6	treated	VBN	O	treat	_	0	SENT_512	[p31l480t592r679b645],
7	for	IN	O	for	_	0	SENT_512	[p31l696t592r779b645],
8	1	CD	DURATION	1	num	9	SENT_512	[p31l798t597r823b644],
9	year	NN	NUMBER	year	prep_for	6	SENT_512	[p31l839t611r960b661],
10	with	IN	O	with	_	0	SENT_512	[p31l976t592r1104b645],
11	combination	NN	O	combination	nn	13	SENT_512	[p31l1123t592r1490b645],
12	ﬂuticasone	NN	O	ﬂuticasone	nn	13	SENT_512	[p31l1508t592r1823b645],
13	propionate	NN	O	propionate	prep_with	9	SENT_512	[p31l1841t596r2153b661],
14	and	CC	O	and	_	0	SENT_512	[p31l149t671r256b725],
15	salmeterol	NN	O	salmeterol	nn	18	SENT_512	[p31l276t671r576b725],
16	or	CC	O	or	_	0	SENT_512	[p31l595t690r654b725],
17	ﬂuticasone	NN	O	ﬂuticasone	nn	18	SENT_512	[p31l671t671r986b725],
18	propionate	NN	O	propionate	conj_and	13	SENT_512	[p31l1005t675r1316b741],
19	alone	RB	O	alone	advmod	6	SENT_512	[p31l1336t671r1504b725],
20	.	.	O	.	_	0	SENT_512	[p31l1336t671r1504b725],

1	Curr	NNP	PERSON	Curr	nn	4	SENT_513	[p31l1532t676r1662b725],
2	Med	NNP	PERSON	Med	nn	4	SENT_513	[p31l1678t671r1797b724],
3	Res	NNP	PERSON	Res	nn	4	SENT_513	[p31l1818t677r1908b724],
4	Opin	NNP	PERSON	Opin	_	0	SENT_513	[p31l1930t673r2067b741],
5	2008	CD	DATE	2008	num	4	SENT_513	[p31l150t757r299b814],
6	;	:	O	;	_	0	SENT_513	[p31l150t757r299b814],
7	24	CD	NUMBER	24	num	9	SENT_513	[p31l322t757r402b806],
8	:	:	O	:	_	0	SENT_513	[p31l322t757r402b806],
9	1669-82	CD	NUMBER	1669-82	dep	4	SENT_513	[p31l425t757r671b806],
10	.	.	O	.	_	0	SENT_513	[p31l425t757r671b806],

1	www	NN	O	www	_	0	SENT_514	[p31l731t996r1272b1048],
2	.	.	O	.	_	0	SENT_514	[p31l731t996r1272b1048],

1	the	DT	O	the	det	2	SENT_515	[p31l731t996r1272b1048],
2	|	NN	O	|	_	0	SENT_515	[p31l731t996r1272b1048],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_515	[p31l731t996r1272b1048],
4	Vol	NNP	O	Vol	dep	2	SENT_515	[p31l1316t996r1403b1048],
5	374	CD	NUMBER	374	num	6	SENT_515	[p31l1424t1003r1527b1056],
6	November21	NN	O	november21	dep	4	SENT_515	[p31l1576t996r2138b1057],
7	,2009	CD	NUMBER	,2009	dep	2	SENT_515	[p31l1576t996r2138b1057],

